nct_id,intervention_name,intervention_type,condition,phase,overall_status,sponsor,smiles
NCT04427072,Capmatinib,DRUG,"Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,Novartis Pharmaceuticals,
NCT04427072,Docetaxel,DRUG,"Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,Novartis Pharmaceuticals,
NCT04515472,Botnia Clamp,DRUG,Transgender Persons,early_phase1,TERMINATED,The University of Texas Health Science Center at San Antonio,
NCT04515472,Withdrawal of Gender Affirming Hormone Therapy (GAHT),OTHER,Transgender Persons,early_phase1,TERMINATED,The University of Texas Health Science Center at San Antonio,
NCT00316212,INS50589 Intravenous Infusion,DRUG,Coronary Disease,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01511081,SBRT (stereotactic body radiotherapy),RADIATION,Non-small-cell Lung Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01511081,SBPT (stereotactic body proton therapy),RADIATION,Non-small-cell Lung Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01882465,etafilcon A,DEVICE,Refractive Error,na,TERMINATED,"Johnson & Johnson Vision Care, Inc.",
NCT01882465,"2-HEMA, EGDMA Non-ionic",DEVICE,Refractive Error,na,TERMINATED,"Johnson & Johnson Vision Care, Inc.",
NCT01882465,hefilcon A,DEVICE,Refractive Error,na,TERMINATED,"Johnson & Johnson Vision Care, Inc.",
NCT03598907,Fresh frozen plasma,OTHER,Lung Transplantation,na,TERMINATED,"University Hospital, Motol",
NCT03542071,Carbohydrate restricted diet,OTHER,"Diabetes, Gestational; Dietary Modification; Tissue Glucose; Body Composition; Birth Weight",na,TERMINATED,Helsinki University Central Hospital,
NCT03542071,Plant-protein based diet,OTHER,"Diabetes, Gestational; Dietary Modification; Tissue Glucose; Body Composition; Birth Weight",na,TERMINATED,Helsinki University Central Hospital,
NCT01341444,Prevena Incision Management System,DEVICE,Surgical Site Reaction,na,TERMINATED,"KCI USA, Inc",
NCT01341444,Standard of Care for Surgical Incisions,OTHER,Surgical Site Reaction,na,TERMINATED,"KCI USA, Inc",
NCT00811434,Lactulose,DRUG,Minimal Hepatic Encephalopathy,phase2,TERMINATED,Indiana University,
NCT00811434,placebo,DRUG,Minimal Hepatic Encephalopathy,phase2,TERMINATED,Indiana University,
NCT03053934,Online video-based counselling,BEHAVIORAL,Videoconferencing,na,TERMINATED,Swinburne University of Technology,
NCT03053934,Traditional in-person counselling,BEHAVIORAL,Videoconferencing,na,TERMINATED,Swinburne University of Technology,
NCT03970109,ANS-6637,DRUG,Alcohol Use Disorder,phase2,TERMINATED,National Institute on Alcohol Abuse and Alcoholism (NIAAA),
NCT03970109,Placebo oral tablet,DRUG,Alcohol Use Disorder,phase2,TERMINATED,National Institute on Alcohol Abuse and Alcoholism (NIAAA),
NCT04975399,CC-92328,DRUG,Multiple Myeloma,phase1,TERMINATED,Celgene,
NCT03199963,4-OH tamoxifen,DRUG,Mammographic Breast Density,phase3,TERMINATED,"BHR Pharma, LLC",
NCT03199963,Placebo,DRUG,Mammographic Breast Density,phase3,TERMINATED,"BHR Pharma, LLC",
NCT00997087,Flumazenil,DRUG,Obsessive Compulsive Disorder,phase2,TERMINATED,Parkway Medical Center,
NCT02176187,Berodual® Respimat® inhaler,DRUG,"Pulmonary Disease, Chronic Obstructive",phase3,TERMINATED,Boehringer Ingelheim,
NCT02176187,Berodual® metered dose inhaler,DRUG,"Pulmonary Disease, Chronic Obstructive",phase3,TERMINATED,Boehringer Ingelheim,
NCT05813314,BMN 111 administration via Injector Pen,OTHER,Achondroplasia,phase1,TERMINATED,BioMarin Pharmaceutical,
NCT05813314,BMN 111 administration via vial and syringe,DRUG,Achondroplasia,phase1,TERMINATED,BioMarin Pharmaceutical,
NCT02246114,piCO+ Smokerlyzer® monitor,DEVICE,Pregnancy; Smoking; Smoking Cessation,na,TERMINATED,Milton S. Hershey Medical Center,
NCT02246114,Text messages,OTHER,Pregnancy; Smoking; Smoking Cessation,na,TERMINATED,Milton S. Hershey Medical Center,
NCT03817606,Tritanium Posterior Lumbar Cage,DEVICE,Degenerative Disc Disease; Degenerative Scoliosis,na,TERMINATED,Riverside Medical Center,
NCT03817606,AVS UniLIF PEEK Posterior Lumbar Cage,DEVICE,Degenerative Disc Disease; Degenerative Scoliosis,na,TERMINATED,Riverside Medical Center,
NCT00321204,TZD reducing the incidence of atrial arrhythmias,PROCEDURE,Atrial Fibrillation,na,TERMINATED,Emory University,
NCT00659204,Silver Nanoparticle Gel,DRUG,Healthy,phase3,TERMINATED,Madigan Army Medical Center,
NCT00659204,alcohol-based hand gel,DRUG,Healthy,phase3,TERMINATED,Madigan Army Medical Center,
NCT00462904,BPI,DRUG,Burns,phase2,TERMINATED,University of Texas Southwestern Medical Center,
NCT02671084,sevoflurane,DRUG,Myocardial Infarction,phase4,TERMINATED,Instituto Dante Pazzanese de Cardiologia,
NCT05589506,Removable partial denture PEEK,DEVICE,Prosthesis Survival,na,TERMINATED,Malo Clinic,
NCT03496584,Pomegranate Juice,OTHER,Erythema; Inflammation,na,TERMINATED,"University of California, Los Angeles",
NCT03496584,Placebo Juice,OTHER,Erythema; Inflammation,na,TERMINATED,"University of California, Los Angeles",
NCT01542047,Carboplatin,DRUG,"Cancer, Metastatic",phase1,TERMINATED,New Mexico Cancer Research Alliance,
NCT01542047,Pazopanib,DRUG,"Cancer, Metastatic",phase1,TERMINATED,New Mexico Cancer Research Alliance,
NCT04601857,Futibatinib,DRUG,Advanced and Metastatic Urothelial Cancer,phase2,TERMINATED,"Taiho Oncology, Inc.",
NCT04601857,Pembrolizumab,DRUG,Advanced and Metastatic Urothelial Cancer,phase2,TERMINATED,"Taiho Oncology, Inc.",
NCT05746481,Tiragolumab,DRUG,Non-small Cell Lung Cancer,phase2,TERMINATED,"Liza Villaruz, MD",
NCT05746481,Atezolizumab,DRUG,Non-small Cell Lung Cancer,phase2,TERMINATED,"Liza Villaruz, MD",
NCT05746481,Pemetrexed,DRUG,Non-small Cell Lung Cancer,phase2,TERMINATED,"Liza Villaruz, MD",
NCT05746481,Carboplatin,DRUG,Non-small Cell Lung Cancer,phase2,TERMINATED,"Liza Villaruz, MD",
NCT00991965,INFUSE® Bone Graft,DEVICE,Alveolar Bone Loss,na,TERMINATED,Medtronic Spinal and Biologics,
NCT02592707,Satoreotide tetraxetan,DRUG,Neuroendocrine Tumors,phase1; phase2,TERMINATED,Ipsen,
NCT02592707,Amino acid solution,OTHER,Neuroendocrine Tumors,phase1; phase2,TERMINATED,Ipsen,
NCT02592707,Antiemetic,OTHER,Neuroendocrine Tumors,phase1; phase2,TERMINATED,Ipsen,
NCT03108911,Best Practice,OTHER,Acute Myeloid Leukemia,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT03108911,Biospecimen Collection,PROCEDURE,Acute Myeloid Leukemia,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT03108911,Dietary Intervention,OTHER,Acute Myeloid Leukemia,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT03108911,Laboratory Biomarker Analysis,OTHER,Acute Myeloid Leukemia,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT03724409,[90]Y-DOTATOC,DRUG,Neuroendocrine Tumors,early_phase1,TERMINATED,Sandeep Laroia,
NCT04336332,Hydroxychloroquine Sulfate + Azithromycin,OTHER,SARS-CoV-2; COVID-19,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT04336332,Hydroxychloroquine Sulfate,DRUG,SARS-CoV-2; COVID-19,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT04601532,Catasyn™ Advanced Technology Hydrogel and SynePure™ Wound Cleanser,DEVICE,Superficial Partial Thickness Burn,phase4,TERMINATED,"J. Peter Rubin, MD",
NCT04601532,Silver Sulfadiazine,DRUG,Superficial Partial Thickness Burn,phase4,TERMINATED,"J. Peter Rubin, MD",
NCT03717532,Placebo,PROCEDURE,Patellofemoral Pain Syndrome,na,TERMINATED,NYU Langone Health,
NCT03717532,Personalized Tourniquet System for Blood Flow Restriction,PROCEDURE,Patellofemoral Pain Syndrome,na,TERMINATED,NYU Langone Health,
NCT03861598,Carvedilol,DRUG,Glioblastoma Multiforme; Glioblastoma,early_phase1,TERMINATED,West Virginia University,
NCT02341963,Oral Ketamine,DRUG,"Acute Pain Management; Analgesic, Nonopioid; Amputation of Lower Extremity, All Causes",phase1,TERMINATED,Rush University Medical Center,
NCT01821963,Pegylated Interferon Alfa 2a,DRUG,Infection,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01821963,Ribavirin,DRUG,Infection,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01821963,Telaprevir,DRUG,Infection,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT04060563,INSPIRSTAR IS02 MICROCURRENT STIMULATOR,DEVICE,Diastasis Recti,na,TERMINATED,Diana Trang,
NCT02394106,Ofatumumab,DRUG,Nephrotic Syndrome,phase2,TERMINATED,Istituto Giannina Gaslini,
NCT02394106,Placebo,OTHER,Nephrotic Syndrome,phase2,TERMINATED,Istituto Giannina Gaslini,
NCT04135352,200 mg of pembrolizumab,DRUG,Neoplasm Metastasis,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT04135352,V938,BIOLOGICAL,Neoplasm Metastasis,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT00286377,prosaptide,DRUG,HIV; Peripheral Nervous System Disorders,phase2,TERMINATED,Savient Pharmaceuticals,
NCT02463175,Plasmalyte,DRUG,Scoliosis; Acute Kidney Injury,na,TERMINATED,University of British Columbia,
NCT02463175,Goal-directed fluid therapy (GDT),PROCEDURE,Scoliosis; Acute Kidney Injury,na,TERMINATED,University of British Columbia,
NCT01402401,AUY922,DRUG,Advanced Gastric Cancer,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01402401,Trastuzumab,DRUG,Advanced Gastric Cancer,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04642612,TCD Measurement,DEVICE,Regional Anesthesia; Horner Syndrome; Cerebral Blood Flow,na,TERMINATED,Stanford University,
NCT00363636,Galiximab in combination with rituximab,DRUG,"Lymphoma, Non-Hodgkin's",phase3,TERMINATED,Biogen,
NCT00363636,Rituximab in combination with placebo,DRUG,"Lymphoma, Non-Hodgkin's",phase3,TERMINATED,Biogen,
NCT05397171,AZD8853,DRUG,"Urinary Bladder Neoplasms; Colorectal Cancer; Carcinoma, Non-Small-Cell Lung",phase1; phase2,TERMINATED,AstraZeneca,
NCT05397171,Zirconium-89 crefmirlimab berdoxam,DRUG,"Urinary Bladder Neoplasms; Colorectal Cancer; Carcinoma, Non-Small-Cell Lung",phase1; phase2,TERMINATED,AstraZeneca,
NCT05263999,Itolizumab,BIOLOGICAL,Graft Versus Host Disease; GVHD; Acute-graft-versus-host Disease; Acute GVHD; aGVHD,phase3,TERMINATED,Equillium,
NCT05263999,EQ001 Placebo,DRUG,Graft Versus Host Disease; GVHD; Acute-graft-versus-host Disease; Acute GVHD; aGVHD,phase3,TERMINATED,Equillium,
NCT00496132,PRO131921,DRUG,Chronic Lymphocytic Leukemia,phase1; phase2,TERMINATED,"Genentech, Inc.",
NCT01650298,Drug (Direct thrombin or Factor Xa inhibitor),OTHER,Atrial Fibrillation,na,TERMINATED,Abbott Medical Devices,
NCT03270163,Transcutaneous electrical stimulation,OTHER,Muscle Weakness,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03270163,Magnetic stimulation,OTHER,Muscle Weakness,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03270163,ultrasound measurement,OTHER,Muscle Weakness,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT02740387,OTO-104,DRUG,Meniere's Disease,phase2,TERMINATED,"Otonomy, Inc.",
NCT01901887,Study Juice,DRUG,Suicide,phase1,TERMINATED,Medical University of South Carolina,
NCT01901887,Placebo Juice,DRUG,Suicide,phase1,TERMINATED,Medical University of South Carolina,
NCT04807387,Vaginal Stent A,DEVICE,Vaginal Stricture,na,TERMINATED,Baylor College of Medicine,
NCT04807387,Vaginal Stent B,DEVICE,Vaginal Stricture,na,TERMINATED,Baylor College of Medicine,
NCT04807387,Vaginal Stent,DEVICE,Vaginal Stricture,na,TERMINATED,Baylor College of Medicine,
NCT01691014,non-interventional study,OTHER,Rheumatoid Arthritis (RA),na,TERMINATED,Pfizer,
NCT01691014,non-interventional study,OTHER,Rheumatoid Arthritis (RA),na,TERMINATED,Pfizer,
NCT01691014,non-interventional study,OTHER,Rheumatoid Arthritis (RA),na,TERMINATED,Pfizer,
NCT01691014,non-interventional study,OTHER,Rheumatoid Arthritis (RA),na,TERMINATED,Pfizer,
NCT04700306,Sophrology,BEHAVIORAL,Craving; Cigarette Smoking,na,TERMINATED,Centre Hospitalier Intercommunal Creteil,
NCT03852706,LORETA,OTHER,Schizophrenia,na,TERMINATED,"University of Dublin, Trinity College",
NCT03852706,Treatment as usual,OTHER,Schizophrenia,na,TERMINATED,"University of Dublin, Trinity College",
NCT04693533,Fremanezumab Prefilled Syringe [Ajovy],DRUG,Migraine Disorders; Sleep Disorder,phase4,TERMINATED,Beth Israel Deaconess Medical Center,
NCT04633447,Guselkumab,DRUG,Giant Cell Arteritis,phase2,TERMINATED,"Janssen Research & Development, LLC",
NCT04633447,Placebo,DRUG,Giant Cell Arteritis,phase2,TERMINATED,"Janssen Research & Development, LLC",
NCT03023072,Incontinence Detection System,OTHER,Incontinence,na,TERMINATED,Hill-Rom,
NCT02645175,TW1025,OTHER,Metastatic Breast Cancer; Fatigue,phase2,TERMINATED,Meriyana Bio Inc.,
NCT02645175,Placebo,OTHER,Metastatic Breast Cancer; Fatigue,phase2,TERMINATED,Meriyana Bio Inc.,
NCT02975557,Brimonidine 0.15%,DRUG,Dry Eye; Ocular Graft vs Host Disease; Meibomian Gland Dysfunction,phase1; phase2,TERMINATED,"Sandeep Jain, MD",
NCT02975557,Brimonidine 0.075%,DRUG,Dry Eye; Ocular Graft vs Host Disease; Meibomian Gland Dysfunction,phase1; phase2,TERMINATED,"Sandeep Jain, MD",
NCT02975557,Placebo,DRUG,Dry Eye; Ocular Graft vs Host Disease; Meibomian Gland Dysfunction,phase1; phase2,TERMINATED,"Sandeep Jain, MD",
NCT01540292,Mesenchymal Stem Cells (MSC),BIOLOGICAL,Crohn's Disease,phase1; phase2,TERMINATED,University of Liege,
NCT04883892,BMAC,PROCEDURE,Ankle Osteoarthritis,na,TERMINATED,Istituto Ortopedico Rizzoli,
NCT04883892,HA,PROCEDURE,Ankle Osteoarthritis,na,TERMINATED,Istituto Ortopedico Rizzoli,
NCT01122511,700 ug dexamethasone,DRUG,Subfoveal Choroidal Neovascularization; Age-Related Maculopathy,phase2,TERMINATED,Allergan,
NCT01122511,ranibizumab,BIOLOGICAL,Subfoveal Choroidal Neovascularization; Age-Related Maculopathy,phase2,TERMINATED,Allergan,
NCT01122511,sham,OTHER,Subfoveal Choroidal Neovascularization; Age-Related Maculopathy,phase2,TERMINATED,Allergan,
NCT04762771,Colchicine,DRUG,Covid19,phase1; phase2,TERMINATED,Baptist Health South Florida,
NCT03253809,Biotronik Vision Guidewire,DEVICE,Cardiomyopathies; Congestive Heart Failure,na,TERMINATED,The Cleveland Clinic,
NCT00597909,sodium phenylacetate and sodium benzoate injection 10% / 10%,DRUG,Hepatic Encephalopathy,phase2,TERMINATED,Amgen,
NCT00597909,sodium phenylacetate and sodium benzoate injection 10% / 10%,DRUG,Hepatic Encephalopathy,phase2,TERMINATED,Amgen,
NCT00597909,placebo solution (10% dextrose),DRUG,Hepatic Encephalopathy,phase2,TERMINATED,Amgen,
NCT04902599,Renuvion/j-Plasma procedure using blunt dissection technique,PROCEDURE,Subdermal Skin Tightening,na,TERMINATED,University of Utah,
NCT04902599,Renuvion/j-Plasma procedure using ultrasound-guided dissection technique,PROCEDURE,Subdermal Skin Tightening,na,TERMINATED,University of Utah,
NCT01332799,allopurinol or placebo,DRUG,Complications of Renal Transplant,phase4,TERMINATED,Roberto S Kalil,
NCT01332799,Placebo,OTHER,Complications of Renal Transplant,phase4,TERMINATED,Roberto S Kalil,
NCT00002899,adjuvant therapy,PROCEDURE,Metastatic Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00002899,radiation therapy,RADIATION,Metastatic Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00002899,stereotactic radiosurgery,RADIATION,Metastatic Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT01385293,BKM120,DRUG,Prostate Cancer; Metastatic (Spread to Other Areas of the Body),phase2,TERMINATED,"Andrew J. Armstrong, MD",
NCT03928314,ORIC-101,DRUG,Solid Tumor,phase1,TERMINATED,ORIC Pharmaceuticals,
NCT03928314,Nab-paclitaxel,DRUG,Solid Tumor,phase1,TERMINATED,ORIC Pharmaceuticals,
NCT03866616,Brain Builders Parenting Class,BEHAVIORAL,Child Development; Mother-Child Interaction,na,TERMINATED,William Marsh Rice University,
NCT03866616,Control (Usual care),BEHAVIORAL,Child Development; Mother-Child Interaction,na,TERMINATED,William Marsh Rice University,
NCT05877404,Surveys,OTHER,Endometrial Cancer,na,TERMINATED,Wake Forest University Health Sciences,
NCT00318747,Amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate (AIC),DRUG,"Asthma; Allergy; Allergic Rhinitis; Rhinitis, Allergic, Seasonal",phase2,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01605747,Culturelle,OTHER,Pediatric Burns,phase2,TERMINATED,Shriners Hospitals for Children,
NCT01605747,Placebo,OTHER,Pediatric Burns,phase2,TERMINATED,Shriners Hospitals for Children,
NCT01151449,gamma-secretase/Notch signalling pathway inhibitor RO4929097,DRUG,Estrogen Receptor-negative Breast Cancer; HER2-negative Breast Cancer; Male Breast Cancer; Progesterone Receptor-negative Breast Cancer; Recurrent Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB B,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01151449,laboratory biomarker analysis,OTHER,Estrogen Receptor-negative Breast Cancer; HER2-negative Breast Cancer; Male Breast Cancer; Progesterone Receptor-negative Breast Cancer; Recurrent Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB B,phase2,TERMINATED,National Cancer Institute (NCI),
NCT05756881,Cosmetic product,OTHER,Acne,na,TERMINATED,Universiti Sains Malaysia,
NCT00483119,intravenous immunoglobulin,DRUG,Pemphigus Vulgaris,phase2,TERMINATED,NYU Langone Health,
NCT00483119,cyclophosphamide,DRUG,Pemphigus Vulgaris,phase2,TERMINATED,NYU Langone Health,
NCT00383630,Intramyocardial injection of bone marrow mononuclear cells,BIOLOGICAL,"Heart Failure, Congestive",phase2,TERMINATED,Columbia University,
NCT00383630,Intramyocardial injection of CD34+ selected bone marrow mononuclear cells,BIOLOGICAL,"Heart Failure, Congestive",phase2,TERMINATED,Columbia University,
NCT00383630,LVAD alone,DEVICE,"Heart Failure, Congestive",phase2,TERMINATED,Columbia University,
NCT00508430,ASP8825,DRUG,Diabetic Neuropathies,phase2,TERMINATED,Astellas Pharma Inc,
NCT00508430,Placebo,DRUG,Diabetic Neuropathies,phase2,TERMINATED,Astellas Pharma Inc,
NCT03437967,LightForce EXPi,DEVICE,Chronic Pain,na,TERMINATED,LiteCure LLC,
NCT03119467,RP4010,DRUG,Lymphoma,phase1,TERMINATED,Rhizen Pharmaceuticals SA,
NCT03607500,caloric intake reduction,BEHAVIORAL,Kidney Transplant; Complications; Glomerular Disease; Weight Gain; Kidney Transplant,na,TERMINATED,University of Michigan,
NCT00361907,Effect of Pulsatile IV insulin on diabetic pt blood markers,PROCEDURE,Diabetes Mellitus,phase2; phase3,TERMINATED,Florida Atlantic University,
NCT00361907,Effect of Pulsatile IV Insulin on blood markers,PROCEDURE,Diabetes Mellitus,phase2; phase3,TERMINATED,Florida Atlantic University,
NCT00361907,Effect of Pulsatile IV insulin on diabetic pt blood markers,PROCEDURE,Diabetes Mellitus,phase2; phase3,TERMINATED,Florida Atlantic University,
NCT02209792,Placebo,DRUG,Crohn Disease,phase2,TERMINATED,Boehringer Ingelheim,
NCT02209792,"BIBR 796 BS, 5 mg",DRUG,Crohn Disease,phase2,TERMINATED,Boehringer Ingelheim,
NCT02209792,"BIBR 796 BS, 20 mg",DRUG,Crohn Disease,phase2,TERMINATED,Boehringer Ingelheim,
NCT03121092,ACEI or ARB,DRUG,Hypertension; Hypotension,na,TERMINATED,State University of New York - Downstate Medical Center,
NCT01246011,Argatroban and warfarin,DRUG,Coronary Artery Bypass Graft Surgery; Presence of Heparin/Platelet Factor 4 Antibody,phase4,TERMINATED,Massachusetts General Hospital,
NCT04584099,Radiofrequency device treatment,DEVICE,Body Fat,na,TERMINATED,"Cynosure, Inc.",
NCT05461599,SparkRx Mobile App,DEVICE,Depressive Symptoms; Major Depressive Disorder; Depression; Cardiology; Gastrointestinal Diseases; Depressive Disorder; Depressive Episode; Adolescent Behavior; Adolescent - Emotional Problem,na,TERMINATED,"Limbix Health, Inc.",
NCT01573299,Mobilization of stroke patients,OTHER,Early Mobilisation in Ischemic Stroke Patients,na,TERMINATED,Nantes University Hospital,
NCT05516498,Part A: Placebo (matching zibotentan capsule & matching dapagliflozin tablet),DRUG,Liver Cirrhosis,phase2,TERMINATED,AstraZeneca,
NCT05516498,Part A: zibotentan (dose B) + dapagliflozin,DRUG,Liver Cirrhosis,phase2,TERMINATED,AstraZeneca,
NCT05516498,Part B: Placebo (matching zibotentan capsule & matching dapagliflozin tablet),DRUG,Liver Cirrhosis,phase2,TERMINATED,AstraZeneca,
NCT05516498,Part B: placebo (matching zibotentan capsule) + dapagliflozin,DRUG,Liver Cirrhosis,phase2,TERMINATED,AstraZeneca,
NCT05516498,Part B: zibotentan (dose A) + dapagliflozin,DRUG,Liver Cirrhosis,phase2,TERMINATED,AstraZeneca,
NCT05516498,Part B: zibotentan (dose B) + dapagliflozin,DRUG,Liver Cirrhosis,phase2,TERMINATED,AstraZeneca,
NCT05516498,Part B: zibotentan (dose C) + dapagliflozin,DRUG,Liver Cirrhosis,phase2,TERMINATED,AstraZeneca,
NCT03735693,Ulstrasound,OTHER,"Amyotrophia; Weakness, Muscle",na,TERMINATED,Association Pro-arte,
NCT00004106,temozolomide,DRUG,Lymphoma,phase2,TERMINATED,Northwestern University,
NCT03478904,Enzalutamide Liquid,DRUG,Prostate Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03478904,Enzalutamide Capsule,DRUG,Prostate Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03959384,Curosurf 80Mg/Ml Intratracheal Suspension,DRUG,"Bronchiolitis, Viral",phase3,TERMINATED,Azienda Ospedaliera Universitaria Integrata Verona,
NCT03959384,Ambient Air,OTHER,"Bronchiolitis, Viral",phase3,TERMINATED,Azienda Ospedaliera Universitaria Integrata Verona,
NCT01693484,ICG (Indocyanine Green),DRUG,"Fractures, Comminuted; Surgical Wound Dehiscence; Necrosis",phase2; phase3,TERMINATED,Louisiana State University Health Sciences Center Shreveport,
NCT05708833,Intraosseous venous access,DEVICE,Hemodynamic Instability,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT05708833,Peripheral venous access,DEVICE,Hemodynamic Instability,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00612833,Vasectomy occlusion techniques,PROCEDURE,Contraception,na,TERMINATED,FHI 360,
NCT00088933,recombinant fowlpox-CEA(6D)/TRICOM vaccine,DRUG,Extensive Stage Small Cell Lung Cancer; Recurrent Colon Cancer; Recurrent Non-small Cell Lung Cancer; Recurrent Rectal Cancer; Recurrent Small Cell Lung Cancer; Stage IV Colon Cancer; Stage IV Non-sma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00088933,recombinant vaccinia-CEA(6D)-TRICOM vaccine,DRUG,Extensive Stage Small Cell Lung Cancer; Recurrent Colon Cancer; Recurrent Non-small Cell Lung Cancer; Recurrent Rectal Cancer; Recurrent Small Cell Lung Cancer; Stage IV Colon Cancer; Stage IV Non-sma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00088933,docetaxel,DRUG,Extensive Stage Small Cell Lung Cancer; Recurrent Colon Cancer; Recurrent Non-small Cell Lung Cancer; Recurrent Rectal Cancer; Recurrent Small Cell Lung Cancer; Stage IV Colon Cancer; Stage IV Non-sma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00088933,sargramostim,DRUG,Extensive Stage Small Cell Lung Cancer; Recurrent Colon Cancer; Recurrent Non-small Cell Lung Cancer; Recurrent Rectal Cancer; Recurrent Small Cell Lung Cancer; Stage IV Colon Cancer; Stage IV Non-sma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00050375,oregovomab,DRUG,Ovarian Cancer,phase3,TERMINATED,Unither Pharmaceuticals,
NCT04727801,Verily Patch,DEVICE,Febrile; Afebrile,na,TERMINATED,Verily Life Sciences LLC,
NCT00180401,CRT-P and CRT-D devices,BEHAVIORAL,Heart Failure,na,TERMINATED,Boston Scientific Corporation,
NCT00220909,Lansoprazole,DRUG,Patients Undergoing Elective Coronary Artery Bypass Graft,phase4,TERMINATED,Temple University,
NCT03986398,Infection prophylaxis,OTHER,Bladder Cancer,na,TERMINATED,Hopital Foch,
NCT03734887,Social Network Feedback,BEHAVIORAL,Diabetes; Atherosclerosis Cardiovascular Disease; Congestive Heart Failure; Poor Medication Adherence,na,TERMINATED,"University of California, Los Angeles",
NCT03734887,Private Feedback,BEHAVIORAL,Diabetes; Atherosclerosis Cardiovascular Disease; Congestive Heart Failure; Poor Medication Adherence,na,TERMINATED,"University of California, Los Angeles",
NCT02163187,Implantation of the InterStimTM,DEVICE,Rectal Cancer; for Bowel Dysfunction Following Surgery for Rectal Cancers,phase2; phase3,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT02163187,MSK BFI questionnaires,BEHAVIORAL,Rectal Cancer; for Bowel Dysfunction Following Surgery for Rectal Cancers,phase2; phase3,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT02163187,The Low Anterior Resection Score (LARS) questionnaires,BEHAVIORAL,Rectal Cancer; for Bowel Dysfunction Following Surgery for Rectal Cancers,phase2; phase3,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT02163187,The EuroQOL5D questionnaires,BEHAVIORAL,Rectal Cancer; for Bowel Dysfunction Following Surgery for Rectal Cancers,phase2; phase3,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT02163187,The Fecal incontinence Quality of Life Scale (FIQOL) questionnaires,BEHAVIORAL,Rectal Cancer; for Bowel Dysfunction Following Surgery for Rectal Cancers,phase2; phase3,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT01200914,GORE VIABAHN® Endoprosthesis with Heparin Bioactive Surface,DEVICE,Renal Failure,na,TERMINATED,"University Health Network, Toronto",
NCT01200914,PTA alone without use of the GORE VIABAHN,PROCEDURE,Renal Failure,na,TERMINATED,"University Health Network, Toronto",
NCT00420914,low dose of 2.25 x 10^11 platelets/transfusion (range 1.5 to 2.9),PROCEDURE,Thrombocytopenia,phase3,TERMINATED,Hamilton Health Sciences Corporation,
NCT01332916,cognitive tests and cerebral IRM,PROCEDURE,Breast Cancer; Healthy,phase2,TERMINATED,Centre Francois Baclesse,
NCT01332916,cognitive tests and cerebral IRM,PROCEDURE,Breast Cancer; Healthy,phase2,TERMINATED,Centre Francois Baclesse,
NCT01739504,Liposuction with Local Anesthesia,PROCEDURE,Osteoarthritis,na,TERMINATED,Ageless Regenerative Institute,
NCT01739504,Intra articular infusion of AD-SVF,BIOLOGICAL,Osteoarthritis,na,TERMINATED,Ageless Regenerative Institute,
NCT01240304,Gemcitabine,DRUG,Pancreatic Cancer,phase2,TERMINATED,University of Arkansas,
NCT01240304,Radiation therapy,RADIATION,Pancreatic Cancer,phase2,TERMINATED,University of Arkansas,
NCT01240304,pancreaticoduodenectomy,PROCEDURE,Pancreatic Cancer,phase2,TERMINATED,University of Arkansas,
NCT00782652,inhaled nitric oxide,DRUG,Right Ventricular Infarction,phase2,TERMINATED,Mallinckrodt,
NCT00782652,nitrogen gas,DRUG,Right Ventricular Infarction,phase2,TERMINATED,Mallinckrodt,
NCT01883947,Touch massage,PROCEDURE,Stroke,na,TERMINATED,Umeå University,
NCT01883947,non-TENS,OTHER,Stroke,na,TERMINATED,Umeå University,
NCT00003911,stereotactic radiosurgery,RADIATION,Melanoma (Skin); Metastatic Cancer,phase2,TERMINATED,SWOG Cancer Research Network,
NCT03613571,ILB,DRUG,Amyotrophic Lateral Sclerosis,phase2,TERMINATED,TikoMed AB,
NCT00368264,infliximab,DRUG,"Lupus Erythematosus, Systemic; Lupus Nephritis",phase2; phase3,TERMINATED,Medical University of Vienna,
NCT00368264,placebo,DRUG,"Lupus Erythematosus, Systemic; Lupus Nephritis",phase2; phase3,TERMINATED,Medical University of Vienna,
NCT01780064,interviews with a psychologist,BEHAVIORAL,Breast Cancer,na,TERMINATED,Centre Oscar Lambret,
NCT01780064,Questionnaires,BEHAVIORAL,Breast Cancer,na,TERMINATED,Centre Oscar Lambret,
NCT00937664,AZD7762,DRUG,Cancer; Solid Tumors; Advanced Solid Malignancies,phase1,TERMINATED,AstraZeneca,
NCT00937664,gemcitabine,DRUG,Cancer; Solid Tumors; Advanced Solid Malignancies,phase1,TERMINATED,AstraZeneca,
NCT01829464,Placebo,DRUG,Diabetes,phase3,TERMINATED,Takeda,
NCT01829464,TAK-875,DRUG,Diabetes,phase3,TERMINATED,Takeda,
NCT01829464,TAK-875,DRUG,Diabetes,phase3,TERMINATED,Takeda,
NCT00790699,I-PORT,DEVICE,Type 1 Diabetes; Type 2 Diabetes,na,TERMINATED,"Texas Diabetes & Endocrinology, P.A.",
NCT00790699,standard injections,OTHER,Type 1 Diabetes; Type 2 Diabetes,na,TERMINATED,"Texas Diabetes & Endocrinology, P.A.",
NCT02442193,Individual Placement and Support,OTHER,"Employment, Supported; Treatment as Usual",na,TERMINATED,Nottinghamshire Healthcare NHS Trust,
NCT02093221,180 mg/kg Alpha1-PI,BIOLOGICAL,Type 1 Diabetes Mellitus,phase2,TERMINATED,Grifols Therapeutics LLC,
NCT02093221,90 mg/kg Alpha1-PI,BIOLOGICAL,Type 1 Diabetes Mellitus,phase2,TERMINATED,Grifols Therapeutics LLC,
NCT02093221,Placebo,BIOLOGICAL,Type 1 Diabetes Mellitus,phase2,TERMINATED,Grifols Therapeutics LLC,
NCT05370521,Tildacerfont,DRUG,Polycystic Ovary Syndrome,phase2,TERMINATED,Spruce Biosciences,
NCT05370521,Placebo,DRUG,Polycystic Ovary Syndrome,phase2,TERMINATED,Spruce Biosciences,
NCT01476514,No intervention,OTHER,Hyperekplexia,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT01840033,group Piccnut,DEVICE,Chronic Intestinal Failure,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT01840033,Tunnelled nutritional central catheter,DEVICE,Chronic Intestinal Failure,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT01794338,Strattice Arm,DEVICE,Ventral Hernia,na,TERMINATED,Wake Forest University Health Sciences,
NCT01794338,Bio-A Arm,DEVICE,Ventral Hernia,na,TERMINATED,Wake Forest University Health Sciences,
NCT02375048,Hypofractionated WBI,RADIATION,Cancer of Breast,phase2,TERMINATED,Istituto Clinico Humanitas,
NCT02375048,Accelerated Partial Breast Irradiation,RADIATION,Cancer of Breast,phase2,TERMINATED,Istituto Clinico Humanitas,
NCT00496158,Clevudine,DRUG,Chronic Hepatitis; Hepatitis B,phase3,TERMINATED,Pharmasset,
NCT00496158,Adefovir,DRUG,Chronic Hepatitis; Hepatitis B,phase3,TERMINATED,Pharmasset,
NCT05454358,Letrozole 2.5mg,DRUG,Endometrial Cancer,phase2; phase3,TERMINATED,Fudan University,
NCT05542355,EXL01,DRUG,Crohn Disease,phase1,TERMINATED,Exeliom Biosciences,
NCT05542355,Placebo,DRUG,Crohn Disease,phase1,TERMINATED,Exeliom Biosciences,
NCT05542355,SoC corticosteroid - Induction Period,OTHER,Crohn Disease,phase1,TERMINATED,Exeliom Biosciences,
NCT05542355,SoC corticosteroid - Tapering,OTHER,Crohn Disease,phase1,TERMINATED,Exeliom Biosciences,
NCT02629055,Respiratory EMG,OTHER,Chronic Obstructive Pulmonary Disease (COPD),na,TERMINATED,University Medical Center Groningen,
NCT04892264,Belantamab Mafodotin,BIOLOGICAL,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT04892264,Daratumumab,BIOLOGICAL,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT04892264,Dexamethasone,DRUG,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT04892264,Lenalidomide,DRUG,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT04892264,Quality-of-Life Assessment,OTHER,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT04892264,Biospecimen Collection,PROCEDURE,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT04892264,Skeletal Survey X-Ray,PROCEDURE,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT04892264,Low Dose Computed Tomography of the Whole Body,PROCEDURE,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT04892264,Bone Marrow Aspiration,PROCEDURE,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT04892264,Bone Marrow Biopsy,PROCEDURE,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT00949299,buprenorphine,DRUG,Healthy Volunteers,phase4,TERMINATED,University of Zurich,
NCT00354432,oral soy protein/isoflavones powder,OTHER,Hot Flashes; Prostate Cancer,phase3,TERMINATED,Wake Forest University Health Sciences,
NCT00354432,Venlafaxine,DRUG,Hot Flashes; Prostate Cancer,phase3,TERMINATED,Wake Forest University Health Sciences,
NCT00354432,Placebo Powder,OTHER,Hot Flashes; Prostate Cancer,phase3,TERMINATED,Wake Forest University Health Sciences,
NCT00354432,Placebo Pill,DRUG,Hot Flashes; Prostate Cancer,phase3,TERMINATED,Wake Forest University Health Sciences,
NCT03877263,Endocervical swab for detection of STI,OTHER,Sexually Transmitted Diseases,na,TERMINATED,OhioHealth,
NCT03877263,Vaginal swab for detection of STI,OTHER,Sexually Transmitted Diseases,na,TERMINATED,OhioHealth,
NCT00503321,"Tegafur/gimeracil/oteracil potassium (S-1), Krestin (PSK)",DRUG,Gastric Cancer,phase2; phase3,TERMINATED,"Eastern Network of Cancer Immunological Therapy, Japan",
NCT00503321,Tegafur/gimeracil/oteracil potassium (S-1),DRUG,Gastric Cancer,phase2; phase3,TERMINATED,"Eastern Network of Cancer Immunological Therapy, Japan",
NCT00737321,Samples will be collected,PROCEDURE,Wounds and Injuries,na,TERMINATED,Gayle Gordillo,
NCT00383214,Epratuzumab,DRUG,Systemic Lupus Erythematosus,phase3,TERMINATED,UCB Pharma,
NCT00383214,Placebo,OTHER,Systemic Lupus Erythematosus,phase3,TERMINATED,UCB Pharma,
NCT01924806,WoundWand™ Debridement Device,DEVICE,Lower Leg Wound,na,TERMINATED,"Smith & Nephew, Inc.",
NCT01924806,Standard of Care sharp debridement,DEVICE,Lower Leg Wound,na,TERMINATED,"Smith & Nephew, Inc.",
NCT03642184,Empagliflozin,DRUG,New Onset Diabetes After Transplant; Kidney Transplant; Complications,phase4,TERMINATED,RenJi Hospital,
NCT03642184,Linagliptin,DRUG,New Onset Diabetes After Transplant; Kidney Transplant; Complications,phase4,TERMINATED,RenJi Hospital,
NCT04596033,GEN-011,BIOLOGICAL,Melanoma; Non-small Cell Lung Cancer; Squamous Cell Carcinoma of Head and Neck; Urothelial Carcinoma; Renal Cell Carcinoma; Small-cell Lung Cancer; Cutaneous Squamous Cell Carcinoma; Anal Squamous Cel,phase1,TERMINATED,"Genocea Biosciences, Inc.",
NCT04596033,IL-2,DRUG,Melanoma; Non-small Cell Lung Cancer; Squamous Cell Carcinoma of Head and Neck; Urothelial Carcinoma; Renal Cell Carcinoma; Small-cell Lung Cancer; Cutaneous Squamous Cell Carcinoma; Anal Squamous Cel,phase1,TERMINATED,"Genocea Biosciences, Inc.",
NCT04596033,Fludarabine,DRUG,Melanoma; Non-small Cell Lung Cancer; Squamous Cell Carcinoma of Head and Neck; Urothelial Carcinoma; Renal Cell Carcinoma; Small-cell Lung Cancer; Cutaneous Squamous Cell Carcinoma; Anal Squamous Cel,phase1,TERMINATED,"Genocea Biosciences, Inc.",
NCT04596033,Cyclophosphamide,DRUG,Melanoma; Non-small Cell Lung Cancer; Squamous Cell Carcinoma of Head and Neck; Urothelial Carcinoma; Renal Cell Carcinoma; Small-cell Lung Cancer; Cutaneous Squamous Cell Carcinoma; Anal Squamous Cel,phase1,TERMINATED,"Genocea Biosciences, Inc.",
NCT04653038,MGD013,DRUG,"Unresectable, Recurrent or Metastatic Melanoma; Untreated Mucosal or Acral Lentiginous Melanoma",phase1,TERMINATED,"Zai Lab (Shanghai) Co., Ltd.",
NCT00515138,"Rituximab, Ifosfamide, Carboplatin, Etoposide, Bortezomib",DRUG,"Lymphoma, B-Cell",early_phase1,TERMINATED,"University of California, San Francisco",
NCT04971148,HFNC flow set at patient peak tidal inspiratory flow,OTHER,Hypoxemic Respiratory Failure,na,TERMINATED,Rush University Medical Center,
NCT04971148,HFNC flow set at 1.33 times of patient peak tidal inspiratory flow,OTHER,Hypoxemic Respiratory Failure,na,TERMINATED,Rush University Medical Center,
NCT04971148,HFNC flow set at 1.67 times of patient peak tidal inspiratory flow,OTHER,Hypoxemic Respiratory Failure,na,TERMINATED,Rush University Medical Center,
NCT04971148,HFNC flow set at 2 times of patient peak tidal inspiratory flow,OTHER,Hypoxemic Respiratory Failure,na,TERMINATED,Rush University Medical Center,
NCT00660855,parecoxib/valdecoxib,DRUG,"Pain, Post Surgical",phase4,TERMINATED,Pfizer,
NCT01437878,Iloprost,DRUG,Chronic Obstructive Pulmonary Disease; Pulmonary Hypertension,phase2,TERMINATED,Actelion,
NCT01437878,Placebo,DRUG,Chronic Obstructive Pulmonary Disease; Pulmonary Hypertension,phase2,TERMINATED,Actelion,
NCT05331885,Suvratoxumab,BIOLOGICAL,Ventilator Associated Pneumonia; Staphylococcus Aureus,phase3,TERMINATED,"Aridis Pharmaceuticals, Inc.",
NCT05331885,Placebo,DRUG,Ventilator Associated Pneumonia; Staphylococcus Aureus,phase3,TERMINATED,"Aridis Pharmaceuticals, Inc.",
NCT01822171,Discharge medication counseling from a pharmacist,OTHER,Heart Failure,na,TERMINATED,Providence Health & Services,
NCT01822171,Home medication if needed,OTHER,Heart Failure,na,TERMINATED,Providence Health & Services,
NCT01822171,Follow-up visit at Medication Therapy Management clinic,OTHER,Heart Failure,na,TERMINATED,Providence Health & Services,
NCT01540864,HPP404,DRUG,Obesity; Overweight,phase2,TERMINATED,"High Point Pharmaceuticals, LLC.",
NCT01540864,Placebo,DRUG,Obesity; Overweight,phase2,TERMINATED,"High Point Pharmaceuticals, LLC.",
NCT04880109,APX-115,DRUG,COVID-19,phase2,TERMINATED,"Aptabio Therapeutics, Inc.",
NCT04880109,Placebo,DRUG,COVID-19,phase2,TERMINATED,"Aptabio Therapeutics, Inc.",
NCT00739609,1-methyl-D-tryptophan,DRUG,Breast Cancer; Lung Cancer; Melanoma; Pancreatic Cancer; Solid Tumors,phase1,TERMINATED,NewLink Genetics Corporation,
NCT00260598,LIFE Bronchoscopy,PROCEDURE,"Non-Small-Cell Lung Carcinoma; Head and Neck Squamous Cell Cancer; Pulmonary Disease, Chronic Obstructive",phase2,TERMINATED,University of Pittsburgh,
NCT01208493,preterm infant formula with high protein levels,OTHER,Prematurity,na,TERMINATED,Société des Produits Nestlé (SPN),
NCT01208493,preterm standard infant formula,OTHER,Prematurity,na,TERMINATED,Société des Produits Nestlé (SPN),
NCT03199404,TRAP,DEVICE,"Stroke, Ischemic",na,TERMINATED,"University of Massachusetts, Worcester",
NCT05826704,Probiotics,OTHER,Stress,na,TERMINATED,Mackay Memorial Hospital,
NCT00961558,Varicocelectomy,PROCEDURE,Male Infertility; Varicoceles,na,TERMINATED,"Mount Sinai Hospital, Canada",
NCT04896658,"Belantamab Mafodotin, Cyclophosphamide and Dexamethasone",DRUG,Relapsed/Refractory Multiple Myeloma,phase1; phase2,TERMINATED,"University of Maryland, Baltimore",
NCT01833455,PVC Suppression using Flecainide,DRUG,Ventricular Premature Complexes; Blood Pressure,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT01833455,No PVC Suppression using Placebo,DRUG,Ventricular Premature Complexes; Blood Pressure,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT01739348,Verubecestat (Part I and Part II),DRUG,Alzheimer's Disease,phase2; phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01739348,Verubecestat (Part I and Part II),DRUG,Alzheimer's Disease,phase2; phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01739348,Verubecestat (Part I and Part II),DRUG,Alzheimer's Disease,phase2; phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01739348,Placebo (Part I),DRUG,Alzheimer's Disease,phase2; phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01739348,Verubecestat (Part II),DRUG,Alzheimer's Disease,phase2; phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT03363009,Optimized group,DEVICE,Surgery,na,TERMINATED,Hopital Foch,
NCT03363009,Control group,DEVICE,Surgery,na,TERMINATED,Hopital Foch,
NCT04232709,Shared electronic patient record,OTHER,Cancer,na,TERMINATED,Women's College Hospital,
NCT03323398,mRNA-2416,BIOLOGICAL,Relapsed/Refractory Solid Tumor Malignancies or Lymphoma; Ovarian Cancer,phase1; phase2,TERMINATED,"ModernaTX, Inc.",
NCT03323398,Durvalumab,BIOLOGICAL,Relapsed/Refractory Solid Tumor Malignancies or Lymphoma; Ovarian Cancer,phase1; phase2,TERMINATED,"ModernaTX, Inc.",
NCT00190216,Magnetic stimulator,DEVICE,Depression,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02275806,Irinotecan,DRUG,"Lung Neoplasms, Non-Small Cell Lung Cancer",phase2,TERMINATED,Leo W. Jenkins Cancer Center,
NCT02275806,Cisplatin,DRUG,"Lung Neoplasms, Non-Small Cell Lung Cancer",phase2,TERMINATED,Leo W. Jenkins Cancer Center,
NCT04968184,Placebo,DRUG,Chronic Kidney Diseases,phase3,TERMINATED,KBP Biosciences,
NCT04968184,KBP-5074,DRUG,Chronic Kidney Diseases,phase3,TERMINATED,KBP Biosciences,
NCT03735433,162mg aspirin dose,DRUG,Preeclampsia,phase4,TERMINATED,Ohio State University,
NCT05324852,Intranasal midazolam,DRUG,Emergence Delirium,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT05324852,Intramuscular loxapine,DRUG,Emergence Delirium,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01781247,Minimal behavioral intervention,BEHAVIORAL,"Stress Disorders, Post-Traumatic; Myocardial Infarction",na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT01781247,Control intervention,BEHAVIORAL,"Stress Disorders, Post-Traumatic; Myocardial Infarction",na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT02363647,Tumor Genomic Analysis,OTHER,Medullary Thyroid Cancer; Colon Cancer,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT01339455,AHSCT,PROCEDURE,Neuromyelitis Optica,phase1; phase2,TERMINATED,University of Calgary,
NCT00004026,CT-2584,DRUG,Prostate Cancer,phase2,TERMINATED,CTI BioPharma,
NCT00004026,chemotherapy,DRUG,Prostate Cancer,phase2,TERMINATED,CTI BioPharma,
NCT00957346,Mifepristone+misoprostol,DRUG,"Abortion, Induced",phase3,TERMINATED,Gynuity Health Projects,
NCT00957346,Placebo+Misoprostol,DRUG,"Abortion, Induced",phase3,TERMINATED,Gynuity Health Projects,
NCT00529386,Botox,DRUG,Prostatitis; Chronic Pain Syndrome,phase1,TERMINATED,Queen's University,
NCT06128369,Dexamethasone Ophthalmic Suspension,DRUG,"Inflammation Eye; Pain, Postoperative; Cataract",phase3,TERMINATED,Oculis,
NCT06128369,Vehicle of OCS-01,OTHER,"Inflammation Eye; Pain, Postoperative; Cataract",phase3,TERMINATED,Oculis,
NCT02497183,ultrasound,DEVICE,Appendicitis,na,TERMINATED,"HaEmek Medical Center, Israel",
NCT02497183,iodine based solution of oral contrast material,OTHER,Appendicitis,na,TERMINATED,"HaEmek Medical Center, Israel",
NCT04158141,Carboplatin,DRUG,Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesotheliom,phase3,TERMINATED,NRG Oncology,
NCT04158141,Cisplatin,DRUG,Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesotheliom,phase3,TERMINATED,NRG Oncology,
NCT04158141,Decortication,PROCEDURE,Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesotheliom,phase3,TERMINATED,NRG Oncology,
NCT04158141,Intensity-Modulated Radiation Therapy,RADIATION,Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesotheliom,phase3,TERMINATED,NRG Oncology,
NCT04158141,Pemetrexed,DRUG,Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesotheliom,phase3,TERMINATED,NRG Oncology,
NCT04158141,Pemetrexed Disodium,DRUG,Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesotheliom,phase3,TERMINATED,NRG Oncology,
NCT04158141,Pencil beam scanning proton therapy,RADIATION,Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesotheliom,phase3,TERMINATED,NRG Oncology,
NCT04158141,Pleurectomy,PROCEDURE,Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesotheliom,phase3,TERMINATED,NRG Oncology,
NCT02013141,Telavancin,DRUG,Gram-Positive Bacterial Infections,phase1,TERMINATED,Cumberland Pharmaceuticals,
NCT03246854,DBPR112,DRUG,Head and Neck Cancer; NSCLC,phase1,TERMINATED,"National Health Research Institutes, Taiwan",
NCT00811694,ocular blood flow measurements,OTHER,Glaucoma,na,TERMINATED,Medical University of Vienna,
NCT02976766,Gypenosides,DRUG,Optic Neuritis,phase2,TERMINATED,First Affiliated Hospital of Guangxi Medical University,
NCT02976766,Placebo,DRUG,Optic Neuritis,phase2,TERMINATED,First Affiliated Hospital of Guangxi Medical University,
NCT03517566,Placebo,DRUG,Atopic Dermatitis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT03517566,ZPL389 3mg,DRUG,Atopic Dermatitis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT03517566,ZPL389 10mg,DRUG,Atopic Dermatitis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT03517566,ZPL389 30mg,DRUG,Atopic Dermatitis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT03517566,ZPL389 50mg,DRUG,Atopic Dermatitis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT05591222,Placebo,DRUG,Discoid Lupus Erythematosus,phase2,TERMINATED,Amgen,
NCT05591222,Daxdilimab,DRUG,Discoid Lupus Erythematosus,phase2,TERMINATED,Amgen,
NCT02300922,Antibody TF2,DRUG,Metastatic Colorectal Cancer,phase1; phase2,TERMINATED,Nantes University Hospital,
NCT02300922,90-Y-IMP-288,DRUG,Metastatic Colorectal Cancer,phase1; phase2,TERMINATED,Nantes University Hospital,
NCT02300922,111-In-IMP-288,DRUG,Metastatic Colorectal Cancer,phase1; phase2,TERMINATED,Nantes University Hospital,
NCT01135329,Fludarabine,DRUG,Lymphoma; Leukemia; Myelodysplastic Syndrome,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01135329,Busulfan,DRUG,Lymphoma; Leukemia; Myelodysplastic Syndrome,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01135329,Cyclophosphamide,DRUG,Lymphoma; Leukemia; Myelodysplastic Syndrome,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01135329,Mycophenolate Mofetil,DRUG,Lymphoma; Leukemia; Myelodysplastic Syndrome,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01135329,Tacrolimus,DRUG,Lymphoma; Leukemia; Myelodysplastic Syndrome,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT02612831,Early bariatric surgery,PROCEDURE,Chronic Kidney Disease; Obesity,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT02612831,Delayed bariatric surgery,PROCEDURE,Chronic Kidney Disease; Obesity,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT03796702,Deileostomy,PROCEDURE,"Ileostomy, Rectal Cancer",na,TERMINATED,Vilnius University,
NCT03634202,IMRT + oral chemotherapy,OTHER,Rectal Cancer; Metastasis; Radiotherapy,na,TERMINATED,Institut Cancerologie de l'Ouest,
NCT05193695,Treadmill exercise,OTHER,"Physical Therapy Modalities; Pain Measurement; Trigger Point Pain, Myofascial; Ankle Fractures; Rehabilitation; Needles",na,TERMINATED,"Becerra, Pablo",
NCT00643175,Automated follow up,BEHAVIORAL,Osteoporosis,na,TERMINATED,State University of New York - Upstate Medical University,
NCT05612412,Morning Exercise,OTHER,Overweight,na,TERMINATED,USDA Grand Forks Human Nutrition Research Center,
NCT05612412,Evening Exercise,OTHER,Overweight,na,TERMINATED,USDA Grand Forks Human Nutrition Research Center,
NCT05655130,Dexamethasone,DRUG,"Fractures, Bone; Fractures, Closed; Radius Fracture Distal",phase1,TERMINATED,Indiana Hand to Shoulder Center,
NCT05655130,Methylprednisolone,DRUG,"Fractures, Bone; Fractures, Closed; Radius Fracture Distal",phase1,TERMINATED,Indiana Hand to Shoulder Center,
NCT05655130,Standard of Care,OTHER,"Fractures, Bone; Fractures, Closed; Radius Fracture Distal",phase1,TERMINATED,Indiana Hand to Shoulder Center,
NCT01910428,L-asparaginase encapsulated in RBC,DRUG,Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma,phase1,TERMINATED,ERYtech Pharma,
NCT03562000,Cough Assistance and Systematic Non-Invasive Ventilation,DEVICE,Patients Intubated in ICU Before Extubation,na,TERMINATED,Hospices Civils de Lyon,
NCT03562000,"control group using the current gold standard of care after extubation, namely the manual drainage by a physiotherapist and the consensual use of Non-invasive ventilation",PROCEDURE,Patients Intubated in ICU Before Extubation,na,TERMINATED,Hospices Civils de Lyon,
NCT00445705,placebo,DRUG,Fibromyalgia,phase2,TERMINATED,Allergan,
NCT00445705,AGN 203818,DRUG,Fibromyalgia,phase2,TERMINATED,Allergan,
NCT00445705,AGN 203818,DRUG,Fibromyalgia,phase2,TERMINATED,Allergan,
NCT00445705,AGN 203818,DRUG,Fibromyalgia,phase2,TERMINATED,Allergan,
NCT03915405,KHK2455,DRUG,Urothelial Carcinoma,phase1,TERMINATED,"Kyowa Kirin, Inc.",
NCT03915405,Avelumab,DRUG,Urothelial Carcinoma,phase1,TERMINATED,"Kyowa Kirin, Inc.",
NCT00000305,Dextroamphetamine,DRUG,Cocaine-Related Disorders,phase1,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT06199466,Gemcitabine,DRUG,Metastatic Pancreatic Cancer,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT06199466,Nab-paclitaxel,DRUG,Metastatic Pancreatic Cancer,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT06199466,YL-13027,DRUG,Metastatic Pancreatic Cancer,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT00441766,AGN 203818,DRUG,Irritable Bowel Syndrome,phase2,TERMINATED,Allergan,
NCT00441766,AGN 203818,DRUG,Irritable Bowel Syndrome,phase2,TERMINATED,Allergan,
NCT00441766,AGN 203818,DRUG,Irritable Bowel Syndrome,phase2,TERMINATED,Allergan,
NCT00441766,placebo,DRUG,Irritable Bowel Syndrome,phase2,TERMINATED,Allergan,
NCT00696631,Dronedarone (SR33589),DRUG,Congestive Heart Failure,phase3,TERMINATED,Sanofi,
NCT00696631,Placebo,DRUG,Congestive Heart Failure,phase3,TERMINATED,Sanofi,
NCT00037622,"ACH-126, 443 (beta-L-Fd4C)",DRUG,Chronic Hepatitis B,na,TERMINATED,"Alexion Pharmaceuticals, Inc.",
NCT01138722,hypofractionated radiation therapy followed by surgery,RADIATION,Early Stage Non-small Cell Lung Cancer,phase2,TERMINATED,"University Hospital, Ghent",
NCT02664051,Nalcrom,DRUG,Dyspepsia,phase4,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT02664051,placebo,DRUG,Dyspepsia,phase4,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT03160729,Dexamethasone,DRUG,Kidney Diseases; Postoperative Complications,phase4,TERMINATED,"Rigshospitalet, Denmark",
NCT02652702,circular stapler-assisted colostomy,PROCEDURE,Colorectal Carcinoma,phase2,TERMINATED,Zhejiang University,
NCT02652702,conventional hand-stitching colostomy,PROCEDURE,Colorectal Carcinoma,phase2,TERMINATED,Zhejiang University,
NCT01817153,hydrocortison hemisuccinate,DRUG,Septic Shock; Adult,phase2; phase3,TERMINATED,Centre Hospitalier Régional d'Orléans,
NCT01817153,placebo followed by hydrocortisone hemisuccinate,DRUG,Septic Shock; Adult,phase2; phase3,TERMINATED,Centre Hospitalier Régional d'Orléans,
NCT04111445,ADG116,DRUG,Solid Tumor,phase1,TERMINATED,Adagene Inc,
NCT03869645,CAPERE Thrombectomy System,DEVICE,Observational Study,na,TERMINATED,Medtronic Endovascular,
NCT03110575,TNX-102 SL,DRUG,PTSD,phase3,TERMINATED,"Tonix Pharmaceuticals, Inc.",
NCT02837757,Biological samples,OTHER,Metastatic Renal Cancer,na,TERMINATED,Centre Hospitalier Universitaire de Besancon,
NCT02029781,LAPP score,PROCEDURE,Appendicitis,na,TERMINATED,University Medical Center Groningen,
NCT01033981,Sunitinib,DRUG,Metastatic Renal Cell Carcinoma,na,TERMINATED,Pfizer,
NCT05348681,RIST4721,DRUG,Hidradenitis Suppurativa,phase2,TERMINATED,"Aristea Therapeutics, Inc.",
NCT05348681,Placebo,DRUG,Hidradenitis Suppurativa,phase2,TERMINATED,"Aristea Therapeutics, Inc.",
NCT02245230,Angiotensin (1-7),DRUG,"Hypertension; Hypertension, Essential",phase1,TERMINATED,Vanderbilt University,
NCT02245230,Trimethaphan,DRUG,"Hypertension; Hypertension, Essential",phase1,TERMINATED,Vanderbilt University,
NCT02245230,Phenylephrine,DRUG,"Hypertension; Hypertension, Essential",phase1,TERMINATED,Vanderbilt University,
NCT00811967,PegIntron (peginterferon alfa-2b; SCH 54031),BIOLOGICAL,"Hepatitis C, Chronic; Liver Cirrhosis",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00811967,Rebetol (ribavirin; SCH 18908),DRUG,"Hepatitis C, Chronic; Liver Cirrhosis",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT04291027,Land Based Exercise,OTHER,Parkinson Disease,na,TERMINATED,Ithaca College,
NCT04291027,Aquatic Exercise,OTHER,Parkinson Disease,na,TERMINATED,Ithaca College,
NCT02628769,Solithromycin,DRUG,"Pulmonary Disease, Chronic Obstructive",phase2,TERMINATED,Imperial College London,
NCT02628769,Placebo,DRUG,"Pulmonary Disease, Chronic Obstructive",phase2,TERMINATED,Imperial College London,
NCT01515969,Erlotinib hydrochloride,DRUG,"Non-small Cell Lung Cancer (NSCLC), Recurrent; Non-small Cell Lung Cancer (NSCLC), Stage IV",phase1,TERMINATED,Heather Wakelee,
NCT01515969,Dovitinib lactate,DRUG,"Non-small Cell Lung Cancer (NSCLC), Recurrent; Non-small Cell Lung Cancer (NSCLC), Stage IV",phase1,TERMINATED,Heather Wakelee,
NCT05204654,In-office fabricated appliance,OTHER,Angle Class 2 Malocclusion,na,TERMINATED,State University of New York at Buffalo,
NCT05204654,Carriere Motion Appliance,DEVICE,Angle Class 2 Malocclusion,na,TERMINATED,State University of New York at Buffalo,
NCT04065841,Tropifexor,DRUG,Non Alcoholic Steatohepatitis (NASH),phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04065841,Licogliflozin,DRUG,Non Alcoholic Steatohepatitis (NASH),phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04065841,Placebo,OTHER,Non Alcoholic Steatohepatitis (NASH),phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02343705,Latella Knee Implant System,DEVICE,Osteoarthritis,na,TERMINATED,"Cotera, Inc.",
NCT03553394,Ringer's Acetate,DRUG,Fluid Therapy; Postoperative Period; Postoperative Complications; Pancreas Disease; Fluid Overload,na,TERMINATED,Uppsala University,
NCT00006994,glutamine,OTHER,Cancer-related Problem/Condition; Head and Neck Cancer; Pain,phase3,TERMINATED,SWOG Cancer Research Network,
NCT00006994,radiation therapy,RADIATION,Cancer-related Problem/Condition; Head and Neck Cancer; Pain,phase3,TERMINATED,SWOG Cancer Research Network,
NCT00006994,l-glutamine placebo,DRUG,Cancer-related Problem/Condition; Head and Neck Cancer; Pain,phase3,TERMINATED,SWOG Cancer Research Network,
NCT01436266,Misoprostol,DRUG,Abortion; Blood Loss,phase3,TERMINATED,Boston University,
NCT01436266,Folic acid,OTHER,Abortion; Blood Loss,phase3,TERMINATED,Boston University,
NCT01842594,Sirolimus and hydroxychloroquine,DRUG,Sarcoma,phase2,TERMINATED,Shin Kong Wu Ho-Su Memorial Hospital,
NCT03421756,Alemtuzumab,DRUG,Sickle Cell Disease,early_phase1,TERMINATED,Kathleen Dorritie,
NCT03421756,Total Body Irradiation,RADIATION,Sickle Cell Disease,early_phase1,TERMINATED,Kathleen Dorritie,
NCT03421756,Sirolimus,DRUG,Sickle Cell Disease,early_phase1,TERMINATED,Kathleen Dorritie,
NCT03964051,Omalizumab Injection,DRUG,Food Allergy,phase4,TERMINATED,Carsten Bindslev-Jensen,
NCT00681629,Quetiapine XR,DRUG,Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder,phase4,TERMINATED,AstraZeneca,
NCT00681629,Integrated Care Program (ICP),OTHER,Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder,phase4,TERMINATED,AstraZeneca,
NCT04858139,Lactate,DRUG,"Stroke, Acute",phase2,TERMINATED,Centre Hospitalier Universitaire Vaudois,
NCT04858139,Placebo,DRUG,"Stroke, Acute",phase2,TERMINATED,Centre Hospitalier Universitaire Vaudois,
NCT01136577,Phototherapy,DEVICE,Hyperbilirubinemia,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02002377,Aflibercept,DRUG,Age Related Macular Degeneration,phase4,TERMINATED,Unity Health Toronto,
NCT00814775,Fastrach Laryngeal Mask,DEVICE,Intubation,na,TERMINATED,The Cleveland Clinic,
NCT00814775,CTrach Laryngeal Mask,DEVICE,Intubation,na,TERMINATED,The Cleveland Clinic,
NCT02485457,Volume loading,PROCEDURE,Anesthesia,na,TERMINATED,Hopital Foch,
NCT02485457,Ringer solution,DRUG,Anesthesia,na,TERMINATED,Hopital Foch,
NCT01525446,SBRT with proton beam radiation,RADIATION,Non-small Cell Lung Cancer,early_phase1,TERMINATED,Massachusetts General Hospital,
NCT02395627,Tamoxifen,DRUG,Breast Neoplasms,phase2,TERMINATED,"University of California, San Francisco",
NCT02395627,Vorinostat,DRUG,Breast Neoplasms,phase2,TERMINATED,"University of California, San Francisco",
NCT02395627,Pembrolizumab,DRUG,Breast Neoplasms,phase2,TERMINATED,"University of California, San Francisco",
NCT00071942,recombinant vaccinia-MUC1 vaccine,BIOLOGICAL,Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00071942,recombinant vaccinia-TRICOM vaccine,BIOLOGICAL,Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00071942,laboratory biomarker analysis,OTHER,Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00071942,quality-of-life assessment,PROCEDURE,Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00257842,"Standard treatment, sham feedback and biofeedback therapy",PROCEDURE,Dyssynergia,na,TERMINATED,Augusta University,
NCT01416883,"ICI176,334-1",DRUG,Healthy,phase1,TERMINATED,AstraZeneca,
NCT05430854,Daxdilimab,BIOLOGICAL,Systemic Lupus Erythematosus,phase2,TERMINATED,Amgen,
NCT02606266,Valganciclovir,DRUG,Congenital Cytomegalovirus (CMV),phase2; phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04315051,Cohort 1 J. Lividum,DRUG,Interdigital Tinea Pedis,phase2,TERMINATED,"DermBiont, Inc.",
NCT04315051,Placebo Gel,OTHER,Interdigital Tinea Pedis,phase2,TERMINATED,"DermBiont, Inc.",
NCT00856453,Home yoga practice,BEHAVIORAL,Depression; Fatigue; Ovarian Cancer,na,TERMINATED,Wake Forest University Health Sciences,
NCT00856453,yoga classes,BEHAVIORAL,Depression; Fatigue; Ovarian Cancer,na,TERMINATED,Wake Forest University Health Sciences,
NCT05909995,INCB 99280 with Ipilimumab,DRUG,Melanoma; Hepatocellular Carcinoma (HCC); Renal Cell Carcinoma (RCC); Microsatellite Instability - High (MSI-H); Mismatch Repair Deficient (dMMR); Colorectal Carcinoma (CRC),phase1,TERMINATED,Incyte Corporation,
NCT05776875,Atezolizumab Injection,DRUG,Hepatocellular Carcinoma; BCLC Stage B Hepatocellular Carcinoma,phase2,TERMINATED,Yale University,
NCT05776875,Bevacizumab,DRUG,Hepatocellular Carcinoma; BCLC Stage B Hepatocellular Carcinoma,phase2,TERMINATED,Yale University,
NCT05776875,Transarterial chemoembolization,OTHER,Hepatocellular Carcinoma; BCLC Stage B Hepatocellular Carcinoma,phase2,TERMINATED,Yale University,
NCT03847675,Reach out and Read,BEHAVIORAL,Child Development,na,TERMINATED,American University of Beirut Medical Center,
NCT03640481,Belumosudil (KD025),DRUG,Chronic Graft-versus-host-disease,phase2,TERMINATED,"Kadmon, a Sanofi Company",
NCT03918681,Therapeutic Intervention,OTHER,Anterior Cruciate Ligament Injury; Knee Osteoarthritis,na,TERMINATED,Keller Army Community Hospital,
NCT04865419,AZD0466,DRUG,Haematological Malignancies,phase1,TERMINATED,AstraZeneca,
NCT04865419,Voriconazole,DRUG,Haematological Malignancies,phase1,TERMINATED,AstraZeneca,
NCT03941119,VR-therapy,OTHER,Dementia; Delirium Superimposed on Dementia,na,TERMINATED,"University Health Network, Toronto",
NCT05384119,TTI-101,DRUG,Breast Cancer,phase1,TERMINATED,"Tvardi Therapeutics, Incorporated",
NCT05384119,Palbociclib,DRUG,Breast Cancer,phase1,TERMINATED,"Tvardi Therapeutics, Incorporated",
NCT05384119,Aromatase inhibitor (AI),DRUG,Breast Cancer,phase1,TERMINATED,"Tvardi Therapeutics, Incorporated",
NCT05384119,fulvestrant,DRUG,Breast Cancer,phase1,TERMINATED,"Tvardi Therapeutics, Incorporated",
NCT05384119,ribociclib,DRUG,Breast Cancer,phase1,TERMINATED,"Tvardi Therapeutics, Incorporated",
NCT01170728,Coloplast Virtue® Male Sling,DEVICE,Stress Urinary Incontinence,na,TERMINATED,Coloplast A/S,
NCT00095888,triapine,DRUG,Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00095888,gemcitabine hydrochloride,DRUG,Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00095888,laboratory biomarker analysis,OTHER,Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00095888,pharmacological study,OTHER,Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00820703,Nexagon®,DRUG,Diabetic Foot Ulcer,phase1; phase2,TERMINATED,"OcuNexus Therapeutics, Inc.",
NCT00820703,Nexagon® vehicle,DRUG,Diabetic Foot Ulcer,phase1; phase2,TERMINATED,"OcuNexus Therapeutics, Inc.",
NCT05611086,N-Acetylcysteine,DRUG,"Lymphoblastic Leukemia, Acute, Childhood",phase4,TERMINATED,Teny Tjitra Sari,
NCT05611086,Placebo,DRUG,"Lymphoblastic Leukemia, Acute, Childhood",phase4,TERMINATED,Teny Tjitra Sari,
NCT00859170,Accordion device,DEVICE,Kidney Stones,na,TERMINATED,"Percutaneous Systems, Inc.",
NCT02670941,Ginger,DRUG,Chemotherapy Symptoms,early_phase1,TERMINATED,University of Rochester,
NCT02670941,Lavender,DRUG,Chemotherapy Symptoms,early_phase1,TERMINATED,University of Rochester,
NCT02670941,Orange,DRUG,Chemotherapy Symptoms,early_phase1,TERMINATED,University of Rochester,
NCT02670941,Jojoba,DRUG,Chemotherapy Symptoms,early_phase1,TERMINATED,University of Rochester,
NCT00113022,Org 24448,DRUG,Depression,phase2,TERMINATED,National Institute of Mental Health (NIMH),
NCT00113022,Placebo,DRUG,Depression,phase2,TERMINATED,National Institute of Mental Health (NIMH),
NCT04486222,Repeated Transcranial Magnetic Stimulation,DEVICE,"Transcranial Magnetic Stimulation; Depressive Disorder, Major",na,TERMINATED,National Taiwan University Hospital,
NCT06137729,PF-07899895,DRUG,Healthy,phase1,TERMINATED,Pfizer,
NCT06137729,Placebo,DRUG,Healthy,phase1,TERMINATED,Pfizer,
NCT00647972,Olanzapine Tablets 20 mg,DRUG,Healthy,phase1,TERMINATED,Mylan Pharmaceuticals Inc,
NCT00647972,Zyprexa® Tablets 20 mg,DRUG,Healthy,phase1,TERMINATED,Mylan Pharmaceuticals Inc,
NCT02139475,Colonoscopy,PROCEDURE,Colorectal Cancer,na,TERMINATED,Yonsei University,
NCT01707875,fetal brain neurosonography,OTHER,Fetal Ventricle Brain Asymmetry,na,TERMINATED,"HaEmek Medical Center, Israel",
NCT02082977,GSK2816126,DRUG,Cancer; Neoplasms,phase1,TERMINATED,GlaxoSmithKline,
NCT03574857,Metolazone Oral Tablet,DRUG,Heart Failure; Heart Failure With Reduced Ejection Fraction; Heart Failure Acute; Cardiovascular Diseases,phase4,TERMINATED,University of Virginia,
NCT03574857,Chlorothiazide Injection,DRUG,Heart Failure; Heart Failure With Reduced Ejection Fraction; Heart Failure Acute; Cardiovascular Diseases,phase4,TERMINATED,University of Virginia,
NCT04678557,VC-01 Combination Product,OTHER,Type 1 Diabetes,phase1; phase2,TERMINATED,ViaCyte,
NCT05229601,HFB301001,DRUG,Soft Tissue Sarcoma; Renal Cell Carcinoma; Uterine Carcinosarcoma; Hepatocellular Carcinoma; Head and Neck Squamous Cell Carcinoma; Melanoma,phase1,TERMINATED,HiFiBiO Therapeutics,
NCT05547412,NovaGuide 2 Intelligent Ultrasound System,DEVICE,Stroke; Acute Ischemic Stroke,na,TERMINATED,NovaSignal Corp.,
NCT04828161,ensovibep,DRUG,COVID-19,phase2; phase3,TERMINATED,Novartis Pharmaceuticals,
NCT04828161,Placebo,DRUG,COVID-19,phase2; phase3,TERMINATED,Novartis Pharmaceuticals,
NCT02346370,PEGylated recombinant human hyaluronidase PH20,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,Halozyme Therapeutics,
NCT02346370,Docetaxel,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,Halozyme Therapeutics,
NCT02042573,rTMS,DEVICE,Depression,phase4,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT02042573,SSRI (SEROPLEX ou ZOLOFT),DRUG,Depression,phase4,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT02042573,Genetic samples,OTHER,Depression,phase4,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT01433354,AFQ056,DRUG,Fragile X Syndrome,phase2; phase3,TERMINATED,Novartis Pharmaceuticals,
NCT01085266,Dimebon (latrepirdine),DRUG,Huntington Disease,phase3,TERMINATED,"Medivation, Inc.",
NCT04579666,Pegcetacoplan (APL-2),DRUG,Amyotrophic Lateral Sclerosis; Motor Neuron Disease,phase2,TERMINATED,"Apellis Pharmaceuticals, Inc.",
NCT04579666,Placebo,OTHER,Amyotrophic Lateral Sclerosis; Motor Neuron Disease,phase2,TERMINATED,"Apellis Pharmaceuticals, Inc.",
NCT00003156,topotecan hydrochloride,DRUG,Sarcoma,phase2,TERMINATED,Gynecologic Oncology Group,
NCT00619229,Alprostadil (prostaglandin E1),DRUG,Macular Degeneration,phase3,TERMINATED,UCB Pharma,
NCT00619229,Placebo,OTHER,Macular Degeneration,phase3,TERMINATED,UCB Pharma,
NCT02154529,Tesevatinib,DRUG,HER-2 Positive Breast Cancer; Metastatic Malignant Neoplasm to Brain,phase1; phase2,TERMINATED,"Kadmon Corporation, LLC",
NCT02154529,Trastuzumab,DRUG,HER-2 Positive Breast Cancer; Metastatic Malignant Neoplasm to Brain,phase1; phase2,TERMINATED,"Kadmon Corporation, LLC",
NCT02966431,Counseling,BEHAVIORAL,Weight Loss,na,TERMINATED,Texas Christian University,
NCT02966431,No Counseling,BEHAVIORAL,Weight Loss,na,TERMINATED,Texas Christian University,
NCT01516645,KHK2898,DRUG,Solid Tumour,phase1,TERMINATED,"Kyowa Kirin Co., Ltd.",
NCT05297045,RGT001-075,DRUG,Type 2 Diabetes Mellitus,phase2,TERMINATED,Regor Pharmaceuticals Inc.,
NCT05297045,Placebo,OTHER,Type 2 Diabetes Mellitus,phase2,TERMINATED,Regor Pharmaceuticals Inc.,
NCT00658372,PD 0332334,DRUG,Generalized Anxiety Disorder,phase3,TERMINATED,Pfizer,
NCT00658372,PD 0332334,DRUG,Generalized Anxiety Disorder,phase3,TERMINATED,Pfizer,
NCT00658372,Paroxetine,DRUG,Generalized Anxiety Disorder,phase3,TERMINATED,Pfizer,
NCT00658372,Placebo,DRUG,Generalized Anxiety Disorder,phase3,TERMINATED,Pfizer,
NCT00459472,laparoscopic training curriculum,BEHAVIORAL,Gall Bladder Disease,na,TERMINATED,Columbia University,
NCT06317272,DIBH using ABC technique,OTHER,Esophageal Cancer,na,TERMINATED,University Medical Center Groningen,
NCT06317272,DIBH using VC technique,OTHER,Esophageal Cancer,na,TERMINATED,University Medical Center Groningen,
NCT02062372,7 T MRI,DEVICE,Glioblastoma,na,TERMINATED,Maastricht Radiation Oncology,
NCT02062372,Biopsy,PROCEDURE,Glioblastoma,na,TERMINATED,Maastricht Radiation Oncology,
NCT04399239,AuriNovo,OTHER,Microtia,phase1; phase2,TERMINATED,3DBio Therapeutics,
NCT01133639,Ketorolac,DRUG,Bunion,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT01133639,Placebo,DRUG,Bunion,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT03248739,Clear Bactiseal 'large' catheter (EVD),DEVICE,Occlusion,na,TERMINATED,Wake Forest University Health Sciences,
NCT03248739,Orange Bactiseal 'small' catheter (EVD),DEVICE,Occlusion,na,TERMINATED,Wake Forest University Health Sciences,
NCT00651339,botox,DRUG,Cerebral Palsy,na,TERMINATED,Soroka University Medical Center,
NCT00634101,nelfilcon A,DEVICE,Refractive Error; Myopia,na,TERMINATED,"Johnson & Johnson Vision Care, Inc.",
NCT00634101,narafilcon A,DEVICE,Refractive Error; Myopia,na,TERMINATED,"Johnson & Johnson Vision Care, Inc.",
NCT02277522,RNA anti-CD19 CAR T cells,BIOLOGICAL,Hodgkin Lymphoma With no Available Curative Treatment Options Who Have a Limited Prognosis,early_phase1,TERMINATED,University of Pennsylvania,
NCT04172922,Topical Sirolimus,DRUG,Vascular Anomaly,phase1,TERMINATED,Nemours Children's Clinic,
NCT00217022,Placebo,OTHER,Lymphocytic Colitis; Diarrhea,phase2; phase3,TERMINATED,Mayo Clinic,
NCT00217022,Budesonide,DRUG,Lymphocytic Colitis; Diarrhea,phase2; phase3,TERMINATED,Mayo Clinic,
NCT03360851,low-dose CT,OTHER,Community-acquired Pneumonia,na,TERMINATED,MJM Bonten,
NCT03360851,PoC-PCR,OTHER,Community-acquired Pneumonia,na,TERMINATED,MJM Bonten,
NCT05494229,Pars-plana vitrectomy,OTHER,Ophthalmopathy,na,TERMINATED,Omer Othman Abdullah,
NCT02762331,Ascorbic Acid,DRUG,Disorder of Vitamin C; Atrial Fibrillation; Complications Due to Coronary Artery Bypass Graft; Heart Valve Disease,phase1,TERMINATED,Virginia Commonwealth University,
NCT02762331,Placebo,DRUG,Disorder of Vitamin C; Atrial Fibrillation; Complications Due to Coronary Artery Bypass Graft; Heart Valve Disease,phase1,TERMINATED,Virginia Commonwealth University,
NCT00960531,ACC-001+ QS21 (3mcg),BIOLOGICAL,Alzheimer Disease,phase2,TERMINATED,Pfizer,
NCT00960531,ACC-001 (10 mcg) + QS-21,BIOLOGICAL,Alzheimer Disease,phase2,TERMINATED,Pfizer,
NCT00960531,ACC-001+QS-21 (30mcg),BIOLOGICAL,Alzheimer Disease,phase2,TERMINATED,Pfizer,
NCT02359331,H. pylori culture and antimicrobial susceptibility testing,PROCEDURE,Helicobacter Infection,na,TERMINATED,Seoul National University Bundang Hospital,
NCT02359331,14 days empirical bismuth quadruple therapy (Proton pump inhibitor),DRUG,Helicobacter Infection,na,TERMINATED,Seoul National University Bundang Hospital,
NCT02359331,Metronidazole,DRUG,Helicobacter Infection,na,TERMINATED,Seoul National University Bundang Hospital,
NCT02359331,Tetracycline,DRUG,Helicobacter Infection,na,TERMINATED,Seoul National University Bundang Hospital,
NCT02359331,tripotassium dicitrate bismuthate,DRUG,Helicobacter Infection,na,TERMINATED,Seoul National University Bundang Hospital,
NCT02359331,7 days tailored therapy Proton Pump Inhibitor,DRUG,Helicobacter Infection,na,TERMINATED,Seoul National University Bundang Hospital,
NCT02359331,Moxifloxacin,DRUG,Helicobacter Infection,na,TERMINATED,Seoul National University Bundang Hospital,
NCT02359331,Amoxicillin,DRUG,Helicobacter Infection,na,TERMINATED,Seoul National University Bundang Hospital,
NCT03080753,Sphinkeeper,DEVICE,Anal Incontinence; Fecal Incontinence,na,TERMINATED,Region Skane,
NCT00832637,Cisplatin,DRUG,Hepatocellular Carcinoma; Cholangiocellular Carcinoma; Cholangiocarcinoma of the Extrahepatic Bile Duct; Bile Duct Cancer; Periampullary Adenocarcinoma; Gallbladder Cancer; Extrahepatic Bile Duct Canc,phase2,TERMINATED,New Mexico Cancer Research Alliance,
NCT00832637,Erlotinib,DRUG,Hepatocellular Carcinoma; Cholangiocellular Carcinoma; Cholangiocarcinoma of the Extrahepatic Bile Duct; Bile Duct Cancer; Periampullary Adenocarcinoma; Gallbladder Cancer; Extrahepatic Bile Duct Canc,phase2,TERMINATED,New Mexico Cancer Research Alliance,
NCT00832637,Gemcitabine,DRUG,Hepatocellular Carcinoma; Cholangiocellular Carcinoma; Cholangiocarcinoma of the Extrahepatic Bile Duct; Bile Duct Cancer; Periampullary Adenocarcinoma; Gallbladder Cancer; Extrahepatic Bile Duct Canc,phase2,TERMINATED,New Mexico Cancer Research Alliance,
NCT02366637,Placebo,DRUG,"Pulmonary Disease, Chronic Obstructive",phase2,TERMINATED,Pfizer,
NCT02366637,PF-03715455,DRUG,"Pulmonary Disease, Chronic Obstructive",phase2,TERMINATED,Pfizer,
NCT04571645,Dociparstat,DRUG,Acute Myeloid Leukemia,phase3,TERMINATED,Jazz Pharmaceuticals,
NCT04571645,Control,OTHER,Acute Myeloid Leukemia,phase3,TERMINATED,Jazz Pharmaceuticals,
NCT02518672,MAG-DHA,OTHER,Cystic Fibrosis,phase2,TERMINATED,SCF Pharma,
NCT02518672,Placebo,OTHER,Cystic Fibrosis,phase2,TERMINATED,SCF Pharma,
NCT04570995,Fish Oil,OTHER,Brain Health; Brain Function; Brain Development,na,TERMINATED,Wake Forest University Health Sciences,
NCT04570995,Safflower Oil,OTHER,Brain Health; Brain Function; Brain Development,na,TERMINATED,Wake Forest University Health Sciences,
NCT01721577,AXL1717,DRUG,Glioblastoma; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma; Anaplastic Ependymoma,phase1; phase2,TERMINATED,Rush University Medical Center,
NCT05453539,DSPE-DOTA-Gd Liposomal Injection,DRUG,Alzheimer Disease,phase1,TERMINATED,"Alzeca Biosciences, Inc.",
NCT03063775,BioOss® + Mucograft Seal®,DEVICE,Tissue Preservation,na,TERMINATED,Medical University of Graz,
NCT03063775,FGG + Bio-Oss®,OTHER,Tissue Preservation,na,TERMINATED,Medical University of Graz,
NCT03063775,FGG + Gelatine sponge (Spongostan®),OTHER,Tissue Preservation,na,TERMINATED,Medical University of Graz,
NCT03063775,Spongostan®+ Mucograft® Seal,DEVICE,Tissue Preservation,na,TERMINATED,Medical University of Graz,
NCT01210365,Diurisa®,DRUG,Congestive Heart Failure,phase3,TERMINATED,Eurofarma Laboratorios S.A.,
NCT01210365,Lasix ®,DRUG,Congestive Heart Failure,phase3,TERMINATED,Eurofarma Laboratorios S.A.,
NCT03428945,Hydroxychloroquine,DRUG,Type1 Diabetes Mellitus,phase2,TERMINATED,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
NCT03428945,Placebo,DRUG,Type1 Diabetes Mellitus,phase2,TERMINATED,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
NCT01059045,cryocontact therapy,PROCEDURE,Hemangioma of Preterm Infants,na,TERMINATED,University Hospital Tuebingen,
NCT01059045,Control,OTHER,Hemangioma of Preterm Infants,na,TERMINATED,University Hospital Tuebingen,
NCT03516695,TheraSphere®,DEVICE,Liver Cancer,na,TERMINATED,Boston Scientific Corporation,
NCT02078375,Protein,OTHER,Rheumatoid Arthritis,na,TERMINATED,Johns Hopkins University,
NCT02078375,Carbohydrate (Placebo),OTHER,Rheumatoid Arthritis,na,TERMINATED,Johns Hopkins University,
NCT02078375,Resistance Exercise Program,OTHER,Rheumatoid Arthritis,na,TERMINATED,Johns Hopkins University,
NCT03349775,Metformin,DRUG,Obesity,early_phase1,TERMINATED,Massachusetts General Hospital,
NCT03349775,Placebo,DRUG,Obesity,early_phase1,TERMINATED,Massachusetts General Hospital,
NCT02382757,insulin human,DRUG,"Diabetes; Diabetes Mellitus, Type 1",na,TERMINATED,Novo Nordisk A/S,
NCT02722512,Heat Shock Protein Peptide Complex-96 (HSPPC-96),BIOLOGICAL,"Glioblastoma Multiforme; Astrocytoma, Grade III; Anaplastic Ependymoma; Clear Cell Ependymoma; Ependymoma",phase1,TERMINATED,Ann & Robert H Lurie Children's Hospital of Chicago,
NCT02722512,Tumor Resection,PROCEDURE,"Glioblastoma Multiforme; Astrocytoma, Grade III; Anaplastic Ependymoma; Clear Cell Ependymoma; Ependymoma",phase1,TERMINATED,Ann & Robert H Lurie Children's Hospital of Chicago,
NCT02722512,Radiation,RADIATION,"Glioblastoma Multiforme; Astrocytoma, Grade III; Anaplastic Ependymoma; Clear Cell Ependymoma; Ependymoma",phase1,TERMINATED,Ann & Robert H Lurie Children's Hospital of Chicago,
NCT02948712,Distress Screening Thermometer,BEHAVIORAL,Adolescent and Young Adult Cancer,na,TERMINATED,Case Comprehensive Cancer Center,
NCT02948712,NCCN Guidelines: Distress management,BEHAVIORAL,Adolescent and Young Adult Cancer,na,TERMINATED,Case Comprehensive Cancer Center,
NCT05427812,ISB 1442 SC injection escalating doses,DRUG,Relapsed/Refractory Multiple Myeloma,phase1; phase2,TERMINATED,Ichnos Sciences SA,
NCT05427812,ISB 1442 SC injection at RP2D,DRUG,Relapsed/Refractory Multiple Myeloma,phase1; phase2,TERMINATED,Ichnos Sciences SA,
NCT03878719,binimetinib,DRUG,Melanoma,phase1,TERMINATED,Pfizer,
NCT03878719,encorafenib,DRUG,Melanoma,phase1,TERMINATED,Pfizer,
NCT00224419,Motivational interviewing for smoking cessation,BEHAVIORAL,Smoking; Pregnancy,phase4,TERMINATED,Duke University,
NCT00224419,Cognitive behaviors therapy,BEHAVIORAL,Smoking; Pregnancy,phase4,TERMINATED,Duke University,
NCT00224419,CBT + NRT,DRUG,Smoking; Pregnancy,phase4,TERMINATED,Duke University,
NCT04297319,Laser diiodo,PROCEDURE,Lasers; Atrophy of Vagina; Atrophy Vulva,na,TERMINATED,Hospital Italiano de Buenos Aires,
NCT04297319,Laser Placebo,PROCEDURE,Lasers; Atrophy of Vagina; Atrophy Vulva,na,TERMINATED,Hospital Italiano de Buenos Aires,
NCT00819819,Gluten,OTHER,Celiac Disease; Infant Nutrition,na,TERMINATED,Massachusetts General Hospital,
NCT00819819,Gluten free diet,OTHER,Celiac Disease; Infant Nutrition,na,TERMINATED,Massachusetts General Hospital,
NCT02907619,PF-06252616,BIOLOGICAL,Duchenne Muscular Dystrophy,phase2,TERMINATED,Pfizer,
NCT03031730,Biospecimen Collection,PROCEDURE,Plasmacytoma; Recurrent Multiple Myeloma; Refractory Multiple Myeloma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03031730,Bone Marrow Aspiration and Biopsy,PROCEDURE,Plasmacytoma; Recurrent Multiple Myeloma; Refractory Multiple Myeloma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03031730,Carfilzomib,DRUG,Plasmacytoma; Recurrent Multiple Myeloma; Refractory Multiple Myeloma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03031730,Dexamethasone,DRUG,Plasmacytoma; Recurrent Multiple Myeloma; Refractory Multiple Myeloma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03031730,Dexamethasone Sodium Phosphate,DRUG,Plasmacytoma; Recurrent Multiple Myeloma; Refractory Multiple Myeloma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03031730,Echocardiography,PROCEDURE,Plasmacytoma; Recurrent Multiple Myeloma; Refractory Multiple Myeloma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03031730,Lenalidomide,DRUG,Plasmacytoma; Recurrent Multiple Myeloma; Refractory Multiple Myeloma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03031730,Navtemadlin,DRUG,Plasmacytoma; Recurrent Multiple Myeloma; Refractory Multiple Myeloma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01416428,oprozomib,DRUG,Multiple Myeloma; Waldenstrom Macroglobulinemia,phase1; phase2,TERMINATED,Amgen,
NCT03906500,High schools High on Life,BEHAVIORAL,Alcohol Drinking,na,TERMINATED,University of Southern Denmark,
NCT00628992,"No specific intervention, standard therapy serving as a control group, passive mobilization of the legs",OTHER,Chronic Obstructive Pulmonary Disease; Acute Respiratory Failure,na,TERMINATED,"University Hospital, Strasbourg, France",
NCT00628992,Electrical stimulation of the thigh,OTHER,Chronic Obstructive Pulmonary Disease; Acute Respiratory Failure,na,TERMINATED,"University Hospital, Strasbourg, France",
NCT00628992,Cycloergometer training,OTHER,Chronic Obstructive Pulmonary Disease; Acute Respiratory Failure,na,TERMINATED,"University Hospital, Strasbourg, France",
NCT00628992,Electrical stimulation of the thigh and cycloergometer training,OTHER,Chronic Obstructive Pulmonary Disease; Acute Respiratory Failure,na,TERMINATED,"University Hospital, Strasbourg, France",
NCT03916692,Carbohydrate drink,OTHER,Glycemic Index,na,TERMINATED,Arizona State University,
NCT03916692,Energy smart Carbohydrate blend,OTHER,Glycemic Index,na,TERMINATED,Arizona State University,
NCT03916692,Liquid Dextrose,OTHER,Glycemic Index,na,TERMINATED,Arizona State University,
NCT01793636,AZD2014,DRUG,Metastatic Clear Cell Renal Carcinoma,phase2,TERMINATED,Queen Mary University of London,
NCT01793636,Everolimus,DRUG,Metastatic Clear Cell Renal Carcinoma,phase2,TERMINATED,Queen Mary University of London,
NCT00335036,ICD lead implant,DEVICE,Ventricular Tachycardia; Ventricular Fibrillation; Cardiomyopathy; Long QT Syndrome; Congenital Heart Disease,na,TERMINATED,Elena Gibson,
NCT00335036,Thin leads,DEVICE,Ventricular Tachycardia; Ventricular Fibrillation; Cardiomyopathy; Long QT Syndrome; Congenital Heart Disease,na,TERMINATED,Elena Gibson,
NCT00670605,medical chart review,OTHER,"Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific",na,TERMINATED,Vanderbilt University,
NCT00670605,study of socioeconomic and demographic variables,OTHER,"Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific",na,TERMINATED,Vanderbilt University,
NCT01705405,Software for acquiring ultrasound and endoscopic images,DEVICE,Prostate Cancer,na,TERMINATED,AdministrateurCIC,
NCT02858466,MRI scan,RADIATION,Neuropathic Pain,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT02560051,Doxorubicin,DRUG,Prostatic Neoplasms,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT02560051,Ketoconazole,DRUG,Prostatic Neoplasms,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT02560051,Docetaxel,DRUG,Prostatic Neoplasms,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT02560051,Estramustine,DRUG,Prostatic Neoplasms,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT02560051,Degarelix,DRUG,Prostatic Neoplasms,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT01358331,MK-8353,DRUG,"Tumor, Solid",phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT00005072,Leuvectin,BIOLOGICAL,Prostate Cancer,phase1; phase2,TERMINATED,Vical,
NCT03926481,Evaluate Healthy Lifestyle Program on cognitive outcomes,BEHAVIORAL,Obesity,na,TERMINATED,Dartmouth-Hitchcock Medical Center,
NCT00477230,Endoscopic Ablation System,DEVICE,Atrial Fibrillation,phase3,TERMINATED,CardioFocus,
NCT00477230,Standard Anti-arrhythmic Drug (AAD) Therapy,DRUG,Atrial Fibrillation,phase3,TERMINATED,CardioFocus,
NCT00987428,ultrasonography with or not sphincterotomy,PROCEDURE,Pancreatitis Acute Biliary,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00987428,Usual procedure,PROCEDURE,Pancreatitis Acute Biliary,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00869167,Ramelteon,DRUG,Insomnia; Asthma,phase3,TERMINATED,Northwestern University,
NCT04677322,Adult patients diagnosed and treated for high blood pressure,DRUG,Arterial Hypertension; Sodium Urine; Primary Care Center; Diet Habit,na,TERMINATED,Instituto de Investigación Marqués de Valdecilla,
NCT00792831,ITF2357,DRUG,Chronic Lymphocytic Leukemia,phase2,TERMINATED,Italfarmaco,
NCT00176553,Dextromethorphan,DRUG,Neurotoxicity Syndromes,na,TERMINATED,University of Medicine and Dentistry of New Jersey,
NCT01018953,BIM 23A760,DRUG,Carcinoid Syndrome,phase2,TERMINATED,Ipsen,
NCT01147601,topical 0.5% Timolol,DRUG,Hemangioma; Infant,early_phase1,TERMINATED,Oregon Health and Science University,
NCT01147601,Control (placebo) group,DRUG,Hemangioma; Infant,early_phase1,TERMINATED,Oregon Health and Science University,
NCT04702230,MRI,OTHER,Liver Neoplasm,na,TERMINATED,University of Zurich,
NCT00183430,Prazosin,DRUG,Post-Traumatic Stress Disorder; Sleep Initiation and Maintenance Disorders,na,TERMINATED,Seattle Institute for Biomedical and Clinical Research,
NCT00183430,Placebo,DRUG,Post-Traumatic Stress Disorder; Sleep Initiation and Maintenance Disorders,na,TERMINATED,Seattle Institute for Biomedical and Clinical Research,
NCT00183430,Psychotherapy,BEHAVIORAL,Post-Traumatic Stress Disorder; Sleep Initiation and Maintenance Disorders,na,TERMINATED,Seattle Institute for Biomedical and Clinical Research,
NCT00629330,Academic Detailing,BEHAVIORAL,Prostate Cancer,phase4,TERMINATED,Columbia University,
NCT03387267,Dysphagia Detection System,DEVICE,Stroke; Parkinson Disease; Multiple Sclerosis; Oropharyngeal Dysphagia; Alzheimer Disease; Dementia,na,TERMINATED,Société des Produits Nestlé (SPN),
NCT05359367,Observational,OTHER,Stroke; Inpatients; Recovery of Function; Observational Study,na,TERMINATED,Danderyd Hospital,
NCT00040391,Investigational drug,DRUG,Colorectal Neoplasms; Diarrhea,phase2,TERMINATED,Celgene Corporation,
NCT00040391,Irinotecan,DRUG,Colorectal Neoplasms; Diarrhea,phase2,TERMINATED,Celgene Corporation,
NCT00040391,5-fluorouracil,DRUG,Colorectal Neoplasms; Diarrhea,phase2,TERMINATED,Celgene Corporation,
NCT00040391,Leucovorin,DRUG,Colorectal Neoplasms; Diarrhea,phase2,TERMINATED,Celgene Corporation,
NCT00128791,Nitroprusside,DRUG,Myocardial Infarction,phase4,TERMINATED,Soroka University Medical Center,
NCT01266018,ADI-PEG 20 (Arginine deiminase pegylated),DRUG,Small Cell Lung Cancer,phase2,TERMINATED,Ludwig Institute for Cancer Research,
NCT02880410,NeuroBlate System,DEVICE,Glioblastoma,phase1,TERMINATED,Monteris Medical,
NCT02880410,Radiation therapy and temozolomide,DRUG,Glioblastoma,phase1,TERMINATED,Monteris Medical,
NCT03633513,LBT-3627,OTHER,Parkinson Disease,na,TERMINATED,Longevity Biotech,
NCT03633513,Immunological profiling,OTHER,Parkinson Disease,na,TERMINATED,Longevity Biotech,
NCT00121420,Motexafin gadolinium,DRUG,Neoplasm Metastasis; Brain Neoplasms,phase2,TERMINATED,Pharmacyclics LLC.,
NCT07194824,Pragmatic allergy management according to risk stratification,OTHER,Allergy Drug; Allergy Penicillin,na,TERMINATED,Althaia Xarxa Assistencial Universitària de Manresa,
NCT00908024,BMS-754807,DRUG,Colorectal Cancer; Head and Neck Cancer; Neoplasm Metastasis,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT00908024,cetuximab (Erbitux®),DRUG,Colorectal Cancer; Head and Neck Cancer; Neoplasm Metastasis,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT00506779,Imatinib Mesylate,DRUG,Uterine Cancer,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00506779,Paclitaxel,DRUG,Uterine Cancer,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02171546,Dabigatran etexilate capsules,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT02171546,Quinidine sulfate tablets,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT02171546,Fexofenadine tablets,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT00490061,Lapatinib,DRUG,"Head and Neck Cancer; Carcinoma, Squamous Cell; Head and Neck Cancers",phase2,TERMINATED,Quynh-Thu Le,
NCT00490061,Radiotherapy (radiation),PROCEDURE,"Head and Neck Cancer; Carcinoma, Squamous Cell; Head and Neck Cancers",phase2,TERMINATED,Quynh-Thu Le,
NCT00490061,"G.E. Healthcare 1.5T MR, systems revision 12.0 M5",DEVICE,"Head and Neck Cancer; Carcinoma, Squamous Cell; Head and Neck Cancers",phase2,TERMINATED,Quynh-Thu Le,
NCT00490061,DCE-MRI,DEVICE,"Head and Neck Cancer; Carcinoma, Squamous Cell; Head and Neck Cancers",phase2,TERMINATED,Quynh-Thu Le,
NCT01537861,Filgrastim,DRUG,Multiple Myeloma,early_phase1,TERMINATED,Washington University School of Medicine,
NCT01537861,Bortezomib,DRUG,Multiple Myeloma,early_phase1,TERMINATED,Washington University School of Medicine,
NCT01537861,Carfilzomib,DRUG,Multiple Myeloma,early_phase1,TERMINATED,Washington University School of Medicine,
NCT01537861,Dexamethasone,DRUG,Multiple Myeloma,early_phase1,TERMINATED,Washington University School of Medicine,
NCT01537861,Cyclophosphamide,DRUG,Multiple Myeloma,early_phase1,TERMINATED,Washington University School of Medicine,
NCT01537861,Thalidomide,DRUG,Multiple Myeloma,early_phase1,TERMINATED,Washington University School of Medicine,
NCT01537861,Lenalidomide,DRUG,Multiple Myeloma,early_phase1,TERMINATED,Washington University School of Medicine,
NCT01537861,Pomalidomide,DRUG,Multiple Myeloma,early_phase1,TERMINATED,Washington University School of Medicine,
NCT03891173,L-DOS47,DRUG,Lung Adenocarcinoma,phase2,TERMINATED,Helix BioPharma Corporation,
NCT03891173,Cisplatin,DRUG,Lung Adenocarcinoma,phase2,TERMINATED,Helix BioPharma Corporation,
NCT03891173,Vinorelbine,DRUG,Lung Adenocarcinoma,phase2,TERMINATED,Helix BioPharma Corporation,
NCT03170869,Surefire Precision Infusion System,DEVICE,Hepatocellular Carcinoma of the Liver; Subjects Eligible for Liver Transplantation,na,TERMINATED,"University of Colorado, Denver",
NCT01046773,Cholecalciferol,DRUG,Crohn's Disease; Vitamin D Deficiency,phase1,TERMINATED,"University of California, Los Angeles",
NCT01046773,Cholecalciferol,DRUG,Crohn's Disease; Vitamin D Deficiency,phase1,TERMINATED,"University of California, Los Angeles",
NCT02943473,Ibrutinib,DRUG,High Risk Smoldering Multiple Myeloma,phase2,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT00871273,capecitabine,DRUG,Adenocarcinoma of the Stomach,phase4,TERMINATED,Cambridge University Hospitals NHS Foundation Trust,
NCT03794583,Inhaled treprostinil solution,DRUG,Pulmonary Hypertension; Chronic Obstructive Pulmonary Disease,phase3,TERMINATED,United Therapeutics,
NCT00634868,Qray light therapy device,OTHER,Diabetic Ulcer,na,TERMINATED,QRay Ltd.,
NCT00634868,Qray light therapy device-Sham,DEVICE,Diabetic Ulcer,na,TERMINATED,QRay Ltd.,
NCT01169350,fludeoxyglucose F 18,RADIATION,Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma; Stage II Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01169350,18F-fluoromisonidazole,OTHER,Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma; Stage II Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01169350,positron emission tomography,PROCEDURE,Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma; Stage II Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01169350,computed tomography,PROCEDURE,Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma; Stage II Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01169350,laboratory biomarker analysis,OTHER,Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma; Stage II Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT02088060,Cannabidiol,DRUG,Schizophrenia,phase2,TERMINATED,"Central Institute of Mental Health, Mannheim",
NCT02088060,Olanzapine,DRUG,Schizophrenia,phase2,TERMINATED,"Central Institute of Mental Health, Mannheim",
NCT02088060,Placebo Cannabidiol,DRUG,Schizophrenia,phase2,TERMINATED,"Central Institute of Mental Health, Mannheim",
NCT02088060,Placebo Olanzapine,DRUG,Schizophrenia,phase2,TERMINATED,"Central Institute of Mental Health, Mannheim",
NCT03098420,2mg Dexamethasone,DRUG,Post Surgical Pain,phase2; phase3,TERMINATED,University of Alabama at Birmingham,
NCT03098420,4mg Dexamethasone,DRUG,Post Surgical Pain,phase2; phase3,TERMINATED,University of Alabama at Birmingham,
NCT03098420,Ropivacaine (TAP blocks),DRUG,Post Surgical Pain,phase2; phase3,TERMINATED,University of Alabama at Birmingham,
NCT03098420,Morphine,DRUG,Post Surgical Pain,phase2; phase3,TERMINATED,University of Alabama at Birmingham,
NCT03098420,Bupivacaine Hydrochloride,DRUG,Post Surgical Pain,phase2; phase3,TERMINATED,University of Alabama at Birmingham,
NCT03098420,Normal saline 1ml,DRUG,Post Surgical Pain,phase2; phase3,TERMINATED,University of Alabama at Birmingham,
NCT03098420,Normal saline 0.5ml,DRUG,Post Surgical Pain,phase2; phase3,TERMINATED,University of Alabama at Birmingham,
NCT00590720,MEDI528 50 mg,BIOLOGICAL,Asthma,phase2,TERMINATED,MedImmune LLC,
NCT00590720,PLACEBO,OTHER,Asthma,phase2,TERMINATED,MedImmune LLC,
NCT04527523,Optical Coherence Tomography,OTHER,Cystoid Macular Edema; Fuchs Dystrophy,na,TERMINATED,Wake Forest University Health Sciences,
NCT00194623,Botulinum Toxin A (Botox),DRUG,Chronic Male Pelvic Pain Syndrome,phase4,TERMINATED,University of Washington,
NCT03655080,Radiation therapy,RADIATION,Cord Compression,phase2,TERMINATED,Washington University School of Medicine,
NCT03655080,nab-Paclitaxel,DRUG,Cord Compression,phase2,TERMINATED,Washington University School of Medicine,
NCT00429403,Goserelin,DRUG,Breast Cancer,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT03597503,SPN-810,DRUG,Attention Deficit Hyperactivity Disorder,phase3,TERMINATED,"Supernus Pharmaceuticals, Inc.",
NCT03597503,Placebo,DRUG,Attention Deficit Hyperactivity Disorder,phase3,TERMINATED,"Supernus Pharmaceuticals, Inc.",
NCT02974803,Dabrafenib,DRUG,Melanoma; Brain Metastases,phase2,TERMINATED,Canadian Cancer Trials Group,
NCT02974803,Trametinib,DRUG,Melanoma; Brain Metastases,phase2,TERMINATED,Canadian Cancer Trials Group,
NCT02697942,cognitive training,OTHER,"Kidney Failure, Chronic",na,TERMINATED,Johns Hopkins Bloomberg School of Public Health,
NCT02697942,exercise training,OTHER,"Kidney Failure, Chronic",na,TERMINATED,Johns Hopkins Bloomberg School of Public Health,
NCT03013842,Raydiant Oximetry Sensor System,DEVICE,"Pregnancy, Abdominal",na,TERMINATED,"University of California, Davis",
NCT05445869,ProSomnus® EVO Sleep and Snore Device,DEVICE,Obstructive Sleep Apnea; Sleep Apnea,na,TERMINATED,ProSomnus Sleep Technologies,
NCT05739669,EEG recording with the comparator device Micromed Brain Quick,DEVICE,Epilepsy,na,TERMINATED,Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology,
NCT05739669,"EEG recording with the investigational device ""Atlas with dry electrodes"" clinic/specialized staff",DEVICE,Epilepsy,na,TERMINATED,Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology,
NCT05739669,"EEG recording with the investigational device ""Atlas with dry electrodes"" home/lay people",DEVICE,Epilepsy,na,TERMINATED,Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology,
NCT01165970,Glandosane,DRUG,Hyposalivation,phase2; phase3,TERMINATED,"Charite University, Berlin, Germany",
NCT01165970,Saliva natura,DEVICE,Hyposalivation,phase2; phase3,TERMINATED,"Charite University, Berlin, Germany",
NCT02716805,Tremelimumab,DRUG,Multiple Myeloma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT02716805,Durvalumab,DRUG,Multiple Myeloma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT02716805,Prevnar-13,BIOLOGICAL,Multiple Myeloma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT02716805,Melphalan,DRUG,Multiple Myeloma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT01428505,[18F]PBR111,RADIATION,Multiple Sclerosis,phase2,TERMINATED,GlaxoSmithKline,
NCT01108705,Brivanib,DRUG,"Carcinoma, Hepatocellular",phase3,TERMINATED,Bristol-Myers Squibb,
NCT01108705,Placebo,DRUG,"Carcinoma, Hepatocellular",phase3,TERMINATED,Bristol-Myers Squibb,
NCT03930290,Vaginal tactile imager,OTHER,Vaginal Prolapse,na,TERMINATED,Rambam Health Care Campus,
NCT03943290,ACE-083,DRUG,Facioscapulohumeral Muscular Dystrophy; Charcot-Marie-Tooth Disease,phase2,TERMINATED,"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
NCT00203190,Topiramate,DRUG,Cluster Headache,phase4,TERMINATED,Thomas Jefferson University,
NCT04002310,BI 754132,DRUG,Macular Degeneration,phase1,TERMINATED,Boehringer Ingelheim,
NCT00391313,Chloroquine,DRUG,Chikungunya Virus,phase3,TERMINATED,Assistance Publique Hopitaux De Marseille,
NCT01614782,MK-5823,DRUG,Type 2 Diabetes Mellitus,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01614782,Placebo,OTHER,Type 2 Diabetes Mellitus,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT04485182,Underwater jet massage (Tangentor),OTHER,Low Back Pain,na,TERMINATED,"Polyclinic of the Hospitaller Brothers of St. John of God, Budapest",
NCT03640988,dermaPACE,DEVICE,Diabetic Foot Ulcer,na,TERMINATED,"SANUWAVE, Inc.",
NCT02457988,Vivify Kit,DEVICE,Cirrhosis,early_phase1,TERMINATED,"University of California, Los Angeles",
NCT00477503,Gallium-67 Citrate (Ga-67),DRUG,Central Nervous System Tumors; Brain Tumors,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT00477503,In-111 DTPA (In-111 pentetate),DRUG,Central Nervous System Tumors; Brain Tumors,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT01127542,Lenalidomide,DRUG,Chronic Lymphocytic Leukaemia,phase2,TERMINATED,The Christie NHS Foundation Trust,
NCT03076242,GEM Registry,OTHER,Prostate Cancer,na,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT00383942,Misoprostol,DRUG,Cesarean Section,phase4,TERMINATED,Loyola University,
NCT00383942,Catheter,DEVICE,Cesarean Section,phase4,TERMINATED,Loyola University,
NCT07020442,integrated neuromuscular training,OTHER,Athletic Injuries,na,TERMINATED,National Taiwan Sport University,
NCT03841942,clinically-based spacing strategy,OTHER,Inflammatory Bowel Diseases,na,TERMINATED,"University Hospital, Montpellier",
NCT03841942,Trough level-based strategy,OTHER,Inflammatory Bowel Diseases,na,TERMINATED,"University Hospital, Montpellier",
NCT00625742,Graded Resistance Training,BEHAVIORAL,Advanced Cancer; Cachexia,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00625742,Aerobic Exercise,BEHAVIORAL,Advanced Cancer; Cachexia,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00625742,Melatonin,DRUG,Advanced Cancer; Cachexia,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00625742,Juven,OTHER,Advanced Cancer; Cachexia,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00625742,Atenolol,DRUG,Advanced Cancer; Cachexia,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00625742,Ibuprofen,DRUG,Advanced Cancer; Cachexia,na,TERMINATED,M.D. Anderson Cancer Center,
NCT03982342,Cather closure of patent ductus arteriosus (PDA),DEVICE,Patent Ductus Arteriosus,na,TERMINATED,Nationwide Children's Hospital,
NCT03982342,Conservative management of patent ductus arteriosus (PDA),OTHER,Patent Ductus Arteriosus,na,TERMINATED,Nationwide Children's Hospital,
NCT01003769,Lenalidomide,DRUG,Recurrent Chronic Lymphocytic Leukemia,phase1; phase2,TERMINATED,Mayo Clinic,
NCT01003769,R-(-)-Gossypol Acetic Acid,DRUG,Recurrent Chronic Lymphocytic Leukemia,phase1; phase2,TERMINATED,Mayo Clinic,
NCT01003769,Laboratory Biomarker Analysis,OTHER,Recurrent Chronic Lymphocytic Leukemia,phase1; phase2,TERMINATED,Mayo Clinic,
NCT01241513,NAC,DRUG,Effects of High Altitude; Hypoxia; Inadequate or Impaired Breathing Pattern or Ventilation; Abnormal Blood Oxygen Pressure,phase4,TERMINATED,United States Army Research Institute of Environmental Medicine,
NCT01241513,Placebo,DRUG,Effects of High Altitude; Hypoxia; Inadequate or Impaired Breathing Pattern or Ventilation; Abnormal Blood Oxygen Pressure,phase4,TERMINATED,United States Army Research Institute of Environmental Medicine,
NCT03211260,EQUISTASI,DEVICE,Freezing of Gait; Parkinson Disease,na,TERMINATED,ASST Gaetano Pini-CTO,
NCT04576923,Velacur by Sonic Incytes,OTHER,NAFLD; NASH - Nonalcoholic Steatohepatitis,na,TERMINATED,Indiana University,
NCT03261388,Activity-Based Locomotor Exercise Program (ABLE),BEHAVIORAL,Spinal Cord Injuries,na,TERMINATED,Allina Health System,
NCT01740388,Besifloxacin,DRUG,Bacterial Conjunctivitis,phase3,TERMINATED,Bausch & Lomb Incorporated,
NCT01740388,Vehicle,DRUG,Bacterial Conjunctivitis,phase3,TERMINATED,Bausch & Lomb Incorporated,
NCT01194427,Vorinostat and Tamoxifen,DRUG,Stage I Breast Cancer; Stage II Breast Cancer; Stage III Breast Cancer; Invasive Breast Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00655642,Ondansetron,DRUG,Nausea,na,TERMINATED,Vanderbilt University,
NCT00655642,Metoclopramide,DRUG,Nausea,na,TERMINATED,Vanderbilt University,
NCT00655642,Promethazine,DRUG,Nausea,na,TERMINATED,Vanderbilt University,
NCT00655642,Normal Saline,DRUG,Nausea,na,TERMINATED,Vanderbilt University,
NCT02474173,Laboratory Biomarker Analysis,OTHER,Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV ,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02474173,Onalespib,DRUG,Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV ,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02474173,Paclitaxel,DRUG,Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV ,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02474173,Pharmacological Study,OTHER,Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV ,phase1,TERMINATED,National Cancer Institute (NCI),
NCT06438783,1200mg of TQB2928 injection+Anlotinib,DRUG,Osteosarcoma; Other Solid Tumors,phase1,TERMINATED,"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.",
NCT06438783,1800mg of TQB2928 injection+Anlotinib,DRUG,Osteosarcoma; Other Solid Tumors,phase1,TERMINATED,"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.",
NCT04665583,Prehabilitation,OTHER,Tricuspid Valve Disease; Tricuspid Regurgitation,na,TERMINATED,Baylor Research Institute,
NCT02998541,SHP640,DRUG,Adenoviral Conjunctivitis,phase3,TERMINATED,Shire,
NCT02998541,PVP-I 0.6%,DRUG,Adenoviral Conjunctivitis,phase3,TERMINATED,Shire,
NCT02998541,Placebo,OTHER,Adenoviral Conjunctivitis,phase3,TERMINATED,Shire,
NCT01974154,Cohort I,OTHER,COPD; Smoking,na,TERMINATED,Weill Medical College of Cornell University,
NCT01974154,Cohort II,OTHER,COPD; Smoking,na,TERMINATED,Weill Medical College of Cornell University,
NCT04338074,Tranexamic acid tablets,DRUG,COVID-19,phase2,TERMINATED,University of Alabama at Birmingham,
NCT04338074,Placebo oral tablet,DRUG,COVID-19,phase2,TERMINATED,University of Alabama at Birmingham,
NCT01334710,Sorafenib and OSI-906,DRUG,Liver Cancer,phase2,TERMINATED,Emory University,
NCT04819360,VESIcare 10Mg Tablet,DRUG,"Urinary Bladder, Neurogenic; Multiple Sclerosis",phase4,TERMINATED,Brigitte Schürch,
NCT04819360,Botox 100 UNT Injection,DRUG,"Urinary Bladder, Neurogenic; Multiple Sclerosis",phase4,TERMINATED,Brigitte Schürch,
NCT02232620,BBI503,DRUG,Gastrointestinal Stromal Tumors,phase2,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT01183923,Broccoli Sprouts,OTHER,Asthma; Allergy,na,TERMINATED,Johns Hopkins University,
NCT01183923,Alfalfa Sprouts,OTHER,Asthma; Allergy,na,TERMINATED,Johns Hopkins University,
NCT00873470,esophagal stimulation,PROCEDURE,Wolff-Parkinson-White Syndrome,na,TERMINATED,Nantes University Hospital,
NCT02453373,ThermoSuit Cooling Induction,DEVICE,Stroke; Brain Ischemia,na,TERMINATED,Life Recovery Systems,
NCT02453373,Magnesium Sulfate,DRUG,Stroke; Brain Ischemia,na,TERMINATED,Life Recovery Systems,
NCT02453373,tPA,DRUG,Stroke; Brain Ischemia,na,TERMINATED,Life Recovery Systems,
NCT02453373,Propofol,DRUG,Stroke; Brain Ischemia,na,TERMINATED,Life Recovery Systems,
NCT02453373,Etomidate,DRUG,Stroke; Brain Ischemia,na,TERMINATED,Life Recovery Systems,
NCT02453373,Neurothrombectomy,PROCEDURE,Stroke; Brain Ischemia,na,TERMINATED,Life Recovery Systems,
NCT04280354,compare data patterns by data-driven algorithms to determine sepsis,OTHER,"Sepsis; Severe Community-acquired Pneumonia (sCAP); Infection, Bacterial",na,TERMINATED,"University Hospital, Basel, Switzerland",
NCT04280354,compare data patterns by data-driven algorithms to predict sepsis-related mortality,OTHER,"Sepsis; Severe Community-acquired Pneumonia (sCAP); Infection, Bacterial",na,TERMINATED,"University Hospital, Basel, Switzerland",
NCT03815266,transcranial Direct Current Stimulation (tDCS),OTHER,Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03815266,Computerized Mirror Therapy (CMT),OTHER,Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03815266,Tolerance Assessment Questionnaire,OTHER,Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03815266,Ashworth's scale,OTHER,Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03815266,Frenchay arm test,OTHER,Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03815266,Abilhand questionnaire,OTHER,Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03815266,Fugl-Meyer test,OTHER,Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03815266,Goal Attainment Scaling (GAS),OTHER,Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT01597518,Riluzole,DRUG,Spinal Cord Injury,phase2; phase3,TERMINATED,AOSpine North America Research Network,
NCT01597518,Placebo,DRUG,Spinal Cord Injury,phase2; phase3,TERMINATED,AOSpine North America Research Network,
NCT02373397,Cacicol20,DEVICE,"Corneal Dystrophy, Epithelial Basement Membrane; Epithelial Recurrent Erosion Dystrophy; Corneal Erosions",na,TERMINATED,Neil Lagali,
NCT02373397,Placebo,DEVICE,"Corneal Dystrophy, Epithelial Basement Membrane; Epithelial Recurrent Erosion Dystrophy; Corneal Erosions",na,TERMINATED,Neil Lagali,
NCT06102213,B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010),DRUG,Hematologic Malignancy,phase2,TERMINATED,Prolacta Bioscience,
NCT06189560,comprehensive rehabilitation,BEHAVIORAL,Dysphagia; Stellate Ganglion Block,na,TERMINATED,Zeng Changhao,
NCT06189560,SGB,DRUG,Dysphagia; Stellate Ganglion Block,na,TERMINATED,Zeng Changhao,
NCT00779220,placebo,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,Chugai Pharmaceutical,
NCT00779220,methotrexate,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,Chugai Pharmaceutical,
NCT00779220,ocrelizumabu 50mg,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,Chugai Pharmaceutical,
NCT00779220,ocrelizumabu 200mg,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,Chugai Pharmaceutical,
NCT00779220,ocrelizumab 500mg,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,Chugai Pharmaceutical,
NCT03172520,APS electrode,DEVICE,Parotid Gland Disorders,na,TERMINATED,Mayo Clinic,
NCT03172520,Facial Nerve Monitor,DEVICE,Parotid Gland Disorders,na,TERMINATED,Mayo Clinic,
NCT02779023,Cognitive-Behavior Therapy for Insomnia (CBT-I),BEHAVIORAL,Insomnia; Cardiovascular Risk Factor,na,TERMINATED,Walter Reed National Military Medical Center,
NCT00745823,Comparator: Raltegravir 400 mg b.i.d.,DRUG,HIV,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00745823,Experimental: Raltegravir 800 mg q.d.,DRUG,HIV,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00745823,TRUVADA™,DRUG,HIV,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01051180,HALO,PROCEDURE,Piles; Bleeding,na,TERMINATED,Poole Hospital NHS Foundation Trust,
NCT04800562,PCS499,DRUG,Necrobiosis Lipoidica,phase2,TERMINATED,Processa Pharmaceuticals,
NCT04800562,placebo,OTHER,Necrobiosis Lipoidica,phase2,TERMINATED,Processa Pharmaceuticals,
NCT02647762,CF101 1 mg,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Can-Fite BioPharma,
NCT02647762,CF101 2 mg,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Can-Fite BioPharma,
NCT02647762,Placebo,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Can-Fite BioPharma,
NCT02647762,MTX,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Can-Fite BioPharma,
NCT05813288,Dexpramipexole Dihydrochloride,DRUG,Eosinophilic Asthma; Asthma; Eosinophilic; Asthma,phase3,TERMINATED,Areteia Therapeutics,
NCT05813288,Placebo,DRUG,Eosinophilic Asthma; Asthma; Eosinophilic; Asthma,phase3,TERMINATED,Areteia Therapeutics,
NCT04450342,Arthroscopic rotator cuff repair with REGENETEN™ Bioinductive Implant augmentation,DEVICE,Rotator Cuff Injuries,na,TERMINATED,"Smith & Nephew, Inc.",
NCT04450342,Arthroscopic rotator cuff repair,PROCEDURE,Rotator Cuff Injuries,na,TERMINATED,"Smith & Nephew, Inc.",
NCT04450342,Arthroscopic rotator cuff repair for revision surgery,DEVICE,Rotator Cuff Injuries,na,TERMINATED,"Smith & Nephew, Inc.",
NCT01090973,LBH589,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT02509273,Clonidine,DRUG,Sedation in Intensive Care,phase3,TERMINATED,University of Erlangen-Nürnberg Medical School,
NCT02509273,Midazolam,DRUG,Sedation in Intensive Care,phase3,TERMINATED,University of Erlangen-Nürnberg Medical School,
NCT00877773,Temsirolimus,DRUG,Advanced Cancers,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02548169,DC Vaccine + Standard of Care Chemotherapy,BIOLOGICAL,Pancreatic Cancer,phase1,TERMINATED,Baylor Research Institute,
NCT04227769,Anakinra Prefilled Syringe,DRUG,Diabetes Mellitus Type 2 in Obese; Inflammation; Metabolic Disease; Glucose Metabolism Disorders (Including Diabetes Mellitus),phase2,TERMINATED,"University Hospital, Basel, Switzerland",
NCT02512783,Lidocaine,DRUG,Pain,na,TERMINATED,Children's Hospitals and Clinics of Minnesota,
NCT02512783,Normal Saline,DRUG,Pain,na,TERMINATED,Children's Hospitals and Clinics of Minnesota,
NCT02512783,Propofol,DRUG,Pain,na,TERMINATED,Children's Hospitals and Clinics of Minnesota,
NCT03878654,Tauroursodeoxycholic Acid,DRUG,Asthma,phase1,TERMINATED,University of Vermont,
NCT03226054,Lifestyle Modifications,BEHAVIORAL,Gastroesophageal Reflux,na,TERMINATED,Mount Carmel Health System,
NCT00270322,Marcaine 0.166% + Fentanyl 3.33 mcg/ml,DRUG,"Pain, Postoperative; Osteoarthritis",phase4,TERMINATED,Rambam Health Care Campus,
NCT00270322,Morphine sulphate,DRUG,"Pain, Postoperative; Osteoarthritis",phase4,TERMINATED,Rambam Health Care Campus,
NCT02335060,Delta-9-THC,DRUG,Healthy,early_phase1,TERMINATED,Yale University,
NCT02335060,N-acetylcysteine,DRUG,Healthy,early_phase1,TERMINATED,Yale University,
NCT02335060,Placebo,DRUG,Healthy,early_phase1,TERMINATED,Yale University,
NCT02335060,Placebo,DRUG,Healthy,early_phase1,TERMINATED,Yale University,
NCT02996760,"Growth Factor, Platelet-Derived",DRUG,Endometrial Development,phase3,TERMINATED,IVI Bilbao,
NCT02617160,MD-Logic Pump Advisor,DEVICE,Type 1 Diabetes,na,TERMINATED,Rabin Medical Center,
NCT02617160,Control Group,OTHER,Type 1 Diabetes,na,TERMINATED,Rabin Medical Center,
NCT00133224,Immunotherapy allogeneic GM-CSF secreting cellular vaccine,BIOLOGICAL,Prostate Cancer,phase3,TERMINATED,Cell Genesys,
NCT00133224,Chemotherapy (docetaxel and prednisone),DRUG,Prostate Cancer,phase3,TERMINATED,Cell Genesys,
NCT01292746,Erchonia MLS,DEVICE,Female Pattern Alopecia,na,TERMINATED,Erchonia Corporation,
NCT00391196,Placebo,DRUG,Obesity,phase3,TERMINATED,Pfizer,
NCT00391196,"CP-945,598",DRUG,Obesity,phase3,TERMINATED,Pfizer,
NCT00391196,"CP-945,598 Treatment B",DRUG,Obesity,phase3,TERMINATED,Pfizer,
NCT01683188,vemurafenib + HD IL-2,DRUG,Metastatic Melanoma,phase4,TERMINATED,"Clinigen, Inc.",
NCT00954603,quetiapine,DRUG,Delirium,phase3,TERMINATED,Chiang Mai University,
NCT00954603,haloperidol,DRUG,Delirium,phase3,TERMINATED,Chiang Mai University,
NCT03477903,TAK-954,DRUG,Critical Illness; Enteral Nutrition; Enteral Feeding Intolerance,phase2,TERMINATED,"Millennium Pharmaceuticals, Inc.",
NCT03477903,Metoclopramide,DRUG,Critical Illness; Enteral Nutrition; Enteral Feeding Intolerance,phase2,TERMINATED,"Millennium Pharmaceuticals, Inc.",
NCT03477903,Normal Saline,DRUG,Critical Illness; Enteral Nutrition; Enteral Feeding Intolerance,phase2,TERMINATED,"Millennium Pharmaceuticals, Inc.",
NCT03878927,CPX-351,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Weill Medical College of Cornell University,
NCT03878927,Gemtuzumab Ozogamicin,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Weill Medical College of Cornell University,
NCT00409461,ATG-Sirolimus-Tacrolimus,DRUG,Islet Transplantation; Type 1 Diabetes,na,TERMINATED,AZ-VUB,
NCT04533373,DIEP Flap Neurotization,PROCEDURE,Breast Cancer; Breast Reconstruction; Sensory Restoration,na,TERMINATED,Johns Hopkins University,
NCT03278873,Prior exposure to AAV-CNGA3 or AAV-CNGB3,BIOLOGICAL,Achromatopsia,na,TERMINATED,MeiraGTx UK II Ltd,
NCT05219370,Cannabis oil,DRUG,ADHD; Hyperactivity; Attention Deficit,phase2,TERMINATED,Brlev Agricultural Crops Ltd,
NCT02459054,SynCardia 50cc temporary Total Artificial Heart (TAH-t),DEVICE,"Heart Failure, Right-Sided; Cardiac Failure; Heart Failure, Left-Sided",na,TERMINATED,SynCardia Systems. LLC,
NCT01467505,Telaprevir,DRUG,Hepatitis C,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT01467505,Ribavirin,DRUG,Hepatitis C,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT01467505,Pegylated Interferon Alfa-2a,DRUG,Hepatitis C,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT01467505,Immunosuppressant Regimen,DRUG,Hepatitis C,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT00630994,Dacogen,DRUG,Chronic Myeloproliferative Disorders; Secondary Myelofibrosis,phase2,TERMINATED,Mayo Clinic,
NCT02972294,Iron Isomaltoside 1000,DRUG,Hip Fractures Pathologic; Anemia,phase3,TERMINATED,"University Hospital, Angers",
NCT02972294,Tranexamic Acid,DRUG,Hip Fractures Pathologic; Anemia,phase3,TERMINATED,"University Hospital, Angers",
NCT02972294,Placebos iron isomaltoside 1000,DRUG,Hip Fractures Pathologic; Anemia,phase3,TERMINATED,"University Hospital, Angers",
NCT02972294,Placebos tranexamic acid,DRUG,Hip Fractures Pathologic; Anemia,phase3,TERMINATED,"University Hospital, Angers",
NCT04781166,Calm program,BEHAVIORAL,Suicidal Ideation; Deliberate Self-harm; Impulsivity,na,TERMINATED,"University of California, Berkeley",
NCT02204124,Thunderbeat,DEVICE,Pancreatic Neoplasms; Bile Duct Carcinoma,na,TERMINATED,Washington University School of Medicine,
NCT02204124,"Standard of care scissors, ligatures, clips, and sutures",DEVICE,Pancreatic Neoplasms; Bile Duct Carcinoma,na,TERMINATED,Washington University School of Medicine,
NCT06348524,Ferumoxytol injection,DRUG,Coronary Artery Disease,phase3,TERMINATED,Transmed Solutions,
NCT02898259,Ixazomib,DRUG,B Cell Lymphoma; Lymphoma,phase1; phase2,TERMINATED,Brian Hill,
NCT02898259,Lenalidomide,DRUG,B Cell Lymphoma; Lymphoma,phase1; phase2,TERMINATED,Brian Hill,
NCT02898259,Rituximab,DRUG,B Cell Lymphoma; Lymphoma,phase1; phase2,TERMINATED,Brian Hill,
NCT01258179,Analysis of PSP and PAP from venous blood samples,OTHER,Patients Undergoing Major Abdominal Surgery,na,TERMINATED,University of Zurich,
NCT05152446,Infusion management scheme,OTHER,"Children,Hospitalized; Infusion; Infections",na,TERMINATED,Children's Hospital of Fudan University,
NCT00871546,SCH 727965,DRUG,"Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00871546,Bortezomib,DRUG,"Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00871546,Alemtuzumab,BIOLOGICAL,"Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00250146,Gluten (behaviour),BEHAVIORAL,Celiac Disease,na,TERMINATED,Università Politecnica delle Marche,
NCT00098488,tanespimycin,DRUG,B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00098488,rituximab,BIOLOGICAL,B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03471286,Epacadostat,DRUG,Solid Tumor,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00828386,Induction chemotherapy + concurrent radiochemotherapy vs. concurrent radiochemotherapy,PROCEDURE,Nasopharyngeal Cancers,phase3,TERMINATED,Groupe Oncologie Radiotherapie Tete et Cou,
NCT00031473,Virazole (Ribavirin) Inhalation Solution,DRUG,Respiratory Syncytial Virus Infections,phase3,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT03274973,Zomacton,DRUG,Growth Disorders,na,TERMINATED,Ferring Pharmaceuticals,
NCT04942054,Part 1,DRUG,HER2-negative Breast Cancer; Advanced Breast Cancer; Hormone Receptor-positive Breast Cancer,phase1,TERMINATED,Sun Pharma Advanced Research Company Limited,
NCT04942054,Part 2,DRUG,HER2-negative Breast Cancer; Advanced Breast Cancer; Hormone Receptor-positive Breast Cancer,phase1,TERMINATED,Sun Pharma Advanced Research Company Limited,
NCT04942054,Part 3,DRUG,HER2-negative Breast Cancer; Advanced Breast Cancer; Hormone Receptor-positive Breast Cancer,phase1,TERMINATED,Sun Pharma Advanced Research Company Limited,
NCT01915654,study population,PROCEDURE,Postoperative; Dysfunction Following Cardiac Surgery; Transfusion Related Complication,na,TERMINATED,Centre Hospitalier Universitaire de Besancon,
NCT01923805,Vitagel,DEVICE,Failed Total Knee Arthroplasty,na,TERMINATED,The Cleveland Clinic,
NCT02563522,Engensis (VM202),OTHER,"Foot Ulcer, Diabetic",phase3,TERMINATED,"Helixmith Co., Ltd.",
NCT02563522,Placebo,DRUG,"Foot Ulcer, Diabetic",phase3,TERMINATED,"Helixmith Co., Ltd.",
NCT02768662,OTO-104,DRUG,Meniere's Disease,phase3,TERMINATED,"Otonomy, Inc.",
NCT03386227,Withholding antibiotic prophylaxis,OTHER,Assisted Reproductive Technology; Antibiotic Prophylaxis; Embryo Transfer,na,TERMINATED,Washington University School of Medicine,
NCT03599661,Interview,OTHER,Malignant Neoplasm,na,TERMINATED,Wake Forest University Health Sciences,
NCT03599661,Questionnaire Administration,OTHER,Malignant Neoplasm,na,TERMINATED,Wake Forest University Health Sciences,
NCT02633761,Mifepristone,DRUG,Fetal Death,phase3,TERMINATED,Gynuity Health Projects,
NCT02633761,Placebo,DRUG,Fetal Death,phase3,TERMINATED,Gynuity Health Projects,
NCT02633761,Misoprostol 200mcg,DRUG,Fetal Death,phase3,TERMINATED,Gynuity Health Projects,
NCT01260870,Cotavance Paclitaxel Coated Balloon,DEVICE,PAD; Infrapopliteal Lesions,phase2,TERMINATED,Bayer,
NCT01260870,Standard balloon angioplasty,DEVICE,PAD; Infrapopliteal Lesions,phase2,TERMINATED,Bayer,
NCT02446769,AVAPS-AE Non-invasive ventilation therapy,DEVICE,Breathing-Related Sleep Disorder,na,TERMINATED,Philips Respironics,
NCT03218683,AZD5991,DRUG,Relapsed or Refractory Acute Myeloid Leukemia (AML),phase1,TERMINATED,AstraZeneca,
NCT03218683,AZD5991 + Venetoclax,DRUG,Relapsed or Refractory Acute Myeloid Leukemia (AML),phase1,TERMINATED,AstraZeneca,
NCT02763254,baltaleucel-T,BIOLOGICAL,"Hodgkin Lymphoma; Lymphoma, Large B-Cell, Diffuse; Post-transplant Lymphoproliferative Disorder",phase2,TERMINATED,Cell Medica Ltd,
NCT00006356,carboplatin,DRUG,Ovarian Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00006356,cisplatin,DRUG,Ovarian Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00006356,conventional surgery,PROCEDURE,Ovarian Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT04004156,PerQdisc® Nucleus Replacement Device.,DEVICE,Degenerative Disc Disease; Chronic Low-back Pain,na,TERMINATED,Spinal Stabilization Technologies,
NCT04303559,Eloctate Injectable Product,DRUG,Hemophilia A Without Inhibitor,phase3,TERMINATED,Margaret Ragni,
NCT04303559,Emicizumab Injection [Hemlibra],DRUG,Hemophilia A Without Inhibitor,phase3,TERMINATED,Margaret Ragni,
NCT04778059,USB002,DRUG,"2019 Novel Coronavirus Infection; COVID-19 Virus Infection; SARS Coronavirus 2 Infection; SARS-CoV-2 Infection; Respiratory Distress Syndrome, Adult; Adult Respiratory Distress Syndrome",phase2,TERMINATED,"US Biotest, Inc.",
NCT04778059,Placebo,DRUG,"2019 Novel Coronavirus Infection; COVID-19 Virus Infection; SARS Coronavirus 2 Infection; SARS-CoV-2 Infection; Respiratory Distress Syndrome, Adult; Adult Respiratory Distress Syndrome",phase2,TERMINATED,"US Biotest, Inc.",
NCT03281746,Dental Procedure,PROCEDURE,Leukemia,na,TERMINATED,Virginia Commonwealth University,
NCT03281746,Educational Intervention (prevention education),OTHER,Leukemia,na,TERMINATED,Virginia Commonwealth University,
NCT03281746,Interview,OTHER,Leukemia,na,TERMINATED,Virginia Commonwealth University,
NCT03281746,Survey Administration,OTHER,Leukemia,na,TERMINATED,Virginia Commonwealth University,
NCT03281746,Educational Intervention (one-on one education),OTHER,Leukemia,na,TERMINATED,Virginia Commonwealth University,
NCT05857488,Transnasal introduction tube,DEVICE,Healthy,na,TERMINATED,Massachusetts General Hospital,
NCT01585103,Cytosponge,DEVICE,Eosinophilic Esophagitis,na,TERMINATED,Mayo Clinic,
NCT04418661,Vociprotafib,DRUG,Metastatic Neoplasm,phase1; phase2,TERMINATED,Sanofi,
NCT04418661,Pembrolizumab,DRUG,Metastatic Neoplasm,phase1; phase2,TERMINATED,Sanofi,
NCT04418661,Adagrasib,DRUG,Metastatic Neoplasm,phase1; phase2,TERMINATED,Sanofi,
NCT01744886,maintain oxygenation during one lung ventilation,PROCEDURE,One-Lung Ventilation,na,TERMINATED,Onze Lieve Vrouw Hospital,
NCT00391586,Erlotinib,DRUG,"Carcinoma, Non-Small-Cell Lung",phase2,TERMINATED,New Mexico Cancer Research Alliance,
NCT00391586,Platinum-based chemotherapy,DRUG,"Carcinoma, Non-Small-Cell Lung",phase2,TERMINATED,New Mexico Cancer Research Alliance,
NCT06431386,Behavioural Activation (BA) Therapy,BEHAVIORAL,"Depressive Disorder, Treatment-Resistant; Depressive Disorder, Major; Bipolar Disorder",na,TERMINATED,The Royal's Institute of Mental Health Research,
NCT06431386,Esketamine,DRUG,"Depressive Disorder, Treatment-Resistant; Depressive Disorder, Major; Bipolar Disorder",na,TERMINATED,The Royal's Institute of Mental Health Research,
NCT00588354,Clonidine,DRUG,Lumbar and Other Intervertebral Disc Disorders With Radiculopathy,na,TERMINATED,Mayo Clinic,
NCT00588354,Triamcinolone hexacetonide,DRUG,Lumbar and Other Intervertebral Disc Disorders With Radiculopathy,na,TERMINATED,Mayo Clinic,
NCT00588354,Lidocaine HCl,DRUG,Lumbar and Other Intervertebral Disc Disorders With Radiculopathy,na,TERMINATED,Mayo Clinic,
NCT00543556,MK0767,DRUG,Type 2 Diabetes Mellitus,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01574222,autologous dendritic cell adenovirus CCL21 vaccine,BIOLOGICAL,Non-Small Cell Lung Cancer (NSCLC),phase1,TERMINATED,VA Office of Research and Development,
NCT00836875,Voriconazole,DRUG,Invasive Aspergillosis,phase3,TERMINATED,Pfizer,
NCT02257775,n/a - observational,OTHER,Metastatic Breast Cancer,na,TERMINATED,"Institute of Cancer Research, United Kingdom",
NCT03105401,Assessment of hallucinations in Parkinson's disease,OTHER,Parkinson Disease,na,TERMINATED,Hospices Civils de Lyon,
NCT01748812,Osteomalacia,DRUG,Osteomalacia,phase1,TERMINATED,National Institute of Dental and Craniofacial Research (NIDCR),
NCT03761030,L-DOPA,DRUG,Major Depressive Disorder; Dysthymia; Depression,phase4,TERMINATED,New York State Psychiatric Institute,
NCT03761030,Placebo Oral Tablet,DRUG,Major Depressive Disorder; Dysthymia; Depression,phase4,TERMINATED,New York State Psychiatric Institute,
NCT00807365,GHRH,DRUG,Elderly,phase2,TERMINATED,Johns Hopkins University,
NCT05259800,Peppermint oil vapors,OTHER,Urinary Retention,na,TERMINATED,TriHealth Inc.,
NCT05259800,Mineral Oil,OTHER,Urinary Retention,na,TERMINATED,TriHealth Inc.,
NCT02222207,"Regorafenib, ophthalmic oily suspension (BAY73-4506)",DRUG,Macular Degeneration,phase2,TERMINATED,Bayer,
NCT02222207,Sham IVT,PROCEDURE,Macular Degeneration,phase2,TERMINATED,Bayer,
NCT02222207,Ranibizumab,DRUG,Macular Degeneration,phase2,TERMINATED,Bayer,
NCT02222207,Placebo,DRUG,Macular Degeneration,phase2,TERMINATED,Bayer,
NCT05179811,Hypnosis sessions,PROCEDURE,Functional Dystonia (Disorder),na,TERMINATED,Fondation Ophtalmologique Adolphe de Rothschild,
NCT00947011,Placebo,DRUG,Glucose Homeostasis,phase2,TERMINATED,Johns Hopkins University,
NCT00947011,Januvia,DRUG,Glucose Homeostasis,phase2,TERMINATED,Johns Hopkins University,
NCT01902771,Dendritic Cell Vaccine,BIOLOGICAL,Glioma; Brain Cancer; Brain Tumor; Glioblastoma Multiforme; High Grade Glioma,phase1,TERMINATED,Edward Ziga,
NCT01902771,Tumor Lysate,BIOLOGICAL,Glioma; Brain Cancer; Brain Tumor; Glioblastoma Multiforme; High Grade Glioma,phase1,TERMINATED,Edward Ziga,
NCT01902771,Imiquimod,OTHER,Glioma; Brain Cancer; Brain Tumor; Glioblastoma Multiforme; High Grade Glioma,phase1,TERMINATED,Edward Ziga,
NCT01902771,Leukapheresis,PROCEDURE,Glioma; Brain Cancer; Brain Tumor; Glioblastoma Multiforme; High Grade Glioma,phase1,TERMINATED,Edward Ziga,
NCT02359864,5 daily fractions of 2 Gy,RADIATION,Alzheimer's Disease,na,TERMINATED,Corewell Health East,
NCT02359864,10 daily fractions of 2 Gy,RADIATION,Alzheimer's Disease,na,TERMINATED,Corewell Health East,
NCT00262132,Mycophenolate,DRUG,Pulmonary Sarcoidosis,phase3,TERMINATED,Medical University of South Carolina,
NCT01820221,Suture vs. staples closure method after c-section in obese women.,PROCEDURE,Obesity; Pregnancy,na,TERMINATED,University of Arkansas,
NCT00461214,Participation in laparoscopic training curriculum,OTHER,Healthy,na,TERMINATED,Columbia University,
NCT04812106,No Intervention,OTHER,Long-chain Fatty Acid Oxidation Disorders (LC-FAOD),na,TERMINATED,Ultragenyx Pharmaceutical Inc,
NCT00747604,mecasermin [rDNA origin] injection,BIOLOGICAL,Primary Insulin-like Growth Factor-1 Deficiency,na,TERMINATED,Ipsen,
NCT03571204,3BNC117 and 10-1074,BIOLOGICAL,HIV,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT03571204,Placebo,BIOLOGICAL,HIV,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00378404,Docetaxel,DRUG,Non-Small Cell Lung Cancer,phase1,TERMINATED,Susanne Arnold,
NCT00378404,Radiation,RADIATION,Non-Small Cell Lung Cancer,phase1,TERMINATED,Susanne Arnold,
NCT04081584,ISS Device,DEVICE,Fetal Distress,na,TERMINATED,"Raydiant Oximetry, Inc.",
NCT03527784,Parietene Macro,DEVICE,Rectal Adenocarcinoma,na,TERMINATED,University of Oulu,
NCT03527784,Parietex Parastomal,DEVICE,Rectal Adenocarcinoma,na,TERMINATED,University of Oulu,
NCT03527784,Dynamesh IPST,DEVICE,Rectal Adenocarcinoma,na,TERMINATED,University of Oulu,
NCT03500484,Liraglutide,DRUG,"Obesity, Childhood; Neural Development",early_phase1,TERMINATED,Yale University,
NCT00312351,Pegaptanib sodium,DRUG,Macular Degeneration,phase4,TERMINATED,Eyetech Pharmaceuticals,
NCT00822029,FOSAMAX,DRUG,Osteoporosis; Cerebral Palsy,phase3,TERMINATED,Department of Clinical Research and Innovation,
NCT00822029,PLACEBO,OTHER,Osteoporosis; Cerebral Palsy,phase3,TERMINATED,Department of Clinical Research and Innovation,
NCT00277329,XL999,DRUG,Non-small Cell Lung Cancer,phase2,TERMINATED,"Symphony Evolution, Inc.",
NCT00455637,Botulinum toxin type A,BIOLOGICAL,Cerebral Palsy,phase2,TERMINATED,Ipsen,
NCT01564095,Tacrolimus,DRUG,Terminal Liver Disease; Ischemia Reperfusion Injury; Graft Dysfunction; Graft Failure; Poor Graft Quality,phase2; phase3,TERMINATED,Ludwig-Maximilians - University of Munich,
NCT01564095,HTK/Placebo,DRUG,Terminal Liver Disease; Ischemia Reperfusion Injury; Graft Dysfunction; Graft Failure; Poor Graft Quality,phase2; phase3,TERMINATED,Ludwig-Maximilians - University of Munich,
NCT00859339,Gemcitabine,DRUG,Transitional Cell Carcinoma of the Bladder,phase2,TERMINATED,"Noah Hahn, M.D.",
NCT00859339,Cisplatin,DRUG,Transitional Cell Carcinoma of the Bladder,phase2,TERMINATED,"Noah Hahn, M.D.",
NCT00859339,Sunitinib Malate,DRUG,Transitional Cell Carcinoma of the Bladder,phase2,TERMINATED,"Noah Hahn, M.D.",
NCT00859339,Radical Cystectomy,PROCEDURE,Transitional Cell Carcinoma of the Bladder,phase2,TERMINATED,"Noah Hahn, M.D.",
NCT00203775,risperidone,DRUG,Psychosis; Aggression,na,TERMINATED,University of Connecticut,
NCT01832857,CPI-613,DRUG,Cancer,phase2,TERMINATED,Cornerstone Pharmaceuticals,
NCT00190528,neoadjuvant chemotherapy + radical hysterectomy,DRUG,Cervical Neoplasms,phase3,TERMINATED,Haruhiko Fukuda,
NCT00190528,radical hysterectomy,PROCEDURE,Cervical Neoplasms,phase3,TERMINATED,Haruhiko Fukuda,
NCT01404767,Esmolol,DRUG,Vascular Disease; Hypertension; Angina; Cardiac Disease,phase4,TERMINATED,"University Health Network, Toronto",
NCT01404767,Metoprolol,DRUG,Vascular Disease; Hypertension; Angina; Cardiac Disease,phase4,TERMINATED,"University Health Network, Toronto",
NCT03599336,Reverse Total Shoulder Arthroplasty (rTSA),PROCEDURE,Humerus Fracture; Humerus; Shoulder Fractures; Shoulder Arthropathy Associated With Other Conditions; Arthropathy Shoulder; Shoulder Injury; Arthropathy,na,TERMINATED,Mayo Clinic,
NCT03599336,Nonoperative Treatment,OTHER,Humerus Fracture; Humerus; Shoulder Fractures; Shoulder Arthropathy Associated With Other Conditions; Arthropathy Shoulder; Shoulder Injury; Arthropathy,na,TERMINATED,Mayo Clinic,
NCT03776864,Pembrolizumab,BIOLOGICAL,Hodgkin's Lymphoma,phase2,TERMINATED,University of Washington,
NCT03776864,Umbralisib,DRUG,Hodgkin's Lymphoma,phase2,TERMINATED,University of Washington,
NCT02916498,Boston Scientific's Precision SPECTRA™ Spinal Cord Stimulation System,DEVICE,Chronic Neuropathic Pain in the Low Back and Legs,na,TERMINATED,Boston Scientific Corporation,
NCT04584151,regional analgesia,PROCEDURE,Liver Transplant Disorder,na,TERMINATED,Vinmec Healthcare System,
NCT05215951,osimertinib,DRUG,Lung Cancer,phase2,TERMINATED,AstraZeneca,
NCT01708629,210 mg brodalumab,DRUG,Plaque Psoriasis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT01708629,140 mg brodalumab,DRUG,Plaque Psoriasis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT01708629,ustekinumab,DRUG,Plaque Psoriasis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT01708629,placebo,DRUG,Plaque Psoriasis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT03026829,CART sound therapy,DEVICE,"Tinnitus, Hearing Loss, Cochlear Implant Users",na,TERMINATED,Cochlear,
NCT00368602,Timoptic,DRUG,Ulcer; Burns,phase2,TERMINATED,"University of California, Davis",
NCT00368602,Placebo,OTHER,Ulcer; Burns,phase2,TERMINATED,"University of California, Davis",
NCT00365937,Immunological peptides and immunological adjuvants,BIOLOGICAL,Melanoma,phase1; phase2,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT00365937,HLA-A2 peptides,BIOLOGICAL,Melanoma,phase1; phase2,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT00365937,Montanide ISA51,BIOLOGICAL,Melanoma,phase1; phase2,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT00365937,IMP321,BIOLOGICAL,Melanoma,phase1; phase2,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT02651272,macitentan,DRUG,Pulmonary Hypertension; Sickle Cell Disease,phase2,TERMINATED,Boston University,
NCT04582539,INCB000928,DRUG,Myelodysplastic Syndromes; Multiple Myeloma; Anemia,phase1; phase2,TERMINATED,Incyte Corporation,
NCT01621477,clofarabine,DRUG,"Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid",phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT01621477,cytarabine,DRUG,"Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid",phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT01621477,busulfan,DRUG,"Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid",phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT01621477,Plerixafor,DRUG,"Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid",phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT01621477,cyclophosphamide,DRUG,"Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid",phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT01621477,antithymocyte globulin (rabbit),DRUG,"Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid",phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT01621477,stem cells,BIOLOGICAL,"Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid",phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT01621477,Tacrolimus,DRUG,"Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid",phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT01621477,mycophenolate mofetil,DRUG,"Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid",phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT05017701,Bridge device,DEVICE,"Pain, Postoperative",na,TERMINATED,Masimo Corporation,
NCT05017701,Sham device,DEVICE,"Pain, Postoperative",na,TERMINATED,Masimo Corporation,
NCT00282412,Hematopoietic Stem Cell Transplantation,BIOLOGICAL,Rheumatoid Arthritis,phase1,TERMINATED,Northwestern University,
NCT00282412,Fludarabine,DRUG,Rheumatoid Arthritis,phase1,TERMINATED,Northwestern University,
NCT00282412,Cyclophosphamide,DRUG,Rheumatoid Arthritis,phase1,TERMINATED,Northwestern University,
NCT00282412,Campath 1H,DRUG,Rheumatoid Arthritis,phase1,TERMINATED,Northwestern University,
NCT00282412,GCSF,DRUG,Rheumatoid Arthritis,phase1,TERMINATED,Northwestern University,
NCT00282412,Cyclosporins,DRUG,Rheumatoid Arthritis,phase1,TERMINATED,Northwestern University,
NCT00282412,Mycophenolate Mofetil,DRUG,Rheumatoid Arthritis,phase1,TERMINATED,Northwestern University,
NCT00807612,AMG 479,BIOLOGICAL,Advanced Squamous Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,"NantCell, Inc.",
NCT00807612,AMG 479,BIOLOGICAL,Advanced Squamous Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,"NantCell, Inc.",
NCT00807612,Carboplatin,DRUG,Advanced Squamous Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,"NantCell, Inc.",
NCT00807612,AMG 479,BIOLOGICAL,Advanced Squamous Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,"NantCell, Inc.",
NCT00807612,Paclitaxel,DRUG,Advanced Squamous Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,"NantCell, Inc.",
NCT03181828,Acetohydroxamic Acid Oral Tablet,DRUG,Urea Cycle Disorder,phase1; phase2,TERMINATED,Nicholas Ah Mew,
NCT03181828,No treatment,OTHER,Urea Cycle Disorder,phase1; phase2,TERMINATED,Nicholas Ah Mew,
NCT05999292,68Ga-R8760 injection at pre-defined dose levels,DRUG,Adrenocortical Carcinoma,phase1,TERMINATED,Radionetics Oncology,
NCT05999292,68Ga-R8760 injection,DRUG,Adrenocortical Carcinoma,phase1,TERMINATED,Radionetics Oncology,
NCT00228371,Neurostimulation,DEVICE,Epilepsy; Drug Resistant,phase2; phase3,TERMINATED,"University Hospital, Grenoble",
NCT01852201,Endovascular Mechanical Thrombectomy,DEVICE,Ischemic Stroke,na,TERMINATED,Medical University of South Carolina,
NCT03052712,social cognition,BEHAVIORAL,Alzheimer Disease; Parkinson Disease; Frontal Dementia; Huntington Disease; Traumatic Brain Injury; Stroke,na,TERMINATED,"Centre Hospitalier Universitaire, Amiens",
NCT01193881,Erlotinib Hydrochloride,DRUG,Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01193881,Gamma-Secretase Inhibitor RO4929097,DRUG,Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01193881,Laboratory Biomarker Analysis,OTHER,Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01193881,Pharmacological Study,OTHER,Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00864630,Computer-based problem solving therapy,BEHAVIORAL,Depression,na,TERMINATED,Massachusetts General Hospital,
NCT00761865,Air Cast Stirrup Brace & High Tide Fracture Boot,DEVICE,Lateral Ankle Sprain,na,TERMINATED,University of Rochester,
NCT00282165,naratriptan,DRUG,Psychotic Disorders; Antisocial Personality Disorder; Impulse Regulation Disorder; Intermittent Explosive Disorder,phase4,TERMINATED,UMC Utrecht,
NCT00282165,placebo,DRUG,Psychotic Disorders; Antisocial Personality Disorder; Impulse Regulation Disorder; Intermittent Explosive Disorder,phase4,TERMINATED,UMC Utrecht,
NCT01703065,Cabozantinib,DRUG,Adenocarcinoma of the Prostate; Castration-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer,phase2,TERMINATED,University of Washington,
NCT01349192,Rifampin,DRUG,Cystic Fibrosis; Methicillin-resistant Staphylococcus Aureus,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT01349192,Trimethoprim/Sulfamethoxazole,DRUG,Cystic Fibrosis; Methicillin-resistant Staphylococcus Aureus,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT01349192,Minocycline,DRUG,Cystic Fibrosis; Methicillin-resistant Staphylococcus Aureus,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT01349192,Mupirocin,DRUG,Cystic Fibrosis; Methicillin-resistant Staphylococcus Aureus,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT01349192,chlorhexidine gluconate oral rinse,DRUG,Cystic Fibrosis; Methicillin-resistant Staphylococcus Aureus,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT01349192,2% Chlorhexidine solution wipes,DRUG,Cystic Fibrosis; Methicillin-resistant Staphylococcus Aureus,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT01349192,Environmental Decontamination,BEHAVIORAL,Cystic Fibrosis; Methicillin-resistant Staphylococcus Aureus,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT03597971,HMPL004-6599,DRUG,Ulcerative Colitis; Crohn Disease,phase1,TERMINATED,Nutrition Science Partners Limited,
NCT03597971,Placebo,DRUG,Ulcerative Colitis; Crohn Disease,phase1,TERMINATED,Nutrition Science Partners Limited,
NCT01283971,tocilizumab [RoActemra/Actemra],DRUG,Rheumatoid Arthritis,phase4,TERMINATED,Hoffmann-La Roche,
NCT01283971,adalimumab,DRUG,Rheumatoid Arthritis,phase4,TERMINATED,Hoffmann-La Roche,
NCT01283971,placebo to tocilizumab,DRUG,Rheumatoid Arthritis,phase4,TERMINATED,Hoffmann-La Roche,
NCT01283971,placebo to adalimumab,DRUG,Rheumatoid Arthritis,phase4,TERMINATED,Hoffmann-La Roche,
NCT01283971,methotrexate,DRUG,Rheumatoid Arthritis,phase4,TERMINATED,Hoffmann-La Roche,
NCT01283971,folate,DRUG,Rheumatoid Arthritis,phase4,TERMINATED,Hoffmann-La Roche,
NCT02030444,PET-MRI and EBUS-TBNA,PROCEDURE,Lung Neoplasms,na,TERMINATED,St. Olavs Hospital,
NCT00138671,Subcutaneous Insulin,DRUG,Diabetes Mellitus; Chronic Obstructive Pulmonary Disease,phase3,TERMINATED,Pfizer,
NCT00138671,Inhaled Insulin,DRUG,Diabetes Mellitus; Chronic Obstructive Pulmonary Disease,phase3,TERMINATED,Pfizer,
NCT01698944,somatropin,DRUG,Growth Hormone Disorder; Adult Growth Hormone Deficiency,phase4,TERMINATED,Novo Nordisk A/S,
NCT03955744,3D translabial ultrasound,OTHER,Pelvic Organ Prolapse,na,TERMINATED,"Western University, Canada",
NCT03720132,Extensive flushing of the port catheter,PROCEDURE,Catheter Related Blood Stream Infections,na,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT00802698,Transcorneal electric stimulation,DEVICE,Central Retinal Artery Occlusion,na,TERMINATED,Asociación para Evitar la Ceguera en México,
NCT00802698,Transcorneal stimulation,DEVICE,Central Retinal Artery Occlusion,na,TERMINATED,Asociación para Evitar la Ceguera en México,
NCT00802698,transcorneal electric stimulation,DEVICE,Central Retinal Artery Occlusion,na,TERMINATED,Asociación para Evitar la Ceguera en México,
NCT04916002,vidutolimod,DRUG,Merkel Cell Carcinoma; Cutaneous Squamous Cell Carcinoma; Basal Cell Carcinoma; Triple Negative Breast Cancer; Non-Small Cell Lung Cancer; Oropharynx Squamous Cell Carcinoma,phase2,TERMINATED,Regeneron Pharmaceuticals,
NCT04916002,cemiplimab,DRUG,Merkel Cell Carcinoma; Cutaneous Squamous Cell Carcinoma; Basal Cell Carcinoma; Triple Negative Breast Cancer; Non-Small Cell Lung Cancer; Oropharynx Squamous Cell Carcinoma,phase2,TERMINATED,Regeneron Pharmaceuticals,
NCT03349645,4 mL injection of AMPION™,BIOLOGICAL,Severe Osteoarthritis of the Knee,phase3,TERMINATED,Ampio Pharmaceuticals. Inc.,
NCT04318145,PL-3994 Aqueous Intravenous Solution Dose Ascention,DRUG,Heart Failure With Preserved Ejection Fraction,phase2,TERMINATED,"Palatin Technologies, Inc",
NCT04318145,PL-3994 Aqueous Intravenous Solution Single Dose,DRUG,Heart Failure With Preserved Ejection Fraction,phase2,TERMINATED,"Palatin Technologies, Inc",
NCT03956745,sleep-wake timing,BEHAVIORAL,"Sleep Wake Disorders; Sleep Disorders, Circadian Rhythm; Sleep Disorders, Intrinsic; Advanced Sleep Phase Syndrome (ASPS); Advanced Sleep Phase Syndrome; Advanced Sleep Phase; Delayed Sleep Phase; Del",na,TERMINATED,Brigham and Women's Hospital,
NCT03956745,constant routine,BEHAVIORAL,"Sleep Wake Disorders; Sleep Disorders, Circadian Rhythm; Sleep Disorders, Intrinsic; Advanced Sleep Phase Syndrome (ASPS); Advanced Sleep Phase Syndrome; Advanced Sleep Phase; Delayed Sleep Phase; Del",na,TERMINATED,Brigham and Women's Hospital,
NCT04335695,Vascular Rehabilitation,BEHAVIORAL,Vascular Diseases; Peripheral Artery Disease; Peripheral Vascular Diseases,na,TERMINATED,Baylor Research Institute,
NCT03798301,CMV-specific T-cells,BIOLOGICAL,CMV Infection; Cytomegalovirus Infections; CMV Viremia; Opportunistic Infections,phase1,TERMINATED,"University of Wisconsin, Madison",
NCT01577212,Individualized dose escalation,RADIATION,Stage III Non-small Cell Lung Cancer; Individualized Radiation Dose Escalation,phase2,TERMINATED,Radboud University Medical Center,
NCT01200212,"Taxane, Avastin",DRUG,Breast Cancer,phase3,TERMINATED,GBG Forschungs GmbH,
NCT01200212,"Taxane, Avastin, Xeloda",DRUG,Breast Cancer,phase3,TERMINATED,GBG Forschungs GmbH,
NCT03189030,pLADD,BIOLOGICAL,Colorectal Neoplasms,phase1,TERMINATED,"Aduro Biotech, Inc.",
NCT00590967,IMRT extended field external beam radiation therapy,RADIATION,Cervical Cancer,phase2,TERMINATED,Washington University School of Medicine,
NCT00590967,Brachytherapy,RADIATION,Cervical Cancer,phase2,TERMINATED,Washington University School of Medicine,
NCT00590967,Cisplatin,DRUG,Cervical Cancer,phase2,TERMINATED,Washington University School of Medicine,
NCT01047007,adavosertib 20 mg,DRUG,Solid Tumors,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01047007,5-FU 1000 mg/m^2/day,DRUG,Solid Tumors,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01047007,CDDP,DRUG,Solid Tumors,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01047007,adavosertib 65 mg,DRUG,Solid Tumors,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT02802592,Epogen,DRUG,Cardiac Surgery-CABG; Cardiac Valve Replacement,phase1; phase2,TERMINATED,Johns Hopkins University,
NCT02802592,Normal Saline,DRUG,Cardiac Surgery-CABG; Cardiac Valve Replacement,phase1; phase2,TERMINATED,Johns Hopkins University,
NCT06215144,NRCT-101SR,DRUG,Attention-Deficit/Hyperactivity Disorder (ADHD),phase2; phase3,TERMINATED,"Neurocentria, Inc.",
NCT04727151,TAC01-HER2,BIOLOGICAL,HER2 Positive Gastric Cancer; Metastatic HER2 Positive Gastroesophageal Junction Cancer,phase1; phase2,TERMINATED,"Triumvira Immunologics, Inc.",
NCT04727151,TAC01-HER2 plus pembrolizumab,BIOLOGICAL,HER2 Positive Gastric Cancer; Metastatic HER2 Positive Gastroesophageal Junction Cancer,phase1; phase2,TERMINATED,"Triumvira Immunologics, Inc.",
NCT03434353,Inarigivir Soproxil,DRUG,Chronic Hepatitis B,phase2,TERMINATED,Gilead Sciences,
NCT03434353,TAF,DRUG,Chronic Hepatitis B,phase2,TERMINATED,Gilead Sciences,
NCT01690637,Oseltamivir phosphate suspension,DRUG,Influenza; Human Influenza,phase4,TERMINATED,Centers for Disease Control and Prevention,
NCT01690637,Placebo,DRUG,Influenza; Human Influenza,phase4,TERMINATED,Centers for Disease Control and Prevention,
NCT01528345,Dovitinib,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01528345,Fulvestrant,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01528345,Dovitinib Placebo,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01078272,Remote ischemic preconditioning,OTHER,Coronary Artery Disease,na,TERMINATED,"St. Francis Hospital, New York",
NCT01078272,Sham Remote Ischemic Preconditioning,OTHER,Coronary Artery Disease,na,TERMINATED,"St. Francis Hospital, New York",
NCT00020839,temozolomide,DRUG,Melanoma (Skin); Metastatic Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00020839,radiation therapy,RADIATION,Melanoma (Skin); Metastatic Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT02727777,TAK228,DRUG,Lymphoma,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02727777,Blood Sugar Testing,OTHER,Lymphoma,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01146457,Morphine,DRUG,Labor Pain,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT01146457,Saline,DRUG,Labor Pain,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT02677857,Common intervention components for Lifestyle,BEHAVIORAL,Breast Cancer; Sedentary Lifestyle,na,TERMINATED,"The University of Tennessee, Knoxville",
NCT03122301,Stellate Ganglion Block injection with bupivicaine,DRUG,Hot Flashes; Hot Flushes; Vasomotor Symptoms,phase2,TERMINATED,Northwestern University,
NCT03122301,Saline,DRUG,Hot Flashes; Hot Flushes; Vasomotor Symptoms,phase2,TERMINATED,Northwestern University,
NCT01416012,Physical Therapy (standard),BEHAVIORAL,Disease Alzheimer,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT01416012,Balance and Gait training in Individualized sessions,BEHAVIORAL,Disease Alzheimer,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT01416012,Kinect,BEHAVIORAL,Disease Alzheimer,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT01416012,Group Xbox Kinect,BEHAVIORAL,Disease Alzheimer,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT02290119,Sensor-assisted TKR (Verasense),DEVICE,Osteoarthritis,na,TERMINATED,"Orthosensor, Inc.",
NCT02290119,Control - Without the use of Verasense,PROCEDURE,Osteoarthritis,na,TERMINATED,"Orthosensor, Inc.",
NCT01833065,Elobixibat 10 mg/day,DRUG,Chronic Idiopathic Constipation,phase3,TERMINATED,Ferring Pharmaceuticals,
NCT01833065,Elobixibat 5 mg/day,DRUG,Chronic Idiopathic Constipation,phase3,TERMINATED,Ferring Pharmaceuticals,
NCT01833065,Placebo,DRUG,Chronic Idiopathic Constipation,phase3,TERMINATED,Ferring Pharmaceuticals,
NCT00913900,autologous CD133+ cells,BIOLOGICAL,Critical Limb Ischemia; Arterial Occlusive Disease; Vascular Diseases,phase1,TERMINATED,"University of Wisconsin, Madison",
NCT02711592,Genetic Panel for Analgesics,OTHER,"Arthroplasty, Replacement, Knee; Pain, Postoperative",na,TERMINATED,TriHealth Inc.,
NCT00110136,St. John's Wort,DRUG,Breast Cancer; Hot Flashes,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT00100711,Motexafin Gadolinium,DRUG,Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma,phase2,TERMINATED,Pharmacyclics LLC.,
NCT06484751,SelfBack,DEVICE,Chronic Low-back Pain,na,TERMINATED,University of Alberta,
NCT02785029,OCT,DEVICE,Glaucoma,na,TERMINATED,Heidelberg Engineering GmbH,
NCT01252329,elective lymph node dissection,PROCEDURE,High Risk Cutaneous Squamous Cell Carcinoma,na,TERMINATED,University of Pittsburgh,
NCT01406795,Gore Viabahn Heparin Coated Stent,DEVICE,Venous Thrombosis,na,TERMINATED,Stanford University,
NCT00528775,HPPH,DRUG,Lung Cancer,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT00528775,endoscopic procedure,PROCEDURE,Lung Cancer,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT02701257,iPhone bionic pancreas,DEVICE,Diabetes Mellitus Type 1,na,TERMINATED,Massachusetts General Hospital,
NCT02701257,iLet bionic pancreas,DEVICE,Diabetes Mellitus Type 1,na,TERMINATED,Massachusetts General Hospital,
NCT02701257,Xeris Xerisol glucagon,DRUG,Diabetes Mellitus Type 1,na,TERMINATED,Massachusetts General Hospital,
NCT02701257,Lilly glucagon,DRUG,Diabetes Mellitus Type 1,na,TERMINATED,Massachusetts General Hospital,
NCT02701257,iLet infusion set,DEVICE,Diabetes Mellitus Type 1,na,TERMINATED,Massachusetts General Hospital,
NCT02701257,Contact Detach infusion set,DEVICE,Diabetes Mellitus Type 1,na,TERMINATED,Massachusetts General Hospital,
NCT01458119,migalastat hydrochloride,DRUG,Fabry Disease,phase3,TERMINATED,Amicus Therapeutics,
NCT00840567,Skin biopsy,PROCEDURE,"Anemia, Sickle Cell",na,TERMINATED,Washington University School of Medicine,
NCT00840567,Blood draw & sample,PROCEDURE,"Anemia, Sickle Cell",na,TERMINATED,Washington University School of Medicine,
NCT06207500,Pharmacist-led Medication Reconciliation,PROCEDURE,Medication Reconciliation,na,TERMINATED,The University Clinic of Pulmonary and Allergic Diseases Golnik,
NCT00989092,darbepoetin alfa,BIOLOGICAL,Anemia; Anemia of Cancer; Cancer; Carcinoma; Neoplasms; Non-Myeloid Malignancies,phase2,TERMINATED,Amgen,
NCT04077164,"No intervention, observational only.",OTHER,"Chronic Pain; Fibromyalgia; Osteoarthritis, Knee; Osteoarthritis, Hip; Osteoarthritis; Ankylosing Spondylitis; Rheumatoid Arthritis; Chronic Low-back Pain; Chronic Shoulder Pain",na,TERMINATED,Illinois Institute of Technology,
NCT00063934,oblimersen sodium,BIOLOGICAL,Male Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00063934,doxorubicin hydrochloride,DRUG,Male Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00063934,docetaxel,DRUG,Male Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00063934,filgrastim,BIOLOGICAL,Male Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00063934,pegfilgrastim,BIOLOGICAL,Male Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00063934,therapeutic conventional surgery,PROCEDURE,Male Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00063934,pharmacological study,OTHER,Male Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00063934,laboratory biomarker analysis,OTHER,Male Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT03306329,DNS-7801 (low-dose),DRUG,Parkinson's Disease,phase2,TERMINATED,"Dart NeuroScience, LLC",
NCT03306329,DNS-7801 (high dose),DRUG,Parkinson's Disease,phase2,TERMINATED,"Dart NeuroScience, LLC",
NCT03306329,Placebo,DRUG,Parkinson's Disease,phase2,TERMINATED,"Dart NeuroScience, LLC",
NCT01204502,HSVTK retrovirally-transduced donor T lymphocytes,BIOLOGICAL,Haploidentical Stem Cell Transplantation,phase1; phase2,TERMINATED,Great Ormond Street Hospital for Children NHS Foundation Trust,
NCT03747601,Temporal Interference (TI) Stimulation,DEVICE,Visual Acuity,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT02036528,Gentamicin Topical Gel,DRUG,Diabetic Foot Ulcers,phase1; phase2,TERMINATED,"Royer Biomedical, Inc.",
NCT02036528,Ciprofloxacin,DRUG,Diabetic Foot Ulcers,phase1; phase2,TERMINATED,"Royer Biomedical, Inc.",
NCT02036528,Doxycycline,DRUG,Diabetic Foot Ulcers,phase1; phase2,TERMINATED,"Royer Biomedical, Inc.",
NCT03975465,Expiratory Muscle Strength Training,BEHAVIORAL,Head and Neck Neoplasms; Deglutition Disorders,na,TERMINATED,"University of Wisconsin, Milwaukee",
NCT03975465,Pharyngeal Muscle Strengthening Exercises,BEHAVIORAL,Head and Neck Neoplasms; Deglutition Disorders,na,TERMINATED,"University of Wisconsin, Milwaukee",
NCT03118700,Aerobic Interval Exercise,OTHER,Exercise; Central Blood Pressure,na,TERMINATED,Arizona State University,
NCT03118700,Continuous exercise,OTHER,Exercise; Central Blood Pressure,na,TERMINATED,Arizona State University,
NCT01739400,"Macitentan 10 mg tablet, once daily.",DRUG,Pulmonary Arterial Hypertension,phase3,TERMINATED,Actelion,
NCT03827200,Ambrisentan,DRUG,Cirrhosis; Portal Hypertension; Ascites,phase2,TERMINATED,Noorik Biopharmaceuticals AG,
NCT04465136,"CES, Alpha-Stim stimulator (Electromedical Products International, Inc., Mineral Wells, Texas, USA)",DEVICE,CES; Anxiety Disorders and Symptoms,na,TERMINATED,Kaohsiung Veterans General Hospital.,
NCT03968107,Reference ultrasound examination,OTHER,Pregnancy Related,na,TERMINATED,"University Hospital, Montpellier",
NCT05398692,On Site Exercise Rehabilitation,OTHER,Post-Acute COVID-19 Syndrome; COVID-19,na,TERMINATED,Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center,
NCT03852771,Cirvo(TM) therapy,DEVICE,Restless Legs Syndrome,na,TERMINATED,"Radial Medical, Inc.",
NCT04861844,mindfulness training,BEHAVIORAL,"Depression, Anxiety",na,TERMINATED,Northwestern University,
NCT04861844,active listening,BEHAVIORAL,"Depression, Anxiety",na,TERMINATED,Northwestern University,
NCT01875653,Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC),BIOLOGICAL,Stage IV Melanoma; Stage III Melanoma,phase3,TERMINATED,"Lisata Therapeutics, Inc.",
NCT01875653,Autologous PBMCs in GM-CSF (MC),BIOLOGICAL,Stage IV Melanoma; Stage III Melanoma,phase3,TERMINATED,"Lisata Therapeutics, Inc.",
NCT00215553,A.1 Lucinactant,DRUG,Acute Respiratory Distress Syndrome,phase2,TERMINATED,Windtree Therapeutics,
NCT00215553,B.3 SoC,OTHER,Acute Respiratory Distress Syndrome,phase2,TERMINATED,Windtree Therapeutics,
NCT00215553,A.2 Lucinactant,DRUG,Acute Respiratory Distress Syndrome,phase2,TERMINATED,Windtree Therapeutics,
NCT00215553,A.3 Lucinactant,DRUG,Acute Respiratory Distress Syndrome,phase2,TERMINATED,Windtree Therapeutics,
NCT00215553,A.4 Lucinactant,DRUG,Acute Respiratory Distress Syndrome,phase2,TERMINATED,Windtree Therapeutics,
NCT00215553,B.1 Lucinactant,DRUG,Acute Respiratory Distress Syndrome,phase2,TERMINATED,Windtree Therapeutics,
NCT00215553,B.2 Lucinactant,DRUG,Acute Respiratory Distress Syndrome,phase2,TERMINATED,Windtree Therapeutics,
NCT03867045,Usability of an electronic symptom management application,DEVICE,Metastatic Renal Cell Carcinoma Treated With Cabozantinib,na,TERMINATED,Duke University,
NCT00556972,Fecal Incontinence Management System,DEVICE,Fecal Incontinence,na,TERMINATED,Coloplast A/S,
NCT01193777,L-Carnitine,DRUG,Septic Shock,phase1,TERMINATED,Wake Forest University Health Sciences,
NCT01193777,Normal Saline,DRUG,Septic Shock,phase1,TERMINATED,Wake Forest University Health Sciences,
NCT05122975,S48168 (ARM210),DRUG,Catecholaminergic Polymorphic Ventricular Tachycardia Type 1,phase2,TERMINATED,"RyCarma Therapeutics, Inc.",
NCT05122975,Matching Placebo,DRUG,Catecholaminergic Polymorphic Ventricular Tachycardia Type 1,phase2,TERMINATED,"RyCarma Therapeutics, Inc.",
NCT01737957,Low-fluence PRP with 532nm green LASER,DEVICE,Proliferative Diabetic Retinopathy,na,TERMINATED,Asociación para Evitar la Ceguera en México,
NCT01737957,Full-Fluence PRP with 532nm LASER,DEVICE,Proliferative Diabetic Retinopathy,na,TERMINATED,Asociación para Evitar la Ceguera en México,
NCT01407081,Telerehabilitation Cognitive Strategy Training,BEHAVIORAL,Cognitive Impairment; Stroke,na,TERMINATED,Nova Scotia Health Authority,
NCT04780581,Dexamethasone,DRUG,Corona Virus Infection,phase4,TERMINATED,Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León,
NCT04780581,Methylprednisolone,DRUG,Corona Virus Infection,phase4,TERMINATED,Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León,
NCT01918930,MGA271,BIOLOGICAL,Melanoma,phase1,TERMINATED,MacroGenics,
NCT01682928,IV/Oral Hydration and Bedrest,DRUG,Oligohydramnios,na,TERMINATED,Pediatrix,
NCT01682928,Hydrotherapy,OTHER,Oligohydramnios,na,TERMINATED,Pediatrix,
NCT03219567,Optical Coherence Tomography (OCT),DEVICE,"Image, Body",na,TERMINATED,Duke University,
NCT03219567,Magnetic resonance imaging (MRI),DEVICE,"Image, Body",na,TERMINATED,Duke University,
NCT01201707,Angioplasty,PROCEDURE,Multiple Sclerosis,na,TERMINATED,"Community Care Physicians, P.C.",
NCT01201707,Observation,OTHER,Multiple Sclerosis,na,TERMINATED,"Community Care Physicians, P.C.",
NCT00151307,INVOS cerebral oximeter,DEVICE,Cardiovascular Diseases; Postoperative Complications,phase2; phase3,TERMINATED,Weill Medical College of Cornell University,
NCT04773392,Twice-daily Tacrolimus,DRUG,Kidney Transplantation; Kidney Transplant Rejection,phase4,TERMINATED,University of Southern California,
NCT04773392,Once-daily envarsus XR,DRUG,Kidney Transplantation; Kidney Transplant Rejection,phase4,TERMINATED,University of Southern California,
NCT04773392,Induction Immunosuppression with Basiliximab or Rabbit Anti Thymoglobulin (rATG),DRUG,Kidney Transplantation; Kidney Transplant Rejection,phase4,TERMINATED,University of Southern California,
NCT04773392,"Methylprednisolone, prednisone",DRUG,Kidney Transplantation; Kidney Transplant Rejection,phase4,TERMINATED,University of Southern California,
NCT04773392,Mycophenolate mofetil (MMF) or Mycophenolic acid (MPA),DRUG,Kidney Transplantation; Kidney Transplant Rejection,phase4,TERMINATED,University of Southern California,
NCT04773392,Azathioprine,DRUG,Kidney Transplantation; Kidney Transplant Rejection,phase4,TERMINATED,University of Southern California,
NCT03656536,Pemigatinib,DRUG,Unresectable Cholangiocarcinoma; Metastatic Cholangiocarcinoma,phase3,TERMINATED,Incyte Corporation,
NCT03656536,Gemcitabine,DRUG,Unresectable Cholangiocarcinoma; Metastatic Cholangiocarcinoma,phase3,TERMINATED,Incyte Corporation,
NCT03656536,Cisplatin,DRUG,Unresectable Cholangiocarcinoma; Metastatic Cholangiocarcinoma,phase3,TERMINATED,Incyte Corporation,
NCT00928811,basiliximab,DRUG,End Stage Renal Disease,phase2; phase3,TERMINATED,Drexel University College of Medicine,
NCT00928811,basiliximab,DRUG,End Stage Renal Disease,phase2; phase3,TERMINATED,Drexel University College of Medicine,
NCT00260234,Allogeneic Cultured Islet Cells (human); Encapsulated,BIOLOGICAL,"Diabetes Mellitus, Type 1",phase1; phase2,TERMINATED,Novocell,
NCT01514734,Brinzolamide/timolol maleate fixed combination,DRUG,Glaucoma,phase4,TERMINATED,Alcon Research,
NCT01079364,Insulin glulisine,DRUG,"Diabetes Mellitus, Type 2",phase4,TERMINATED,Sanofi,
NCT01079364,Insulin glargine,DRUG,"Diabetes Mellitus, Type 2",phase4,TERMINATED,Sanofi,
NCT01079364,Premixed insulin (Insulin Aspart 30/70 ),DRUG,"Diabetes Mellitus, Type 2",phase4,TERMINATED,Sanofi,
NCT05703464,Elobixibat 10mg,DRUG,Chronic Constipation,phase4,TERMINATED,International University of Health and Welfare,
NCT04187937,Stereotactic image-guided resection,DEVICE,Liver Neoplasm,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT00429039,L-leucyl-L-leucine methyl ester (LLME),DRUG,ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION,phase2,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT00278577,Immune Ablation and Hematopoietic Stem Cell Support,BIOLOGICAL,CROHN'S DISEASE,phase1,TERMINATED,"Richard Burt, MD",
NCT00740181,chemotherapy,DRUG,Myelodysplasia; Leukemia,phase2,TERMINATED,Brown University,
NCT03978312,Nominal consensus group,OTHER,Cancer; Oncologic Disorders; Haematological Malignancy; Nutrition Aspect of Cancer,na,TERMINATED,Nottingham University Hospitals NHS Trust,
NCT03978312,Observational cohort (validity and reliability testing),OTHER,Cancer; Oncologic Disorders; Haematological Malignancy; Nutrition Aspect of Cancer,na,TERMINATED,Nottingham University Hospitals NHS Trust,
NCT04746612,HH30134,DRUG,Advanced Solid Tumors,phase1,TERMINATED,"Haihe Biopharma Co., Ltd.",
NCT00224965,Behavior Therapy,BEHAVIORAL,Tobacco Use,phase1,TERMINATED,National Institute on Drug Abuse (NIDA),
NCT04345692,Hydroxychloroquine,DRUG,COVID-19,phase3,TERMINATED,Queen's Medical Center,
NCT00401401,zalutumumab,DRUG,Head and Neck Cancer; Squamous Cell Cancer,phase1; phase2,TERMINATED,Genmab,
NCT00401401,cisplatin,DRUG,Head and Neck Cancer; Squamous Cell Cancer,phase1; phase2,TERMINATED,Genmab,
NCT00401401,Radiotherapy,PROCEDURE,Head and Neck Cancer; Squamous Cell Cancer,phase1; phase2,TERMINATED,Genmab,
NCT03042312,177Lu-PSMA-617,DRUG,Metastatic Castration Resistant Prostate Cancer,phase2,TERMINATED,Endocyte,
NCT00720512,bevacizumab,BIOLOGICAL,Colorectal Cancer,phase3,TERMINATED,Gruppo Oncologico del Nord-Ovest,
NCT00720512,fluorouracil,DRUG,Colorectal Cancer,phase3,TERMINATED,Gruppo Oncologico del Nord-Ovest,
NCT00720512,irinotecan hydrochloride,DRUG,Colorectal Cancer,phase3,TERMINATED,Gruppo Oncologico del Nord-Ovest,
NCT00720512,leucovorin calcium,DRUG,Colorectal Cancer,phase3,TERMINATED,Gruppo Oncologico del Nord-Ovest,
NCT00720512,oxaliplatin,DRUG,Colorectal Cancer,phase3,TERMINATED,Gruppo Oncologico del Nord-Ovest,
NCT02820519,Loxapine,DRUG,Neuropathic Pain,phase2,TERMINATED,University of Witten/Herdecke,
NCT01772719,Simvastatin and zoledronic acid,DRUG,Multiple Myeloma,na,TERMINATED,University of Louisville,
NCT00676728,JNJ-26481585,DRUG,Advanced or Refractory Leukemia; Myelodysplastic Syndromes,phase1,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT00210028,Tamoxifen,DRUG,Breast Neoplasms,phase2,TERMINATED,Institut Claudius Regaud,
NCT00210028,Zarnestra,DRUG,Breast Neoplasms,phase2,TERMINATED,Institut Claudius Regaud,
NCT04033328,ORIC-101,DRUG,Prostatic Neoplasms,phase1,TERMINATED,ORIC Pharmaceuticals,
NCT04033328,enzalutamide 40 MG oral capsule [Xtandi],DRUG,Prostatic Neoplasms,phase1,TERMINATED,ORIC Pharmaceuticals,
NCT01335165,ALXN1102,DRUG,Paroxysmal Nocturnal Hemoglobinuria (PNH),phase1,TERMINATED,"Alexion Pharmaceuticals, Inc.",
NCT01335165,ALXN1103,DRUG,Paroxysmal Nocturnal Hemoglobinuria (PNH),phase1,TERMINATED,"Alexion Pharmaceuticals, Inc.",
NCT02596867,propanolol,DRUG,Breast Cancer,phase2,TERMINATED,"Texas Tech University Health Sciences Center, El Paso",
NCT00278200,Inactivated EBV-infected vaccine,BIOLOGICAL,Lymphoproliferative Disorder,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT02635100,CPAP machine with MNT algorithm,OTHER,Sleep Apnea; Sleep Disordered Breathing,na,TERMINATED,NYU Langone Health,
NCT04047771,SCB-313,DRUG,Peritoneal Carcinomatosis,phase1,TERMINATED,"Sichuan Clover Biopharmaceuticals, Inc.",
NCT02219334,NoseFrida,DEVICE,Bronchiolitis,na,TERMINATED,Baylor College of Medicine,
NCT04921332,Bright Light Therapy (BLT) Lamp,DEVICE,Cystic Fibrosis; Depressive Symptoms; Chronic Obstructive Pulmonary Disease,na,TERMINATED,Erica Osborn,
NCT02088632,Incobotulinumtoxina,BIOLOGICAL,Trigeminal Neuralgia,phase2,TERMINATED,Thomas Jefferson University,
NCT02088632,Placebo Comparator,OTHER,Trigeminal Neuralgia,phase2,TERMINATED,Thomas Jefferson University,
NCT02227563,Active tDCS,DEVICE,Schizophrenia,na,TERMINATED,Herzog Hospital,
NCT02227563,control,DEVICE,Schizophrenia,na,TERMINATED,Herzog Hospital,
NCT04638387,PB125,OTHER,"Osteoarthritis, Knee; Muscle Weakness; Pain, Joint",na,TERMINATED,Colorado State University,
NCT04638387,Placebo,OTHER,"Osteoarthritis, Knee; Muscle Weakness; Pain, Joint",na,TERMINATED,Colorado State University,
NCT05236387,99m Tc-TM,DRUG,Breast Cancer,na,TERMINATED,Johns Hopkins University,
NCT02674204,Atorvastatin,DRUG,Breast Cancer; Heart Disease; Cardiotoxicity; Myocardial Dysfunction,phase2,TERMINATED,Cedars-Sinai Medical Center,
NCT02674204,Placebo,DRUG,Breast Cancer; Heart Disease; Cardiotoxicity; Myocardial Dysfunction,phase2,TERMINATED,Cedars-Sinai Medical Center,
NCT02541604,Atezolizumab,DRUG,Solid Tumor,phase1; phase2,TERMINATED,Hoffmann-La Roche,
NCT02061449,Romidepsin,DRUG,Cutaneous T-cell Lymphoma,phase1,TERMINATED,NYU Langone Health,
NCT02061449,Poly ICLC,DRUG,Cutaneous T-cell Lymphoma,phase1,TERMINATED,NYU Langone Health,
NCT02061449,Focal lesional radiation,RADIATION,Cutaneous T-cell Lymphoma,phase1,TERMINATED,NYU Langone Health,
NCT01404065,Transcranial Direct Current Stimulation (tDCS),PROCEDURE,Chronic Pain; Spinal Cord Injury,na,TERMINATED,Spaulding Rehabilitation Hospital,
NCT05644600,Nintedanib,DRUG,Healthy Subjects,phase1,TERMINATED,AstraZeneca,
NCT05644600,AZD5055,DRUG,Healthy Subjects,phase1,TERMINATED,AstraZeneca,
NCT05037500,Decitabine and Cedazuridine,DRUG,Castration-Resistant Prostate Carcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT05037500,Enzalutamide,DRUG,Castration-Resistant Prostate Carcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT00731692,FTY720,DRUG,Primary Progressive Multiple Sclerosis,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT00731692,Placebo,DRUG,Primary Progressive Multiple Sclerosis,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT01798836,Oestradiol pre-treatment and combination of GnRH agonist/antagonist protocol,PROCEDURE,Infertility,phase2; phase3,TERMINATED,National and Kapodistrian University of Athens,
NCT01798836,GnRH agonist or antagonist protocol without oestradiol pre-treatment,PROCEDURE,Infertility,phase2; phase3,TERMINATED,National and Kapodistrian University of Athens,
NCT02339311,Educational intervention of Lifestyle and patient activation in diabetics,OTHER,Diabetes,na,TERMINATED,University of New Mexico,
NCT00787111,Fluoxetine (prozac),DRUG,Autistic Disorder,phase3,TERMINATED,Neuropharm,
NCT03713944,Carboplatin,DRUG,"NSCLC Stage IV; NSCLC, Recurrent",phase2,TERMINATED,Nasser Hanna,
NCT03713944,Pemetrexed,DRUG,"NSCLC Stage IV; NSCLC, Recurrent",phase2,TERMINATED,Nasser Hanna,
NCT03713944,Atezolizumab,DRUG,"NSCLC Stage IV; NSCLC, Recurrent",phase2,TERMINATED,Nasser Hanna,
NCT03713944,Bevacizumab,DRUG,"NSCLC Stage IV; NSCLC, Recurrent",phase2,TERMINATED,Nasser Hanna,
NCT04659044,Polatuzumab Vedotin,DRUG,Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent M,phase2,TERMINATED,Academic and Community Cancer Research United,
NCT04659044,Rituximab,BIOLOGICAL,Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent M,phase2,TERMINATED,Academic and Community Cancer Research United,
NCT04659044,Rituximab and Hyaluronidase Human,BIOLOGICAL,Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent M,phase2,TERMINATED,Academic and Community Cancer Research United,
NCT04659044,Venetoclax,DRUG,Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent M,phase2,TERMINATED,Academic and Community Cancer Research United,
NCT03749564,SMT,BEHAVIORAL,Low Back Pain; Opioid Use,na,TERMINATED,University of Utah,
NCT03749564,Activation Exercises,BEHAVIORAL,Low Back Pain; Opioid Use,na,TERMINATED,University of Utah,
NCT03749564,Mobilizing Exercises,BEHAVIORAL,Low Back Pain; Opioid Use,na,TERMINATED,University of Utah,
NCT03749564,Extended SMT,BEHAVIORAL,Low Back Pain; Opioid Use,na,TERMINATED,University of Utah,
NCT00672009,Ixabepilone,DRUG,"Prostatic Diseases; Genital Neoplasms, Male; Urogenital Neoplasms; Genital Diseases, Male; Adenocarcinoma; Prostatic Neoplasms; Neoplasms, Glandular and Epithelial; Carcinoma",phase2,TERMINATED,Cedars-Sinai Medical Center,
NCT01026909,Aristospan 20mg,DRUG,Legg-Calve Perthes Disease,na,TERMINATED,Seattle Children's Hospital,
NCT04441099,NBE-002,DRUG,Advanced Solid Tumor; Advanced Cancer; Triple Negative Breast Cancer,phase1; phase2,TERMINATED,NBE-Therapeutics AG,
NCT02829814,"TNX-102 SL Tablet, 2.8 mg",DRUG,Fibromyalgia; Myofascial Pain Syndromes; Muscular Diseases; Nervous System Diseases; Neuromuscular Diseases; Rheumatic Diseases; Musculoskeletal Diseases,phase3,TERMINATED,"Tonix Pharmaceuticals, Inc.",
NCT02829814,Placebo SL Tablet,DRUG,Fibromyalgia; Myofascial Pain Syndromes; Muscular Diseases; Nervous System Diseases; Neuromuscular Diseases; Rheumatic Diseases; Musculoskeletal Diseases,phase3,TERMINATED,"Tonix Pharmaceuticals, Inc.",
NCT02978833,PRP,BIOLOGICAL,Tendinopathy; Hip Pain,phase4,TERMINATED,"Hospital for Special Surgery, New York",
NCT02978833,Whole Blood,BIOLOGICAL,Tendinopathy; Hip Pain,phase4,TERMINATED,"Hospital for Special Surgery, New York",
NCT02978833,Ultrasound,DEVICE,Tendinopathy; Hip Pain,phase4,TERMINATED,"Hospital for Special Surgery, New York",
NCT00783952,Cerebral/Somatic Tissue Oximeter device,DEVICE,Mixed Venous Oxygen Saturation; Tissue Oxygenation,na,TERMINATED,Massachusetts General Hospital,
NCT00783952,Pulmonary artery catheter,DEVICE,Mixed Venous Oxygen Saturation; Tissue Oxygenation,na,TERMINATED,Massachusetts General Hospital,
NCT01298752,Mapracorat,DRUG,Inflammation; Pain; Cataract,phase3,TERMINATED,Bausch & Lomb Incorporated,
NCT01298752,Vehicle,DRUG,Inflammation; Pain; Cataract,phase3,TERMINATED,Bausch & Lomb Incorporated,
NCT00394212,Transoral Suturing,DEVICE,Obesity,phase3,TERMINATED,C. R. Bard,
NCT00394212,Sham Endoscopy,OTHER,Obesity,phase3,TERMINATED,C. R. Bard,
NCT00828230,budesonide,DRUG,Radiation Proctitis,phase2,TERMINATED,Dr. Falk Pharma GmbH,
NCT00828230,Placebo foam,DRUG,Radiation Proctitis,phase2,TERMINATED,Dr. Falk Pharma GmbH,
NCT01439828,N-acetylcystein,DRUG,Cannabis Dependence; Cannabis Abuse,phase2,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01900665,Solanezumab,DRUG,Alzheimer's Disease,phase3,TERMINATED,Eli Lilly and Company,
NCT01900665,Placebo,DRUG,Alzheimer's Disease,phase3,TERMINATED,Eli Lilly and Company,
NCT03097536,Luna Bar,OTHER,Migraine Headache,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT00162071,apadenoson,DRUG,Cardiovascular Disease; Ischemic Heart Disease,phase2,TERMINATED,Forest Laboratories,
NCT00098371,alvocidib,DRUG,B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia,phase2,TERMINATED,National Cancer Institute (NCI),
NCT03645564,Specialized nurse consultation,OTHER,Atrial Fibrillation,na,TERMINATED,"University Hospital, Bordeaux",
NCT00425464,Standard Monofocal Intraocular Lens,DEVICE,Cataract,phase3,TERMINATED,Abbott Medical Optics,
NCT00425464,Synchrony® Dual Optic Intraocular Lens,DEVICE,Cataract,phase3,TERMINATED,Abbott Medical Optics,
NCT00457899,Quetiapine IR (Immediate Release),DRUG,Schizophrenia; Schizoaffective Disorders; Psychotic Disorders,phase3,TERMINATED,AstraZeneca,
NCT01217632,FG-3019,DRUG,Liver Fibrosis Due to Chronic Hepatitis B Infection,phase2,TERMINATED,Kyntra Bio,
NCT01217632,Placebo,DRUG,Liver Fibrosis Due to Chronic Hepatitis B Infection,phase2,TERMINATED,Kyntra Bio,
NCT01217632,Entecavir,DRUG,Liver Fibrosis Due to Chronic Hepatitis B Infection,phase2,TERMINATED,Kyntra Bio,
NCT03658798,Functional Electrical Stimulation,PROCEDURE,Stroke; Spinal Cord Injuries,na,TERMINATED,Milos Popovic,
NCT00567463,Fluticasone,DEVICE,Asthma; Bronchial Hyperreactivity,na,TERMINATED,Laval University,
NCT01318421,ELND002,DRUG,Multiple Sclerosis,phase1,TERMINATED,Elan Pharmaceuticals,
NCT01295216,Mobile technology to promote lifestyle modification,BEHAVIORAL,Hypertension; Prehypertension,na,TERMINATED,Institute of Nutrition of Central America and Panama,
NCT03318016,Cyclophosphamide 500 MG,DRUG,Acute Myeloid Leukemia; Relapsed/Refractory Acute Myeloid Leukemia,phase1,TERMINATED,"University of Colorado, Denver",
NCT03318016,Cyclophosphamide 1000 MG,DRUG,Acute Myeloid Leukemia; Relapsed/Refractory Acute Myeloid Leukemia,phase1,TERMINATED,"University of Colorado, Denver",
NCT03318016,Cyclophosphamide 2000 MG,DRUG,Acute Myeloid Leukemia; Relapsed/Refractory Acute Myeloid Leukemia,phase1,TERMINATED,"University of Colorado, Denver",
NCT03318016,Cyclophosphamide 3000 MG,DRUG,Acute Myeloid Leukemia; Relapsed/Refractory Acute Myeloid Leukemia,phase1,TERMINATED,"University of Colorado, Denver",
NCT03318016,Cyclophosphamide 4000 MG,DRUG,Acute Myeloid Leukemia; Relapsed/Refractory Acute Myeloid Leukemia,phase1,TERMINATED,"University of Colorado, Denver",
NCT03028012,Ketorolac,DRUG,Myofascial Pain,phase4,TERMINATED,University of Utah,
NCT03028012,Lidocaine,DRUG,Myofascial Pain,phase4,TERMINATED,University of Utah,
NCT03028012,Dexamethasone,DRUG,Myofascial Pain,phase4,TERMINATED,University of Utah,
NCT00289081,Total Knee Replacement,DEVICE,"Osteoarthritis; Arthritis, Rheumatoid; Avascular Necrosis of Bone; Post-traumatic Arthritis; Rheumatoid Arthritis",na,TERMINATED,DePuy Orthopaedics,
NCT00289081,Total knee replacement,DEVICE,"Osteoarthritis; Arthritis, Rheumatoid; Avascular Necrosis of Bone; Post-traumatic Arthritis; Rheumatoid Arthritis",na,TERMINATED,DePuy Orthopaedics,
NCT00306267,epoetin alfa,DRUG,Anemia; Cancer; Epoetin Alfa,phase2,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT02508636,Enzalutamide,DRUG,Prostatic Neoplasms; Pelvic Nodal,phase2,TERMINATED,"University of California, San Francisco",
NCT02508636,Leuprolide,DRUG,Prostatic Neoplasms; Pelvic Nodal,phase2,TERMINATED,"University of California, San Francisco",
NCT02508636,Intensity-Modulated Radiation Therapy,RADIATION,Prostatic Neoplasms; Pelvic Nodal,phase2,TERMINATED,"University of California, San Francisco",
NCT03380936,Tacrolimus Extended Release Oral Tablet [Envarsus],DRUG,Kidney Transplant Rejection,early_phase1,TERMINATED,"University of Colorado, Denver",
NCT03380936,Plasma Exchange and IVIG (Intravenous Immunoglobulin ),OTHER,Kidney Transplant Rejection,early_phase1,TERMINATED,"University of Colorado, Denver",
NCT04006392,Erchonia FX-635,DEVICE,Diabetic Peripheral Neuropathy,na,TERMINATED,Erchonia Corporation,
NCT04006392,Placebo Laser,DEVICE,Diabetic Peripheral Neuropathy,na,TERMINATED,Erchonia Corporation,
NCT05501171,DREAMLAND,BEHAVIORAL,AML; Acute Myeloid Leukemia,na,TERMINATED,Massachusetts General Hospital,
NCT05501171,CERENA,BEHAVIORAL,AML; Acute Myeloid Leukemia,na,TERMINATED,Massachusetts General Hospital,
NCT04340544,Hydroxychloroquine,DRUG,COVID-19,phase2,TERMINATED,University Hospital Tuebingen,
NCT04340544,Placebo,DRUG,COVID-19,phase2,TERMINATED,University Hospital Tuebingen,
NCT02393209,Docetaxel,DRUG,Non-small Cell Lung Cancer,phase1; phase2,TERMINATED,"Millennium Pharmaceuticals, Inc.",
NCT02393209,TAK-117,DRUG,Non-small Cell Lung Cancer,phase1; phase2,TERMINATED,"Millennium Pharmaceuticals, Inc.",
NCT05298709,Hyperventilation and CO2 challenge,OTHER,Cerebral Cavernous Malformation,na,TERMINATED,University of New Mexico,
NCT06101199,Acute Intermittent Hypercapnic Hypoxia,OTHER,Cervical Spinal Cord Injury,na,TERMINATED,Thomas Jefferson University,
NCT06101199,Transcutaneous spinal cord stimulation,OTHER,Cervical Spinal Cord Injury,na,TERMINATED,Thomas Jefferson University,
NCT06101199,SHAM Acute Intermittent Hypercapnic Hypoxia,OTHER,Cervical Spinal Cord Injury,na,TERMINATED,Thomas Jefferson University,
NCT06101199,SHAM Transcutaneous spinal cord stimulation,OTHER,Cervical Spinal Cord Injury,na,TERMINATED,Thomas Jefferson University,
NCT00488332,Optical Coherence Tomography,PROCEDURE,Head and Neck Cancer; Oral Mucositis,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00488332,Fluorescence Spectroscopy,PROCEDURE,Head and Neck Cancer; Oral Mucositis,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00488332,Pain Scale Questionnaire,BEHAVIORAL,Head and Neck Cancer; Oral Mucositis,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00570063,PF-02545920,DRUG,Schizophrenia,phase2,TERMINATED,Pfizer,
NCT00570063,Placebo,DRUG,Schizophrenia,phase2,TERMINATED,Pfizer,
NCT00638963,temozolomide,DRUG,Breast Neoplasm; Brain Neoplasm; Second Neoplasm,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01552616,Thermal-aided muscle activation,PROCEDURE,Critically-ill,na,TERMINATED,"Niveus Medical, Inc.",
NCT01810016,Ipilimumab,BIOLOGICAL,Unresectable or Metastatic Melanoma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT01810016,NY-ESO-1 Protein Vaccine,BIOLOGICAL,Unresectable or Metastatic Melanoma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT01810016,NY-ESO-1 OLP4 Vaccine with Poly-ICLC and Montanide,BIOLOGICAL,Unresectable or Metastatic Melanoma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT01810016,NY-ESO-1 OLP4 Vaccine with Poly-ICLC,BIOLOGICAL,Unresectable or Metastatic Melanoma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT03002506,Ceftolozane/tazobactam,DRUG,Burns; Pharmacokinetics,phase4,TERMINATED,Texas Tech University Health Sciences Center,
NCT00112684,alvocidib,DRUG,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,National Cancer Institute (NCI),
NCT00112684,pharmacological study,OTHER,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,National Cancer Institute (NCI),
NCT00112684,laboratory biomarker analysis,OTHER,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,National Cancer Institute (NCI),
NCT03118284,urine collection,OTHER,Urethra Injury; Catheter Site Discomfort,na,TERMINATED,Washington University School of Medicine,
NCT03118284,Blood collection,OTHER,Urethra Injury; Catheter Site Discomfort,na,TERMINATED,Washington University School of Medicine,
NCT03118284,NRS,BEHAVIORAL,Urethra Injury; Catheter Site Discomfort,na,TERMINATED,Washington University School of Medicine,
NCT03172195,rectosigmoidoscopy,PROCEDURE,"Colitis, Ulcerative",na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03172195,biopsies,BIOLOGICAL,"Colitis, Ulcerative",na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03172195,blood sample,BIOLOGICAL,"Colitis, Ulcerative",na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03896295,M281,DRUG,Generalized Myasthenia Gravis,phase2,TERMINATED,"Momenta Pharmaceuticals, Inc.",
NCT02608957,Latella Knee Implant System,DEVICE,Osteoarthritis,na,TERMINATED,"Cotera, Inc.",
NCT04329312,Thoracic computed tomography,RADIATION,Pulmonary Hypertension,na,TERMINATED,Medical University of Graz,
NCT02527681,Ceftobiprole medocaril,DRUG,Bacterial Infections,phase1,TERMINATED,Basilea Pharmaceutica,
NCT05307471,Thoracotomy/scopy,OTHER,Thoracotomy; Thoracoscopy,na,TERMINATED,"University Hospital, Clermont-Ferrand",
NCT03340909,Prednisolone,DRUG,Schizophrenia and Related Disorders; Immune Suppression; Psychosis; Cognitive Change,phase2,TERMINATED,Haukeland University Hospital,
NCT03340909,Placebo,OTHER,Schizophrenia and Related Disorders; Immune Suppression; Psychosis; Cognitive Change,phase2,TERMINATED,Haukeland University Hospital,
NCT01492998,"guggulsterone, a natural FXR antagonist.",OTHER,Chronic Hepatitis C,na,TERMINATED,Hospices Civils de Lyon,
NCT03755063,Speech therapy apps,OTHER,Stroke Sequelae,na,TERMINATED,Ottawa Hospital Research Institute,
NCT00702221,Angiotensin Therapeutic Vaccine plus CoVaccine HT™ adjuvant,BIOLOGICAL,Hypertension; Cardiovascular Disease,phase2,TERMINATED,BTG International Inc.,
NCT00702221,CoVaccine HT™ adjuvant,BIOLOGICAL,Hypertension; Cardiovascular Disease,phase2,TERMINATED,BTG International Inc.,
NCT03305614,tDCS,PROCEDURE,Aphasia Following Cerebral Infarction; Aphasia Following Nontraumatic Intracerebral Hemorrhage,phase2,TERMINATED,"University Hospital, Ghent",
NCT03305614,Aphasia therapy,PROCEDURE,Aphasia Following Cerebral Infarction; Aphasia Following Nontraumatic Intracerebral Hemorrhage,phase2,TERMINATED,"University Hospital, Ghent",
NCT05180006,Atezolizumab Injection,DRUG,Breast Cancer,phase2,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT05180006,Bevacizumab,DRUG,Breast Cancer,phase2,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT05180006,Pertuzumab,DRUG,Breast Cancer,phase2,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT05180006,Trastuzumab,DRUG,Breast Cancer,phase2,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT05376839,Cedirogant,DRUG,Hepatic Impairment,phase1,TERMINATED,AbbVie,
NCT02607501,Implant eCLIPs,DEVICE,Saccular Aneurysm; Intracranial Aneurysm,na,TERMINATED,Evasc Medical Systems Corp.,
NCT00922467,NaCl 9/00,DRUG,Anesthesia,phase3,TERMINATED,Hopital Foch,
NCT00922467,Esmolol,DRUG,Anesthesia,phase3,TERMINATED,Hopital Foch,
NCT01819428,NOV120101 (Poziotinib),DRUG,Adenocarcinoma of Lung Stage IIIB; Adenocarcinoma of Lung Stage IV,phase2,TERMINATED,National OncoVenture,
NCT04484428,K-285,DRUG,Acute Pain,phase2,TERMINATED,"Kowa Research Institute, Inc.",
NCT04484428,Menthol,DRUG,Acute Pain,phase2,TERMINATED,"Kowa Research Institute, Inc.",
NCT01727336,Dalantercept and axitinib,DRUG,Advanced Renal Cell Carcinoma,phase2,TERMINATED,"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
NCT01727336,Placebo and axitinib,DRUG,Advanced Renal Cell Carcinoma,phase2,TERMINATED,"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
NCT03131011,UV fluorescent ink,OTHER,Breast Cancer Female; Body Image Disturbance,na,TERMINATED,CancerCare Manitoba,
NCT03322371,2-lead limited electroencephalography recording,DEVICE,Sleep Deprivation; Sleep,na,TERMINATED,University of Utah,
NCT00839644,High frequency chest wall oscillation,DEVICE,Cystic Fibrosis,na,TERMINATED,"University of Colorado, Denver",
NCT00839644,Oscillatory Positive Expiratory Pressure,DEVICE,Cystic Fibrosis,na,TERMINATED,"University of Colorado, Denver",
NCT00839644,PD&P: Postural drainage and percussion,OTHER,Cystic Fibrosis,na,TERMINATED,"University of Colorado, Denver",
NCT00596544,questionnaires,BEHAVIORAL,Ovarian Cancer; Sexual Dysfunction,na,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00596544,questionnaires,BEHAVIORAL,Ovarian Cancer; Sexual Dysfunction,na,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00440544,Ag85B-ESAT6 fusion protein H1,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,"St George's, University of London",
NCT00440544,Ag85B-ESAT6 fusion protein H1,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,"St George's, University of London",
NCT00440544,Ag85B-ESAT6 fusion protein H1,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,"St George's, University of London",
NCT00440544,Ag85B-ESAT6 fusion protein H1,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,"St George's, University of London",
NCT00440544,Ag85B-ESAT6 fusion protein H1,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,"St George's, University of London",
NCT00440544,Ag85B-ESAT6 fusion protein H1,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,"St George's, University of London",
NCT00504699,Ovarian stimulation in vitro fertilization cryopreservation,PROCEDURE,Breast Cancer,na,TERMINATED,New York Medical College,
NCT01871532,Gonal-f®,DRUG,Infertility; Monofollicular Development,phase4,TERMINATED,"Merck KGaA, Darmstadt, Germany",
NCT00510887,Bortezomib,DRUG,"Lymphoma, Follicular",phase2,TERMINATED,Duke University,
NCT00510887,Rituximab,DRUG,"Lymphoma, Follicular",phase2,TERMINATED,Duke University,
NCT00510887,Fludarabine,DRUG,"Lymphoma, Follicular",phase2,TERMINATED,Duke University,
NCT00510887,Mitoxantrone,DRUG,"Lymphoma, Follicular",phase2,TERMINATED,Duke University,
NCT00510887,Dexamethasone,DRUG,"Lymphoma, Follicular",phase2,TERMINATED,Duke University,
NCT00684957,Recombinant Human Growth Hormone,DRUG,Growth Hormone Deficiency,phase1; phase2,TERMINATED,Columbia University,
NCT00684957,Recombinant Human IGF-1,DRUG,Growth Hormone Deficiency,phase1; phase2,TERMINATED,Columbia University,
NCT03809481,Danaparoid Sodium,DRUG,Heparin-induced Thrombocytopenia,phase3,TERMINATED,Aspen Global Incorporated,
NCT03809481,Argatroban,DRUG,Heparin-induced Thrombocytopenia,phase3,TERMINATED,Aspen Global Incorporated,
NCT01390181,Cozaar,DRUG,Bicuspid Aortic Valve; Thoracic Aortic Aneurysm,na,TERMINATED,University of Michigan,
NCT02162628,Exair Prolapse Repair System,DEVICE,Pelvic Organ Prolapse,na,TERMINATED,Coloplast A/S,
NCT02162628,Total Native Tissue Repair,PROCEDURE,Pelvic Organ Prolapse,na,TERMINATED,Coloplast A/S,
NCT03785392,Group 1 In-plane,PROCEDURE,Acute Pain; Brachial Plexus Block,na,TERMINATED,"The University of Texas Medical Branch, Galveston",
NCT03785392,Group 2 out of plane,PROCEDURE,Acute Pain; Brachial Plexus Block,na,TERMINATED,"The University of Texas Medical Branch, Galveston",
NCT06421311,nivolumab,DRUG,Urothelial Carcinoma,na,TERMINATED,Bristol-Myers Squibb,
NCT03319771,Treadmill Walking Exercise Training,BEHAVIORAL,Multiple Sclerosis; Physical Activity; Memory Impairment; Cognitive Change,na,TERMINATED,University of Alabama at Birmingham,
NCT03319771,Stretching-and-toning Exercise Training,BEHAVIORAL,Multiple Sclerosis; Physical Activity; Memory Impairment; Cognitive Change,na,TERMINATED,University of Alabama at Birmingham,
NCT05569044,Control Group,OTHER,Hydration,na,TERMINATED,Abbott Nutrition,
NCT05569044,Oral Rehydration Solution,OTHER,Hydration,na,TERMINATED,Abbott Nutrition,
NCT05569044,Water,OTHER,Hydration,na,TERMINATED,Abbott Nutrition,
NCT04040244,Exhaled Breath Collection,OTHER,Pneumonitis; Nonsmall Cell Lung Cancer Stage III,na,TERMINATED,Wake Forest University Health Sciences,
NCT04040244,Blood sample,OTHER,Pneumonitis; Nonsmall Cell Lung Cancer Stage III,na,TERMINATED,Wake Forest University Health Sciences,
NCT03132571,Naltrexone,DRUG,"Schizophrenia; Diabetes Mellitus, Type 2; Obesity",phase2,TERMINATED,Yale University,
NCT03132571,Bupropion,DRUG,"Schizophrenia; Diabetes Mellitus, Type 2; Obesity",phase2,TERMINATED,Yale University,
NCT03132571,Placebo,OTHER,"Schizophrenia; Diabetes Mellitus, Type 2; Obesity",phase2,TERMINATED,Yale University,
NCT04122898,Pelvic Floor Muscle Training,OTHER,Urinary Incontinence; Stress Urinary Incontinence,na,TERMINATED,Norwegian School of Sport Sciences,
NCT00051532,Seocalcitol,DRUG,Liver Neoplasms,na,TERMINATED,LEO Pharma,
NCT00093132,Satraplatin,DRUG,"Carcinoma, Non-small Cell Lung; Lung Cancer",phase1; phase2,TERMINATED,Agennix,
NCT03462537,Low level laser therapy,DEVICE,Metabolic Disease,na,TERMINATED,Escola Superior de Tecnologia da Saúde do Porto,
NCT03462537,Aerobic Exercise,DEVICE,Metabolic Disease,na,TERMINATED,Escola Superior de Tecnologia da Saúde do Porto,
NCT03462537,Low level laser therapy without power,DEVICE,Metabolic Disease,na,TERMINATED,Escola Superior de Tecnologia da Saúde do Porto,
NCT03712345,IFX-1 low dose,DRUG,Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA),phase2,TERMINATED,InflaRx GmbH,
NCT03712345,IFX-1 high dose,DRUG,Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA),phase2,TERMINATED,InflaRx GmbH,
NCT03712345,Placebo,DRUG,Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA),phase2,TERMINATED,InflaRx GmbH,
NCT01822275,Chemotherapy with Temodar.,DRUG,Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV),phase2,TERMINATED,"University of Maryland, Baltimore",
NCT01822275,Radiation therapy,RADIATION,Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV),phase2,TERMINATED,"University of Maryland, Baltimore",
NCT03325101,Cryosurgery,PROCEDURE,Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7,phase1; phase2,TERMINATED,Mayo Clinic,
NCT03325101,Pembrolizumab,BIOLOGICAL,Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7,phase1; phase2,TERMINATED,Mayo Clinic,
NCT03325101,Pheresis,PROCEDURE,Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7,phase1; phase2,TERMINATED,Mayo Clinic,
NCT03325101,Therapeutic Autologous Dendritic Cells,BIOLOGICAL,Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7,phase1; phase2,TERMINATED,Mayo Clinic,
NCT05359081,SEP-363856,DRUG,Schizophrenia,phase3,TERMINATED,"Sumitomo Pharma Co., Ltd.",
NCT04089319,Music recording,OTHER,Chronic Pain,na,TERMINATED,University of Utah,
NCT04089319,Mindfulness recording,OTHER,Chronic Pain,na,TERMINATED,University of Utah,
NCT02584400,"Injection with the hypoxia tracer [18F]HX4,",DRUG,"Prostatic Neoplasms; Esophageal Neoplasms; Neoplasm Metastases, Brain; Rectal Neoplasms; Brain Neoplasm, Primary",phase2,TERMINATED,Maastricht Radiation Oncology,
NCT02720211,Gray tinted spectacle lenses,DEVICE,Headache Migraine Chronic,na,TERMINATED,University of Utah,
NCT02720211,Thin-Film spectacle lenses,DEVICE,Headache Migraine Chronic,na,TERMINATED,University of Utah,
NCT03127371,Nitrous Oxide,DRUG,Abscess,na,TERMINATED,Albert Einstein Healthcare Network,
NCT03127371,Oxygen,DRUG,Abscess,na,TERMINATED,Albert Einstein Healthcare Network,
NCT00268164,lactobacilus acidophilus & bifidobacterium animalis/lactis,DRUG,Ulcerative Colitis,phase2,TERMINATED,Hvidovre University Hospital,
NCT03506009,Argatroban combined with rt-PA,DRUG,"Argatroban, Rt-PA",phase4,TERMINATED,Hui-Sheng Chen,
NCT03506009,rt-PA,DRUG,"Argatroban, Rt-PA",phase4,TERMINATED,Hui-Sheng Chen,
NCT00537732,omeprazole,DRUG,Gastroesophageal Reflux,phase4,TERMINATED,Matthias Schwab,
NCT00537732,omeprazole,DRUG,Gastroesophageal Reflux,phase4,TERMINATED,Matthias Schwab,
NCT03387332,APG-1252,DRUG,Small Cell Lung Cancer and Other Solid Tumors,phase1,TERMINATED,Ascentage Pharma Group Inc.,
NCT01478932,diaphragmatic breathing retraining,BEHAVIORAL,Dyspnea,na,TERMINATED,University of Nebraska,
NCT01478932,Health Promotion,BEHAVIORAL,Dyspnea,na,TERMINATED,University of Nebraska,
NCT02154087,HP802-247,BIOLOGICAL,Venous Leg Ulcers,phase2,TERMINATED,Healthpoint,
NCT01001793,Levacor Ventricular Assist Device,DEVICE,Refractory Heart Failure,na,TERMINATED,World Heart Corporation,
NCT00750919,esmirtazapine,DRUG,"Sleep Initiation and Maintenance Disorders; Mental Disorders; Dyssomnias; Sleep Disorders; Sleep Disorders, Intrinsic",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00290719,cisplatin,DRUG,Esophageal Cancer,phase1,TERMINATED,"University of California, San Francisco",
NCT00290719,gefitinib,DRUG,Esophageal Cancer,phase1,TERMINATED,"University of California, San Francisco",
NCT00290719,irinotecan hydrochloride,DRUG,Esophageal Cancer,phase1,TERMINATED,"University of California, San Francisco",
NCT00290719,conventional surgery,PROCEDURE,Esophageal Cancer,phase1,TERMINATED,"University of California, San Francisco",
NCT00290719,neoadjuvant therapy,PROCEDURE,Esophageal Cancer,phase1,TERMINATED,"University of California, San Francisco",
NCT00290719,radiation therapy,RADIATION,Esophageal Cancer,phase1,TERMINATED,"University of California, San Francisco",
NCT03614728,GSK3326595,DRUG,Neoplasms,phase1; phase2,TERMINATED,GlaxoSmithKline,
NCT03614728,5-Azacitidine,DRUG,Neoplasms,phase1; phase2,TERMINATED,GlaxoSmithKline,
NCT02433392,CM-BC2,PROCEDURE,Glioma,phase1,TERMINATED,Boston Scientific Corporation,
NCT05486611,W-GenZD Mobile Application,DEVICE,Depression,na,TERMINATED,Woebot Health,
NCT05486611,Digital Education Application (W-EdZD),DEVICE,Depression,na,TERMINATED,Woebot Health,
NCT03169309,Brain Entrainment Technology,DEVICE,"Sleep; Sleep Disorders; Sleep Deprivation; Sleep Disturbance; Sleep Disorders, Intrinsic; Sleep Disorders, Circadian Rhythm",na,TERMINATED,Landstuhl Regional Medical Center,
NCT00758732,Docetaxel,DRUG,Ovarian Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00758732,Carboplatin,DRUG,Ovarian Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00758732,Docetaxel,DRUG,Ovarian Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00758732,Liposomal doxorubicin,DRUG,Ovarian Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00494663,DIO-902,DRUG,Type 2 Diabetes,phase2,TERMINATED,DiObex,
NCT00494663,DIO-902,DRUG,Type 2 Diabetes,phase2,TERMINATED,DiObex,
NCT00494663,DIO-902,DRUG,Type 2 Diabetes,phase2,TERMINATED,DiObex,
NCT00494663,DIO-902 placebo,DRUG,Type 2 Diabetes,phase2,TERMINATED,DiObex,
NCT00494663,DIO-902,DRUG,Type 2 Diabetes,phase2,TERMINATED,DiObex,
NCT00494663,DIO-902,DRUG,Type 2 Diabetes,phase2,TERMINATED,DiObex,
NCT00494663,DIO-902,DRUG,Type 2 Diabetes,phase2,TERMINATED,DiObex,
NCT00494663,DIO-902 placebo,DRUG,Type 2 Diabetes,phase2,TERMINATED,DiObex,
NCT04598321,Talazoparib Oral Capsule,DRUG,BRCA1 Mutation; BRCA2 Mutation; Ovarian Cancer; Fallopian Tube Cancer; High Grade Serous Carcinoma,phase1,TERMINATED,Brown University,
NCT00208416,DePuy MI System,PROCEDURE,Osteoarthritis(Primary),phase4,TERMINATED,DePuy International,
NCT00208416,Conventional surgical technique,PROCEDURE,Osteoarthritis(Primary),phase4,TERMINATED,DePuy International,
NCT02085616,Proactive service,BEHAVIORAL,Smoking Cessation; Tobacco Cessation,na,TERMINATED,Uppsala University,
NCT02085616,Reactive service,BEHAVIORAL,Smoking Cessation; Tobacco Cessation,na,TERMINATED,Uppsala University,
NCT02048904,Sitagliptin,DRUG,Type 2 Diabetes; Microalbuminuria,phase4,TERMINATED,University of Missouri-Columbia,
NCT02048904,Placebo,DRUG,Type 2 Diabetes; Microalbuminuria,phase4,TERMINATED,University of Missouri-Columbia,
NCT04807933,Heart rate variability Biofeedback [HRV-BFB],BEHAVIORAL,Somatoform Disorders; Irritable Bowel Syndrome; Psychogenic Non-Epileptic Seizure,na,TERMINATED,"University Hospital, Grenoble",
NCT03212352,Mifepristone,DRUG,Early Pregnancy Failure,phase4,TERMINATED,Radboud University Medical Center,
NCT03212352,Misoprostol,DRUG,Early Pregnancy Failure,phase4,TERMINATED,Radboud University Medical Center,
NCT00588900,cediranib maleate,DRUG,Colorectal Cancer,phase2,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT00588900,irinotecan hydrochloride,DRUG,Colorectal Cancer,phase2,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT01444911,Vaginal Renewal Program,DEVICE,"Sexual Dysfunction, Physiological",phase2,TERMINATED,"University of Wisconsin, Madison",
NCT01444911,Vaginal Dilator,DEVICE,"Sexual Dysfunction, Physiological",phase2,TERMINATED,"University of Wisconsin, Madison",
NCT01732211,PD 0360324,BIOLOGICAL,Pulmonary Sarcoidosis,phase2,TERMINATED,Pfizer,
NCT01732211,Normal Saline for injection,OTHER,Pulmonary Sarcoidosis,phase2,TERMINATED,Pfizer,
NCT01337544,HAPLOIDENTICAL IL-15 STIMULATED NK CELLS,OTHER,Childhood Solid Tumor,phase1; phase2,TERMINATED,"Hospital Infantil Universitario Niño Jesús, Madrid, Spain",
NCT05229744,sequence MRI 3D FLAIR,DEVICE,Endolymphatic Hydrops,na,TERMINATED,Fondation Ophtalmologique Adolphe de Rothschild,
NCT00587899,Pulmonary Vein Isolation,PROCEDURE,Atrial Fibrillation,na,TERMINATED,Mayo Clinic,
NCT02373787,creos xenoprotect,DEVICE,Implant,na,TERMINATED,Nobel Biocare,
NCT02373787,Bio-Gide,DEVICE,Implant,na,TERMINATED,Nobel Biocare,
NCT01095887,Eculizumab,DRUG,Kidney Transplant,phase1; phase2,TERMINATED,Mayo Clinic,
NCT01787721,Ankle manipulation,PROCEDURE,Gait,na,TERMINATED,University of Bridgeport,
NCT01787721,Sham manipulation,OTHER,Gait,na,TERMINATED,University of Bridgeport,
NCT03886714,Screening for Fabry disease,OTHER,Fabry Disease; Nephropathy,na,TERMINATED,"University Hospital, Montpellier",
NCT03886714,Screen for α-galactosidase mutation,OTHER,Fabry Disease; Nephropathy,na,TERMINATED,"University Hospital, Montpellier",
NCT06654414,PRIDE QUIT,BEHAVIORAL,Smoking Cessation; Depression; Anxiety; Nicotine Dependence; Gender Minority Stress,na,TERMINATED,Massachusetts General Hospital,
NCT06654414,Enhanced Treatment As Usual (ETAU),BEHAVIORAL,Smoking Cessation; Depression; Anxiety; Nicotine Dependence; Gender Minority Stress,na,TERMINATED,Massachusetts General Hospital,
NCT04642014,COVID-19 convalescent plasma treatment,BIOLOGICAL,COVID-19 Convalescent Plasma Treatment,na,TERMINATED,Wroclaw Medical University,
NCT01919606,EXPAREL,DRUG,Postoperative Pain,phase4,TERMINATED,"Pacira Pharmaceuticals, Inc",
NCT00232206,Neoadjuvant Therapy with Cisplatin Plus Docetaxel,DRUG,Non-small-Cell Lung Carcinoma,phase2,TERMINATED,Providence Health & Services,
NCT04524949,IMCY-0098 450 μg,DRUG,"Diabetes Mellitus, Type 1",phase2,TERMINATED,Imcyse SA,
NCT04524949,IMCY-0098 1350 μg,DRUG,"Diabetes Mellitus, Type 1",phase2,TERMINATED,Imcyse SA,
NCT04524949,Placebo,DRUG,"Diabetes Mellitus, Type 1",phase2,TERMINATED,Imcyse SA,
NCT00523367,24 hour pH testing,PROCEDURE,Gastroesophageal Reflux; Chronic Obstructive Pulmonary Disease,na,TERMINATED,University of Florida,
NCT02373800,Cervical ultrasound with elastography,DEVICE,"Labor, Induced",na,TERMINATED,Centre Hospitalier Universitaire de Nīmes,
NCT02889211,Gambling Task,BEHAVIORAL,Depression; Insulin Resistance,na,TERMINATED,University of Pittsburgh,
NCT04943744,Entero-tracker,DEVICE,Eosinophilic Disorder; Food Allergy,early_phase1,TERMINATED,Stanford University,
NCT04943744,omalizumab,BIOLOGICAL,Eosinophilic Disorder; Food Allergy,early_phase1,TERMINATED,Stanford University,
NCT04943744,dupliumab,BIOLOGICAL,Eosinophilic Disorder; Food Allergy,early_phase1,TERMINATED,Stanford University,
NCT01268644,Leptin,DRUG,Type 1 Diabetes,phase1,TERMINATED,University of Texas Southwestern Medical Center,
NCT05570409,Mycophenolate Mofetil,DRUG,Inflammatory Cardiomyopathy,phase2; phase3,TERMINATED,LMU Klinikum,
NCT05570409,Prednisolone,DRUG,Inflammatory Cardiomyopathy,phase2; phase3,TERMINATED,LMU Klinikum,
NCT05570409,Mycophenolate Mofetil Placebo,DRUG,Inflammatory Cardiomyopathy,phase2; phase3,TERMINATED,LMU Klinikum,
NCT05570409,Prednisolone Placebo,DRUG,Inflammatory Cardiomyopathy,phase2; phase3,TERMINATED,LMU Klinikum,
NCT01334099,"CP-675,206",BIOLOGICAL,Metastatic Breast Cancer,phase1,TERMINATED,"University Health Network, Toronto",
NCT01334099,External local radiation therapy,RADIATION,Metastatic Breast Cancer,phase1,TERMINATED,"University Health Network, Toronto",
NCT00704821,PTC299,DRUG,Advanced Cancer,phase1,TERMINATED,PTC Therapeutics,
NCT00704821,Docetaxel,DRUG,Advanced Cancer,phase1,TERMINATED,PTC Therapeutics,
NCT06264921,NKT3447,DRUG,"Solid Tumor; Solid Tumor, Adult; Advanced Solid Tumor; Metastatic Tumor; Ovarian Cancer; Ovarian Neoplasms; Ovarian Carcinoma; Metastatic Ovarian Carcinoma; Endometrial Cancer; Endometrial Neoplasms; ",phase1,TERMINATED,"NiKang Therapeutics, Inc.",
NCT03555721,Oral examination with incandescent light,OTHER,Oral Cavity Cancer; Oropharyngeal Cancer,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT03555721,Oral examination with OralID,OTHER,Oral Cavity Cancer; Oropharyngeal Cancer,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT03555721,Biopsy,OTHER,Oral Cavity Cancer; Oropharyngeal Cancer,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT03555721,CytID,OTHER,Oral Cavity Cancer; Oropharyngeal Cancer,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT03555721,hpvID,OTHER,Oral Cavity Cancer; Oropharyngeal Cancer,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT05497206,"One of the following hip implants may be used within this arm of the study: G7 Acetabular System, Taperloc Complete System, Avenir and Avenir Complete Systems, and Echo Bi-Metric System",DEVICE,"Osteoarthritis, Hip; Avascular Necrosis of Hip",na,TERMINATED,Zimmer Biomet,
NCT03358004,Vinorelbine Tartrate,DRUG,Triple Negative Breast Cancer,phase2,TERMINATED,Mario Negri Institute for Pharmacological Research,
NCT03358004,Capecitabine 500 MG,DRUG,Triple Negative Breast Cancer,phase2,TERMINATED,Mario Negri Institute for Pharmacological Research,
NCT03509584,hypofractionated radiotherapy,RADIATION,Non-small Cell Lung Cancer,phase1,TERMINATED,Assistance Publique Hopitaux De Marseille,
NCT03509584,nivolumab,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,Assistance Publique Hopitaux De Marseille,
NCT03509584,Ipilimumab,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,Assistance Publique Hopitaux De Marseille,
NCT05309733,VOR33,OTHER,"Leukemia, Myeloid, Acute",na,TERMINATED,Vor Biopharma,
NCT01145417,pregabalin (Lyrica),DRUG,HIV-1 Infection; Neuropathic Pain,phase3,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT04496674,CC-1 and Toczilizumab,DRUG,Lung Cancer Squamous Cell,phase1; phase2,TERMINATED,German Cancer Research Center,
NCT01761760,Videogame-based smoking cessation intervention,BEHAVIORAL,Smoking Cessation,na,TERMINATED,Rowan University,
NCT04586920,LY3509754,DRUG,Healthy,phase1,TERMINATED,Eli Lilly and Company,
NCT04586920,Placebo,DRUG,Healthy,phase1,TERMINATED,Eli Lilly and Company,
NCT04586920,Itraconazole,DRUG,Healthy,phase1,TERMINATED,Eli Lilly and Company,
NCT04586920,Midazolam,DRUG,Healthy,phase1,TERMINATED,Eli Lilly and Company,
NCT03660423,Integrative Dance,OTHER,Developmental Disability,na,TERMINATED,Skidmore College,
NCT02927080,ACE-083,DRUG,Facioscapulohumeral Muscular Dystrophy,phase2,TERMINATED,"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
NCT02927080,ACE-083 or placebo,DRUG,Facioscapulohumeral Muscular Dystrophy,phase2,TERMINATED,"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
NCT04305379,Augmented Bladder Neck Reconstruction,PROCEDURE,Prostate Cancer; Urinary Incontinence; Surgery,na,TERMINATED,Johns Hopkins University,
NCT04305379,Standard Bladder Neck Reconstruction,PROCEDURE,Prostate Cancer; Urinary Incontinence; Surgery,na,TERMINATED,Johns Hopkins University,
NCT03394196,HIV-2 Genotypic Drug Resistance Testing using DBS,OTHER,HIV-2 Infection,na,TERMINATED,University of Washington,
NCT03394196,2nd line ART ( Zidovudine 300mg BID + Lamivudine 150mg BID or Tenofovir DF 300mg QD + Lamividine 300mg QD or Emtricitabine 200mg QD + Lopinavir/Ritonavir 400/100mg BID),DRUG,HIV-2 Infection,na,TERMINATED,University of Washington,
NCT03394196,2nd line ART (Tenofovir DF 300mg QD + Lamividine 300mg QD or Emtricitabine 200mg QD + Lopinavir/Ritonavir 400/100mg BID + Raltegravir 400mg BID ),DRUG,HIV-2 Infection,na,TERMINATED,University of Washington,
NCT03394196,2nd line ART (Tenofovir DF 300mg QD + Lamividine 300mg QD or Tenofovir DF 300mg QD + Emtricitabine 200mg QD + Darunavir 600mg BID-Ritonavir 100mg BID +Raltegravir 400mg BID),DRUG,HIV-2 Infection,na,TERMINATED,University of Washington,
NCT02520427,AMG 330,DRUG,Relapsed/Refractory AML; Minimal Residual Disease Positive AML; Myelodysplastic Syndrome,phase1,TERMINATED,Amgen,
NCT01461915,Nab paclitaxel,DRUG,Metastatic Pancreatic Cancer,phase2,TERMINATED,Jazz Pharmaceuticals,
NCT01461915,Gemcitabine,DRUG,Metastatic Pancreatic Cancer,phase2,TERMINATED,Jazz Pharmaceuticals,
NCT01461915,Dociparstat,DRUG,Metastatic Pancreatic Cancer,phase2,TERMINATED,Jazz Pharmaceuticals,
NCT00316550,AV608,DRUG,Irritable Bowel Syndrome (IBS),phase1,TERMINATED,Avera Pharmaceuticals,
NCT04078191,Tc 99m tilmanocept,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,Navidea Biopharmaceuticals,
NCT00187590,Case manager phone call after an ER visit,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT04264182,ICD programming,OTHER,"Heart Failure, Systolic; Left Ventricular Assist Device; ICD",na,TERMINATED,The Cleveland Clinic,
NCT00003624,amifostine trihydrate,DRUG,Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Neurotoxicity; Ovarian Cancer; Primary Peritoneal Cavity Cancer; Sarcoma,phase2,TERMINATED,Gynecologic Oncology Group,
NCT00003624,cisplatin,DRUG,Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Neurotoxicity; Ovarian Cancer; Primary Peritoneal Cavity Cancer; Sarcoma,phase2,TERMINATED,Gynecologic Oncology Group,
NCT00003624,paclitaxel,DRUG,Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Neurotoxicity; Ovarian Cancer; Primary Peritoneal Cavity Cancer; Sarcoma,phase2,TERMINATED,Gynecologic Oncology Group,
NCT02728323,Levobupivacaine,DRUG,Pain,phase3,TERMINATED,Emiliano Petrucci,
NCT02728323,Saline,DRUG,Pain,phase3,TERMINATED,Emiliano Petrucci,
NCT00762359,Lansoprazole,DRUG,Stomach Ulcer; Duodenal Ulcer,phase3,TERMINATED,Takeda,
NCT00762359,Gefarnate,DRUG,Stomach Ulcer; Duodenal Ulcer,phase3,TERMINATED,Takeda,
NCT03355079,SmofKabiven® E,DRUG,Cancer-related Malnutrition,phase4,TERMINATED,Fresenius Kabi,
NCT01876979,IMF Screws,DEVICE,Mandible Fracture,na,TERMINATED,Christiana Care Health Services,
NCT01876979,Erich Arch Bars,DEVICE,Mandible Fracture,na,TERMINATED,Christiana Care Health Services,
NCT00949988,Dasatinib and Rituximab,DRUG,Chronic Lymphocytic Leukemia,phase1; phase2,TERMINATED,"University of California, San Diego",
NCT03566303,Rivaroxaban 15 mg,DRUG,Prostheses and Implants; Stroke; Valve Heart Disease; Anticoagulants and Bleeding Disorders,phase2; phase3,TERMINATED,Hospital Geral Roberto Santos,
NCT03566303,Warfarin,DRUG,Prostheses and Implants; Stroke; Valve Heart Disease; Anticoagulants and Bleeding Disorders,phase2; phase3,TERMINATED,Hospital Geral Roberto Santos,
NCT03254927,CDX-3379 and cetuximab,DRUG,Advanced Head and Neck Squamous Cell Carcinoma,phase2,TERMINATED,Celldex Therapeutics,
NCT00836927,Ridaforolimus Tablet,DRUG,Advanced Cancers,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00836927,Ridaforolimus Intravenous (IV) Infusion,DRUG,Advanced Cancers,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT05819827,Blood and Tissue,OTHER,Bladder Cancer; Prostate Cancer; Testicular Cancer; Bladder Carcinoma; Genitourinary System Carcinoma; Malignant Testicular Neoplasm; Melanoma; Prostate Carcinoma; Sarcoma,na,TERMINATED,Mayo Clinic,
NCT00248261,"ziprasidone, sertraline",DRUG,Post-traumatic Stress Disorder,na,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT00590135,atorvastatin (Lipitor),DRUG,Aortic Valve Stenosis,phase4,TERMINATED,The Cleveland Clinic,
NCT01636817,NNC0109-0012,DRUG,Inflammation; Rheumatoid Arthritis,phase2,TERMINATED,Novo Nordisk A/S,
NCT01636817,placebo,DRUG,Inflammation; Rheumatoid Arthritis,phase2,TERMINATED,Novo Nordisk A/S,
NCT03401489,PACESETTER,DEVICE,Blood Pressure; Hypertension; Mhealth,na,TERMINATED,Northern California Institute of Research and Education,
NCT01308489,therapeutic conventional surgery,PROCEDURE,Adult Spinal Cord Neoplasm; Recurrent Adult Spinal Cord Neoplasm; Spinal Bone Metastases; Spinal Cord Metastases,na,TERMINATED,City of Hope Medical Center,
NCT01308489,therapeutic conventional surgery,PROCEDURE,Adult Spinal Cord Neoplasm; Recurrent Adult Spinal Cord Neoplasm; Spinal Bone Metastases; Spinal Cord Metastases,na,TERMINATED,City of Hope Medical Center,
NCT01308489,quality-of-life assessment,PROCEDURE,Adult Spinal Cord Neoplasm; Recurrent Adult Spinal Cord Neoplasm; Spinal Bone Metastases; Spinal Cord Metastases,na,TERMINATED,City of Hope Medical Center,
NCT02216097,PF-04457845,DRUG,Post-Traumatic Stress Disorder,phase2,TERMINATED,Pfizer,
NCT02216097,Placebo,DRUG,Post-Traumatic Stress Disorder,phase2,TERMINATED,Pfizer,
NCT01226420,Alefacept,DRUG,Chronic Graft-versus-host Disease,phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT02893982,brachytherapy,RADIATION,Liver Cancer,phase1,TERMINATED,University of Texas Southwestern Medical Center,
NCT01737359,amdoxovir 300 mg bid,DRUG,Human Immunodeficiency Virus Infection,phase2,TERMINATED,"RFS Pharma, LLC",
NCT01737359,amdoxovir 500 mg bid,DRUG,Human Immunodeficiency Virus Infection,phase2,TERMINATED,"RFS Pharma, LLC",
NCT01737359,tenofovir DF 300 mg qd,DRUG,Human Immunodeficiency Virus Infection,phase2,TERMINATED,"RFS Pharma, LLC",
NCT03421496,Cannabidiol Oral Solution,DRUG,Infantile Spasm,phase3,TERMINATED,"Radius Pharmaceuticals, Inc.",
NCT03421496,Placebo,DRUG,Infantile Spasm,phase3,TERMINATED,"Radius Pharmaceuticals, Inc.",
NCT03421496,Vigabatrin,DRUG,Infantile Spasm,phase3,TERMINATED,"Radius Pharmaceuticals, Inc.",
NCT03285308,Placebo,DRUG,Gastroparesis; Diabetes Mellitus,phase3,TERMINATED,Allergan,
NCT03285308,Relamorelin,DRUG,Gastroparesis; Diabetes Mellitus,phase3,TERMINATED,Allergan,
NCT04614025,PLX-PAD,BIOLOGICAL,COVID; ARDS,phase2,TERMINATED,Pluristem Ltd.,
NCT04440540,Dietitian led life style modification intervention,BEHAVIORAL,Non-alcoholic Fatty Liver Disease,na,TERMINATED,Chinese University of Hong Kong,
NCT04440540,Conventional care (control),BEHAVIORAL,Non-alcoholic Fatty Liver Disease,na,TERMINATED,Chinese University of Hong Kong,
NCT02285140,Cefazolin,DRUG,Thoracic Surgery; Antibiotic Prophylaxis,na,TERMINATED,Hamilton Health Sciences Corporation,
NCT02285140,Vancomycin,DRUG,Thoracic Surgery; Antibiotic Prophylaxis,na,TERMINATED,Hamilton Health Sciences Corporation,
NCT01791218,"CABG, AVR or CABG+AVR and PVI",PROCEDURE,Paroxysmal Atrial Fibrillation; Coronary Artery Disease,na,TERMINATED,Kuopio University Hospital,
NCT01791218,"CABG, AVR or CABG+AVR",PROCEDURE,Paroxysmal Atrial Fibrillation; Coronary Artery Disease,na,TERMINATED,Kuopio University Hospital,
NCT03680560,ACTR T Cell Product,BIOLOGICAL,Solid Tumor; HER-2 Protein Overexpression,phase1,TERMINATED,"Cogent Biosciences, Inc.",
NCT03680560,Trastuzumab,DRUG,Solid Tumor; HER-2 Protein Overexpression,phase1,TERMINATED,"Cogent Biosciences, Inc.",
NCT01805960,Canakinumab,BIOLOGICAL,Atrial Fibrillation,phase2,TERMINATED,"University Hospital, Basel, Switzerland",
NCT01805960,Placebo,BIOLOGICAL,Atrial Fibrillation,phase2,TERMINATED,"University Hospital, Basel, Switzerland",
NCT05543759,Ready-To-Use Therapeutic Food (RUTF),OTHER,Acute Malnutrition in Childhood; Wasting; Child Malnutrition,na,TERMINATED,UNICEF - Venezuela,
NCT00240162,PTK787/ZK 222584,DRUG,Multiple Myeloma,phase2,TERMINATED,Washington University School of Medicine,
NCT03619746,POCUS Educational Intervention,BEHAVIORAL,Cellulitis; Insect Bites; Insect Stings,na,TERMINATED,New York City Health and Hospitals Corporation,
NCT03043976,Actigraph GT9X Link device,DEVICE,"Hypertension, Pulmonary",na,TERMINATED,Imperial College Healthcare NHS Trust,
NCT04541225,NUV-422,DRUG,"Glioma; Glioma, Malignant; Glioma, Mixed; Glial Cell Tumors; Breast Cancer; Breast Carcinoma; Cancer of Breast; Cancer of the Breast; Breast Tumor; Malignant Tumor of Breast; Advanced Breast Cancer; A",phase1,TERMINATED,Nuvation Bio Inc.,
NCT02749825,Trelstar,DRUG,Prostate Cancer,phase4,TERMINATED,Pharmatech,
NCT02749825,Lupron,DRUG,Prostate Cancer,phase4,TERMINATED,Pharmatech,
NCT02749825,Zoladex,DRUG,Prostate Cancer,phase4,TERMINATED,Pharmatech,
NCT03559517,Ontamalimab,BIOLOGICAL,Crohn's Disease,phase3,TERMINATED,Shire,
NCT03559517,Placebo,OTHER,Crohn's Disease,phase3,TERMINATED,Shire,
NCT00412217,Placebo,DRUG,Head and Neck Cancer,phase3,TERMINATED,Hoffmann-La Roche,
NCT00412217,Erlotinib,DRUG,Head and Neck Cancer,phase3,TERMINATED,Hoffmann-La Roche,
NCT00412217,Standard of care,OTHER,Head and Neck Cancer,phase3,TERMINATED,Hoffmann-La Roche,
NCT02448550,Bivalirudin,DRUG,Percutaneous Coronary Intervention,phase3,TERMINATED,Kaiser Permanente,
NCT02448550,Unfractionated heparin,DRUG,Percutaneous Coronary Intervention,phase3,TERMINATED,Kaiser Permanente,
NCT02583191,Rivaroxaban,DRUG,Venous Thromboembolism; Cancer,phase3,TERMINATED,AIO-Studien-gGmbH,
NCT02583191,low-molecular heparine,DRUG,Venous Thromboembolism; Cancer,phase3,TERMINATED,AIO-Studien-gGmbH,
NCT03736720,Fluorouracil,DRUG,Locally Advanced Digestive System Neuroendocrine Carcinoma; Locally Advanced Pancreatic Neuroendocrine Carcinoma; Metastatic Digestive System Neuroendocrine Carcinoma; Metastatic Pancreatic Neuroendoc,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT03736720,Leucovorin,DRUG,Locally Advanced Digestive System Neuroendocrine Carcinoma; Locally Advanced Pancreatic Neuroendocrine Carcinoma; Metastatic Digestive System Neuroendocrine Carcinoma; Metastatic Pancreatic Neuroendoc,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT03736720,Liposomal Irinotecan,DRUG,Locally Advanced Digestive System Neuroendocrine Carcinoma; Locally Advanced Pancreatic Neuroendocrine Carcinoma; Metastatic Digestive System Neuroendocrine Carcinoma; Metastatic Pancreatic Neuroendoc,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT03736720,Quality-of-Life Assessment,PROCEDURE,Locally Advanced Digestive System Neuroendocrine Carcinoma; Locally Advanced Pancreatic Neuroendocrine Carcinoma; Metastatic Digestive System Neuroendocrine Carcinoma; Metastatic Pancreatic Neuroendoc,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT02828124,BMS-986183,BIOLOGICAL,Hepatocellular Carcinoma,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT02828124,Nivolumab,BIOLOGICAL,Hepatocellular Carcinoma,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT02058303,Exparel Forearm block,DRUG,Hand Injuries; Wrist Injuries; Finger Injuries,phase4,TERMINATED,"Jose Soberon, MD",
NCT02058303,Bupivacaine supraclavicular block,DRUG,Hand Injuries; Wrist Injuries; Finger Injuries,phase4,TERMINATED,"Jose Soberon, MD",
NCT05343143,NeuraGen 3D Nerve Guide Matrix,DEVICE,Digital Nerve Injury,na,TERMINATED,Integra LifeSciences Corporation,
NCT02749708,IRX5183,DRUG,Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia (CMML),phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT05086835,Working Memory Task,OTHER,Opioid Use Disorder,na,TERMINATED,Mclean Hospital,
NCT05086835,Visual Search Task,OTHER,Opioid Use Disorder,na,TERMINATED,Mclean Hospital,
NCT02454517,Behavioral Dietary Intervention,BEHAVIORAL,Prostate Adenocarcinoma; Stage I Prostate Cancer AJCC V7; Stage IIA Prostate Cancer AJCC v7,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT02454517,Exercise Intervention,BEHAVIORAL,Prostate Adenocarcinoma; Stage I Prostate Cancer AJCC V7; Stage IIA Prostate Cancer AJCC v7,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT02454517,Informational Intervention,OTHER,Prostate Adenocarcinoma; Stage I Prostate Cancer AJCC V7; Stage IIA Prostate Cancer AJCC v7,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT02454517,Laboratory Biomarker Analysis,OTHER,Prostate Adenocarcinoma; Stage I Prostate Cancer AJCC V7; Stage IIA Prostate Cancer AJCC v7,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT02454517,Quality-of-Life Assessment,OTHER,Prostate Adenocarcinoma; Stage I Prostate Cancer AJCC V7; Stage IIA Prostate Cancer AJCC v7,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT02454517,Questionnaire Administration,OTHER,Prostate Adenocarcinoma; Stage I Prostate Cancer AJCC V7; Stage IIA Prostate Cancer AJCC v7,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT01884740,SIACI of Erbitux and Bevacizumab,DRUG,Glioblastoma Multiforme; Fibrillary Astrocytoma of Brain; Glioma of Brainstem; Anaplastic Astrocytoma; Pilomyxoid Astrocytoma; Mixed Oligodendroglioma-Astrocytoma; Brain Stem Glioma; Diffuse Intrinsic,phase1; phase2,TERMINATED,Weill Medical College of Cornell University,
NCT00338091,Benazepril,DRUG,"Renal Insufficiency,Chronic; Disease Progression; Proteinuria; Dose-Response Relationship,Drug; ACE Inhibitor; Angiotensin II Type 1 Receptor Blockers",na,TERMINATED,"Southern Medical University, China",
NCT00338091,Losartan,DRUG,"Renal Insufficiency,Chronic; Disease Progression; Proteinuria; Dose-Response Relationship,Drug; ACE Inhibitor; Angiotensin II Type 1 Receptor Blockers",na,TERMINATED,"Southern Medical University, China",
NCT00543491,MK0767,DRUG,"Diabetes Mellitus, Type 2",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00542191,Doxorubicin / Cyclophosphamide / Paclitaxel / Carboplatin,DRUG,Breast Cancer,phase2,TERMINATED,Leo W. Jenkins Cancer Center,
NCT00542191,Definitive Surgery,PROCEDURE,Breast Cancer,phase2,TERMINATED,Leo W. Jenkins Cancer Center,
NCT00542191,Radiotherapy,RADIATION,Breast Cancer,phase2,TERMINATED,Leo W. Jenkins Cancer Center,
NCT01290718,capecitabine [Xeloda],DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT01290718,trastuzumab [Herceptin],DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT03023410,VERASENSE,PROCEDURE,Knee Osteoarthritis,na,TERMINATED,"Orthosensor, Inc.",
NCT03966313,ventricular assist device implantation,DEVICE,End-stage Heart Failure,na,TERMINATED,"University Hospital, Strasbourg, France",
NCT03657082,PEP-10,DEVICE,Chronic Obstructive Pulmonary Disease,na,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT03657082,PEP-1,DEVICE,Chronic Obstructive Pulmonary Disease,na,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT00280280,intramuscular Botox versus oral baclofen,DRUG,Spasticity,phase1,TERMINATED,Vanderbilt University,
NCT00640679,Abrupt Clopidogrel Interruption,DRUG,Coronary Artery Disease,phase4,TERMINATED,Deutsches Herzzentrum Muenchen,
NCT00640679,Clopidogrel Tapering,DRUG,Coronary Artery Disease,phase4,TERMINATED,Deutsches Herzzentrum Muenchen,
NCT00769262,Conservative weaning,OTHER,Premature Neonates,na,TERMINATED,University of Missouri-Columbia,
NCT00769262,Aggressive Weaning,OTHER,Premature Neonates,na,TERMINATED,University of Missouri-Columbia,
NCT02309515,Laboratory Biomarker Analysis,OTHER,Monoclonal B-Cell Lymphocytosis; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma,phase2,TERMINATED,Mayo Clinic,
NCT02309515,Lenalidomide,DRUG,Monoclonal B-Cell Lymphocytosis; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma,phase2,TERMINATED,Mayo Clinic,
NCT02309515,Pneumococcal 13-valent Conjugate Vaccine,BIOLOGICAL,Monoclonal B-Cell Lymphocytosis; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma,phase2,TERMINATED,Mayo Clinic,
NCT01555515,implantation of autologous skin graft after ex-vivo treatment,PROCEDURE,Anemia; End Stage Renal Disease,phase1; phase2,TERMINATED,Medgenics Medical Israel Ltd.,
NCT01555515,Subcutan implantation of autologus skin graft after ex-vivo treatment,BIOLOGICAL,Anemia; End Stage Renal Disease,phase1; phase2,TERMINATED,Medgenics Medical Israel Ltd.,
NCT04698915,Drug GC4711,DRUG,SBRT; Borderline Resectable Pancreatic Cancer; Unresectable Pancreatic Cancer,phase2,TERMINATED,"Galera Therapeutics, Inc.",
NCT04698915,Placebo,DRUG,SBRT; Borderline Resectable Pancreatic Cancer; Unresectable Pancreatic Cancer,phase2,TERMINATED,"Galera Therapeutics, Inc.",
NCT01456208,Para-aminohippuric Acid,DRUG,Hypertension,na,TERMINATED,Brigham and Women's Hospital,
NCT01456208,Angiotensin II,DRUG,Hypertension,na,TERMINATED,Brigham and Women's Hospital,
NCT01456208,Norepinephrine,DRUG,Hypertension,na,TERMINATED,Brigham and Women's Hospital,
NCT00176540,dextromethorphan hydrobromide,DRUG,"Fatigue; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific",na,TERMINATED,University of Medicine and Dentistry of New Jersey,
NCT04835597,Behavioral Assessment,BEHAVIORAL,Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC,na,TERMINATED,M.D. Anderson Cancer Center,
NCT04835597,Electronic Health Record Review,OTHER,Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC,na,TERMINATED,M.D. Anderson Cancer Center,
NCT02420080,Brincidofovir,DRUG,Adenovirus,na,TERMINATED,Jazz Pharmaceuticals,
NCT02061696,Vascular Access Device,DEVICE,Coronary Artery Disease,na,TERMINATED,Frank Saltiel,
NCT02061696,Standard Manual Compression,PROCEDURE,Coronary Artery Disease,na,TERMINATED,Frank Saltiel,
NCT00584662,Oxymetazoline Hydrochloride,DRUG,Chronic Rhinitis,na,TERMINATED,University of South Florida,
NCT04812535,Vilobelimab,DRUG,SCC - Squamous Cell Carcinoma of Skin,phase2,TERMINATED,InflaRx GmbH,
NCT04812535,Vilobelimab + pembrolizumab combination therapy,DRUG,SCC - Squamous Cell Carcinoma of Skin,phase2,TERMINATED,InflaRx GmbH,
NCT00108108,HCD122,DRUG,Chronic Lymphocytic Leukemia,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT00479089,Docetaxel,DRUG,Bladder Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00479089,ZD1839,DRUG,Bladder Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00479089,Dexamethasone,DRUG,Bladder Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01821768,Sentinel Lymph Node Biopsy,PROCEDURE,Breast Neoplasms,na,TERMINATED,Washington University School of Medicine,
NCT00310050,pemetrexed disodium,DRUG,Pancreatic Cancer,phase1,TERMINATED,Wake Forest University Health Sciences,
NCT00310050,Radiotherapy,DEVICE,Pancreatic Cancer,phase1,TERMINATED,Wake Forest University Health Sciences,
NCT03333382,Plastic biliary stent,DEVICE,Bile Leak,na,TERMINATED,Vanderbilt University Medical Center,
NCT03333382,FCSEMS,DEVICE,Bile Leak,na,TERMINATED,Vanderbilt University Medical Center,
NCT03607682,Tumor Treating Fields (TTF) Therapy,PROCEDURE,Extensive Stage Small Cell Lung Carcinoma,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT03607682,NovoTTF-200A Device,DEVICE,Extensive Stage Small Cell Lung Carcinoma,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT03607682,Quality-of-Life Assessment,OTHER,Extensive Stage Small Cell Lung Carcinoma,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT02678715,Solubrux®,DEVICE,"Temporomandibular Joint Dysfunction Syndrome; Tooth Injuries; Dental Occlusion, Traumatic",na,TERMINATED,Eva Willaert Jiménez-Pajarero,
NCT02678715,Customized Appliance,DEVICE,"Temporomandibular Joint Dysfunction Syndrome; Tooth Injuries; Dental Occlusion, Traumatic",na,TERMINATED,Eva Willaert Jiménez-Pajarero,
NCT02678715,Somatics®,DEVICE,"Temporomandibular Joint Dysfunction Syndrome; Tooth Injuries; Dental Occlusion, Traumatic",na,TERMINATED,Eva Willaert Jiménez-Pajarero,
NCT01676935,ABT-126,DRUG,Alzheimer's Disease,phase2,TERMINATED,"AbbVie (prior sponsor, Abbott)",
NCT05061940,Tumor Profiling,OTHER,"Head and Neck Cancer; Melanoma; HPV-Related Malignancy; HPV-Related Carcinoma; HPV-Related Cervical Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; Lung Cancer, Nonsmall Cell; Melanoma ",na,TERMINATED,Repertoire Immune Medicines,
NCT02709889,Rovalpituzumab tesirine,DRUG,Malignant Melanoma; Medullary Thyroid Cancer; Glioblastoma; Large-Cell Neuroendocrine Carcinoma; Neuroendocrine Prostate Cancer; High Grade Gastroenteropancreatic Neuroendocrine Carcinoma; Other Neuro,phase1; phase2,TERMINATED,AbbVie,
NCT02709889,Dexamethasone,DRUG,Malignant Melanoma; Medullary Thyroid Cancer; Glioblastoma; Large-Cell Neuroendocrine Carcinoma; Neuroendocrine Prostate Cancer; High Grade Gastroenteropancreatic Neuroendocrine Carcinoma; Other Neuro,phase1; phase2,TERMINATED,AbbVie,
NCT01238991,ACC-001,BIOLOGICAL,Alzheimer's Disease,phase2,TERMINATED,Pfizer,
NCT01238991,ACC-001,BIOLOGICAL,Alzheimer's Disease,phase2,TERMINATED,Pfizer,
NCT01238991,ACC-001,BIOLOGICAL,Alzheimer's Disease,phase2,TERMINATED,Pfizer,
NCT00284024,domperidone,DRUG,Insufficient Breastmilk Production,phase2,TERMINATED,Hamilton Health Sciences Corporation,
NCT03782623,Analysis of eicosanoid profile prior to and after PRBC transfusion,OTHER,Anemia; Critical Illness; Lung Transplantation; Open Aortic Surgery,na,TERMINATED,Medical University of Vienna,
NCT04142359,BCG in Combination with N-803,BIOLOGICAL,Pharmacokinetics,na,TERMINATED,Altor BioScience,
NCT04142359,N-803 alone,DRUG,Pharmacokinetics,na,TERMINATED,Altor BioScience,
NCT03593980,Cranberry juice,OTHER,Pregnancy; Respiratory Aspiration of Gastric Contents,na,TERMINATED,"Samuel Lunenfeld Research Institute, Mount Sinai Hospital",
NCT03475680,Sennosides colonic preparation,DRUG,Colon Cancer,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT03475680,Oral Gentamycin,DRUG,Colon Cancer,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT03475680,Oral Ornidazole,DRUG,Colon Cancer,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT03475680,Oral placebo Gentamycin,DRUG,Colon Cancer,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT03475680,Oral placebo Ornidazole,DRUG,Colon Cancer,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT05188235,Acoustical Resonance Device,DEVICE,Developmental Dysplasia of the Hip,na,TERMINATED,NYU Langone Health,
NCT01911325,Buparlisib,DRUG,Squamous Non-small Cell Lung Cancer,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT01911325,Buparlisib matching placebo,DRUG,Squamous Non-small Cell Lung Cancer,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT01911325,Docetaxel,DRUG,Squamous Non-small Cell Lung Cancer,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT00948389,Dasatinib,DRUG,Glioblastoma,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT00948389,Lomustine,DRUG,Glioblastoma,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT00423189,Ranibizumab (Lucentis),DRUG,Age-Related Macular Degeneration,phase4,TERMINATED,"David M. Brown, M.D.",
NCT00423189,0.5mg ranibizumab,DRUG,Age-Related Macular Degeneration,phase4,TERMINATED,"David M. Brown, M.D.",
NCT02248740,Ablation of the incompetent small saphenous vein,PROCEDURE,Chronic Venous Insufficiency,phase4,TERMINATED,Virginia Commonwealth University,
NCT02189668,Antibiotics only (Zosyn then Augmentin),DRUG,Appendicitis,na,TERMINATED,Peter Minneci,
NCT02841891,Sylys® Surgical Sealant,DEVICE,Colorectal and Ileorectal Anastomosis; Colocolic and Ileocolic Anastomosis; Coloanal and Ileoanal Anastomosis,na,TERMINATED,"Cohera Medical, Inc.",
NCT02841891,Stapled Anastomosis Colectomy Procedure,PROCEDURE,Colorectal and Ileorectal Anastomosis; Colocolic and Ileocolic Anastomosis; Coloanal and Ileoanal Anastomosis,na,TERMINATED,"Cohera Medical, Inc.",
NCT00464490,Dexmedetomidine,DRUG,Intubation; Difficult; Respiration Disorders,na,TERMINATED,"University of California, San Francisco",
NCT00627497,Single-Level Posterior Decompression,PROCEDURE,Degenerative Lumbar Spinal Stenosis,phase3,TERMINATED,Medtronic Spinal and Biologics,
NCT00627497,DIAM Spinal Stabilization,DEVICE,Degenerative Lumbar Spinal Stenosis,phase3,TERMINATED,Medtronic Spinal and Biologics,
NCT00627497,DIAM Spinal Stabilization,DEVICE,Degenerative Lumbar Spinal Stenosis,phase3,TERMINATED,Medtronic Spinal and Biologics,
NCT00627497,Fusion,DEVICE,Degenerative Lumbar Spinal Stenosis,phase3,TERMINATED,Medtronic Spinal and Biologics,
NCT04366310,capillary refill index,DEVICE,Peripheral Perfusion,na,TERMINATED,Nihon Kohden,
NCT04366310,rewarming,PROCEDURE,Peripheral Perfusion,na,TERMINATED,Nihon Kohden,
NCT02480010,Pertuzumab,DRUG,Prostate Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT01965782,[^14C]-LY3023703,DRUG,Healthy Volunteers,phase1,TERMINATED,Eli Lilly and Company,
NCT03608020,BMX-001,DRUG,Multiple Brain Metastases,phase1; phase2,TERMINATED,"BioMimetix JV, LLC",
NCT03608020,Whole Brain Radiation Therapy,RADIATION,Multiple Brain Metastases,phase1; phase2,TERMINATED,"BioMimetix JV, LLC",
NCT03900182,Hyperbaric Oxygen Therapy,DEVICE,"Brain Injuries, Traumatic; Neuropsychology",na,TERMINATED,Hung-Chen Wang,
NCT00110123,fotemustine,DRUG,Intraocular Melanoma; Metastatic Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00110123,isolated perfusion,DRUG,Intraocular Melanoma; Metastatic Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT02914015,Continous QLB (quadratus lumborum block),PROCEDURE,Hepatectomy; Analgesia; Nerve Block,na,TERMINATED,Cui Xulei,
NCT02914015,Philip CX50 Ultrasound Scanner,DEVICE,Hepatectomy; Analgesia; Nerve Block,na,TERMINATED,Cui Xulei,
NCT02914015,Ropivacaine,DRUG,Hepatectomy; Analgesia; Nerve Block,na,TERMINATED,Cui Xulei,
NCT02914015,Morphine given as IPCA,DRUG,Hepatectomy; Analgesia; Nerve Block,na,TERMINATED,Cui Xulei,
NCT05352217,Mobile app ovarian cancer followup (ePRO),DEVICE,Patient Reported Outcome Measures; Ovarian Neoplasms,na,TERMINATED,Stiftung Swiss Tumor Institute,
NCT01440517,Tc99m-Maraciclatide,DRUG,Diabetes Mellitus; Heart Failure,phase2,TERMINATED,GE Healthcare,
NCT03473340,Pirfenidone Capsule,DRUG,Disorder Related to Lung Transplantation; Chronic Lung Allograft Dysfunction,phase2,TERMINATED,University of Michigan,
NCT03473340,Placebo Capsule,DRUG,Disorder Related to Lung Transplantation; Chronic Lung Allograft Dysfunction,phase2,TERMINATED,University of Michigan,
NCT01753674,TA-65,OTHER,Metabolic Syndrome; Insulin Resistance,phase1,TERMINATED,University of Connecticut,
NCT01753674,Placebo,OTHER,Metabolic Syndrome; Insulin Resistance,phase1,TERMINATED,University of Connecticut,
NCT00034697,temozolomide,DRUG,"Metastases, Neoplasm; Carcinoma, Non-Small-Cell Lung; Brain Neoplasms",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT02176824,"Total Sleep deprivation, Sleep Phase Advance, and Bright Light Therapy",BEHAVIORAL,Major Depressive Disorder; Bipolar Depression; Suicidal Ideation,na,TERMINATED,Medical University of South Carolina,
NCT02176824,"Partial Sleep deprivation, Sleep Phase Delay, and Low amber light.",BEHAVIORAL,Major Depressive Disorder; Bipolar Depression; Suicidal Ideation,na,TERMINATED,Medical University of South Carolina,
NCT02176824,Treatment as usual,OTHER,Major Depressive Disorder; Bipolar Depression; Suicidal Ideation,na,TERMINATED,Medical University of South Carolina,
NCT02333123,Aspirin,DRUG,Venous Leg Ulcer,phase2,TERMINATED,"St George's, University of London",
NCT02333123,Placebo (for Aspirin),DRUG,Venous Leg Ulcer,phase2,TERMINATED,"St George's, University of London",
NCT02818023,Pembrolizumab,DRUG,Melanoma,phase1,TERMINATED,Yana Najjar,
NCT02818023,Vemurafenib,DRUG,Melanoma,phase1,TERMINATED,Yana Najjar,
NCT02818023,Cobimetinib,DRUG,Melanoma,phase1,TERMINATED,Yana Najjar,
NCT01067859,Cinaciguat (BAY58-2667),DRUG,Acute Heart Failure,phase2,TERMINATED,Bayer,
NCT01067859,Cinaciguat (BAY58-2667),DRUG,Acute Heart Failure,phase2,TERMINATED,Bayer,
NCT01067859,Placebo,DRUG,Acute Heart Failure,phase2,TERMINATED,Bayer,
NCT05506930,Intrathecal Morphine,DRUG,Pain Control; Ureteral Reimplantation; Pediatrics; Intrathecal Morphine,phase4,TERMINATED,Medical University of South Carolina,
NCT05506930,Quadratus lumborum block,DRUG,Pain Control; Ureteral Reimplantation; Pediatrics; Intrathecal Morphine,phase4,TERMINATED,Medical University of South Carolina,
NCT04443192,ZF874,DRUG,Alpha1 Anti-Trypsin Deficiency,phase1,TERMINATED,Z Factor Limited,
NCT04443192,Placebo,DRUG,Alpha1 Anti-Trypsin Deficiency,phase1,TERMINATED,Z Factor Limited,
NCT03595371,dapansutrile,DRUG,Schnitzler Syndrome,phase2,TERMINATED,Olatec Therapeutics LLC,
NCT00216164,Rituximab,DRUG,"Lymphoma, B-Cell",phase2,TERMINATED,Hoosier Cancer Research Network,
NCT00216164,Gemcitabine,DRUG,"Lymphoma, B-Cell",phase2,TERMINATED,Hoosier Cancer Research Network,
NCT04028609,Healthy at Home,BEHAVIORAL,Chronic Disease (Physical); Mental Disorder,na,TERMINATED,University of Illinois at Chicago,
NCT04028609,Services as Usual,OTHER,Chronic Disease (Physical); Mental Disorder,na,TERMINATED,University of Illinois at Chicago,
NCT03099499,ONC201,DRUG,Endometrial Cancer,phase2,TERMINATED,Fox Chase Cancer Center,
NCT01980199,Fexinidazole,DRUG,Visceral Leishmaniasis,phase2,TERMINATED,Drugs for Neglected Diseases,
NCT02992132,Pimavanserin 34 mg,DRUG,Agitation and Aggression in Alzheimer's Disease,phase2,TERMINATED,ACADIA Pharmaceuticals Inc.,
NCT02992132,Pimavanserin 20 mg,DRUG,Agitation and Aggression in Alzheimer's Disease,phase2,TERMINATED,ACADIA Pharmaceuticals Inc.,
NCT02992132,Placebo,OTHER,Agitation and Aggression in Alzheimer's Disease,phase2,TERMINATED,ACADIA Pharmaceuticals Inc.,
NCT02055963,Minocycline,DRUG,Head And Neck Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02055963,Placebo,DRUG,Head And Neck Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02055963,Questionnaires,BEHAVIORAL,Head And Neck Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT05957484,Investigational brainstem neuromodulation device,DEVICE,Schizophrenia; Anosognosia,na,TERMINATED,Centre for Addiction and Mental Health,
NCT01486784,Birinapant,DRUG,Acute Myelogenous Leukemia,phase1; phase2,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT02653833,Tadalafil 20 MG,DRUG,Muscular Dystrophy,early_phase1,TERMINATED,Cedars-Sinai Medical Center,
NCT02653833,beetroot juice extract,OTHER,Muscular Dystrophy,early_phase1,TERMINATED,Cedars-Sinai Medical Center,
NCT01332552,GSK2485852 70 mg,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01332552,GSK2485852 420 mg,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01332552,placebo,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01332552,placebo,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01332552,GSK2485852 420 mg,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01332552,GSK2485852 420 mg,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01332552,GSK2485852 630 mg,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01332552,GSK2485852 70 mg + Ritonavir 100mg,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01332552,GSK2485852 210 mg + Ritonavir 100mg,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01332552,GSK2485852 210 mg +Ritonavir 100mg,DRUG,Hepatitis C,phase1,TERMINATED,GlaxoSmithKline,
NCT01299415,Vadimezan™,DRUG,Solid Tumors,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT02702115,SB-318,BIOLOGICAL,MPS I,phase1; phase2,TERMINATED,Sangamo Therapeutics,
NCT06067425,SAR442501,DRUG,Osteochondrodysplasia,phase2,TERMINATED,Sanofi,
NCT04638517,Danazol,DRUG,Pulmonary Fibrosis; Telomere Shortening; Telomere Disease; Dyskeratosis Congenita,phase2,TERMINATED,The University of Queensland,
NCT04638517,Placebo,DRUG,Pulmonary Fibrosis; Telomere Shortening; Telomere Disease; Dyskeratosis Congenita,phase2,TERMINATED,The University of Queensland,
NCT03303950,Busulfan,DRUG,Anemia; ASXL1 Gene Mutation; EZH2 Gene Mutation; IDH1 Gene Mutation; IDH2 Gene Mutation; Plasma Cell Myeloma; Primary Myelofibrosis; Recurrent Plasma Cell Myeloma; Secondary Myelofibrosis; Thrombocyto,phase2,TERMINATED,University of Utah,
NCT03303950,Cyclophosphamide,DRUG,Anemia; ASXL1 Gene Mutation; EZH2 Gene Mutation; IDH1 Gene Mutation; IDH2 Gene Mutation; Plasma Cell Myeloma; Primary Myelofibrosis; Recurrent Plasma Cell Myeloma; Secondary Myelofibrosis; Thrombocyto,phase2,TERMINATED,University of Utah,
NCT03303950,Fludarabine,DRUG,Anemia; ASXL1 Gene Mutation; EZH2 Gene Mutation; IDH1 Gene Mutation; IDH2 Gene Mutation; Plasma Cell Myeloma; Primary Myelofibrosis; Recurrent Plasma Cell Myeloma; Secondary Myelofibrosis; Thrombocyto,phase2,TERMINATED,University of Utah,
NCT03303950,Hematopoietic Cell Transplantation,PROCEDURE,Anemia; ASXL1 Gene Mutation; EZH2 Gene Mutation; IDH1 Gene Mutation; IDH2 Gene Mutation; Plasma Cell Myeloma; Primary Myelofibrosis; Recurrent Plasma Cell Myeloma; Secondary Myelofibrosis; Thrombocyto,phase2,TERMINATED,University of Utah,
NCT03303950,Laboratory Biomarker Analysis,OTHER,Anemia; ASXL1 Gene Mutation; EZH2 Gene Mutation; IDH1 Gene Mutation; IDH2 Gene Mutation; Plasma Cell Myeloma; Primary Myelofibrosis; Recurrent Plasma Cell Myeloma; Secondary Myelofibrosis; Thrombocyto,phase2,TERMINATED,University of Utah,
NCT01284491,PEAK PlasmaBlade 4.0,DEVICE,Macromastia,na,TERMINATED,Medtronic Surgical Technologies,
NCT01284491,Traditional Electrosurgery with scalpel,DEVICE,Macromastia,na,TERMINATED,Medtronic Surgical Technologies,
NCT02837991,CDX-014,DRUG,Renal Cell Carcinoma (RCC); Clear-cell Renal Cell Carcinoma; Papillary Renal Cell Carcinoma; Kidney Neoplasms; Metastatic Renal Cell Carcinoma; Ovarian Clear Cell Carcinoma,phase1,TERMINATED,Celldex Therapeutics,
NCT00142974,Tegaserod,DRUG,Diabetic Gastropathy,phase2,TERMINATED,Novartis,
NCT04749797,Liposomal bupivacaine,DRUG,Craniotomy Surgery,phase4,TERMINATED,University of Pennsylvania,
NCT04749797,Bupivacaine Injection,DRUG,Craniotomy Surgery,phase4,TERMINATED,University of Pennsylvania,
NCT04749797,Saline,DRUG,Craniotomy Surgery,phase4,TERMINATED,University of Pennsylvania,
NCT00638820,Stem Cell or Umbilical Cord Blood Transplantation,PROCEDURE,Osteopetrosis,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00638820,"Campath, Busulfan, Clofarabine",DRUG,Osteopetrosis,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00638820,Total Lymphoid Irradiation,PROCEDURE,Osteopetrosis,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00797082,MRI,DEVICE,Coronary Insufficiency,phase4,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00797082,MPS,DEVICE,Coronary Insufficiency,phase4,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04784182,probiotic plus prebiotic supplement,OTHER,Anxiety Generalized; Breast Cancer Female,na,TERMINATED,Auburn University,
NCT04784182,placebo,OTHER,Anxiety Generalized; Breast Cancer Female,na,TERMINATED,Auburn University,
NCT03691376,Aldesleukin,BIOLOGICAL,Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Ovarian Carcinoma; Platinum-Resistant Primary Peritoneal Carcinoma; Platinum-Sensitive Fallopian Tube Carcinoma; Platinum-Sensitive Ovar,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT03691376,Autologous NY-ESO-1-specific CD8-positive T Lymphocytes,BIOLOGICAL,Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Ovarian Carcinoma; Platinum-Resistant Primary Peritoneal Carcinoma; Platinum-Sensitive Fallopian Tube Carcinoma; Platinum-Sensitive Ovar,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT03691376,Cellular Therapy,OTHER,Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Ovarian Carcinoma; Platinum-Resistant Primary Peritoneal Carcinoma; Platinum-Sensitive Fallopian Tube Carcinoma; Platinum-Sensitive Ovar,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT03691376,Melphalan,DRUG,Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Ovarian Carcinoma; Platinum-Resistant Primary Peritoneal Carcinoma; Platinum-Sensitive Fallopian Tube Carcinoma; Platinum-Sensitive Ovar,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT02292225,IPI-145 (duvelisib),DRUG,"Lymphocytic Leukemia, Chronic; Lymphoma, Small Lymphocytic",phase1,TERMINATED,SecuraBio,
NCT02292225,Obinutuzumab,DRUG,"Lymphocytic Leukemia, Chronic; Lymphoma, Small Lymphocytic",phase1,TERMINATED,SecuraBio,
NCT06199076,Oxytocin nasal spray,DRUG,Alcohol Use Disorder,phase2,TERMINATED,Karolinska Institutet,
NCT00668317,Omeprazole,DRUG,Cough,phase3,TERMINATED,Hull University Teaching Hospitals NHS Trust,
NCT00668317,Ranitidine,DRUG,Cough,phase3,TERMINATED,Hull University Teaching Hospitals NHS Trust,
NCT01777217,Solifenacin succinate,DRUG,Over-Active Bladder,phase4,TERMINATED,Advanced Research Network,
NCT01777217,Placebo,DRUG,Over-Active Bladder,phase4,TERMINATED,Advanced Research Network,
NCT03347617,Ferumoxytol,DRUG,Glioblastoma,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT03347617,Laboratory Biomarker Analysis,OTHER,Glioblastoma,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT03347617,Magnetic Resonance Imaging,PROCEDURE,Glioblastoma,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT03347617,Pembrolizumab,BIOLOGICAL,Glioblastoma,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT01750840,Biomet® EBI Bone Healing System,DEVICE,"Fusion of Spine (Disease); Fractures, Ununited",na,TERMINATED,Zimmer Biomet,
NCT01750840,Biomet Orthopak® Non-Invasive Bone Growth Stimulator System,DEVICE,"Fusion of Spine (Disease); Fractures, Ununited",na,TERMINATED,Zimmer Biomet,
NCT01750840,Biomet SpinalPak® Non-Invasive Spine Fusion Stimulator,DEVICE,"Fusion of Spine (Disease); Fractures, Ununited",na,TERMINATED,Zimmer Biomet,
NCT01454440,Eptifibatide,DRUG,Coronary Artery Disease,phase4,TERMINATED,"University of Turin, Italy",
NCT05517668,Intravenous infusion of N-acetylcysteine,DRUG,Acetaminophen; Drug Overdose; Acetaminophen Overdose; Acetaminophen Poisoning; Drug-induced Liver Injury; Liver Failure; Liver Toxicity,phase2,TERMINATED,"Richard Dart, MD, PhD",
NCT05517668,Intravenous infusion of Fomepizole (4-MP),DRUG,Acetaminophen; Drug Overdose; Acetaminophen Overdose; Acetaminophen Poisoning; Drug-induced Liver Injury; Liver Failure; Liver Toxicity,phase2,TERMINATED,"Richard Dart, MD, PhD",
NCT02844582,Cabazitaxel,DRUG,Hormone-Resistant Prostate Cancer; Stage IV Prostate Adenocarcinoma,phase2,TERMINATED,"University of California, Davis",
NCT02844582,Prednisone,DRUG,Hormone-Resistant Prostate Cancer; Stage IV Prostate Adenocarcinoma,phase2,TERMINATED,"University of California, Davis",
NCT05087524,BinaxNOW Ag Card,OTHER,SARS-CoV2 Infection; COVID-19,na,TERMINATED,"University of Wisconsin, Madison",
NCT01668940,Lillipops Iced Soothies (4 flavours),OTHER,Morning Sickness,na,TERMINATED,The Hospital for Sick Children,
NCT01668940,Mr. Freeze Freezies,OTHER,Morning Sickness,na,TERMINATED,The Hospital for Sick Children,
NCT01668940,Lillipop Iced Soothies (Ginger flavour),OTHER,Morning Sickness,na,TERMINATED,The Hospital for Sick Children,
NCT01601340,HQK-1001,DRUG,Sickle Cell Disease; Sickle Cell Anemia; Sickle Cell Disorders; Hemoglobin S Disease; Sickling Disorder Due to Hemoglobin S,phase2,TERMINATED,HemaQuest Pharmaceuticals Inc.,
NCT01601340,Placebo,DRUG,Sickle Cell Disease; Sickle Cell Anemia; Sickle Cell Disorders; Hemoglobin S Disease; Sickling Disorder Due to Hemoglobin S,phase2,TERMINATED,HemaQuest Pharmaceuticals Inc.,
NCT02232568,Feedback,BEHAVIORAL,Compliance With Restrictive RBC Transfusion Guideline,na,TERMINATED,Brigham and Women's Hospital,
NCT04427774,Surufatinib plus Sintilimab,DRUG,Advanced or Metastatic Solid Tumors,phase1,TERMINATED,Innovent Biologics (Suzhou) Co. Ltd.,
NCT01545518,IVIG,DRUG,"Epilepsy, Cryptogenic; Epilepsy, Partial; Seizure Disorder; Autoimmune Diseases, Nervous System; Limbic Encephalitis",phase2,TERMINATED,Emory University,
NCT00171860,imatinib mesylate,DRUG,Hypereosinophilic Syndrome,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT00363610,Oncaspar & Gemzar; advanced and/or solid tumors and lymphoma,DRUG,Tumors; Lymphoma,phase1,TERMINATED,"Enzon Pharmaceuticals, Inc.",
NCT05609760,SIMAP,OTHER,"Asthma Chronic; Adherence, Medication; Primary Health Care",na,TERMINATED,Universidad de Concepcion,
NCT05609760,Usual Care,OTHER,"Asthma Chronic; Adherence, Medication; Primary Health Care",na,TERMINATED,Universidad de Concepcion,
NCT04235660,Yttrium-90 Radiation Segmentectomy,RADIATION,Hepatocellular Carcinoma (HCC),na,TERMINATED,Indiana University,
NCT04235660,Stereotactic Body Radiation Therapy,RADIATION,Hepatocellular Carcinoma (HCC),na,TERMINATED,Indiana University,
NCT00130260,Staph aureus types 5 and 8 conjugate vaccine,BIOLOGICAL,Staphylococcal Infections; Chronic Kidney Failure,phase3,TERMINATED,Nabi Biopharmaceuticals,
NCT00130260,placebo,BIOLOGICAL,Staphylococcal Infections; Chronic Kidney Failure,phase3,TERMINATED,Nabi Biopharmaceuticals,
NCT02532660,Escitalopram 10mg,DRUG,Depression,phase3,TERMINATED,Laboratório Catarinense SA,
NCT02532660,LABCAT TCJUSS,DRUG,Depression,phase3,TERMINATED,Laboratório Catarinense SA,
NCT02532660,LABCAT TCJUSS Placebo,DRUG,Depression,phase3,TERMINATED,Laboratório Catarinense SA,
NCT02532660,Escitalopram Placebo,DRUG,Depression,phase3,TERMINATED,Laboratório Catarinense SA,
NCT02446860,nivolumab,DRUG,Renal Cell Carcinoma,phase2,TERMINATED,Royal Marsden NHS Foundation Trust,
NCT01327508,TRIGEN SURESHOT Distal Targeting Instrumentation.,DEVICE,Femoral Shaft Fracture,na,TERMINATED,"Smith & Nephew, Inc.",
NCT01327508,Free-hand technique,OTHER,Femoral Shaft Fracture,na,TERMINATED,"Smith & Nephew, Inc.",
NCT04206917,Multi Pulse Therapy,DEVICE,"Atrial Fibrillation, Paroxysmal; Atrial Fibrillation, Persistent; Atrial Fibrillation",na,TERMINATED,"Cardialen, Inc.",
NCT03654417,EMLA,DRUG,Any Condition Requiring Vulvar Biopsy,phase4,TERMINATED,Duke University,
NCT03654417,Lidocaine,DRUG,Any Condition Requiring Vulvar Biopsy,phase4,TERMINATED,Duke University,
NCT01356368,"Cisplatin, Gemzar, Docetaxel, Alimta",DRUG,Non-Small Cell Lung Cancer,phase2,TERMINATED,National Guard Health Affairs,
NCT00169091,Clozapine,DRUG,Schizophrenia,phase4,TERMINATED,Harvard Medical School (HMS and HSDM),
NCT00169091,Haloperidol,DRUG,Schizophrenia,phase4,TERMINATED,Harvard Medical School (HMS and HSDM),
NCT04208997,Antiarrhythmic drug,DRUG,"Tachycardia, Ventricular; Catheter Ablation",phase3,TERMINATED,Vanderbilt University Medical Center,
NCT02158013,Levorag Emulgel,OTHER,Chronic Anal Fissure,na,TERMINATED,Bispebjerg Hospital,
NCT02158013,Diltiazem,DRUG,Chronic Anal Fissure,na,TERMINATED,Bispebjerg Hospital,
NCT03581513,Deferred or Immediate Stent Implantation,PROCEDURE,Microcirculatory Perfusion; ST Elevation Myocardial Infarction,na,TERMINATED,Harbin Medical University,
NCT01924182,SynchroMed Infusion System and Intrathecal Morphine Sulfate,DEVICE,Chronic Pain,na,TERMINATED,MedtronicNeuro,
NCT01924182,Conventional Medicine,OTHER,Chronic Pain,na,TERMINATED,MedtronicNeuro,
NCT01321008,Radiation,RADIATION,Lymphoma,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01321008,Cyclophosphamide,DRUG,Lymphoma,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01321008,Doxorubicin,DRUG,Lymphoma,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01321008,Vincristine,DRUG,Lymphoma,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01321008,Prednisone,DRUG,Lymphoma,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00777335,Panobinostat - LBH589,DRUG,Breast Cancer,phase2,TERMINATED,Translational Research in Oncology,
NCT00777335,Panobinostat - LBH589,DRUG,Breast Cancer,phase2,TERMINATED,Translational Research in Oncology,
NCT04854135,CGM4Home,DEVICE,Type 1 Diabetes; Type2 Diabetes; Hyperglycemia; Hypoglycemia; Hypoglycemia Unawareness,na,TERMINATED,Washington University School of Medicine,
NCT02012608,Glutamine,DRUG,Breast Cancer,phase2,TERMINATED,University of Arkansas,
NCT02012608,Placebo,DRUG,Breast Cancer,phase2,TERMINATED,University of Arkansas,
NCT04558125,TNKase,DRUG,Pulmonary Embolism; COVID,phase4,TERMINATED,Cedars-Sinai Medical Center,
NCT04558125,Placebo,DRUG,Pulmonary Embolism; COVID,phase4,TERMINATED,Cedars-Sinai Medical Center,
NCT04558125,Enoxaparin,DRUG,Pulmonary Embolism; COVID,phase4,TERMINATED,Cedars-Sinai Medical Center,
NCT04713176,DWJ1248 with Remdesivir,DRUG,Severe COVID-19,phase3,TERMINATED,Daewoong Pharmaceutical Co. LTD.,
NCT04713176,Placebo with Remdesivir,DRUG,Severe COVID-19,phase3,TERMINATED,Daewoong Pharmaceutical Co. LTD.,
NCT02419976,a breath analysis using the Aeonose,OTHER,Fasting,na,TERMINATED,Mayo Clinic,
NCT02419976,Aeonose,DEVICE,Fasting,na,TERMINATED,Mayo Clinic,
NCT01158417,Placebo,DRUG,Type 2 Diabetes; Obesity; Insulin Resistance,na,TERMINATED,University at Buffalo,
NCT01158417,Resveratrol 40 mg oral three times a day,DRUG,Type 2 Diabetes; Obesity; Insulin Resistance,na,TERMINATED,University at Buffalo,
NCT01158417,Resveratrol 500 mg oral once daily.,DRUG,Type 2 Diabetes; Obesity; Insulin Resistance,na,TERMINATED,University at Buffalo,
NCT06592768,Briquilimab,DRUG,Allergic Asthma,phase1,TERMINATED,"Jasper Therapeutics, Inc.",
NCT06592768,Placebo Comparator,OTHER,Allergic Asthma,phase1,TERMINATED,"Jasper Therapeutics, Inc.",
NCT00245791,Levofloxacin,DRUG,Complicated Urinary Infection,phase4,TERMINATED,University of Manitoba,
NCT05676697,Linperlisib,DRUG,Autoimmune Hemolytic Anemia; Failure of Two Rounds of Treatment,phase1,TERMINATED,"Institute of Hematology & Blood Diseases Hospital, China",
NCT01277510,cinacalcet capsule,DRUG,"Chronic Kidney Disease; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Disease; Secondary Hyperparathyroidism",phase3,TERMINATED,Amgen,
NCT01277510,placebo,DRUG,"Chronic Kidney Disease; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Disease; Secondary Hyperparathyroidism",phase3,TERMINATED,Amgen,
NCT01277510,Standard of Care,DRUG,"Chronic Kidney Disease; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Disease; Secondary Hyperparathyroidism",phase3,TERMINATED,Amgen,
NCT04176913,LUCAR-20S CAR-T cells,DRUG,Diffuse Large B Cell Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma,phase1,TERMINATED,The First Affiliated Hospital with Nanjing Medical University,
NCT00793182,Ioversol 320 mgI/mL,DRUG,Renal Impairment,phase4,TERMINATED,Guerbet,
NCT00793182,Iodixanol 320 mgI/mL,DRUG,Renal Impairment,phase4,TERMINATED,Guerbet,
NCT04358315,Behavioral Intervention,BEHAVIORAL,Current Vaper; Healthy Subject,na,TERMINATED,Roswell Park Cancer Institute,
NCT04358315,Questionnaire Administration,OTHER,Current Vaper; Healthy Subject,na,TERMINATED,Roswell Park Cancer Institute,
NCT04721535,DWJ1248,DRUG,Covid19; SARS-COV-2 Infection,phase3,TERMINATED,Daewoong Pharmaceutical Co. LTD.,
NCT04721535,Placebo,DRUG,Covid19; SARS-COV-2 Infection,phase3,TERMINATED,Daewoong Pharmaceutical Co. LTD.,
NCT04588389,Ropivacaine injection Location 1,DRUG,Pain; Opioid Use; Lumbar Disc Herniation,phase3,TERMINATED,"University of Massachusetts, Worcester",
NCT04588389,Ropivacaine injection Location 2,DRUG,Pain; Opioid Use; Lumbar Disc Herniation,phase3,TERMINATED,"University of Massachusetts, Worcester",
NCT04588389,Multimodal Pharmacological Management,DRUG,Pain; Opioid Use; Lumbar Disc Herniation,phase3,TERMINATED,"University of Massachusetts, Worcester",
NCT02196389,Nasal dilator Nasanita,DEVICE,Incompetence of Nasal Valve,phase4,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT02196389,Nasal dilator Nozovent,DEVICE,Incompetence of Nasal Valve,phase4,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT02196389,Nasal dilator Breath Right,DEVICE,Incompetence of Nasal Valve,phase4,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT02196389,Nasal dilator Airmax,DEVICE,Incompetence of Nasal Valve,phase4,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT04144140,E7766,DRUG,Lymphoma; Advanced Solid Tumors,phase1,TERMINATED,Eisai Inc.,
NCT00423150,Temozolomide,DRUG,"Colorectal Neoplasm; Head and Neck Neoplasm; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasm",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT05619874,HIFCT-S,BEHAVIORAL,Healthy Volunteers,na,TERMINATED,Universidad de Antioquia,
NCT05619874,HIFCT-P,BEHAVIORAL,Healthy Volunteers,na,TERMINATED,Universidad de Antioquia,
NCT00526890,selenomethionine,OTHER,Lung Cancer,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT00526890,carboplatin,DRUG,Lung Cancer,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT00526890,paclitaxel,DRUG,Lung Cancer,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT00526890,laboratory biomarker analysis,OTHER,Lung Cancer,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT00526890,radiation therapy,RADIATION,Lung Cancer,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT05252390,NUV-868,DRUG,Advanced Solid Tumor; Ovarian Cancer; Ovary Cancer; Cancer of Ovary; Cancer of the Ovary; Ovary Neoplasm; Pancreatic Cancer; Pancreas Cancer; Cancer of Pancreas; Cancer of the Pancreas; Pancreas Neopl,phase1,TERMINATED,Nuvation Bio Inc.,
NCT05252390,Olaparib,DRUG,Advanced Solid Tumor; Ovarian Cancer; Ovary Cancer; Cancer of Ovary; Cancer of the Ovary; Ovary Neoplasm; Pancreatic Cancer; Pancreas Cancer; Cancer of Pancreas; Cancer of the Pancreas; Pancreas Neopl,phase1,TERMINATED,Nuvation Bio Inc.,
NCT05252390,Enzalutamide,DRUG,Advanced Solid Tumor; Ovarian Cancer; Ovary Cancer; Cancer of Ovary; Cancer of the Ovary; Ovary Neoplasm; Pancreatic Cancer; Pancreas Cancer; Cancer of Pancreas; Cancer of the Pancreas; Pancreas Neopl,phase1,TERMINATED,Nuvation Bio Inc.,
NCT00529113,Bardoxolone methyl,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00529113,Bardoxolone methyl,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00529113,Bardoxolone methyl,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00529113,Bardoxolone methyl,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00529113,Bardoxolone methyl,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00529113,Bardoxolone methyl,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00529113,Bardoxolone methyl,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00529113,Gemcitabine,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00529113,Placebo,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00529113,Bardoxolone methyl,DRUG,Pancreatic Neoplasms; Pancreatic Cancer,phase1,TERMINATED,Biogen,
NCT00543010,MK0767,DRUG,"Diabetes Mellitus, Type 2",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT03220178,Palbociclib,DRUG,Breast Neoplasm,phase4,TERMINATED,Palleos Healthcare GmbH,
NCT03220178,Fulvestrant,DRUG,Breast Neoplasm,phase4,TERMINATED,Palleos Healthcare GmbH,
NCT03220178,Anastrozole,DRUG,Breast Neoplasm,phase4,TERMINATED,Palleos Healthcare GmbH,
NCT03220178,Letrozole,DRUG,Breast Neoplasm,phase4,TERMINATED,Palleos Healthcare GmbH,
NCT03220178,Exemestane,DRUG,Breast Neoplasm,phase4,TERMINATED,Palleos Healthcare GmbH,
NCT00964743,DepoCyt,DRUG,Neoplastic Meningitis,na,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00964743,Sorafenib,DRUG,Neoplastic Meningitis,na,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT01591343,Depigoid® (500 DPP/ml),BIOLOGICAL,Allergic Rhinitis; Rhinoconjunctivitis; Mild Persistent Asthma; Mild Intermittent Asthma,phase2,TERMINATED,"Laboratorios Leti, S.L.",
NCT00776100,clinical observation,OTHER,Lung Cancer,phase2,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT00776100,radiation therapy,RADIATION,Lung Cancer,phase2,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT04261907,ASC09/ritonavir group,DRUG,2019-nCoV,na,TERMINATED,First Affiliated Hospital of Zhejiang University,
NCT04261907,lopinavir/ritonavir group,DRUG,2019-nCoV,na,TERMINATED,First Affiliated Hospital of Zhejiang University,
NCT03509207,Vorinostat Oral Capsule,DRUG,Leiomyosarcoma; Endometrial Stromal Tumors; Carcinosarcomas Uterine,phase2,TERMINATED,Medical University of Graz,
NCT02302092,Flomoxef,DRUG,Urinary Tract Infection,phase3,TERMINATED,Takeda,
NCT02302092,Cefepime,DRUG,Urinary Tract Infection,phase3,TERMINATED,Takeda,
NCT01300611,TXA127 300 mcg/kg/day,DRUG,Double Cord Blood Transplant; Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Myelofibrosis; Acute Lymphoblastic Leukemia; Chronic Myelocytic Leukemia; Non Hodgkins Lymphoma; Hodgkins Lymphoma; ,phase1,TERMINATED,Tarix Pharmaceuticals,
NCT01300611,TXA127 1000 mcg/kg/day,DRUG,Double Cord Blood Transplant; Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Myelofibrosis; Acute Lymphoblastic Leukemia; Chronic Myelocytic Leukemia; Non Hodgkins Lymphoma; Hodgkins Lymphoma; ,phase1,TERMINATED,Tarix Pharmaceuticals,
NCT01292811,Functional Electrical Stimulation (Compex Motion Stimulator),DEVICE,Spinal Cord Injury,na,TERMINATED,Toronto Rehabilitation Institute,
NCT01292811,Conventional Occupational therapy,OTHER,Spinal Cord Injury,na,TERMINATED,Toronto Rehabilitation Institute,
NCT00503971,Vorinostat plus Erlotinib,DRUG,Non-small Cell Lung Cancer,phase1; phase2,TERMINATED,Spanish Lung Cancer Group,
NCT01953744,Fluconazole,DRUG,Cutaneous Leishmaniasis,phase3,TERMINATED,Hospital Universitário Professor Edgard Santos,
NCT01953744,Meglumine Antimoniate,DRUG,Cutaneous Leishmaniasis,phase3,TERMINATED,Hospital Universitário Professor Edgard Santos,
NCT02940509,Ketamine plus Magnesium sulfate,DRUG,Chronic Pain,phase1,TERMINATED,Milton S. Hershey Medical Center,
NCT02940509,Placebo,DRUG,Chronic Pain,phase1,TERMINATED,Milton S. Hershey Medical Center,
NCT03180398,Multiparametric MRI,DEVICE,Prostate Cancer,na,TERMINATED,Henry Ford Health System,
NCT02105363,measure of skin movement on surface of the back,OTHER,Movement of Thoracic and Lumbar Skin,na,TERMINATED,"Rutgers, The State University of New Jersey",
NCT02105363,Measurement of skin movement on surface of back,OTHER,Movement of Thoracic and Lumbar Skin,na,TERMINATED,"Rutgers, The State University of New Jersey",
NCT03118206,lumbar traction,DEVICE,Lumbar Spinal Stenosis; Spinal Manipulation; Physical Therapy; Surgery,na,TERMINATED,Shin Kong Wu Ho-Su Memorial Hospital,
NCT03118206,spinal manipulation,PROCEDURE,Lumbar Spinal Stenosis; Spinal Manipulation; Physical Therapy; Surgery,na,TERMINATED,Shin Kong Wu Ho-Su Memorial Hospital,
NCT03118206,surgery,PROCEDURE,Lumbar Spinal Stenosis; Spinal Manipulation; Physical Therapy; Surgery,na,TERMINATED,Shin Kong Wu Ho-Su Memorial Hospital,
NCT03550352,TN-TC11M2 oral capsules (THC 2.5 mg/CBD 2.5 mg),DRUG,HIV Infections,phase2,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT03550352,TN-C200M2 oral capsules (CBD 200 mg),DRUG,HIV Infections,phase2,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT04421547,Letrozole 2.5mg,DRUG,Epithelial Ovarian Cancer,phase3,TERMINATED,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,
NCT04421547,Standard single agent chemotherapy,DRUG,Epithelial Ovarian Cancer,phase3,TERMINATED,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,
NCT00995449,KB003,BIOLOGICAL,Rheumatoid Arthritis,phase2,TERMINATED,"Humanigen, Inc.",
NCT00995449,Placebo Comparator,OTHER,Rheumatoid Arthritis,phase2,TERMINATED,"Humanigen, Inc.",
NCT01148992,Lofexidine,DRUG,Cocaine Related Disorders,phase1,TERMINATED,National Institute on Drug Abuse (NIDA),
NCT01148992,Placebo,DRUG,Cocaine Related Disorders,phase1,TERMINATED,National Institute on Drug Abuse (NIDA),
NCT03015792,Dexamethasone,DRUG,Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT03015792,Ibrutinib,DRUG,Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT03015792,Laboratory Biomarker Analysis,OTHER,Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT03015792,Lenalidomide,DRUG,Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT03015792,Pharmacological Study,OTHER,Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT03015792,Quality-of-Life Assessment,OTHER,Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma,phase1,TERMINATED,Mayo Clinic,
NCT00976534,AZD1386,DRUG,Pain; Neuropathic Pain,phase2,TERMINATED,AstraZeneca,
NCT00976534,Placebo,DRUG,Pain; Neuropathic Pain,phase2,TERMINATED,AstraZeneca,
NCT01368263,goserelin acetate,DRUG,Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer,phase2,TERMINATED,Washington University School of Medicine,
NCT01368263,letrozole,DRUG,Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer,phase2,TERMINATED,Washington University School of Medicine,
NCT01368263,anastrozole,DRUG,Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer,phase2,TERMINATED,Washington University School of Medicine,
NCT01368263,chemotherapy,DRUG,Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer,phase2,TERMINATED,Washington University School of Medicine,
NCT01368263,Surgery,PROCEDURE,Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer,phase2,TERMINATED,Washington University School of Medicine,
NCT00116987,Dual chamber cardiac pacemaker,DEVICE,"Atrial Fibrillation; Cardiac Pacing, Artificial",na,TERMINATED,University of Calgary,
NCT00116987,Single chamber cardiac pacemaker,DEVICE,"Atrial Fibrillation; Cardiac Pacing, Artificial",na,TERMINATED,University of Calgary,
NCT04989387,INCA00186,DRUG,Advanced Solid Tumors; Squamous Cell Carcinoma of the Head and Neck (SCCHN); Gastrointestinal (GI) Malignancies,phase1,TERMINATED,Incyte Corporation,
NCT04989387,Retifanlimab,DRUG,Advanced Solid Tumors; Squamous Cell Carcinoma of the Head and Neck (SCCHN); Gastrointestinal (GI) Malignancies,phase1,TERMINATED,Incyte Corporation,
NCT04989387,INCB106385,DRUG,Advanced Solid Tumors; Squamous Cell Carcinoma of the Head and Neck (SCCHN); Gastrointestinal (GI) Malignancies,phase1,TERMINATED,Incyte Corporation,
NCT03960606,PUR1900,OTHER,Allergic Bronchopulmonary Aspergillosis,phase2,TERMINATED,Pulmatrix Inc.,
NCT03960606,Placebo,OTHER,Allergic Bronchopulmonary Aspergillosis,phase2,TERMINATED,Pulmatrix Inc.,
NCT02489500,Bortezomib,DRUG,AL Amyloidosis,phase3,TERMINATED,Boston Medical Center,
NCT02489500,Melphalan,DRUG,AL Amyloidosis,phase3,TERMINATED,Boston Medical Center,
NCT02489500,Neupogen,DRUG,AL Amyloidosis,phase3,TERMINATED,Boston Medical Center,
NCT02489500,Stem Cell Collection,PROCEDURE,AL Amyloidosis,phase3,TERMINATED,Boston Medical Center,
NCT02489500,Stem cell infusion,PROCEDURE,AL Amyloidosis,phase3,TERMINATED,Boston Medical Center,
NCT01108263,INTEGRA™ Flowable Matrix (Collagen),DRUG,Diabetes; Foot Ulcer,phase4,TERMINATED,Georgetown University,
NCT05336721,Chiauranib,DRUG,Triple-negative Breast Cancer,phase2,TERMINATED,"Chipscreen Biosciences, Ltd.",
NCT05336721,capecitabine,DRUG,Triple-negative Breast Cancer,phase2,TERMINATED,"Chipscreen Biosciences, Ltd.",
NCT01545752,teaching by non-interactive CD,OTHER,Interactive CD-based Education,phase2; phase3,TERMINATED,Mashhad University of Medical Sciences,
NCT01545752,Interactive CD,OTHER,Interactive CD-based Education,phase2; phase3,TERMINATED,Mashhad University of Medical Sciences,
NCT00590538,Sodium 4-Phenylbutyrate,DRUG,Cystic Fibrosis,phase1; phase2,TERMINATED,Children's Hospital of Philadelphia,
NCT00590538,Genistein (Unconjugated Isoflavones 100),DRUG,Cystic Fibrosis,phase1; phase2,TERMINATED,Children's Hospital of Philadelphia,
NCT00590538,Placebo,DRUG,Cystic Fibrosis,phase1; phase2,TERMINATED,Children's Hospital of Philadelphia,
NCT02783911,MTA,DEVICE,Primary Teeth; Pulpotomy,na,TERMINATED,Loma Linda University,
NCT02783911,Ferric Sulfate,DRUG,Primary Teeth; Pulpotomy,na,TERMINATED,Loma Linda University,
NCT00968799,Hyperthermic intraoperative intraperitoneal chemotherapy,PROCEDURE,Epithelial Ovarian Cancer; Fallopian Tube Carcinoma,na,TERMINATED,Cantonal Hospital of St. Gallen,
NCT00968799,Cytoreduction,PROCEDURE,Epithelial Ovarian Cancer; Fallopian Tube Carcinoma,na,TERMINATED,Cantonal Hospital of St. Gallen,
NCT00968799,Cisplatin,DRUG,Epithelial Ovarian Cancer; Fallopian Tube Carcinoma,na,TERMINATED,Cantonal Hospital of St. Gallen,
NCT00587132,Synthetic Human Secretin,DRUG,Pancreatic Cancer,phase1; phase2,TERMINATED,Mayo Clinic,
NCT05980598,TransCon TLR7/8 Agonist,DRUG,Head and Neck Neoplasms,phase2,TERMINATED,Ascendis Pharma A/S,
NCT05980598,Pembrolizumab,DRUG,Head and Neck Neoplasms,phase2,TERMINATED,Ascendis Pharma A/S,
NCT05980598,TransCon IL-2 β/γ,DRUG,Head and Neck Neoplasms,phase2,TERMINATED,Ascendis Pharma A/S,
NCT04382898,BNT112,BIOLOGICAL,Prostate Cancer,phase1; phase2,TERMINATED,BioNTech SE,
NCT04382898,Cemiplimab,DRUG,Prostate Cancer,phase1; phase2,TERMINATED,BioNTech SE,
NCT01209663,Postoperative Intermediate Care,OTHER,Emergency Abdominal Surgery,na,TERMINATED,Copenhagen University Hospital at Herlev,
NCT02438787,Placebo,DRUG,Axial Spondyloarthritis,phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02438787,Ustekinumab 45 mg,DRUG,Axial Spondyloarthritis,phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02438787,Ustekinumab 90 mg,DRUG,Axial Spondyloarthritis,phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02438787,Golimumab 50 mg,DRUG,Axial Spondyloarthritis,phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02907593,Budesonide in Calfactant,DRUG,Bronchopulmonary Dysplasia (BPD),phase1; phase2,TERMINATED,Cynthia McEvoy,
NCT02743793,Blood Draw,PROCEDURE,Kidney Transplant; Liver Transplant,na,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT03376321,Pimodivir 600 mg,DRUG,Influenza A,phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT03376321,Placebo,DRUG,Influenza A,phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT03376321,SOC Treatment,OTHER,Influenza A,phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT05094206,0.75x10^6 cells/kg CAR20.19.22 cells,BIOLOGICAL,B-cell Non Hodgkin Lymphoma; B-cell Chronic Lymphocytic Leukemia,phase1,TERMINATED,Medical College of Wisconsin,
NCT05094206,1x10^6 cells/kg CAR20.19.22 cells,BIOLOGICAL,B-cell Non Hodgkin Lymphoma; B-cell Chronic Lymphocytic Leukemia,phase1,TERMINATED,Medical College of Wisconsin,
NCT05094206,2.5x10^6 cells/kg CAR20.19.22 cells,BIOLOGICAL,B-cell Non Hodgkin Lymphoma; B-cell Chronic Lymphocytic Leukemia,phase1,TERMINATED,Medical College of Wisconsin,
NCT05094206,5x10^6 cells/kg CAR20.19.22 cells,BIOLOGICAL,B-cell Non Hodgkin Lymphoma; B-cell Chronic Lymphocytic Leukemia,phase1,TERMINATED,Medical College of Wisconsin,
NCT05094206,Dose expansion: The maximum tolerated dose of CAR20.19.22 cells,BIOLOGICAL,B-cell Non Hodgkin Lymphoma; B-cell Chronic Lymphocytic Leukemia,phase1,TERMINATED,Medical College of Wisconsin,
NCT02936206,Fulvestrant,DRUG,Breast Cancer,phase1,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT02936206,Tamoxifen,DRUG,Breast Cancer,phase1,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT02899533,[18F] FES,DRUG,Pulmonary Arterial Hypertension,na,TERMINATED,University of Pennsylvania,
NCT01369433,Tivozanib + paclitaxel,DRUG,Solid Tumors,na,TERMINATED,"AVEO Pharmaceuticals, Inc.",
NCT01369433,Tivozanib + temsirolimus,DRUG,Solid Tumors,na,TERMINATED,"AVEO Pharmaceuticals, Inc.",
NCT01369433,Tivozanib,DRUG,Solid Tumors,na,TERMINATED,"AVEO Pharmaceuticals, Inc.",
NCT01369433,Tivozanib (AV-951),DRUG,Solid Tumors,na,TERMINATED,"AVEO Pharmaceuticals, Inc.",
NCT01369433,Tivozanib + capecitabine,DRUG,Solid Tumors,na,TERMINATED,"AVEO Pharmaceuticals, Inc.",
NCT01369433,Tivo,DRUG,Solid Tumors,na,TERMINATED,"AVEO Pharmaceuticals, Inc.",
NCT02059252,SmartMatrix dermal replacement scaffold,DEVICE,Basal Cell Carcinoma; Squamous Cell Carcinoma,phase1; phase2,TERMINATED,Smart Matrix Limited,
NCT04806152,High intensity exercise,OTHER,Sarcopenia,na,TERMINATED,The University of The West Indies,
NCT04806152,Usual care home exercise,OTHER,Sarcopenia,na,TERMINATED,The University of The West Indies,
NCT03241147,Lu AF35700,DRUG,Renal Failure,phase1,TERMINATED,H. Lundbeck A/S,
NCT00283049,Insulin Glargine,DRUG,"Diabetes Mellitus, Type 2",phase4,TERMINATED,Sanofi,
NCT00283049,Insulin Glulisine,DRUG,"Diabetes Mellitus, Type 2",phase4,TERMINATED,Sanofi,
NCT02281344,MMV390048 20mg,DRUG,"Malaria, Falciparum",phase1,TERMINATED,Medicines for Malaria Venture,
NCT05515744,Childbirth,PROCEDURE,Gestational Diabetes Mellitus,na,TERMINATED,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),
NCT01882764,HMPL-004,DRUG,Ulcerative Colitis,phase3,TERMINATED,Hutchison Medipharma Limited,
NCT01882764,Placebo,DRUG,Ulcerative Colitis,phase3,TERMINATED,Hutchison Medipharma Limited,
NCT04804709,Panobinostat 15 MG,DRUG,"Diffuse Intrinsic Pontine Glioma; Diffuse Pontine and Thalamic Gliomas; Diffuse Midline Glioma, H3 K27M-Mutant",phase1,TERMINATED,Columbia University,
NCT04804709,Focused Ultrasound with neuro-navigator-controlled sonication,DEVICE,"Diffuse Intrinsic Pontine Glioma; Diffuse Pontine and Thalamic Gliomas; Diffuse Midline Glioma, H3 K27M-Mutant",phase1,TERMINATED,Columbia University,
NCT03121599,Diagnostic (18F-FLT PET/CT),DEVICE,"Essential Thrombocythemia; Primary Myelofibrosis, Fibrotic Stage; Primary Myelofibrosis, Prefibrotic Stage; Polycythemia Vera",na,TERMINATED,Hamad Medical Corporation,
NCT02020499,"Somatuline Autogel® (lanreotide) 60, 90, 120 mg.",DRUG,Acromegaly,na,TERMINATED,Ipsen,
NCT00297232,Natalizumab,DRUG,Relapsing-Remitting Multiple Sclerosis,phase3,TERMINATED,Biogen,
NCT01067963,Computer assisted education and motivational interviewing.,BEHAVIORAL,"Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic",na,TERMINATED,"University of Colorado, Denver",
NCT01067963,Group talks/social chat,BEHAVIORAL,"Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic",na,TERMINATED,"University of Colorado, Denver",
NCT02832687,Acetaminophen,DRUG,Recovery Following Cholecystectomy,phase4,TERMINATED,"Rutgers, The State University of New Jersey",
NCT02832687,normal saline,DRUG,Recovery Following Cholecystectomy,phase4,TERMINATED,"Rutgers, The State University of New Jersey",
NCT01117987,Imatinib,DRUG,Pulmonary Arterial Hypertension,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT01117987,Placebo,DRUG,Pulmonary Arterial Hypertension,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT04042714,All patients- TAS-102,DRUG,High-grade Extra Pulmonary Neuroendocrine Cancer,phase2,TERMINATED,Baylor Research Institute,
NCT02740114,Bupivacaine,DRUG,Malignant Neoplasms of Female Genital Organs; Gynecologic Cancer,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT02740114,Liposomal Bupivacaine,DRUG,Malignant Neoplasms of Female Genital Organs; Gynecologic Cancer,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT02740114,Oxycodone,DRUG,Malignant Neoplasms of Female Genital Organs; Gynecologic Cancer,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT02740114,Pill Diary,BEHAVIORAL,Malignant Neoplasms of Female Genital Organs; Gynecologic Cancer,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT02740114,Symptom Questionnaire,BEHAVIORAL,Malignant Neoplasms of Female Genital Organs; Gynecologic Cancer,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT03661814,Prevena,DEVICE,Surgical Wound Infection,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT02538614,Idelalisib,DRUG,Chronic Lymphocytic Leukemia (CLL),phase1,TERMINATED,Gilead Sciences,
NCT02538614,BI 836826,DRUG,Chronic Lymphocytic Leukemia (CLL),phase1,TERMINATED,Gilead Sciences,
NCT01411514,Prednisone,DRUG,Multiple Sclerosis,phase4,TERMINATED,Claudio Gobbi,
NCT01411514,Placebo,DRUG,Multiple Sclerosis,phase4,TERMINATED,Claudio Gobbi,
NCT05423106,JNJ-64457744,DRUG,"Healthy; Hepatitis B, Chronic",phase1,TERMINATED,"Janssen Research & Development, LLC",
NCT05423106,Placebo,DRUG,"Healthy; Hepatitis B, Chronic",phase1,TERMINATED,"Janssen Research & Development, LLC",
NCT05423106,Tenofovir Disoproxil Fumarate (TDF),DRUG,"Healthy; Hepatitis B, Chronic",phase1,TERMINATED,"Janssen Research & Development, LLC",
NCT05423106,Tenofovir Alafenamide (TAF),DRUG,"Healthy; Hepatitis B, Chronic",phase1,TERMINATED,"Janssen Research & Development, LLC",
NCT05423106,Entecavir (ETV),DRUG,"Healthy; Hepatitis B, Chronic",phase1,TERMINATED,"Janssen Research & Development, LLC",
NCT05423106,JNJ-64457744,DRUG,"Healthy; Hepatitis B, Chronic",phase1,TERMINATED,"Janssen Research & Development, LLC",
NCT00983047,Nimotuzumab and Docetaxel,DRUG,Advanced Non-Small Cell Lung Cancer,phase2,TERMINATED,"Biotech Pharmaceutical Co., Ltd.",
NCT00394147,pemetrexed,DRUG,Head and Neck Cancer,phase2,TERMINATED,Fox Chase Cancer Center,
NCT00394147,gemcitabine,DRUG,Head and Neck Cancer,phase2,TERMINATED,Fox Chase Cancer Center,
NCT01498744,Oral Clindamycin,DRUG,Abscess Soft Tissue; Methicillin-resistant Staphylococcus Aureus (MRSA) Infection; Skin Abscess,na,TERMINATED,Ann & Robert H Lurie Children's Hospital of Chicago,
NCT05200364,STRO-002,DRUG,Ovarian Cancer; Ovarian Carcinoma; Ovary Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma,phase1,TERMINATED,"Sutro Biopharma, Inc.",
NCT05200364,Bevacizumab,DRUG,Ovarian Cancer; Ovarian Carcinoma; Ovary Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma,phase1,TERMINATED,"Sutro Biopharma, Inc.",
NCT00526799,Sorafenib,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,"Daniela Matei, MD",
NCT00526799,Topotecan,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,"Daniela Matei, MD",
NCT02591199,URG101,DRUG,Interstitial Cystitis; Bladder Pain Syndrome,phase2,TERMINATED,Urigen,
NCT02591199,Placebo,DRUG,Interstitial Cystitis; Bladder Pain Syndrome,phase2,TERMINATED,Urigen,
NCT02591199,Lidocaine,DRUG,Interstitial Cystitis; Bladder Pain Syndrome,phase2,TERMINATED,Urigen,
NCT02591199,Heparin,DRUG,Interstitial Cystitis; Bladder Pain Syndrome,phase2,TERMINATED,Urigen,
NCT03184584,PBI-4050,DRUG,Alström Syndrome,phase2; phase3,TERMINATED,Liminal BioSciences Ltd.,
NCT03345784,Adavosertib,DRUG,Cervical Carcinoma; Endometrioid Adenocarcinoma; Malignant Female Reproductive System Neoplasm; Recurrent Cervical Carcinoma; Stage I Uterine Corpus Cancer AJCC v7; Stage I Vaginal Cancer AJCC v6 and ,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03345784,Cisplatin,DRUG,Cervical Carcinoma; Endometrioid Adenocarcinoma; Malignant Female Reproductive System Neoplasm; Recurrent Cervical Carcinoma; Stage I Uterine Corpus Cancer AJCC v7; Stage I Vaginal Cancer AJCC v6 and ,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03345784,External Beam Radiation Therapy,RADIATION,Cervical Carcinoma; Endometrioid Adenocarcinoma; Malignant Female Reproductive System Neoplasm; Recurrent Cervical Carcinoma; Stage I Uterine Corpus Cancer AJCC v7; Stage I Vaginal Cancer AJCC v6 and ,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03472833,High-dose,DRUG,Pancreas Cancer; Vitamin D Deficiency; Quality of Life,phase3,TERMINATED,Medical University of Graz,
NCT03472833,Standard dose,DRUG,Pancreas Cancer; Vitamin D Deficiency; Quality of Life,phase3,TERMINATED,Medical University of Graz,
NCT04282564,Co-OP treatment,OTHER,Cerebrovascular Accident,na,TERMINATED,"University Hospital, Toulouse",
NCT03784599,Trastuzumab emtansine,DRUG,"Carcinoma, Non-Small-Cell Lung",phase2,TERMINATED,The Netherlands Cancer Institute,
NCT03784599,Osimertinib,DRUG,"Carcinoma, Non-Small-Cell Lung",phase2,TERMINATED,The Netherlands Cancer Institute,
NCT01212887,MFE23 scFv-expressing autologous anti-CEA MFEz T lymphocytes,BIOLOGICAL,"Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Cancer Research UK,
NCT01212887,aldesleukin,BIOLOGICAL,"Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Cancer Research UK,
NCT01212887,cyclophosphamide,DRUG,"Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Cancer Research UK,
NCT01212887,fludarabine phosphate,DRUG,"Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Cancer Research UK,
NCT01212887,laboratory biomarker analysis,OTHER,"Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Cancer Research UK,
NCT01212887,pharmacological study,OTHER,"Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Cancer Research UK,
NCT04335721,Voxelotor,DRUG,Sickle Cell Disease; Sickle Cell Nephropathy,phase1; phase2,TERMINATED,University of Illinois at Chicago,
NCT03688763,Cognitive Behavioral Therapy for Insomnia (CBT-i),BEHAVIORAL,Insomnia,na,TERMINATED,Palo Alto Veterans Institute for Research,
NCT01981187,LGX818,DRUG,Solid Tumor; Hematologic Malignancies,phase2,TERMINATED,Pfizer,
NCT03120793,Esophageal balloon catheter,DEVICE,ARDS; Respiratory Failure,na,TERMINATED,"University of North Carolina, Chapel Hill",
NCT00580216,Idrabiotaparinux sodium,DRUG,Atrial Fibrillation,phase3,TERMINATED,Sanofi,
NCT00580216,Warfarin,DRUG,Atrial Fibrillation,phase3,TERMINATED,Sanofi,
NCT00580216,Placebo (for idrabiotaparinux),DRUG,Atrial Fibrillation,phase3,TERMINATED,Sanofi,
NCT00580216,Placebo (for warfarin),DRUG,Atrial Fibrillation,phase3,TERMINATED,Sanofi,
NCT00580216,Avidin,DRUG,Atrial Fibrillation,phase3,TERMINATED,Sanofi,
NCT00580216,Placebo (for avidin),DRUG,Atrial Fibrillation,phase3,TERMINATED,Sanofi,
NCT03078504,continuous renal replacement therapy using System One (TM) setup (Nxstage),DEVICE,Acute Kidney Injury; End-stage Renal Disease,na,TERMINATED,St. Louis University,
NCT05226533,DWRX2003,DRUG,COVID-19,phase2,TERMINATED,Daewoong Pharmaceutical Co. LTD.,
NCT05226533,Placebo,DRUG,COVID-19,phase2,TERMINATED,Daewoong Pharmaceutical Co. LTD.,
NCT00464347,Avastin,DRUG,Age-Related Macular Degeneration,phase2,TERMINATED,National Eye Institute (NEI),
NCT00464347,Photodynamic Therapy (PDT),PROCEDURE,Age-Related Macular Degeneration,phase2,TERMINATED,National Eye Institute (NEI),
NCT00464347,Preservative-Free Triamcinolone Acetonide (TAC-PF),DRUG,Age-Related Macular Degeneration,phase2,TERMINATED,National Eye Institute (NEI),
NCT02520011,Alvocidib,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT02520011,Cytarabine,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT02520011,Mitoxantrone,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT00023634,KLH,BIOLOGICAL,Brain Tumors; Gastric Cancer; Ovarian Cancer; Prostate Cancer,phase1,TERMINATED,SWOG Cancer Research Network,
NCT00023634,GMCSF,BIOLOGICAL,Brain Tumors; Gastric Cancer; Ovarian Cancer; Prostate Cancer,phase1,TERMINATED,SWOG Cancer Research Network,
NCT01516034,Cupola Tattoo Removal device,DEVICE,Tattooing,na,TERMINATED,Cupola Medical Ltd,
NCT02432664,ODM-108 Part I,DRUG,Healthy,phase1,TERMINATED,"Orion Corporation, Orion Pharma",
NCT02432664,Placebo Part I,DRUG,Healthy,phase1,TERMINATED,"Orion Corporation, Orion Pharma",
NCT02432664,ODM-108-Part II,DRUG,Healthy,phase1,TERMINATED,"Orion Corporation, Orion Pharma",
NCT02432664,Placebo Part II,DRUG,Healthy,phase1,TERMINATED,"Orion Corporation, Orion Pharma",
NCT02432664,ODM-108 Part III,DRUG,Healthy,phase1,TERMINATED,"Orion Corporation, Orion Pharma",
NCT02432664,Midazolam,DRUG,Healthy,phase1,TERMINATED,"Orion Corporation, Orion Pharma",
NCT06422364,Weighted Wearable Blanket provided by Dreamland Baby Co.,DEVICE,Sleep,na,TERMINATED,Indiana University,
NCT06422364,Weighted Wearable Blanket provided by Dreamland Baby Co.,DEVICE,Sleep,na,TERMINATED,Indiana University,
NCT01582009,panobinostat,DRUG,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01582009,everolimus,DRUG,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01582009,laboratory biomarker analysis,OTHER,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01582009,pharmacological study,OTHER,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01582009,liquid chromatography,OTHER,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01582009,mass spectrometry,OTHER,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01582009,enzyme-linked immunosorbent assay,OTHER,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01582009,immunohistochemistry staining method,OTHER,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01287663,Permethrin impregnated,DRUG,Body's Louses,na,TERMINATED,Assistance Publique Hopitaux De Marseille,
NCT01287663,no Permethrin impregnated,DRUG,Body's Louses,na,TERMINATED,Assistance Publique Hopitaux De Marseille,
NCT04262193,Suvorexant,DRUG,Opioid-use Disorder; Sleep,phase2,TERMINATED,Wayne State University,
NCT04262193,Suvorexant Placebo,DRUG,Opioid-use Disorder; Sleep,phase2,TERMINATED,Wayne State University,
NCT01928693,Besivance 0.6% Ophthalmic Suspension,DRUG,Corneal Ulcers,phase2,TERMINATED,Cornea Consultants Of Nashville,
NCT01928693,Zymaxid 0.5% Ophthalmic Solution,DRUG,Corneal Ulcers,phase2,TERMINATED,Cornea Consultants Of Nashville,
NCT01928693,Vigamox 0.5% Ophthalmic Solution,DRUG,Corneal Ulcers,phase2,TERMINATED,Cornea Consultants Of Nashville,
NCT00240214,sirolimus,DRUG,Renal Transplantation,na,TERMINATED,Wyeth is now a wholly owned subsidiary of Pfizer,
NCT00259714,dialysate sodium individualization,DRUG,Hypertension; Hemodialysis Patients,phase1,TERMINATED,Yale University,
NCT00259714,standard dialysate sodium,DRUG,Hypertension; Hemodialysis Patients,phase1,TERMINATED,Yale University,
NCT02907814,Optical Coherence Tomography (OCT),DEVICE,Uveitis,na,TERMINATED,"Rutgers, The State University of New Jersey",
NCT02907814,Eye Exam,OTHER,Uveitis,na,TERMINATED,"Rutgers, The State University of New Jersey",
NCT00437606,GK Activator (2),DRUG,"Diabetes Mellitus, Type 2",phase1,TERMINATED,Hoffmann-La Roche,
NCT00437606,Ethanol,DRUG,"Diabetes Mellitus, Type 2",phase1,TERMINATED,Hoffmann-La Roche,
NCT01796106,Resin infiltration,DEVICE,"Caries,Dental",na,TERMINATED,DMG Dental Material Gesellschaft mbH,
NCT01796106,Fluoride varnish & Oral hygiene instruction,DEVICE,"Caries,Dental",na,TERMINATED,DMG Dental Material Gesellschaft mbH,
NCT04579133,Olaparib,DRUG,Bladder Cancer; Urothelial Carcinoma,phase2,TERMINATED,Latin American Cooperative Oncology Group,
NCT04579133,Durvalumab,DRUG,Bladder Cancer; Urothelial Carcinoma,phase2,TERMINATED,Latin American Cooperative Oncology Group,
NCT02007447,OCYTOCINA - SPRAY NASAL,DRUG,Autism Spectrum Disorder,phase2; phase3,TERMINATED,University of Sao Paulo General Hospital,
NCT02893332,Radiation: SBRT,RADIATION,Stage IV EGFR Mutated Non-Small Cell Lung Cancer,phase3,TERMINATED,Sichuan Provincial People's Hospital,
NCT02893332,TKI (Gefitinib or Tarceva ),DRUG,Stage IV EGFR Mutated Non-Small Cell Lung Cancer,phase3,TERMINATED,Sichuan Provincial People's Hospital,
NCT02541721,LabiaStick#01,DEVICE,Chronic Disease of Skin,na,TERMINATED,Health Products Research and Development Lda.,
NCT00913393,FG-3019,DRUG,Type 2 Diabetes Mellitus; Diabetic Nephropathy; Diabetic Kidney Disease,phase2,TERMINATED,Kyntra Bio,
NCT00913393,FG-3019,DRUG,Type 2 Diabetes Mellitus; Diabetic Nephropathy; Diabetic Kidney Disease,phase2,TERMINATED,Kyntra Bio,
NCT00913393,Placebo,DRUG,Type 2 Diabetes Mellitus; Diabetic Nephropathy; Diabetic Kidney Disease,phase2,TERMINATED,Kyntra Bio,
NCT02400814,Anti-PD-L1 Monoclonal Antibody MPDL3280A,DRUG,Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer,phase1,TERMINATED,"Megan Daly, MD",
NCT02400814,Stereotactic Body Radiation Therapy,RADIATION,Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer,phase1,TERMINATED,"Megan Daly, MD",
NCT02490384,Physical exam indicated cerclage,PROCEDURE,"Twin Pregnancy, Antepartum Condition or Complication; Preterm Birth; Cervical Dilation Premature",na,TERMINATED,Thomas Jefferson University,
NCT03232749,intraarticular corticosteroid injections (IACSI),PROCEDURE,Osteoarthritis of the Glenohumeral Joint,phase4,TERMINATED,University of Florida,
NCT03232749,corticosteroid injections,DRUG,Osteoarthritis of the Glenohumeral Joint,phase4,TERMINATED,University of Florida,
NCT03232749,Ultrasound,DEVICE,Osteoarthritis of the Glenohumeral Joint,phase4,TERMINATED,University of Florida,
NCT00100347,PPI-2458,DRUG,"Non-Hodgkin's Lymphoma,; Solid Tumors",phase1,TERMINATED,PRAECIS Pharmaceuticals Inc.,
NCT00267787,genetic analysis,OTHER,Rectal Cancer; Colon Cancer; Colonic Neoplasms; Anal Cancer,na,TERMINATED,Stanford University,
NCT01592006,Peginterferon alfa-2a,DRUG,Hepatitis C,phase4,TERMINATED,University of Chicago,
NCT01592006,Ribavirin,DRUG,Hepatitis C,phase4,TERMINATED,University of Chicago,
NCT01592006,telaprevir,DRUG,Hepatitis C,phase4,TERMINATED,University of Chicago,
NCT00162084,apadenoson,DRUG,Heart Disease; Ischemic Heart Disease,phase3,TERMINATED,Forest Laboratories,
NCT03502447,TearCare,DEVICE,Dry Eye Syndromes,na,TERMINATED,"Sight Sciences, Inc.",
NCT03502447,Warm Compress and Lid Massage,DEVICE,Dry Eye Syndromes,na,TERMINATED,"Sight Sciences, Inc.",
NCT04612049,Immersive virtual reality visuo-motor skill assessment,DEVICE,Cerebral Palsy; Hemiplegia,na,TERMINATED,Northeastern University,
NCT01849796,tDCS,DEVICE,Facial Pain,phase2,TERMINATED,Beth Israel Medical Center,
NCT04050462,Nivolumab 240 mg IV every 2 weeks + Cabiralizumab 4 mg/kg IV every 2 weeks,DRUG,Hepatocellular Carcinoma,phase2,TERMINATED,NYU Langone Health,
NCT04050462,Nivolumab 240 mg IV every 2 weeks + BMS-986253 1200 mg IV every 2 weeks,DRUG,Hepatocellular Carcinoma,phase2,TERMINATED,NYU Langone Health,
NCT04050462,Nivolumab 240 mg IV every 2 weeks,DRUG,Hepatocellular Carcinoma,phase2,TERMINATED,NYU Langone Health,
NCT00588146,Pegylated Interferon Alpha2b,DRUG,Anemia; Liver Disease; Hypoxemia,phase2,TERMINATED,Mayo Clinic,
NCT00588146,Standard care,OTHER,Anemia; Liver Disease; Hypoxemia,phase2,TERMINATED,Mayo Clinic,
NCT00190346,Humidification devices: HH vs HME,DEVICE,Respiratory Failure; COPD; Hypoxemia; Non Invasive Ventilation,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02491970,Fluticasone/Formoterol,DRUG,Asthma,phase4,TERMINATED,Mundipharma Korea Ltd,
NCT02491970,Fluticasone/Salmeterol,DRUG,Asthma,phase4,TERMINATED,Mundipharma Korea Ltd,
NCT00559286,Telmisartan,DRUG,Arterial Hypertension; Diabetes Mellitus Type 2 IRC or NIR,phase4,TERMINATED,RWTH Aachen University,
NCT00983541,Fluorouracil (5-FU),DRUG,Cancer,phase2,TERMINATED,University of Utah,
NCT00983541,Brachytherapy or SBRT (Stereotactic body radiation therapy),RADIATION,Cancer,phase2,TERMINATED,University of Utah,
NCT00983541,Gemcitabine,DRUG,Cancer,phase2,TERMINATED,University of Utah,
NCT02351869,Nitrous Oxide,DRUG,Bipolar Disorder,phase2,TERMINATED,Sunnybrook Health Sciences Centre,
NCT02351869,Midazolam,DRUG,Bipolar Disorder,phase2,TERMINATED,Sunnybrook Health Sciences Centre,
NCT00555841,ALC and Placebo,DRUG,Breast Cancer,phase2,TERMINATED,"Sigma-Tau Research, Inc.",
NCT05351554,Namilumab,DRUG,"Sarcoidosis, Cardiac",phase2,TERMINATED,Kinevant Sciences GmbH,
NCT04761679,Applying the Mepilex foam,BEHAVIORAL,Pressure Ulcer of Skin; Pressure Injury,na,TERMINATED,Columbia University,
NCT02162979,sildenafil,DRUG,Parkinson's Disease,phase2,TERMINATED,Loma Linda University,
NCT02162979,Placebo,DRUG,Parkinson's Disease,phase2,TERMINATED,Loma Linda University,
NCT03126903,KeraKlear Non-Penetrating Keratoprosthesis,DEVICE,Corneal Blindness,na,TERMINATED,"KeraMed, Inc.",
NCT02443103,Guanabenz acetate,DRUG,Bone Cancer; Metastasis,na,TERMINATED,Kathy Miller,
NCT03603288,idebenone 150 mg film-coated tablets,DRUG,Duchenne Muscular Dystrophy,phase3,TERMINATED,Santhera Pharmaceuticals,
NCT05200403,Crisaborole 2%,DRUG,Atopic Dermatitis,phase4,TERMINATED,Boston University,
NCT05200403,Vehicle treatment,DRUG,Atopic Dermatitis,phase4,TERMINATED,Boston University,
NCT05200403,Accelerometry device for children,DEVICE,Atopic Dermatitis,phase4,TERMINATED,Boston University,
NCT05200403,Accelerometry device for adult caregivers,DEVICE,Atopic Dermatitis,phase4,TERMINATED,Boston University,
NCT01834703,UAE,PROCEDURE,Uterine Fibroids,na,TERMINATED,Chinese University of Hong Kong,
NCT01834703,HIFU,PROCEDURE,Uterine Fibroids,na,TERMINATED,Chinese University of Hong Kong,
NCT03444727,Ice Pre-treatment,OTHER,"Vulvar Diseases; Anesthesia; Anesthesia, Local",na,TERMINATED,University of Missouri-Columbia,
NCT03444727,Room Temperature Water Pre-treatment,OTHER,"Vulvar Diseases; Anesthesia; Anesthesia, Local",na,TERMINATED,University of Missouri-Columbia,
NCT03134027,Bone marrow biopsy,PROCEDURE,Genito Urinary Cancer; Bladder Cancer; Kidney Cancer; Prostate Cancer,na,TERMINATED,Duke University,
NCT03134027,Tumor biopsy,PROCEDURE,Genito Urinary Cancer; Bladder Cancer; Kidney Cancer; Prostate Cancer,na,TERMINATED,Duke University,
NCT04976686,Diet modification,OTHER,"Diet, Healthy",na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT00962273,Interactive computerized learning resource,BEHAVIORAL,Psychological Stress,na,TERMINATED,"Mount Sinai Hospital, Canada",
NCT00962273,Didactic computerized learning resource,BEHAVIORAL,Psychological Stress,na,TERMINATED,"Mount Sinai Hospital, Canada",
NCT01379469,Drug-Carbamazepine (Tegretol XR),DRUG,Alpha-1-antitrypsin Deficiency; Liver Cirrhosis,phase2,TERMINATED,Washington University School of Medicine,
NCT01379469,Carbamazepine (Tegretol XR) Placebo,DRUG,Alpha-1-antitrypsin Deficiency; Liver Cirrhosis,phase2,TERMINATED,Washington University School of Medicine,
NCT01625741,Rituximab,DRUG,Chronic Lymphocytic Leukemia,phase2,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT03090880,Tinzaparin Sodium,DRUG,Venous Thromboembolism; Lung Neoplasm,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04409080,REGN7257,DRUG,Severe Aplastic Anemia (SAA),phase1,TERMINATED,Regeneron Pharmaceuticals,
NCT00853879,"Folic Acid, Vitamin B6, Vitamin B12",OTHER,Parkinson's Disease,na,TERMINATED,Northwell Health,
NCT00853879,"B6, B12, L-methylfolate",OTHER,Parkinson's Disease,na,TERMINATED,Northwell Health,
NCT00853879,"B6, B12, Placebo",OTHER,Parkinson's Disease,na,TERMINATED,Northwell Health,
NCT02140788,Metformin,DRUG,Schizophrenia; Schizo-affective Disorder,phase4,TERMINATED,Duke University,
NCT02140788,Fish Oil,DRUG,Schizophrenia; Schizo-affective Disorder,phase4,TERMINATED,Duke University,
NCT05201703,Fycompa,DRUG,Catamenial Epilepsy,phase4,TERMINATED,University of Florida,
NCT05201703,Fycompa with a boost,DRUG,Catamenial Epilepsy,phase4,TERMINATED,University of Florida,
NCT02871427,Nelotanserin,DRUG,Lewy Body Dementia; Dementia With Lewy Bodies; Parkinson's Disease Dementia; Visual Hallucinations; REM Sleep Behavior Disorder,phase2,TERMINATED,Axovant Sciences Ltd.,
NCT04705727,Budesonide Formoterol Drug Combination,DRUG,Asthma in Children,phase3,TERMINATED,Centre Hospitalier Intercommunal Creteil,
NCT04705727,nebulisation of terbutaline,DRUG,Asthma in Children,phase3,TERMINATED,Centre Hospitalier Intercommunal Creteil,
NCT03367169,minimally invasive method,PROCEDURE,Pilon Fractures; Fractures; Bone; Leg Injuries,na,TERMINATED,"University Hospital, Clermont-Ferrand",
NCT03367169,open reduction method,PROCEDURE,Pilon Fractures; Fractures; Bone; Leg Injuries,na,TERMINATED,"University Hospital, Clermont-Ferrand",
NCT00142883,Pregabalin,DRUG,Cocaine Abuse; Cocaine-Related Disorders,na,TERMINATED,Yale University,
NCT00142883,placebo,DRUG,Cocaine Abuse; Cocaine-Related Disorders,na,TERMINATED,Yale University,
NCT05034341,Multimodal Prehabilitation,OTHER,Lumbar Spine Injury; Spinal Fusion; Frailty; Prehabilitation; Nutritional Supplementation; Functional Outcome,na,TERMINATED,University of Florida,
NCT05034341,Standard Pre-Surgical Clinical Care,OTHER,Lumbar Spine Injury; Spinal Fusion; Frailty; Prehabilitation; Nutritional Supplementation; Functional Outcome,na,TERMINATED,University of Florida,
NCT01593241,Carboplatin,DRUG,Seminoma,phase2,TERMINATED,Swiss Cancer Institute,
NCT01593241,Involved node RT,RADIATION,Seminoma,phase2,TERMINATED,Swiss Cancer Institute,
NCT02225496,Transoral Robotic Surgery (TORS),PROCEDURE,Oropharyngeal Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02225496,Modified Barium Swallow (MBS),PROCEDURE,Oropharyngeal Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02225496,Questionnaires,BEHAVIORAL,Oropharyngeal Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT04588246,Biospecimen Collection,PROCEDURE,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Breast Neoplasm; Metastatic Malignant Digestive System Neo,phase3,TERMINATED,NRG Oncology,
NCT04588246,Computed Tomography,PROCEDURE,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Breast Neoplasm; Metastatic Malignant Digestive System Neo,phase3,TERMINATED,NRG Oncology,
NCT04588246,Magnetic Resonance Imaging,PROCEDURE,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Breast Neoplasm; Metastatic Malignant Digestive System Neo,phase3,TERMINATED,NRG Oncology,
NCT04588246,Memantine,DRUG,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Breast Neoplasm; Metastatic Malignant Digestive System Neo,phase3,TERMINATED,NRG Oncology,
NCT04588246,Quality-of-Life Assessment,OTHER,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Breast Neoplasm; Metastatic Malignant Digestive System Neo,phase3,TERMINATED,NRG Oncology,
NCT04588246,Questionnaire Administration,OTHER,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Breast Neoplasm; Metastatic Malignant Digestive System Neo,phase3,TERMINATED,NRG Oncology,
NCT04588246,Stereotactic Radiosurgery,RADIATION,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Breast Neoplasm; Metastatic Malignant Digestive System Neo,phase3,TERMINATED,NRG Oncology,
NCT04588246,Whole-Brain Radiotherapy,RADIATION,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Breast Neoplasm; Metastatic Malignant Digestive System Neo,phase3,TERMINATED,NRG Oncology,
NCT04794088,Imatinib Mesylate intravenous solution,DRUG,ARDS; Acute Respiratory Distress Syndrome; Covid19; Endothelial Dysfunction; Pulmonary Edema,phase2,TERMINATED,Dr. Jurjan Aman,
NCT04794088,Placebo,DRUG,ARDS; Acute Respiratory Distress Syndrome; Covid19; Endothelial Dysfunction; Pulmonary Edema,phase2,TERMINATED,Dr. Jurjan Aman,
NCT03245827,Clomiphene,DRUG,"Hypogonadism, Hypogonadotropic",phase2,TERMINATED,"Sandeep Singh Dhindsa, M.D., F.A.C.E",
NCT03245827,Placebo,DRUG,"Hypogonadism, Hypogonadotropic",phase2,TERMINATED,"Sandeep Singh Dhindsa, M.D., F.A.C.E",
NCT02918227,Search retrograde ejaculation,PROCEDURE,Prostate; Ejaculation; Benign Prostatic Hyperplasia,na,TERMINATED,"University Hospital, Limoges",
NCT00856427,radiation therapy treatment planning/simulation,RADIATION,Lung Cancer,phase1,TERMINATED,Virginia Commonwealth University,
NCT00856427,implanted fiducial-based imaging,PROCEDURE,Lung Cancer,phase1,TERMINATED,Virginia Commonwealth University,
NCT03811769,Best Medical Therapy,OTHER,Stroke,na,TERMINATED,"University Hospital, Montpellier",
NCT03811769,Mechanical Thrombectomy,PROCEDURE,Stroke,na,TERMINATED,"University Hospital, Montpellier",
NCT00581269,low-impact aerobic exercise,BEHAVIORAL,Chronic Kidney Disease,phase2,TERMINATED,Vanderbilt University,
NCT00581269,low-calorie (low-fat) diet,OTHER,Chronic Kidney Disease,phase2,TERMINATED,Vanderbilt University,
NCT04815083,Aminolevulinic Acid Hydrochloride,DRUG,Breast Neoplasm Female; Breast Cancer,phase3,TERMINATED,"SBI ALApharma Canada, Inc.",
NCT04815083,Eagle V1.2 Imaging System,DEVICE,Breast Neoplasm Female; Breast Cancer,phase3,TERMINATED,"SBI ALApharma Canada, Inc.",
NCT04815083,Placebo,DRUG,Breast Neoplasm Female; Breast Cancer,phase3,TERMINATED,"SBI ALApharma Canada, Inc.",
NCT00955305,Bevacizumab,BIOLOGICAL,Large Cell Lung Carcinoma; Lung Adenocarcinoma; Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer; Bronchioloalveolar Lung Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00955305,Carboplatin,DRUG,Large Cell Lung Carcinoma; Lung Adenocarcinoma; Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer; Bronchioloalveolar Lung Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00955305,Cixutumumab,BIOLOGICAL,Large Cell Lung Carcinoma; Lung Adenocarcinoma; Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer; Bronchioloalveolar Lung Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00955305,Paclitaxel,DRUG,Large Cell Lung Carcinoma; Lung Adenocarcinoma; Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer; Bronchioloalveolar Lung Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01667666,Nebulized hypertonic saline,DRUG,Acute Lung Injury; Adult Respiratory Distress Syndrome,phase1,TERMINATED,Denver Health and Hospital Authority,
NCT01784159,Aspirin,DRUG,Sepsis,phase2,TERMINATED,Federal University of São Paulo,
NCT02343159,dimethyl fumarate,DRUG,Multiple Sclerosis,phase4,TERMINATED,Biogen,
NCT02343159,Medication Event Monitoring System (MEMS),DEVICE,Multiple Sclerosis,phase4,TERMINATED,Biogen,
NCT02343159,Adherence counseling,BEHAVIORAL,Multiple Sclerosis,phase4,TERMINATED,Biogen,
NCT03618979,PPP treatment,BIOLOGICAL,Low Back Pain,na,TERMINATED,"Regenexx, LLC",
NCT03618979,PRP treatment,BIOLOGICAL,Low Back Pain,na,TERMINATED,"Regenexx, LLC",
NCT03618979,PRP and PL Combo treatment,BIOLOGICAL,Low Back Pain,na,TERMINATED,"Regenexx, LLC",
NCT03261479,Thermal image,OTHER,Pneumonia,na,TERMINATED,Massachusetts General Hospital,
NCT04579679,Surufatinib,DRUG,Neuroendocrine Tumours; Neuroendocrine Tumour of the Lung; Small Intestinal NET,phase2,TERMINATED,Hutchmed,
NCT02538146,acetyl-L-carnitine 1000mg 2X per day for 3 months,OTHER,Chronic Pancreatitis,early_phase1,TERMINATED,Karin High,
NCT00430027,Capecitabine,DRUG,Esophageal Adenocarcinoma,na,TERMINATED,"University of Colorado, Denver",
NCT00430027,Oxaliplatin,DRUG,Esophageal Adenocarcinoma,na,TERMINATED,"University of Colorado, Denver",
NCT00430027,Cetuximab,DRUG,Esophageal Adenocarcinoma,na,TERMINATED,"University of Colorado, Denver",
NCT04309227,Strength Training,OTHER,"Rheumatoid Arthritis; Myositis; Osteoarthritis; Weakness, Muscle",na,TERMINATED,Louisiana State University Health Sciences Center Shreveport,
NCT00209027,fMRI,OTHER,Schizophrenia,na,TERMINATED,Emory University,
NCT00209027,Aripiprazole,DRUG,Schizophrenia,na,TERMINATED,Emory University,
NCT03754361,automated peritoneal dialysis,PROCEDURE,ESRD,na,TERMINATED,Peking Union Medical College Hospital,
NCT03754361,IHD,PROCEDURE,ESRD,na,TERMINATED,Peking Union Medical College Hospital,
NCT05487586,ceftazidime avibactam group,DRUG,Hospital Acquired Pneumonia; Ventilator Acquired Pneumonia; Complicated Intra Abdominal Infections,na,TERMINATED,Pfizer,
NCT00816270,Bilateral Upper eyelid blepharoplasty,PROCEDURE,Blepharoptosis,na,TERMINATED,Federal University of São Paulo,
NCT03425370,Closure of surgical wounds using buried sutures or tissue adhesive on aesthetic outcome.,PROCEDURE,Surgical Wound,na,TERMINATED,West Virginia University,
NCT01966380,Leia,DEVICE,Leg Ulcer; Diabetic Foot Ulcer; Pressure Ulcer,phase2,TERMINATED,Molnlycke Health Care AB,
NCT02200380,CDX-301,DRUG,For Donors; Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling; For Recipients; Acute Myelogenous Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Myelodysplastic Syndrome (MDS);,phase2,TERMINATED,Celldex Therapeutics,
NCT02200380,CDX-301 and plerixafor,DRUG,For Donors; Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling; For Recipients; Acute Myelogenous Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Myelodysplastic Syndrome (MDS);,phase2,TERMINATED,Celldex Therapeutics,
NCT02794246,CART-19 cells,BIOLOGICAL,Multiple Myeloma,phase2,TERMINATED,University of Pennsylvania,
NCT04157088,"Darolutamide (Nubeqa, BAY1841788)",DRUG,"Prostatic Cancer, Castration-Resistant",phase2,TERMINATED,Bayer,
NCT04157088,Enzalutamide,DRUG,"Prostatic Cancer, Castration-Resistant",phase2,TERMINATED,Bayer,
NCT04454788,Tenecteplase,DRUG,Ischemic Stroke,phase3,TERMINATED,University of Melbourne,
NCT04454788,Standard Care (which may include intravenous Alteplase),DRUG,Ischemic Stroke,phase3,TERMINATED,University of Melbourne,
NCT01728103,APTIMA® Trichomonas vaginalis & APTIMA® COMBO 2® Assays,DEVICE,Chlamydia Infections; Gonorrhea; Trichomonas Infections,na,TERMINATED,"Gen-Probe, Incorporated",
NCT00281827,carboplatin,DRUG,Lung Cancer,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00281827,gemcitabine hydrochloride,DRUG,Lung Cancer,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00281827,thalidomide,DRUG,Lung Cancer,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00281827,conventional surgery,PROCEDURE,Lung Cancer,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT01700569,Temozolomide,DRUG,Grade IV Astrocytoma; Glioblastoma,phase1,TERMINATED,Institut Cancerologie de l'Ouest,
NCT01700569,folinic acid at pharmacological dose is the escalated drug,DRUG,Grade IV Astrocytoma; Glioblastoma,phase1,TERMINATED,Institut Cancerologie de l'Ouest,
NCT01700569,High voltage radiation therapy (linear accelerator),RADIATION,Grade IV Astrocytoma; Glioblastoma,phase1,TERMINATED,Institut Cancerologie de l'Ouest,
NCT03760159,Kinocardiography unintrusive recording,DEVICE,Sleep Disorder; Breathing-Related; Cardiovascular Diseases; Cardiovascular Risk Factor; Cardiovascular Complication,na,TERMINATED,Erasme University Hospital,
NCT00352859,"Nexavar (Sorafenib, BAY43-9006) with addition of gemcitabine or interferon",DRUG,"Carcinoma, Renal Cell",phase4,TERMINATED,Bayer,
NCT00352859,Gemcitabine or Interferon (only),DRUG,"Carcinoma, Renal Cell",phase4,TERMINATED,Bayer,
NCT02517359,RV6153 single dose,DRUG,Asthma; Healthy Volunteers,phase1,TERMINATED,Respivert Ltd,
NCT02517359,RV6153 matching placebo single dose,DRUG,Asthma; Healthy Volunteers,phase1,TERMINATED,Respivert Ltd,
NCT02517359,RV6153 14 day repeat dose,DRUG,Asthma; Healthy Volunteers,phase1,TERMINATED,Respivert Ltd,
NCT02517359,RV6153 matching placebo 14 day repeat dose,DRUG,Asthma; Healthy Volunteers,phase1,TERMINATED,Respivert Ltd,
NCT02517359,RV6153 28 day repeat dose,DRUG,Asthma; Healthy Volunteers,phase1,TERMINATED,Respivert Ltd,
NCT02517359,RV6153 matching placebo 28 day repeat dose,DRUG,Asthma; Healthy Volunteers,phase1,TERMINATED,Respivert Ltd,
NCT00211380,aripiprazole,DRUG,Schizophrenia; Schizoaffective Disorder,na,TERMINATED,Louisiana State University Health Sciences Center Shreveport,
NCT01847196,Angel® Catheter,DEVICE,Pulmonary Embolism; Deep Vein Thrombosis; Venous Thromboembolism,na,TERMINATED,BiO2 Medical,
NCT01315496,Immunoglobulin G,DRUG,Severe Sepsis; Septic Shock,phase3,TERMINATED,Green Cross Corporation,
NCT03698162,Dynamic Contrast-Enhanced Magnetic Resonance Imaging,OTHER,Brain Metastases; Glioma of Brain; Brain Tumor; Metastatic Melanoma,na,TERMINATED,University of Southern California,
NCT03698162,Bevacizumab Injection,OTHER,Brain Metastases; Glioma of Brain; Brain Tumor; Metastatic Melanoma,na,TERMINATED,University of Southern California,
NCT02436642,AVERT Plus System,DEVICE,Coronary Artery Disease,na,TERMINATED,"Osprey Medical, Inc",
NCT00655070,Timi3 Transthoracic ultrasound,DEVICE,Myocardial Ischemia,early_phase1,TERMINATED,"University of California, San Francisco",
NCT02813369,naloxegol,DRUG,Opioid Induced Constipation,na,TERMINATED,Kyowa Kirin Pharmaceutical Development Ltd,
NCT02813369,non-PAMORA laxative,DRUG,Opioid Induced Constipation,na,TERMINATED,Kyowa Kirin Pharmaceutical Development Ltd,
NCT06610279,TAK-951,DRUG,Healthy Volunteers,phase1,TERMINATED,Takeda,
NCT06610279,Placebo,DRUG,Healthy Volunteers,phase1,TERMINATED,Takeda,
NCT01434862,Closed loop with pramlintide,DRUG,Type 1 Diabetes Mellitus,na,TERMINATED,University of Virginia,
NCT01434862,Closed loop without pramlintide,DEVICE,Type 1 Diabetes Mellitus,na,TERMINATED,University of Virginia,
NCT01434862,Open loop with pramlintide,DRUG,Type 1 Diabetes Mellitus,na,TERMINATED,University of Virginia,
NCT04188288,Experimental feedback,DEVICE,Opioid-Related Disorders,na,TERMINATED,Yale University,
NCT04188288,Control feedback,DEVICE,Opioid-Related Disorders,na,TERMINATED,Yale University,
NCT04188288,fMRI,DEVICE,Opioid-Related Disorders,na,TERMINATED,Yale University,
NCT04142788,Patiromer,DRUG,Heart Failure，Congestive,phase4,TERMINATED,NHS Greater Glasgow and Clyde,
NCT02630186,Rociletinib,DRUG,Non-small Cell Lung Cancer,phase1; phase2,TERMINATED,"Clovis Oncology, Inc.",
NCT02630186,MPDL3280A,DRUG,Non-small Cell Lung Cancer,phase1; phase2,TERMINATED,"Clovis Oncology, Inc.",
NCT01137773,Insulin,DRUG,"Acute, Non-traumatic Subarachnoid Hemorrhage; Intraparenchymal Hemorrhage; Brain Injuries",phase4,TERMINATED,University of Louisville,
NCT01137773,Conventional insulin treatment,DRUG,"Acute, Non-traumatic Subarachnoid Hemorrhage; Intraparenchymal Hemorrhage; Brain Injuries",phase4,TERMINATED,University of Louisville,
NCT05292196,TQC3721 suspension for inhalation,DRUG,Chronic Obstructive Pulmonary Disease (COPD),phase2,TERMINATED,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",
NCT05292196,TQC3721 suspension placebo for inhalation,DRUG,Chronic Obstructive Pulmonary Disease (COPD),phase2,TERMINATED,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",
NCT02710279,Trier Social Stress Test (TSST),BEHAVIORAL,Unipolar Depression,na,TERMINATED,"University Hospital, Montpellier",
NCT02710279,smartphone,DEVICE,Unipolar Depression,na,TERMINATED,"University Hospital, Montpellier",
NCT04051996,Glasdegib,DRUG,ACUTE MYELOID LEUKEMIA,phase2,TERMINATED,Yale University,
NCT04051996,Decitabine,DRUG,ACUTE MYELOID LEUKEMIA,phase2,TERMINATED,Yale University,
NCT05288062,Bone Marrow Biopsy,PROCEDURE,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma,phase2,TERMINATED,Mayo Clinic,
NCT05288062,Dexamethasone,DRUG,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma,phase2,TERMINATED,Mayo Clinic,
NCT05288062,Lenalidomide,DRUG,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma,phase2,TERMINATED,Mayo Clinic,
NCT05288062,Pomalidomide,DRUG,Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma,phase2,TERMINATED,Mayo Clinic,
NCT02440646,Coronary computed tomography angiography,RADIATION,Coronary Atherosclerosis; Coronary Artery Disease; Contrast-induced Nephropathy; Cerebrovascular Disease; Alzheimer Disease; Chronic Coronary Insufficiency; Stable Chronic Angina,na,TERMINATED,Central Clinical Hospital of the Russian Academy of Sciences,
NCT02440646,"Quantitative coronary angiography, intravascular imaging with percutaneous intervention",RADIATION,Coronary Atherosclerosis; Coronary Artery Disease; Contrast-induced Nephropathy; Cerebrovascular Disease; Alzheimer Disease; Chronic Coronary Insufficiency; Stable Chronic Angina,na,TERMINATED,Central Clinical Hospital of the Russian Academy of Sciences,
NCT02545127,Merotocin,DRUG,Preterm Delivery; Inadequate Milk Production,phase2,TERMINATED,Ferring Pharmaceuticals,
NCT02545127,Placebo,DRUG,Preterm Delivery; Inadequate Milk Production,phase2,TERMINATED,Ferring Pharmaceuticals,
NCT00461773,Letrozole,DRUG,Hormone-Sensitive Breast Cancer; Breast Cancer,phase2,TERMINATED,Yale University,
NCT00461773,Bevacizumab,DRUG,Hormone-Sensitive Breast Cancer; Breast Cancer,phase2,TERMINATED,Yale University,
NCT04493320,Carbidopa/levodopa,DRUG,Depression; Cognitive Impairment; Gait Impairment,phase4,TERMINATED,New York State Psychiatric Institute,
NCT04493320,Placebo,DRUG,Depression; Cognitive Impairment; Gait Impairment,phase4,TERMINATED,New York State Psychiatric Institute,
NCT04433182,Copanlisib,DRUG,Diffuse Large B-cell Lymphoma,phase2,TERMINATED,Fondazione Italiana Linfomi - ETS,
NCT05751382,Surefil one,DEVICE,Tooth Restoration,na,TERMINATED,Dentsply Sirona Implants and Consumables,
NCT05751382,Venus Pearl,DEVICE,Tooth Restoration,na,TERMINATED,Dentsply Sirona Implants and Consumables,
NCT01045382,Mesenchymal stem cells,BIOLOGICAL,"Leukemia, Myeloid, Acute; Leukemia, Lymphoblastic, Acute; Leukemia, Myelocytic, Chronic; Myeloproliferative Disorders; Myelodysplastic Syndromes; Multiple Myeloma; Leukemia, Lymphocytic, Chronic; Hodg",phase2,TERMINATED,University of Liege,
NCT01045382,Isotonic solution,OTHER,"Leukemia, Myeloid, Acute; Leukemia, Lymphoblastic, Acute; Leukemia, Myelocytic, Chronic; Myeloproliferative Disorders; Myelodysplastic Syndromes; Multiple Myeloma; Leukemia, Lymphocytic, Chronic; Hodg",phase2,TERMINATED,University of Liege,
NCT02050724,Radioactive labelling of pulmonary nodules,DRUG,Solitary Pulmonary Nodule; Bronchial Neoplasms,phase2,TERMINATED,Cantonal Hospital of St. Gallen,
NCT02050724,CT guided radioactive labelling,DEVICE,Solitary Pulmonary Nodule; Bronchial Neoplasms,phase2,TERMINATED,Cantonal Hospital of St. Gallen,
NCT02050724,Electromagnetic guided bronchoscopic radioactive labelling,DEVICE,Solitary Pulmonary Nodule; Bronchial Neoplasms,phase2,TERMINATED,Cantonal Hospital of St. Gallen,
NCT00970424,Placebo,DRUG,"Diabetes Mellitus, Type II",phase3,TERMINATED,Forest Laboratories,
NCT00970424,Dutogliptin,DRUG,"Diabetes Mellitus, Type II",phase3,TERMINATED,Forest Laboratories,
NCT05549323,PF-07054894,DRUG,Ulcerative Colitis,phase1,TERMINATED,Pfizer,
NCT05549323,Placebo,DRUG,Ulcerative Colitis,phase1,TERMINATED,Pfizer,
NCT01059123,Amoxicillin,DRUG,Erysipelas,phase4,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01059123,Amoxicillin,DRUG,Erysipelas,phase4,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT03081923,Durvalumab,DRUG,Germ Cell Tumor,phase2,TERMINATED,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano",
NCT03081923,Tremelimumab,DRUG,Germ Cell Tumor,phase2,TERMINATED,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano",
NCT05361967,The Tack Endovascular System,DEVICE,PAD - Peripheral Arterial Disease; PAD; Dissection; Arterial Dissection; Peripheral Arterial Disease; Peripheral Vascular Diseases,na,TERMINATED,Spectranetics Corporation,
NCT04367467,Kidney Function Test,OTHER,Solid Tumor; Ovarian Cancer; Breast Cancer,na,TERMINATED,University of Pennsylvania,
NCT00126607,trastuzumab,BIOLOGICAL,High-grade Salivary Gland Mucoepidermoid Carcinoma; Recurrent Salivary Gland Cancer; Salivary Gland Acinic Cell Tumor; Salivary Gland Adenocarcinoma; Salivary Gland Poorly Differentiated Carcinoma; St,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00126607,laboratory biomarker analysis,OTHER,High-grade Salivary Gland Mucoepidermoid Carcinoma; Recurrent Salivary Gland Cancer; Salivary Gland Acinic Cell Tumor; Salivary Gland Adenocarcinoma; Salivary Gland Poorly Differentiated Carcinoma; St,phase2,TERMINATED,National Cancer Institute (NCI),
NCT04544800,Use of Splint for UADT Visualization,DEVICE,Splints,na,TERMINATED,"University Health Network, Toronto",
NCT02362100,Non operative,OTHER,Proximal Humerus Fracture,na,TERMINATED,Ottawa Hospital Research Institute,
NCT02362100,locking plate surgical fixation,PROCEDURE,Proximal Humerus Fracture,na,TERMINATED,Ottawa Hospital Research Institute,
NCT02647892,lidocaine,DRUG,Local Anesthesia,phase4,TERMINATED,University of Nebraska,
NCT02647892,sodium bicarbonate,DRUG,Local Anesthesia,phase4,TERMINATED,University of Nebraska,
NCT00245544,MK0759,DRUG,"Neuralgia, Postherpetic",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT02439944,Nicotine patch,DRUG,Tobacco Use Disorder; Nicotine Dependence,phase2; phase3,TERMINATED,Centre for Addiction and Mental Health,
NCT02439944,Nicotine mouthspray,DRUG,Tobacco Use Disorder; Nicotine Dependence,phase2; phase3,TERMINATED,Centre for Addiction and Mental Health,
NCT02461134,Ponesimod,DRUG,Chronic Graft Versus Host Disease,phase2,TERMINATED,Actelion,
NCT01973764,Ultrasound guided ventricular drain insertion,PROCEDURE,Hydrocephalus; Intracranial Hypertension,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT01973764,landmark-based ventricular drain insertion,PROCEDURE,Hydrocephalus; Intracranial Hypertension,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT02438514,Biological Sample Collection,OTHER,Psychological Stress,na,TERMINATED,Yale University,
NCT03312387,Exercise,OTHER,"Heart Failure, Diastolic",na,TERMINATED,Arizona State University,
NCT03312387,Essential Amino Acids,OTHER,"Heart Failure, Diastolic",na,TERMINATED,Arizona State University,
NCT03312387,Placebo,OTHER,"Heart Failure, Diastolic",na,TERMINATED,Arizona State University,
NCT01854307,Pneumoperitoneum and SVV/PPV,PROCEDURE,Pneumoperitoneum,na,TERMINATED,Haukeland University Hospital,
NCT02932111,osteopathic session,PROCEDURE,Irritable Bowel Syndrome,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02932111,Placebo manipulative session,PROCEDURE,Irritable Bowel Syndrome,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02081911,High Volume Adductor Canal Block,PROCEDURE,Osteoarthritis (Knee),na,TERMINATED,"Hospital for Special Surgery, New York",
NCT02081911,Low Volume Adductor Canal Block,PROCEDURE,Osteoarthritis (Knee),na,TERMINATED,"Hospital for Special Surgery, New York",
NCT02081911,Femoral Nerve Block,PROCEDURE,Osteoarthritis (Knee),na,TERMINATED,"Hospital for Special Surgery, New York",
NCT01054911,Sunitinib,DRUG,Tumor,na,TERMINATED,University of Alabama at Birmingham,
NCT01054911,Surgery,PROCEDURE,Tumor,na,TERMINATED,University of Alabama at Birmingham,
NCT05638334,89Zr-S095012 tracer and S095012 will be administered via an IV infusion,DRUG,Advanced Solid Tumor,phase1,TERMINATED,Institut de Recherches Internationales Servier,
NCT04025632,zilucoplan,DRUG,Immune Mediated Necrotizing Myopathy,phase2,TERMINATED,Ra Pharmaceuticals,
NCT04025632,Placebo,OTHER,Immune Mediated Necrotizing Myopathy,phase2,TERMINATED,Ra Pharmaceuticals,
NCT02561832,Olaparib,DRUG,Breast Cancer,phase1,TERMINATED,AstraZeneca,
NCT02561832,Carboplatin,DRUG,Breast Cancer,phase1,TERMINATED,AstraZeneca,
NCT02561832,Anthracycline,DRUG,Breast Cancer,phase1,TERMINATED,AstraZeneca,
NCT02561832,Cyclophosphamide,DRUG,Breast Cancer,phase1,TERMINATED,AstraZeneca,
NCT01291498,High Intensity Focused Ultrasound,DEVICE,Parathyroid Adenomas,na,TERMINATED,Oxford University Hospitals NHS Trust,
NCT05695898,XmAb22841,DRUG,Metastatic Melanoma; Advanced Melanoma,phase1,TERMINATED,"University of California, San Francisco",
NCT05695898,XmAb23104,DRUG,Metastatic Melanoma; Advanced Melanoma,phase1,TERMINATED,"University of California, San Francisco",
NCT01093963,Lisdexamfetamine,DRUG,Bipolar Depression,phase3,TERMINATED,Lindner Center of HOPE,
NCT01093963,Placebo,DRUG,Bipolar Depression,phase3,TERMINATED,Lindner Center of HOPE,
NCT04154787,LNP023,DRUG,Idiopathic Membranous Nephropathy,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04154787,Rituximab,DRUG,Idiopathic Membranous Nephropathy,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT00931021,Varenicline (Chantix),DRUG,Smoking Cessation,early_phase1,TERMINATED,Yale University,
NCT00931021,Nicotine Patch,DRUG,Smoking Cessation,early_phase1,TERMINATED,Yale University,
NCT03153514,Obinutuzumab,BIOLOGICAL,Chronic Lymphocytic Leukemia; Richter's Transformation,phase2,TERMINATED,German CLL Study Group,
NCT00933114,MRI and PET imaging,PROCEDURE,Head and Neck Cancer,na,TERMINATED,Duke University,
NCT04361214,Leflunomide,DRUG,COVID-19,phase1,TERMINATED,University of Chicago,
NCT01099592,Citalopram,DRUG,Acute Coronary Syndrome; Major Depressive Episode,phase4,TERMINATED,Centre hospitalier de l'Université de Montréal (CHUM),
NCT02213536,VMAT (Volumetric Modulated Arc Therapy),RADIATION,Metastatic Brain Cancer,na,TERMINATED,HCA International Limited,
NCT02104336,EPI-743,DRUG,Pearson Syndrome,phase2,TERMINATED,Edison Pharmaceuticals Inc,
NCT01316536,provide headphones with music playing,OTHER,Music Therapy for Pain and Sedation,na,TERMINATED,"University of California, San Francisco",
NCT01316536,Sounds,OTHER,Music Therapy for Pain and Sedation,na,TERMINATED,"University of California, San Francisco",
NCT01521936,cholecalciferol,OTHER,Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblast,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01521936,pharmacological study,OTHER,Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblast,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01521936,cholecalciferol,OTHER,Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblast,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT01521936,laboratory biomarker analysis,OTHER,Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblast,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT03701711,Lenalidomide,DRUG,Demyelinating Sensorimotor Neuropathy,phase1,TERMINATED,Ohio State University,
NCT06353971,Briquilimab,DRUG,Chronic Inducible Urticaria,phase1; phase2,TERMINATED,"Jasper Therapeutics, Inc.",
NCT03275571,cCBT intervention,BEHAVIORAL,HIV Infections; Depression; CBT,na,TERMINATED,McGill University,
NCT00208364,Pinnacle Acetabular Cup System,DEVICE,Rheumatoid Arthritis; Osteoarthritis; Post-traumatic Arthritis; Collagen Disorders; Avascular Necrosis; Traumatic Femoral Fractures; Nonunion of Femoral Fractures; Congenital Hip Dysplasia; Slipped Ca,phase4,TERMINATED,DePuy International,
NCT04270864,Ipilimumab,DRUG,Advanced Cancer,phase1,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT04270864,Nivolumab,DRUG,Advanced Cancer,phase1,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT04270864,Tilsotolimod,DRUG,Advanced Cancer,phase1,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT03607864,coral bone graft and xenograft,DEVICE,Badly Decayed Anterior Maxillary Teeth,na,TERMINATED,Cairo University,
NCT03611764,Body Scan,BEHAVIORAL,Hematological Malignancy,phase1,TERMINATED,Washington University School of Medicine,
NCT03611764,Rotterdam Symptom Checklist,OTHER,Hematological Malignancy,phase1,TERMINATED,Washington University School of Medicine,
NCT03611764,Practice Logs,OTHER,Hematological Malignancy,phase1,TERMINATED,Washington University School of Medicine,
NCT01159964,"Immunotherapeutic GSK2302032A, different formulations",BIOLOGICAL,"Lung Cancer, Non-Small Cell",phase1,TERMINATED,GlaxoSmithKline,
NCT03871309,Tigertriever,DEVICE,Ischemic Stroke,na,TERMINATED,Rapid Medical,
NCT04336163,Optical Coherence Tomography,DEVICE,Port-Wine Stain; Rosacea; Telangiectasia; Angioma,na,TERMINATED,"University of California, Irvine",
NCT00005987,carmustine,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,cyclophosphamide,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,dexamethasone,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,etoposide,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,filgrastim,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,mitoxantrone hydrochloride,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,recombinant interferon alfa,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,sargramostim,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,bone marrow ablation with stem cell support,PROCEDURE,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,peripheral blood stem cell transplantation,PROCEDURE,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00005987,radiation therapy,PROCEDURE,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT03177187,AZD5069,DRUG,Metastatic Castration Resistant Prostate Cancer,phase1; phase2,TERMINATED,"Institute of Cancer Research, United Kingdom",
NCT03177187,Enzalutamide 40 MG,DRUG,Metastatic Castration Resistant Prostate Cancer,phase1; phase2,TERMINATED,"Institute of Cancer Research, United Kingdom",
NCT01071993,placebo,DRUG,Nephropathy,na,TERMINATED,University of Oklahoma,
NCT01071993,atorvastatin,DRUG,Nephropathy,na,TERMINATED,University of Oklahoma,
NCT04158921,Control:Diabetes mobile app,OTHER,"Insulin Treated Type 2 Diabetes Mellitus; Diabetes Mellitus, Type 1",na,TERMINATED,Brigham and Women's Hospital,
NCT05748184,ULDCT PACS prototype,DEVICE,Ultra-low-dose CT; Thoracic,na,TERMINATED,Philips Electronics Nederland B.V. acting through Philips CTO organization,
NCT05748184,PACS viewer prototype,DEVICE,Ultra-low-dose CT; Thoracic,na,TERMINATED,Philips Electronics Nederland B.V. acting through Philips CTO organization,
NCT05748184,Optimized ULDCT viewer prototype version(s),DEVICE,Ultra-low-dose CT; Thoracic,na,TERMINATED,Philips Electronics Nederland B.V. acting through Philips CTO organization,
NCT00023907,paclitaxel,DRUG,Ovarian Cancer; Primary Peritoneal Cavity Cancer,phase2,TERMINATED,Gynecologic Oncology Group,
NCT00566007,Discectomy/ micro discectomy,PROCEDURE,Lumbar Herniated Disc,phase2,TERMINATED,Kovacs Foundation,
NCT00566007,Ozone therapy,DRUG,Lumbar Herniated Disc,phase2,TERMINATED,Kovacs Foundation,
NCT00566007,Oxygen therapy,DRUG,Lumbar Herniated Disc,phase2,TERMINATED,Kovacs Foundation,
NCT01224964,Montelukast,DRUG,Asthmatic Patients,na,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT01224964,long acting beta2 mimetic,DRUG,Asthmatic Patients,na,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT00077064,captopril,DRUG,Lung Cancer; Pulmonary Complications; Radiation Fibrosis,phase2,TERMINATED,Radiation Therapy Oncology Group,
NCT01170364,Sibutramine,DRUG,Obesity,phase4,TERMINATED,New York State Psychiatric Institute,
NCT01170364,Placebo,DRUG,Obesity,phase4,TERMINATED,New York State Psychiatric Institute,
NCT00019864,filgrastim,BIOLOGICAL,Cardiac Toxicity; Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00019864,cisplatin,DRUG,Cardiac Toxicity; Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00019864,dexrazoxane hydrochloride,DRUG,Cardiac Toxicity; Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00019864,doxorubicin hydrochloride,DRUG,Cardiac Toxicity; Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00019864,leucovorin calcium,DRUG,Cardiac Toxicity; Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00019864,methotrexate,DRUG,Cardiac Toxicity; Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00019864,adjuvant therapy,PROCEDURE,Cardiac Toxicity; Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00019864,conventional surgery,PROCEDURE,Cardiac Toxicity; Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00019864,neoadjuvant therapy,PROCEDURE,Cardiac Toxicity; Sarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT06116799,Orthotic,DEVICE,Plantar Fasciitis,na,TERMINATED,Massachusetts General Hospital,
NCT04115098,Celecoxib,DRUG,Axial Spondyloarthritis,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT04115098,Naproxen,DRUG,Axial Spondyloarthritis,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT04115098,Meloxicam,DRUG,Axial Spondyloarthritis,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT00003567,filgrastim,BIOLOGICAL,"Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Case Comprehensive Cancer Center,
NCT00003567,sargramostim,BIOLOGICAL,"Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Case Comprehensive Cancer Center,
NCT00003567,therapeutic autologous lymphocytes,BIOLOGICAL,"Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Case Comprehensive Cancer Center,
NCT00003567,O6-benzylguanine,DRUG,"Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Case Comprehensive Cancer Center,
NCT00003567,carmustine,DRUG,"Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Case Comprehensive Cancer Center,
NCT00003567,temozolomide,DRUG,"Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Case Comprehensive Cancer Center,
NCT00003567,in vitro-treated peripheral blood stem cell transplantation,PROCEDURE,"Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,Case Comprehensive Cancer Center,
NCT03013192,Text message reminder,OTHER,Rotator Cuff Tendinopathy,na,TERMINATED,St. Louis University,
NCT02244164,Incretinomimetics,DRUG,Type 2 Diabetes; Incretinomimetics; Pancreas,na,TERMINATED,Erasme University Hospital,
NCT02244164,DPP-4 inhibitors,DRUG,Type 2 Diabetes; Incretinomimetics; Pancreas,na,TERMINATED,Erasme University Hospital,
NCT06535009,ONO-7914,DRUG,Solid Tumor,phase1,TERMINATED,Ono Pharmaceutical Co. Ltd,
NCT06535009,ONO-4538,DRUG,Solid Tumor,phase1,TERMINATED,Ono Pharmaceutical Co. Ltd,
NCT00745732,ZD6474 (ZACTIMA),DRUG,Non-Small Cell Lung Cancer,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT00745732,Radiation Therapy,RADIATION,Non-Small Cell Lung Cancer,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02431663,Ketamine,DRUG,Status Epilepticus,phase3,TERMINATED,Meyer Children's Hospital IRCCS,
NCT03684187,Mindfulness Based Intervention,BEHAVIORAL,Primary Biliary Cholangitis,na,TERMINATED,Yale University,
NCT04088487,New in Town-Interner Intervention for Migrants,BEHAVIORAL,Self Efficacy; Loneliness; Social Skills,na,TERMINATED,"University of Social Sciences and Humanities, Warsaw",
NCT05492500,Main cohort (Cohort A): Ponsegromab low dose,DRUG,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,Main cohort (Cohort A): Ponsegromab medium dose,DRUG,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,Main cohort (Cohort A): ponsegromab high dose,DRUG,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,Main cohort (Cohort A): Matched placebo,OTHER,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,"Open-label, PK Cohort (Cohort B): ponsegromab low dose",DRUG,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,"Open-label, PK Cohort (Cohort B): ponsegromab medium dose",DRUG,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,"Open-label, PK Cohort (Cohort B): ponsegromab high dose",DRUG,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,Optional Cohort C: Ponsegromab low dose,DRUG,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,Optional Cohort C: Matched placebo,OTHER,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,Optional Cohort D: Ponsegromab high dose,DRUG,Heart Failure,phase2,TERMINATED,Pfizer,
NCT05492500,Optional Cohort D: Matched placebo,OTHER,Heart Failure,phase2,TERMINATED,Pfizer,
NCT07199400,physical activity program,BEHAVIORAL,Mildly Frail; Fragile and More Vulnerable,na,TERMINATED,National Taiwan Normal University,
NCT00729807,pentamidine,DRUG,Melanoma (Skin),phase2,TERMINATED,"University of Maryland, Baltimore",
NCT03562767,Group-based Cognitive Behavioral Intervention,BEHAVIORAL,"Diabetes Mellitus, Type 2",na,TERMINATED,Emory University,
NCT03562767,Web-based Cognitive Behavioral Intervention,BEHAVIORAL,"Diabetes Mellitus, Type 2",na,TERMINATED,Emory University,
NCT03562767,Usual Care,BEHAVIORAL,"Diabetes Mellitus, Type 2",na,TERMINATED,Emory University,
NCT01053507,sumatriptan/naproxen sodium,DRUG,Post-Traumatic Headache,phase4,TERMINATED,"Cady, Roger, M.D.",
NCT01053507,Placebo,DRUG,Post-Traumatic Headache,phase4,TERMINATED,"Cady, Roger, M.D.",
NCT01351792,Foster® 100/6 µg/unit dose,DRUG,Chronic Obstructive Pulmonary Disease,phase3,TERMINATED,Chiesi Farmaceutici S.p.A.,
NCT01351792,Symbicort® Turbohaler® 200/6 μg/actuation,DRUG,Chronic Obstructive Pulmonary Disease,phase3,TERMINATED,Chiesi Farmaceutici S.p.A.,
NCT04721171,The Bridge device,DEVICE,Cyclic Vomiting Syndrome,na,TERMINATED,Medical College of Wisconsin,
NCT03930771,Capecitabine,DRUG,Recurrent Pituitary Adenomas,phase2,TERMINATED,Weill Medical College of Cornell University,
NCT03930771,Temozolomide,DRUG,Recurrent Pituitary Adenomas,phase2,TERMINATED,Weill Medical College of Cornell University,
NCT03219164,AZLI,DRUG,Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization; Cystic Fibrosis,phase3,TERMINATED,Gilead Sciences,
NCT03219164,Placebo,DRUG,Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization; Cystic Fibrosis,phase3,TERMINATED,Gilead Sciences,
NCT06472609,enhanced interactive education,BEHAVIORAL,Diabetes Mellitus; Latent Tuberculosis Infection; Continuous Glucose Monitoring; Quality of Life,na,TERMINATED,Taipei Medical University WanFang Hospital,
NCT00727532,Sorafenib,DRUG,Hereditary Clear Cell Renal Cell Carcinoma; Kidney Cancer,na,TERMINATED,Northwestern University,
NCT02052921,Rectal resection,PROCEDURE,Rectal Cancer,na,TERMINATED,Instituto do Cancer do Estado de São Paulo,
NCT02052921,Observation,OTHER,Rectal Cancer,na,TERMINATED,Instituto do Cancer do Estado de São Paulo,
NCT01335867,Vigabatrin,DRUG,Alcoholism; Cocaine Dependence,phase2,TERMINATED,University of Pennsylvania,
NCT01335867,Placebo,DRUG,Alcoholism; Cocaine Dependence,phase2,TERMINATED,University of Pennsylvania,
NCT02323100,Ravicti low dose,DRUG,Cystic Fibrosis,phase1; phase2,TERMINATED,National Jewish Health,
NCT02323100,Ravicti high dose,DRUG,Cystic Fibrosis,phase1; phase2,TERMINATED,National Jewish Health,
NCT02323100,Placebo,DRUG,Cystic Fibrosis,phase1; phase2,TERMINATED,National Jewish Health,
NCT03267836,Avelumab,DRUG,"Meningioma; Meningioma, Adult",phase1,TERMINATED,Washington University School of Medicine,
NCT03267836,Proton Therapy,RADIATION,"Meningioma; Meningioma, Adult",phase1,TERMINATED,Washington University School of Medicine,
NCT03267836,Surgery,PROCEDURE,"Meningioma; Meningioma, Adult",phase1,TERMINATED,Washington University School of Medicine,
NCT03877692,Experimental dosing of labetalol,DRUG,Preeclampsia With Severe Features; Chronic Hypertension in Obstetric Context,phase4,TERMINATED,Albany Medical College,
NCT03877692,Standard dosing of labetalol,OTHER,Preeclampsia With Severe Features; Chronic Hypertension in Obstetric Context,phase4,TERMINATED,Albany Medical College,
NCT00664209,"clartihromycin, amoxicillin, and omeprazole",DRUG,Parkinson's Disease; Helicobacter Infections; Motor Fluctuations,phase3,TERMINATED,"University of California, Los Angeles",
NCT00664209,placebo,DRUG,Parkinson's Disease; Helicobacter Infections; Motor Fluctuations,phase3,TERMINATED,"University of California, Los Angeles",
NCT00515099,Antithymocyte globulin,DRUG,New-onset Type 1 Diabetes Mellitus,phase2,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00515099,Placebo,DRUG,New-onset Type 1 Diabetes Mellitus,phase2,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01248299,FU-CDDP,DRUG,Squamous Cell Carcinoma of Esophagus,phase2,TERMINATED,Centre Oscar Lambret,
NCT01248299,LV5FU2-CDDP,DRUG,Squamous Cell Carcinoma of Esophagus,phase2,TERMINATED,Centre Oscar Lambret,
NCT01248299,FOLFOX,DRUG,Squamous Cell Carcinoma of Esophagus,phase2,TERMINATED,Centre Oscar Lambret,
NCT01248299,TPF,DRUG,Squamous Cell Carcinoma of Esophagus,phase2,TERMINATED,Centre Oscar Lambret,
NCT01248299,Best Supportive Care,OTHER,Squamous Cell Carcinoma of Esophagus,phase2,TERMINATED,Centre Oscar Lambret,
NCT00912899,Noscapine HCl,DRUG,Refractory Multiple Myeloma,phase1,TERMINATED,"Cougar Biotechnology, Inc.",
NCT04733898,SamenSpelen.app,OTHER,Loneliness,na,TERMINATED,Radboud University Medical Center,
NCT04733898,FijnSpelen.app,OTHER,Loneliness,na,TERMINATED,Radboud University Medical Center,
NCT00402298,Full Dose Midomafetamine HCl,DRUG,Posttraumatic Stress Disorder,phase2,TERMINATED,Lykos Therapeutics,
NCT00402298,Low Dose Midomafetamine HCl,DRUG,Posttraumatic Stress Disorder,phase2,TERMINATED,Lykos Therapeutics,
NCT05012787,CpG 1018/Alum-adjuvanted SCB-2019 vaccine,BIOLOGICAL,COVID-19,phase3,TERMINATED,Clover Biopharmaceuticals AUS Pty,
NCT05012787,Havrix,BIOLOGICAL,COVID-19,phase3,TERMINATED,Clover Biopharmaceuticals AUS Pty,
NCT05012787,Placebo; 0.9% saline,OTHER,COVID-19,phase3,TERMINATED,Clover Biopharmaceuticals AUS Pty,
NCT06140407,Cisplatin,DRUG,Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer,phase2,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT06140407,Carboplatin,DRUG,Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer,phase2,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT06140407,Etoposide,DRUG,Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer,phase2,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT06140407,Pembrolizumab,BIOLOGICAL,Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer,phase2,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT06140407,Computed Tomography,PROCEDURE,Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer,phase2,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT06140407,Positron Emission Tomography,PROCEDURE,Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer,phase2,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT06140407,Magnetic Resonance Imaging,PROCEDURE,Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer,phase2,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT06140407,Biospecimen Collection,PROCEDURE,Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer,phase2,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT06140407,Radiation Therapy,RADIATION,Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer,phase2,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT05814536,AB-218 capsule,DRUG,Cholangiocarcinoma With IDH1 Mutation; Solid Tumors With IDH1 Mutation,phase1,TERMINATED,AnHeart Therapeutics Inc.,
NCT02386111,Combination of varlilumab and sunitinib,DRUG,"Carcinoma, Renal Cell; Kidney Diseases; Kidney Neoplasms; Urogenital Neoplasms; Urologic Diseases; Urologic Neoplasms; Neoplasms; Neoplasms by Histologic Type; Clear-cell Metastatic Renal Cell Carcino",phase1,TERMINATED,Celldex Therapeutics,
NCT02953444,Thirty-Second Mindfulness Practice,OTHER,Depression; Anxiety; Mental Disorders,na,TERMINATED,Duke University,
NCT02953444,Three-Minute Mindfulness Practice,OTHER,Depression; Anxiety; Mental Disorders,na,TERMINATED,Duke University,
NCT01820364,LGX818,DRUG,Melanoma,phase2,TERMINATED,Array BioPharma,
NCT01636609,Azacitidine,DRUG,Acute Myeloid Leukemia; High Risk Myelodysplastic Syndrome,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT01636609,Cytarabine,DRUG,Acute Myeloid Leukemia; High Risk Myelodysplastic Syndrome,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT01636609,Tosedostat,DRUG,Acute Myeloid Leukemia; High Risk Myelodysplastic Syndrome,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02179099,BTX mixed with TC-3 Gel,DEVICE,Overactive Bladder,phase1; phase2,TERMINATED,UroGen Pharma Ltd.,
NCT00293332,bevacizumab,BIOLOGICAL,Lung Cancer,phase2,TERMINATED,"University of California, San Francisco",
NCT00293332,carboplatin,DRUG,Lung Cancer,phase2,TERMINATED,"University of California, San Francisco",
NCT00293332,docetaxel,DRUG,Lung Cancer,phase2,TERMINATED,"University of California, San Francisco",
NCT00293332,conventional surgery,PROCEDURE,Lung Cancer,phase2,TERMINATED,"University of California, San Francisco",
NCT04641598,Endometrial Scratch,PROCEDURE,Fertility Disorders; Fertility Issues,na,TERMINATED,Carilion Clinic,
NCT04641598,Sham procedure,PROCEDURE,Fertility Disorders; Fertility Issues,na,TERMINATED,Carilion Clinic,
NCT01399398,Brain Scan-PET,PROCEDURE,Healthy,phase1,TERMINATED,National Institute of Mental Health (NIMH),
NCT01399398,Brain Scan-MRI,PROCEDURE,Healthy,phase1,TERMINATED,National Institute of Mental Health (NIMH),
NCT01399398,Arterial Line,PROCEDURE,Healthy,phase1,TERMINATED,National Institute of Mental Health (NIMH),
NCT01399398,Venous Line,PROCEDURE,Healthy,phase1,TERMINATED,National Institute of Mental Health (NIMH),
NCT01399398,Blood Sampling,PROCEDURE,Healthy,phase1,TERMINATED,National Institute of Mental Health (NIMH),
NCT02496598,In Vitro Follicle Activation (IVA),PROCEDURE,Primary Ovarian Insufficiency; Infertility,na,TERMINATED,National Foundation for Fertility Research,
NCT02496598,Follicle Activation,DRUG,Primary Ovarian Insufficiency; Infertility,na,TERMINATED,National Foundation for Fertility Research,
NCT03110263,Multicomponent internet-based self-help,OTHER,Insomnia,na,TERMINATED,University of Bern,
NCT03110263,Internet-based sleep restriction,OTHER,Insomnia,na,TERMINATED,University of Bern,
NCT02181387,Acetaminophen,DRUG,Pain,phase4,TERMINATED,Wake Forest University Health Sciences,
NCT02181387,Placebo,DRUG,Pain,phase4,TERMINATED,Wake Forest University Health Sciences,
NCT01579136,Home blood pressure monitor,BEHAVIORAL,Hypertension; Diabetes Mellitus,na,TERMINATED,Exempla Saint Joseph Hospital,
NCT03370536,CardioInsight ECGI Mapping System,DEVICE,Atrial Fibrillation; Persistent Atrial Fibrillation,na,TERMINATED,Vivek Reddy,
NCT03370536,AF ablation,PROCEDURE,Atrial Fibrillation; Persistent Atrial Fibrillation,na,TERMINATED,Vivek Reddy,
NCT03370536,Ibutilide,DRUG,Atrial Fibrillation; Persistent Atrial Fibrillation,na,TERMINATED,Vivek Reddy,
NCT04544267,"Quadrivalent influenza vaccine, high-dose",BIOLOGICAL,Influenza,phase3,TERMINATED,"Sanofi Pasteur, a Sanofi Company",
NCT04544267,"Quadrivalent influenza vaccine, standard dose",BIOLOGICAL,Influenza,phase3,TERMINATED,"Sanofi Pasteur, a Sanofi Company",
NCT04430036,AGEN1884,DRUG,Urinary Bladder Neoplasms,phase2,TERMINATED,The University of Texas Health Science Center at San Antonio,
NCT04430036,AGEN2034,DRUG,Urinary Bladder Neoplasms,phase2,TERMINATED,The University of Texas Health Science Center at San Antonio,
NCT04430036,Cisplatin,DRUG,Urinary Bladder Neoplasms,phase2,TERMINATED,The University of Texas Health Science Center at San Antonio,
NCT04430036,Gemcitabine,DRUG,Urinary Bladder Neoplasms,phase2,TERMINATED,The University of Texas Health Science Center at San Antonio,
NCT03206736,Loop DS surgery,OTHER,"Obesity, Morbid",na,TERMINATED,University of Nebraska,
NCT02246309,Embryoscope Time Lapse System,DEVICE,Infertility,na,TERMINATED,Center for Human Reproduction,
NCT02246309,Standard Embryo Culture,DEVICE,Infertility,na,TERMINATED,Center for Human Reproduction,
NCT05292898,LCAR-AIO Cells,BIOLOGICAL,Acute Lymphocytic Leukemia,phase1,TERMINATED,"Institute of Hematology & Blood Diseases Hospital, China",
NCT02145598,Lenalidomide,DRUG,Multiple Myeloma,phase2; phase3,TERMINATED,Dr. med. Lars-Olof Muegge,
NCT02145598,Placebo,DRUG,Multiple Myeloma,phase2; phase3,TERMINATED,Dr. med. Lars-Olof Muegge,
NCT00205998,"Locking Compression Plate 2,4mm",DEVICE,Distal Radius Fractures,phase4,TERMINATED,AO Clinical Investigation and Publishing Documentation,
NCT00205998,"Locking Compression Plate 3,5mm",DEVICE,Distal Radius Fractures,phase4,TERMINATED,AO Clinical Investigation and Publishing Documentation,
NCT04128319,T-Guard,DRUG,Steroid-Refractory Acute Graft Versus Host Disease,phase3,TERMINATED,Xenikos,
NCT00059228,17beta Estradiol,DRUG,Postpartum Depression; Depression,phase2,TERMINATED,National Institute of Mental Health (NIMH),
NCT00059228,Placebos,DRUG,Postpartum Depression; Depression,phase2,TERMINATED,National Institute of Mental Health (NIMH),
NCT03875365,POPE,PROCEDURE,Achalasia,na,TERMINATED,Mayo Clinic,
NCT02231567,Neurocognitive Rehabilitation,OTHER,Hip Osteoarthritis,na,TERMINATED,University of Roma La Sapienza,
NCT02231567,Traditional Rehabilitation,OTHER,Hip Osteoarthritis,na,TERMINATED,University of Roma La Sapienza,
NCT03486067,CC-93269,DRUG,Multiple Myeloma,phase1,TERMINATED,Celgene,
NCT00788619,Transfer of embryos on day 3 or day 5 after fertilization.,PROCEDURE,Infertility,na,TERMINATED,Johns Hopkins University,
NCT00788619,Day 5 transfer,PROCEDURE,Infertility,na,TERMINATED,Johns Hopkins University,
NCT02103465,Rotigotine,DRUG,Parkinson's Disease,phase2,TERMINATED,Azienda Ospedaliera Cardinale G. Panico,
NCT02103465,Placebo,DRUG,Parkinson's Disease,phase2,TERMINATED,Azienda Ospedaliera Cardinale G. Panico,
NCT01817257,Low Molecular Weight Heparin (LMWH),DRUG,Cancer; Thrombosis; Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolus,phase2,TERMINATED,Cardiff University,
NCT02550119,Aprepitant,DRUG,Malignant Digestive System Neoplasm; Nausea and Vomiting,na,TERMINATED,University of Southern California,
NCT02550119,Dexamethasone,DRUG,Malignant Digestive System Neoplasm; Nausea and Vomiting,na,TERMINATED,University of Southern California,
NCT02550119,Dolasetron Mesylate,DRUG,Malignant Digestive System Neoplasm; Nausea and Vomiting,na,TERMINATED,University of Southern California,
NCT02550119,Placebo,DRUG,Malignant Digestive System Neoplasm; Nausea and Vomiting,na,TERMINATED,University of Southern California,
NCT02169830,nortriptyline,DRUG,Migraine Disorders,na,TERMINATED,St. Louis University,
NCT02169830,Topiramate,DRUG,Migraine Disorders,na,TERMINATED,St. Louis University,
NCT02169830,Diet Modification,BEHAVIORAL,Migraine Disorders,na,TERMINATED,St. Louis University,
NCT02204319,Cold laser,DEVICE,Vulvar Vestibulitis; Vestibulodynia,na,TERMINATED,"ProHealth Care, Inc",
NCT02586519,SurroSense Rx System,DEVICE,Diabetes; Diabetes Complications; Neuropathy; Peripheral Neuropathy; Diabetic Foot Ulcer,na,TERMINATED,University of Calgary,
NCT05016830,Bilateral transcranial direct current stimulation,DEVICE,Amblyopia,na,TERMINATED,University of Chile,
NCT04755881,Occurence of biphasic reaction following anaphylaxis,OTHER,Anaphylaxis; Biphasic Anaphylactic Reaction; Rebound Anaphylactic Reaction,na,TERMINATED,Université de Sherbrooke,
NCT01096381,laboratory biomarker analysis,OTHER,"Breast Cancer; Cardiovascular Complications; Colorectal Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Ovarian Cancer; Peritoneal Cavity Cancer; Unspecified Adult Solid Tumor, Proto",na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT01096381,questionnaire administration,OTHER,"Breast Cancer; Cardiovascular Complications; Colorectal Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Ovarian Cancer; Peritoneal Cavity Cancer; Unspecified Adult Solid Tumor, Proto",na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT02704312,Radiotherapy by Prone and decubitus,RADIATION,Breast Cancer,na,TERMINATED,University Hospital Center of Martinique,
NCT02834481,ANI/NIPE,DEVICE,Pain,na,TERMINATED,"University Hospital, Toulouse",
NCT00892801,RAD001,DRUG,Lung Cancer; Metastatic Cancer,phase1,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT00892801,whole-brain radiation therapy,RADIATION,Lung Cancer; Metastatic Cancer,phase1,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT05615701,EOSedge imaging,OTHER,Hip Osteoarthritis; Hip Prosthesis Infection,na,TERMINATED,"University Hospital, Montpellier",
NCT04990219,Lu AG06466,DRUG,Multiple Sclerosis,phase1,TERMINATED,H. Lundbeck A/S,
NCT04990219,Placebo,DRUG,Multiple Sclerosis,phase1,TERMINATED,H. Lundbeck A/S,
NCT03537612,Clonidine,DRUG,Scoliosis,phase3,TERMINATED,"Dr. Jean A. Ouellet, MD, FRCSC",
NCT03537612,Morphine,OTHER,Scoliosis,phase3,TERMINATED,"Dr. Jean A. Ouellet, MD, FRCSC",
NCT00515281,inhaled nitric oxide,DRUG,Prematurity; Bronchopulmonary Dysplasia; Intraventricular Hemorrhage; Periventricular Leukomalacia,phase2; phase3,TERMINATED,University of Chicago,
NCT00515281,oxygen,DRUG,Prematurity; Bronchopulmonary Dysplasia; Intraventricular Hemorrhage; Periventricular Leukomalacia,phase2; phase3,TERMINATED,University of Chicago,
NCT03246919,Oxytocin,DRUG,"Blood Loss, Surgical; Postpartum Hemorrhage; Bleed Pregnancy; Pregnancy Related; Cesarean Section Complications",phase4,TERMINATED,Loyola University,
NCT03246919,Placebo,DRUG,"Blood Loss, Surgical; Postpartum Hemorrhage; Bleed Pregnancy; Pregnancy Related; Cesarean Section Complications",phase4,TERMINATED,Loyola University,
NCT00122512,Tenofovir Disoproxil Fumarate,DRUG,HIV Infections,phase2,TERMINATED,FHI 360,
NCT04701112,Temporary His bundle pacing,DEVICE,"Heart Failure, Systolic; Left Bundle Branch Block; Wide QRS Complex",na,TERMINATED,Region Skane,
NCT02966119,Clopidogrel or Aspirin and/or Dypyridamole,DRUG,Cerebral Hemorrhage,phase3,TERMINATED,"University Hospital, Lille",
NCT00771719,Ceftobiprole,DRUG,Ventilator Associated Pneumonia,phase1,TERMINATED,Basilea Pharmaceutica,
NCT01751412,Proton Radiation,RADIATION,Lymphoma,na,TERMINATED,Massachusetts General Hospital,
NCT00846781,Denufosol tetrasodium Inhalation Solution,DRUG,Cystic Fibrosis,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01461330,DASH diet plus exercise,OTHER,Blood Pressure,na,TERMINATED,Hospital de Clinicas de Porto Alegre,
NCT01461330,ADA diet,OTHER,Blood Pressure,na,TERMINATED,Hospital de Clinicas de Porto Alegre,
NCT01648101,Retigabine 900mg/day,DRUG,Epilepsy,phase3,TERMINATED,GlaxoSmithKline,
NCT01648101,Retigabine 600mg/day,DRUG,Epilepsy,phase3,TERMINATED,GlaxoSmithKline,
NCT01648101,Placebo,OTHER,Epilepsy,phase3,TERMINATED,GlaxoSmithKline,
NCT01446601,Hypoglossal Nerve Stimulation (HGNS) System (Apnex Medical ),DEVICE,Obstructive Sleep Apnea,phase3,TERMINATED,"Apnex Medical, Inc.",
NCT01299701,ASA404,DRUG,Advanced Solid Tumors,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT01232881,Tumor Sample,PROCEDURE,Breast Cancer,na,TERMINATED,Hoosier Cancer Research Network,
NCT01232881,Serum Sample,PROCEDURE,Breast Cancer,na,TERMINATED,Hoosier Cancer Research Network,
NCT04747730,Transcendental Meditation training,OTHER,Well-being,na,TERMINATED,Queen Mary University of London,
NCT01785030,50% Nitrous oxide,DRUG,Peripheral Vein Vasodilation,phase1,TERMINATED,Columbia University,
NCT00208975,"Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF",DRUG,Lymphoma,phase2,TERMINATED,Emory University,
NCT04822701,BI 767551 intravenous,DRUG,COVID-19,phase2; phase3,TERMINATED,Boehringer Ingelheim,
NCT04822701,BI 767551 inhaled,DRUG,COVID-19,phase2; phase3,TERMINATED,Boehringer Ingelheim,
NCT04822701,Placebo intravenous,DRUG,COVID-19,phase2; phase3,TERMINATED,Boehringer Ingelheim,
NCT04822701,Placebo inhaled,DRUG,COVID-19,phase2; phase3,TERMINATED,Boehringer Ingelheim,
NCT02953119,Prehabilitation,OTHER,Prehabilitation,na,TERMINATED,Nicolas DEMARTINES,
NCT02334319,Ganetespib,DRUG,Stage I Hypopharyngeal Squamous Cell Carcinoma; Stage I Laryngeal Squamous Cell Carcinoma; Stage I Oral Cavity Squamous Cell Carcinoma; Stage I Oropharyngeal Squamous Cell Carcinoma; Stage II Hypophar,phase1,TERMINATED,Emory University,
NCT02334319,Therapeutic Conventional Surgery,PROCEDURE,Stage I Hypopharyngeal Squamous Cell Carcinoma; Stage I Laryngeal Squamous Cell Carcinoma; Stage I Oral Cavity Squamous Cell Carcinoma; Stage I Oropharyngeal Squamous Cell Carcinoma; Stage II Hypophar,phase1,TERMINATED,Emory University,
NCT02334319,Laboratory Biomarker Analysis,OTHER,Stage I Hypopharyngeal Squamous Cell Carcinoma; Stage I Laryngeal Squamous Cell Carcinoma; Stage I Oral Cavity Squamous Cell Carcinoma; Stage I Oropharyngeal Squamous Cell Carcinoma; Stage II Hypophar,phase1,TERMINATED,Emory University,
NCT00840112,Vitamin E supplement,OTHER,Peripheral Neuropathy; Mitochondrial Trifunctional Protein Deficiency,na,TERMINATED,Oregon Health and Science University,
NCT00879619,sunitinib malate,DRUG,Prostate Cancer; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer,phase1; phase2,TERMINATED,John P. Fruehauf,
NCT00879619,docetaxel,DRUG,Prostate Cancer; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer,phase1; phase2,TERMINATED,John P. Fruehauf,
NCT00879619,prednisone,DRUG,Prostate Cancer; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer,phase1; phase2,TERMINATED,John P. Fruehauf,
NCT01341730,Atorvastatin 20mg,DRUG,Atherosclerosis; Coronary Artery Disease,phase4,TERMINATED,The Catholic University of Korea,
NCT01341730,Atorvastatin 20 mg + Pioglitazone 30 mg,DRUG,Atherosclerosis; Coronary Artery Disease,phase4,TERMINATED,The Catholic University of Korea,
NCT05460065,single E4 28.3 mg,DRUG,Safety; Pharmacokinetics,phase1,TERMINATED,NEURALIS s.a.,
NCT05460065,single E4 94.4 mg,DRUG,Safety; Pharmacokinetics,phase1,TERMINATED,NEURALIS s.a.,
NCT05460065,multiple E4 94.4 mg,DRUG,Safety; Pharmacokinetics,phase1,TERMINATED,NEURALIS s.a.,
NCT05460065,Placebo,DRUG,Safety; Pharmacokinetics,phase1,TERMINATED,NEURALIS s.a.,
NCT04182867,Dietary intervention,OTHER,Shift Work,na,TERMINATED,King's College London,
NCT01034592,Lenalidomide,DRUG,Anemia; Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS),phase1,TERMINATED,Jason Robert Gotlib,
NCT00016692,Z-100,DRUG,HIV Infections,phase1,TERMINATED,Zeria Pharmaceutical,
NCT02419664,Gallium-68 DOTATOC PET,DRUG,Pituitary Tumours,phase3,TERMINATED,Göteborg University,
NCT01550198,Advanced hemodynamic monitoring,DEVICE,Impact of Advanced Hemodynamic Monitoring,na,TERMINATED,Radboud University Medical Center,
NCT01144221,Intramyocardial Cell therapy,PROCEDURE,Heart Disease,na,TERMINATED,"Kai Jaquet, PhD, DSc",
NCT04684914,HepTcell,BIOLOGICAL,"Hepatitis B, Chronic",phase2,TERMINATED,"Altimmune, Inc.",
NCT04684914,Placebo,DRUG,"Hepatitis B, Chronic",phase2,TERMINATED,"Altimmune, Inc.",
NCT00438204,bevacizumab,BIOLOGICAL,Lung Cancer,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00438204,gemcitabine hydrochloride,DRUG,Lung Cancer,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00438204,pemetrexed disodium,DRUG,Lung Cancer,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT03772652,Observation,OTHER,Peri-Implantitis,na,TERMINATED,University of Michigan,
NCT02829047,Vibrating Capsule,DEVICE,Constipation,na,TERMINATED,Vibrant Ltd.,
NCT01534949,rituximab,BIOLOGICAL,Diffuse Large B-Cell Lymphoma,phase1,TERMINATED,Celltrion,
NCT01989858,peri-operative cht,OTHER,Gastric Adenocarcinoma,phase3,TERMINATED,Mario Negri Institute for Pharmacological Research,
NCT01989858,post-operative CHT,OTHER,Gastric Adenocarcinoma,phase3,TERMINATED,Mario Negri Institute for Pharmacological Research,
NCT01989858,peri-operative cht + post-operative cht-rtx,OTHER,Gastric Adenocarcinoma,phase3,TERMINATED,Mario Negri Institute for Pharmacological Research,
NCT01989858,post-operative cht + post-operative cht-rtx,OTHER,Gastric Adenocarcinoma,phase3,TERMINATED,Mario Negri Institute for Pharmacological Research,
NCT04027348,Dexamethasone,DRUG,Malignant Bowel Obstruction,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT04027348,Metoclopramide,DRUG,Malignant Bowel Obstruction,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT04027348,Octreotide,DRUG,Malignant Bowel Obstruction,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT05824455,JS109 combine with irinotecan,OTHER,Advanced Solid Tumors,phase1; phase2,TERMINATED,"Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd.",
NCT00003726,lepirudin,BIOLOGICAL,Lung Cancer,phase1; phase2,TERMINATED,Dartmouth-Hitchcock Medical Center,
NCT02182765,Nevirapine,DRUG,HIV Infections,phase1,TERMINATED,Boehringer Ingelheim,
NCT02182765,Amprenavir,DRUG,HIV Infections,phase1,TERMINATED,Boehringer Ingelheim,
NCT02182765,Abacavir,DRUG,HIV Infections,phase1,TERMINATED,Boehringer Ingelheim,
NCT00224692,Low dose ketamine,DRUG,Cancer; Mucositis,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04258436,Serratus anterior block,PROCEDURE,"Opioid Use; Post-thoracotomy Pain Syndrome; Local Anaesthetic Agent Overdose; Local Anesthetic Complication; Pain, Postoperative",na,TERMINATED,Indiana University,
NCT04398199,Hypofractionated Radiation Therapy,DRUG,"Nonsmall Cell Lung Cancer, Stage II; Nonsmall Cell Lung Cancer Stage III",phase2,TERMINATED,Wake Forest University Health Sciences,
NCT04398199,Radiation Boost,RADIATION,"Nonsmall Cell Lung Cancer, Stage II; Nonsmall Cell Lung Cancer Stage III",phase2,TERMINATED,Wake Forest University Health Sciences,
NCT00695487,THC 9-d-tetra hydro cannabinol,DRUG,Nausea; Vomiting,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT03584516,Itacitinib,DRUG,Chronic Graft-versus-host Disease,phase2; phase3,TERMINATED,Incyte Corporation,
NCT03584516,Placebo,DRUG,Chronic Graft-versus-host Disease,phase2; phase3,TERMINATED,Incyte Corporation,
NCT03584516,Methylprednisolone,DRUG,Chronic Graft-versus-host Disease,phase2; phase3,TERMINATED,Incyte Corporation,
NCT03584516,Prednisone,DRUG,Chronic Graft-versus-host Disease,phase2; phase3,TERMINATED,Incyte Corporation,
NCT01246752,Human Stem Cell Transplantation,BIOLOGICAL,"Leukemia, Myeloid, Acute",phase3,TERMINATED,University Hospital Carl Gustav Carus,
NCT01246752,"Consolidation chemotherapy, i.e. High-dose Cytarabine (HiDAC)",DRUG,"Leukemia, Myeloid, Acute",phase3,TERMINATED,University Hospital Carl Gustav Carus,
NCT03670147,PF-SCS programming,DEVICE,SCS; Chronic Pain,na,TERMINATED,Massachusetts General Hospital,
NCT00395655,Hydralazine and magnesium valproate administration,DRUG,Locally Advanced Breast Cancer,phase2,TERMINATED,National Institute of Cancerología,
NCT00395655,Core-needle biopsy of the breast,PROCEDURE,Locally Advanced Breast Cancer,phase2,TERMINATED,National Institute of Cancerología,
NCT03029585,NanoPac® 100 mg/m2,DRUG,Ovarian Carcinoma,phase2,TERMINATED,"NanOlogy, LLC",
NCT03029585,NanoPac® 200 mg/m2,DRUG,Ovarian Carcinoma,phase2,TERMINATED,"NanOlogy, LLC",
NCT03029585,NanoPac® 300 mg/m2,DRUG,Ovarian Carcinoma,phase2,TERMINATED,"NanOlogy, LLC",
NCT03029585,NanoPac® 400 mg/m2,DRUG,Ovarian Carcinoma,phase2,TERMINATED,"NanOlogy, LLC",
NCT03029585,Standard of Care Intravenous Chemotherapy,DRUG,Ovarian Carcinoma,phase2,TERMINATED,"NanOlogy, LLC",
NCT04877743,None (Observational study),OTHER,Coronavirus Disease 2019 (COVID-19),na,TERMINATED,AstraZeneca,
NCT04063228,Simple Skill Group,OTHER,Neurological Injury,na,TERMINATED,NYU Langone Health,
NCT04063228,Complex Skill Group,OTHER,Neurological Injury,na,TERMINATED,NYU Langone Health,
NCT02576665,Toca 511,BIOLOGICAL,Colorectal Cancer; Triple Negative Breast Cancer; Pancreatic Cancer; Non-Small Cell Lung Cancer; Head and Neck Cancer; Ovarian Cancer; Lymphoma; Sarcoma; Bladder Cancer; Melanoma; IDH1 Mutated Solid T,phase1,TERMINATED,Tocagen Inc.,
NCT02576665,Toca FC,DRUG,Colorectal Cancer; Triple Negative Breast Cancer; Pancreatic Cancer; Non-Small Cell Lung Cancer; Head and Neck Cancer; Ovarian Cancer; Lymphoma; Sarcoma; Bladder Cancer; Melanoma; IDH1 Mutated Solid T,phase1,TERMINATED,Tocagen Inc.,
NCT00101907,AMG 706,DRUG,Lung Cancer; Pancreatic Cancer; Esophageal Cancer,phase1,TERMINATED,Amgen,
NCT00101907,Panitumumab,BIOLOGICAL,Lung Cancer; Pancreatic Cancer; Esophageal Cancer,phase1,TERMINATED,Amgen,
NCT00101907,Gemcitabine,DRUG,Lung Cancer; Pancreatic Cancer; Esophageal Cancer,phase1,TERMINATED,Amgen,
NCT00101907,Cisplatin,DRUG,Lung Cancer; Pancreatic Cancer; Esophageal Cancer,phase1,TERMINATED,Amgen,
NCT03402607,Percutaneous Local Ablation,PROCEDURE,Hepatocellular Carcinoma,na,TERMINATED,Duke University,
NCT03402607,Hypofractionated Image Guided Radiation Therapy,RADIATION,Hepatocellular Carcinoma,na,TERMINATED,Duke University,
NCT03747211,Aerobic exercise,BEHAVIORAL,Late-Onset Asthma,na,TERMINATED,"Rigshospitalet, Denmark",
NCT02329171,Imiquimod,DRUG,Cervical Intraepithelial Neoplasia,phase3,TERMINATED,Maastricht University Medical Center,
NCT02329171,LLETZ,PROCEDURE,Cervical Intraepithelial Neoplasia,phase3,TERMINATED,Maastricht University Medical Center,
NCT00951171,Intrauterine Insemination,PROCEDURE,Infertility,phase3,TERMINATED,Women and Infants Hospital of Rhode Island,
NCT00951171,IUI with the standard inseminator,PROCEDURE,Infertility,phase3,TERMINATED,Women and Infants Hospital of Rhode Island,
NCT02254044,bivatuzumab mertansine,DRUG,"Carcinoma, Squamous Cell",phase1,TERMINATED,Boehringer Ingelheim,
NCT01831544,HeartWare MVAD® System,DEVICE,Heart Failure,na,TERMINATED,Medtronic Cardiac Rhythm and Heart Failure,
NCT00530634,cisplatin,DRUG,Lung Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00530634,gemcitabine hydrochloride,DRUG,Lung Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00530634,gene expression analysis,OTHER,Lung Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00530634,reverse transcriptase-polymerase chain reaction,OTHER,Lung Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00530634,immunohistochemistry staining method,OTHER,Lung Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00530634,adjuvant therapy,PROCEDURE,Lung Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00530634,conventional surgery,PROCEDURE,Lung Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00530634,radiation therapy,RADIATION,Lung Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT05280821,daily ferrous sulfate,OTHER,Iron-deficiency,na,TERMINATED,Swiss Federal Institute of Technology,
NCT05280821,alternate day ferrous sulfate,OTHER,Iron-deficiency,na,TERMINATED,Swiss Federal Institute of Technology,
NCT03076606,ophthalmologist examination,OTHER,Visual Acuity; Accidental Fall; Aging; Nurse's Role,na,TERMINATED,"University Hospital, Caen",
NCT02808052,Minocin (minocycline) for Injection,DRUG,"Renal Insufficiency, Acute; Renal Insufficiency, Chronic; Healthy Subjects",phase1,TERMINATED,"Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)",
NCT01802658,Zoledronic acid,DRUG,Bone Demineralization Lesions in the Injured Marrow,phase3,TERMINATED,Nantes University Hospital,
NCT01802658,NA Cl,DRUG,Bone Demineralization Lesions in the Injured Marrow,phase3,TERMINATED,Nantes University Hospital,
NCT06479148,enVista® Aspire™,DEVICE,Cataract,na,TERMINATED,Bausch & Lomb Incorporated,
NCT06479148,An IOL with a slightly extended depth of focus,DEVICE,Cataract,na,TERMINATED,Bausch & Lomb Incorporated,
NCT06479148,MX60E,DEVICE,Cataract,na,TERMINATED,Bausch & Lomb Incorporated,
NCT03276026,Sugammadex,DRUG,Postoperative Nausea and Vomiting; Respiratory Conditions Due to Other External Agents,phase4,TERMINATED,"Virtua Health, Inc.",
NCT03276026,Neostigmine,DRUG,Postoperative Nausea and Vomiting; Respiratory Conditions Due to Other External Agents,phase4,TERMINATED,"Virtua Health, Inc.",
NCT01554085,ALS-002158,DRUG,"Hepatitis C, Chronic",phase1,TERMINATED,Alios Biopharma Inc.,
NCT01554085,Placebo,DRUG,"Hepatitis C, Chronic",phase1,TERMINATED,Alios Biopharma Inc.,
NCT05008835,ACP-044 Dose A,DRUG,Osteoarthritis Pain,phase2,TERMINATED,ACADIA Pharmaceuticals Inc.,
NCT05008835,ACP-044 Dose B,DRUG,Osteoarthritis Pain,phase2,TERMINATED,ACADIA Pharmaceuticals Inc.,
NCT05008835,Placebo,DRUG,Osteoarthritis Pain,phase2,TERMINATED,ACADIA Pharmaceuticals Inc.,
NCT03624907,Daily Stereotactic Body Radiotherapy,RADIATION,Non-small Cell Lung Cancer,na,TERMINATED,University of Florida,
NCT03624907,Non-Daily Stereotactic Body Radiotherapy,RADIATION,Non-small Cell Lung Cancer,na,TERMINATED,University of Florida,
NCT00286936,Zolpidem,DRUG,Hip Fracture; Delirium,phase4,TERMINATED,Hvidovre University Hospital,
NCT03946709,Action Observation,OTHER,Muscle Weakness; Dynapenia; Sarcopenia,na,TERMINATED,University of Central Florida,
NCT01177709,Metformin,DRUG,Schizophrenia; Obesity,na,TERMINATED,Nathan Kline Institute for Psychiatric Research,
NCT05155709,siremadlin,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT05155709,venetoclax,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT05155709,azacitidine,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT01152216,Dimebon,DRUG,Alzheimer's Disease,phase3,TERMINATED,"Medivation, Inc.",
NCT02915484,Transcranial Direct Current Stimulation,DEVICE,Apathy; Stroke,na,TERMINATED,Stony Brook University,
NCT02257684,pegcrisantaspase,DRUG,Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma,phase2,TERMINATED,Jazz Pharmaceuticals,
NCT02319733,Bioresorbable vascular scaffold,DEVICE,Vulnerable Plaque,na,TERMINATED,Canisius-Wilhelmina Hospital,
NCT01885949,Tivozanib,DRUG,Prostate Cancer,phase2,TERMINATED,Massachusetts General Hospital,
NCT01885949,Enzalutamide,DRUG,Prostate Cancer,phase2,TERMINATED,Massachusetts General Hospital,
NCT01422226,Misoprostol,DRUG,Contraception,na,TERMINATED,"University of Colorado, Denver",
NCT01422226,Placebo,OTHER,Contraception,na,TERMINATED,"University of Colorado, Denver",
NCT02606578,Questionnaires,OTHER,"Esophageal Achalasia; Achalasia; Achalasia, Esophageal",na,TERMINATED,Mayo Clinic,
NCT00423800,Combination of pegylated interferon alfa-2b (PEG) and ribavirin (RBV),DRUG,"Hepatitis C, Chronic",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT03554200,Empagliflozin,DRUG,"Diabetes Mellitus, Type 2; Acute Heart Failure",phase2,TERMINATED,RWTH Aachen University,
NCT03554200,Placebo,DRUG,"Diabetes Mellitus, Type 2; Acute Heart Failure",phase2,TERMINATED,RWTH Aachen University,
NCT02074436,EACA,DRUG,Hematological Malignancies; Thrombocytopenia,phase2,TERMINATED,Emory University,
NCT02074436,Platelet transfusion,OTHER,Hematological Malignancies; Thrombocytopenia,phase2,TERMINATED,Emory University,
NCT01838044,pregabalin and celecoxib,DRUG,Chronic Low Back Pain With a Neuropathic Component,phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT01838044,Placebo and celecoxib,DRUG,Chronic Low Back Pain With a Neuropathic Component,phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT03990064,musicotherapy,OTHER,"Stress Disorder, Post Traumatic",na,TERMINATED,Institut de Recherche Biomedicale des Armees,
NCT01708109,no measures taken to clear bile ductus,OTHER,Cholelithiasis,na,TERMINATED,Karolinska Institutet,
NCT01708109,clearance of bile ductus,PROCEDURE,Cholelithiasis,na,TERMINATED,Karolinska Institutet,
NCT04012099,BMT101,DRUG,Hypertrophic Scar,phase2,TERMINATED,Hugel,
NCT01836432,FOLFIRINOX,DRUG,Pancreatic Cancer; Pancreatic Carcinoma Non-resectable; Locally Advanced Malignant Neoplasm,phase3,TERMINATED,NewLink Genetics Corporation,
NCT01836432,Algenpantucel-L Immunotherapy,BIOLOGICAL,Pancreatic Cancer; Pancreatic Carcinoma Non-resectable; Locally Advanced Malignant Neoplasm,phase3,TERMINATED,NewLink Genetics Corporation,
NCT01836432,5-FU Chemoradiation,RADIATION,Pancreatic Cancer; Pancreatic Carcinoma Non-resectable; Locally Advanced Malignant Neoplasm,phase3,TERMINATED,NewLink Genetics Corporation,
NCT01836432,Gemcitabine,DRUG,Pancreatic Cancer; Pancreatic Carcinoma Non-resectable; Locally Advanced Malignant Neoplasm,phase3,TERMINATED,NewLink Genetics Corporation,
NCT01836432,Capecitabine,DRUG,Pancreatic Cancer; Pancreatic Carcinoma Non-resectable; Locally Advanced Malignant Neoplasm,phase3,TERMINATED,NewLink Genetics Corporation,
NCT01836432,Nab-Paclitaxel,DRUG,Pancreatic Cancer; Pancreatic Carcinoma Non-resectable; Locally Advanced Malignant Neoplasm,phase3,TERMINATED,NewLink Genetics Corporation,
NCT02614898,Eculizumab,OTHER,Atypical Hemolytic Uremic Syndrome,na,TERMINATED,"Alexion Pharmaceuticals, Inc.",
NCT00739063,Tarceva,DRUG,Breast Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT03044821,Open-Uterus Fetal Repair,PROCEDURE,Neural Tube Defect,na,TERMINATED,Baylor College of Medicine,
NCT05662306,Aripiprazole Lauroxil,DRUG,Schizophrenia,phase4,TERMINATED,University of Miami,
NCT05662306,Computerized cognitive and functional skills training,BEHAVIORAL,Schizophrenia,phase4,TERMINATED,University of Miami,
NCT03746704,89Zr˗DFO˗REGN3504,DRUG,Advanced PD-L1 Positive Malignancies,phase1,TERMINATED,Regeneron Pharmaceuticals,
NCT05984784,Placebo,DRUG,Atopic Dermatitis; Moderate-to-severe Atopic Dermatitis; AD,phase1; phase2,TERMINATED,Inmagene LLC,
NCT05984784,IMG-007,DRUG,Atopic Dermatitis; Moderate-to-severe Atopic Dermatitis; AD,phase1; phase2,TERMINATED,Inmagene LLC,
NCT03436433,Lacosamide,DRUG,Glioma; Glioma of Brain; Brain Tumor,phase2,TERMINATED,Duke University,
NCT03436433,Levetiracetam,DRUG,Glioma; Glioma of Brain; Brain Tumor,phase2,TERMINATED,Duke University,
NCT04688658,Nivolumab,DRUG,Unresectable Melanoma,phase1; phase2,TERMINATED,John Kirkwood,
NCT04688658,Duvelisib,DRUG,Unresectable Melanoma,phase1; phase2,TERMINATED,John Kirkwood,
NCT01153958,Colposeptine,DRUG,"Vaginosis, Bacterial",phase4,TERMINATED,"Merck KGaA, Darmstadt, Germany",
NCT01153958,Metronidazole,DRUG,"Vaginosis, Bacterial",phase4,TERMINATED,"Merck KGaA, Darmstadt, Germany",
NCT00736528,PF-04447943,DRUG,Healthy; Elderly,phase1,TERMINATED,Pfizer,
NCT00736528,PF-04447943,DRUG,Healthy; Elderly,phase1,TERMINATED,Pfizer,
NCT00736528,PF-04447943,DRUG,Healthy; Elderly,phase1,TERMINATED,Pfizer,
NCT00736528,Placebo,DRUG,Healthy; Elderly,phase1,TERMINATED,Pfizer,
NCT00524030,pregabalin 600 mg/day,DRUG,"Epilepsies, Partial",phase3,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT00524030,pregabalin 150 mg/day,DRUG,"Epilepsies, Partial",phase3,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT03381365,CuraSeal Percutaneous Intraluminal Closure System,DEVICE,Fistula in Ano,na,TERMINATED,London North West Healthcare NHS Trust,
NCT02293811,Analysis,OTHER,Crohn Disease-Associated Colorectal Adenocarcinoma,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT00546598,Total hip replacement/arthroplasty,DEVICE,Non-inflammatory Joint Disease; Osteoarthritis; Avascular Necrosis; Congenital Hip Dysplasia; Post-traumatic Arthritis,phase4,TERMINATED,DePuy Orthopaedics,
NCT03137693,Standard of Care Schedule Variation: SABR,OTHER,Breast Cancer; Breast Cancer Female; Breast Adenocarcinoma,na,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT03137693,Breast-conserving Surgery,PROCEDURE,Breast Cancer; Breast Cancer Female; Breast Adenocarcinoma,na,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT04818814,Mindfulness Meditation App,BEHAVIORAL,Spinal Cord Injuries; Chronic Pain,na,TERMINATED,Baylor College of Medicine,
NCT04818814,Engagement and Distraction App,BEHAVIORAL,Spinal Cord Injuries; Chronic Pain,na,TERMINATED,Baylor College of Medicine,
NCT02214316,Hypertonic Saline,OTHER,Pediatric Mild Traumatic Brain Injury,phase1; phase2,TERMINATED,Washington University School of Medicine,
NCT03728933,Rotigotine 1 milligram/24 hours,DRUG,Restless Legs Syndrome,phase3,TERMINATED,UCB Biopharma SRL,
NCT03728933,Rotigotine 2 milligram/24 hours,DRUG,Restless Legs Syndrome,phase3,TERMINATED,UCB Biopharma SRL,
NCT03728933,Placebo,DRUG,Restless Legs Syndrome,phase3,TERMINATED,UCB Biopharma SRL,
NCT04282733,Mindfulness Rounds,BEHAVIORAL,Healthcare Practitioner Stress; Patient Satisfaction,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT00602147,laboratory biomarker analysis,OTHER,Mucositis; Multiple Myeloma and Plasma Cell Neoplasm,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT04626947,Bezlotoxumab,BIOLOGICAL,Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn Disease; C. Diff. Infections,phase4,TERMINATED,"David Binion, MD",
NCT02433158,Rivipansel,DRUG,Sickle Cell Anemia; Sickle Cell Disease; Sickle Cell Disorders; Pain Crisis; Vaso-occlusive Crisis,phase3,TERMINATED,GlycoMimetics Incorporated,
NCT02999100,IH Oxytocin,DRUG,Postpartum Hemorrhage,phase1,TERMINATED,GlaxoSmithKline,
NCT02999100,IM Oxytocin,DRUG,Postpartum Hemorrhage,phase1,TERMINATED,GlaxoSmithKline,
NCT02999100,IV Oxytocin,DRUG,Postpartum Hemorrhage,phase1,TERMINATED,GlaxoSmithKline,
NCT02999100,ROTAHALER,DEVICE,Postpartum Hemorrhage,phase1,TERMINATED,GlaxoSmithKline,
NCT00833365,Ibuprofen,DRUG,Patent Ductus Arteriosus; Prematurity,na,TERMINATED,University of Utah,
NCT00833365,Ibuprofen,DRUG,Patent Ductus Arteriosus; Prematurity,na,TERMINATED,University of Utah,
NCT02204007,3D imaging & surrogate bone model,DEVICE,Arthritis,na,TERMINATED,The Cleveland Clinic,
NCT04493411,WBMRI,PROCEDURE,Multiple Myeloma,na,TERMINATED,University of Texas Southwestern Medical Center,
NCT04493411,Positron Emission Tomography/Computed Tomography (PET/CT),PROCEDURE,Multiple Myeloma,na,TERMINATED,University of Texas Southwestern Medical Center,
NCT04405271,Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet,DRUG,Healthcare Workers; COVID-19; SARS-CoV 2,phase3,TERMINATED,Hospital Italiano de Buenos Aires,
NCT04405271,Placebo,DRUG,Healthcare Workers; COVID-19; SARS-CoV 2,phase3,TERMINATED,Hospital Italiano de Buenos Aires,
NCT02986698,in utero hematopoietic stem cell transplantation,BIOLOGICAL,Alpha Thalassemia Major; Hemoglobinopathy; with Thalassemia; Hemoglobinopathies; Fetal Anemia; Fetal Hydrops; Alpha; Thalassemia; Thalassemia Major; Thalassemia Alpha; A-Thalassemia,phase1,TERMINATED,"University of California, San Francisco",
NCT01505933,Dexmedetomidine,DRUG,Airway Remodeling,phase2,TERMINATED,Milton S. Hershey Medical Center,
NCT01505933,propofol,DRUG,Airway Remodeling,phase2,TERMINATED,Milton S. Hershey Medical Center,
NCT05491447,BMX-010,DRUG,Atopic Dermatitis,phase2,TERMINATED,"BioMimetix JV, LLC",
NCT05491447,Placebo,DRUG,Atopic Dermatitis,phase2,TERMINATED,"BioMimetix JV, LLC",
NCT04266158,Myoelectric UE Device-UE Orthosis-No Device,DEVICE,Paresis; Stroke,na,TERMINATED,Ohio State University,
NCT01795638,Sodium chloride,DRUG,Extreme Immaturity,phase4,TERMINATED,"Children's Hospital Medical Center, Cincinnati",
NCT01795638,Placebo,DRUG,Extreme Immaturity,phase4,TERMINATED,"Children's Hospital Medical Center, Cincinnati",
NCT01616758,GTx-024 9mg,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,GTx,
NCT06189365,Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder,DEVICE,Non-Valvular Atrial Fibrillation,na,TERMINATED,Abbott Medical Devices,
NCT04229667,Improved Community Health Volunteer (CHV) program,OTHER,"Hypertension; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Comorbidities and Coexisting Conditions",na,TERMINATED,International Rescue Committee,
NCT05867667,Cardiac Rehab,OTHER,Breast Cancer; Cardiovascular Diseases,na,TERMINATED,University of Michigan Rogel Cancer Center,
NCT05536336,Condom,DEVICE,Performance of Synthetic Polyurethane Male Condom,na,TERMINATED,"Okamoto Industries, Inc.",
NCT04031911,Hydroposturotherapy,DEVICE,"Calculi, Urinary",na,TERMINATED,"GUILLEMIN Francis, MD",
NCT04031911,Standard support in urology,DEVICE,"Calculi, Urinary",na,TERMINATED,"GUILLEMIN Francis, MD",
NCT00702611,Granulocyte Monocyte Apheresis (GMA-Apheresis),DEVICE,Ulcerative Colitis,phase4,TERMINATED,Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa,
NCT00017134,fenretinide,DRUG,Ovarian Cancer,na,TERMINATED,Gynecologic Oncology Group,
NCT00017134,conventional surgery,PROCEDURE,Ovarian Cancer,na,TERMINATED,Gynecologic Oncology Group,
NCT00672334,Sodium Bicarbonate,DRUG,Cardiac Surgery; Cardiopulmonary Bypass,phase2; phase3,TERMINATED,Austin Health,
NCT00672334,Sodium Chloride,DRUG,Cardiac Surgery; Cardiopulmonary Bypass,phase2; phase3,TERMINATED,Austin Health,
NCT04980898,WoundEL medical device,DEVICE,Leg Ulcer; Electrical Remodeling,na,TERMINATED,CEN Biotech,
NCT04980898,Standard cares,OTHER,Leg Ulcer; Electrical Remodeling,na,TERMINATED,CEN Biotech,
NCT00073463,tgAAVCF,OTHER,Cystic Fibrosis,phase2; phase3,TERMINATED,Targeted Genetics Corporation,
NCT03772821,Data collection,OTHER,Femoral Bifurcation Surgery,na,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT03772821,Incision/scar measurement,OTHER,Femoral Bifurcation Surgery,na,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT01382706,docetaxel,DRUG,Recurrent Bladder Cancer; Stage III Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder,phase2,TERMINATED,University of Southern California,
NCT01382706,lapatinib ditosylate,DRUG,Recurrent Bladder Cancer; Stage III Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder,phase2,TERMINATED,University of Southern California,
NCT01382706,immunohistochemistry staining method,OTHER,Recurrent Bladder Cancer; Stage III Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder,phase2,TERMINATED,University of Southern California,
NCT01382706,fluorescence in situ hybridization,OTHER,Recurrent Bladder Cancer; Stage III Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder,phase2,TERMINATED,University of Southern California,
NCT01382706,laboratory biomarker analysis,OTHER,Recurrent Bladder Cancer; Stage III Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder,phase2,TERMINATED,University of Southern California,
NCT02705404,Multifocal Tissue Banking,OTHER,Lung Neoplasms; Carcinoma Non-small-cell Lung,na,TERMINATED,Mayo Clinic,
NCT01890733,Best Repair of torn Rotator Cuff,DEVICE,Full- Thickness Massive RCT (MRCT) of at Least 5 cm in Diameter Including Fatty Infiltration Grade III or IV,na,TERMINATED,OrthoSpace Ltd.,
NCT01890733,InSpace™ system,DEVICE,Full- Thickness Massive RCT (MRCT) of at Least 5 cm in Diameter Including Fatty Infiltration Grade III or IV,na,TERMINATED,OrthoSpace Ltd.,
NCT01729884,HER-2/neu peptide vaccine,BIOLOGICAL,HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,University of Washington,
NCT04243252,Healthy Pantry Program,BEHAVIORAL,Food Selection,na,TERMINATED,Massachusetts General Hospital,
NCT04243252,Waitlist Control,OTHER,Food Selection,na,TERMINATED,Massachusetts General Hospital,
NCT02872428,Valproic Acid,DRUG,"Shock,Hemorrhagic; Trauma",phase1,TERMINATED,Dr. Hasan Alam,
NCT02872428,Isotonic saline solution,DRUG,"Shock,Hemorrhagic; Trauma",phase1,TERMINATED,Dr. Hasan Alam,
NCT03837665,Platelet Rich Plasma,BIOLOGICAL,Tympanic Membrane Perforation,phase1; phase2,TERMINATED,University of Kansas Medical Center,
NCT00422565,"Endeavor, Medtronic",DEVICE,Myocardial Infarction,phase4,TERMINATED,Seung-Jung Park,
NCT00422565,"Cypher, Cordis",DEVICE,Myocardial Infarction,phase4,TERMINATED,Seung-Jung Park,
NCT00422565,"Taxus Liberte, Boston Scientific",DEVICE,Myocardial Infarction,phase4,TERMINATED,Seung-Jung Park,
NCT03125200,ADCT-502,DRUG,Breast Cancer; Non Small Cell Lung Cancer; GastroEsophageal Cancer; Bladder Cancer,phase1,TERMINATED,ADC Therapeutics S.A.,
NCT02936492,BAY1003803 0.01% lipophilic cream,DRUG,Psoriasis,phase1,TERMINATED,Bayer,
NCT02936492,BAY1003803 0.1% lipophilic cream,DRUG,Psoriasis,phase1,TERMINATED,Bayer,
NCT02936492,BAY1003803 0.01% ointment,DRUG,Psoriasis,phase1,TERMINATED,Bayer,
NCT02936492,BAY1003803 0.1% ointment,DRUG,Psoriasis,phase1,TERMINATED,Bayer,
NCT02936492,Lipophilic cream vehicle,DRUG,Psoriasis,phase1,TERMINATED,Bayer,
NCT02936492,Ointment vehicle,DRUG,Psoriasis,phase1,TERMINATED,Bayer,
NCT02936492,Clobetasol propionate,DRUG,Psoriasis,phase1,TERMINATED,Bayer,
NCT00520364,Observation of IVF outcomes in relation to chemo history and AMH,OTHER,Cancer,na,TERMINATED,New York Medical College,
NCT00390364,everolimus,DRUG,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00390364,antiangiogenesis therapy,PROCEDURE,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00390364,biopsy,PROCEDURE,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00390364,diagnostic procedure,PROCEDURE,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00390364,gene expression analysis,PROCEDURE,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00390364,immunohistochemistry staining method,PROCEDURE,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00390364,laboratory biomarker analysis,PROCEDURE,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00390364,mutation analysis,PROCEDURE,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00390364,protein tyrosine kinase inhibitor therapy,PROCEDURE,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00390364,reverse transcriptase-polymerase chain reaction,PROCEDURE,Colorectal Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT04526509,GSK3901961,DRUG,Neoplasms,phase1,TERMINATED,Adaptimmune,
NCT04526509,GSK3845097,DRUG,Neoplasms,phase1,TERMINATED,Adaptimmune,
NCT04526509,GSK4427296,DRUG,Neoplasms,phase1,TERMINATED,Adaptimmune,
NCT04526509,Cyclophosphamide,DRUG,Neoplasms,phase1,TERMINATED,Adaptimmune,
NCT04526509,Fludarabine,DRUG,Neoplasms,phase1,TERMINATED,Adaptimmune,
NCT03216187,Pregabalin,DRUG,Persistent Postoperative Pain,phase3,TERMINATED,Benno Rehberg-Klug,
NCT03216187,Placebos,DRUG,Persistent Postoperative Pain,phase3,TERMINATED,Benno Rehberg-Klug,
NCT01146821,0.20 gm/kg fish oil,OTHER,Sepsis,phase2,TERMINATED,University Hospital Carl Gustav Carus,
NCT01146821,0.50 gm/kg fish oil,OTHER,Sepsis,phase2,TERMINATED,University Hospital Carl Gustav Carus,
NCT05055921,Multi Pulse Therapy as delivered from the Cardialen External Stimulation System,DEVICE,Atrial Fibrillation; Paroxysmal Atrial Fibrillation; Persistent Atrial Fibrillation,na,TERMINATED,"Cardialen, Inc.",
NCT02948114,Control: Cow milk-based infant formula,OTHER,Metabolomics,na,TERMINATED,Mead Johnson Nutrition,
NCT02948114,Experimental 1: Cow milk-based infant formula,OTHER,Metabolomics,na,TERMINATED,Mead Johnson Nutrition,
NCT02948114,Experimental 2: Cow milk-based infant formula,OTHER,Metabolomics,na,TERMINATED,Mead Johnson Nutrition,
NCT02948114,Experimental 3: Cow milk-based infant formula,OTHER,Metabolomics,na,TERMINATED,Mead Johnson Nutrition,
NCT01259284,Atorvastatin,DRUG,Advanced Cancers,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01259284,Fish Oil Supplement,OTHER,Advanced Cancers,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01259284,Placebo,OTHER,Advanced Cancers,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT02096133,Cholecalciferol,DRUG,Multiple Sclerosis,phase2,TERMINATED,Academic MS Center Limburg,
NCT02096133,Placebo comparator,OTHER,Multiple Sclerosis,phase2,TERMINATED,Academic MS Center Limburg,
NCT04305249,ATG-017,DRUG,Solid Tumor; Hematological Malignancy,phase1,TERMINATED,Antengene Therapeutics Limited,
NCT04305249,ATG-017+Nivolumab,DRUG,Solid Tumor; Hematological Malignancy,phase1,TERMINATED,Antengene Therapeutics Limited,
NCT02524249,Caffeine,DRUG,Bronchopulmonary Dysplasia; Apnea of Prematurity,na,TERMINATED,Wayne State University,
NCT02524249,Placebo (dextrose),DRUG,Bronchopulmonary Dysplasia; Apnea of Prematurity,na,TERMINATED,Wayne State University,
NCT02247648,tramadol,DRUG,Pain; Vertigo; Nausea; Pruritus,phase2,TERMINATED,Centre hospitalier de l'Université de Montréal (CHUM),
NCT02247648,Placebo,DRUG,Pain; Vertigo; Nausea; Pruritus,phase2,TERMINATED,Centre hospitalier de l'Université de Montréal (CHUM),
NCT00396955,PLA-695,DRUG,Osteoarthritis,phase2,TERMINATED,Wyeth is now a wholly owned subsidiary of Pfizer,
NCT03296085,Exam for quantity of edema,PROCEDURE,Edema,na,TERMINATED,Geisinger Clinic,
NCT02087228,Genesys HydroTherm Ablator,DEVICE,Menorrhagia,na,TERMINATED,Baylor Research Institute,
NCT02087228,radiofrequency energy ablation device,DEVICE,Menorrhagia,na,TERMINATED,Baylor Research Institute,
NCT00962936,CT-011,DRUG,Chronic Hepatitis C,phase1; phase2,TERMINATED,CureTech Ltd,
NCT01718444,Progestin,DRUG,Polycystic Ovary Syndrome; Infertility,na,TERMINATED,University of Illinois at Chicago,
NCT01718444,Clomiphene Citrate,DRUG,Polycystic Ovary Syndrome; Infertility,na,TERMINATED,University of Illinois at Chicago,
NCT06447506,GSK1070806,DRUG,"Dermatitis, Atopic",phase2,TERMINATED,GlaxoSmithKline,
NCT04262947,Near Infrared Vein Imaging,DEVICE,"Catheterization, Peripheral",na,TERMINATED,Lahey Clinic,
NCT04262947,Conventional IV placement,OTHER,"Catheterization, Peripheral",na,TERMINATED,Lahey Clinic,
NCT02221947,Bryostatin 1,DRUG,Alzheimer's Disease,phase1; phase2,TERMINATED,"Neurotrope Bioscience, Inc.",
NCT02221947,Placebo,DRUG,Alzheimer's Disease,phase1; phase2,TERMINATED,"Neurotrope Bioscience, Inc.",
NCT03134638,SY-1365 (Part 1),DRUG,Advanced Solid Tumors; Ovarian Cancer; Breast Cancer,phase1,TERMINATED,Syros Pharmaceuticals,
NCT03134638,Carboplatin,DRUG,Advanced Solid Tumors; Ovarian Cancer; Breast Cancer,phase1,TERMINATED,Syros Pharmaceuticals,
NCT03134638,Fulvestrant,DRUG,Advanced Solid Tumors; Ovarian Cancer; Breast Cancer,phase1,TERMINATED,Syros Pharmaceuticals,
NCT03134638,SY-1365 (Cohort 2),DRUG,Advanced Solid Tumors; Ovarian Cancer; Breast Cancer,phase1,TERMINATED,Syros Pharmaceuticals,
NCT03134638,SY-1365 (Cohort 5),DRUG,Advanced Solid Tumors; Ovarian Cancer; Breast Cancer,phase1,TERMINATED,Syros Pharmaceuticals,
NCT03134638,SY-1365 (Part 2 Single Agent),DRUG,Advanced Solid Tumors; Ovarian Cancer; Breast Cancer,phase1,TERMINATED,Syros Pharmaceuticals,
NCT04853043,Cetuximab,DRUG,Colorectal Cancer,phase2,TERMINATED,University of Utah,
NCT03736343,Alcohol,DRUG,Alcohol Use Disorder (AUD); Subjective Response to Alcohol (SR),early_phase1,TERMINATED,University of Florida,
NCT01551628,Recombinant human arginase 1 Peg5000,DRUG,Leukemia; Lymphoma,phase1,TERMINATED,Bio-Cancer Treatment International Limited,
NCT02469311,chlorhexidine impregnated cloths,OTHER,Osteoarthritis; Infection,phase2,TERMINATED,LifeBridge Health,
NCT02469311,Standard of care bathing with antibacterial soap and water,OTHER,Osteoarthritis; Infection,phase2,TERMINATED,LifeBridge Health,
NCT00547911,Droxidopa,DRUG,Parkinson Disease; Multiple System Atrophy; Autonomic Nervous System Diseases,phase1; phase2,TERMINATED,National Institute of Neurological Disorders and Stroke (NINDS),
NCT00547911,Carbidopa,DRUG,Parkinson Disease; Multiple System Atrophy; Autonomic Nervous System Diseases,phase1; phase2,TERMINATED,National Institute of Neurological Disorders and Stroke (NINDS),
NCT00547911,Entacapone,DRUG,Parkinson Disease; Multiple System Atrophy; Autonomic Nervous System Diseases,phase1; phase2,TERMINATED,National Institute of Neurological Disorders and Stroke (NINDS),
NCT04327934,GnRH antagonist,DRUG,Polycystic Ovary Syndrome; Hypertension,early_phase1,TERMINATED,Yale University,
NCT04327934,GnRH antagonist + MethylTESTOSTERone 5 MG,DRUG,Polycystic Ovary Syndrome; Hypertension,early_phase1,TERMINATED,Yale University,
NCT01002534,Vardenafil,DRUG,Cystic Fibrosis,phase2,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT01002534,Placebo,DRUG,Cystic Fibrosis,phase2,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT02410564,cognitive behavioral therapy for insomnia (CBTI),BEHAVIORAL,Cancer; Chronic Insomnia,na,TERMINATED,Virginia Commonwealth University,
NCT02410564,Waitlist control condition,BEHAVIORAL,Cancer; Chronic Insomnia,na,TERMINATED,Virginia Commonwealth University,
NCT00986999,rosuvastatin,DRUG,HIV Infections; Cardiovascular Disease,phase2; phase3,TERMINATED,University of Hawaii,
NCT02147132,Nicotine Nasal Spray,DRUG,Cigarette Smoking; Methadone Maintenance,phase4,TERMINATED,University of Cincinnati,
NCT02147132,Varenicline,DRUG,Cigarette Smoking; Methadone Maintenance,phase4,TERMINATED,University of Cincinnati,
NCT02147132,Placebo Nasal Spray,DRUG,Cigarette Smoking; Methadone Maintenance,phase4,TERMINATED,University of Cincinnati,
NCT02147132,Placebo Varenicline,DRUG,Cigarette Smoking; Methadone Maintenance,phase4,TERMINATED,University of Cincinnati,
NCT00726232,Ruxolitinib,DRUG,Myeloproliferative Neoplasm (MPN),phase2,TERMINATED,Incyte Corporation,
NCT01429363,Targeted disc decompression,PROCEDURE,Lumbar Spine Disc Herniation,na,TERMINATED,Rijnstate Hospital,
NCT02101021,Momelotinib,DRUG,Metastatic Pancreatic Ductal Adenocarcinoma,phase3,TERMINATED,Sierra Oncology LLC - a GSK company,
NCT02101021,Placebo to match momelotinib,DRUG,Metastatic Pancreatic Ductal Adenocarcinoma,phase3,TERMINATED,Sierra Oncology LLC - a GSK company,
NCT02101021,Nab-paclitaxel,DRUG,Metastatic Pancreatic Ductal Adenocarcinoma,phase3,TERMINATED,Sierra Oncology LLC - a GSK company,
NCT02101021,Gemcitabine,DRUG,Metastatic Pancreatic Ductal Adenocarcinoma,phase3,TERMINATED,Sierra Oncology LLC - a GSK company,
NCT05742347,DriGo Skin Protectant Textile,DEVICE,Erythema; Maceration; Lesion Skin; Skin Folds,na,TERMINATED,Medline Industries,
NCT02556138,ORBERA Intragastric Balloon,DEVICE,Obesity; Liver Cirrhosis,na,TERMINATED,Mayo Clinic,
NCT01758458,Aldesleukin,BIOLOGICAL,Recurrent Merkel Cell Carcinoma; Stage IV Merkel Cell Carcinoma,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT01758458,Laboratory Biomarker Analysis,OTHER,Recurrent Merkel Cell Carcinoma; Stage IV Merkel Cell Carcinoma,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT01758458,MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells,BIOLOGICAL,Recurrent Merkel Cell Carcinoma; Stage IV Merkel Cell Carcinoma,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT01758458,Radiation Therapy,RADIATION,Recurrent Merkel Cell Carcinoma; Stage IV Merkel Cell Carcinoma,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT01758458,Recombinant Interferon Beta,BIOLOGICAL,Recurrent Merkel Cell Carcinoma; Stage IV Merkel Cell Carcinoma,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT02900248,Provider determined,OTHER,Neoplasms; Lung Neoplasms; Colon Neoplasms; Breast Neoplasms; Pancreatic Neoplasms; Prostate Neoplasms; Kidney Neoplasms; Liver Neoplasms; Rectal Neoplasms; Hematologic Neoplasms; Multiple Myeloma; My,na,TERMINATED,CureOne,
NCT04393155,COVID-19+ observational,OTHER,COVID-19; Acute Respiratory Failure,na,TERMINATED,University of Vermont,
NCT05660265,GSK4172239D,DRUG,"Hematologic Diseases; Anaemia, Sickle Cell",phase1,TERMINATED,GlaxoSmithKline,
NCT05660265,Placebo,OTHER,"Hematologic Diseases; Anaemia, Sickle Cell",phase1,TERMINATED,GlaxoSmithKline,
NCT01198067,Pomalidomide,DRUG,Recurrent Waldenstrom Macroglobulinemia; Refractory Waldenstrom Macroglobulinemia,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT04106167,Allogeneic natural killer (NK) cell,OTHER,Advanced Solid Tumor; Lymphoma; Gastric Cancer; Colorectal Cancer; Head and Neck Cancer; Squamous Cell Carcinoma; EGFR Positive Solid Tumor; HER2-positive Breast Cancer; Hepatocellular Carcinoma; Smal,na,TERMINATED,Fate Therapeutics,
NCT03894007,Docetaxel,DRUG,Early-stage Breast Cancer; HER2-positive Breast Cancer,phase2,TERMINATED,Renske Altena,
NCT03894007,Carboplatin,DRUG,Early-stage Breast Cancer; HER2-positive Breast Cancer,phase2,TERMINATED,Renske Altena,
NCT03894007,Trastuzumab,DRUG,Early-stage Breast Cancer; HER2-positive Breast Cancer,phase2,TERMINATED,Renske Altena,
NCT03894007,Pertuzumab,DRUG,Early-stage Breast Cancer; HER2-positive Breast Cancer,phase2,TERMINATED,Renske Altena,
NCT03894007,Epirubicin,DRUG,Early-stage Breast Cancer; HER2-positive Breast Cancer,phase2,TERMINATED,Renske Altena,
NCT03894007,Cyclophosphamide,DRUG,Early-stage Breast Cancer; HER2-positive Breast Cancer,phase2,TERMINATED,Renske Altena,
NCT03894007,Atezolizumab,DRUG,Early-stage Breast Cancer; HER2-positive Breast Cancer,phase2,TERMINATED,Renske Altena,
NCT03894007,Trastuzumab emtansine,DRUG,Early-stage Breast Cancer; HER2-positive Breast Cancer,phase2,TERMINATED,Renske Altena,
NCT03894007,Paclitaxel,DRUG,Early-stage Breast Cancer; HER2-positive Breast Cancer,phase2,TERMINATED,Renske Altena,
NCT02932371,ECOM™.,DEVICE,Cardiac Surgery,na,TERMINATED,Hopital Foch,
NCT02932371,Trans-esophageal echography,DEVICE,Cardiac Surgery,na,TERMINATED,Hopital Foch,
NCT04958434,TST005,DRUG,Locally Advanced or Metastatic Cancers; Metastatic Human Papillomavirus-Related Malignant Neoplasm,phase1,TERMINATED,"Suzhou Transcenta Therapeutics Co., Ltd.",
NCT01637987,Unassisted vein visualization,PROCEDURE,PIV Catheter Insertion; Vein Visualization,na,TERMINATED,University of Nebraska,
NCT01637987,Wee Sight® Transilluminator,PROCEDURE,PIV Catheter Insertion; Vein Visualization,na,TERMINATED,University of Nebraska,
NCT01637987,"VeinViewer® (Christie Digital Systems, Cypress, CA)",PROCEDURE,PIV Catheter Insertion; Vein Visualization,na,TERMINATED,University of Nebraska,
NCT01287221,Rifampicin,DRUG,Multiple System Atrophy,phase3,TERMINATED,Phillip Low,
NCT01287221,placebo,DRUG,Multiple System Atrophy,phase3,TERMINATED,Phillip Low,
NCT00212004,pioglitazone,DRUG,Diabetes Mellitus; Myocardial Infarction,phase4,TERMINATED,"National Cerebral and Cardiovascular Center, Japan",
NCT00212004,control,OTHER,Diabetes Mellitus; Myocardial Infarction,phase4,TERMINATED,"National Cerebral and Cardiovascular Center, Japan",
NCT04294784,Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor),DRUG,Gastric Cancer; GastroEsophageal Cancer,phase2,TERMINATED,Huazhong University of Science and Technology,
NCT04294784,Albumin-bound Paclitaxel,DRUG,Gastric Cancer; GastroEsophageal Cancer,phase2,TERMINATED,Huazhong University of Science and Technology,
NCT04589884,Hyperspectral Imaging,OTHER,Parathyroid Diseases; Thyroid Diseases; Liver Cancer; Liver Metastases; Digestive Cancer; Digestive Perfusion,na,TERMINATED,IHU Strasbourg,
NCT00625833,Placebo,DRUG,Diabetic Neuropathies,phase2,TERMINATED,Pfizer,
NCT00625833,"[S,S]-Reboxetine",DRUG,Diabetic Neuropathies,phase2,TERMINATED,Pfizer,
NCT02762149,Nerve stimulator,DEVICE,Labor Pain,na,TERMINATED,"Samuel Lunenfeld Research Institute, Mount Sinai Hospital",
NCT00171938,imatinib mesylate,DRUG,Glioblastoma,phase2,TERMINATED,Novartis,
NCT03619655,SPECT CT,PROCEDURE,Prostate Cancer,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT03619655,18F-DCFPyL PET/CT,DRUG,Prostate Cancer,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT03619655,18F-NaF PET/CT,DRUG,Prostate Cancer,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT03619655,WB-MRI,PROCEDURE,Prostate Cancer,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT06419855,Human collagen matrix graft,DEVICE,Cerebrospinal Fluid Leakage,na,TERMINATED,Top Health S.A.P.I DE C.V.,
NCT06419855,Bovine collagen matrix graft,DEVICE,Cerebrospinal Fluid Leakage,na,TERMINATED,Top Health S.A.P.I DE C.V.,
NCT03585855,MSC transplantation,OTHER,Interventional,na,TERMINATED,University Medical Centre Ljubljana,
NCT01006785,DLBS1425,DRUG,Breast Cancer,phase2,TERMINATED,Dexa Medica Group,
NCT01006785,DLBS1425,DRUG,Breast Cancer,phase2,TERMINATED,Dexa Medica Group,
NCT00354185,tanespimycin,DRUG,Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intra,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00354185,belinostat,DRUG,Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intra,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00354185,laboratory biomarker analysis,OTHER,Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intra,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00354185,pharmacological study,OTHER,Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intra,phase1,TERMINATED,National Cancer Institute (NCI),
NCT04649515,TY027,BIOLOGICAL,Coronavirus Disease-2019 (COVID-19),phase3,TERMINATED,Tychan Pte Ltd.,
NCT04649515,TY027,BIOLOGICAL,Coronavirus Disease-2019 (COVID-19),phase3,TERMINATED,Tychan Pte Ltd.,
NCT04649515,0.9% saline,OTHER,Coronavirus Disease-2019 (COVID-19),phase3,TERMINATED,Tychan Pte Ltd.,
NCT00356187,Propranolol,DRUG,Trauma,phase2,TERMINATED,Denver Health and Hospital Authority,
NCT02020616,LY3053102,DRUG,Type 2 Diabetes Mellitus,phase1; phase2,TERMINATED,Eli Lilly and Company,
NCT02020616,Exenatide ER,DRUG,Type 2 Diabetes Mellitus,phase1; phase2,TERMINATED,Eli Lilly and Company,
NCT02020616,Placebo,DRUG,Type 2 Diabetes Mellitus,phase1; phase2,TERMINATED,Eli Lilly and Company,
NCT02020616,Metformin,DRUG,Type 2 Diabetes Mellitus,phase1; phase2,TERMINATED,Eli Lilly and Company,
NCT01276704,Placebo,DRUG,Breast Cancer,phase2,TERMINATED,"Carol Fabian, MD",
NCT01276704,secoisolariciresinol,DRUG,Breast Cancer,phase2,TERMINATED,"Carol Fabian, MD",
NCT00895284,Robotic hysterectomy,PROCEDURE,Hysterectomy,phase4,TERMINATED,Mayo Clinic,
NCT00895284,Standard Hysterectomy,PROCEDURE,Hysterectomy,phase4,TERMINATED,Mayo Clinic,
NCT02521558,Intervention Group,BEHAVIORAL,Memory Disorders; Mild Cognitive Impairment; Alzheimer's Disease,na,TERMINATED,Boston University,
NCT02521558,Control Group,BEHAVIORAL,Memory Disorders; Mild Cognitive Impairment; Alzheimer's Disease,na,TERMINATED,Boston University,
NCT01646515,Placebo,DRUG,Systolic Heart Failure,phase3,TERMINATED,Seoul National University Hospital,
NCT01646515,Udenafil (Zydena),DRUG,Systolic Heart Failure,phase3,TERMINATED,Seoul National University Hospital,
NCT03624608,AuryzoN Family of Devices,DEVICE,"Ear Deformities, Acquired; Ear; Deformity, Congenital; Microtia; Nose Deformity; Nose Deformities, Acquired; Nose; Deformity, Congenital; Nose; Deformity, Congenital, Bent or Squashed; Nose; Deformity",na,TERMINATED,"Reconstrata, LLC",
NCT00329108,ziprasidone hydrochloride,DRUG,"Acute Mania; Bipolar Disorder, Manic",phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT00329108,olanzapine,DRUG,"Acute Mania; Bipolar Disorder, Manic",phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT01578785,Glatiramer Acetate,DRUG,Relapsing-Remitting Multiple Sclerosis,phase3,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT01578785,Placebo,DRUG,Relapsing-Remitting Multiple Sclerosis,phase3,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT02582476,Bumetanide,DRUG,Hypokalemic Periodic Paralysis,phase2,TERMINATED,"University College, London",
NCT02582476,Placebo,DRUG,Hypokalemic Periodic Paralysis,phase2,TERMINATED,"University College, London",
NCT04632940,Pamrevlumab,DRUG,Duchenne Muscular Dystrophy,phase3,TERMINATED,Kyntra Bio,
NCT04632940,Placebo,DRUG,Duchenne Muscular Dystrophy,phase3,TERMINATED,Kyntra Bio,
NCT04632940,Corticosteroids,DRUG,Duchenne Muscular Dystrophy,phase3,TERMINATED,Kyntra Bio,
NCT03245840,Budesonide oral suspension,DRUG,Eosinophilic Esophagitis (EoE),phase3,TERMINATED,Shire,
NCT02588040,Leukocyte- and Platelet-Rich Plasma (L-PRP),BIOLOGICAL,Lateral Epicondylitis,na,TERMINATED,Zimmer Biomet,
NCT02698189,Birabresib Dose 20 mg,DRUG,AML Including AML de Novo and AML Secondary to MDS; DLBCL,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT00516516,L-Carnitine,OTHER,Muscle Cramp,na,TERMINATED,University of Southern California,
NCT00516516,Placebo,OTHER,Muscle Cramp,na,TERMINATED,University of Southern California,
NCT01230216,control systolic blood pressure less than 120 mmHg,DRUG,Coronary Artery Disease; Hypertension,phase4,TERMINATED,Takeshi Morimoto,
NCT01230216,control systolic blood pressure less than 140 mmHg,DRUG,Coronary Artery Disease; Hypertension,phase4,TERMINATED,Takeshi Morimoto,
NCT00875004,epoetin beta,BIOLOGICAL,"Anemia; Unspecified Adult Solid Tumor, Protocol Specific",na,TERMINATED,Institut du Cancer de Montpellier - Val d'Aurelle,
NCT00875004,systemic chemotherapy,DRUG,"Anemia; Unspecified Adult Solid Tumor, Protocol Specific",na,TERMINATED,Institut du Cancer de Montpellier - Val d'Aurelle,
NCT00875004,quality-of-life assessment,PROCEDURE,"Anemia; Unspecified Adult Solid Tumor, Protocol Specific",na,TERMINATED,Institut du Cancer de Montpellier - Val d'Aurelle,
NCT02268604,BIIB 722 CL,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT02268604,Placebo,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT02631252,Hydroxychloroquine,DRUG,"Leukemia, Acute Myelogenous",phase1,TERMINATED,"Alison Sehgal, MD, MS",
NCT02631252,Mitoxantrone,DRUG,"Leukemia, Acute Myelogenous",phase1,TERMINATED,"Alison Sehgal, MD, MS",
NCT02631252,Etoposide,DRUG,"Leukemia, Acute Myelogenous",phase1,TERMINATED,"Alison Sehgal, MD, MS",
NCT03255252,Cisplatin injection,DRUG,Cervical Cancer,phase2,TERMINATED,Institut du Cancer de Montpellier - Val d'Aurelle,
NCT03255252,radiotherapy,OTHER,Cervical Cancer,phase2,TERMINATED,Institut du Cancer de Montpellier - Val d'Aurelle,
NCT00276952,Gonyautoxin,DRUG,Tension-Type Headache,phase2,TERMINATED,University of Chile,
NCT01081938,INSULIN GLARGINE,DRUG,"Diabetes Mellitus, Type 2",phase4,TERMINATED,Sanofi,
NCT01081938,INSULIN GLULISINE,DRUG,"Diabetes Mellitus, Type 2",phase4,TERMINATED,Sanofi,
NCT01120158,Bevacizumab,DRUG,Breast Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT01120158,Paclitaxel,DRUG,Breast Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT03647085,Wearable cardiac monitor,DEVICE,Atrial Fibrillation; Atrial Flutter,na,TERMINATED,Boston Scientific Corporation,
NCT06210243,C752,BIOLOGICAL,"Lymphoma, B-Cell; CAR-T",phase1,TERMINATED,920th Hospital of Joint Logistics Support Force of People's Liberation Army of China,
NCT02029235,Acetaminophen/Ibuprofen,DRUG,Carpal Tunnel; Ganglion Cyst; Trigger Finger; De Quervain Disease,phase4,TERMINATED,"Alexander Payatakes, M.D.",
NCT02029235,Acetaminophen/Hydrocodone,DRUG,Carpal Tunnel; Ganglion Cyst; Trigger Finger; De Quervain Disease,phase4,TERMINATED,"Alexander Payatakes, M.D.",
NCT04857008,BNT001,DEVICE,Cancer,na,TERMINATED,Blue Note Therapeutics,
NCT00217217,Echo-Planar Magnetic Resonance Imaging (EP-MRSI),DEVICE,Bipolar Depression; Bipolar Disorder; Depression,phase3,TERMINATED,Mclean Hospital,
NCT00472706,excision,PROCEDURE,Bowen's Disease,phase4,TERMINATED,Catharina Ziekenhuis Eindhoven,
NCT00472706,Photodynamic therapy,PROCEDURE,Bowen's Disease,phase4,TERMINATED,Catharina Ziekenhuis Eindhoven,
NCT02749006,iTBS repetitive Transcranial Magnetic Stimulation (rTMS),DEVICE,Bipolar Depression,na,TERMINATED,University of British Columbia,
NCT02749006,Sham rTMS,DEVICE,Bipolar Depression,na,TERMINATED,University of British Columbia,
NCT05096884,Metoprolol Succinate,DRUG,Tachycardia; Dyspnea; COVID-19,early_phase1,TERMINATED,Hackensack Meridian Health,
NCT03474458,Doxycycline,DRUG,Cardiac AL Amyloidosis,phase2; phase3,TERMINATED,Fondazione IRCCS Policlinico San Matteo di Pavia,
NCT03474458,Standard of care therapy,DRUG,Cardiac AL Amyloidosis,phase2; phase3,TERMINATED,Fondazione IRCCS Policlinico San Matteo di Pavia,
NCT00843115,donepezil,OTHER,Alzheimer's Disease,na,TERMINATED,Pfizer,
NCT02389985,CRLX101,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,NewLink Genetics Corporation,
NCT02389985,Paclitaxel,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,NewLink Genetics Corporation,
NCT02984085,Genetically corrected cultured epidermal autograft (ATMP),DRUG,Recessive Dystrophic Epidermolysis Bullosa,phase1; phase2,TERMINATED,Holostem s.r.l.,
NCT04379076,Interleukin-7,DRUG,COVID-19; Lymphocytopenia,phase2,TERMINATED,Revimmune,
NCT04379076,Placebos,DRUG,COVID-19; Lymphocytopenia,phase2,TERMINATED,Revimmune,
NCT03598140,Sildenafil Citrate,DRUG,"Vascular System Injuries; Concussion, Brain; Post-Concussion Syndrome",phase2,TERMINATED,University of Texas Southwestern Medical Center,
NCT03598140,Placebo oral capsule,DRUG,"Vascular System Injuries; Concussion, Brain; Post-Concussion Syndrome",phase2,TERMINATED,University of Texas Southwestern Medical Center,
NCT00986440,CS-7017,DRUG,Colorectal Cancer,phase2,TERMINATED,Daiichi Sankyo,
NCT00986440,Placebo,DRUG,Colorectal Cancer,phase2,TERMINATED,Daiichi Sankyo,
NCT05462340,[18F]ASEM,DRUG,Schizophrenia,phase1,TERMINATED,Washington University School of Medicine,
NCT05462340,[18F]AZAN,DRUG,Schizophrenia,phase1,TERMINATED,Washington University School of Medicine,
NCT00202540,S18986,DRUG,Mild Cognitive Impairment,phase2,TERMINATED,Institut de Recherches Internationales Servier,
NCT05561140,Voxelotor Oral Tablet,DRUG,Sickle Cell Disease; Leg Ulcers,phase3,TERMINATED,Pfizer,
NCT05561140,Placebo,OTHER,Sickle Cell Disease; Leg Ulcers,phase3,TERMINATED,Pfizer,
NCT00540189,Initial appendectomy,PROCEDURE,Perforated Appendicitis,na,TERMINATED,University of Michigan,
NCT00540189,Interval appendectomy,PROCEDURE,Perforated Appendicitis,na,TERMINATED,University of Michigan,
NCT00894465,midazolam,DRUG,Vesicoureteral Reflux,na,TERMINATED,Washington University School of Medicine,
NCT00894465,placebo,DRUG,Vesicoureteral Reflux,na,TERMINATED,Washington University School of Medicine,
NCT02150967,BGJ398 (infigratinib),DRUG,Advanced Cholangiocarcinoma; FGFR2 Gene Mutation,phase2,TERMINATED,"QED Therapeutics, a BridgeBio company",
NCT02826967,Colonic Irrigation,PROCEDURE,Colonic Irrigation,na,TERMINATED,NYU Langone Health,
NCT01264965,long acting oxycodone,DRUG,Arthritis; Pain; Cognitive Impairment,phase4,TERMINATED,University of Chicago,
NCT01264965,extra strength acetaminophen,DRUG,Arthritis; Pain; Cognitive Impairment,phase4,TERMINATED,University of Chicago,
NCT01499667,Fingolimod,DRUG,Relapsing Remitting Multiple Sclerosis (RRMS),phase3,TERMINATED,Novartis Pharmaceuticals,
NCT01499667,Placebo,DRUG,Relapsing Remitting Multiple Sclerosis (RRMS),phase3,TERMINATED,Novartis Pharmaceuticals,
NCT01667107,Posaconazole,DRUG,Fungal Infection,phase4,TERMINATED,Merck Sharp & Dohme LLC,
NCT01667107,Calogen®,DRUG,Fungal Infection,phase4,TERMINATED,Merck Sharp & Dohme LLC,
NCT00210236,Conventional surgery WITHOUT Axillary Lymph Node Excision,PROCEDURE,Breast Cancer,phase3,TERMINATED,Institut Bergonié,
NCT00210236,Conventional surgery WITH Axillary Lymph Node Excision,PROCEDURE,Breast Cancer,phase3,TERMINATED,Institut Bergonié,
NCT04725071,Impact Advanced Recovery,OTHER,Burn Wound,na,TERMINATED,"University of Wisconsin, Madison",
NCT04725071,Boost High Protein,OTHER,Burn Wound,na,TERMINATED,"University of Wisconsin, Madison",
NCT01759134,Post discharge formula,OTHER,Premature Birth of Newborn,phase4,TERMINATED,Shaare Zedek Medical Center,
NCT01694264,Entecavir,DRUG,Chronic Hepatitis B; Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis; Juvenile Idiopathic Arthritis,phase3,TERMINATED,Seoul National University Hospital,
NCT01694264,Placebo,DRUG,Chronic Hepatitis B; Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis; Juvenile Idiopathic Arthritis,phase3,TERMINATED,Seoul National University Hospital,
NCT05232864,Secukinumab,DRUG,Lupus Nephritis,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT05239663,Ganglioside-Monosialic Acid,DRUG,Chemotherapy-Related Cognitive Impairment; Breast Cancer,phase3,TERMINATED,Sun Yat-sen University,
NCT05239663,250ml normal saline (NS),DRUG,Chemotherapy-Related Cognitive Impairment; Breast Cancer,phase3,TERMINATED,Sun Yat-sen University,
NCT05129163,Exercise,BEHAVIORAL,Frailty,na,TERMINATED,"Academia Sinica, Taiwan",
NCT05129163,Nutrition activities,BEHAVIORAL,Frailty,na,TERMINATED,"Academia Sinica, Taiwan",
NCT01874821,Dynasplint,DEVICE,Adhesive Capsulitis,na,TERMINATED,"Dynasplint Systems, Inc.",
NCT01874821,Standard of Care,OTHER,Adhesive Capsulitis,na,TERMINATED,"Dynasplint Systems, Inc.",
NCT03707314,Angiography with follow-on revascularisation if indicated,PROCEDURE,Cardiovascular; Attack,na,TERMINATED,"University Hospitals, Leicester",
NCT02034916,talazoparib,DRUG,Breast Neoplasms; BRCA 1 Gene Mutation; BRCA 2 Gene Mutation,phase2,TERMINATED,Pfizer,
NCT00526604,work related rehabilitation,BEHAVIORAL,Low Back Pain,phase3,TERMINATED,Ullevaal University Hospital,
NCT05219604,DiphenhydrAMINE Injectable Solution,DRUG,Central Nervous System Effects of Diphenhydramine; Pharmacokinetics of Diphenhydramine,phase4,TERMINATED,Dent Neuroscience Research Center,
NCT04191733,KINCISE(TM) Surgical Automated System,DEVICE,Osteoarthritis; Rheumatoid Arthritis; Post Traumatic Arthritis,na,TERMINATED,DePuy Orthopaedics,
NCT00618384,Sorafenib,DRUG,Hepatocellular Carcinoma,phase2,TERMINATED,"Heinrich-Heine University, Duesseldorf",
NCT03605758,Ivermectin,DRUG,Strongyloides Stercoralis Infection; Strongyloidiasis,phase3,TERMINATED,Albert Einstein College of Medicine,
NCT05735600,AyuDa Virtual: Aprender y Utilizar Decisiones Apreciables (Spanish) - Learning and Utilizing Significant Choices (English),BEHAVIORAL,Childhood Obesity,na,TERMINATED,Ana Maria Linares,
NCT05735600,AyuDa Written: Aprender y Utilizar Decisiones Apreciables (Spanish) - Learning and Utilizing Significant Choices (English),BEHAVIORAL,Childhood Obesity,na,TERMINATED,Ana Maria Linares,
NCT00975611,"Amantadine Hydrochloride, USP",DRUG,Schizophrenia; Schizoaffective Disorder,phase4,TERMINATED,"David C. Henderson, MD",
NCT00975611,"Amantadine Hydrochloride, USP",DRUG,Schizophrenia; Schizoaffective Disorder,phase4,TERMINATED,"David C. Henderson, MD",
NCT00975611,Placebo,DRUG,Schizophrenia; Schizoaffective Disorder,phase4,TERMINATED,"David C. Henderson, MD",
NCT05394064,SBT101,OTHER,AMN; AMN Gene Mutation; X-ALD,phase1; phase2,TERMINATED,"SwanBio Therapeutics, Inc.",
NCT05394064,Imitation Procedure,PROCEDURE,AMN; AMN Gene Mutation; X-ALD,phase1; phase2,TERMINATED,"SwanBio Therapeutics, Inc.",
NCT02041299,Deferiprone,DRUG,Iron Overload; Sickle Cell Disease; Other Anemias,phase4,TERMINATED,ApoPharma,
NCT02041299,Deferoxamine,DRUG,Iron Overload; Sickle Cell Disease; Other Anemias,phase4,TERMINATED,ApoPharma,
NCT07105332,OMI and Photometer,DEVICE,Diabetes (DM),na,TERMINATED,EyeSense GmbH,
NCT03603587,biopsy,PROCEDURE,Skin Aging; Skin Cancer,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03603587,blood sample,OTHER,Skin Aging; Skin Cancer,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03603587,questionnaire on sun exposure,OTHER,Skin Aging; Skin Cancer,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03603587,examination of the scalp,OTHER,Skin Aging; Skin Cancer,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03603587,Norwood scale,OTHER,Skin Aging; Skin Cancer,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03603587,questionnaire of clinicals signs,OTHER,Skin Aging; Skin Cancer,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03603587,scinexa score,OTHER,Skin Aging; Skin Cancer,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03603587,questionnaire of the history of the hair loss,OTHER,Skin Aging; Skin Cancer,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT06282614,Mucogyne Ovule,DEVICE,Vaginal Dryness,na,TERMINATED,Biocodex,
NCT03722316,Immersive Nature Video,OTHER,Mild Dementia; Mild Cognitive Impairment,na,TERMINATED,University of Southern California,
NCT03722316,Neutral Video,OTHER,Mild Dementia; Mild Cognitive Impairment,na,TERMINATED,University of Southern California,
NCT06500533,rTMS combined with tDCS,DEVICE,Major Depression; Treatment Resistant Depression,na,TERMINATED,Regionspsykiatrien Gødstrup,
NCT01602328,AC607,BIOLOGICAL,Acute Kidney Injury,phase2,TERMINATED,AlloCure Inc.,
NCT01602328,Vehicle Only,BIOLOGICAL,Acute Kidney Injury,phase2,TERMINATED,AlloCure Inc.,
NCT02911467,Pyruvate (13C),DRUG,Prostate Cancer,phase1,TERMINATED,Rahul Aggarwal,
NCT02911467,MRI,DEVICE,Prostate Cancer,phase1,TERMINATED,Rahul Aggarwal,
NCT02115971,Jumping exercise,OTHER,Joint Instability; Chronic Disease; Sprains,na,TERMINATED,Swanenburg,
NCT02115971,Strength exercise,OTHER,Joint Instability; Chronic Disease; Sprains,na,TERMINATED,Swanenburg,
NCT03106571,Pomaglumetad methionil,DRUG,Methamphetamine Use Disorder,phase1,TERMINATED,"University of California, Los Angeles",
NCT03106571,Placebo,DRUG,Methamphetamine Use Disorder,phase1,TERMINATED,"University of California, Los Angeles",
NCT03106571,Methamphetamine,DRUG,Methamphetamine Use Disorder,phase1,TERMINATED,"University of California, Los Angeles",
NCT00003009,aldesleukin,BIOLOGICAL,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,University of Southern California,
NCT03809663,Tezepelumab,DRUG,Atopic Dermatitis,phase2,TERMINATED,Amgen,
NCT03809663,Placebo,OTHER,Atopic Dermatitis,phase2,TERMINATED,Amgen,
NCT00110721,GM-CT-01 plus 5-Fluorouracil,DRUG,Colorectal Cancer,phase2,TERMINATED,Galectin Therapeutics Inc.,
NCT01005914,cyclophosphamide,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT01005914,cytarabine,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT01005914,dexamethasone,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT01005914,doxorubicin hydrochloride,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT01005914,imatinib mesylate,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT01005914,methotrexate,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT01005914,methylprednisolone,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT01005914,pegaspargase,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT01005914,vincristine sulfate,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT02382614,Spiration Valve System,DEVICE,Pulmonary Air Leaks,na,TERMINATED,Olympus Corporation of the Americas,
NCT02282514,Autologous Hematopoietic Stem Cells,BIOLOGICAL,Stiff-Person Syndrome,phase1; phase2,TERMINATED,Northwestern University,
NCT02282514,Cyclophosphamide,DRUG,Stiff-Person Syndrome,phase1; phase2,TERMINATED,Northwestern University,
NCT02282514,Mesna,DRUG,Stiff-Person Syndrome,phase1; phase2,TERMINATED,Northwestern University,
NCT02282514,rATG,DRUG,Stiff-Person Syndrome,phase1; phase2,TERMINATED,Northwestern University,
NCT02282514,Methylprednisolone,DRUG,Stiff-Person Syndrome,phase1; phase2,TERMINATED,Northwestern University,
NCT02282514,G-CSF,DRUG,Stiff-Person Syndrome,phase1; phase2,TERMINATED,Northwestern University,
NCT02282514,Rituxan,DRUG,Stiff-Person Syndrome,phase1; phase2,TERMINATED,Northwestern University,
NCT02557516,monalizumab,DRUG,Chronic Lymphocytic Leukemia,phase1; phase2,TERMINATED,Innate Pharma,
NCT04520906,microwave ablation,DEVICE,Hepatocellular Carcinoma,na,TERMINATED,Suzhou Hengruihongyuan Medical Technology Co. LTD,
NCT05390606,Flourish HEC and BioGenesis,OTHER,Infertility; Infertility Unexplained,phase1,TERMINATED,Vaginal Biome Science,
NCT00028704,conventional surgery,PROCEDURE,Breast Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00028704,radiation therapy,RADIATION,Breast Cancer,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT01643733,Using Flow measurements to guide fistula angioplasty (Transonics),DEVICE,End Stage Renal Failure on Dialysis; Renal Failure,na,TERMINATED,Richard Lindsay,
NCT01657149,Lymphatic massage and individual physiotherapy,PROCEDURE,Total Knee Replacement,na,TERMINATED,Rabin Medical Center,
NCT01657149,individual physiotherapy only,PROCEDURE,Total Knee Replacement,na,TERMINATED,Rabin Medical Center,
NCT05384249,Izokibep,DRUG,Uveitis,phase2,TERMINATED,ACELYRIN Inc.,
NCT05384249,Placebo,DRUG,Uveitis,phase2,TERMINATED,ACELYRIN Inc.,
NCT02825849,Intrauterine infusion of platelet rich plasma,BIOLOGICAL,Infertility; Asherman's Syndrome,phase2,TERMINATED,"University of California, San Francisco",
NCT03562949,Test Product,DRUG,Asthma,phase3,TERMINATED,Amneal Ireland Limited,
NCT03562949,Reference Product,DRUG,Asthma,phase3,TERMINATED,Amneal Ireland Limited,
NCT03562949,Placebo,DRUG,Asthma,phase3,TERMINATED,Amneal Ireland Limited,
NCT00300885,"Nexavar (Sorafenib, BAY43-9006) + carboplatin + paclitaxel",DRUG,"Carcinoma, Non-Small Cell Lung",phase3,TERMINATED,Bayer,
NCT00300885,Carboplatin plus Paclitaxel,DRUG,"Carcinoma, Non-Small Cell Lung",phase3,TERMINATED,Bayer,
NCT03462576,Methacetin Breath Test,OTHER,Decompensated Cirrhosis,na,TERMINATED,"Meridian Bioscience, Inc.",
NCT03462576,Emricasan,DRUG,Decompensated Cirrhosis,na,TERMINATED,"Meridian Bioscience, Inc.",
NCT03462576,Placebo oral capsule,DRUG,Decompensated Cirrhosis,na,TERMINATED,"Meridian Bioscience, Inc.",
NCT02770989,Vimecon Laser CAI percutaneous cardiac ablation,PROCEDURE,Atrial Fibrillation,na,TERMINATED,Vimecon GmbH,
NCT02093468,MST-188,DRUG,Acute Limb Ischemia,phase2,TERMINATED,"Mast Therapeutics, Inc.",
NCT02093468,Saline,DRUG,Acute Limb Ischemia,phase2,TERMINATED,"Mast Therapeutics, Inc.",
NCT04685850,sequela evaluation,OTHER,"Meningitis, Meningococcal; Sequela",na,TERMINATED,Centre Hospitalier Intercommunal Creteil,
NCT03287050,Pembrolizumab,DRUG,Urothelial Carcinoma,phase2,TERMINATED,University of Michigan Rogel Cancer Center,
NCT03287050,SBRT,RADIATION,Urothelial Carcinoma,phase2,TERMINATED,University of Michigan Rogel Cancer Center,
NCT03640650,Dropless Therapy,OTHER,Cataract Surgery,phase4,TERMINATED,PeriPharm,
NCT03640650,Usual Care,DRUG,Cataract Surgery,phase4,TERMINATED,PeriPharm,
NCT02758990,Vitamin A,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Vitamin B6,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Vitamin C,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Nicotinamide,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Vitamin D3,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Vitamin E,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Broccoli,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Spinach,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Caffeine,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Coffee,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Axon Eyewear,DEVICE,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT02758990,Chocolate,OTHER,"Obesity; Rhinitis; Rhinitis, Allergic; Respiratory Sounds; Dyspnea; Headache; Migraine Disorders; Arthritis; Arthralgia; Anxiety; Sleep Initiation and Maintenance Disorders; Sleep Deprivation",na,TERMINATED,Verifomics LLC,
NCT03267810,TENS,DEVICE,Spinal Cord Injuries,na,TERMINATED,University of Miami,
NCT03267810,Sham TENS,OTHER,Spinal Cord Injuries,na,TERMINATED,University of Miami,
NCT02892682,BLOOD TEST,OTHER,"Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency",na,TERMINATED,"University Hospital, Montpellier",
NCT03104348,COPD screening,OTHER,COPD,na,TERMINATED,"University Hospital, Brest",
NCT00280748,pemetrexed disodium,DRUG,Lung Cancer; Metastatic Cancer,phase2,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT00280748,radiation therapy,RADIATION,Lung Cancer; Metastatic Cancer,phase2,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT03714555,Safety Laboratories,OTHER,Metastatic Pancreatic Cancer,phase2,TERMINATED,HonorHealth Research Institute,
NCT03714555,AE Assessment,OTHER,Metastatic Pancreatic Cancer,phase2,TERMINATED,HonorHealth Research Institute,
NCT03714555,Physical Exam,OTHER,Metastatic Pancreatic Cancer,phase2,TERMINATED,HonorHealth Research Institute,
NCT03714555,Concomitant Medication Review,OTHER,Metastatic Pancreatic Cancer,phase2,TERMINATED,HonorHealth Research Institute,
NCT03714555,Tumor Imaging,OTHER,Metastatic Pancreatic Cancer,phase2,TERMINATED,HonorHealth Research Institute,
NCT03714555,nab-paclitaxel (Abraxane)/gemcitabine (Gemzar) Protocol Plus Disulfiram/Copper Gluconate,DRUG,Metastatic Pancreatic Cancer,phase2,TERMINATED,HonorHealth Research Institute,
NCT03714555,FOLFIRINOX regimen Plus Disulfiram/Copper Gluconate,DRUG,Metastatic Pancreatic Cancer,phase2,TERMINATED,HonorHealth Research Institute,
NCT03714555,Single-agent gemcitabine (Gemzar) regimen Plus Disulfiram/Copper Gluconate,DRUG,Metastatic Pancreatic Cancer,phase2,TERMINATED,HonorHealth Research Institute,
NCT04436055,No Intervention will be used,OTHER,"Cannabis Use; Drug Use; Development, Infant",na,TERMINATED,Duke University,
NCT02998008,high intensity interval training,BEHAVIORAL,"Diabetes Mellitus, Type 2",na,TERMINATED,Norwegian University of Science and Technology,
NCT01058408,Intensity modulated radiotherapy,RADIATION,Head and Neck Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT01058408,RAD001,DRUG,Head and Neck Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT01058408,cisplatin,DRUG,Head and Neck Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT00152308,2% rapamycin-eluting YUKONdes PEARL-stent,DEVICE,Coronary Disease,phase4,TERMINATED,Translumina GmbH,
NCT00152308,1% rapamycin-eluting YUKONdes PEARL-stent,DEVICE,Coronary Disease,phase4,TERMINATED,Translumina GmbH,
NCT00152308,YUKONdes PEARL-stent coated with placebo (ethanol),DEVICE,Coronary Disease,phase4,TERMINATED,Translumina GmbH,
NCT05267925,CuraLin,OTHER,Type 2 Diabetes,na,TERMINATED,National University of Natural Medicine,
NCT02707276,Active Low Field Magnetic Stimulation,DEVICE,Bipolar Depression Depressed Phase,na,TERMINATED,Mclean Hospital,
NCT02707276,Sham Low Field Magnetic Stimulation,DEVICE,Bipolar Depression Depressed Phase,na,TERMINATED,Mclean Hospital,
NCT00806468,Desmotabs,DRUG,Parkinson Disease,phase4,TERMINATED,Johannes Gutenberg University Mainz,
NCT03342950,Topical Solution,DRUG,Neuralgia Peripheral,phase2,TERMINATED,Terence J. Coderre,
NCT03342950,Placebos,DRUG,Neuralgia Peripheral,phase2,TERMINATED,Terence J. Coderre,
NCT01469091,Smoking intervention.,BEHAVIORAL,Vascular Disease,na,TERMINATED,"Rigshospitalet, Denmark",
NCT02671890,Chemotherapy,DRUG,Metastatic Pancreatic Adenocarcinoma; Refractory Malignant Solid Neoplasm; Stage IV Pancreatic Cancer AJCC v8,phase1,TERMINATED,Mayo Clinic,
NCT02671890,Disulfiram,DRUG,Metastatic Pancreatic Adenocarcinoma; Refractory Malignant Solid Neoplasm; Stage IV Pancreatic Cancer AJCC v8,phase1,TERMINATED,Mayo Clinic,
NCT02671890,Gemcitabine Hydrochloride,DRUG,Metastatic Pancreatic Adenocarcinoma; Refractory Malignant Solid Neoplasm; Stage IV Pancreatic Cancer AJCC v8,phase1,TERMINATED,Mayo Clinic,
NCT02671890,Laboratory Biomarker Analysis,OTHER,Metastatic Pancreatic Adenocarcinoma; Refractory Malignant Solid Neoplasm; Stage IV Pancreatic Cancer AJCC v8,phase1,TERMINATED,Mayo Clinic,
NCT00823810,PET/CT,OTHER,Colorectal Cancer,na,TERMINATED,Turku University Hospital,
NCT05039710,JNJ-75220795,DRUG,Fatty Liver,phase1,TERMINATED,Janssen Pharmaceutical K.K.,
NCT05039710,Placebo,OTHER,Fatty Liver,phase1,TERMINATED,Janssen Pharmaceutical K.K.,
NCT04365660,18-F FTC 146,DRUG,Osteosarcoma,phase2,TERMINATED,"Davidzon, Guido, M.D.",
NCT02806960,Nasal Glucagon,DRUG,"Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2",phase1,TERMINATED,Eli Lilly and Company,
NCT03750006,Short session HIIT,BEHAVIORAL,Frailty,na,TERMINATED,VA Office of Research and Development,
NCT02994784,Propylene Glycol-Free Melphalan Hydrochloride,DRUG,Amyloidosis; Systemic,phase2,TERMINATED,Boston Medical Center,
NCT04633278,CMP-001,DRUG,Squamous Cell Carcinoma of Head and Neck,phase2,TERMINATED,Regeneron Pharmaceuticals,
NCT04633278,Pembrolizumab,DRUG,Squamous Cell Carcinoma of Head and Neck,phase2,TERMINATED,Regeneron Pharmaceuticals,
NCT00333385,ceftazidime,DRUG,Cystic Fibrosis; Pseudomonas Aeruginosa; Pulmonary Exacerbation,phase4,TERMINATED,"Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche",
NCT00881608,Placebo,DRUG,Amenorrhea,phase1,TERMINATED,Repros Therapeutics Inc.,
NCT00881608,Proellex,DRUG,Amenorrhea,phase1,TERMINATED,Repros Therapeutics Inc.,
NCT02863991,ONC201,DRUG,Multiple Myeloma,phase1; phase2,TERMINATED,Jazz Pharmaceuticals,
NCT02863991,Dexamethasone,DRUG,Multiple Myeloma,phase1; phase2,TERMINATED,Jazz Pharmaceuticals,
NCT00406874,omega 3 fats,DRUG,Infertility,phase2,TERMINATED,Reproductive Partners Medical Group,
NCT00406874,folic acid,DRUG,Infertility,phase2,TERMINATED,Reproductive Partners Medical Group,
NCT01012297,Bevacizumab,BIOLOGICAL,Recurrent Uterine Corpus Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma; Uterine Corpus Leiomyosarcom,phase3,TERMINATED,National Cancer Institute (NCI),
NCT01012297,Docetaxel,DRUG,Recurrent Uterine Corpus Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma; Uterine Corpus Leiomyosarcom,phase3,TERMINATED,National Cancer Institute (NCI),
NCT01012297,Filgrastim,BIOLOGICAL,Recurrent Uterine Corpus Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma; Uterine Corpus Leiomyosarcom,phase3,TERMINATED,National Cancer Institute (NCI),
NCT01012297,Gemcitabine Hydrochloride,DRUG,Recurrent Uterine Corpus Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma; Uterine Corpus Leiomyosarcom,phase3,TERMINATED,National Cancer Institute (NCI),
NCT01012297,Pegfilgrastim,BIOLOGICAL,Recurrent Uterine Corpus Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma; Uterine Corpus Leiomyosarcom,phase3,TERMINATED,National Cancer Institute (NCI),
NCT01012297,Placebo,OTHER,Recurrent Uterine Corpus Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma; Uterine Corpus Leiomyosarcom,phase3,TERMINATED,National Cancer Institute (NCI),
NCT00461110,BMS-663513,DRUG,Non Small Cell Lung Cancer,phase1,TERMINATED,Bristol-Myers Squibb,
NCT00497926,Enriched Hematopoietic Stem Cell Infusion,BIOLOGICAL,Kidney Failure,phase2,TERMINATED,Talaris Therapeutics Inc.,
NCT04109885,Paracervical injection,DRUG,"Headache Disorders, Primary; Pain Management; Emergency Department",phase2,TERMINATED,"Christian Fromm, MD",
NCT04109885,prochlorperazine and diphenhydramine.(Standard Treatment),DRUG,"Headache Disorders, Primary; Pain Management; Emergency Department",phase2,TERMINATED,"Christian Fromm, MD",
NCT03425435,QoL and developed questionnaires for healthcare research,OTHER,Tumors and Home Parenteral Nutrition,na,TERMINATED,Fresenius Kabi,
NCT03775915,Neurofeedback,OTHER,Stroke,na,TERMINATED,University of Oxford,
NCT03775915,Sham Neurofeedback,OTHER,Stroke,na,TERMINATED,University of Oxford,
NCT03297450,tDCS,DEVICE,Aphasia Following Cerebral Infarction,na,TERMINATED,"University Hospital, Ghent",
NCT03297450,Aphasia therapy,BEHAVIORAL,Aphasia Following Cerebral Infarction,na,TERMINATED,"University Hospital, Ghent",
NCT03297450,Sham-tDCS,DEVICE,Aphasia Following Cerebral Infarction,na,TERMINATED,"University Hospital, Ghent",
NCT05582018,BioTraceIO 360,DEVICE,Hepatocellular Carcinoma; Metastatic Liver Cancer,na,TERMINATED,Techsomed Medical Technologies LTD,
NCT01756560,dexamethsone,DRUG,Duration of Pain Relief,phase4,TERMINATED,University of Chicago,
NCT01756560,Bupivacaine,DRUG,Duration of Pain Relief,phase4,TERMINATED,University of Chicago,
NCT02503124,Single night's wake therapy,BEHAVIORAL,Depression,na,TERMINATED,Sahlgrenska University Hospital,
NCT02503124,Bright light,DEVICE,Depression,na,TERMINATED,Sahlgrenska University Hospital,
NCT02503124,Treatment as usual - inpatient care,OTHER,Depression,na,TERMINATED,Sahlgrenska University Hospital,
NCT02503124,Informative meeting,OTHER,Depression,na,TERMINATED,Sahlgrenska University Hospital,
NCT02503124,Treatment as usual - medicine,DRUG,Depression,na,TERMINATED,Sahlgrenska University Hospital,
NCT02479880,Tenofovir DF,DRUG,Hepatitis B,phase4,TERMINATED,Gilead Sciences,
NCT02479880,DEXA Scan,RADIATION,Hepatitis B,phase4,TERMINATED,Gilead Sciences,
NCT00199524,Navigator Ureteral Access Sheath,DEVICE,Urinary Calculi,phase4,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT01168024,CINCOR™ System and contrast conservation unit (CCS-1),DEVICE,Radiographic Contrast Agent Nephropathy,na,TERMINATED,"Osprey Medical, Inc",
NCT01168024,Standard of Care plus peri-procedural hydration,OTHER,Radiographic Contrast Agent Nephropathy,na,TERMINATED,"Osprey Medical, Inc",
NCT03985423,Emapalumab-Lzsg,DRUG,Hemophagocytic Lymphohistiocytoses,phase2; phase3,TERMINATED,Swedish Orphan Biovitrum,
NCT02242578,1 Hz rTMS,DEVICE,Schizophrenia,na,TERMINATED,Seton Healthcare Family,
NCT02242578,10 Hz rTMS,DEVICE,Schizophrenia,na,TERMINATED,Seton Healthcare Family,
NCT02685735,Gabapentin,DRUG,Pain; Total Knee Replacement; Total Hip Replacement,phase4,TERMINATED,Wake Forest University Health Sciences,
NCT02685735,Placebo,DRUG,Pain; Total Knee Replacement; Total Hip Replacement,phase4,TERMINATED,Wake Forest University Health Sciences,
NCT00509925,insulin detemir,DRUG,"Diabetes; Diabetes Mellitus, Type 1",phase4,TERMINATED,Novo Nordisk A/S,
NCT00509925,insulin NPH,DRUG,"Diabetes; Diabetes Mellitus, Type 1",phase4,TERMINATED,Novo Nordisk A/S,
NCT00509925,insulin aspart,DRUG,"Diabetes; Diabetes Mellitus, Type 1",phase4,TERMINATED,Novo Nordisk A/S,
NCT01545817,Pazopanib followed by everolimus,DRUG,"Carcinoma, Renal Cell",phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01499940,Vitamin D3,DRUG,Neurotoxicity,phase2,TERMINATED,"Gerald Higa, PharmD.",
NCT01873690,Ciprofloxacin,DRUG,Urolithiasis,phase3,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT01873690,Placebo,DRUG,Urolithiasis,phase3,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT00864097,tanezumab,BIOLOGICAL,Osteoarthritis,phase3,TERMINATED,Pfizer,
NCT00864097,diclofenac,DRUG,Osteoarthritis,phase3,TERMINATED,Pfizer,
NCT00864097,tanezumab,BIOLOGICAL,Osteoarthritis,phase3,TERMINATED,Pfizer,
NCT00864097,diclofenac,DRUG,Osteoarthritis,phase3,TERMINATED,Pfizer,
NCT00864097,tanezumab,BIOLOGICAL,Osteoarthritis,phase3,TERMINATED,Pfizer,
NCT00864097,diclofenac,DRUG,Osteoarthritis,phase3,TERMINATED,Pfizer,
NCT00864097,diclofenac,DRUG,Osteoarthritis,phase3,TERMINATED,Pfizer,
NCT00864097,IV placebo,OTHER,Osteoarthritis,phase3,TERMINATED,Pfizer,
NCT02704910,Subthalamic stimulation,BEHAVIORAL,Parkinson Disease,na,TERMINATED,"University Hospital, Grenoble",
NCT04617860,WVE-120102,DRUG,Huntington Disease,phase1; phase2,TERMINATED,Wave Life Sciences Ltd.,
NCT02643524,Nutrition and Exercise Counseling,BEHAVIORAL,Foot Injury; Ankle Injury,na,TERMINATED,"Nell Blake, DPM",
NCT02643524,Control,BEHAVIORAL,Foot Injury; Ankle Injury,na,TERMINATED,"Nell Blake, DPM",
NCT05286580,Morbidity and mortality conference toolkit,BEHAVIORAL,Surgery; Surgery--Complications,na,TERMINATED,Poudre Valley Health System,
NCT02083679,Part 1: Sym004 6 mg/kg + Cisplatin/Gemcitabine,DRUG,"Carcinoma, Non-Small-Cell Lung",phase1,TERMINATED,EMD Serono,
NCT02083679,Part 1: Sym004 6 mg/kg + Cisplatin/Pemetrexed,DRUG,"Carcinoma, Non-Small-Cell Lung",phase1,TERMINATED,EMD Serono,
NCT02083679,Part 1: Sym004 6 mg/kg + Carboplatin/Paclitaxel,DRUG,"Carcinoma, Non-Small-Cell Lung",phase1,TERMINATED,EMD Serono,
NCT02083679,Part 1: Sym004 6/12 mg/kg + Carboplatin/Paclitaxel,DRUG,"Carcinoma, Non-Small-Cell Lung",phase1,TERMINATED,EMD Serono,
NCT05511779,Brincidofovir,DRUG,BK Virus Infection; Nephropathy; Kidney Transplantation,phase2,TERMINATED,SymBio Pharmaceuticals,
NCT01900496,Brentuximab vedotin,BIOLOGICAL,Lymphoma,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01900496,Rituximab,BIOLOGICAL,Lymphoma,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT02137096,Etoposide phosphate,DRUG,Recurrent Nasopharynx Carcinoma,phase3,TERMINATED,University of Florida,
NCT02137096,Carboplatin,DRUG,Recurrent Nasopharynx Carcinoma,phase3,TERMINATED,University of Florida,
NCT02137096,Ifosfamide,DRUG,Recurrent Nasopharynx Carcinoma,phase3,TERMINATED,University of Florida,
NCT02137096,Autologous Stem Cell Transplantation,PROCEDURE,Recurrent Nasopharynx Carcinoma,phase3,TERMINATED,University of Florida,
NCT01667146,PHARLAP mechanical ventilation strategy,OTHER,Acute Respiratory Distress Syndrome,na,TERMINATED,Australian and New Zealand Intensive Care Research Centre,
NCT01667146,Control group mechanical ventilation strategy,OTHER,Acute Respiratory Distress Syndrome,na,TERMINATED,Australian and New Zealand Intensive Care Research Centre,
NCT05281562,Lovaza,DRUG,Diabetes Mellitus; Diabetic Peripheral Neuropathy; Diabetic Foot Ulcer,phase2; phase3,TERMINATED,Prisma Health-Midlands,
NCT05281562,L-Arginine Powder,DRUG,Diabetes Mellitus; Diabetic Peripheral Neuropathy; Diabetic Foot Ulcer,phase2; phase3,TERMINATED,Prisma Health-Midlands,
NCT05281562,Vitamin C,DRUG,Diabetes Mellitus; Diabetic Peripheral Neuropathy; Diabetic Foot Ulcer,phase2; phase3,TERMINATED,Prisma Health-Midlands,
NCT02818946,MRI,DEVICE,Disorder of Nipple; Breast Neoplasms,na,TERMINATED,Duke University,
NCT00247988,Weekly Taxotere with weekly carboplatin,DRUG,Platinum Sensitive Relapsed Ovarian Cancer,phase2,TERMINATED,University of Saskatchewan,
NCT03691415,BELKYRA Inj.,DRUG,Submental Fullness,na,TERMINATED,Allergan,
NCT02759315,Uprifosbuvir 450 mg,DRUG,"Hepatitis C, Chronic",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT02759315,Ruzasvir 60 mg,DRUG,"Hepatitis C, Chronic",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT02323776,Trimodality protocol,OTHER,Esophageal Cancer,na,TERMINATED,Maastricht Radiation Oncology,
NCT01119118,ZD4054,DRUG,Prostate Cancer,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT00387010,Fentanyl Buccal Tablets,DRUG,Pain; Chronic Pain; Breakthrough Pain,phase3,TERMINATED,Cephalon,
NCT02602210,Hydrocortisone,DRUG,Liver Cirrhosis,phase3,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT02602210,NaCL 0.9%,DRUG,Liver Cirrhosis,phase3,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT02212210,Methylprednisolone,DRUG,"Fever; Labor Pain; Complication of Anesthesia During Pregnancy, Unspecified",early_phase1,TERMINATED,Medical University of South Carolina,
NCT02212210,Normal saline,DRUG,"Fever; Labor Pain; Complication of Anesthesia During Pregnancy, Unspecified",early_phase1,TERMINATED,Medical University of South Carolina,
NCT03053960,Computed Tomography,DEVICE,Oral Cavity Squamous Cell Carcinoma,na,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT03053960,Positron Emission Tomography and Computed Tomography Scan,DEVICE,Oral Cavity Squamous Cell Carcinoma,na,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT03053960,Cone-Beam Computed Tomography,DEVICE,Oral Cavity Squamous Cell Carcinoma,na,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT03053960,Magnetic Resonance Imaging,DEVICE,Oral Cavity Squamous Cell Carcinoma,na,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT03053960,Therapeutic Conventional Surgery,PROCEDURE,Oral Cavity Squamous Cell Carcinoma,na,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT03053960,Histopathologic Examination,PROCEDURE,Oral Cavity Squamous Cell Carcinoma,na,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT03355482,Methylprednisolone,DRUG,Systemic Lupus Erythematosus Arthritis,phase2,TERMINATED,Oklahoma Medical Research Foundation,
NCT03355482,Placebos,DRUG,Systemic Lupus Erythematosus Arthritis,phase2,TERMINATED,Oklahoma Medical Research Foundation,
NCT01928082,Transdermal estradiol,DRUG,"Hypercalciuria; Hypercalciuria, Familial Idiopathic; Osteopenia; Osteoporosis",phase2,TERMINATED,University of Chicago,
NCT02360059,Metformin,DRUG,Breast Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02360059,Placebo,OTHER,Breast Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02360059,Questionnaires,BEHAVIORAL,Breast Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02360059,Sensory and Fine-Motor Tests,OTHER,Breast Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00631059,Hem(A)+ Technology,OTHER,Leukemia,na,TERMINATED,"University of California, Irvine",
NCT01083615,custirsen sodium,DRUG,Castrate-Resistant Prostate Cancer; Hormone Refractory Prostate Cancer,phase3,TERMINATED,Achieve Life Sciences,
NCT01083615,"isotonic, 0.9% sodium chloride",DRUG,Castrate-Resistant Prostate Cancer; Hormone Refractory Prostate Cancer,phase3,TERMINATED,Achieve Life Sciences,
NCT01083615,docetaxel,DRUG,Castrate-Resistant Prostate Cancer; Hormone Refractory Prostate Cancer,phase3,TERMINATED,Achieve Life Sciences,
NCT01083615,cabazitaxel,DRUG,Castrate-Resistant Prostate Cancer; Hormone Refractory Prostate Cancer,phase3,TERMINATED,Achieve Life Sciences,
NCT01083615,prednisone,DRUG,Castrate-Resistant Prostate Cancer; Hormone Refractory Prostate Cancer,phase3,TERMINATED,Achieve Life Sciences,
NCT00128115,MK0677,DRUG,Hip Fracture,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT05086315,SAR443579,DRUG,Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasia,phase1; phase2,TERMINATED,Sanofi,
NCT05700435,Stress Management and Resilience Training,BEHAVIORAL,Stress; Quality; Anxiety; Resilience,na,TERMINATED,University of New Mexico,
NCT05082025,Copanlisib,DRUG,Endometrial Cancer; Ovarian Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT05082025,fulvestrant,DRUG,Endometrial Cancer; Ovarian Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02191917,Respiratory muscle strength measurements by different techniques.,PROCEDURE,Late-onset Pompe Disease,na,TERMINATED,BioMarin Pharmaceutical,
NCT02937168,Reslizumab,DRUG,Asthma,phase4,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT02937168,Fludeoxyglucose F 18 (FDG),DRUG,Asthma,phase4,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT02937168,Placebo,DRUG,Asthma,phase4,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT00933374,paclitaxel,DRUG,Bladder Cancer,phase2,TERMINATED,"Heinrich-Heine University, Duesseldorf",
NCT00933374,RAD001,DRUG,Bladder Cancer,phase2,TERMINATED,"Heinrich-Heine University, Duesseldorf",
NCT01913197,An MRI-based technique to identify prostate cancer,OTHER,Prostate Cancer,phase1; phase2,TERMINATED,St. Luke's-Roosevelt Hospital Center,
NCT04771897,BXQ-350 - Part 1 Dose Escalation: Safety and Tolerance,DRUG,"Diffuse Intrinsic Pontine Glioma; Diffuse Midline Glioma, H3 K27M-Mutant",phase1,TERMINATED,"Bexion Pharmaceuticals, Inc.",
NCT04771897,BXQ-350 - Part 2 BXQ-350 Tumor and Plasma Concentrations,DRUG,"Diffuse Intrinsic Pontine Glioma; Diffuse Midline Glioma, H3 K27M-Mutant",phase1,TERMINATED,"Bexion Pharmaceuticals, Inc.",
NCT04258020,BiPAP,DEVICE,Ventilatory Failure,na,TERMINATED,OhioHealth,
NCT04258020,HFNC,DEVICE,Ventilatory Failure,na,TERMINATED,OhioHealth,
NCT03185182,Ioflupane I123,DRUG,Clear Cell Renal Cell Carcinoma,phase2,TERMINATED,Region Skane,
NCT03335124,Vitamin C,DRUG,Sepsis; Septic Shock; Critical Illness; Fluid Overload,phase4,TERMINATED,University Medical Centre Ljubljana,
NCT03335124,Hydrocortisone,DRUG,Sepsis; Septic Shock; Critical Illness; Fluid Overload,phase4,TERMINATED,University Medical Centre Ljubljana,
NCT03335124,Thiamine,DRUG,Sepsis; Septic Shock; Critical Illness; Fluid Overload,phase4,TERMINATED,University Medical Centre Ljubljana,
NCT03335124,0.9% Sodium Chloride Injection,DRUG,Sepsis; Septic Shock; Critical Illness; Fluid Overload,phase4,TERMINATED,University Medical Centre Ljubljana,
NCT02482948,Active Leptospermum Honey (Medihoney),DEVICE,Ulcer; Wounds,na,TERMINATED,Integra LifeSciences Corporation,
NCT02482948,Collagenase,DRUG,Ulcer; Wounds,na,TERMINATED,Integra LifeSciences Corporation,
NCT04831255,triamcinolone acetonide extended-release injectable suspension,DRUG,Adhesive Capsulitis; Frozen Shoulder; Adhesive Capsulitis of Shoulder,phase1,TERMINATED,University of Virginia,
NCT01486043,Metformin,DRUG,Acute Lymphoblastic Leukemia; Hyperglycemia; Insulin Resistance; Diabetes Mellitus,na,TERMINATED,Children's Hospital Los Angeles,
NCT01187615,Regorafenib (BAY73-4506) - sequential / Cisplatin / Pemetrexed,DRUG,Small Cell Lung Carcinoma,phase1,TERMINATED,Bayer,
NCT01187615,Regorafenib (BAY73-4506) - continuous / Cisplatin / Pemetrexed,DRUG,Small Cell Lung Carcinoma,phase1,TERMINATED,Bayer,
NCT02624635,Manual Therapy,OTHER,Plantar Fasciitis,na,TERMINATED,Centro Universitário Augusto Motta,
NCT02624635,Manual Therapy and Hip Strengthening,OTHER,Plantar Fasciitis,na,TERMINATED,Centro Universitário Augusto Motta,
NCT04693208,Laser therapy,DEVICE,"Pain, Postoperative",na,TERMINATED,IRCCS Burlo Garofolo,
NCT04368676,Sudarshan Kriya Yoga (SKY),OTHER,Job Stress; Workplace Stress; Compassion Fatigue; Psychological Trauma; Healthcare Workers; Healthcare Providers,early_phase1,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT04368676,Health Enhancement Program,OTHER,Job Stress; Workplace Stress; Compassion Fatigue; Psychological Trauma; Healthcare Workers; Healthcare Providers,early_phase1,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT00566540,Cisplatin,DRUG,Head and Neck Cancer,phase2,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT00566540,Paclitaxel,DRUG,Head and Neck Cancer,phase2,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT00566540,Intensity-Modulated Radiation Therapy (IMRT) External Beam Radiation,RADIATION,Head and Neck Cancer,phase2,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT00566540,Triple endoscopy and biopsy,PROCEDURE,Head and Neck Cancer,phase2,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT04407689,Interleukin-7,DRUG,COVID-19; Lymphocytopenia,phase2,TERMINATED,Revimmune,
NCT04407689,Placebo,DRUG,COVID-19; Lymphocytopenia,phase2,TERMINATED,Revimmune,
NCT02730091,Letrozole,DRUG,Breast Cancer,phase3,TERMINATED,Centre Hospitalier Universitaire de Besancon,
NCT02730091,Anastrozole,DRUG,Breast Cancer,phase3,TERMINATED,Centre Hospitalier Universitaire de Besancon,
NCT02730091,Vinorelbine,DRUG,Breast Cancer,phase3,TERMINATED,Centre Hospitalier Universitaire de Besancon,
NCT04775797,AB-836,DRUG,Chronic Hepatitis,phase1,TERMINATED,Arbutus Biopharma Corporation,
NCT04775797,Placebo,DRUG,Chronic Hepatitis,phase1,TERMINATED,Arbutus Biopharma Corporation,
NCT04775797,AB-836,DRUG,Chronic Hepatitis,phase1,TERMINATED,Arbutus Biopharma Corporation,
NCT04775797,Placebo,DRUG,Chronic Hepatitis,phase1,TERMINATED,Arbutus Biopharma Corporation,
NCT04775797,Nucleos(t)ide Analogue,DRUG,Chronic Hepatitis,phase1,TERMINATED,Arbutus Biopharma Corporation,
NCT03929497,Lu AF11167,DRUG,Schizophrenia,phase2,TERMINATED,H. Lundbeck A/S,
NCT03371160,Nutriplace™ System,DEVICE,Enteral Nutrition,na,TERMINATED,Nutriseal L.P,
NCT01425424,Vitamin D supplementation,OTHER,Prediabetes; Prehypertension,na,TERMINATED,Pennington Biomedical Research Center,
NCT01156480,hydrocortisone,DRUG,Necrotizing Enterocolitis,na,TERMINATED,Endeavor Health,
NCT01156480,placebo,DRUG,Necrotizing Enterocolitis,na,TERMINATED,Endeavor Health,
NCT00027508,trabectedin,DRUG,Malignant Mesothelioma,phase2,TERMINATED,PharmaMar,
NCT00550108,Ethanol lavage,OTHER,Pancreatic Cyst,phase3,TERMINATED,Massachusetts General Hospital,
NCT00581217,Aquacel Ag,OTHER,Burns,na,TERMINATED,"University of California, Irvine",
NCT00581217,Glucan II,OTHER,Burns,na,TERMINATED,"University of California, Irvine",
NCT00205517,Daily interruption of sedation versus sedation algorithm,PROCEDURE,Sedation; Mechanical Ventilation; Depression; Post-traumatic Stress Disorder; Quality of Life,na,TERMINATED,Virginia Commonwealth University,
NCT00634517,Armstrong Albuterol Sulfate Inhalation Aerosol,DRUG,Asthma,phase3,TERMINATED,"Amphastar Pharmaceuticals, Inc.",
NCT00634517,Albuterol Sulfate Inhalation Aerosol,DRUG,Asthma,phase3,TERMINATED,"Amphastar Pharmaceuticals, Inc.",
NCT05382650,Human rabies immune globulin 300 IU/mL,BIOLOGICAL,Rabies; Rabies Human; Rabies Virus Infection; Pediatrics,na,TERMINATED,The Methodist Hospital Research Institute,
NCT02355691,PREVENA,DEVICE,"Complications; Arthroplasty, Infection or Inflammation; Wound Complication",na,TERMINATED,"University of North Carolina, Chapel Hill",
NCT04047797,Ixazomib,DRUG,Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT04047797,Ixazomib Citrate,DRUG,Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT04047797,Rituximab,BIOLOGICAL,Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01818297,PrimeAdvanced® neurostimulator system,DEVICE,Failed Back Surgery Syndrome; Post-laminectomy Syndrome,na,TERMINATED,MedtronicNeuro,
NCT03822013,Miglustat,DRUG,GM2 Gangliosidosis; Supportive Care,phase3,TERMINATED,Tehran University of Medical Sciences,
NCT00595920,Tovaxin,BIOLOGICAL,"Multiple Sclerosis, Relapsing-Remitting; Clinically Isolated Syndrome",phase2,TERMINATED,"Opexa Therapeutics, Inc.",
NCT03794024,The Nuvectra Algovita Dorsal Column Spinal Cord Stimulator,DEVICE,Complex Regional Pain Syndrome,na,TERMINATED,The Cleveland Clinic,
NCT03794024,The Axium Neurostimulator System,DEVICE,Complex Regional Pain Syndrome,na,TERMINATED,The Cleveland Clinic,
NCT03419624,Dapagliflozin 10mg,DRUG,"Obesity; Diabetes Mellitus, Type 2",phase3,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT03419624,Exenatide 2 mg [Bydureon],DRUG,"Obesity; Diabetes Mellitus, Type 2",phase3,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT03419624,Placebo Oral Tablet,DRUG,"Obesity; Diabetes Mellitus, Type 2",phase3,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT03419624,Placebo injection,DRUG,"Obesity; Diabetes Mellitus, Type 2",phase3,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT03419624,Insulin,DRUG,"Obesity; Diabetes Mellitus, Type 2",phase3,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT03419624,"Metformin, if taken before",DRUG,"Obesity; Diabetes Mellitus, Type 2",phase3,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT01754623,Capecitabine,DRUG,Pancreatic Cancer,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT01754623,Gemcitabine,DRUG,Pancreatic Cancer,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT01754623,Docetaxel,DRUG,Pancreatic Cancer,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT01754623,Stereotactic body radiation therapy (SBRT),RADIATION,Pancreatic Cancer,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT01754623,Restaging review after radiation,OTHER,Pancreatic Cancer,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT01754623,Surgery,PROCEDURE,Pancreatic Cancer,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT01754623,5-Fluorouracil,DRUG,Pancreatic Cancer,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT04313179,Music therapy,OTHER,Pain,na,TERMINATED,New York City Health and Hospitals Corporation,
NCT04313179,Sucrose,OTHER,Pain,na,TERMINATED,New York City Health and Hospitals Corporation,
NCT02716896,Radiation and chemoradiation,RADIATION,Muscle Invasive Bladder Cancer,na,TERMINATED,The University of Texas Health Science Center at San Antonio,
NCT02716896,Radical cystectomy,PROCEDURE,Muscle Invasive Bladder Cancer,na,TERMINATED,The University of Texas Health Science Center at San Antonio,
NCT01086696,FPAC,DRUG,Breast Cancer; Lung Cancer; Renal Cancer; Adrenal Cancer,early_phase1,TERMINATED,National Cancer Institute (NCI),
NCT00189046,driving and laboratory tests,BEHAVIORAL,Chronic Pain,na,TERMINATED,UMC Utrecht,
NCT06215755,VRG50635,DRUG,Amyotrophic Lateral Sclerosis,phase1,TERMINATED,Verge Genomics,
NCT00838578,KRN330,BIOLOGICAL,Colorectal Cancer,phase1; phase2,TERMINATED,"Kyowa Kirin Co., Ltd.",
NCT00838578,Irinotecan,DRUG,Colorectal Cancer,phase1; phase2,TERMINATED,"Kyowa Kirin Co., Ltd.",
NCT01005615,Non-FES Upper Extremity Exercise,DEVICE,Spinal Cord Injury,phase1; phase2,TERMINATED,"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.",
NCT01005615,"RT300-SLSA, from Restorative Therapies, Inc.",DEVICE,Spinal Cord Injury,phase1; phase2,TERMINATED,"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.",
NCT01168908,Sildenafil,DRUG,Duchenne Muscular Dystrophy; Becker Muscular Dystrophy,phase2,TERMINATED,"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.",
NCT02802176,INVOcell device,DEVICE,Infertility,na,TERMINATED,"University of California, San Francisco",
NCT02802176,Traditional IVF,OTHER,Infertility,na,TERMINATED,"University of California, San Francisco",
NCT00309517,Fluourouracil,DRUG,"Rectal Cancer Dukes B, Dukes C",phase3,TERMINATED,Austrian Breast & Colorectal Cancer Study Group,
NCT00309517,Leucovorin,DRUG,"Rectal Cancer Dukes B, Dukes C",phase3,TERMINATED,Austrian Breast & Colorectal Cancer Study Group,
NCT00309517,MAb 17-1A,DRUG,"Rectal Cancer Dukes B, Dukes C",phase3,TERMINATED,Austrian Breast & Colorectal Cancer Study Group,
NCT02777489,Perindopril,DRUG,Obesity,phase2,TERMINATED,Gene PreDiT,
NCT01204450,Temsirolimus,DRUG,"Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific",phase1,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT01204450,Valproic Acid,DRUG,"Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific",phase1,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT00993018,JNJ-42160443 (1 mg),DRUG,Diabetic Neuropathy,phase2,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT00993018,JNJ-42160443 (3 mg),DRUG,Diabetic Neuropathy,phase2,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT00993018,JNJ-42160443 (10 mg),DRUG,Diabetic Neuropathy,phase2,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT00993018,Placebo,DRUG,Diabetic Neuropathy,phase2,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT02561897,Edoxaban,DRUG,Atrial Fibrillation,phase4,TERMINATED,Electrophysiology Research Foundation,
NCT02561897,Warfarin,DRUG,Atrial Fibrillation,phase4,TERMINATED,Electrophysiology Research Foundation,
NCT03851510,Vector ventilator,DEVICE,Chronic Obstructive Pulmonary Disease; Noninvasive Ventilation,na,TERMINATED,Philips Respironics,
NCT03851510,Resmon Pro,DEVICE,Chronic Obstructive Pulmonary Disease; Noninvasive Ventilation,na,TERMINATED,Philips Respironics,
NCT02676310,Bimatoprost,DRUG,"Alopecia; Alopecia, Androgenetic; Baldness",phase1,TERMINATED,Allergan,
NCT04876820,Pharmacist intervention,OTHER,Epilepsy,na,TERMINATED,"University Hospital, Lille",
NCT04876820,Standard of care,OTHER,Epilepsy,na,TERMINATED,"University Hospital, Lille",
NCT03904420,Clinical Education and Treatment Model,OTHER,"Sensorineural Hearing Loss, Bilateral",na,TERMINATED,Cochlear,
NCT03904420,Traditional Model,OTHER,"Sensorineural Hearing Loss, Bilateral",na,TERMINATED,Cochlear,
NCT02832323,Reticera,BIOLOGICAL,"Renal Insufficiency, Chronic",na,TERMINATED,"University Hospital, Brest",
NCT00827580,Eniluracil,DRUG,Breast Cancer; Colon Cancer,phase1,TERMINATED,West Virginia University,
NCT00403780,pregabalin,DRUG,Critical Limb Ischemia; Arterial Occlusive Disease; Pain; Ischemia,phase4,TERMINATED,Karolinska Institutet,
NCT00403780,placebo,DRUG,Critical Limb Ischemia; Arterial Occlusive Disease; Pain; Ischemia,phase4,TERMINATED,Karolinska Institutet,
NCT01611662,gemcitabine hydrochloride,DRUG,Distal Urethral Cancer; Proximal Urethral Cancer; Squamous Cell Carcinoma of the Bladder; Stage II Bladder Cancer; Stage III Bladder Cancer; Urethral Cancer Associated With Invasive Bladder Cancer,phase2,TERMINATED,Fox Chase Cancer Center,
NCT01611662,cisplatin,DRUG,Distal Urethral Cancer; Proximal Urethral Cancer; Squamous Cell Carcinoma of the Bladder; Stage II Bladder Cancer; Stage III Bladder Cancer; Urethral Cancer Associated With Invasive Bladder Cancer,phase2,TERMINATED,Fox Chase Cancer Center,
NCT01611662,therapeutic conventional surgery,PROCEDURE,Distal Urethral Cancer; Proximal Urethral Cancer; Squamous Cell Carcinoma of the Bladder; Stage II Bladder Cancer; Stage III Bladder Cancer; Urethral Cancer Associated With Invasive Bladder Cancer,phase2,TERMINATED,Fox Chase Cancer Center,
NCT01611662,laboratory biomarker analysis,OTHER,Distal Urethral Cancer; Proximal Urethral Cancer; Squamous Cell Carcinoma of the Bladder; Stage II Bladder Cancer; Stage III Bladder Cancer; Urethral Cancer Associated With Invasive Bladder Cancer,phase2,TERMINATED,Fox Chase Cancer Center,
NCT05144308,Images of the operated eye (s),PROCEDURE,Cataract; Astigmatism,na,TERMINATED,Fondation Ophtalmologique Adolphe de Rothschild,
NCT05296525,GDA-201,DRUG,Non-Hodgkin Lymphoma,phase1; phase2,TERMINATED,Gamida Cell ltd,
NCT01808950,0.06% Resiquimod Gel - A,DRUG,Nodular Basal Cell Carcinoma,phase1; phase2,TERMINATED,Spirig Pharma Ltd.,
NCT01808950,0.06% Resiquimod Gel - B,DRUG,Nodular Basal Cell Carcinoma,phase1; phase2,TERMINATED,Spirig Pharma Ltd.,
NCT01808950,0.06% Resiquimod Gel - C,DRUG,Nodular Basal Cell Carcinoma,phase1; phase2,TERMINATED,Spirig Pharma Ltd.,
NCT02575391,Whole Food Intervention,OTHER,Esophagitis,phase1; phase2,TERMINATED,Providence Health & Services,
NCT00947791,ketamine,DRUG,Bipolar Disorder,phase4,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT00947791,midazolam,DRUG,Bipolar Disorder,phase4,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT00687674,dexamethasone,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase1,TERMINATED,Mayo Clinic,
NCT00687674,sorafenib tosylate,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase1,TERMINATED,Mayo Clinic,
NCT00687674,Lenalidomide,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase1,TERMINATED,Mayo Clinic,
NCT00098618,sorafenib tosylate,DRUG,Clear Cell Renal Cell Carcinoma; Papillary Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00098618,recombinant interferon alfa,BIOLOGICAL,Clear Cell Renal Cell Carcinoma; Papillary Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00098618,laboratory biomarker analysis,OTHER,Clear Cell Renal Cell Carcinoma; Papillary Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00087724,FK962,DRUG,Alzheimer's Disease,phase2,TERMINATED,Astellas Pharma Inc,
NCT01094496,CDX-1307 Vaccine Regimen,BIOLOGICAL,Bladder Cancer,phase2,TERMINATED,Celldex Therapeutics,
NCT01094496,Chemotherapy,DRUG,Bladder Cancer,phase2,TERMINATED,Celldex Therapeutics,
NCT01591096,Tissue plasminogen activator (Activase®),DRUG,Stroke,phase1,TERMINATED,Seattle Children's Hospital,
NCT02772562,PROSTVAC-V/F,BIOLOGICAL,Prostatic Neoplasms,phase2,TERMINATED,Medical University of South Carolina,
NCT00697762,RWJ-333369,DRUG,Seizures,phase3,TERMINATED,"SK Life Science, Inc.",
NCT00697762,RWJ-333369,DRUG,Seizures,phase3,TERMINATED,"SK Life Science, Inc.",
NCT00697762,Placebo,DRUG,Seizures,phase3,TERMINATED,"SK Life Science, Inc.",
NCT03819543,Transcranial Direct Current Stimulation,DEVICE,Status Epilepticus,na,TERMINATED,University of Manitoba,
NCT03492125,MS-553,DRUG,Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Aggressive Lymphoma,phase1; phase2,TERMINATED,"MingSight Pharmaceuticals, Inc",
NCT03492125,MS-553,DRUG,Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Aggressive Lymphoma,phase1; phase2,TERMINATED,"MingSight Pharmaceuticals, Inc",
NCT03492125,acalabrutinib,DRUG,Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Aggressive Lymphoma,phase1; phase2,TERMINATED,"MingSight Pharmaceuticals, Inc",
NCT03492125,venetoclax,DRUG,Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Aggressive Lymphoma,phase1; phase2,TERMINATED,"MingSight Pharmaceuticals, Inc",
NCT03492125,Rituximab,DRUG,Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Aggressive Lymphoma,phase1; phase2,TERMINATED,"MingSight Pharmaceuticals, Inc",
NCT03492125,obinutuzumab,DRUG,Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Aggressive Lymphoma,phase1; phase2,TERMINATED,"MingSight Pharmaceuticals, Inc",
NCT00543517,MK0767,DRUG,"Diabetes Mellitus, Type 2",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT03377517,radiosurgical hypophysectomy,RADIATION,Bone Metastases,na,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00550017,Epofolate,DRUG,Advanced Solid Tumors,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT05910697,MyProstateScore 2.0 Results,OTHER,Prostate Cancer,na,TERMINATED,"Qure Healthcare, LLC",
NCT03923010,Itraconazole,DRUG,Mycoses,phase4,TERMINATED,"Janssen Research & Development, LLC",
NCT04634110,Brigatinib,DRUG,Brain Metastases; Lung Cancer,phase2,TERMINATED,"University of Colorado, Denver",
NCT02840513,Smartphone app/CO self-monitoring,OTHER,Smoking; HIV,phase4,TERMINATED,Alain Nordmann,
NCT04778982,KN026 combined with Palbociclib and Fulvestrant,DRUG,HER2-positive Metastatic Breast Cancer,na,TERMINATED,"Jiangsu Alphamab Biopharmaceuticals Co., Ltd",
NCT00318682,FIBROSCAN,DEVICE,"Hepatitis, Viral, Human",na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04581824,Dostarlimab,DRUG,"Lung Cancer, Non-Small Cell",phase2,TERMINATED,GlaxoSmithKline,
NCT04581824,Pembrolizumab,DRUG,"Lung Cancer, Non-Small Cell",phase2,TERMINATED,GlaxoSmithKline,
NCT04581824,Chemotherapy,DRUG,"Lung Cancer, Non-Small Cell",phase2,TERMINATED,GlaxoSmithKline,
NCT01230788,rituximab,DRUG,Leukemia; Acute Lymphoblastic Leukemia; ALL,na,TERMINATED,Emory University,
NCT00315003,Telithromycin,DRUG,"Otitis Media, Suppurative; Otitis Media, Purulent",phase3,TERMINATED,Sanofi,
NCT00315003,Azithromycin,DRUG,"Otitis Media, Suppurative; Otitis Media, Purulent",phase3,TERMINATED,Sanofi,
NCT02358603,Chronotropic Incompetence Diagnostic Algorithm,OTHER,Heart Failure,na,TERMINATED,Medtronic Cardiac Rhythm and Heart Failure,
NCT02955485,"Patients do not undergo any type of interventions, but standard care if offered and accepted.",OTHER,Chronic Ankle Instability,na,TERMINATED,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),
NCT04467515,CAM-H2,DRUG,"Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment",phase1; phase2,TERMINATED,Precirix,
NCT01103908,HCE101 Cardiopulmonary Support Monitor,DEVICE,Cardiac Output,na,TERMINATED,Transonic Systems Inc.,
NCT03874325,Durvalumab,DRUG,Breast Cancer; Hormone Receptor Positive Tumor,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT03874325,Anastrozole 1mg,DRUG,Breast Cancer; Hormone Receptor Positive Tumor,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT03874325,Letrozole 2.5mg,DRUG,Breast Cancer; Hormone Receptor Positive Tumor,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT03874325,Exemestane 25 MG,DRUG,Breast Cancer; Hormone Receptor Positive Tumor,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00258440,Weekly procrit dosing,DRUG,"Anemia; Fatigue; Unspecified Adult Solid Tumor, Protocol Specific",na,TERMINATED,OHSU Knight Cancer Institute,
NCT00258440,Interval Dosing,DRUG,"Anemia; Fatigue; Unspecified Adult Solid Tumor, Protocol Specific",na,TERMINATED,OHSU Knight Cancer Institute,
NCT02606591,Electroencephalograph,PROCEDURE,Health and Wellness,na,TERMINATED,M.D. Anderson Cancer Center,
NCT02606591,Cognitive Tests,BEHAVIORAL,Health and Wellness,na,TERMINATED,M.D. Anderson Cancer Center,
NCT02606591,Hair Sample,OTHER,Health and Wellness,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00131391,Comparator: taranabant,DRUG,Obesity,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00131391,Comparator: placebo,DRUG,Obesity,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01626391,TRx0237,DRUG,Alzheimer's Disease,phase2,TERMINATED,TauRx Therapeutics Ltd,
NCT01626391,Placebo,DRUG,Alzheimer's Disease,phase2,TERMINATED,TauRx Therapeutics Ltd,
NCT00488774,Placebo,OTHER,"Colitis, Ulcerative",phase2; phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT00488774,Golimumab 1 mg per kg,DRUG,"Colitis, Ulcerative",phase2; phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT00488774,Golimumab 2 mg per kg,DRUG,"Colitis, Ulcerative",phase2; phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT00488774,Golimumab 4 mg per kg,DRUG,"Colitis, Ulcerative",phase2; phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT05190510,Data collection,OTHER,Internal Carotid Artery; Atheromatous Stenosis,na,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT05190510,collection of the carotid plaque (surgical specimen),PROCEDURE,Internal Carotid Artery; Atheromatous Stenosis,na,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT05190510,"anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens",OTHER,Internal Carotid Artery; Atheromatous Stenosis,na,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT01103713,Azithromycin plus chloroquine,DRUG,Asymptomatic Parasitemia In Pregnancy,phase3,TERMINATED,Pfizer,
NCT02728310,Levobupivacaine,DRUG,Pain,phase3,TERMINATED,San Salvatore Hospital of L'Aquila,
NCT02728310,Saline,DRUG,Pain,phase3,TERMINATED,San Salvatore Hospital of L'Aquila,
NCT00005920,"L-743,872",DRUG,"Candidiasis, Oral; HIV Infections",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00000824,"Lymphocytes, Activated",DRUG,HIV Infections,na,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00764062,Amoxicillin,DRUG,Odontogenic Infection,phase4,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00907946,NT 1 day before PCNL,PROCEDURE,Urolithiasis,na,TERMINATED,Washington University School of Medicine,
NCT02737488,Trauma Systems Therapy (TST),BEHAVIORAL,Trauma; Post-Traumatic Stress Disorder,phase3,TERMINATED,NYU Langone Health,
NCT02737488,Treatment as Usual (TAU),BEHAVIORAL,Trauma; Post-Traumatic Stress Disorder,phase3,TERMINATED,NYU Langone Health,
NCT03923478,ABI-M201,DRUG,Ulcerative Colitis Chronic Mild; Ulcerative Colitis Chronic Moderate,phase1,TERMINATED,Assembly Biosciences,
NCT03923478,Placebo,DRUG,Ulcerative Colitis Chronic Mild; Ulcerative Colitis Chronic Moderate,phase1,TERMINATED,Assembly Biosciences,
NCT01500785,levosimendan,DRUG,Myocardial Stunning,phase4,TERMINATED,Tampere University Hospital,
NCT01500785,Vitamin B 12,DRUG,Myocardial Stunning,phase4,TERMINATED,Tampere University Hospital,
NCT00005015,Fluoxetine,DRUG,Bipolar Disorder; Depression,phase3,TERMINATED,National Institute of Mental Health (NIMH),
NCT03224208,Vemurafenib,DRUG,Melanoma; Melanoma (Skin); Melanoma Stage,phase2,TERMINATED,Fondazione Melanoma Onlus,
NCT03224208,Cobimetinib,DRUG,Melanoma; Melanoma (Skin); Melanoma Stage,phase2,TERMINATED,Fondazione Melanoma Onlus,
NCT00767468,sorafenib tosylate,DRUG,Liver Cancer,phase1,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT02029274,BAF312,DRUG,Active Dermatomyositis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02029274,Placebo,DRUG,Active Dermatomyositis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02058810,Nasal high flow,DEVICE,Decompensated Heartfailure; Cardio-renal Syndrom,na,TERMINATED,University Hospital Regensburg,
NCT02058810,Conventional nasal oxygen,DEVICE,Decompensated Heartfailure; Cardio-renal Syndrom,na,TERMINATED,University Hospital Regensburg,
NCT03323879,LDR/HDR,RADIATION,Carcinoma Prostate,phase1; phase2,TERMINATED,Sunnybrook Health Sciences Centre,
NCT01671579,Bowel ultrasound,PROCEDURE,Crohn Disease,na,TERMINATED,"Children's Hospital Medical Center, Cincinnati",
NCT01671579,magnetic resonance enterography (MRE),PROCEDURE,Crohn Disease,na,TERMINATED,"Children's Hospital Medical Center, Cincinnati",
NCT00730262,TLN-4601,DRUG,Glioblastoma Multiforme,phase2,TERMINATED,Thallion Pharmaceuticals,
NCT02525562,Triathlon Total Knee System with X3 insert,DEVICE,"Arthroplasty, Replacement, Knee",na,TERMINATED,Stryker Orthopaedics,
NCT02525562,Scorpio NRG Total Knee System with X3 insert,DEVICE,"Arthroplasty, Replacement, Knee",na,TERMINATED,Stryker Orthopaedics,
NCT02525562,Triathlon PKR System with X3 insert,DEVICE,"Arthroplasty, Replacement, Knee",na,TERMINATED,Stryker Orthopaedics,
NCT02525562,Total Knee Replacement,PROCEDURE,"Arthroplasty, Replacement, Knee",na,TERMINATED,Stryker Orthopaedics,
NCT02525562,Partial Knee Resurfacing,PROCEDURE,"Arthroplasty, Replacement, Knee",na,TERMINATED,Stryker Orthopaedics,
NCT02425878,Ulipristal Acetate,DRUG,Intramural Fibroids; Uterine Fibroids,phase3,TERMINATED,"Instituto Valenciano de Infertilidad, IVI VALENCIA",
NCT02425878,Placebo,DRUG,Intramural Fibroids; Uterine Fibroids,phase3,TERMINATED,"Instituto Valenciano de Infertilidad, IVI VALENCIA",
NCT02241343,"Venous occlusion (leg tourniquet, made in-house)",DEVICE,Venous Occlusion,na,TERMINATED,Imperial College London,
NCT03455985,Discharge Order Set (DOS),OTHER,"Diabetes Mellitus, Type 2; Patient Discharge; Blood Glucose, Low; Blood Glucose, High",na,TERMINATED,Ohio State University,
NCT03455985,Enhanced Standard Care (ESC),OTHER,"Diabetes Mellitus, Type 2; Patient Discharge; Blood Glucose, Low; Blood Glucose, High",na,TERMINATED,Ohio State University,
NCT02586415,Endovascular Thrombectomy,PROCEDURE,"Stroke, Acute; Cerebral Infarction",na,TERMINATED,Gregory W Albers,
NCT02586415,Trevo Retriever,DEVICE,"Stroke, Acute; Cerebral Infarction",na,TERMINATED,Gregory W Albers,
NCT02586415,Solitaire™ FR Revascularization Device,DEVICE,"Stroke, Acute; Cerebral Infarction",na,TERMINATED,Gregory W Albers,
NCT02586415,Penumbra thrombectomy system,DEVICE,"Stroke, Acute; Cerebral Infarction",na,TERMINATED,Gregory W Albers,
NCT02586415,Covidien MindFrame Capture Revascularization Device,DEVICE,"Stroke, Acute; Cerebral Infarction",na,TERMINATED,Gregory W Albers,
NCT02341625,BMS-986148,DRUG,Advanced Cancer,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT02341625,Nivolumab,BIOLOGICAL,Advanced Cancer,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT01377376,ARQ 197 and Erlotinib,DRUG,Non-small-cell Lung Cancer,phase3,TERMINATED,"Kyowa Kirin Co., Ltd.",
NCT01377376,Placebo and Erlotinib,DRUG,Non-small-cell Lung Cancer,phase3,TERMINATED,"Kyowa Kirin Co., Ltd.",
NCT05044676,patients with hepatocellular carcinoma,OTHER,Hepatocellular Carcinoma,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01750476,Mirena,DRUG,Initiation of Oral Contraception (OC); Initiation of Depo-Provera (DMPA); Initiation of Mirena (LNG-IUD),na,TERMINATED,"Thomas Cherpes, DVM, MD",
NCT01750476,Oral contraception,DRUG,Initiation of Oral Contraception (OC); Initiation of Depo-Provera (DMPA); Initiation of Mirena (LNG-IUD),na,TERMINATED,"Thomas Cherpes, DVM, MD",
NCT01750476,Depo-Provera,DRUG,Initiation of Oral Contraception (OC); Initiation of Depo-Provera (DMPA); Initiation of Mirena (LNG-IUD),na,TERMINATED,"Thomas Cherpes, DVM, MD",
NCT02306876,PF-06412562 3mg BID,DRUG,Healthy,phase1,TERMINATED,Pfizer,
NCT02306876,PF-06412562 15mg BID,DRUG,Healthy,phase1,TERMINATED,Pfizer,
NCT02306876,Placebo,OTHER,Healthy,phase1,TERMINATED,Pfizer,
NCT05314868,PhotoFix,DEVICE,Congenital Heart Disease; Cardiac Anomaly,na,TERMINATED,Artivion Inc.,
NCT01062191,"Aquacel AG, typical carboxymethylcellulose dressing",DEVICE,Burn,na,TERMINATED,ULURU Inc.,
NCT01062191,Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing,DEVICE,Burn,na,TERMINATED,ULURU Inc.,
NCT01243918,Oxygen therapy delivery systems,OTHER,Acute Respiratory Failure,na,TERMINATED,Nantes University Hospital,
NCT00610818,Palifermin,OTHER,Skin Rash,na,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT05177718,Natalizumab 300 MG in 15 ML Injection,DRUG,Multiple Sclerosis,phase4,TERMINATED,Vanderbilt University Medical Center,
NCT06056310,Xevinapant,DRUG,Head and Neck Cancer,phase1,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT06056310,Cisplatin,DRUG,Head and Neck Cancer,phase1,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT06056310,intensity-modulated radiation therapy (IMRT),RADIATION,Head and Neck Cancer,phase1,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02490813,Treatment - Chinese Herbal Formula - X,OTHER,Allergy to Fish; Allergy to Shrimp; Allergy to Crab,na,TERMINATED,Hong Kong Sanatorium & Hospital,
NCT02490813,Placebo,OTHER,Allergy to Fish; Allergy to Shrimp; Allergy to Crab,na,TERMINATED,Hong Kong Sanatorium & Hospital,
NCT00005982,nelarabine,DRUG,Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00005982,pharmacological study,OTHER,Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome,phase2,TERMINATED,National Cancer Institute (NCI),
NCT02256124,Lamotrigine,DRUG,Neurofibromatosis Type 1,phase2; phase3,TERMINATED,Erasmus Medical Center,
NCT02256124,Placebo,DRUG,Neurofibromatosis Type 1,phase2; phase3,TERMINATED,Erasmus Medical Center,
NCT04134624,Sepsis care bundle,OTHER,"Sepsis; Sepsis, Severe; Septic Shock",na,TERMINATED,HealthPartners Institute,
NCT02754323,Apparatus CODESNA,DEVICE,"Stress, Physiological",na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT00116623,Indomethacin,DRUG,"Labor, Premature",phase4,TERMINATED,University of Pennsylvania,
NCT00116623,Magnesium sulfate,DRUG,"Labor, Premature",phase4,TERMINATED,University of Pennsylvania,
NCT03795350,Beclometasone dipropionate Formoterol Fumarate Glycopyrronium Bromide,DRUG,Chronic Obstructive Pulmonary Disease; Asthma,phase1,TERMINATED,Chiesi Farmaceutici S.p.A.,
NCT01303250,balanced 6% hydroxyethylstarch 130/0.4,DRUG,"Surgery, Colorectal",phase4,TERMINATED,University Hospital Muenster,
NCT01303250,balanced crystalloid,DRUG,"Surgery, Colorectal",phase4,TERMINATED,University Hospital Muenster,
NCT01249950,feasibility,OTHER,Morbid Obesity,na,TERMINATED,"University Hospital, Toulouse",
NCT00041691,hMN14 (labetuzumab),DRUG,Colorectal Neoplasms,phase1,TERMINATED,Gilead Sciences,
NCT03013491,CX-072,DRUG,Solid Tumor; Lymphoma,phase1; phase2,TERMINATED,CytomX Therapeutics,
NCT03013491,ipilimumab,DRUG,Solid Tumor; Lymphoma,phase1; phase2,TERMINATED,CytomX Therapeutics,
NCT03013491,vemurafenib,DRUG,Solid Tumor; Lymphoma,phase1; phase2,TERMINATED,CytomX Therapeutics,
NCT05703490,IADLSys system,OTHER,Dementia; Cognitive Impairment; Alzheimer Disease,na,TERMINATED,"Bijan Najafi, PhD",
NCT03401710,Erythropoietin,DRUG,Anemia Renal,na,TERMINATED,Saint-Joseph University,
NCT02275923,Reveal LINQ™ Insertable Cardiac Monitor,DEVICE,End Stage Renal Disease,na,TERMINATED,Medtronic Cardiac Rhythm and Heart Failure,
NCT03284723,PF-06804103,DRUG,Breast Neoplasms,phase1,TERMINATED,Pfizer,
NCT03284723,PF-06804103 + Palbociclib +Letrozole,DRUG,Breast Neoplasms,phase1,TERMINATED,Pfizer,
NCT04797780,Tamibarotene,DRUG,Myelodysplastic Syndromes,phase3,TERMINATED,Syros Pharmaceuticals,
NCT04797780,Placebo,DRUG,Myelodysplastic Syndromes,phase3,TERMINATED,Syros Pharmaceuticals,
NCT04797780,Azacitidine,DRUG,Myelodysplastic Syndromes,phase3,TERMINATED,Syros Pharmaceuticals,
NCT00683696,Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D),DEVICE,Heart Failure; Ventricular Dyssynchrony,phase2; phase3,TERMINATED,"Biotronik, Inc.",
NCT00581061,Vesicare,DRUG,Incontinence,na,TERMINATED,"University of California, Irvine",
NCT02611661,PET/MRI,DEVICE,Metastatic Colorectal Cancer,phase1,TERMINATED,Washington University School of Medicine,
NCT02611661,Percutaneous ablation,RADIATION,Metastatic Colorectal Cancer,phase1,TERMINATED,Washington University School of Medicine,
NCT02611661,Stereotactic body radiotherapy,RADIATION,Metastatic Colorectal Cancer,phase1,TERMINATED,Washington University School of Medicine,
NCT00403442,Verteporfin Therapy/ Drug: Bevacizumab,DEVICE,Macular Degeneration,phase1,TERMINATED,Vitreous -Retina- Macula Consultants of New York,
NCT05557942,AV-101,DRUG,Pulmonary Arterial Hypertension,phase3,TERMINATED,Aerovate Therapeutics,
NCT03379818,Shape training intervention,BEHAVIORAL,Language Delay; Language Development Disorders,na,TERMINATED,University of Birmingham,
NCT03379818,Specific word training,BEHAVIORAL,Language Delay; Language Development Disorders,na,TERMINATED,University of Birmingham,
NCT00617890,robatumumab,BIOLOGICAL,"Osteosarcoma; Sarcoma, Ewing's; Peripheral Neuroectodermal Tumor",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT03717480,ClinicMACs,DEVICE,Hematologic Malignancy,phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT01631279,PR610,DRUG,"Unspecified Adult Solid Tumor, Protocol Specific",phase1; phase2,TERMINATED,"Proacta, Incorporated",
NCT04490096,[11C]-PBR28,DRUG,ALS,phase1,TERMINATED,University of Pennsylvania,
NCT01901562,Ductoscopic papillectomy,DEVICE,Breast Discharge Infected; Intraductal Papilloma of Breast,na,TERMINATED,Montefiore Medical Center,
NCT03600961,Orsiro Sirolimus Eluting Coronary Stent System,DEVICE,Ischemic Heart Disease,na,TERMINATED,Biotronik AG,
NCT03459443,Danicopan,DRUG,C3 Glomerulonephritis; C3 Glomerulopathy; Immune Complex Membranoproliferative Glomerulonephritis; IC-MPGN; Dense Deposit Disease,phase2,TERMINATED,"Alexion Pharmaceuticals, Inc.",
NCT03093935,StimRouter Neuromodulation System,DEVICE,Chronic Pain; Hemiplegic Shoulder Pain,na,TERMINATED,Bioness Inc,
NCT01233635,no drug,OTHER,Atrial Fibrillation,phase4,TERMINATED,University of Pittsburgh,
NCT01233635,start cozaar,DRUG,Atrial Fibrillation,phase4,TERMINATED,University of Pittsburgh,
NCT01233635,continue cozaar,DRUG,Atrial Fibrillation,phase4,TERMINATED,University of Pittsburgh,
NCT02842125,Ad-P53,DRUG,Metastatic Solid Tumor Cancer; Recurrent Head and Neck Cancer,phase1; phase2,TERMINATED,"MultiVir, Inc.",
NCT02842125,Xeloda,DRUG,Metastatic Solid Tumor Cancer; Recurrent Head and Neck Cancer,phase1; phase2,TERMINATED,"MultiVir, Inc.",
NCT02842125,Keytruda,DRUG,Metastatic Solid Tumor Cancer; Recurrent Head and Neck Cancer,phase1; phase2,TERMINATED,"MultiVir, Inc.",
NCT02842125,Opdivo,DRUG,Metastatic Solid Tumor Cancer; Recurrent Head and Neck Cancer,phase1; phase2,TERMINATED,"MultiVir, Inc.",
NCT02307708,8° incline shoe,DEVICE,Tendinopathy; Rupture of Achilles Tendon; Chronic Disease,na,TERMINATED,Nantes University Hospital,
NCT02307708,kinesitherapy,OTHER,Tendinopathy; Rupture of Achilles Tendon; Chronic Disease,na,TERMINATED,Nantes University Hospital,
NCT04389840,Dociparstat sodium,DRUG,Coronavirus Disease 2019 (COVID-19); Acute Lung Injury; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),phase2; phase3,TERMINATED,Jazz Pharmaceuticals,
NCT04389840,Placebo,DRUG,Coronavirus Disease 2019 (COVID-19); Acute Lung Injury; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),phase2; phase3,TERMINATED,Jazz Pharmaceuticals,
NCT03342989,Speed of Processing Training,BEHAVIORAL,Delirium; Dementia,na,TERMINATED,University of Alabama at Birmingham,
NCT03342989,Internet-Based Contact Control,BEHAVIORAL,Delirium; Dementia,na,TERMINATED,University of Alabama at Birmingham,
NCT00314691,Blood samples,OTHER,Hereditary Diseases,na,TERMINATED,"University Hospital, Strasbourg, France",
NCT04079491,questionnaire survey,OTHER,Oral Lichen Planus; Oral Leukoplakia; Erythroplakia,na,TERMINATED,"Dalarna County Council, Sweden",
NCT03704974,Video-Based Parent Training Program,BEHAVIORAL,Parenting; Child Rearing; Child Behavior Problem,na,TERMINATED,Children's Hospital Los Angeles,
NCT00502918,CLM - HA Continuous Monitoring System Heart Application,DEVICE,Obstetrics; Labor,na,TERMINATED,Barnev Ltd,
NCT01490710,collection of clinical and biological parameters,OTHER,Invasive Ventilatory Support,na,TERMINATED,Nantes University Hospital,
NCT01490710,assign optimal ventilatory mode,OTHER,Invasive Ventilatory Support,na,TERMINATED,Nantes University Hospital,
NCT00089713,alagebrium chloride (ALT-711),DRUG,Hypertension,phase2,TERMINATED,"Synvista Therapeutics, Inc",
NCT05079620,Ceftriaxone,DRUG,Aspiration; Aspiration Pneumonia,phase4,TERMINATED,UConn Health,
NCT05079620,Amoxicillin clavulanic acid,DRUG,Aspiration; Aspiration Pneumonia,phase4,TERMINATED,UConn Health,
NCT05079620,Cefepime,DRUG,Aspiration; Aspiration Pneumonia,phase4,TERMINATED,UConn Health,
NCT05079620,Vancomycin,DRUG,Aspiration; Aspiration Pneumonia,phase4,TERMINATED,UConn Health,
NCT05079620,Levofloxacin,DRUG,Aspiration; Aspiration Pneumonia,phase4,TERMINATED,UConn Health,
NCT06206278,Infigratinib,DRUG,Gastric Cancer; Gastroesophageal Junction Adenocarcinoma,phase2,TERMINATED,LianBio LLC,
NCT04876378,Magnetic Resonance Imaging,PROCEDURE,Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC,na,TERMINATED,"University of California, San Francisco",
NCT04876378,Questionnaire Administration,OTHER,Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC,na,TERMINATED,"University of California, San Francisco",
NCT03094715,Thrombectomy,DEVICE,"Stroke, Acute; Cerebral Stroke; Cerebrovascular Stroke; Apoplexy; Brain",na,TERMINATED,University Hospital Heidelberg,
NCT03094715,Best medical care,OTHER,"Stroke, Acute; Cerebral Stroke; Cerebrovascular Stroke; Apoplexy; Brain",na,TERMINATED,University Hospital Heidelberg,
NCT00544908,dasatinib,DRUG,Pancreatic Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00544908,immunoenzyme technique,OTHER,Pancreatic Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00544908,immunohistochemistry staining method,OTHER,Pancreatic Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00544908,laboratory biomarker analysis,OTHER,Pancreatic Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00544908,quality-of-life assessment,PROCEDURE,Pancreatic Cancer,phase2,TERMINATED,City of Hope Medical Center,
NCT00983008,Protected time and Dedicated time,BEHAVIORAL,Fatigue; Sleep Deprivation; Depression,na,TERMINATED,Providence Health & Services,
NCT02836340,2-Iminobiotin,DRUG,Cardiac Arrest; Hypoxic Ischemic Brain Injury,phase1; phase2,TERMINATED,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),
NCT02155140,Jejunal feeding,OTHER,Surgical Resection of an Upper Gastrointestinal Malignancy; Nutritional Supplementation Via a Jejunostomy Post Discharge From Hospital,na,TERMINATED,University Hospital Plymouth NHS Trust,
NCT05192174,NIB101,BIOLOGICAL,Solid Tumor,phase1,TERMINATED,"Noile-Immune Biotech, Inc",
NCT00758797,Photoimmunotherapy,OTHER,Metastatic Melanoma,phase1,TERMINATED,Northwestern University,
NCT03993210,Magnetic Resonance Fingerprinting (MRF),DEVICE,Gynecologic Tumor,na,TERMINATED,Dana-Farber Cancer Institute,
NCT03993210,Q-space Trajectory Imaging (QTI),DEVICE,Gynecologic Tumor,na,TERMINATED,Dana-Farber Cancer Institute,
NCT03993210,Magnetic Resonance Imaging Machine (MRI),DEVICE,Gynecologic Tumor,na,TERMINATED,Dana-Farber Cancer Institute,
NCT01515020,vancomycin monotherapy,DRUG,Nosocomial Infection; Healthcare-associated Infection,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01515020,daptomycin monotherapy,DRUG,Nosocomial Infection; Healthcare-associated Infection,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04509024,Incidental training,BEHAVIORAL,Healthy; Language,na,TERMINATED,Carnegie Mellon University,
NCT04509024,Explicit training,BEHAVIORAL,Healthy; Language,na,TERMINATED,Carnegie Mellon University,
NCT04509024,Classroom training,BEHAVIORAL,Healthy; Language,na,TERMINATED,Carnegie Mellon University,
NCT04509024,Classroom and incidental training,BEHAVIORAL,Healthy; Language,na,TERMINATED,Carnegie Mellon University,
NCT04509024,Classroom and explicit training,BEHAVIORAL,Healthy; Language,na,TERMINATED,Carnegie Mellon University,
NCT01336959,BCT197 Part A,DRUG,Acute Kidney Injury,phase2,TERMINATED,Mereo BioPharma,
NCT01336959,Placebo,DRUG,Acute Kidney Injury,phase2,TERMINATED,Mereo BioPharma,
NCT01336959,BCT197 Part B,DRUG,Acute Kidney Injury,phase2,TERMINATED,Mereo BioPharma,
NCT02818959,JenaValve Pericardial TAVR System,DEVICE,Aortic Valve Stenosis; Heart Valve Diseases; Heart Diseases; Cardiovascular Diseases,na,TERMINATED,"JenaValve Technology, Inc.",
NCT00065117,ZD6126,DRUG,"Colorectal Neoplasms; Metastases, Neoplasm",phase2,TERMINATED,AstraZeneca,
NCT00065117,Placebo,DRUG,"Colorectal Neoplasms; Metastases, Neoplasm",phase2,TERMINATED,AstraZeneca,
NCT00065117,5-fluorouracil,DRUG,"Colorectal Neoplasms; Metastases, Neoplasm",phase2,TERMINATED,AstraZeneca,
NCT00065117,leucovorin,DRUG,"Colorectal Neoplasms; Metastases, Neoplasm",phase2,TERMINATED,AstraZeneca,
NCT00065117,oxaliplatin,DRUG,"Colorectal Neoplasms; Metastases, Neoplasm",phase2,TERMINATED,AstraZeneca,
NCT01605968,BCT Silver Bandage,DEVICE,Surgical Wound,na,TERMINATED,"Bio-medical Carbon Technology Co., Ltd.",
NCT01605968,Aquacel® Ag. Dressing,DEVICE,Surgical Wound,na,TERMINATED,"Bio-medical Carbon Technology Co., Ltd.",
NCT00765050,CD133+ cells transplant,BIOLOGICAL,Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF,phase1; phase2,TERMINATED,PETHEMA Foundation,
NCT02862691,Acetaminophen/Oxycodone (Oral analgesic),DRUG,Toothache,phase2,TERMINATED,Stony Brook University,
NCT02862691,Bupivicaine (Injectable local anesthetic),DRUG,Toothache,phase2,TERMINATED,Stony Brook University,
NCT04140474,Archimedes procedure,DEVICE,Bronchoscopy; Lung Cancer; Solitary Pulmonary Nodule,na,TERMINATED,"University Hospital, Limoges",
NCT02415010,Enterprise 2 Vascular Reconstruction Device,DEVICE,Intracranial Aneurysm,na,TERMINATED,"Cerenovus, Part of DePuy Synthes Products, Inc.",
NCT00087620,XELODA [capecitabine],DRUG,Breast Cancer,phase4,TERMINATED,Hoffmann-La Roche,
NCT01648959,EEG Recording,OTHER,Complex Partial Seizures,na,TERMINATED,"University Health Network, Toronto",
NCT00620659,Comparator: MK0249,DRUG,"Sleep Apnea, Obstructive; Hypopnea Syndrome; Excessive Daytime Sleepiness",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00620659,Comparator: placebo,DRUG,"Sleep Apnea, Obstructive; Hypopnea Syndrome; Excessive Daytime Sleepiness",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00620659,Comparator: modafinil,DRUG,"Sleep Apnea, Obstructive; Hypopnea Syndrome; Excessive Daytime Sleepiness",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00043459,intravenous T900607-sodium,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Tularik,
NCT01816659,Metformin ER,DRUG,Colorectal Carcinoma,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT03708380,Dietary intervention,BEHAVIORAL,Diabetes,na,TERMINATED,NYU Langone Health,
NCT04927247,Inclacumab,DRUG,Sickle Cell Disease; Vaso-occlusive Crisis; Vaso-occlusive Pain Episode in Sickle Cell Disease,phase3,TERMINATED,Pfizer,
NCT04927247,Placebo,DRUG,Sickle Cell Disease; Vaso-occlusive Crisis; Vaso-occlusive Pain Episode in Sickle Cell Disease,phase3,TERMINATED,Pfizer,
NCT00064649,Transurethral Microwave Thermotherapy (TUMT),DEVICE,Benign Prostatic Hyperplasia,phase3,TERMINATED,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
NCT00064649,Transurethral Needle Ablation (TUNA) Therapy,DEVICE,Benign Prostatic Hyperplasia,phase3,TERMINATED,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
NCT00064649,Finasteride and Alfuzosin,DRUG,Benign Prostatic Hyperplasia,phase3,TERMINATED,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
NCT05516758,Peresolimab,DRUG,Rheumatoid Arthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases,phase2,TERMINATED,Eli Lilly and Company,
NCT05516758,Placebo,DRUG,Rheumatoid Arthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases,phase2,TERMINATED,Eli Lilly and Company,
NCT02510248,AL-704,DRUG,Chronic Hepatitits C,phase1,TERMINATED,Alios Biopharma Inc.,
NCT02510248,Placebo,DRUG,Chronic Hepatitits C,phase1,TERMINATED,Alios Biopharma Inc.,
NCT00126178,HSPPC-96,BIOLOGICAL,Kidney Cancer; Renal Cell Carcinoma,phase3,TERMINATED,Agenus Inc.,
NCT00187135,Fentanyl,DRUG,Bone Marrow Disease; Pain,phase3,TERMINATED,St. Jude Children's Research Hospital,
NCT00187135,EMLA,DRUG,Bone Marrow Disease; Pain,phase3,TERMINATED,St. Jude Children's Research Hospital,
NCT00187135,L.M.X4,DRUG,Bone Marrow Disease; Pain,phase3,TERMINATED,St. Jude Children's Research Hospital,
NCT00187135,Propofol,DRUG,Bone Marrow Disease; Pain,phase3,TERMINATED,St. Jude Children's Research Hospital,
NCT05238025,MVA-BN-RSV vaccine,BIOLOGICAL,Respiratory Syncytial Virus Infections,phase3,TERMINATED,Bavarian Nordic,
NCT05238025,Tris Buffered Saline (TBS),BIOLOGICAL,Respiratory Syncytial Virus Infections,phase3,TERMINATED,Bavarian Nordic,
NCT00606476,Bapineuzumab (AAB-001),DRUG,Alzheimer's Disease,phase2,TERMINATED,"JANSSEN Alzheimer Immunotherapy Research & Development, LLC",
NCT02373540,Algovita Spinal Cord Stimulation system,DEVICE,Chronic Pain,na,TERMINATED,Nuvectra,
NCT01755650,18F FPM,RADIATION,Squamous Cell Carcinoma,early_phase1,TERMINATED,"Peter MacCallum Cancer Centre, Australia",
NCT00276991,"""Kallunk oxide (Immunotherapy) """,DRUG,HIV Infections,phase1; phase2,TERMINATED,"Traditional Alternative Medicine Research, India",
NCT02277210,Flushing,OTHER,Infertility,na,TERMINATED,The University of Hong Kong,
NCT04757610,2.0 mg OPT-302,BIOLOGICAL,Neovascular Age-related Macular Degeneration,phase3,TERMINATED,Opthea Limited,
NCT04757610,0.5 mg ranibizumab,BIOLOGICAL,Neovascular Age-related Macular Degeneration,phase3,TERMINATED,Opthea Limited,
NCT04757610,Sham,PROCEDURE,Neovascular Age-related Macular Degeneration,phase3,TERMINATED,Opthea Limited,
NCT02044510,Mirabegron,DRUG,"Urinary Bladder, Neurogenic",phase2; phase3,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02044510,Placebo,DRUG,"Urinary Bladder, Neurogenic",phase2; phase3,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT01338025,HAART regimen,DRUG,HIV Disease,phase4,TERMINATED,International Maternal Pediatric Adolescent AIDS Clinical Trials Group,
NCT01338025,3TC or FTC monotherapy,DRUG,HIV Disease,phase4,TERMINATED,International Maternal Pediatric Adolescent AIDS Clinical Trials Group,
NCT02279576,Pazopanib,DRUG,Penile Squamous Cell Carcinoma Stage IV,phase2,TERMINATED,Spanish Oncology Genito-Urinary Group,
NCT02279576,Paclitaxel,DRUG,Penile Squamous Cell Carcinoma Stage IV,phase2,TERMINATED,Spanish Oncology Genito-Urinary Group,
NCT00147550,PD-0325901,DRUG,Melanoma; Colonic Neoplasms; Breast Neoplasms,phase1; phase2,TERMINATED,Pfizer,
NCT00947674,Cellsorba EX,DEVICE,Ulcerative Colitis,phase4,TERMINATED,"Asahi Kasei Medical Co., Ltd.",
NCT01975389,bococizumab (PF-04950615),DRUG,Cardiovascular Disease,phase3,TERMINATED,Pfizer,
NCT01975389,Placebo,DRUG,Cardiovascular Disease,phase3,TERMINATED,Pfizer,
NCT01379274,Lenalidomide and azacitidine combination,DRUG,MDS,phase2,TERMINATED,Rush University Medical Center,
NCT05326074,Animal assisted therapy cohort,OTHER,Anxiety; Depression; Psychiatric or Mood Diseases or Conditions,na,TERMINATED,Wake Forest University Health Sciences,
NCT03327974,DEPASSE Apllication,OTHER,Current Major Depressive Disorder,na,TERMINATED,"University Hospital, Montpellier",
NCT05481918,Home-based therapy after ACL reconstruction,PROCEDURE,Anterior Cruciate Ligament Reconstruction,na,TERMINATED,Karl Landsteiner University of Health Sciences,
NCT05481918,Standardized ambulant therapy after ACL reconstruction,PROCEDURE,Anterior Cruciate Ligament Reconstruction,na,TERMINATED,Karl Landsteiner University of Health Sciences,
NCT00420810,MK0928 / Duration of Treatment : 8 Weeks,DRUG,Primary Insomnia,phase3,TERMINATED,H. Lundbeck A/S,
NCT05693610,Portable OSP,DEVICE,"Hearing Loss; Hearing Loss, Sensorineural",na,TERMINATED,Northwestern University,
NCT05693610,Cloud-based OSP,DEVICE,"Hearing Loss; Hearing Loss, Sensorineural",na,TERMINATED,Northwestern University,
NCT03893318,IV lidocaine,DRUG,Systemic Lidocaine Improves Pain Control After Surgery by Attenuating the Systemic Inflammatory Response to Surgery,phase4,TERMINATED,Washington University School of Medicine,
NCT03893318,Placebos,DRUG,Systemic Lidocaine Improves Pain Control After Surgery by Attenuating the Systemic Inflammatory Response to Surgery,phase4,TERMINATED,Washington University School of Medicine,
NCT01667913,6 minutes walking test,OTHER,Hip Fracture,na,TERMINATED,"Lolland Community, Denmark",
NCT01001260,No ASA,DRUG,Coronary Artery Disease; Acute Coronary Syndrome; Stable Angina,na,TERMINATED,University of Pennsylvania,
NCT01001260,Low dose ASA,DRUG,Coronary Artery Disease; Acute Coronary Syndrome; Stable Angina,na,TERMINATED,University of Pennsylvania,
NCT01001260,325 mg ASA,DRUG,Coronary Artery Disease; Acute Coronary Syndrome; Stable Angina,na,TERMINATED,University of Pennsylvania,
NCT04634604,Bevacizumab,DRUG,Retinopathy of Prematurity,phase3,TERMINATED,Jaeb Center for Health Research,
NCT04634604,Laser,PROCEDURE,Retinopathy of Prematurity,phase3,TERMINATED,Jaeb Center for Health Research,
NCT03608033,OMS721,BIOLOGICAL,IgA Nephropathy,phase3,TERMINATED,Omeros Corporation,
NCT03608033,Vehicle (D5W or saline),OTHER,IgA Nephropathy,phase3,TERMINATED,Omeros Corporation,
NCT00640549,Atorvastatin,DRUG,"Hyperlipidemia; Diabetes Mellitus, Type 2; Non-Insulin Dependent Diabetes Mellitus",phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT00640549,Placebo,DRUG,"Hyperlipidemia; Diabetes Mellitus, Type 2; Non-Insulin Dependent Diabetes Mellitus",phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT00555048,alemtuzumab,BIOLOGICAL,Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00555048,busulfan,DRUG,Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00555048,cyclophosphamide,DRUG,Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00555048,methotrexate,DRUG,Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00555048,tacrolimus,DRUG,Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00555048,allogeneic hematopoietic stem cell transplantation,PROCEDURE,Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00555048,peripheral blood stem cell transplantation,PROCEDURE,Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT03283826,ATA188,BIOLOGICAL,Primary Progressive Multiple Sclerosis; Secondary Progressive Multiple Sclerosis,phase1; phase2,TERMINATED,Atara Biotherapeutics,
NCT03283826,Placebo,DRUG,Primary Progressive Multiple Sclerosis; Secondary Progressive Multiple Sclerosis,phase1; phase2,TERMINATED,Atara Biotherapeutics,
NCT04984278,Nabiximols,DRUG,Spasticity With Multiple Sclerosis,phase3,TERMINATED,Jazz Pharmaceuticals,
NCT04984278,Placebo,DRUG,Spasticity With Multiple Sclerosis,phase3,TERMINATED,Jazz Pharmaceuticals,
NCT01526785,Alglucosidase alfa,DRUG,Pompe Disease,phase4,TERMINATED,"Genzyme, a Sanofi Company",
NCT02479178,BIND-014 (docetaxel nanoparticles for injectable suspension),DRUG,Urothelial Carcinoma; Cholangiocarcinoma; Cervical Cancer; Squamous Cell Carcinoma of Head and Neck,phase2,TERMINATED,BIND Therapeutics,
NCT01801917,Placebo,DRUG,Polymyositis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01801917,BAF312,DRUG,Polymyositis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT00036517,PHY906,DRUG,Colorectal Neoplasms; Diarrhea,phase1; phase2,TERMINATED,PhytoCeutica,
NCT02230540,SelfCath (comparator),DEVICE,Spinal Cord Injuries,na,TERMINATED,Coloplast A/S,
NCT02230540,"Product A SelfCath and urine bag, Conveen Security+",DEVICE,Spinal Cord Injuries,na,TERMINATED,Coloplast A/S,
NCT02230540,"Product B SelfCath and urine bag, Conveen Contour",DEVICE,Spinal Cord Injuries,na,TERMINATED,Coloplast A/S,
NCT00892268,acupuncture therapy,PROCEDURE,Breast Cancer; Menopausal Symptoms; Pain,phase2,TERMINATED,University of Arizona,
NCT00892268,pain therapy,PROCEDURE,Breast Cancer; Menopausal Symptoms; Pain,phase2,TERMINATED,University of Arizona,
NCT03394768,No additional intervention,OTHER,"Cardiac Output, Low",na,TERMINATED,Changi General Hospital,
NCT01721850,control formula,OTHER,Infantile Colic,na,TERMINATED,HiPP GmbH & Co. Vertrieb KG,
NCT01721850,intervention formula 1,OTHER,Infantile Colic,na,TERMINATED,HiPP GmbH & Co. Vertrieb KG,
NCT01721850,intervention formula 2,OTHER,Infantile Colic,na,TERMINATED,HiPP GmbH & Co. Vertrieb KG,
NCT04260191,AMG 910,DRUG,Gastric and Gastroesophageal Junction Adenocarcinoma,phase1,TERMINATED,Amgen,
NCT00960297,Carboplatin,DRUG,Non-Small Cell Lung Cancer,phase2,TERMINATED,"SCRI Development Innovations, LLC",
NCT00960297,Paclitaxel,DRUG,Non-Small Cell Lung Cancer,phase2,TERMINATED,"SCRI Development Innovations, LLC",
NCT00960297,Bevacizumab,DRUG,Non-Small Cell Lung Cancer,phase2,TERMINATED,"SCRI Development Innovations, LLC",
NCT00962221,laboratory analysis,PROCEDURE,Subclinical Hypothyroidism,na,TERMINATED,"HaEmek Medical Center, Israel",
NCT02850406,Voxelotor,DRUG,Sickle Cell Disease,phase2,TERMINATED,Pfizer,
NCT03494933,CRT-P implantation,PROCEDURE,Chronic Heart Failure,na,TERMINATED,Helios Health Institute GmbH,
NCT03494933,CRT-D implantation,PROCEDURE,Chronic Heart Failure,na,TERMINATED,Helios Health Institute GmbH,
NCT01170949,Miltefosine,DRUG,Chronic Urticaria,phase2,TERMINATED,Marcus Maurer,
NCT01170949,Placebo,DRUG,Chronic Urticaria,phase2,TERMINATED,Marcus Maurer,
NCT03054038,Afatinib,DRUG,Non-Small Cell Lung Carcinoma,phase1,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT03054038,Necitumumab,BIOLOGICAL,Non-Small Cell Lung Carcinoma,phase1,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT03054038,Laboratory Biomarker Analysis,OTHER,Non-Small Cell Lung Carcinoma,phase1,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT05280158,mRNA-1273 (Moderna COVID-19 vaccine),DRUG,Lung Transplant Recipient; SARS-CoV-2; Immunosuppression,phase1; phase2,TERMINATED,"University of California, Los Angeles",
NCT00280085,MR imaging,PROCEDURE,Diabetes Mellitus,na,TERMINATED,Pfizer,
NCT00280085,Glucose clamp,PROCEDURE,Diabetes Mellitus,na,TERMINATED,Pfizer,
NCT00280085,Arginine,DRUG,Diabetes Mellitus,na,TERMINATED,Pfizer,
NCT03257215,Stoss vitamin D,DRUG,Atopic Dermatitis,phase4,TERMINATED,Murdoch Childrens Research Institute,
NCT03257215,Daily vitamin D,DRUG,Atopic Dermatitis,phase4,TERMINATED,Murdoch Childrens Research Institute,
NCT03257215,Stoss placebo,DRUG,Atopic Dermatitis,phase4,TERMINATED,Murdoch Childrens Research Institute,
NCT03257215,Daily placebo,DRUG,Atopic Dermatitis,phase4,TERMINATED,Murdoch Childrens Research Institute,
NCT04517435,ME-401,DRUG,Diffuse Large B-Cell Lymphoma,phase1; phase2,TERMINATED,Deepa Jagadeesh,
NCT04517435,Rituximab,DRUG,Diffuse Large B-Cell Lymphoma,phase1; phase2,TERMINATED,Deepa Jagadeesh,
NCT04517435,Cyclophosphamide,DRUG,Diffuse Large B-Cell Lymphoma,phase1; phase2,TERMINATED,Deepa Jagadeesh,
NCT04517435,Doxorubicin,DRUG,Diffuse Large B-Cell Lymphoma,phase1; phase2,TERMINATED,Deepa Jagadeesh,
NCT04517435,Vincristine,DRUG,Diffuse Large B-Cell Lymphoma,phase1; phase2,TERMINATED,Deepa Jagadeesh,
NCT04517435,Prednisone,DRUG,Diffuse Large B-Cell Lymphoma,phase1; phase2,TERMINATED,Deepa Jagadeesh,
NCT03813108,CPS-immunization,BIOLOGICAL,"Malaria,Falciparum; Controlled Human Malaria Infection; Immunization; Infection",na,TERMINATED,Radboud University Medical Center,
NCT03813108,"malaria challenge infection, P. falciparum NF135.C10",BIOLOGICAL,"Malaria,Falciparum; Controlled Human Malaria Infection; Immunization; Infection",na,TERMINATED,Radboud University Medical Center,
NCT03813108,"malaria challenge infection, P. falciparum NF54",BIOLOGICAL,"Malaria,Falciparum; Controlled Human Malaria Infection; Immunization; Infection",na,TERMINATED,Radboud University Medical Center,
NCT03813108,CPS-immunization (A/L),BIOLOGICAL,"Malaria,Falciparum; Controlled Human Malaria Infection; Immunization; Infection",na,TERMINATED,Radboud University Medical Center,
NCT03813108,Atovaquone / Proguanil Oral Tablet [Malarone],DRUG,"Malaria,Falciparum; Controlled Human Malaria Infection; Immunization; Infection",na,TERMINATED,Radboud University Medical Center,
NCT00291850,"Paclitaxel, Cisplatin, Pegfilgrastim",DRUG,Non-Small Cell Lung Cancer,phase2,TERMINATED,Central European Cooperative Oncology Group,
NCT03764306,Carotid Artery Stenting,PROCEDURE,"Carotid Artery Stenosis; Carotid Atherosclerosis; Stroke, Ischemic",na,TERMINATED,Jagiellonian University,
NCT03764306,Endarterectomy carotid artery,PROCEDURE,"Carotid Artery Stenosis; Carotid Atherosclerosis; Stroke, Ischemic",na,TERMINATED,Jagiellonian University,
NCT02734147,Ascorbic Acid,DRUG,Sepsis,phase2,TERMINATED,Christiana Care Health Services,
NCT02734147,Normal Saline,OTHER,Sepsis,phase2,TERMINATED,Christiana Care Health Services,
NCT04642638,INO-4800,DRUG,Coronavirus Infection; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); COVID-19 Disease,phase2; phase3,TERMINATED,Inovio Pharmaceuticals,
NCT04642638,CELLECTRA® 2000,DEVICE,Coronavirus Infection; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); COVID-19 Disease,phase2; phase3,TERMINATED,Inovio Pharmaceuticals,
NCT04642638,Placebo,DRUG,Coronavirus Infection; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); COVID-19 Disease,phase2; phase3,TERMINATED,Inovio Pharmaceuticals,
NCT04642638,CELLECTRA® 2000,DEVICE,Coronavirus Infection; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); COVID-19 Disease,phase2; phase3,TERMINATED,Inovio Pharmaceuticals,
NCT03203447,suprachoroidal CLS-TA,DRUG,Macular Edema; Retinal Vein Occlusion,phase3,TERMINATED,"Clearside Biomedical, Inc.",
NCT03203447,suprachoroidal sham,DRUG,Macular Edema; Retinal Vein Occlusion,phase3,TERMINATED,"Clearside Biomedical, Inc.",
NCT03203447,Lucentis or Avastin,DRUG,Macular Edema; Retinal Vein Occlusion,phase3,TERMINATED,"Clearside Biomedical, Inc.",
NCT04940949,Lu AF90103,DRUG,Healthy,phase1,TERMINATED,H. Lundbeck A/S,
NCT04940949,Placebo,DRUG,Healthy,phase1,TERMINATED,H. Lundbeck A/S,
NCT01252355,Teriflunomide,DRUG,Multiple Sclerosis Relapse,phase3,TERMINATED,Sanofi,
NCT01252355,Placebo (for teriflunomide),DRUG,Multiple Sclerosis Relapse,phase3,TERMINATED,Sanofi,
NCT01252355,Interferon-beta (IFN-beta),DRUG,Multiple Sclerosis Relapse,phase3,TERMINATED,Sanofi,
NCT03935178,Measuring Right Ventricular Size and Function,OTHER,Pulmonary Hypertension; Valvular Heart Disease; Congenital Heart Disease; Congestive Heart Failure; Pulmonary Embolism; Acute Coronary Syndrome,na,TERMINATED,Dartmouth-Hitchcock Medical Center,
NCT02700308,Kyphoplasty,DEVICE,Solid Tumors; Spine Metastasis,phase2,TERMINATED,Centre Leon Berard,
NCT02700308,Conventional vertebroplasty,DEVICE,Solid Tumors; Spine Metastasis,phase2,TERMINATED,Centre Leon Berard,
NCT01844076,Quinacrine and Capecitabine,DRUG,Colorectal Adenocarcinoma,phase1; phase2,TERMINATED,Fox Chase Cancer Center,
NCT05287217,Comparison of medication administration for pain control,OTHER,Chronic Rhinosinusitis (Diagnosis),na,TERMINATED,University of Illinois at Chicago,
NCT03764540,Cabazitaxel plus prednisone,DRUG,Metastatic Prostate Cancer,phase2,TERMINATED,Centre hospitalier de l'Université de Montréal (CHUM),
NCT03764540,Docetaxel plus prednisone,DRUG,Metastatic Prostate Cancer,phase2,TERMINATED,Centre hospitalier de l'Université de Montréal (CHUM),
NCT02441140,Culdocentesis,PROCEDURE,Stage III Ovarian Cancer; Stage IV Ovarian Cancer,na,TERMINATED,Dana-Farber Cancer Institute,
NCT02441140,Vaginal Swab,PROCEDURE,Stage III Ovarian Cancer; Stage IV Ovarian Cancer,na,TERMINATED,Dana-Farber Cancer Institute,
NCT02441140,Chromopertubation,PROCEDURE,Stage III Ovarian Cancer; Stage IV Ovarian Cancer,na,TERMINATED,Dana-Farber Cancer Institute,
NCT02441140,Blood collection,PROCEDURE,Stage III Ovarian Cancer; Stage IV Ovarian Cancer,na,TERMINATED,Dana-Farber Cancer Institute,
NCT02441140,Tissue collection,PROCEDURE,Stage III Ovarian Cancer; Stage IV Ovarian Cancer,na,TERMINATED,Dana-Farber Cancer Institute,
NCT01366989,Radiographic evaluation of previously implanted patients,DEVICE,"Arthrodesis; Degenerative Arthritis; Rheumatoid Arthritis; Complications; Arthroplasty, Mechanical",na,TERMINATED,Stryker Trauma and Extremities,
NCT04679389,Placebo,DRUG,Pmm2-CDG; CDG1A,phase2; phase3,TERMINATED,Mayo Clinic,
NCT04679389,Acetazolamide,DRUG,Pmm2-CDG; CDG1A,phase2; phase3,TERMINATED,Mayo Clinic,
NCT01079104,Hepa Wash,DEVICE,Liver Dysfunction; Critical Illness,na,TERMINATED,Hepa Wash GmbH,
NCT01079104,Standard Medical Therapy,PROCEDURE,Liver Dysfunction; Critical Illness,na,TERMINATED,Hepa Wash GmbH,
NCT02005484,Trastuzumab,DRUG,Gastric Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT03077347,Transcranial Direct Current Stimulation,DEVICE,Schizophrenia,na,TERMINATED,"University of California, Davis",
NCT00818649,bortezomib,DRUG,Leukemia; Myelodysplastic Syndrome,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00818649,vorinostat,DRUG,Leukemia; Myelodysplastic Syndrome,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT02087449,E1-Hip Bearing,DEVICE,Osteoarthritis; Avascular Necrosis; Traumatic Arthritis; Rheumatoid Arthritis; Legg-perthes Disease,na,TERMINATED,Zimmer Biomet,
NCT03912649,RemovAid,DEVICE,Removal Contraceptive Implant,na,TERMINATED,RemovAid AS,
NCT01973985,Pleural Manometry,OTHER,Pleural Effusion,na,TERMINATED,University of Oxford,
NCT01973985,Thoracic ultrasonography,OTHER,Pleural Effusion,na,TERMINATED,University of Oxford,
NCT01973985,Pleural aspiration catheter OR chest drain (standard care),PROCEDURE,Pleural Effusion,na,TERMINATED,University of Oxford,
NCT01973985,Talc slurry pleurodesis via chest drain (standard care),PROCEDURE,Pleural Effusion,na,TERMINATED,University of Oxford,
NCT01195285,Single-Incision Laparoscopic Surgery cholecystectomy,PROCEDURE,Biliary Dyskinesia; Gallstones; Cholecystitis; Cholelithiasis,na,TERMINATED,Saint Luke's Health System,
NCT01195285,Traditional Laparoscopic Cholecystectomy (TLC),PROCEDURE,Biliary Dyskinesia; Gallstones; Cholecystitis; Cholelithiasis,na,TERMINATED,Saint Luke's Health System,
NCT05213143,Lurasidone,DRUG,Schizophrenia,phase4,TERMINATED,"Sumitomo Pharma (Suzhou) Co., Ltd.",
NCT00374543,Ziprasidone,DRUG,Generalized Anxiety Disorder; Bipolar Disorder,phase4,TERMINATED,Massachusetts General Hospital,
NCT00374543,Placebo,DRUG,Generalized Anxiety Disorder; Bipolar Disorder,phase4,TERMINATED,Massachusetts General Hospital,
NCT02957825,Continuous wireless monitoring,DEVICE,"Complication, Postoperative",na,TERMINATED,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),
NCT00215540,Lucinactant 175 mg/kg,DRUG,"Respiratory Distress Syndrome, Newborn; Premature Birth; Bronchopulmonary Dysplasia",phase2,TERMINATED,Windtree Therapeutics,
NCT00215540,Lucinactant 90 mg/kg,DRUG,"Respiratory Distress Syndrome, Newborn; Premature Birth; Bronchopulmonary Dysplasia",phase2,TERMINATED,Windtree Therapeutics,
NCT00215540,Placebo,DRUG,"Respiratory Distress Syndrome, Newborn; Premature Birth; Bronchopulmonary Dysplasia",phase2,TERMINATED,Windtree Therapeutics,
NCT00625040,"Oral glucose tolerance test (OGTT), isoglycemic iv. clamp, liquid meal test, gastric emptying rate",OTHER,Obesity,na,TERMINATED,"Glostrup University Hospital, Copenhagen",
NCT04679350,hzVSF-v13,DRUG,COVID-19,phase2,TERMINATED,"ImmuneMed, Inc.",
NCT04679350,Placebo (Normal saline solution),DRUG,COVID-19,phase2,TERMINATED,"ImmuneMed, Inc.",
NCT03627091,Ontamalimab,DRUG,Crohn's Disease,phase3,TERMINATED,Shire,
NCT03627091,Placebo,OTHER,Crohn's Disease,phase3,TERMINATED,Shire,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,Placebo capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,SLV354 capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT01133574,Placebo capsules,DRUG,Cognition Disorders,phase1,TERMINATED,Abbott,
NCT03560518,Rapastinel,DRUG,"Depressive Disorder, Major",phase3,TERMINATED,"Naurex, Inc, an affiliate of Allergan plc",
NCT03560518,Placebo,DRUG,"Depressive Disorder, Major",phase3,TERMINATED,"Naurex, Inc, an affiliate of Allergan plc",
NCT00658593,capecitabine,DRUG,Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer,phase3,TERMINATED,NCIC Clinical Trials Group,
NCT00658593,gemcitabine hydrochloride,DRUG,Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer,phase3,TERMINATED,NCIC Clinical Trials Group,
NCT00658593,quality-of-life assessment,PROCEDURE,Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer,phase3,TERMINATED,NCIC Clinical Trials Group,
NCT04521621,Gebasaxturev,BIOLOGICAL,Neoplasm Metastasis,phase1; phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT04521621,Pembrolizumab,DRUG,Neoplasm Metastasis,phase1; phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01921114,BioFlo™ Peripherally Inserted Central Catheter (PICC),DEVICE,Patients Indicated for a PICC for Any Medical Condition,na,TERMINATED,"Angiodynamics, Inc.",
NCT01921114,Bard® Dual-Lumen PowerPICC SOLO2®,DEVICE,Patients Indicated for a PICC for Any Medical Condition,na,TERMINATED,"Angiodynamics, Inc.",
NCT02319304,"FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}",DRUG,Rectal Adenocarcinoma,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT02319304,Low dose fractionated radiation therapy (LDFRT),RADIATION,Rectal Adenocarcinoma,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT00124033,Transcystic Stenting (Facilitated ERCP),PROCEDURE,Choledocholithiasis; Cholelithiasis,na,TERMINATED,South West Sydney Local Health District,
NCT00441584,PegIntron (peginterferon alfa-2b),BIOLOGICAL,"Hepatitis C, Chronic",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00441584,Rebetol (ribavirin),DRUG,"Hepatitis C, Chronic",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT02499952,Pembrolizumab,DRUG,"Germ Cell Neoplasms; Testicular Neoplasms; Non Seminomatous Germ Cell Tumors; Mediastinal Neoplasms; Genital Neoplasms, Male; Genital Neoplasms, Female; Ovarian Neoplasms",phase2,TERMINATED,"Nasser Hanna, M.D.",
NCT02584647,PLX3397,DRUG,Sarcoma; Malignant Peripheral Nerve Sheath Tumors,phase1; phase2,TERMINATED,Gulam Manji,
NCT02584647,sirolimus,DRUG,Sarcoma; Malignant Peripheral Nerve Sheath Tumors,phase1; phase2,TERMINATED,Gulam Manji,
NCT04495738,Control Infant Formula,OTHER,Respiratory Infections in Children,na,TERMINATED,Abbott Nutrition,
NCT04495738,Control Toddler Drink,OTHER,Respiratory Infections in Children,na,TERMINATED,Abbott Nutrition,
NCT04495738,Experimental Infant Formula,OTHER,Respiratory Infections in Children,na,TERMINATED,Abbott Nutrition,
NCT04495738,Experimental Toddler Drink,OTHER,Respiratory Infections in Children,na,TERMINATED,Abbott Nutrition,
NCT04495738,Supplemental Formula for HM Group,OTHER,Respiratory Infections in Children,na,TERMINATED,Abbott Nutrition,
NCT04495738,Toddler Drink for HM group,OTHER,Respiratory Infections in Children,na,TERMINATED,Abbott Nutrition,
NCT04227938,ALPN-101,DRUG,Graft Vs Host Disease,phase1,TERMINATED,"Alpine Immune Sciences, Inc.",
NCT03867058,Electrode selection/electrode configuration,BEHAVIORAL,Deafness,na,TERMINATED,East Carolina University,
NCT05861258,Minocycline,DRUG,Mycobacterium Avium Complex Pulmonary Disease,phase2,TERMINATED,Radboud University Medical Center,
NCT04171843,PBCAR269A,OTHER,Relapsed/Refractory Multiple Myeloma,phase1,TERMINATED,"Precision BioSciences, Inc.",
NCT04171843,Fludarabine,DRUG,Relapsed/Refractory Multiple Myeloma,phase1,TERMINATED,"Precision BioSciences, Inc.",
NCT04171843,Cyclophosphamide,DRUG,Relapsed/Refractory Multiple Myeloma,phase1,TERMINATED,"Precision BioSciences, Inc.",
NCT04171843,Nirogacestat,DRUG,Relapsed/Refractory Multiple Myeloma,phase1,TERMINATED,"Precision BioSciences, Inc.",
NCT05764915,RGT-264 phosphate tablets,DRUG,Advanced Solid Tumor,phase1,TERMINATED,Regor Pharmaceuticals Inc.,
NCT01468376,GLU-01,OTHER,Impaired Glucose Tolerance,phase1,TERMINATED,Afexa Life Sciences Inc,
NCT01468376,GLU-02,OTHER,Impaired Glucose Tolerance,phase1,TERMINATED,Afexa Life Sciences Inc,
NCT01468376,GLU-03,OTHER,Impaired Glucose Tolerance,phase1,TERMINATED,Afexa Life Sciences Inc,
NCT01468376,GLU-04,OTHER,Impaired Glucose Tolerance,phase1,TERMINATED,Afexa Life Sciences Inc,
NCT01468376,GLU-05,OTHER,Impaired Glucose Tolerance,phase1,TERMINATED,Afexa Life Sciences Inc,
NCT01468376,GLU-06,OTHER,Impaired Glucose Tolerance,phase1,TERMINATED,Afexa Life Sciences Inc,
NCT03137576,Paravertebral Block (PVB),PROCEDURE,Lung Neoplasms,na,TERMINATED,IRCCS Sacro Cuore Don Calabria di Negrar,
NCT03137576,Erector Spinae Plane Block (ESPB),PROCEDURE,Lung Neoplasms,na,TERMINATED,IRCCS Sacro Cuore Don Calabria di Negrar,
NCT05417217,Discontinued ventilation,PROCEDURE,Cardiovascular Diseases; Coronary Artery Disease; Myocardial Ischemia; Hypoxia,na,TERMINATED,Jessa Hospital,
NCT05417217,Continued ventilation,PROCEDURE,Cardiovascular Diseases; Coronary Artery Disease; Myocardial Ischemia; Hypoxia,na,TERMINATED,Jessa Hospital,
NCT03435640,NKTR-262,DRUG,Melanoma; Merkel Cell Carcinoma; Triple Negative Breast Cancer; Head and Neck Squamous Cell Carcinoma; Renal Cell Carcinoma; Colorectal Cancer; Sarcoma,phase1; phase2,TERMINATED,Nektar Therapeutics,
NCT03435640,bempegaldesleukin,DRUG,Melanoma; Merkel Cell Carcinoma; Triple Negative Breast Cancer; Head and Neck Squamous Cell Carcinoma; Renal Cell Carcinoma; Colorectal Cancer; Sarcoma,phase1; phase2,TERMINATED,Nektar Therapeutics,
NCT03435640,nivolumab,DRUG,Melanoma; Merkel Cell Carcinoma; Triple Negative Breast Cancer; Head and Neck Squamous Cell Carcinoma; Renal Cell Carcinoma; Colorectal Cancer; Sarcoma,phase1; phase2,TERMINATED,Nektar Therapeutics,
NCT04343976,Pegylated interferon lambda,DRUG,COVID-19; COVID,phase2,TERMINATED,Raymond Chung,
NCT01132768,Atenolol,DRUG,Essential Hypertension; Carotid Plaque,phase4,TERMINATED,"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company",
NCT01132768,olmesartan medoxomil,DRUG,Essential Hypertension; Carotid Plaque,phase4,TERMINATED,"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company",
NCT03716050,Nitroglycerin,DRUG,Perfusion; Complications,phase2; phase3,TERMINATED,Wake Forest University Health Sciences,
NCT03716050,Negative Pressure Wound Therapy/ Wound VAC,DEVICE,Perfusion; Complications,phase2; phase3,TERMINATED,Wake Forest University Health Sciences,
NCT03716050,Fluorescent Angiography with indocyanine-green (not to exceed 5mg/kg),OTHER,Perfusion; Complications,phase2; phase3,TERMINATED,Wake Forest University Health Sciences,
NCT03716050,No treatment,OTHER,Perfusion; Complications,phase2; phase3,TERMINATED,Wake Forest University Health Sciences,
NCT05763121,Dexpramipexole Dihydrochloride,DRUG,Eosinophilic Asthma; Asthma; Eosinophilic; Asthma,phase3,TERMINATED,Areteia Therapeutics,
NCT05763121,Placebo,DRUG,Eosinophilic Asthma; Asthma; Eosinophilic; Asthma,phase3,TERMINATED,Areteia Therapeutics,
NCT02133521,DLBS1033,DRUG,Acute Ischemic Stroke; Partial Anterior Circulation Infarct; Lacunar Anterior Circulation Infarct,phase2; phase3,TERMINATED,Dexa Medica Group,
NCT02133521,Placebo,DRUG,Acute Ischemic Stroke; Partial Anterior Circulation Infarct; Lacunar Anterior Circulation Infarct,phase2; phase3,TERMINATED,Dexa Medica Group,
NCT03943147,BMS-986165,DRUG,Lupus Nephritis,phase2,TERMINATED,Bristol-Myers Squibb,
NCT03943147,Placebo,DRUG,Lupus Nephritis,phase2,TERMINATED,Bristol-Myers Squibb,
NCT03943147,Mycophenolate Mofetil,DRUG,Lupus Nephritis,phase2,TERMINATED,Bristol-Myers Squibb,
NCT02543749,DC vaccine,BIOLOGICAL,"Myeloid Leukemia, Chronic",phase1; phase2,TERMINATED,"Charite University, Berlin, Germany",
NCT04883138,GIGA-2050,DRUG,COVID-19,phase1,TERMINATED,"GigaGen, Inc.",
NCT04393038,ABX464,DRUG,COVID-19,phase2; phase3,TERMINATED,Abivax S.A.,
NCT04393038,Placebo,DRUG,COVID-19,phase2; phase3,TERMINATED,Abivax S.A.,
NCT02134015,Patritumab,DRUG,Lung Cancer; Non-small Cell Lung Cancer,phase3,TERMINATED,Daiichi Sankyo,
NCT02134015,Erlotinib,DRUG,Lung Cancer; Non-small Cell Lung Cancer,phase3,TERMINATED,Daiichi Sankyo,
NCT02134015,Placebo,DRUG,Lung Cancer; Non-small Cell Lung Cancer,phase3,TERMINATED,Daiichi Sankyo,
NCT02800135,Furosemide,DRUG,Critical Illness; Oliguria,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT00791076,Placebo,DRUG,"Diabetes Mellitus, Type 1",phase2,TERMINATED,Johns Hopkins University,
NCT00791076,Pancreatic Polypeptide (PP),DRUG,"Diabetes Mellitus, Type 1",phase2,TERMINATED,Johns Hopkins University,
NCT01732640,Afatinib,DRUG,Squamous Cell Carcinoma of the Head and Neck,phase1; phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01732640,Paclitaxel,DRUG,Squamous Cell Carcinoma of the Head and Neck,phase1; phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01732640,Carboplatin,DRUG,Squamous Cell Carcinoma of the Head and Neck,phase1; phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01732640,Cisplatin,DRUG,Squamous Cell Carcinoma of the Head and Neck,phase1; phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01732640,Intensity Modulated Radiation Therapy,RADIATION,Squamous Cell Carcinoma of the Head and Neck,phase1; phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00364689,Rifaximin,DRUG,Hepatic Encephalopathy,phase3,TERMINATED,University of Miami,
NCT00364689,Lactulose,DRUG,Hepatic Encephalopathy,phase3,TERMINATED,University of Miami,
NCT00364689,Placebo,OTHER,Hepatic Encephalopathy,phase3,TERMINATED,University of Miami,
NCT00932191,Standard phacoemulsification,PROCEDURE,Cataracts,phase2; phase3,TERMINATED,"University of California, San Francisco",
NCT00932191,Reduced ultrasound phacoemulsification,PROCEDURE,Cataracts,phase2; phase3,TERMINATED,"University of California, San Francisco",
NCT01060865,Aliskiren,DRUG,"Blood Pressure, High",phase4,TERMINATED,Meir Medical Center,
NCT01280565,Masitinib,DRUG,Metastatic Melanoma,phase3,TERMINATED,AB Science,
NCT01280565,Dacarbazine,DRUG,Metastatic Melanoma,phase3,TERMINATED,AB Science,
NCT01713907,Ulthera® Treatment,DEVICE,Wrinkles; Rhytids; Skin Laxity,na,TERMINATED,"Ulthera, Inc",
NCT03988192,VOC analysis,DEVICE,"Lung Cancer, Non-small Cell",na,TERMINATED,Hopital Foch,
NCT02532036,Aerosol inhaled MVA85A,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,University of Oxford,
NCT02532036,Intramuscular MVA85A,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,University of Oxford,
NCT02532036,Intramuscular Saline placebo,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,University of Oxford,
NCT02532036,Aerosol inhaled Saline placebo,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,University of Oxford,
NCT00646971,CPAP device,DEVICE,Obstructive Sleep Apnea Syndrome; Endothelial Dysfunction; Oxidative Stress; Intermittent Hypoxia; Cardiovascular Risk,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00646971,Placebo device,DEVICE,Obstructive Sleep Apnea Syndrome; Endothelial Dysfunction; Oxidative Stress; Intermittent Hypoxia; Cardiovascular Risk,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02731144,Peptamen intense,OTHER,Sepsis; Septic Shock,phase4,TERMINATED,Hospital Sao Domingos,
NCT02731144,Novasource senior,OTHER,Sepsis; Septic Shock,phase4,TERMINATED,Hospital Sao Domingos,
NCT01201434,Bio-25 probiotic,OTHER,Cystic Fibrosis,na,TERMINATED,Sheba Medical Center,
NCT03382899,Pegilodecakin,BIOLOGICAL,Non Small Cell Lung Cancer,phase2,TERMINATED,Eli Lilly and Company,
NCT03382899,Pembrolizumab,DRUG,Non Small Cell Lung Cancer,phase2,TERMINATED,Eli Lilly and Company,
NCT01616199,PX-866,DRUG,Advanced BRAF-mutant Cancers,phase1; phase2,TERMINATED,Cascadian Therapeutics Inc.,
NCT01616199,vemurafenib,DRUG,Advanced BRAF-mutant Cancers,phase1; phase2,TERMINATED,Cascadian Therapeutics Inc.,
NCT03663699,Exergaming,BEHAVIORAL,Sedentary Lifestyle,na,TERMINATED,Norwegian University of Science and Technology,
NCT00637832,rituximab,BIOLOGICAL,Lymphoma,phase2,TERMINATED,University of Southampton,
NCT00637832,cyclophosphamide,DRUG,Lymphoma,phase2,TERMINATED,University of Southampton,
NCT00637832,doxorubicin hydrochloride,DRUG,Lymphoma,phase2,TERMINATED,University of Southampton,
NCT00637832,prednisolone,DRUG,Lymphoma,phase2,TERMINATED,University of Southampton,
NCT00637832,vincristine sulfate,DRUG,Lymphoma,phase2,TERMINATED,University of Southampton,
NCT00637832,yttrium Y 90 ibritumomab tiuxetan,RADIATION,Lymphoma,phase2,TERMINATED,University of Southampton,
NCT03997487,TOFTEE,OTHER,Trachoma,na,TERMINATED,London School of Hygiene and Tropical Medicine,
NCT00442416,Epoetin alfa,DRUG,Anemia,phase3,TERMINATED,Hoffmann-La Roche,
NCT00442416,methoxy polyethylene glycol-epoetin beta [Mircera],DRUG,Anemia,phase3,TERMINATED,Hoffmann-La Roche,
NCT02924506,Mobi-C prothesis,DEVICE,Neck Pain; Back Pain,na,TERMINATED,Centre Hospitalier Régional d'Orléans,
NCT02924506,ProDisc-C prothesis,DEVICE,Neck Pain; Back Pain,na,TERMINATED,Centre Hospitalier Régional d'Orléans,
NCT01068184,AZD6553,DRUG,Chronic Obstructive Pulmonary Disease,phase1,TERMINATED,AstraZeneca,
NCT01068184,Placebo,DRUG,Chronic Obstructive Pulmonary Disease,phase1,TERMINATED,AstraZeneca,
NCT01054404,Furosemide,DRUG,Brain Swelling; Brain Edema; Dehydration,na,TERMINATED,Northwestern University,
NCT01054404,Placebo,DRUG,Brain Swelling; Brain Edema; Dehydration,na,TERMINATED,Northwestern University,
NCT02953106,Azelastine-Fluticasone Nasal,DRUG,"Asthma, Allergic; Rhinitis,Allergic; Allergy",phase4,TERMINATED,University of Dundee,
NCT02953106,Placebos,DRUG,"Asthma, Allergic; Rhinitis,Allergic; Allergy",phase4,TERMINATED,University of Dundee,
NCT00144833,fosamprenavir/ritonavir (700mg/100mg BID),DRUG,HIV-1,phase3,TERMINATED,GlaxoSmithKline,
NCT00144833,fosamprenavir/ritonavir (1400mg/100mg BID),DRUG,HIV-1,phase3,TERMINATED,GlaxoSmithKline,
NCT00144833,fosamprenavir/lopinavir/ritonavir (1400mg/533mg/100mg BID),DRUG,HIV-1,phase3,TERMINATED,GlaxoSmithKline,
NCT00038649,Gleevec,DRUG,"Myelogenous Leukemia, Chronic, Chronic Phase",phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01649258,granisetron transdermal system,DRUG,Breast Cancer; Nausea; Vomiting,phase1,TERMINATED,University of Southern California,
NCT01649258,fosaprepitant dimeglumine,DRUG,Breast Cancer; Nausea; Vomiting,phase1,TERMINATED,University of Southern California,
NCT01649258,laboratory biomarker analysis,OTHER,Breast Cancer; Nausea; Vomiting,phase1,TERMINATED,University of Southern California,
NCT01665248,18-F Sodium Fluoride Uptake in Positron emission tomography,OTHER,Coronary Artery Diseases,na,TERMINATED,"CHEOL WHAN LEE, MD, PhD.",
NCT01676415,Prednisone,DRUG,Chronic Rhinosinusitis Without Nasal Polyps,phase4,TERMINATED,Northwestern University,
NCT01676415,Topical mometasone,DRUG,Chronic Rhinosinusitis Without Nasal Polyps,phase4,TERMINATED,Northwestern University,
NCT02494635,Laboratory Biomarker Analysis,OTHER,Bladder Papillary Urothelial Carcinoma; Stage 0a Bladder Urothelial Carcinoma; Stage 0is Bladder Urothelial Carcinoma; Stage I Bladder Cancer With Carcinoma In Situ; Stage I Bladder Urothelial Carcino,na,TERMINATED,University of Southern California,
NCT04016935,Observational,OTHER,Primary Invasive Breast Cancer,na,TERMINATED,"Myriad Genetic Laboratories, Inc.",
NCT04209725,CPX-351,DRUG,"Leukemia, Myeloid, Acute",phase2,TERMINATED,"SCRI Development Innovations, LLC",
NCT04209725,Quizartinib,DRUG,"Leukemia, Myeloid, Acute",phase2,TERMINATED,"SCRI Development Innovations, LLC",
NCT06322576,177Lu-PNT2002,DRUG,Adenoid Cystic Carcinoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT02324868,Shower patch IV catheter protection,DEVICE,Cystic Fibrosis; Pulmonary Hypertension; Neoplasms,na,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT02324868,Conventional IV catheter protection,DEVICE,Cystic Fibrosis; Pulmonary Hypertension; Neoplasms,na,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT04403646,ARBOX,OTHER,COVID-19; SARS-CoV 2; Coronavirus Infection,na,TERMINATED,Hospital de Clinicas José de San Martín,
NCT04403646,PLACEBO,OTHER,COVID-19; SARS-CoV 2; Coronavirus Infection,na,TERMINATED,Hospital de Clinicas José de San Martín,
NCT01908803,AL-60371/AL-817 otic suspension,DRUG,Acute Otitis Media,phase2,TERMINATED,Alcon Research,
NCT01908803,Ciprofloxacin 0.3%/dexamethasone 0.1% otic suspension,DRUG,Acute Otitis Media,phase2,TERMINATED,Alcon Research,
NCT01788761,Probiotic Supplemented Group,OTHER,Feeding Tolerance,na,TERMINATED,Mercy Health System,
NCT01788761,Control Group,OTHER,Feeding Tolerance,na,TERMINATED,Mercy Health System,
NCT00315042,Telithromycin (HMR3647),DRUG,Tonsillitis; Pharyngitis,phase3,TERMINATED,Sanofi,
NCT00315042,Penicillin,DRUG,Tonsillitis; Pharyngitis,phase3,TERMINATED,Sanofi,
NCT03605342,Buprenorphine,DRUG,Post-Traumatic Stress Disorders; Opiate Use Disorder,phase2,TERMINATED,VA Office of Research and Development,
NCT03605342,Cognitive Processing Therapy (CPT),BEHAVIORAL,Post-Traumatic Stress Disorders; Opiate Use Disorder,phase2,TERMINATED,VA Office of Research and Development,
NCT03605342,Individual Drug Counseling (IDC),BEHAVIORAL,Post-Traumatic Stress Disorders; Opiate Use Disorder,phase2,TERMINATED,VA Office of Research and Development,
NCT01562873,Ruxolitinib,DRUG,Breast Cancer,phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT04990973,Average American Diet (AAD),BEHAVIORAL,Sleep,na,TERMINATED,Columbia University,
NCT04990973,Mediterranean Diet,BEHAVIORAL,Sleep,na,TERMINATED,Columbia University,
NCT01234883,multiple electrolyte solution,DRUG,Dehydration; Gastroenteritis,phase4,TERMINATED,Baxter Healthcare Corporation,
NCT01234883,saline,DRUG,Dehydration; Gastroenteritis,phase4,TERMINATED,Baxter Healthcare Corporation,
NCT03060954,MINI WELL READY ®,DEVICE,Cataract; Presbyopia,na,TERMINATED,SIFI SpA,
NCT03060954,FINE VISION®,DEVICE,Cataract; Presbyopia,na,TERMINATED,SIFI SpA,
NCT02351505,Selinexor,DRUG,Recurrent Small Cell Lung Carcinoma,phase2,TERMINATED,Erin Bertino,
NCT02351505,Laboratory Biomarker Analysis,OTHER,Recurrent Small Cell Lung Carcinoma,phase2,TERMINATED,Erin Bertino,
NCT02351505,Pharmacological Study,OTHER,Recurrent Small Cell Lung Carcinoma,phase2,TERMINATED,Erin Bertino,
NCT01680029,PBASE-system 2.0,DEVICE,Acute Migraine,na,TERMINATED,Chordate Medical,
NCT01518153,Fludarabine,DRUG,Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01518153,Melphalan,DRUG,Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01518153,Alemtuzumab,DRUG,Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01518153,Stem Cell Infusion,PROCEDURE,Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01518153,Tacrolimus,DRUG,Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01518153,Methotrexate,DRUG,Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01518153,G-CSF,DRUG,Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01518153,Low Dose Donor T-Cells,PROCEDURE,Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01518153,High Dose Donor T-Cells,PROCEDURE,Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00715845,Carbon dioxide insufflation,PROCEDURE,Cardiovascular Disease; Mitral Valve Repair; Cerebral Microemboli; Cognitive Decline,phase2; phase3,TERMINATED,"University Health Network, Toronto",
NCT03938272,Oxabact OC5 - Oxalobacter formigenes Strain HC-1,BIOLOGICAL,"Hyperoxaluria, Primary",phase3,TERMINATED,OxThera,
NCT02641795,Minimally invasive robotic cochlear implantation,DEVICE,Sensory Hearing Loss,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT01824095,Dietary supplement,OTHER,Ankle Sprains,phase3,TERMINATED,"Logan University, Inc.",
NCT02090439,Silodosin,DRUG,Kidney Stone; Expulsive Medical Therapy,phase3,TERMINATED,Centre Hospitalier Departemental Vendee,
NCT04978779,VIP152,DRUG,Relapsed Non Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Richter Syndrome; MYC Amplification; MYC Overexpression; MYC Translocation,phase1,TERMINATED,"Vincerx Pharma, Inc.",
NCT04978779,BTKi,DRUG,Relapsed Non Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Richter Syndrome; MYC Amplification; MYC Overexpression; MYC Translocation,phase1,TERMINATED,"Vincerx Pharma, Inc.",
NCT04990388,UX053,BIOLOGICAL,Glycogen Storage Disease Type III,phase1; phase2,TERMINATED,Ultragenyx Pharmaceutical Inc,
NCT04990388,Placebo,OTHER,Glycogen Storage Disease Type III,phase1; phase2,TERMINATED,Ultragenyx Pharmaceutical Inc,
NCT04990388,Antipyretic,DRUG,Glycogen Storage Disease Type III,phase1; phase2,TERMINATED,Ultragenyx Pharmaceutical Inc,
NCT04990388,H2 Blocker,DRUG,Glycogen Storage Disease Type III,phase1; phase2,TERMINATED,Ultragenyx Pharmaceutical Inc,
NCT04990388,H1 Blocker,DRUG,Glycogen Storage Disease Type III,phase1; phase2,TERMINATED,Ultragenyx Pharmaceutical Inc,
NCT05367661,CHK336,DRUG,Healthy Volunteers,phase1,TERMINATED,"Chinook Therapeutics, Inc.",
NCT05367661,Placebo,DRUG,Healthy Volunteers,phase1,TERMINATED,"Chinook Therapeutics, Inc.",
NCT00892242,Zoledronic acid,DRUG,Adenocarcinoma,phase1,TERMINATED,Washington University School of Medicine,
NCT00799942,Neramexane mesylate,DRUG,"Nystagmus, Congenital; Nystagmus, Acquired; Multiple Sclerosis",phase2,TERMINATED,Merz Pharmaceuticals GmbH,
NCT02956486,Elenbecestat,DRUG,Alzheimer's Disease,phase3,TERMINATED,"Eisai Co., Ltd.",
NCT02956486,Placebo,DRUG,Alzheimer's Disease,phase3,TERMINATED,"Eisai Co., Ltd.",
NCT02104154,Samsung LABGEO PT10 Hepatic Panel,DEVICE,Hepatic Disease,na,TERMINATED,Samsung Electronics,
NCT00758966,Fluoxetine 60 mg,DRUG,Obsessive-Compulsive Disorder,phase2,TERMINATED,"Orexigen Therapeutics, Inc",
NCT00758966,Naltrexone 32 mg and fluoxetine 60 mg,DRUG,Obsessive-Compulsive Disorder,phase2,TERMINATED,"Orexigen Therapeutics, Inc",
NCT00758966,Naltrexone SR 32 mg,DRUG,Obsessive-Compulsive Disorder,phase2,TERMINATED,"Orexigen Therapeutics, Inc",
NCT00276822,communication intervention,OTHER,Breast Cancer,na,TERMINATED,Northwestern University,
NCT02047851,Acupuncture,OTHER,Psoriasis; Arthralgia,na,TERMINATED,"University Hospital, Gentofte, Copenhagen",
NCT02369029,BAY 1238097,DRUG,Neoplasms,phase1,TERMINATED,Bayer,
NCT01027702,Infusion of donor lymphocytes,BIOLOGICAL,Immunodeficiency,phase1; phase2,TERMINATED,Wake Forest University Health Sciences,
NCT01480453,Trabecular Metal Humeral Stem,DEVICE,Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis; Ununited Humeral Head Fracture; Irreducible 3- and 4-part Proximal Humeral Fractures; Avascular Necrosis,na,TERMINATED,Zimmer Biomet,
NCT00351637,Sublingual Methadone,DRUG,Cancer; Pain,phase2,TERMINATED,Alberta Health services,
NCT04160039,Cycle ergometry,DEVICE,Liver Cirrhoses; Liver Failure; ICU Acquired Weakness,na,TERMINATED,Medical College of Wisconsin,
NCT04292275,Biobeat Wrist Watch,DEVICE,Heart Failure,na,TERMINATED,Amgen,
NCT04292275,Standard of Care,OTHER,Heart Failure,na,TERMINATED,Amgen,
NCT05135546,Recombinant nonimmunogenic staphylokinase,DRUG,COVID-19,phase2; phase3,TERMINATED,"Supergene, LLC",
NCT05135546,Placebo,DRUG,COVID-19,phase2; phase3,TERMINATED,"Supergene, LLC",
NCT02422446,Icosapent ethyl,DRUG,Type 2 Diabetes; Coronary Artery Disease,phase3,TERMINATED,Brigham and Women's Hospital,
NCT05327803,Epetraborole,DRUG,MAC Lung Disease; Treatment Refractory MAC Lung Disease,phase2; phase3,TERMINATED,"AN2 Therapeutics, Inc",
NCT05327803,Placebo,DRUG,MAC Lung Disease; Treatment Refractory MAC Lung Disease,phase2; phase3,TERMINATED,"AN2 Therapeutics, Inc",
NCT05126303,RMC-035,DRUG,Acute Kidney Injury,phase2,TERMINATED,Guard Therapeutics AB,
NCT05126303,Placebo,DRUG,Acute Kidney Injury,phase2,TERMINATED,Guard Therapeutics AB,
NCT05113342,Descartes-25,DRUG,Multiple Myeloma; Relapse Multiple Myeloma,phase1,TERMINATED,Cartesian Therapeutics,
NCT06357169,Venus Glow,DEVICE,Lichen Planopilaris of Scalp; Alopecia Areata,na,TERMINATED,University of Minnesota,
NCT01607554,Irinotecan,DRUG,Non-small Cell Lung Cancer,phase1; phase2,TERMINATED,New Mexico Cancer Research Alliance,
NCT02117466,Dose escalation cetuximab,DRUG,Metastatic Colorectal Cancer,phase1; phase2,TERMINATED,"Amsterdam UMC, location VUmc",
NCT02117466,Standard dose cetuximab,DRUG,Metastatic Colorectal Cancer,phase1; phase2,TERMINATED,"Amsterdam UMC, location VUmc",
NCT01414166,ERN/LRPT,DRUG,Dyslipidemia,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01414166,placebo,DRUG,Dyslipidemia,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00122551,Intermittent antiretroviral therapy,PROCEDURE,HIV Infections,phase3,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT05126329,amcenestrant,DRUG,Hepatic Function Abnormal,phase1,TERMINATED,Sanofi,
NCT02791529,Electrocautery,PROCEDURE,Carpal Tunnel Syndrome,phase1,TERMINATED,Turku University Hospital,
NCT02791529,Scalpel,PROCEDURE,Carpal Tunnel Syndrome,phase1,TERMINATED,Turku University Hospital,
NCT01009931,12-O-tetradecanoylphorbol-13-acetate,DRUG,Leukemia,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT01009931,Dexamethasone,DRUG,Leukemia,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT01009931,Choline magnesium trisalicylate,DRUG,Leukemia,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT01385345,Vitamin D3 cholecalciferol,DRUG,Vitamin D Deficiency; Insulin Resistance,na,TERMINATED,University of Leicester,
NCT05008445,LM-102 Injection,BIOLOGICAL,Advanced Solid Tumor,phase1; phase2,TERMINATED,"LaNova Medicines Development Co., Ltd.",
NCT05008445,LM-102 Injection combined with SOC,OTHER,Advanced Solid Tumor,phase1; phase2,TERMINATED,"LaNova Medicines Development Co., Ltd.",
NCT01100203,Eplerenone,DRUG,Chronic Kidney Disease,phase3,TERMINATED,Lene Boesby,
NCT01642342,laboratory biomarker analysis,OTHER,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,University of Southern California,
NCT01642342,pharmacological study,OTHER,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,University of Southern California,
NCT01642342,recombinant albumin fusion protein sEphB4-HSA,BIOLOGICAL,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,University of Southern California,
NCT02829242,NIRS Monitoring (SenSmart Monitor),DEVICE,Nontraumatic Compartment Syndrome of Leg,na,TERMINATED,Medical University of Vienna,
NCT06037369,customized standardized educational program sent by LINE software.,BEHAVIORAL,Diabetic Foot Ulcer,na,TERMINATED,Chang Gung Memorial Hospital,
NCT03294941,HepQuant SHUNT Liver Diagnostic Kit,OTHER,NASH - Nonalcoholic Steatohepatitis,phase2,TERMINATED,"HepQuant, LLC",
NCT02030405,Ixazomib,DRUG,Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myelob,phase2,TERMINATED,Steven E. Coutre,
NCT03806556,Tranexamic Acid,DRUG,Pediatric Cancer; Thrombocytopenia; Hemostatic Disorder; Coagulation Defect; Acquired,phase1; phase2,TERMINATED,Meghan McCormick,
NCT03806556,Normal saline,DRUG,Pediatric Cancer; Thrombocytopenia; Hemostatic Disorder; Coagulation Defect; Acquired,phase1; phase2,TERMINATED,Meghan McCormick,
NCT04908956,Osimertinib,DRUG,NSCLC Stage IV; EGFR Gene Mutation,phase2,TERMINATED,ETOP IBCSG Partners Foundation,
NCT04908956,Stereotactic Body Radiation Therapy (SBRT),RADIATION,NSCLC Stage IV; EGFR Gene Mutation,phase2,TERMINATED,ETOP IBCSG Partners Foundation,
NCT01430429,NI-0801,DRUG,Primary Biliary Cirrhosis,phase2,TERMINATED,Light Chain Bioscience - Novimmune SA,
NCT03024437,Atezolizumab,DRUG,Metastatic Cancer; Renal Cancer,phase1; phase2,TERMINATED,Roberto Pili,
NCT03024437,Bevacizumab,DRUG,Metastatic Cancer; Renal Cancer,phase1; phase2,TERMINATED,Roberto Pili,
NCT03024437,Entinostat,DRUG,Metastatic Cancer; Renal Cancer,phase1; phase2,TERMINATED,Roberto Pili,
NCT01582672,Standard Treatment,DRUG,Advanced Renal Cell Carcinoma; Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma,phase3,TERMINATED,Argos Therapeutics,
NCT01582672,AGS-003,BIOLOGICAL,Advanced Renal Cell Carcinoma; Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma,phase3,TERMINATED,Argos Therapeutics,
NCT00953472,brain natriuretic peptide,DRUG,Hypertension Stage 1,phase1,TERMINATED,Mayo Clinic,
NCT00953472,no-added salt diet,OTHER,Hypertension Stage 1,phase1,TERMINATED,Mayo Clinic,
NCT04326439,Cytarabine,DRUG,"Acute Myeloid Leukemia; AML, Childhood",phase2,TERMINATED,Emory University,
NCT04326439,Daunorubicin,DRUG,"Acute Myeloid Leukemia; AML, Childhood",phase2,TERMINATED,Emory University,
NCT04326439,Erwinase,DRUG,"Acute Myeloid Leukemia; AML, Childhood",phase2,TERMINATED,Emory University,
NCT04326439,Etoposide,DRUG,"Acute Myeloid Leukemia; AML, Childhood",phase2,TERMINATED,Emory University,
NCT04326439,Gemtuzumab ozogamicin,DRUG,"Acute Myeloid Leukemia; AML, Childhood",phase2,TERMINATED,Emory University,
NCT04326439,Stem cell transplantation (SCT),PROCEDURE,"Acute Myeloid Leukemia; AML, Childhood",phase2,TERMINATED,Emory University,
NCT04326439,Sorafenib,DRUG,"Acute Myeloid Leukemia; AML, Childhood",phase2,TERMINATED,Emory University,
NCT03376659,Durvalumab,DRUG,Metastatic Colorectal Cancer; Colorectal Adenocarcinoma; Pancreatic Adenocarcinoma; Metastatic Pancreatic Cancer,phase1; phase2,TERMINATED,Georgetown University,
NCT03376659,CV301,BIOLOGICAL,Metastatic Colorectal Cancer; Colorectal Adenocarcinoma; Pancreatic Adenocarcinoma; Metastatic Pancreatic Cancer,phase1; phase2,TERMINATED,Georgetown University,
NCT03376659,Capecitabine,DRUG,Metastatic Colorectal Cancer; Colorectal Adenocarcinoma; Pancreatic Adenocarcinoma; Metastatic Pancreatic Cancer,phase1; phase2,TERMINATED,Georgetown University,
NCT03376659,Bevacizumab,DRUG,Metastatic Colorectal Cancer; Colorectal Adenocarcinoma; Pancreatic Adenocarcinoma; Metastatic Pancreatic Cancer,phase1; phase2,TERMINATED,Georgetown University,
NCT00706446,tiotropium bromide,DRUG,Asthma,na,TERMINATED,Brigham and Women's Hospital,
NCT00706446,Salmeterol,DRUG,Asthma,na,TERMINATED,Brigham and Women's Hospital,
NCT00706446,Formoterol,DRUG,Asthma,na,TERMINATED,Brigham and Women's Hospital,
NCT00706446,Fluticasone propionate,DRUG,Asthma,na,TERMINATED,Brigham and Women's Hospital,
NCT00706446,budesonide,DRUG,Asthma,na,TERMINATED,Brigham and Women's Hospital,
NCT03787303,Triiodothyronine (T3),DRUG,Metastatic Breast Cancer; Thyroid Dysfunction,phase2,TERMINATED,Aultman Health Foundation,
NCT00199342,KW-2871,DRUG,Stage IV Melanoma,phase1; phase2,TERMINATED,"Kyowa Kirin, Inc.",
NCT00733486,L.C.S. APG Knee Anterior Posterior Glide knee,DEVICE,Osteoarthritis,phase4,TERMINATED,DePuy International,
NCT01028586,"Safinamide, MAO-B inhibitor",DRUG,Idiopathic Parkinson's Disease,phase3,TERMINATED,Newron Pharmaceuticals SPA,
NCT01028586,"Safinamide, MAO-B inhibitor",DRUG,Idiopathic Parkinson's Disease,phase3,TERMINATED,Newron Pharmaceuticals SPA,
NCT01028586,Placebo,DRUG,Idiopathic Parkinson's Disease,phase3,TERMINATED,Newron Pharmaceuticals SPA,
NCT04243070,3-channel Holter ECG recording,OTHER,Heart Diseases; Rhythm; Abnormal,na,TERMINATED,Biotronik SE & Co. KG,
NCT04243070,12-channel Holter ECG recording,OTHER,Heart Diseases; Rhythm; Abnormal,na,TERMINATED,Biotronik SE & Co. KG,
NCT00453856,Sulfadoxine Pyrimethamine,DRUG,Malaria,phase4,TERMINATED,"Albert Schweitzer Hospital, Netherlands",
NCT03016156,CRADLE,OTHER,"Retinoblastoma; Cataracts Infantile; Glaucoma, Congenital; Leucocoria",na,TERMINATED,St. Jude Children's Research Hospital,
NCT03016156,Red reflex testing,OTHER,"Retinoblastoma; Cataracts Infantile; Glaucoma, Congenital; Leucocoria",na,TERMINATED,St. Jude Children's Research Hospital,
NCT01198522,L19IL2 monoclonal antibody-cytokine fusion protein in combination with gemcitabine,DRUG,Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection,phase1,TERMINATED,Philogen S.p.A.,
NCT05271929,Current standard of care and COVID-19 convalescent and vaccinated plasma,BIOLOGICAL,COVID-19,phase3,TERMINATED,Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen,
NCT05271929,Current standard of care,OTHER,COVID-19,phase3,TERMINATED,Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen,
NCT00861237,Nux vomica (active comparator),DRUG,Atrial Fibrillation,phase4,TERMINATED,Medical University of Vienna,
NCT00861237,Placebo (placebo comparator),DRUG,Atrial Fibrillation,phase4,TERMINATED,Medical University of Vienna,
NCT03029845,Propranolol 1,DRUG,Fibromyalgia Pain,phase1,TERMINATED,University of Utah,
NCT03029845,Propranolol 2,DRUG,Fibromyalgia Pain,phase1,TERMINATED,University of Utah,
NCT03029845,Placebo,DRUG,Fibromyalgia Pain,phase1,TERMINATED,University of Utah,
NCT02602145,follow-up CTA,OTHER,Femoropopliteal Stenting,na,TERMINATED,University of Nebraska,
NCT03850470,clinical examination,OTHER,Musculoskeletal Pain; Musculoskeletal Injury,na,TERMINATED,High Point University,
NCT03850470,MRI,OTHER,Musculoskeletal Pain; Musculoskeletal Injury,na,TERMINATED,High Point University,
NCT03924869,Stereotactic Body Radiotherapy (SBRT),RADIATION,Non-Small Cell Lung Cancer,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT03924869,Pembrolizumab,BIOLOGICAL,Non-Small Cell Lung Cancer,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT03924869,Placebo,DRUG,Non-Small Cell Lung Cancer,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01223105,slow freeze,PROCEDURE,Women Diagnosed With Cancer; Egg Donors; Single Women; Failed Sperm Procurement in IVF,phase2; phase3,TERMINATED,Reproductive Medicine Associates of New Jersey,
NCT01223105,Vitrification,PROCEDURE,Women Diagnosed With Cancer; Egg Donors; Single Women; Failed Sperm Procurement in IVF,phase2; phase3,TERMINATED,Reproductive Medicine Associates of New Jersey,
NCT00289822,intracoronary infusion of progenitor cells,DRUG,Coronary Artery Disease,phase2,TERMINATED,Johann Wolfgang Goethe University Hospital,
NCT03227822,Short spot stenting,PROCEDURE,Peripheral Arterial Disease,na,TERMINATED,Catharina Ziekenhuis Eindhoven,
NCT03227822,Long lesion stenting,PROCEDURE,Peripheral Arterial Disease,na,TERMINATED,Catharina Ziekenhuis Eindhoven,
NCT03166631,BI 891065,DRUG,"Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung",phase1,TERMINATED,Boehringer Ingelheim,
NCT03166631,BI 754091,DRUG,"Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung",phase1,TERMINATED,Boehringer Ingelheim,
NCT01543737,3ml hyaluronic acid (DUROLANE),DEVICE,Knee Osteoarthritis,na,TERMINATED,Bioventus LLC,
NCT01543737,"2ml hyaluronic acid, (HYALGAN)",DEVICE,Knee Osteoarthritis,na,TERMINATED,Bioventus LLC,
NCT02399072,No intervention,OTHER,Geographic Atrophy,na,TERMINATED,Hoffmann-La Roche,
NCT01969539,Combivent Respimat via tee adapter,DRUG,"Pulmonary Disease, Chronic Obstructive",phase4,TERMINATED,Boehringer Ingelheim,
NCT01969539,Combivent Respimat via ventilator adapter,DRUG,"Pulmonary Disease, Chronic Obstructive",phase4,TERMINATED,Boehringer Ingelheim,
NCT02971839,VX-561,DRUG,Cystic Fibrosis,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT02971839,Placebo,DRUG,Cystic Fibrosis,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT02971839,IVA,DRUG,Cystic Fibrosis,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT00816777,Chemoembolization with irinotecan Bead,PROCEDURE,Unresectable Metastatic Colo-rectal Cancer,phase1; phase2,TERMINATED,"Generic Devices Consulting, Inc.",
NCT00816777,Irinotecan,DRUG,Unresectable Metastatic Colo-rectal Cancer,phase1; phase2,TERMINATED,"Generic Devices Consulting, Inc.",
NCT01249157,Positron Emission Mammography (PEM) and Magnetic Resonance Imaging (MRI),DEVICE,Breast Cancer,na,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00484601,Ifosfamide,DRUG,Refractory Nasopharyngeal Carcinoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00484601,Doxorubicin,DRUG,Refractory Nasopharyngeal Carcinoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT06096181,Remifentanil TIVA,DRUG,Adolescent Idiopathic Scoliosis; Multimodal Analgesia; Opioid Induced Hyperalgesia; Remifentanil; Dexmedetomidine; Posterior Spinal Fusion,phase2,TERMINATED,Cedars-Sinai Medical Center,
NCT06096181,Dexmedetomidine TIVA,DRUG,Adolescent Idiopathic Scoliosis; Multimodal Analgesia; Opioid Induced Hyperalgesia; Remifentanil; Dexmedetomidine; Posterior Spinal Fusion,phase2,TERMINATED,Cedars-Sinai Medical Center,
NCT06096181,Propofol TIVA,DRUG,Adolescent Idiopathic Scoliosis; Multimodal Analgesia; Opioid Induced Hyperalgesia; Remifentanil; Dexmedetomidine; Posterior Spinal Fusion,phase2,TERMINATED,Cedars-Sinai Medical Center,
NCT00767481,Travoprost/Brinzolamide,DRUG,Glaucoma; Ocular Hypertension,phase3,TERMINATED,Alcon Research,
NCT00767481,Cosopt,DRUG,Glaucoma; Ocular Hypertension,phase3,TERMINATED,Alcon Research,
NCT00209703,Oxaliplatin,DRUG,Colorectal Cancer,phase2,TERMINATED,Hokkaido Gastrointestinal Cancer Study Group,
NCT00209703,l-Leucovorin,DRUG,Colorectal Cancer,phase2,TERMINATED,Hokkaido Gastrointestinal Cancer Study Group,
NCT00209703,5-Fluorouracil,DRUG,Colorectal Cancer,phase2,TERMINATED,Hokkaido Gastrointestinal Cancer Study Group,
NCT04240886,fosmanogepix,DRUG,Invasive Fungal Infections,phase2,TERMINATED,Basilea Pharmaceutica,
NCT05937373,Continuous Glucose monitor,DEVICE,Diabetes Mellitus,na,TERMINATED,Wake Forest University Health Sciences,
NCT05937373,Standard of Care,OTHER,Diabetes Mellitus,na,TERMINATED,Wake Forest University Health Sciences,
NCT00621673,Kogenate (BAY 14-2222),DRUG,Hemophilia A,phase4,TERMINATED,Bayer,
NCT02990273,Blood transfusion,BIOLOGICAL,"Cirrhosis, Coagulopathy",na,TERMINATED,Johns Hopkins University,
NCT05180669,OARSCM Software Application,OTHER,Opioid Use Disorder,na,TERMINATED,"Q2i, LLC",
NCT05180669,MyMAT Software Application,OTHER,Opioid Use Disorder,na,TERMINATED,"Q2i, LLC",
NCT04136769,Visceral Debranching,PROCEDURE,Pancreas Cancer,na,TERMINATED,"Ulrich Ronellenfitsch, MD",
NCT02860169,Participants self-administered questionnaire and assessment,BEHAVIORAL,Cognition,na,TERMINATED,GlaxoSmithKline,
NCT03250169,Alemtuzumab,DRUG,Multiple Sclerosis,na,TERMINATED,Queen Mary University of London,
NCT00393094,Bevacizumab,BIOLOGICAL,High-Grade Gliomas,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00393094,Irinotecan hydrochloride,DRUG,High-Grade Gliomas,phase2,TERMINATED,National Cancer Institute (NCI),
NCT03574194,Methionine-restricted diet,OTHER,Cancer; Lung Cancer; Prostate Cancer; Breast Cancer,na,TERMINATED,West Virginia University,
NCT02707666,Pembrolizumab,DRUG,Pleural Mesothelioma,phase1,TERMINATED,University of Chicago,
NCT02707666,Cisplatin and Pemetrexed,DRUG,Pleural Mesothelioma,phase1,TERMINATED,University of Chicago,
NCT02874651,Apatinib,DRUG,Nasopharyngeal Neoplasms,phase2,TERMINATED,Sun Yat-sen University,
NCT02874651,Placebo,DRUG,Nasopharyngeal Neoplasms,phase2,TERMINATED,Sun Yat-sen University,
NCT05979831,DS-2325a,DRUG,Netherton Syndrome,phase1; phase2,TERMINATED,Daiichi Sankyo,
NCT05979831,Placebo,OTHER,Netherton Syndrome,phase1; phase2,TERMINATED,Daiichi Sankyo,
NCT03093831,Ibrutinib,DRUG,"Lymphoma, B-Cell, Marginal Zone",phase2,TERMINATED,"National Cancer Centre, Singapore",
NCT02124902,Docetaxel,DRUG,Triple Negative Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT02124902,Carboplatin,DRUG,Triple Negative Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT02124902,FDG-PET/MR,PROCEDURE,Triple Negative Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT00847002,Standard Wound Care,DEVICE,Venous Ulcer,na,TERMINATED,"Tactile Systems Technology, Inc.",
NCT00847002,Flexitouch System with Standard Wound Care,DEVICE,Venous Ulcer,na,TERMINATED,"Tactile Systems Technology, Inc.",
NCT04577053,Scientific Consciousness Interface Operations (SCIO) Class II FDA approved medical device,DEVICE,Lyme Disease; Lyme Neuroborreliosis; Lyme Arthritis; Unknown Origin Fever,na,TERMINATED,Kasey Phifer,
NCT02889172,Problem Solving Therapy,BEHAVIORAL,"Diabetes Mellitus, Type 2",na,TERMINATED,Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente,
NCT01587495,Ertapenem,DRUG,Endometritis,phase1,TERMINATED,Daniel Benjamin,
NCT04695977,CMP-001,DRUG,Melanoma; Advanced Melanoma; Metastatic Melanoma; Unresectable Melanoma,phase2; phase3,TERMINATED,Regeneron Pharmaceuticals,
NCT04695977,Nivolumab,DRUG,Melanoma; Advanced Melanoma; Metastatic Melanoma; Unresectable Melanoma,phase2; phase3,TERMINATED,Regeneron Pharmaceuticals,
NCT02000375,DHEA,DRUG,Metastatic Breastcancer; Estrogen Receptor Positive Breast Cancer; Estrogen Receptor Negative Neoplasm; Progesterone Receptor Positive Tumor; Progesterone Receptor Negative Neoplasm; Androgen Receptor,phase2,TERMINATED,Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS,
NCT02547142,Early Palliative Care,OTHER,Esophageal Cancer,na,TERMINATED,McMaster University,
NCT01423786,Early Oral Nutrition,OTHER,Acute Pediatric Pancreatitis,na,TERMINATED,Nationwide Children's Hospital,
NCT02507986,Single lead ECG device,DEVICE,Atrial Fibrillation; Ischemic Stroke; Transient Ischemic Attack,na,TERMINATED,Leiden University,
NCT02507986,7-Day Holter monitor.,DEVICE,Atrial Fibrillation; Ischemic Stroke; Transient Ischemic Attack,na,TERMINATED,Leiden University,
NCT01632969,The The Family Assessment of Treatment at the End of life (FATE ) survey,BEHAVIORAL,The Families or Next of Kin of Patients Treated at MSKCC for Non-cutaneous Squamous Cell Carcinomas of the; Upper Aerodigestive Tract,na,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT02133183,Laboratory Biomarker Analysis,OTHER,Glioblastoma; Gliosarcoma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02133183,Pharmacological Study,OTHER,Glioblastoma; Gliosarcoma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02133183,Sapanisertib,DRUG,Glioblastoma; Gliosarcoma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02133183,Therapeutic Conventional Surgery,PROCEDURE,Glioblastoma; Gliosarcoma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02129205,PF-06650808,DRUG,Neoplasms; Breast Cancer,phase1,TERMINATED,Pfizer,
NCT02129205,PF-06650808,DRUG,Neoplasms; Breast Cancer,phase1,TERMINATED,Pfizer,
NCT03455751,PGx-guided post-operative pain management,OTHER,Colorectal Cancer; Diverticular Disease; Crohn Disease; Ulcerative Colitis,na,TERMINATED,The Cleveland Clinic,
NCT03159429,Standard rehabilitation,BEHAVIORAL,Hyperventilation Syndrome,na,TERMINATED,"University Hospital, Montpellier",
NCT03159429,Nasal breathing rehabilitation,BEHAVIORAL,Hyperventilation Syndrome,na,TERMINATED,"University Hospital, Montpellier",
NCT03862131,MyoStrain®,DEVICE,Cardiotoxicity; Breast Cancer; Lymphoma; Sarcoma; Leukemia; Myeloma; Lung Cancer,phase2,TERMINATED,Washington University School of Medicine,
NCT03881553,NEATCAP,DEVICE,Infant Apnea; Neonatal Abstinence Syndrome; Sleep,na,TERMINATED,"Elisabeth Salisbury, PhD",
NCT03881553,SVS mattress,DEVICE,Infant Apnea; Neonatal Abstinence Syndrome; Sleep,na,TERMINATED,"Elisabeth Salisbury, PhD",
NCT05383937,Speech Therapy INTENS-DYS,OTHER,"Dyslexia; Speech Therapy; Children, Only",na,TERMINATED,Centre Hospitalier Universitaire de Besancon,
NCT00879645,Sodium Sulfide,DRUG,Renal Impairment,phase1,TERMINATED,Mallinckrodt,
NCT00879645,Sodium Sulfide,DRUG,Renal Impairment,phase1,TERMINATED,Mallinckrodt,
NCT00879645,Sodium Sulfide,DRUG,Renal Impairment,phase1,TERMINATED,Mallinckrodt,
NCT00879645,Sodium Sulfide,DRUG,Renal Impairment,phase1,TERMINATED,Mallinckrodt,
NCT01055145,"levofloxacin, moxifloxacin",DRUG,TB,phase3,TERMINATED,Seoul National University Hospital,
NCT03289039,Neratinib,DRUG,Breast Cancer,phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT03289039,Fulvestrant,DRUG,Breast Cancer,phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT00717275,Temozolomide,DRUG,Brain Metastases,phase2,TERMINATED,University of Florida,
NCT04097301,MLM-CAR44.1 T-cells at day 0 Single intravenous infusion,DRUG,Acute Myeloid Leukemia; Multiple Myeloma,phase1; phase2,TERMINATED,AGC Biologics S.p.A.,
NCT02087085,400 µg Brimonidine Implant,DRUG,Geographic Atrophy; Macular Degeneration,phase2,TERMINATED,Allergan,
NCT02087085,Sham,OTHER,Geographic Atrophy; Macular Degeneration,phase2,TERMINATED,Allergan,
NCT04781543,HZN-825 BID,DRUG,"Diffuse Cutaneous Systemic Sclerosis; Sclerosis, Systemic",phase2,TERMINATED,Amgen,
NCT04781543,Placebo,DRUG,"Diffuse Cutaneous Systemic Sclerosis; Sclerosis, Systemic",phase2,TERMINATED,Amgen,
NCT04781543,HZN-825 QD,DRUG,"Diffuse Cutaneous Systemic Sclerosis; Sclerosis, Systemic",phase2,TERMINATED,Amgen,
NCT02364843,Amino Acid: Threonine,OTHER,Surgical Infants on NG/NJ/J/G-tube Feeds; Tracheoesophageal Fistula; Pierre-Robin Syndrome; Diaphragmatic Hernia,na,TERMINATED,The Hospital for Sick Children,
NCT03481543,In-line nebulization through NIV mask,PROCEDURE,Chronic Obstructive Pulmonary Disease (COPD); Type 2 Respiratory Failure,na,TERMINATED,"National University Health System, Singapore",
NCT03481543,Off-NIV nebulization,PROCEDURE,Chronic Obstructive Pulmonary Disease (COPD); Type 2 Respiratory Failure,na,TERMINATED,"National University Health System, Singapore",
NCT02154243,Midodrine,DRUG,Orthostatic Hypotension,na,TERMINATED,"Hospital for Special Surgery, New York",
NCT02154243,Intravenous fluid bolus,OTHER,Orthostatic Hypotension,na,TERMINATED,"Hospital for Special Surgery, New York",
NCT00159640,"PD-217,014",DRUG,Pain,phase2,TERMINATED,Pfizer,
NCT02430389,Remifentanil,DRUG,Surgery,na,TERMINATED,Northwestern University,
NCT02430389,Normal Saline,DRUG,Surgery,na,TERMINATED,Northwestern University,
NCT04386668,Let It Out (LIO)-C,OTHER,COVID19,na,TERMINATED,"University College, London",
NCT04386668,Neutral writing control,OTHER,COVID19,na,TERMINATED,"University College, London",
NCT04972968,ABBV-154,DRUG,Polymyalgia Rheumatica,phase2,TERMINATED,AbbVie,
NCT04972968,Placebo,DRUG,Polymyalgia Rheumatica,phase2,TERMINATED,AbbVie,
NCT04972968,Glucocorticoid,DRUG,Polymyalgia Rheumatica,phase2,TERMINATED,AbbVie,
NCT01035268,fatty tissue transfer,PROCEDURE,Breast Cancer,phase3,TERMINATED,Institut Claudius Regaud,
NCT04132791,placebo after awakening + aspirin before bedtime,OTHER,Cardiovascular Diseases,na,TERMINATED,Leiden University Medical Center,
NCT04132791,aspirin after awakening + placebo before bedtime,OTHER,Cardiovascular Diseases,na,TERMINATED,Leiden University Medical Center,
NCT04259385,Exposure to sugar-sweetened beverage warning labels,BEHAVIORAL,Food Preferences,na,TERMINATED,University of Pennsylvania,
NCT04259385,Exposure to beverage calorie information,BEHAVIORAL,Food Preferences,na,TERMINATED,University of Pennsylvania,
NCT05794243,LY3493269,DRUG,Healthy,phase1,TERMINATED,Eli Lilly and Company,
NCT05794243,Sodium Caprate (C10),DRUG,Healthy,phase1,TERMINATED,Eli Lilly and Company,
NCT05794243,Salcaprozate Sodium (SNAC),DRUG,Healthy,phase1,TERMINATED,Eli Lilly and Company,
NCT00119015,Placebo,DRUG,"Rhinitis, Allergic, Perennial",phase4,TERMINATED,University of Chicago,
NCT00119015,Montelukast,DRUG,"Rhinitis, Allergic, Perennial",phase4,TERMINATED,University of Chicago,
NCT00119015,Fluticasone propionate,DRUG,"Rhinitis, Allergic, Perennial",phase4,TERMINATED,University of Chicago,
NCT05279235,JT001,DRUG,Moderate to Severe COVID-19,phase3,TERMINATED,"Shanghai Vinnerna Biosciences Co., Ltd.",
NCT05279235,JT001 placebo,DRUG,Moderate to Severe COVID-19,phase3,TERMINATED,"Shanghai Vinnerna Biosciences Co., Ltd.",
NCT05279235,Favipiravir,DRUG,Moderate to Severe COVID-19,phase3,TERMINATED,"Shanghai Vinnerna Biosciences Co., Ltd.",
NCT05279235,Favipiravir placebo,DRUG,Moderate to Severe COVID-19,phase3,TERMINATED,"Shanghai Vinnerna Biosciences Co., Ltd.",
NCT05875935,ECoG : electrocorticography,PROCEDURE,Electrocorticography; Karnofski Index; Glioma,na,TERMINATED,Ramsay Générale de Santé,
NCT04321525,Cognitive-behavioral therapy,BEHAVIORAL,Depression,na,TERMINATED,University of Barcelona,
NCT04321525,Personal Construct Therapy,BEHAVIORAL,Depression,na,TERMINATED,University of Barcelona,
NCT04321525,Personal Construct Therapy with virtual reality,BEHAVIORAL,Depression,na,TERMINATED,University of Barcelona,
NCT05314517,Namilumab,DRUG,"Sarcoidosis, Pulmonary",phase2,TERMINATED,Kinevant Sciences GmbH,
NCT05314517,Placebo,DRUG,"Sarcoidosis, Pulmonary",phase2,TERMINATED,Kinevant Sciences GmbH,
NCT03246568,Renal Nerve Denervation,PROCEDURE,Atrial Fibrillation,na,TERMINATED,Chinese University of Hong Kong,
NCT03246568,Pulmonary vein isolation,PROCEDURE,Atrial Fibrillation,na,TERMINATED,Chinese University of Hong Kong,
NCT00879450,Booklet,OTHER,Torticollis,na,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT02780791,Transplantation into pelvic wall,OTHER,"Infertility; Ovarian Failure, Premature",na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT02780791,Transplantation into the ovary,OTHER,"Infertility; Ovarian Failure, Premature",na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT02368691,GTx-024,DRUG,Triple Negative Breast Cancer,phase2,TERMINATED,GTx,
NCT00775320,FLT-PET scan,PROCEDURE,Brain Tumor,na,TERMINATED,University of Oklahoma,
NCT04054180,"CPAP associated with connected devices: blood pressure monitor , scales and activity monitor",OTHER,Obstructive Sleep Apnea Syndrome,na,TERMINATED,"University Hospital, Grenoble",
NCT05172596,PHE885,BIOLOGICAL,Multiple Myeloma,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT03295942,OMP-336B11,DRUG,Locally Advanced Malignant Neoplasm; Metastatic Cancer,phase1,TERMINATED,"OncoMed Pharmaceuticals, Inc.",
NCT03705169,SAR441236,BIOLOGICAL,HIV-1-infection,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT03705169,Placebo,BIOLOGICAL,HIV-1-infection,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00005641,anti-thymocyte globulin,BIOLOGICAL,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005641,busulfan,DRUG,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005641,cyclophosphamide,DRUG,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005641,cyclosporine,DRUG,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005641,leucovorin calcium,DRUG,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005641,methotrexate,DRUG,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005641,methylprednisolone,DRUG,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005641,allogeneic bone marrow transplantation,PROCEDURE,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005641,in vitro-treated bone marrow transplantation,PROCEDURE,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005641,radiation therapy,RADIATION,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT04499651,Navigation,BEHAVIORAL,HIV (Human Immunodeficiency Virus); Hepatitis C,na,TERMINATED,"University of California, Los Angeles",
NCT00543751,MK0767,DRUG,"Diabetes Mellitus, Type 2",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT05414331,Discontinuing all beta-blocker,OTHER,Coronary Artery Bypass,na,TERMINATED,Yale University,
NCT01904253,TAS-102,DRUG,Small Cell Lung Cancer (SCLC),phase2,TERMINATED,"Taiho Oncology, Inc.",
NCT01904253,Amrubicin (Japan),DRUG,Small Cell Lung Cancer (SCLC),phase2,TERMINATED,"Taiho Oncology, Inc.",
NCT01904253,Topotecan (Japan/Europe),DRUG,Small Cell Lung Cancer (SCLC),phase2,TERMINATED,"Taiho Oncology, Inc.",
NCT00845845,Omega-3-acid ethyl esters (Lovaza),DRUG,Nonalcoholic Steatohepatitis (NASH); Hepatic Steatosis,phase2,TERMINATED,University of Illinois at Chicago,
NCT00845845,Placebo,DRUG,Nonalcoholic Steatohepatitis (NASH); Hepatic Steatosis,phase2,TERMINATED,University of Illinois at Chicago,
NCT04398420,TVERP,DEVICE,Benign Prostatic Hypertrophy,na,TERMINATED,Olympus Surgical Technologies Europe,
NCT04398420,TURis,DEVICE,Benign Prostatic Hypertrophy,na,TERMINATED,Olympus Surgical Technologies Europe,
NCT04398420,HoLEP,DEVICE,Benign Prostatic Hypertrophy,na,TERMINATED,Olympus Surgical Technologies Europe,
NCT02956980,Blood Plasmacytoid dendritic cells (pDCs) absolute number,BIOLOGICAL,Innate Immune Responses,na,TERMINATED,"University Hospital, Toulouse",
NCT02029586,MB12066 200mg,DRUG,Nonalcoholic Fatty Liver Disease,phase2,TERMINATED,"Yungjin Pharm. Co., Ltd.",
NCT02029586,Placebo,DRUG,Nonalcoholic Fatty Liver Disease,phase2,TERMINATED,"Yungjin Pharm. Co., Ltd.",
NCT00981370,deferasirox,DRUG,"Anemia, Sickle Cell; Transfusion Hemosiderosis",phase3,TERMINATED,Children's Hospital Los Angeles,
NCT01266070,Dovitinib,DRUG,Von Hippel-Lindau Syndrome,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01483170,Tablets Fexinidazole,DRUG,"Trypanosomiasis, African",phase1,TERMINATED,Drugs for Neglected Diseases,
NCT01483170,Placebo,DRUG,"Trypanosomiasis, African",phase1,TERMINATED,Drugs for Neglected Diseases,
NCT00642694,Escitalopram,DRUG,Major Depressive Disorder; Insomnia,phase3,TERMINATED,University of Texas Southwestern Medical Center,
NCT00642694,Ramelteon,DRUG,Major Depressive Disorder; Insomnia,phase3,TERMINATED,University of Texas Southwestern Medical Center,
NCT00642694,Placebo,OTHER,Major Depressive Disorder; Insomnia,phase3,TERMINATED,University of Texas Southwestern Medical Center,
NCT01498666,L. reuteri protectis,OTHER,Abdominal Pain,na,TERMINATED,BioGaia AB,
NCT01498666,Placebo tablet,OTHER,Abdominal Pain,na,TERMINATED,BioGaia AB,
NCT04162470,REGN3918,DRUG,Paroxysmal Nocturnal Hemoglobinuria,phase3,TERMINATED,Regeneron Pharmaceuticals,
NCT00022841,Pamidronate,DRUG,Osteoporosis,phase1; phase2,TERMINATED,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),
NCT01281254,AMG386 plus PLD,DRUG,Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cancer,phase3,TERMINATED,Amgen,
NCT01281254,Placebo plus PLD,DRUG,Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cancer,phase3,TERMINATED,Amgen,
NCT03294694,Ribociclib,DRUG,Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer; HER2-Negative Breast Cancer; Metastatic Epithelial Ovarian Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT03294694,PDR001,DRUG,Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer; HER2-Negative Breast Cancer; Metastatic Epithelial Ovarian Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT03294694,Fulvestrant,DRUG,Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer; HER2-Negative Breast Cancer; Metastatic Epithelial Ovarian Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT03602456,Kentucky HEALTH,OTHER,Health Insurance,na,TERMINATED,University of Pennsylvania,
NCT01213329,Alemtuzumab,DRUG,Kidney Transplant,phase4,TERMINATED,Northwestern University,
NCT03025529,Transcranial Magnetic Stimulation,DEVICE,Essential Tremor,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT03025529,Sham Transcranial Magnetic Stimulation,DEVICE,Essential Tremor,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT02180529,Methylphenidate,DRUG,Mild Cognitive Impairment (MCI),na,TERMINATED,Meir Medical Center,
NCT02180529,Placebo,DRUG,Mild Cognitive Impairment (MCI),na,TERMINATED,Meir Medical Center,
NCT03440437,FS118,DRUG,Advanced Cancer; Metastatic Cancer; Squamous Cell Carcinoma of Head and Neck,phase1; phase2,TERMINATED,invoX Pharma Limited,
NCT03440437,Paclitaxel,DRUG,Advanced Cancer; Metastatic Cancer; Squamous Cell Carcinoma of Head and Neck,phase1; phase2,TERMINATED,invoX Pharma Limited,
NCT03426137,Oxycodone,DRUG,Trauma; Opioid Use; Spine Fusion,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT03426137,Ketorolac,DRUG,Trauma; Opioid Use; Spine Fusion,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT03426137,Placebo,OTHER,Trauma; Opioid Use; Spine Fusion,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT01677845,Radiation,RADIATION,Prostate Cancer,phase1,TERMINATED,NYU Langone Health,
NCT00511745,Rabeprazol,DRUG,Gastroesophageal Reflux; Gastric Ulcer,na,TERMINATED,"Janssen-Cilag, S.A.",
NCT02022072,measures of assisted vital capacity by a mechanical insufflation/exsufflation (Cough Assist®),DEVICE,Respiration Disorders; Neuromuscular Disease,phase2,TERMINATED,Centre d'Investigation Clinique et Technologique 805,
NCT03204695,Percutaneous LAA Closure,DEVICE,Non-valvular Atrial Fibrillation,na,TERMINATED,Coherex Medical,
NCT03204695,Anticoagulation or Clopidogrel,DRUG,Non-valvular Atrial Fibrillation,na,TERMINATED,Coherex Medical,
NCT04159896,Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981,DRUG,Castration Levels of Testosterone; Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Prostate Carcinoma Metastatic in the Bone; Stage IVB Prostate Cancer AJCC v8,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT04159896,Nivolumab,BIOLOGICAL,Castration Levels of Testosterone; Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Prostate Carcinoma Metastatic in the Bone; Stage IVB Prostate Cancer AJCC v8,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT02093962,TH-302 combination with pemetrexed,DRUG,Non-small Cell Lung Cancer,phase2,TERMINATED,ImmunoGenesis,
NCT02093962,Matched placebo in combination with pemetrexed,DRUG,Non-small Cell Lung Cancer,phase2,TERMINATED,ImmunoGenesis,
NCT01550562,Boston Scientific Precision Plus spinal cord stimulation therapy,DEVICE,Low Back Pain,na,TERMINATED,Boston Scientific Corporation,
NCT00746603,Simvastatin,DRUG,Carotid Artery Disease,na,TERMINATED,Columbia University,
NCT01158703,clopidogrel,DRUG,Coronary Graft Patency,phase4,TERMINATED,Ahmad Slim,
NCT01158703,sugar pill,DRUG,Coronary Graft Patency,phase4,TERMINATED,Ahmad Slim,
NCT01158703,Aspirin,DRUG,Coronary Graft Patency,phase4,TERMINATED,Ahmad Slim,
NCT03925961,Preoperative education,OTHER,Patient Education,na,TERMINATED,Johns Hopkins University,
NCT03602261,Calcifediol Oral Capsule,DRUG,Secondary Hyperparathyroidism Due to Renal Causes; Chronic Kidney Diseases; Vitamin D Deficiency; Stage 5 Chronic Kidney Disease,phase2,TERMINATED,"OPKO Health, Inc.",
NCT03602261,Placebo oral capsule,DRUG,Secondary Hyperparathyroidism Due to Renal Causes; Chronic Kidney Diseases; Vitamin D Deficiency; Stage 5 Chronic Kidney Disease,phase2,TERMINATED,"OPKO Health, Inc.",
NCT03522142,INCB081776,DRUG,Advanced Solid Tumors,phase1,TERMINATED,Incyte Corporation,
NCT03522142,INCMGA00012,DRUG,Advanced Solid Tumors,phase1,TERMINATED,Incyte Corporation,
NCT00706186,Sodium Oxybate,DRUG,Mild Alzheimer's Disease,phase4,TERMINATED,Clayton Sleep Insititute,
NCT04747470,GS-3583,DRUG,Advanced Solid Tumors,phase1,TERMINATED,Gilead Sciences,
NCT04747470,Zimberelimab,DRUG,Advanced Solid Tumors,phase1,TERMINATED,Gilead Sciences,
NCT04747470,Cisplatin,DRUG,Advanced Solid Tumors,phase1,TERMINATED,Gilead Sciences,
NCT04747470,Carboplatin,DRUG,Advanced Solid Tumors,phase1,TERMINATED,Gilead Sciences,
NCT04747470,5-Fluorouracil,DRUG,Advanced Solid Tumors,phase1,TERMINATED,Gilead Sciences,
NCT04747470,Docetaxel,DRUG,Advanced Solid Tumors,phase1,TERMINATED,Gilead Sciences,
NCT00537173,Core Biopsy,PROCEDURE,Breast Cancer,na,TERMINATED,Hoosier Cancer Research Network,
NCT00537173,Blood Collection,PROCEDURE,Breast Cancer,na,TERMINATED,Hoosier Cancer Research Network,
NCT00537173,Paclitaxel,DRUG,Breast Cancer,na,TERMINATED,Hoosier Cancer Research Network,
NCT00537173,Avastin,DRUG,Breast Cancer,na,TERMINATED,Hoosier Cancer Research Network,
NCT05834673,SMS messages,OTHER,Atherosclerotic Cardiovascular Disease (ASCVD); Coronary Heart Disease (CHD); Cerebrovascular Disease; Peripheral Arterial Disease (PAD),na,TERMINATED,Monash University,
NCT05834673,Telephone-based support calls,OTHER,Atherosclerotic Cardiovascular Disease (ASCVD); Coronary Heart Disease (CHD); Cerebrovascular Disease; Peripheral Arterial Disease (PAD),na,TERMINATED,Monash University,
NCT05834673,GP Education,OTHER,Atherosclerotic Cardiovascular Disease (ASCVD); Coronary Heart Disease (CHD); Cerebrovascular Disease; Peripheral Arterial Disease (PAD),na,TERMINATED,Monash University,
NCT00518869,PG2,DRUG,Quality of Life; Fatigue; Complementary,phase2; phase3,TERMINATED,PhytoHealth Corporation,
NCT01009983,panitumumab,BIOLOGICAL,Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT01009983,paclitaxel,DRUG,Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT01009983,carboplatin,DRUG,Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT01009983,laboratory biomarker analysis,PROCEDURE,Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT01009983,immunohistochemistry staining method,PROCEDURE,Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT05559541,AK119,DRUG,"Solid Tumor, Adult",phase1; phase2,TERMINATED,Akeso,
NCT05559541,AK104,DRUG,"Solid Tumor, Adult",phase1; phase2,TERMINATED,Akeso,
NCT03600805,Sarilumab SAR153191,DRUG,Giant Cell Arteritis,phase3,TERMINATED,Sanofi,
NCT03600805,Sarilumab matching placebo,DRUG,Giant Cell Arteritis,phase3,TERMINATED,Sanofi,
NCT03600805,Prednisone,DRUG,Giant Cell Arteritis,phase3,TERMINATED,Sanofi,
NCT03600805,Prednisone matching placebo,DRUG,Giant Cell Arteritis,phase3,TERMINATED,Sanofi,
NCT00936494,Cold ablation inferior turbinate reduction,PROCEDURE,Sleep Related Breathing Disorder; Upper Airway Resistance Syndrome; Obstructive Sleep Apnea,na,TERMINATED,University of Missouri-Columbia,
NCT04677166,Negative pressure wound therapy coupled with instillation,DEVICE,Wound; Ulcer; Burns,na,TERMINATED,Loma Linda University,
NCT04677166,Standard Negative Pressure Wound Therapy,DEVICE,Wound; Ulcer; Burns,na,TERMINATED,Loma Linda University,
NCT01748851,XELOX,DRUG,Gastric Carcinoma Stage IV,phase3,TERMINATED,Dong-A University Hospital,
NCT01748851,FOLFOX,DRUG,Gastric Carcinoma Stage IV,phase3,TERMINATED,Dong-A University Hospital,
NCT02995031,BAY987521,DRUG,Sunscreening Agents,na,TERMINATED,Bayer,
NCT02995031,SPF Control,DRUG,Sunscreening Agents,na,TERMINATED,Bayer,
NCT04765202,AG Tx,PROCEDURE,Full Thickness Thermal Burn,phase1; phase2,TERMINATED,"Stratatech, a Mallinckrodt Company",
NCT04765202,SOMA Tx,BIOLOGICAL,Full Thickness Thermal Burn,phase1; phase2,TERMINATED,"Stratatech, a Mallinckrodt Company",
NCT05265013,ASP-1929 Photoimmunotherapy,OTHER,Head and Neck Cancer,phase2,TERMINATED,"Rakuten Medical, Inc.",
NCT05265013,pembrolizumab,BIOLOGICAL,Head and Neck Cancer,phase2,TERMINATED,"Rakuten Medical, Inc.",
NCT00587223,Apligraf,DEVICE,"Epidermolysis Bullosa, Junctional; Epidermolysis Bullosa Dystrophica",phase3,TERMINATED,Organogenesis,
NCT00587223,Standard dressing regimen,OTHER,"Epidermolysis Bullosa, Junctional; Epidermolysis Bullosa Dystrophica",phase3,TERMINATED,Organogenesis,
NCT01940796,Brentuximab Vedotin,DRUG,Graft-vs-Host Disease; GVHD,phase1,TERMINATED,Massachusetts General Hospital,
NCT01872988,Tenofovir,DRUG,Chronic Hepatitis B; Hepatocellular Carcinoma,phase3,TERMINATED,Taichung Veterans General Hospital,
NCT01872988,Placebo,DRUG,Chronic Hepatitis B; Hepatocellular Carcinoma,phase3,TERMINATED,Taichung Veterans General Hospital,
NCT02109627,Ficlatuzumab,DRUG,Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia,phase1,TERMINATED,C. Babis Andreadis,
NCT02109627,Cytarabine,DRUG,Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia,phase1,TERMINATED,C. Babis Andreadis,
NCT02765386,Hybrid fittings for cochlear implant recipients,DEVICE,Hearing Loss,na,TERMINATED,The Hearing Cooperative Research Centre,
NCT00003469,Antineoplaston therapy (Atengenal + Astugenal),DRUG,Rhabdoid Neoplasm of CNS,phase2,TERMINATED,Burzynski Research Institute,
NCT01501383,VX-765 Part A,DRUG,Epilepsy,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT01501383,Placebo,DRUG,Epilepsy,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT01501383,VX-765 Part B,DRUG,Epilepsy,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT03005054,StrataGraft Skin Tissue,BIOLOGICAL,Trauma-related Wound; Burns; Skin Wound,phase2,TERMINATED,"Stratatech, a Mallinckrodt Company",
NCT03005054,Autograft,PROCEDURE,Trauma-related Wound; Burns; Skin Wound,phase2,TERMINATED,"Stratatech, a Mallinckrodt Company",
NCT02980705,SUNPG1622 I dose,DRUG,Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis,phase2,TERMINATED,Sun Pharmaceutical Industries Limited,
NCT02980705,Placebo dose,DRUG,Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis,phase2,TERMINATED,Sun Pharmaceutical Industries Limited,
NCT01581905,Conventional Laparoscopic Hysterectomy (LH),PROCEDURE,Menorrhagia; Dysfunctional Uterine Bleeding; Leiomyoma; Pelvic Pain; Endometriosis,na,TERMINATED,Milton S. Hershey Medical Center,
NCT01581905,Robot Assisted Hysterectomy,PROCEDURE,Menorrhagia; Dysfunctional Uterine Bleeding; Leiomyoma; Pelvic Pain; Endometriosis,na,TERMINATED,Milton S. Hershey Medical Center,
NCT00878956,Sodium Bicarbonate,DRUG,Acute Kidney Injury,phase2,TERMINATED,Austin Health,
NCT00878956,Sodium Chloride,DRUG,Acute Kidney Injury,phase2,TERMINATED,Austin Health,
NCT01164956,methylphenidate,DRUG,Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT01164956,Placebo,OTHER,Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT05128682,Urodynamic testing with and without pudendal nerve stimulation,OTHER,Urinary Incontinence,na,TERMINATED,Corewell Health East,
NCT04735796,Drug：LM-102,DRUG,Advanced Solid Tumors,phase1,TERMINATED,LaNova Medicines Limited,
NCT00569179,CliniMACS CD34 Reagent System,DEVICE,"Leukemia, Myeloid, Acute; Leukemia, Lymphoid; Myelodysplastic Syndromes; Leukemia, Myelogenous, Chronic",phase1,TERMINATED,Indiana University School of Medicine,
NCT01432496,Ropivacaine 150 mg,DRUG,Postoperative Pain,phase3,TERMINATED,San Gerardo Hospital,
NCT01432496,saline 15 ml,DRUG,Postoperative Pain,phase3,TERMINATED,San Gerardo Hospital,
NCT01598662,Mirena (levonorgestrel-releasing intrauterine system),DEVICE,Contraception,na,TERMINATED,University of Louisville,
NCT00952627,Pycnogenol,OTHER,Cardiac Fibrosis; Diastolic Dysfunction,phase2,TERMINATED,University of Arizona,
NCT00952627,Placebo,OTHER,Cardiac Fibrosis; Diastolic Dysfunction,phase2,TERMINATED,University of Arizona,
NCT03541369,AMG 427,DRUG,Relapsed/Refractory Acute Myeloid Leukemia (AML),phase1,TERMINATED,Amgen,
NCT02878083,VEDOLIZUMAB,DRUG,ULCERATIVE COLITIS,na,TERMINATED,Nantes University Hospital,
NCT02878083,ADALIMUMAB,DRUG,ULCERATIVE COLITIS,na,TERMINATED,Nantes University Hospital,
NCT02901405,"Negative Pressure Wound Therapy (ActivVAC, KCI)",DEVICE,Sarcoma; Wound Infection,na,TERMINATED,NHS Greater Glasgow and Clyde,
NCT02901405,Standard dressings,DEVICE,Sarcoma; Wound Infection,na,TERMINATED,NHS Greater Glasgow and Clyde,
NCT03573505,BG00011,DRUG,Idiopathic Pulmonary Fibrosis,phase2,TERMINATED,Biogen,
NCT03573505,Placebo,DRUG,Idiopathic Pulmonary Fibrosis,phase2,TERMINATED,Biogen,
NCT00825266,bosentan,DRUG,"Hypertension, Pulmonary",phase2,TERMINATED,Stanford University,
NCT00825266,Pioglitazone,DRUG,"Hypertension, Pulmonary",phase2,TERMINATED,Stanford University,
NCT00634010,Morphine,DRUG,Advanced Cancer; Solid Tumors,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT00634010,Methadone,DRUG,Advanced Cancer; Solid Tumors,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT04963413,Autologous DCs derived from PBMC loaded with RNA encoding the human CMV matrix protein pp65-flLAMP plus GM-CSF,BIOLOGICAL,Glioblastoma,phase1,TERMINATED,University of Florida,
NCT03922620,Liposomal bupivacaine,DRUG,"Pain, Acute; Surgery; Anesthesia; Opioid Use",phase4,TERMINATED,Geisinger Clinic,
NCT03922620,Peripheral Nerve Block,DRUG,"Pain, Acute; Surgery; Anesthesia; Opioid Use",phase4,TERMINATED,Geisinger Clinic,
NCT01226524,"Bu Zhong Yi Qi Tang, Zhi Xue Tang, Chuan xin lian kang yan pian mod, Tian Wang Bu xin Dan",DRUG,Childhood Chronic Immune Thrombocytopenia,phase2; phase3,TERMINATED,Hadassah Medical Organization,
NCT03807479,Ponatinib,DRUG,"Leukemia, Myeloid, Chronic-Phase",phase2,TERMINATED,GWT-TUD GmbH,
NCT01425996,Lipotecan® (TLC388),DRUG,"Carcinoma, Hepatocellular",phase1; phase2,TERMINATED,Taiwan Liposome Company,
NCT05507996,Recombinant adeno-associated virus administration,DRUG,Menkes Syndrome,early_phase1,TERMINATED,Kunming Hope of Health Hospital,
NCT01623427,Application of vacuum,PROCEDURE,Post-laparoscopy Umbilical Port-site Wound Infection,na,TERMINATED,University of Manitoba,
NCT01623427,No vacuum,PROCEDURE,Post-laparoscopy Umbilical Port-site Wound Infection,na,TERMINATED,University of Manitoba,
NCT01318642,Gemcitabine,DRUG,Adenocarcinoma of the Pancreas; Locally Advanced; Unresectable,phase2,TERMINATED,"NantBioScience, Inc.",
NCT01318642,AMG 479,DRUG,Adenocarcinoma of the Pancreas; Locally Advanced; Unresectable,phase2,TERMINATED,"NantBioScience, Inc.",
NCT01318642,Placebo,DRUG,Adenocarcinoma of the Pancreas; Locally Advanced; Unresectable,phase2,TERMINATED,"NantBioScience, Inc.",
NCT05746169,Health Questionnaires,OTHER,Cancer,na,TERMINATED,"University of California, San Francisco",
NCT05746169,Specimen sample collection,OTHER,Cancer,na,TERMINATED,"University of California, San Francisco",
NCT01887756,Tele Rehabilitation,DEVICE,Stroke,na,TERMINATED,Clalit Health Services,
NCT01725256,AIR001 (sodium nitrite inhalation solution),DRUG,Pulmonary Arterial Hypertension,phase2,TERMINATED,"Aires Pharmaceuticals, Inc.",
NCT01534351,Finasteride,DRUG,Benign Prostatic Hyperplasia,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01534351,Tamsulosin,DRUG,Benign Prostatic Hyperplasia,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01534351,Finasteride-matching placebo,DRUG,Benign Prostatic Hyperplasia,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01534351,Tamsulosin-matching placebo,DRUG,Benign Prostatic Hyperplasia,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01402817,Sutent®/Sunitinib,DRUG,Neurofibromatosis; NF1; Plexiform Neurofibromas,phase2,TERMINATED,Indiana University,
NCT03720418,OXB-102,DRUG,Parkinson Disease,phase1; phase2,TERMINATED,Sio Gene Therapies,
NCT03720418,Imitation Surgical Procedure (ISP),OTHER,Parkinson Disease,phase1; phase2,TERMINATED,Sio Gene Therapies,
NCT01657318,Olivamine containing wound care products,OTHER,Ulcer; Skin Ulcer; Leg Ulcer; Diabetic Foot,na,TERMINATED,De La Salle University Medical Center,
NCT03954990,Metronidazole Oral,DRUG,Bacterial Vaginoses,phase1,TERMINATED,"The University of Texas Medical Branch, Galveston",
NCT03954990,Placebo Oral Tablet,DRUG,Bacterial Vaginoses,phase1,TERMINATED,"The University of Texas Medical Branch, Galveston",
NCT02811679,Blinatumomab,DRUG,Non-Hodgkin Lymphoma,phase2,TERMINATED,Massachusetts General Hospital,
NCT01773603,Embryoscope,DEVICE,Infertility,na,TERMINATED,Dr. Murat Çetinkaya,
NCT00029042,Infliximab,DRUG,Juvenile Rheumatoid Arthritis,phase2,TERMINATED,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),
NCT06153186,Flunarizine Hydrochloride,DRUG,Childhood Absence Epilepsy; Juvenile Absence Epilepsy; Juvenile Myoclonic Epilepsy,phase2,TERMINATED,University of British Columbia,
NCT02581059,Regorafenib,DRUG,Colorectal Cancer; Palliative Medicine; Supportive Care,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT02581059,Ginseng,OTHER,Colorectal Cancer; Palliative Medicine; Supportive Care,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT04766996,Guided mindfulness exercises,BEHAVIORAL,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Self-administered aromatherapy,OTHER,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Baby aspirin,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Tylenol/Acetaminophen,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Pregabalin,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Prednisone,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Meloxicam,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Prilosec,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Tramadol,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Voltaren,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Zofran,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Pepcid,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Reglan,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Versed,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Lidocaine,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Propofol,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Ancef,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Tranexamic Acid (TXA),DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Decadron,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Bupivacaine hydrochloride,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT04766996,Toradol,DRUG,Anesthesia; Opioid Use,phase4,TERMINATED,Emory University,
NCT02152046,ROP exam with spring loaded retractor,PROCEDURE,Pain During ROP Exam,na,TERMINATED,Wake Forest University Health Sciences,
NCT02152046,ROP exam with screw retractor,PROCEDURE,Pain During ROP Exam,na,TERMINATED,Wake Forest University Health Sciences,
NCT04730427,GX-I7,DRUG,Covid19,phase1,TERMINATED,"Genexine, Inc.",
NCT04730427,GX-I7 vehicle,DRUG,Covid19,phase1,TERMINATED,"Genexine, Inc.",
NCT00548886,Epinephrine,DRUG,Congenital Disorders,na,TERMINATED,Emory University,
NCT01619670,Apligraf,DEVICE,Epidermolysis Bullosa; Wound Healing,phase4,TERMINATED,"University Hospital, Basel, Switzerland",
NCT01113541,Ziprasidone HCL (oral),DRUG,Bipolar Disorder,phase3,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT05592054,Balloon guide catheters (BGCs),PROCEDURE,Acute Ischemic Stroke; Large Vessel Occlusion; Thrombectomy; Thrombosis,na,TERMINATED,Changhai Hospital,
NCT05592054,Standard guide catheter,PROCEDURE,Acute Ischemic Stroke; Large Vessel Occlusion; Thrombectomy; Thrombosis,na,TERMINATED,Changhai Hospital,
NCT04331054,2: Usual practice + SYMBICORT RAPIHALER,DRUG,Covid-19 Infection; Hospitalization in Respiratory Disease Department,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04331054,1: Usual practice,OTHER,Covid-19 Infection; Hospitalization in Respiratory Disease Department,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04207905,Healthy Michigan Plan (HMP) coverage with work requirements,OTHER,Health Insurance,na,TERMINATED,University of Michigan,
NCT03325894,SHP465,DRUG,Attention Deficit Hyperactivity Disorder (ADHD),phase3,TERMINATED,Shire,
NCT00448266,"Intensified Cyclophophamide, Carboplatin and Thiotepa",DRUG,Breast Cancer,phase2; phase3,TERMINATED,The Netherlands Cancer Institute,
NCT00448266,dose dense adriamycine and cyclophosphamide,DRUG,Breast Cancer,phase2; phase3,TERMINATED,The Netherlands Cancer Institute,
NCT03455556,Anetumab Ravtansine,BIOLOGICAL,Mesothelin Positive; Stage III Non-Small Cell Lung Cancer AJCC v7; Stage IIIA Non-Small Cell Lung Cancer AJCC v7; Stage IIIB Non-Small Cell Lung Cancer AJCC v7; Stage IV Non-Small Cell Lung Cancer AJC,phase1,TERMINATED,Mayo Clinic,
NCT03455556,Atezolizumab,BIOLOGICAL,Mesothelin Positive; Stage III Non-Small Cell Lung Cancer AJCC v7; Stage IIIA Non-Small Cell Lung Cancer AJCC v7; Stage IIIB Non-Small Cell Lung Cancer AJCC v7; Stage IV Non-Small Cell Lung Cancer AJC,phase1,TERMINATED,Mayo Clinic,
NCT03455556,Laboratory Biomarker Analysis,OTHER,Mesothelin Positive; Stage III Non-Small Cell Lung Cancer AJCC v7; Stage IIIA Non-Small Cell Lung Cancer AJCC v7; Stage IIIB Non-Small Cell Lung Cancer AJCC v7; Stage IV Non-Small Cell Lung Cancer AJC,phase1,TERMINATED,Mayo Clinic,
NCT02927366,QCC374,DRUG,Pulmonary Arterial Hypertension,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02927366,Placebo Matching,DRUG,Pulmonary Arterial Hypertension,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01077531,Otelixizumab,DRUG,"Arthritis, Rheumatoid",phase1,TERMINATED,GlaxoSmithKline,
NCT01077531,Matching placebo,DRUG,"Arthritis, Rheumatoid",phase1,TERMINATED,GlaxoSmithKline,
NCT02000453,GSK2586184 400mg,DRUG,"Colitis, Ulcerative",phase1,TERMINATED,GlaxoSmithKline,
NCT02574637,Brazikumab IV Infusion,DRUG,Crohn's Disease,phase2,TERMINATED,AstraZeneca,
NCT02574637,Brazikumab SC Injection,DRUG,Crohn's Disease,phase2,TERMINATED,AstraZeneca,
NCT02574637,Placebo,DRUG,Crohn's Disease,phase2,TERMINATED,AstraZeneca,
NCT00361088,PS-341,DRUG,Multiple Myeloma,phase1; phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00361088,R11577,DRUG,Multiple Myeloma,phase1; phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT01643161,Treatment As Usual,BEHAVIORAL,Functional Neurologic Disease,na,TERMINATED,Mayo Clinic,
NCT01643161,Guided Self-Help,BEHAVIORAL,Functional Neurologic Disease,na,TERMINATED,Mayo Clinic,
NCT00263042,Rimonabant,DRUG,Cardiovascular Disease,phase3,TERMINATED,Sanofi,
NCT00263042,Placebo (for Rimonabant),DRUG,Cardiovascular Disease,phase3,TERMINATED,Sanofi,
NCT02524886,GPi DBS with Medtronic electorde and Activa PC pulsegenerator,DEVICE,Tardive Dyskinesia; Tardive Dystonia,na,TERMINATED,GGZ Centraal,
NCT03291054,Pembrolizumab,DRUG,Gastrointestinal Stromal Tumors,phase2,TERMINATED,Columbia University,
NCT03291054,Epacadostat,DRUG,Gastrointestinal Stromal Tumors,phase2,TERMINATED,Columbia University,
NCT03197805,PAM 50 test,OTHER,Breast Cancer,na,TERMINATED,Centre Jean Perrin,
NCT03369756,Prontosan Wound Irrigation Solution and Prontosan Wound Gel,DEVICE,Wound of Lower Leg (Physical Finding),na,TERMINATED,B. Braun Medical Inc.,
NCT05906251,SRP-6004,OTHER,Limb Girdle Muscular Dystrophy,phase1,TERMINATED,"Sarepta Therapeutics, Inc.",
NCT05304390,Patient Navigation,BEHAVIORAL,Lung Carcinoma,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT05304390,Questionnaire Administration,OTHER,Lung Carcinoma,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT05304390,Smoking Cessation Intervention,BEHAVIORAL,Lung Carcinoma,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT05304390,Carbon Monoxide Measurement,PROCEDURE,Lung Carcinoma,na,TERMINATED,Fred Hutchinson Cancer Center,
NCT00737360,TAS-106,DRUG,Head and Neck Cancer,phase2,TERMINATED,"Taiho Pharmaceutical Co., Ltd.",
NCT01259024,transarterial chemoembolization using a drug-eluting bead,DEVICE,Hepatocellular Carcinoma,na,TERMINATED,Washington University School of Medicine,
NCT02681523,Eribulin,DRUG,Breast Cancer,phase2,TERMINATED,Imperial College London,
NCT03920059,Mycophenolate Mofetil,DRUG,Lupus Nephritis,phase4,TERMINATED,Chulalongkorn University,
NCT02780180,QGC001,DRUG,Heart Failure,phase2,TERMINATED,Quantum Genomics SA,
NCT02780180,Placebo,DRUG,Heart Failure,phase2,TERMINATED,Quantum Genomics SA,
NCT02018523,Lenalidomide,DRUG,"Carcinoma, Non-Small-Cell Lung",phase1,TERMINATED,Jun Zhang,
NCT05205759,Bamlanivimab Etesevimab,DRUG,COVID-19,phase3,TERMINATED,Azienda Ospedaliera Universitaria Integrata Verona,
NCT05205759,Sotrovimab,DRUG,COVID-19,phase3,TERMINATED,Azienda Ospedaliera Universitaria Integrata Verona,
NCT05205759,Casirivimab-Imdevimab,DRUG,COVID-19,phase3,TERMINATED,Azienda Ospedaliera Universitaria Integrata Verona,
NCT04677179,LY3471851,DRUG,"Colitis, Ulcerative",phase2,TERMINATED,Nektar Therapeutics,
NCT04677179,Placebo,DRUG,"Colitis, Ulcerative",phase2,TERMINATED,Nektar Therapeutics,
NCT02174003,High intensity whole-body infrared heating,DEVICE,Depression; Anxiety; PTSD; Fibromyalgia; Chronic Fatigue Syndrome,na,TERMINATED,University of Arizona,
NCT02413827,Combination of varlilumab and ipilimumab,DRUG,Unresectable Stage III or Stage IV Melanoma,phase1; phase2,TERMINATED,Celldex Therapeutics,
NCT02413827,"Cohort A: varlilumab & ipilimumab; Cohort B: varlilumab, ipilimumab, CDX-1401 & poly-ICLC",DRUG,Unresectable Stage III or Stage IV Melanoma,phase1; phase2,TERMINATED,Celldex Therapeutics,
NCT01631942,NNC172-2021,DRUG,Congenital Bleeding Disorder; Haemophilia A; Healthy,phase1,TERMINATED,Novo Nordisk A/S,
NCT01439542,Stereotactic Body Radiation,RADIATION,Prostate Cancer,phase2,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT01439542,Luteinizing Hormone Releasing Hormone (LHRH) Agonist,DRUG,Prostate Cancer,phase2,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT04979442,RAIN-32,DRUG,Dedifferentiated Liposarcoma,phase3,TERMINATED,Rain Oncology Inc,
NCT04979442,Trabectedin,DRUG,Dedifferentiated Liposarcoma,phase3,TERMINATED,Rain Oncology Inc,
NCT01392586,upfront breast surgery,PROCEDURE,Metastatic Breast Cancer,phase3,TERMINATED,Jeroen Bosch Ziekenhuis,
NCT01392586,systemic therapy,OTHER,Metastatic Breast Cancer,phase3,TERMINATED,Jeroen Bosch Ziekenhuis,
NCT00732355,Syph-Check POC,DEVICE,Screening for Syphilis Infections,na,TERMINATED,"Healthcare Providers Direct, Inc.",
NCT04159935,iLux® system,DEVICE,Dry Eye,phase4,TERMINATED,University of Waterloo,
NCT01863225,RVX000222,DRUG,Dyslipidemia; Coronary Artery Disease,phase2,TERMINATED,Resverlogix Corp,
NCT01863225,Rosuvastatin,DRUG,Dyslipidemia; Coronary Artery Disease,phase2,TERMINATED,Resverlogix Corp,
NCT01863225,Atorvastatin,DRUG,Dyslipidemia; Coronary Artery Disease,phase2,TERMINATED,Resverlogix Corp,
NCT01863225,Rosuvastatin,DRUG,Dyslipidemia; Coronary Artery Disease,phase2,TERMINATED,Resverlogix Corp,
NCT01863225,Atorvastatin,DRUG,Dyslipidemia; Coronary Artery Disease,phase2,TERMINATED,Resverlogix Corp,
NCT02138825,"Riociguat (Adempas, BAY63-2521)",DRUG,"Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary",phase2,TERMINATED,Bayer,
NCT02138825,Placebo,DRUG,"Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary",phase2,TERMINATED,Bayer,
NCT04675489,Procedure: Vivity Toric IOL,OTHER,Refractive Assessment,na,TERMINATED,EVP Eye Care,
NCT00104468,Troxatyl™ (Cytotoxic Chemotherapeutic),DRUG,Acute Myelogenous Leukemia,phase1; phase2,TERMINATED,"SGX Pharmaceuticals, Inc.",
NCT01192074,Ultrasound,DEVICE,Pregnancy,na,TERMINATED,University of Missouri-Columbia,
NCT05292950,ARO-MUC5AC,DRUG,Asthma; Chronic Obstructive Pulmonary Disease,phase1; phase2,TERMINATED,Arrowhead Pharmaceuticals,
NCT05292950,Placebo,DRUG,Asthma; Chronic Obstructive Pulmonary Disease,phase1; phase2,TERMINATED,Arrowhead Pharmaceuticals,
NCT01355874,Iferanserin,DRUG,Internal Hemorrhoids,phase3,TERMINATED,"Ventrus Biosciences, Inc",
NCT01355874,Placebo,DRUG,Internal Hemorrhoids,phase3,TERMINATED,"Ventrus Biosciences, Inc",
NCT01355874,Iferanserin + Placebo,DRUG,Internal Hemorrhoids,phase3,TERMINATED,"Ventrus Biosciences, Inc",
NCT05410574,Family-based Behavioral Weight Loss Treatment,BEHAVIORAL,Acute Lymphoblastic Leukemia,na,TERMINATED,Washington University School of Medicine,
NCT05087810,Psychological stress induction,BEHAVIORAL,"Overactive Bladder; Stress, Psychological; Anxiety",na,TERMINATED,Vanderbilt University Medical Center,
NCT05087810,Accelerated oral hydration,OTHER,"Overactive Bladder; Stress, Psychological; Anxiety",na,TERMINATED,Vanderbilt University Medical Center,
NCT02063113,Vulnerability and therapeutic changes in older patients with multiple myeloma.,OTHER,Multiple Myeloma in Older Patients,na,TERMINATED,Nantes University Hospital,
NCT02687360,Active rTMS treatment,DEVICE,Chronic Pain; Opioid-use Disorder,na,TERMINATED,New York State Psychiatric Institute,
NCT02687360,Sham rTMS treatment,DEVICE,Chronic Pain; Opioid-use Disorder,na,TERMINATED,New York State Psychiatric Institute,
NCT03354260,Personalized adapted oral diet and nutritional education,OTHER,Food Intake; Critically Ill Patients; Nutrition,na,TERMINATED,"University Hospital, Montpellier",
NCT05155020,AK120,BIOLOGICAL,Asthma,phase2,TERMINATED,Akeso,
NCT05155020,AK120,BIOLOGICAL,Asthma,phase2,TERMINATED,Akeso,
NCT05155020,AK120,BIOLOGICAL,Asthma,phase2,TERMINATED,Akeso,
NCT05155020,Placebo,BIOLOGICAL,Asthma,phase2,TERMINATED,Akeso,
NCT01333124,chemoradiotherapy with Gemcitabine,RADIATION,Resectable Pancreatic Carcinoma,phase2,TERMINATED,"National Cancer Center, Korea",
NCT01333124,Radiation: chemoradiotherapy with Gemcitabine,RADIATION,Resectable Pancreatic Carcinoma,phase2,TERMINATED,"National Cancer Center, Korea",
NCT03777124,SHR-1210,DRUG,NSCLC Stage IV; KRAS Gene Mutation; PD-1 Antibody; Chemotherapy Effect,phase2,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT03777124,Apatinib,DRUG,NSCLC Stage IV; KRAS Gene Mutation; PD-1 Antibody; Chemotherapy Effect,phase2,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT03777124,Pemetrexed,DRUG,NSCLC Stage IV; KRAS Gene Mutation; PD-1 Antibody; Chemotherapy Effect,phase2,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT03777124,Carboplatin,DRUG,NSCLC Stage IV; KRAS Gene Mutation; PD-1 Antibody; Chemotherapy Effect,phase2,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT00037180,Celecoxib,DRUG,Neoplasm Metastasis; Colorectal Neoplasms,phase2,TERMINATED,Pfizer,
NCT00037180,Irinotecan,DRUG,Neoplasm Metastasis; Colorectal Neoplasms,phase2,TERMINATED,Pfizer,
NCT00037180,5-fluorouracil,DRUG,Neoplasm Metastasis; Colorectal Neoplasms,phase2,TERMINATED,Pfizer,
NCT00037180,Leucovorin,DRUG,Neoplasm Metastasis; Colorectal Neoplasms,phase2,TERMINATED,Pfizer,
NCT00946088,Progesterone,DRUG,Pregnancy Complications,phase2; phase3,TERMINATED,Stanford University,
NCT00946088,Polyethylene glycol&hydrogenated vegetable oil.,DRUG,Pregnancy Complications,phase2; phase3,TERMINATED,Stanford University,
NCT03997903,Imatinib Mesylate,DRUG,Sickle Cell Disease,phase1; phase2,TERMINATED,Indiana University,
NCT02722603,gabapentin,DRUG,Chronic Pain,phase3,TERMINATED,Pharmaceutical Research Management srl,
NCT02722603,tramadol,DRUG,Chronic Pain,phase3,TERMINATED,Pharmaceutical Research Management srl,
NCT02722603,placebo tramadol,OTHER,Chronic Pain,phase3,TERMINATED,Pharmaceutical Research Management srl,
NCT02722603,placebo gabapentin,OTHER,Chronic Pain,phase3,TERMINATED,Pharmaceutical Research Management srl,
NCT02829827,Radiprodil,DRUG,Infantile Spasms (IS),phase2,TERMINATED,UCB Biopharma S.P.R.L.,
NCT04247061,Educational video,OTHER,"Smoking, Cessation",na,TERMINATED,Boston University,
NCT04247061,Text-message program,OTHER,"Smoking, Cessation",na,TERMINATED,Boston University,
NCT01138761,Nurse instruction,BEHAVIORAL,Atopic Dermatitis,na,TERMINATED,University of Missouri-Columbia,
NCT01784861,X-82,DRUG,Adenocarcinoma; Pancreatic Neoplasms,phase1; phase2,TERMINATED,Washington University School of Medicine,
NCT01784861,Everolimus,DRUG,Adenocarcinoma; Pancreatic Neoplasms,phase1; phase2,TERMINATED,Washington University School of Medicine,
NCT05160168,THE-630,DRUG,"Gastrointestinal Stromal Tumors (GIST); Neoplasms, Connective Tissue; Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type; Neoplasms; Gastrointestinal Neoplasms; Digestive System Neopl",phase1; phase2,TERMINATED,Theseus Pharmaceuticals,
NCT02741050,Tailored Physical Activity Intervention,BEHAVIORAL,Diabetes; Sedentary Lifestyle,na,TERMINATED,"University of California, San Diego",
NCT02741050,Standard of Care,BEHAVIORAL,Diabetes; Sedentary Lifestyle,na,TERMINATED,"University of California, San Diego",
NCT01779050,Doxorubicin,DRUG,Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT01779050,Trastuzumab,BIOLOGICAL,Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT01779050,Cyclophosphamide,DRUG,Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT01779050,Paclitaxel,DRUG,Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT01779050,Epirubicin,DRUG,Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT01779050,Docetaxel,DRUG,Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT01779050,Carboplatin,DRUG,Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT01779050,Fluorouracil,DRUG,Breast Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT00048750,Micafungin,DRUG,Invasive Fungal Infections,phase3,TERMINATED,Astellas Pharma Inc,
NCT00048750,Placebo,DRUG,Invasive Fungal Infections,phase3,TERMINATED,Astellas Pharma Inc,
NCT00547118,Rimonabant,DRUG,Schizophrenia; Schizoaffective Disorder; Obesity; Hypertension; Smoking,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT00547118,Placebo,DRUG,Schizophrenia; Schizoaffective Disorder; Obesity; Hypertension; Smoking,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT05788497,Hemorrane plus,DRUG,Haemorrhoids Without Complication,phase3,TERMINATED,"Faes Farma, S.A.",
NCT05788497,Hemorrane,DRUG,Haemorrhoids Without Complication,phase3,TERMINATED,"Faes Farma, S.A.",
NCT05788497,Placebo,DRUG,Haemorrhoids Without Complication,phase3,TERMINATED,"Faes Farma, S.A.",
NCT04238013,Whole Body Vibration (WBV),OTHER,Spinal Cord Injuries; Spastic Gait; Foot Drop,na,TERMINATED,"Shepherd Center, Atlanta GA",
NCT04238013,Electrical Stimulation,OTHER,Spinal Cord Injuries; Spastic Gait; Foot Drop,na,TERMINATED,"Shepherd Center, Atlanta GA",
NCT01581060,WX-554,DRUG,Advanced Solid Tumours,phase1; phase2,TERMINATED,Heidelberg Pharma AG,
NCT01564524,Fat graft surgical procedure,PROCEDURE,Facial Injuries; Adipose Tissue,na,TERMINATED,University of Pittsburgh,
NCT04909723,NOV-001,OTHER,Healthy Volunteers; Enteric Hyperoxaluria,phase1; phase2,TERMINATED,Novome Biotechnologies Inc,
NCT04909723,NB1000S,BIOLOGICAL,Healthy Volunteers; Enteric Hyperoxaluria,phase1; phase2,TERMINATED,Novome Biotechnologies Inc,
NCT04909723,NB2000P,DRUG,Healthy Volunteers; Enteric Hyperoxaluria,phase1; phase2,TERMINATED,Novome Biotechnologies Inc,
NCT04909723,Placebo,DRUG,Healthy Volunteers; Enteric Hyperoxaluria,phase1; phase2,TERMINATED,Novome Biotechnologies Inc,
NCT03451123,FET PET/MRI,DRUG,Pediatric Brain Tumors,early_phase1,TERMINATED,University of Alabama at Birmingham,
NCT01037959,Norfloxacin,DRUG,Cirrhosis,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01037959,Placebo,DRUG,Cirrhosis,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00702962,"Vorinostat, Carboplatin, Etoposide",DRUG,Small Cell Lung Cancer,phase1; phase2,TERMINATED,Milton S. Hershey Medical Center,
NCT06939946,Parathyroid auto-fluorescence imaging,DEVICE,Thyroid Disease; Thyroid Surgery; Parathyroid Gland,phase1,TERMINATED,"OPTOSURGICAL, LLC",
NCT06939946,Indocyanine green,DRUG,Thyroid Disease; Thyroid Surgery; Parathyroid Gland,phase1,TERMINATED,"OPTOSURGICAL, LLC",
NCT01405846,Gefitinib,DRUG,Lung Cancer; Head and Neck Cancer,phase2,TERMINATED,Papworth Hospital NHS Foundation Trust,
NCT05081388,REGN14256,DRUG,SARS-CoV-2,phase1; phase2,TERMINATED,Regeneron Pharmaceuticals,
NCT05081388,imdevimab,DRUG,SARS-CoV-2,phase1; phase2,TERMINATED,Regeneron Pharmaceuticals,
NCT05081388,casirivimab + imdevimab,DRUG,SARS-CoV-2,phase1; phase2,TERMINATED,Regeneron Pharmaceuticals,
NCT05081388,Placebo,DRUG,SARS-CoV-2,phase1; phase2,TERMINATED,Regeneron Pharmaceuticals,
NCT02465203,Previous treatment in DEB025 study,DRUG,"Hepatitis C, Chronic",phase3,TERMINATED,Novartis Pharmaceuticals,
NCT01243970,Phenylephrine,DRUG,Spinal Anesthesia; Pregnancy,phase4,TERMINATED,University College London Hospitals,
NCT01243970,Ephedrine,DRUG,Spinal Anesthesia; Pregnancy,phase4,TERMINATED,University College London Hospitals,
NCT05785715,NX-13 250mg,DRUG,Ulcerative Colitis,phase2,TERMINATED,AbbVie,
NCT05785715,NX-13 750mg,DRUG,Ulcerative Colitis,phase2,TERMINATED,AbbVie,
NCT05785715,NX-13 Placebo,DRUG,Ulcerative Colitis,phase2,TERMINATED,AbbVie,
NCT02846376,Nivolumab,DRUG,Acute Myeloid Leukemia and Myelodysplastic Syndrome,phase1,TERMINATED,Hackensack Meridian Health,
NCT02846376,Ipilimumab,DRUG,Acute Myeloid Leukemia and Myelodysplastic Syndrome,phase1,TERMINATED,Hackensack Meridian Health,
NCT01080768,Aliskiren/amlodipine,DRUG,Hypertension; Ankle Edema,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01080768,Amlodipine,DRUG,Hypertension; Ankle Edema,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01080768,Placebo to Aliskiren/amlodipine,DRUG,Hypertension; Ankle Edema,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01080768,Placebo to Amlodipine,DRUG,Hypertension; Ankle Edema,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT00755950,Silymarin,OTHER,Acute Hepatitis A; Acute Hepatitis B; Acute Hepatitis C; Acute Hepatitis E; Acute EBV Hepatitis; Acute CMV Hepatitis,phase2; phase3,TERMINATED,"University of Maryland, Baltimore",
NCT00755950,Silymarin,OTHER,Acute Hepatitis A; Acute Hepatitis B; Acute Hepatitis C; Acute Hepatitis E; Acute EBV Hepatitis; Acute CMV Hepatitis,phase2; phase3,TERMINATED,"University of Maryland, Baltimore",
NCT00755950,Lactose monohydrate,OTHER,Acute Hepatitis A; Acute Hepatitis B; Acute Hepatitis C; Acute Hepatitis E; Acute EBV Hepatitis; Acute CMV Hepatitis,phase2; phase3,TERMINATED,"University of Maryland, Baltimore",
NCT02245074,Sputum induction,OTHER,Infantile Asthma,na,TERMINATED,"University Hospital, Rouen",
NCT03782818,Olaparib,DRUG,Pulmonary Arterial Hypertension,phase1; phase2,TERMINATED,Laval University,
NCT00750997,hypertonic saline,DRUG,Hemorrhagic Shock; Traumatic Brain Injury,na,TERMINATED,University of Washington,
NCT01820520,brilliant blue G,DRUG,Macular Hole; Epiretinal Membrane,phase3,TERMINATED,Asociación para Evitar la Ceguera en México,
NCT02759120,Antimicrobial therapy: Co-trimoxazole or Doxycycline,DRUG,Idiopathic Pulmonary Fibrosis,phase3,TERMINATED,Weill Medical College of Cornell University,
NCT02759120,No Intervention: Standard of Care,OTHER,Idiopathic Pulmonary Fibrosis,phase3,TERMINATED,Weill Medical College of Cornell University,
NCT00651482,Everolimus,DRUG,Kidney Neoplasms; Kidney (Renal Cell) Cancer,phase2,TERMINATED,Sandy Srinivas,
NCT00651482,Bevacizumab,DRUG,Kidney Neoplasms; Kidney (Renal Cell) Cancer,phase2,TERMINATED,Sandy Srinivas,
NCT00751920,Enhanced MRI Scan,PROCEDURE,Metastatic Pulmonary Nodules,phase3,TERMINATED,The Hospital for Sick Children,
NCT00075023,Thalidomide Gel,DRUG,Graft-versus-Host Disease; Stomatitis,phase2,TERMINATED,National Institute of Nursing Research (NINR),
NCT00075023,Placebo Gel,DRUG,Graft-versus-Host Disease; Stomatitis,phase2,TERMINATED,National Institute of Nursing Research (NINR),
NCT00252876,tesaglitazar,DRUG,Type 2 Diabetes,phase3,TERMINATED,AstraZeneca,
NCT03731117,Furosemide,DRUG,Acute Kidney Injury,phase4,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01842217,FES-PET,PROCEDURE,Psychiatric/Mood Disorder | Patient; Estrogen Receptor Levels; Premenopausal; Postmenopausal,na,TERMINATED,University Medical Center Groningen,
NCT00685217,TVT Secur (Gynecare),PROCEDURE,"Urinary Incontinence, Stress",phase3,TERMINATED,University of Calgary,
NCT00685217,TVT (Gynecare),PROCEDURE,"Urinary Incontinence, Stress",phase3,TERMINATED,University of Calgary,
NCT02568189,SonoSite Maxx Series Ultrasound System,DEVICE,Sepsis; Gastroenteritis; Dehydration,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT01842789,Acessa Procedure,DEVICE,Uterine Fibroids,na,TERMINATED,"Acessa Health, Inc.",
NCT03346850,Nasogastric tube (NGT) feeding,DEVICE,Enteral Feeding in Bronchiolitis,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT03346850,Nasoduodenal tube (NDT) feeding,DEVICE,Enteral Feeding in Bronchiolitis,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT02379390,Cabazitaxel XRP6258,DRUG,Prostate Cancer Metastatic,phase2,TERMINATED,Sanofi,
NCT02379390,Ezalutamide,DRUG,Prostate Cancer Metastatic,phase2,TERMINATED,Sanofi,
NCT02379390,Abiraterone acetate,DRUG,Prostate Cancer Metastatic,phase2,TERMINATED,Sanofi,
NCT02379390,Prednisone,DRUG,Prostate Cancer Metastatic,phase2,TERMINATED,Sanofi,
NCT03603080,Administration of weight loss drug (Metformin or Topiramate),DRUG,Obesity,phase4,TERMINATED,Hartford Hospital,
NCT00304980,ARTEMETHER + LUMEFANTRINE VS. SULFADOXINE + PYRIMETHAMINE,DRUG,Plasmodium Falciparum Malaria,na,TERMINATED,"Institute of Tropical Medicine, Belgium",
NCT02932579,Pharmacogenomic Testing,OTHER,Pain,phase4,TERMINATED,University of Rochester,
NCT02932579,Ibuprofen,DRUG,Pain,phase4,TERMINATED,University of Rochester,
NCT02932579,hydroxycontin/acetominophen,DRUG,Pain,phase4,TERMINATED,University of Rochester,
NCT02932579,acetominophen,DRUG,Pain,phase4,TERMINATED,University of Rochester,
NCT02932579,Oxycontin/acetominophen,DRUG,Pain,phase4,TERMINATED,University of Rochester,
NCT01735396,Abiraterone Acetate,DRUG,Prostate Cancer,phase2,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT00904488,Addition of oral Metolazone,DRUG,Acute Decompensated Heart Failure,phase4,TERMINATED,"University of North Carolina, Chapel Hill",
NCT00904488,Furosemide dose escalation,DRUG,Acute Decompensated Heart Failure,phase4,TERMINATED,"University of North Carolina, Chapel Hill",
NCT00180388,endoscopic vein harvesting,PROCEDURE,Coronary Artery Disease,phase4,TERMINATED,Boston Scientific Corporation,
NCT00180388,open vein harvesting,PROCEDURE,Coronary Artery Disease,phase4,TERMINATED,Boston Scientific Corporation,
NCT03644927,Progressive exercise training,BEHAVIORAL,Chronic Low Back Pain; Posttraumatic Stress Disorder,na,TERMINATED,Boston University,
NCT03644927,Waitlist Control,BEHAVIORAL,Chronic Low Back Pain; Posttraumatic Stress Disorder,na,TERMINATED,Boston University,
NCT00515489,Risperidone,DRUG,Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorders,na,TERMINATED,"Janssen-Cilag, S.A.",
NCT03476174,Pembrolizumab,DRUG,Melanoma,phase2,TERMINATED,Ralph Hauke,
NCT03476174,Interleukin-2,DRUG,Melanoma,phase2,TERMINATED,Ralph Hauke,
NCT02324491,ZGN-440 for Injectable Suspension,DRUG,Obesity; Type 2 Diabetes,phase2,TERMINATED,"Zafgen, Inc.",
NCT02324491,ZGN-440 Placebo for Injectable Suspension,DRUG,Obesity; Type 2 Diabetes,phase2,TERMINATED,"Zafgen, Inc.",
NCT04084990,S9 VPAP Adapt,DEVICE,Obstructive Sleep Apnea; Fetal Growth Restriction; Pregnancy Related,phase3,TERMINATED,Washington University School of Medicine,
NCT03213210,easy-graft CLASSIC (beta-Tricalcium Phosphate),DEVICE,Peri-Implantitis,na,TERMINATED,Sunstar Americas,
NCT00003513,Antineoplaston therapy (Atengenal + Astugenal),DRUG,Neuroblastoma,phase2,TERMINATED,Burzynski Research Institute,
NCT02945813,Metformin,DRUG,Prostate Cancer,phase2,TERMINATED,Swiss Cancer Institute,
NCT02945813,Salvage Radiotherapy SRT,RADIATION,Prostate Cancer,phase2,TERMINATED,Swiss Cancer Institute,
NCT01996982,CCS Device,DEVICE,Hypothermia,na,TERMINATED,Seton Healthcare Family,
NCT00444223,fluorine F 18 FEQA + positron emission tomography,PROCEDURE,Lung Cancer,na,TERMINATED,Jonsson Comprehensive Cancer Center,
NCT05552859,Insulin glargine 300 U/mL,DRUG,Type 2 Diabetes Mellitus; Renal Impairment,phase4,TERMINATED,Sanofi,
NCT05552859,Insulin degludec 100 U/mL,DRUG,Type 2 Diabetes Mellitus; Renal Impairment,phase4,TERMINATED,Sanofi,
NCT01238679,PF-04958242,DRUG,Healthy Volunteers,phase1,TERMINATED,Biogen,
NCT01238679,Placebo,DRUG,Healthy Volunteers,phase1,TERMINATED,Biogen,
NCT00237679,Neuromuscular Electrical Stimulation,BEHAVIORAL,Voice Disorders; Gastroesophageal Reflux,na,TERMINATED,"University of Wisconsin, Madison",
NCT00237679,Unstimulated,BEHAVIORAL,Voice Disorders; Gastroesophageal Reflux,na,TERMINATED,"University of Wisconsin, Madison",
NCT00006096,cisplatin,DRUG,Vulvar Cancer,phase3,TERMINATED,Gynecologic Oncology Group,
NCT00006096,radiation therapy,RADIATION,Vulvar Cancer,phase3,TERMINATED,Gynecologic Oncology Group,
NCT01622088,Dexpramipexole,DRUG,Amyotrophic Lateral Sclerosis,phase3,TERMINATED,Knopp Biosciences,
NCT02038803,TOBIpodhaler,DRUG,Cystic Fibrosis,na,TERMINATED,Rush University Medical Center,
NCT02503527,Diben 1.5 kcal HP,OTHER,Aneurysmal Subarachnoid Hemorrhage,na,TERMINATED,Fresenius Kabi,
NCT02503527,Fresubin HP Energy Fibre (1.5 kcal),OTHER,Aneurysmal Subarachnoid Hemorrhage,na,TERMINATED,Fresenius Kabi,
NCT00313261,Clevudine,DRUG,Hepatitis B,phase2,TERMINATED,Bukwang Pharmaceutical,
NCT04956042,Fosciclopirox,DRUG,Refractory Acute Myeloid Leukemia; Recurrent Acute Myeloid Leukemia,phase1; phase2,TERMINATED,CicloMed LLC,
NCT04956042,Fosciclopirox + Cytarabine,DRUG,Refractory Acute Myeloid Leukemia; Recurrent Acute Myeloid Leukemia,phase1; phase2,TERMINATED,CicloMed LLC,
NCT04165642,Laser ballon ablation for Pulmonary vein isolation,OTHER,Assessment of Safety of Laser Balloon Ablation; Assessment of Procedural Times of Laser Ballon Ablation,na,TERMINATED,IRCCS Policlinico S. Donato,
NCT04060342,GB1275,DRUG,Pancreatic Adenocarcinoma; Esophageal Adenocarcinoma; Esophageal Squamous Cell Carcinoma; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Triple Negative Breast Cancer; Castration-re,phase1,TERMINATED,"GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.",
NCT04060342,nab-paclitaxel and gemcitabine,DRUG,Pancreatic Adenocarcinoma; Esophageal Adenocarcinoma; Esophageal Squamous Cell Carcinoma; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Triple Negative Breast Cancer; Castration-re,phase1,TERMINATED,"GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.",
NCT04060342,pembrolizumab,DRUG,Pancreatic Adenocarcinoma; Esophageal Adenocarcinoma; Esophageal Squamous Cell Carcinoma; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Triple Negative Breast Cancer; Castration-re,phase1,TERMINATED,"GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.",
NCT01573286,Glucagon-Like Peptide 2,DRUG,Intestinal Failure; Short Bowel Syndrome,phase1; phase2,TERMINATED,Alberta Children's Hospital,
NCT01573286,Glucagon like peptide-2,DRUG,Intestinal Failure; Short Bowel Syndrome,phase1; phase2,TERMINATED,Alberta Children's Hospital,
NCT03868943,Soliramfetol,DRUG,Glioma; Glioblastoma,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT01318915,ATG,DRUG,Renal Transplant Recipients,early_phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01318915,Rituximab,DRUG,Renal Transplant Recipients,early_phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01318915,Tacrolimus,DRUG,Renal Transplant Recipients,early_phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01318915,Sirolimus,DRUG,Renal Transplant Recipients,early_phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01318915,MMF,DRUG,Renal Transplant Recipients,early_phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02689635,Sodium Restricted Diet,OTHER,Heart Failure,na,TERMINATED,Maya Guglin,
NCT02689635,Regular Diet,OTHER,Heart Failure,na,TERMINATED,Maya Guglin,
NCT04249817,Video Conferencing with Exteneded Role Practitioner (VC-ERP),OTHER,Inflammatory Arthritis,na,TERMINATED,Sunnybrook Health Sciences Centre,
NCT04040140,APA Treatment,OTHER,Cancer-related Pain; Acupressure,na,TERMINATED,Johns Hopkins University,
NCT04310397,Dabrafenib,DRUG,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT04310397,Spartalizumab,BIOLOGICAL,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT04310397,Therapeutic Conventional Surgery,PROCEDURE,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT04310397,Trametinib,DRUG,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT04705597,BGE-175,DRUG,Covid19,phase2,TERMINATED,"BioAge Labs, Inc.",
NCT04705597,Placebo,OTHER,Covid19,phase2,TERMINATED,"BioAge Labs, Inc.",
NCT03793010,FX006,DRUG,"Osteoarthritis, Hip",phase3,TERMINATED,"Pacira Pharmaceuticals, Inc",
NCT03793010,Normal saline,DRUG,"Osteoarthritis, Hip",phase3,TERMINATED,"Pacira Pharmaceuticals, Inc",
NCT02419820,APD791,DRUG,Acute Coronary Syndrome,phase1,TERMINATED,IlDong Pharmaceutical Co Ltd,
NCT02419820,Clopidogrel,DRUG,Acute Coronary Syndrome,phase1,TERMINATED,IlDong Pharmaceutical Co Ltd,
NCT02419820,Aspirin,DRUG,Acute Coronary Syndrome,phase1,TERMINATED,IlDong Pharmaceutical Co Ltd,
NCT02419820,Placebo for APD791,DRUG,Acute Coronary Syndrome,phase1,TERMINATED,IlDong Pharmaceutical Co Ltd,
NCT04096482,Peregrine Drivable ENT Scope,DEVICE,Sinus Problem,na,TERMINATED,Emory University,
NCT04096482,Standard 30° 4mm Endoscope,DEVICE,Sinus Problem,na,TERMINATED,Emory University,
NCT01994824,rabbit antithymocyte globulin,DRUG,Graft-vs-host Disease,phase2,TERMINATED,University of Calgary,
NCT03054623,DRIL procedure,PROCEDURE,Steal Syndrome; Chronic Kidney Diseases; Arterio-Venous Fistula,na,TERMINATED,University of South Florida,
NCT00602680,SSR180711C,DRUG,Alzheimer's Disease,phase2,TERMINATED,Sanofi,
NCT00602680,donepezil,DRUG,Alzheimer's Disease,phase2,TERMINATED,Sanofi,
NCT00602680,placebo,DRUG,Alzheimer's Disease,phase2,TERMINATED,Sanofi,
NCT03873662,Blood sample,OTHER,Out-Of-Hospital Cardiac Arrest,na,TERMINATED,Brno University Hospital,
NCT01789489,"Medison Accuvix V20, sonde 3D5-9EK (Endovaginal 3 dimensional echography)",DEVICE,Endometrial or Uterine Pathology,na,TERMINATED,Hopital Foch,
NCT03943550,RO7049665,DRUG,Ulcerative Colitis,phase1,TERMINATED,Hoffmann-La Roche,
NCT03943550,Placebo,DRUG,Ulcerative Colitis,phase1,TERMINATED,Hoffmann-La Roche,
NCT00155610,intravesical current perception test,DEVICE,Diabetes Mellitus,na,TERMINATED,National Taiwan University Hospital,
NCT04609410,Neuromuscular blockade,PROCEDURE,Neuromuscular Blockade; Intraoperative Bleeding; Hepatic Cancer,na,TERMINATED,Università Vita-Salute San Raffaele,
NCT03122613,Curcumin,OTHER,Ulcerative Colitis in Remission,na,TERMINATED,Chinese University of Hong Kong,
NCT03122613,Placebo,DRUG,Ulcerative Colitis in Remission,na,TERMINATED,Chinese University of Hong Kong,
NCT03656913,Extremely low dose CT,OTHER,Nephrolithiasis; Ureterolithiases,na,TERMINATED,"Children's Hospital Medical Center, Cincinnati",
NCT01460823,Percutaneous Cochlear Implantation using image guided surgical techniques,PROCEDURE,Hearing Loss,na,TERMINATED,Vanderbilt University,
NCT01769196,Simtuzumab,DRUG,Idiopathic Pulmonary Fibrosis,phase2,TERMINATED,Gilead Sciences,
NCT01769196,Simtuzumab placebo,DRUG,Idiopathic Pulmonary Fibrosis,phase2,TERMINATED,Gilead Sciences,
NCT00402662,everolimus,DRUG,Metastatic Melanoma,phase2,TERMINATED,Yale University,
NCT00402662,Imatinib,DRUG,Metastatic Melanoma,phase2,TERMINATED,Yale University,
NCT00354562,ABT-751,DRUG,Lung Cancer; Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,Abbott,
NCT00354562,Placebo,DRUG,Lung Cancer; Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,Abbott,
NCT00354562,Docetaxel,DRUG,Lung Cancer; Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,Abbott,
NCT02665988,tDCS,DEVICE,Chronic Pain; Psychiatric Disorders,na,TERMINATED,Baylor College of Medicine,
NCT02665988,Sham tDCS,DEVICE,Chronic Pain; Psychiatric Disorders,na,TERMINATED,Baylor College of Medicine,
NCT02798003,Functional magnetic resonance imaging (fMRI),OTHER,Cachexia; Chronic Obstructive Pulmonary Disease; Non-small Cell Lung Cancer; Pancreatic Cancer,na,TERMINATED,Maastricht University Medical Center,
NCT01312818,Bortezomib,DRUG,Acute Lymphoblastic Leukemia,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT01312818,Vorinostat,DRUG,Acute Lymphoblastic Leukemia,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT01312818,Dexamethasone,DRUG,Acute Lymphoblastic Leukemia,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT01312818,Methotrexate,DRUG,Acute Lymphoblastic Leukemia,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT01312818,Imatinib mesylate,DRUG,Acute Lymphoblastic Leukemia,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00705913,Mitroflow Aortic Pericardial Heart Valve (CarboMedics),DEVICE,Aortic Valve Disease,na,TERMINATED,"Sorin Group USA, Inc.",
NCT00705913,Carpentier-Edwards Magna Tissue Valve,DEVICE,Aortic Valve Disease,na,TERMINATED,"Sorin Group USA, Inc.",
NCT02478320,Ilorasertib,DRUG,Advanced Cancers,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01025882,gemcitabine hydrochloride,DRUG,Pancreatic Cancer,phase1,TERMINATED,University of Texas Southwestern Medical Center,
NCT01025882,stereotactic body radiation therapy,RADIATION,Pancreatic Cancer,phase1,TERMINATED,University of Texas Southwestern Medical Center,
NCT00872482,nimotuzumab,DRUG,Metastatic Non-Small Cell Lung Cancer,phase2,TERMINATED,YM BioSciences,
NCT02885324,Cabozantinib,DRUG,Glioblastoma Multiforme; Anaplastic Astrocytoma; Malignant Brain Tumor; High Grade Glioma,phase2,TERMINATED,Indiana University,
NCT05050123,iPhone Google Cardboard virtual reality meditation/relaxation app,BEHAVIORAL,Anxiety; Pain,na,TERMINATED,Mayo Clinic,
NCT05050123,Standard relaxation training,BEHAVIORAL,Anxiety; Pain,na,TERMINATED,Mayo Clinic,
NCT03958279,Ultrasound measurement of residual volume in the urinary bladder,OTHER,Urinary Retention,na,TERMINATED,Comenius University,
NCT03958279,Questionnaire,OTHER,Urinary Retention,na,TERMINATED,Comenius University,
NCT02932488,Sumatriptan,DRUG,Healthy Volunteers,phase1,TERMINATED,Gitte Moos Knudsen,
NCT04759872,Hyperinsulinemic-euglycemic Clamp,OTHER,Overweight and Obesity; Insulin Resistance; Metabolic Disease; Mitochondrial Metabolism; Sedentary Lifestyle,na,TERMINATED,Oregon State University,
NCT04882072,Ustekinumab,DRUG,Takayasu Arteritis,phase3,TERMINATED,Janssen Pharmaceutical K.K.,
NCT04882072,Placebo,OTHER,Takayasu Arteritis,phase3,TERMINATED,Janssen Pharmaceutical K.K.,
NCT04882072,Glucorticoid Taper Regimen,DRUG,Takayasu Arteritis,phase3,TERMINATED,Janssen Pharmaceutical K.K.,
NCT00608777,Calcipotriene/betamethasone,DRUG,Plaque Psoriasis,phase4,TERMINATED,"Derm Research, PLLC",
NCT01712477,Intravenous sedation using propofol,DRUG,Traumatic Brain Injury,phase4,TERMINATED,Michigan State University,
NCT01712477,Intravenous sedation with midazolam,DRUG,Traumatic Brain Injury,phase4,TERMINATED,Michigan State University,
NCT06054477,ALE.C04,DRUG,Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma,phase1; phase2,TERMINATED,Alentis Therapeutics AG,
NCT06054477,Pembrolizumab,DRUG,Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma,phase1; phase2,TERMINATED,Alentis Therapeutics AG,
NCT02439177,Blood glucose monitoring system (Omnitest 3),DEVICE,Diabetes,na,TERMINATED,B. Braun Melsungen AG,
NCT02439177,Blood glucose monitoring system (Omnitest 5),DEVICE,Diabetes,na,TERMINATED,B. Braun Melsungen AG,
NCT06865677,Sacituzumab Govitecan,DRUG,Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT06865677,EKG,OTHER,Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT06865677,Brain MRI,OTHER,Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT06865677,CT scans,OTHER,Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT06865677,Tumor biopsy,PROCEDURE,Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT06865677,Loperamide,DRUG,Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT06865677,Octreotide,DRUG,Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT06865677,Diphenoxylate/Atropine,DRUG,Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT06865677,Antiemetics,DRUG,Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT02345577,Stochastic whole body vibration (WBV) therapy - Physiotherapeutical intervention,OTHER,Kidney Transplantation,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT02345577,Stochastic whole body vibration (WBV) therapy - Sham physiotherapeutical intervention,OTHER,Kidney Transplantation,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT00787072,AZD8075,DRUG,Healthy Volunteers,phase1,TERMINATED,AstraZeneca,
NCT00787072,Placebo,DRUG,Healthy Volunteers,phase1,TERMINATED,AstraZeneca,
NCT01648595,Fentanyl,DRUG,Decrease Labor Pain,phase2; phase3,TERMINATED,Mashhad University of Medical Sciences,
NCT01485757,L-arginine,DRUG,Heart Transplant,phase1,TERMINATED,University of Michigan,
NCT02318901,Pembrolizumab,DRUG,Advanced Cancer; Breast Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer,phase1; phase2,TERMINATED,Western Regional Medical Center,
NCT02318901,Trastuzumab,DRUG,Advanced Cancer; Breast Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer,phase1; phase2,TERMINATED,Western Regional Medical Center,
NCT02318901,ado-trastuzumab emtansine,DRUG,Advanced Cancer; Breast Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer,phase1; phase2,TERMINATED,Western Regional Medical Center,
NCT02318901,Cetuximab,DRUG,Advanced Cancer; Breast Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer,phase1; phase2,TERMINATED,Western Regional Medical Center,
NCT04528199,[18F]FLOR (FC303) Injection,DRUG,Metastatic Prostate Cancer,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT03287063,Tumor Biopsy,OTHER,Glioblastoma,na,TERMINATED,University of Michigan Rogel Cancer Center,
NCT04193293,Duvelisib,DRUG,Head and Neck Squamous Cell Carcinoma,phase1; phase2,TERMINATED,SecuraBio,
NCT04193293,Pembrolizumab,BIOLOGICAL,Head and Neck Squamous Cell Carcinoma,phase1; phase2,TERMINATED,SecuraBio,
NCT02047214,TPI 287,DRUG,Glioblastoma Multiforme,phase2,TERMINATED,"Cortice Biosciences, Inc.",
NCT02047214,Bevacizumab,DRUG,Glioblastoma Multiforme,phase2,TERMINATED,"Cortice Biosciences, Inc.",
NCT06173063,Mobility+ Enteral Feeding System,DEVICE,Enteral Feeding,na,TERMINATED,Rockfield Medical Devices,
NCT04583163,Transcranial Doppler,OTHER,"Cerebral Aneurysm; Stroke; Vasospasm, Cerebral; Subarachnoid Hemorrhage, Aneurysmal; Aneurysmal Subarachnoid Hemorrhage; Cerebral Ischemia",na,TERMINATED,Hackensack Meridian Health,
NCT03573921,Gastrograﬁn,DRUG,Small Bowel Obstruction,phase2; phase3,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT03573921,Saline solution (control treatment),OTHER,Small Bowel Obstruction,phase2; phase3,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02032784,octreotide,DRUG,Adenoma,phase4,TERMINATED,AdventHealth,
NCT02032784,No Octreotide,OTHER,Adenoma,phase4,TERMINATED,AdventHealth,
NCT02957604,evolocumab,DRUG,Hypercholesterolemia; ASCVD; Pregnancy,na,TERMINATED,Amgen,
NCT00978133,Dermabond ProPen (2-octylcyanoacrylate),PROCEDURE,Wound,phase2,TERMINATED,Singapore General Hospital,
NCT00978133,Skin closure with skin staples,PROCEDURE,Wound,phase2,TERMINATED,Singapore General Hospital,
NCT03609749,Mindfulness Training for Primary Care,BEHAVIORAL,Anxiety; Depression,na,TERMINATED,Cambridge Health Alliance,
NCT00385138,Cangrelor,DRUG,Atherosclerosis; Acute Coronary Syndrome (ACS),phase3,TERMINATED,The Medicines Company,
NCT00385138,clopidogrel,DRUG,Atherosclerosis; Acute Coronary Syndrome (ACS),phase3,TERMINATED,The Medicines Company,
NCT00385138,Placebo bolus & placebo infusion,DRUG,Atherosclerosis; Acute Coronary Syndrome (ACS),phase3,TERMINATED,The Medicines Company,
NCT00385138,Placebo capsules - end of PCI,DRUG,Atherosclerosis; Acute Coronary Syndrome (ACS),phase3,TERMINATED,The Medicines Company,
NCT00385138,Placebo capsules - end of infusion,DRUG,Atherosclerosis; Acute Coronary Syndrome (ACS),phase3,TERMINATED,The Medicines Company,
NCT00207948,Dose adjustment of Kaletra,DRUG,HIV Infections,na,TERMINATED,Children's National Research Institute,
NCT05587530,Treatment engagement and retention intervention for suicidal clients,BEHAVIORAL,Suicide,na,TERMINATED,Columbia University,
NCT01356667,DARTNA,BEHAVIORAL,Substance Use Disorders,na,TERMINATED,"University of California, Los Angeles",
NCT01356667,Treatment-As-Usual,BEHAVIORAL,Substance Use Disorders,na,TERMINATED,"University of California, Los Angeles",
NCT01199367,KW-2450 in combination with lapatinib and letrozole,DRUG,Breast Cancer,phase1,TERMINATED,"Kyowa Kirin Co., Ltd.",
NCT01159119,EUR-1066-A,DRUG,Chronic Pancreatitis,phase1,TERMINATED,Forest Laboratories,
NCT01159119,Zenpep,DRUG,Chronic Pancreatitis,phase1,TERMINATED,Forest Laboratories,
NCT01159119,EUR-1066-B,DRUG,Chronic Pancreatitis,phase1,TERMINATED,Forest Laboratories,
NCT02772081,LISA combination product (Curosurf+catheter CHF6440),OTHER,Respiratory Distress Syndrome (RDS),phase3,TERMINATED,Chiesi Farmaceutici S.p.A.,
NCT02772081,Curosurf through conventional administration (endotracheal tube),DRUG,Respiratory Distress Syndrome (RDS),phase3,TERMINATED,Chiesi Farmaceutici S.p.A.,
NCT00248157,Octreotide acetate in microspheres,DRUG,Diabetic Retinopathy,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT00576901,bevacizumab [Avastin],DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT00576901,Docetaxel,DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT00576901,Xeloda,DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT03433755,evolocumab,DRUG,Primary Hypercholesterolemia; Mixed Dyslipidemia,phase3,TERMINATED,Amgen,
NCT03433755,placebo,DRUG,Primary Hypercholesterolemia; Mixed Dyslipidemia,phase3,TERMINATED,Amgen,
NCT02313012,CC-90003,DRUG,Neoplasm Metastasis,phase1,TERMINATED,Celgene,
NCT04696848,CKD-516 plus Durvalumab,DRUG,Colorectal Cancer; Solid Tumor,phase1; phase2,TERMINATED,Tae Won Kim,
NCT02691455,Baerveldt Glaucoma Implant 350-mm2 / BG101-350,DEVICE,Glaucoma,na,TERMINATED,Robert Feldman,
NCT02691455,Transscleral Diode Laser Cyclophotocoagulation,PROCEDURE,Glaucoma,na,TERMINATED,Robert Feldman,
NCT02691455,Ahmed Model FP7 Flexible Plate,DEVICE,Glaucoma,na,TERMINATED,Robert Feldman,
NCT02691455,Baerveldt Glaucoma Implant 250-mm2 / BG103-250,DEVICE,Glaucoma,na,TERMINATED,Robert Feldman,
NCT04625426,3M Cavilon No-Rinse Skin Cleanser and 3M Cavilon Advanced Skin Protectant,DEVICE,Incontinence-associated Dermatitis,na,TERMINATED,Tan Tock Seng Hospital,
NCT04625426,Conveen EasiCleanse and Conveen Critic Barrier,DEVICE,Incontinence-associated Dermatitis,na,TERMINATED,Tan Tock Seng Hospital,
NCT04625426,Standard cleansing and Conveen Critic Barrier,DEVICE,Incontinence-associated Dermatitis,na,TERMINATED,Tan Tock Seng Hospital,
NCT00712426,Creatine Monohydrate,DRUG,Huntington's Disease,phase3,TERMINATED,Massachusetts General Hospital,
NCT00712426,Placebo,DRUG,Huntington's Disease,phase3,TERMINATED,Massachusetts General Hospital,
NCT00995501,Dexamethasone Sodium Sulfate,DRUG,Inflammation; Perioperative Morbidity,na,TERMINATED,d sessler,
NCT00995501,Insulin,DRUG,Inflammation; Perioperative Morbidity,na,TERMINATED,d sessler,
NCT00995501,anesthesia management,DRUG,Inflammation; Perioperative Morbidity,na,TERMINATED,d sessler,
NCT00995501,Dexamethasone - placebo,OTHER,Inflammation; Perioperative Morbidity,na,TERMINATED,d sessler,
NCT00995501,Insulin - Placebo,OTHER,Inflammation; Perioperative Morbidity,na,TERMINATED,d sessler,
NCT00995501,Anesthesia management -Placebo,OTHER,Inflammation; Perioperative Morbidity,na,TERMINATED,d sessler,
NCT01538901,photodynamic therapy,OTHER,Actinic Keratoses,phase4,TERMINATED,Medical University of Vienna,
NCT01538901,imiquimod 5% cream,DRUG,Actinic Keratoses,phase4,TERMINATED,Medical University of Vienna,
NCT00005812,temozolomide,DRUG,Brain Tumors; Central Nervous System Tumors; Leptomeningeal Metastases,phase2,TERMINATED,Dartmouth-Hitchcock Medical Center,
NCT03995212,CR845 1.0 mg,DRUG,Cholestatic Pruritus,phase2,TERMINATED,"Cara Therapeutics, Inc.",
NCT03995212,Placebo,DRUG,Cholestatic Pruritus,phase2,TERMINATED,"Cara Therapeutics, Inc.",
NCT01367301,paclitaxel,DRUG,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01367301,carboplatin,DRUG,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01367301,external beam radiation therapy,RADIATION,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01367301,brachytherapy,RADIATION,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01367301,intensity-modulated radiation therapy,RADIATION,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01367301,laboratory biomarker analysis,OTHER,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT03970642,Video directly observed therapy,OTHER,Depression,na,TERMINATED,UConn Health,
NCT05838742,GSK3858279,DRUG,"Pain; Osteoarthritis, Knee",phase2,TERMINATED,GlaxoSmithKline,
NCT05838742,Placebo,DRUG,"Pain; Osteoarthritis, Knee",phase2,TERMINATED,GlaxoSmithKline,
NCT03346083,Betrixaban,DRUG,VTE Prophylaxis,phase1,TERMINATED,"Alexion Pharmaceuticals, Inc.",
NCT01886105,Sm-EDTMP,DRUG,Metastatic Osteosarcoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01886105,Autologous Stem Cell Infusion,OTHER,Metastatic Osteosarcoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01886105,External Beam Radiotherapy,RADIATION,Metastatic Osteosarcoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00594594,Probiotic Lactobacillus GR-1 and RC-14,OTHER,Spinal Cord Injury; Urinary Tract Infections,phase1,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT03169894,MDGN-002,DRUG,Crohn Disease; Ulcerative Colitis,phase1,TERMINATED,"Avalo Therapeutics, Inc.",
NCT04911166,Atezolizumab and Interleukin-12 Gene Therapy,OTHER,Non-small Cell Lung Cancer,phase1,TERMINATED,The Methodist Hospital Research Institute,
NCT02392156,rFVIIIFc,BIOLOGICAL,Hemophilia A; Hemophilia B,na,TERMINATED,Bioverativ Therapeutics Inc.,
NCT02392156,rFIXFc,BIOLOGICAL,Hemophilia A; Hemophilia B,na,TERMINATED,Bioverativ Therapeutics Inc.,
NCT02392156,non-Fc FVIII replacement products,DRUG,Hemophilia A; Hemophilia B,na,TERMINATED,Bioverativ Therapeutics Inc.,
NCT02392156,non-Fc FIX replacement products,DRUG,Hemophilia A; Hemophilia B,na,TERMINATED,Bioverativ Therapeutics Inc.,
NCT04920929,Hydrophilic Biomaterial,DEVICE,Peripheral ICC,na,TERMINATED,Access Vascular Inc,
NCT04920929,Thermoplastic Polyurethane,DEVICE,Peripheral ICC,na,TERMINATED,Access Vascular Inc,
NCT05446129,Ezabenlimab,DRUG,Colorectal Cancer,phase1,TERMINATED,Boehringer Ingelheim,
NCT05446129,BI 765063,DRUG,Colorectal Cancer,phase1,TERMINATED,Boehringer Ingelheim,
NCT05446129,Pembrolizumab,DRUG,Colorectal Cancer,phase1,TERMINATED,Boehringer Ingelheim,
NCT06340672,Augmented Reality Enhanced Preoperative Counseling,OTHER,Anterior Cervical Discectomy and Fusion,na,TERMINATED,University of Pittsburgh,
NCT06340672,Standard preoperative counseling,OTHER,Anterior Cervical Discectomy and Fusion,na,TERMINATED,University of Pittsburgh,
NCT00301795,oblimersen sodium,BIOLOGICAL,Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage I,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00301795,rituximab,BIOLOGICAL,Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage I,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00301795,laboratory biomarker analysis,OTHER,Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage I,phase2,TERMINATED,National Cancer Institute (NCI),
NCT03236181,SFA,OTHER,Overweight; Obesity,na,TERMINATED,USDA Grand Forks Human Nutrition Research Center,
NCT03236181,MUFA,OTHER,Overweight; Obesity,na,TERMINATED,USDA Grand Forks Human Nutrition Research Center,
NCT03236181,PUFA,OTHER,Overweight; Obesity,na,TERMINATED,USDA Grand Forks Human Nutrition Research Center,
NCT03236181,LCn3,OTHER,Overweight; Obesity,na,TERMINATED,USDA Grand Forks Human Nutrition Research Center,
NCT02964481,Whole exome sequencing,OTHER,Malignant Hyperthermia,na,TERMINATED,"Children's Hospital Medical Center, Cincinnati",
NCT04157036,Ibuprofen,DRUG,Irreversible Pulpitis,phase3,TERMINATED,Walter Reed National Military Medical Center,
NCT04157036,Methylprednisolone,DRUG,Irreversible Pulpitis,phase3,TERMINATED,Walter Reed National Military Medical Center,
NCT01615211,Letrozole,DRUG,"Medical Abortion, Complete or Unspecified, Without Complication",phase2,TERMINATED,Kristina Gemzell Danielsson,
NCT01615211,Trilostane,DRUG,"Medical Abortion, Complete or Unspecified, Without Complication",phase2,TERMINATED,Kristina Gemzell Danielsson,
NCT02010411,Prolastin (drug),DRUG,Cystic Fibrosis,phase2,TERMINATED,Université de Sherbrooke,
NCT00630799,leuprolide acetate,DRUG,Prostate Cancer,phase3,TERMINATED,GP-Pharm,
NCT03982199,RSV Vaccine,BIOLOGICAL,Respiratory Syncytial Viruses; Respiratory Tract Diseases,phase2,TERMINATED,Janssen Vaccines & Prevention B.V.,
NCT03982199,Placebo,BIOLOGICAL,Respiratory Syncytial Viruses; Respiratory Tract Diseases,phase2,TERMINATED,Janssen Vaccines & Prevention B.V.,
NCT00905398,Nilotinib,DRUG,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Acute Lymphoblastic Leukemia,phase1; phase2,TERMINATED,Rony Schaffel,
NCT01898598,Placebo,DRUG,Basal Cell Carcinoma,phase2,TERMINATED,Hoffmann-La Roche,
NCT01898598,Vismodegib,DRUG,Basal Cell Carcinoma,phase2,TERMINATED,Hoffmann-La Roche,
NCT05532163,Natalizumab,DRUG,"Multiple Sclerosis, Relapsing-Remitting",phase4,TERMINATED,Biogen,
NCT00640016,Placebo,OTHER,Asthma,phase2,TERMINATED,MedImmune LLC,
NCT00640016,CAT-354 1 mg/kg,BIOLOGICAL,Asthma,phase2,TERMINATED,MedImmune LLC,
NCT00640016,CAT-354 5 mg/kg,BIOLOGICAL,Asthma,phase2,TERMINATED,MedImmune LLC,
NCT00640016,CAT-354 10 mg/kg,OTHER,Asthma,phase2,TERMINATED,MedImmune LLC,
NCT01632306,LY2090314,DRUG,Pancreatic Cancer,phase1; phase2,TERMINATED,Eli Lilly and Company,
NCT01632306,FOLFOX,DRUG,Pancreatic Cancer,phase1; phase2,TERMINATED,Eli Lilly and Company,
NCT01632306,Gemcitabine,DRUG,Pancreatic Cancer,phase1; phase2,TERMINATED,Eli Lilly and Company,
NCT01632306,Nab-paclitaxel,DRUG,Pancreatic Cancer,phase1; phase2,TERMINATED,Eli Lilly and Company,
NCT02633384,SMOFlipid,OTHER,"Intrahepatic, Cholestasis",phase4,TERMINATED,Centro Hospitalar de Lisboa Central,
NCT02633384,Lipofundin,OTHER,"Intrahepatic, Cholestasis",phase4,TERMINATED,Centro Hospitalar de Lisboa Central,
NCT00748449,Colonoscopy,PROCEDURE,Colorectal Cancer,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00748449,CT-colonography,PROCEDURE,Colorectal Cancer,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01474122,Macitentan 3 mg,DRUG,Digital Ulcers,phase3,TERMINATED,Actelion,
NCT01474122,Macitentan 10 mg,DRUG,Digital Ulcers,phase3,TERMINATED,Actelion,
NCT01474122,Placebo,DRUG,Digital Ulcers,phase3,TERMINATED,Actelion,
NCT03992131,Rucaparib,DRUG,Ovarian Cancer; Triple-negative Breast Cancer; Urothelial Carcinoma; Solid Tumor,phase1; phase2,TERMINATED,pharmaand GmbH,
NCT03992131,Lucitanib,DRUG,Ovarian Cancer; Triple-negative Breast Cancer; Urothelial Carcinoma; Solid Tumor,phase1; phase2,TERMINATED,pharmaand GmbH,
NCT03992131,Sacituzumab govitecan,DRUG,Ovarian Cancer; Triple-negative Breast Cancer; Urothelial Carcinoma; Solid Tumor,phase1; phase2,TERMINATED,pharmaand GmbH,
NCT04785651,Tibial osteotomy with Tranexamic acid,DRUG,Monocompartimental Tibiofemoral Osteoarthritis; Osteoarthritis,na,TERMINATED,Istituto Ortopedico Rizzoli,
NCT04785651,Tibial osteotomy without Tranexamic acid,PROCEDURE,Monocompartimental Tibiofemoral Osteoarthritis; Osteoarthritis,na,TERMINATED,Istituto Ortopedico Rizzoli,
NCT04957602,Blood collection,OTHER,Non Small Cell Lung Cancer,na,TERMINATED,Hospices Civils de Lyon,
NCT01126502,alvespimycin hydrochloride,DRUG,B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01126502,diagnostic laboratory biomarker analysis,OTHER,B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01126502,pharmacogenomic studies,OTHER,B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01126502,pharmacological study,OTHER,B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01198002,LY2127399,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Eli Lilly and Company,
NCT01198002,Placebo Q2W,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Eli Lilly and Company,
NCT01198002,Placebo Q4W,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Eli Lilly and Company,
NCT01198002,Methotrexate,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Eli Lilly and Company,
NCT00657137,apricoxib + lapatinib + capecitabine,DRUG,Breast Cancer,phase2,TERMINATED,"Tragara Pharmaceuticals, Inc.",
NCT00657137,placebo + lapatinib + capecitabine,DRUG,Breast Cancer,phase2,TERMINATED,"Tragara Pharmaceuticals, Inc.",
NCT00657553,Bortezomib,DRUG,Multiple Myeloma,phase3,TERMINATED,University of Arkansas,
NCT00593645,Clofarabine,DRUG,Myelodysplastic Syndromes; Acute Myeloid Leukemia,phase2,TERMINATED,Washington University School of Medicine,
NCT00593645,Cytarabine,DRUG,Myelodysplastic Syndromes; Acute Myeloid Leukemia,phase2,TERMINATED,Washington University School of Medicine,
NCT00593645,Thymoglobulin,DRUG,Myelodysplastic Syndromes; Acute Myeloid Leukemia,phase2,TERMINATED,Washington University School of Medicine,
NCT00593645,Stem cell infusion,PROCEDURE,Myelodysplastic Syndromes; Acute Myeloid Leukemia,phase2,TERMINATED,Washington University School of Medicine,
NCT00607477,Minoxidil,DRUG,Treatment Induced Hypertension,na,TERMINATED,University of Chicago,
NCT00607477,Hydralazine,DRUG,Treatment Induced Hypertension,na,TERMINATED,University of Chicago,
NCT02614157,LLND,PROCEDURE,Rectal Cancer,na,TERMINATED,West China Hospital,
NCT02614157,labeled line,DEVICE,Rectal Cancer,na,TERMINATED,West China Hospital,
NCT01945281,Caspofungin,DRUG,"Candidiasis, Invasive",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01945281,Amphotericin B Deoxycholate,DRUG,"Candidiasis, Invasive",phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00165581,High Dose Intracavitary Brachytherapy,DEVICE,Breast Cancer,na,TERMINATED,Dana-Farber Cancer Institute,
NCT01410136,Chondrofix Osteochondral Allograft,PROCEDURE,Articular Cartilage Disorder; Degeneration; Articular Cartilage; Chronic Cartilage Injury; Acute Cartilage Injury; Defect of Articular Cartilage,na,TERMINATED,"Zimmer Orthobiologics, Inc.",
NCT02412371,Paclitaxel,DRUG,Non-small Cell Lung Cancer Stage III,phase1; phase2,TERMINATED,AbbVie,
NCT02412371,Placebo for Veliparib,DRUG,Non-small Cell Lung Cancer Stage III,phase1; phase2,TERMINATED,AbbVie,
NCT02412371,Carboplatin,DRUG,Non-small Cell Lung Cancer Stage III,phase1; phase2,TERMINATED,AbbVie,
NCT02412371,Veliparib,DRUG,Non-small Cell Lung Cancer Stage III,phase1; phase2,TERMINATED,AbbVie,
NCT02412371,Radiotherapy,RADIATION,Non-small Cell Lung Cancer Stage III,phase1; phase2,TERMINATED,AbbVie,
NCT02699671,Bioresorbable Vascular Scaffold,DEVICE,Arterial Occlusive Diseases; Cardiovascular Diseases; Coronary Artery Disease,na,TERMINATED,"Duk-Woo Park, MD",
NCT00964834,Doxycycline and Valortim,DRUG,Anthrax,phase1,TERMINATED,"PharmAthene, Inc.",
NCT00964834,Placebo Antibiotic and Valortim,DRUG,Anthrax,phase1,TERMINATED,"PharmAthene, Inc.",
NCT00964834,Placebo Antibiotic and Placebo Valortim,DRUG,Anthrax,phase1,TERMINATED,"PharmAthene, Inc.",
NCT04174963,eToke + TPsy,BEHAVIORAL,Cannabis Use; Psychiatric Disorder,na,TERMINATED,Rhode Island Hospital,
NCT03218163,MEDI-551 Maintenance,DRUG,Multiple Myeloma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01706887,Diet Amiloride,OTHER,Hypertension,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02651116,Dextromethorphan Hydrobromide,DRUG,Cough,phase4,TERMINATED,Pfizer,
NCT02651116,Placebo,DRUG,Cough,phase4,TERMINATED,Pfizer,
NCT02651116,Cough recording device,DEVICE,Cough,phase4,TERMINATED,Pfizer,
NCT00923806,PG13-CEA_TCR (Anti-CEA TCR PBL),BIOLOGICAL,Metastatic Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00923806,Aldesleukin,DRUG,Metastatic Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02844933,Cannabidiol,DRUG,Prader-Willi Syndrome,phase2,TERMINATED,"Radius Pharmaceuticals, Inc.",
NCT02844933,Placebo,DRUG,Prader-Willi Syndrome,phase2,TERMINATED,"Radius Pharmaceuticals, Inc.",
NCT04501952,RDV,DRUG,COVID-19,phase3,TERMINATED,Gilead Sciences,
NCT04501952,Placebo to Match RDV,DRUG,COVID-19,phase3,TERMINATED,Gilead Sciences,
NCT04866407,Mentha x piperita,OTHER,Muscle Soreness,na,TERMINATED,"Rutgers, The State University of New Jersey",
NCT04866407,Eucalyptus globulus,OTHER,Muscle Soreness,na,TERMINATED,"Rutgers, The State University of New Jersey",
NCT03700892,Cinnamaldehyde e-liquid,OTHER,Smoking; Healthy,na,TERMINATED,"University of North Carolina, Chapel Hill",
NCT03700892,PG/VG e-liquid,OTHER,Smoking; Healthy,na,TERMINATED,"University of North Carolina, Chapel Hill",
NCT01681264,Morphine,DRUG,Chronic Pain,phase4,TERMINATED,Massachusetts General Hospital,
NCT01681264,Guanfacine 1mg,DRUG,Chronic Pain,phase4,TERMINATED,Massachusetts General Hospital,
NCT01681264,Guanfacine 2mg,DRUG,Chronic Pain,phase4,TERMINATED,Massachusetts General Hospital,
NCT01681264,Placebo,DRUG,Chronic Pain,phase4,TERMINATED,Massachusetts General Hospital,
NCT00485563,EC90 (KLH-FITC),BIOLOGICAL,Renal Cell Carcinoma,phase2,TERMINATED,Endocyte,
NCT00485563,GPI-0100,BIOLOGICAL,Renal Cell Carcinoma,phase2,TERMINATED,Endocyte,
NCT00485563,EC17 (Folate-FITC),DRUG,Renal Cell Carcinoma,phase2,TERMINATED,Endocyte,
NCT00485563,Interleukin-2,DRUG,Renal Cell Carcinoma,phase2,TERMINATED,Endocyte,
NCT00485563,Interferon-alpha,DRUG,Renal Cell Carcinoma,phase2,TERMINATED,Endocyte,
NCT03716687,Prophylactic negative pressure wound dressing after laparotomy,DEVICE,"Surgical Wound; Wound Dehiscence, Surgical; Surgical Site Infection; Dehiscence of Internal Surgical Wound",na,TERMINATED,St. Borbala Hospital,
NCT02337387,Blosozumab,BIOLOGICAL,"Osteoporosis, Postmenopausal",phase1,TERMINATED,Eli Lilly and Company,
NCT02337387,Placebo,OTHER,"Osteoporosis, Postmenopausal",phase1,TERMINATED,Eli Lilly and Company,
NCT00952016,Methotrexate,DRUG,Advanced Colorectal Cancer,phase2,TERMINATED,Royal Marsden NHS Foundation Trust,
NCT01053884,Anidulafungin,DRUG,Hematologic Malignancies,phase2,TERMINATED,Elisabethinen Hospital,
NCT01806584,SRM003,BIOLOGICAL,Arteriovenous Graft,phase2,TERMINATED,Shire,
NCT01806584,Participating Site's standard practice,OTHER,Arteriovenous Graft,phase2,TERMINATED,Shire,
NCT02817906,ITI-007,DRUG,"Agitation in Dementia, Including Alzheimer's Disease",phase3,TERMINATED,"Intra-Cellular Therapies, Inc.",
NCT02817906,Placebo,DRUG,"Agitation in Dementia, Including Alzheimer's Disease",phase3,TERMINATED,"Intra-Cellular Therapies, Inc.",
NCT03929484,Nasal reservoir cannula,DEVICE,Pneumonia Childhood,na,TERMINATED,"University of California, San Francisco",
NCT00290771,Imatinib tablets,DRUG,Recurrent Glioblastoma Multiforme (GBM),phase2,TERMINATED,Novartis,
NCT00290771,Hydroxyurea capsules,DRUG,Recurrent Glioblastoma Multiforme (GBM),phase2,TERMINATED,Novartis,
NCT04254809,Re-Evaluating Suicidal Thoughts,BEHAVIORAL,Suicidal Ideation,na,TERMINATED,Florida State University,
NCT04254809,Healthy Social Living,BEHAVIORAL,Suicidal Ideation,na,TERMINATED,Florida State University,
NCT05313009,Sotorasib and Tarloxotinib,DRUG,Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,Medical University of South Carolina,
NCT05313009,Sotorasib and Tarloxotinib,DRUG,Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,Medical University of South Carolina,
NCT03967093,BXQ-350,DRUG,Neoplasms,phase1,TERMINATED,"Bexion Pharmaceuticals, Inc.",
NCT04123093,Noxsano Bandage (Healthy Volunteers),DEVICE,"Wound Heal; Peripheral Artery Disease; Ulcer, Leg; Ulcer Foot; Diabetic Foot Ulcer; Arterial Insufficiency",na,TERMINATED,OhioHealth,
NCT04123093,Noxsano Bandage (Wound Care),DEVICE,"Wound Heal; Peripheral Artery Disease; Ulcer, Leg; Ulcer Foot; Diabetic Foot Ulcer; Arterial Insufficiency",na,TERMINATED,OhioHealth,
NCT00692614,triamcinolone acetonide,DRUG,Macular Edema,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT05169684,BMS-986218,BIOLOGICAL,"Prostatic Neoplasms, Castration-Resistant",phase2,TERMINATED,Bristol-Myers Squibb,
NCT05169684,Docetaxel,DRUG,"Prostatic Neoplasms, Castration-Resistant",phase2,TERMINATED,Bristol-Myers Squibb,
NCT05169684,Nivolumab,BIOLOGICAL,"Prostatic Neoplasms, Castration-Resistant",phase2,TERMINATED,Bristol-Myers Squibb,
NCT02966184,preservative free albuterol,DRUG,Status Asthmaticus,phase4,TERMINATED,Norton Healthcare,
NCT06442384,Tobacco and non-tobacco e-cigarettes,OTHER,Tobacco Use,na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT06442384,Tobacco only e-cigarettes,OTHER,Tobacco Use,na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT01981707,F-Choline-PET,DEVICE,Castration-resistant Prostate Cancer,phase2; phase3,TERMINATED,"University Hospital, Grenoble",
NCT02320292,Quality-of-Life Assessment,OTHER,Ann Arbor Stage I Grade 1 Follicular Lymphoma; Ann Arbor Stage I Grade 2 Follicular Lymphoma; Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Folli,phase3,TERMINATED,Mayo Clinic,
NCT02320292,Rituximab,BIOLOGICAL,Ann Arbor Stage I Grade 1 Follicular Lymphoma; Ann Arbor Stage I Grade 2 Follicular Lymphoma; Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Folli,phase3,TERMINATED,Mayo Clinic,
NCT02320292,Yttrium Y-90 Ibritumomab Tiuxetan,RADIATION,Ann Arbor Stage I Grade 1 Follicular Lymphoma; Ann Arbor Stage I Grade 2 Follicular Lymphoma; Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Folli,phase3,TERMINATED,Mayo Clinic,
NCT01763736,Music,BEHAVIORAL,Stress; Anxiety; Sleep,na,TERMINATED,Brigham and Women's Hospital,
NCT04902911,COVID-19 SARS-CoV IgG/IgM antibody rapid test,DEVICE,Covid19,na,TERMINATED,Medical College of Wisconsin,
NCT05701371,Biological samples collection,OTHER,Healthy Aging,na,TERMINATED,Bioaster,
NCT05664763,[18F]FPEB with PET,DRUG,Cannabis Use Disorder,early_phase1,TERMINATED,Yale University,
NCT05664763,Cannabis abstinence,BEHAVIORAL,Cannabis Use Disorder,early_phase1,TERMINATED,Yale University,
NCT02370563,18F-FSPG,DRUG,Brain Cancer,phase1,TERMINATED,Life Molecular Imaging SA,
NCT03828487,Masimo O3 Neonatal Sensors,DEVICE,Regional Saturation of Oxygen (rSO2),na,TERMINATED,Masimo Corporation,
NCT03828487,510(k) cleared sensor,DEVICE,Regional Saturation of Oxygen (rSO2),na,TERMINATED,Masimo Corporation,
NCT02756533,Telemonitoring of daily parameters recorded by NIV,OTHER,Chronic Obstructive Pulmonary Disease,na,TERMINATED,"University Hospital, Grenoble",
NCT02756533,Placebo,OTHER,Chronic Obstructive Pulmonary Disease,na,TERMINATED,"University Hospital, Grenoble",
NCT04166136,Transition from the Rearfoot to the Forefoot and Midfoot,OTHER,Chronic Musculoskeletal Pain,na,TERMINATED,Centro Universitário Augusto Motta,
NCT04166136,Usual Treatment Group,OTHER,Chronic Musculoskeletal Pain,na,TERMINATED,Centro Universitário Augusto Motta,
NCT04166136,Muscle Strengthening Group,OTHER,Chronic Musculoskeletal Pain,na,TERMINATED,Centro Universitário Augusto Motta,
NCT04870164,Ensovibep,DRUG,COVID-19,phase1,TERMINATED,Molecular Partners AG,
NCT04870164,Placebo,DRUG,COVID-19,phase1,TERMINATED,Molecular Partners AG,
NCT01993693,Ultrasonic Diathermy Device,DEVICE,Knee Osteoarthritis,na,TERMINATED,"ZetrOZ, Inc.",
NCT01993693,Sham Ultrasonic Diathermy Device,DEVICE,Knee Osteoarthritis,na,TERMINATED,"ZetrOZ, Inc.",
NCT05222321,Sensory-Play Based (SenPlay) Intervention,OTHER,Attention Deficit Hyperactivity Disorder,na,TERMINATED,University of Oklahoma,
NCT05222321,"Spontaneous, Free Play",OTHER,Attention Deficit Hyperactivity Disorder,na,TERMINATED,University of Oklahoma,
NCT03757416,Data collection,OTHER,Carpal Tunnel Syndrome,na,TERMINATED,University of Tennessee,
NCT03225716,Ulocuplumab,DRUG,Waldenstrom's Macroglobulinemia,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT03225716,Ibrutinib,DRUG,Waldenstrom's Macroglobulinemia,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT00995384,CT Scan,PROCEDURE,Endocarditis,na,TERMINATED,Corewell Health East,
NCT01928043,Curcumin,DRUG,Bipolar Disorder,phase2,TERMINATED,Sunnybrook Health Sciences Centre,
NCT00492843,Ibandronate (Bondronat),DRUG,Lung Cancer,phase4,TERMINATED,Chinese Society of Lung Cancer,
NCT01492725,Intra-arterial Clot Retrieval with Solitaire device,DEVICE,Ischemic Stroke,phase2,TERMINATED,Neuroscience Trials Australia,
NCT01492725,intravenous tissue plasminogen activator (tPA),OTHER,Ischemic Stroke,phase2,TERMINATED,Neuroscience Trials Australia,
NCT00906776,Emdogain PLUS,DEVICE,Periodontitis,na,TERMINATED,Institut Straumann AG,
NCT00906776,Autogenous bone,DEVICE,Periodontitis,na,TERMINATED,Institut Straumann AG,
NCT03884517,BAT8003,DRUG,Advanced Solid Cancer,phase1,TERMINATED,Bio-Thera Solutions,
NCT03332940,Tc 99M Sulfur Colloid,DRUG,Nonalcoholic Steatohepatitis; NASH - Nonalcoholic Steatohepatitis,phase1,TERMINATED,Navidea Biopharmaceuticals,
NCT03332940,Tc99m-tilmanocept,DRUG,Nonalcoholic Steatohepatitis; NASH - Nonalcoholic Steatohepatitis,phase1,TERMINATED,Navidea Biopharmaceuticals,
NCT01597440,N-carbamylglutamate,DRUG,Propionic Acidemia; Methylmalonic Acidemia,phase2,TERMINATED,Mendel Tuchman,
NCT01597440,Standard of Care,OTHER,Propionic Acidemia; Methylmalonic Acidemia,phase2,TERMINATED,Mendel Tuchman,
NCT03311191,Measurement of skin oxygenation and oxygen consumption,DEVICE,Healthy; Sun Exposure,na,TERMINATED,Massachusetts General Hospital,
NCT05457491,Human platelet extract (cosmetic product),BIOLOGICAL,Skin Aging,phase1,TERMINATED,Mayo Clinic,
NCT05457491,Vanicream Gentle Facial Cleanser,OTHER,Skin Aging,phase1,TERMINATED,Mayo Clinic,
NCT05457491,EltaMD UV Daily Broad-Spectrum SPF 40,OTHER,Skin Aging,phase1,TERMINATED,Mayo Clinic,
NCT05457491,EltaMD PM Therapy Facial Moisturizer,OTHER,Skin Aging,phase1,TERMINATED,Mayo Clinic,
NCT05457491,Vanicream Lite Lotion,OTHER,Skin Aging,phase1,TERMINATED,Mayo Clinic,
NCT00217074,acupuncture,OTHER,Hot Flashes,phase3,TERMINATED,Mayo Clinic,
NCT06888518,OMNi-BiOTiC® FLORA plus+,OTHER,Bacterial Vaginosis (BV),early_phase1,TERMINATED,Institut AllergoSan Pharma GmbH,
NCT06888518,antibiotic,DRUG,Bacterial Vaginosis (BV),early_phase1,TERMINATED,Institut AllergoSan Pharma GmbH,
NCT01704690,S-1 and Paclitaxel,DRUG,Esophageal Cancer,phase2; phase3,TERMINATED,Peking University,
NCT01704690,Paclitaxel and Cisplatin,DRUG,Esophageal Cancer,phase2; phase3,TERMINATED,Peking University,
NCT01704690,5-FU and Cisplatin,DRUG,Esophageal Cancer,phase2; phase3,TERMINATED,Peking University,
NCT00699413,nutrition education plus active supplement,DRUG,"Obesity; Diabetes Mellitus, Type 2",phase4,TERMINATED,University of Southern California,
NCT00699413,nutrition education plus inactive supplement,DRUG,"Obesity; Diabetes Mellitus, Type 2",phase4,TERMINATED,University of Southern California,
NCT01992120,Debriefing of high-fidelity sepsis simulation scenarios,OTHER,Medical Knowledge; Clinical Performance,na,TERMINATED,NYU Langone Health,
NCT01992120,Placebo: Debriefing of high-fidelity non-sepsis simulation scenarios,OTHER,Medical Knowledge; Clinical Performance,na,TERMINATED,NYU Langone Health,
NCT00057343,Zevalin (ibritumomab tiuxetan),DRUG,Non-Hodgkin's Lymphoma,phase3,TERMINATED,Biogen,
NCT00057343,Rituxan (rituximab),DRUG,Non-Hodgkin's Lymphoma,phase3,TERMINATED,Biogen,
NCT00909935,Dexmedetomidine,DRUG,MRI Sedation,na,TERMINATED,Boston Children's Hospital,
NCT03707925,Cone-Beam Computed Tomography,PROCEDURE,Lung Carcinoid Tumor; Lung Non-Small Cell Carcinoma; Metastatic Lung Carcinoma; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8,na,TERMINATED,M.D. Anderson Cancer Center,
NCT03707925,Conventional Surgery,PROCEDURE,Lung Carcinoid Tumor; Lung Non-Small Cell Carcinoma; Metastatic Lung Carcinoma; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8,na,TERMINATED,M.D. Anderson Cancer Center,
NCT03707925,Laser Ablation,PROCEDURE,Lung Carcinoid Tumor; Lung Non-Small Cell Carcinoma; Metastatic Lung Carcinoma; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8,na,TERMINATED,M.D. Anderson Cancer Center,
NCT01173276,Sperm Washing with Intrauterine Insemination (IUI),OTHER,HIV-1; Fertility; Infertility,na,TERMINATED,Boston Medical Center,
NCT06343376,Biopsy,PROCEDURE,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Biospecimen Collection,PROCEDURE,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Bone Marrow Aspiration,PROCEDURE,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Bone Marrow Biopsy,PROCEDURE,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Computed Tomography,PROCEDURE,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Cyclophosphamide,DRUG,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Echocardiography,PROCEDURE,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,EGFRt/19-28z/IL-12 CAR T-lymphocytes,BIOLOGICAL,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Fludarabine Phosphate,DRUG,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Leukapheresis,PROCEDURE,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Multigated Acquisition Scan,PROCEDURE,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT06343376,Positron Emission Tomography,PROCEDURE,Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transfor,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT02698176,Birabresib,DRUG,NUT Midline Carcinoma (NMC); Triple Negative Breast Cancer (TNBC); Non-small Cell Lung Cancer (NSCLC); Castration-resistant Prostate Cancer (CRPC),phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT03891576,Niraparib,DRUG,Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma,phase2,TERMINATED,Mario Negri Institute for Pharmacological Research,
NCT03573076,Photodynamic therapy,OTHER,Photodamaged Skin,phase4,TERMINATED,Merete Haedersdal,
NCT03573076,Non-ablative Thulium laser (NAFL),DEVICE,Photodamaged Skin,phase4,TERMINATED,Merete Haedersdal,
NCT03573076,Radio-frequency microneedles (RF-MN),DEVICE,Photodamaged Skin,phase4,TERMINATED,Merete Haedersdal,
NCT03781817,Intravenous Ketamine,DRUG,"Trauma; Fractures, Closed; Children, Only; Deep Sedation; Ketamine",phase4,TERMINATED,University of Alabama at Birmingham,
NCT03781817,Intranasal Ketamine,DRUG,"Trauma; Fractures, Closed; Children, Only; Deep Sedation; Ketamine",phase4,TERMINATED,University of Alabama at Birmingham,
NCT03750240,Sodium (Na) Magnetic Resonance Imaging (MRI),OTHER,Breast Cancer; Triple Negative Breast Cancer,na,TERMINATED,NYU Langone Health,
NCT03750240,Dynamic Contrast- Enhanced (DCE) MRI,OTHER,Breast Cancer; Triple Negative Breast Cancer,na,TERMINATED,NYU Langone Health,
NCT02867618,Carfilzomib,DRUG,"Hodgkin Disease; Lymphoma, Non-hodgkin",phase1; phase2,TERMINATED,Columbia University,
NCT02867618,TGR-1202,DRUG,"Hodgkin Disease; Lymphoma, Non-hodgkin",phase1; phase2,TERMINATED,Columbia University,
NCT04773197,Beating the Blues (BtB),BEHAVIORAL,"Depression, Anxiety; Cancer",na,TERMINATED,University of Michigan Rogel Cancer Center,
NCT04773197,Entertain Me Well (EMW),BEHAVIORAL,"Depression, Anxiety; Cancer",na,TERMINATED,University of Michigan Rogel Cancer Center,
NCT04773197,Coaching,BEHAVIORAL,"Depression, Anxiety; Cancer",na,TERMINATED,University of Michigan Rogel Cancer Center,
NCT04964960,Pembrolizumab,DRUG,Lung Cancer; Lung Cancer Metastatic; Brain Cancer; Cancer,phase2,TERMINATED,"John L. Villano, MD, PhD",
NCT04964960,Nab paclitaxel,DRUG,Lung Cancer; Lung Cancer Metastatic; Brain Cancer; Cancer,phase2,TERMINATED,"John L. Villano, MD, PhD",
NCT04964960,Paclitaxel,DRUG,Lung Cancer; Lung Cancer Metastatic; Brain Cancer; Cancer,phase2,TERMINATED,"John L. Villano, MD, PhD",
NCT04964960,Pemetrexed,DRUG,Lung Cancer; Lung Cancer Metastatic; Brain Cancer; Cancer,phase2,TERMINATED,"John L. Villano, MD, PhD",
NCT04964960,Carboplatin,DRUG,Lung Cancer; Lung Cancer Metastatic; Brain Cancer; Cancer,phase2,TERMINATED,"John L. Villano, MD, PhD",
NCT04142060,Enzalutamide,DRUG,Breast Cancer,phase2,TERMINATED,SOLTI Breast Cancer Research Group,
NCT03744715,Poziotinib,DRUG,NSCLC; Breast Cancer,phase2,TERMINATED,"Spectrum Pharmaceuticals, Inc",
NCT00759876,Ataluren,DRUG,Duchenne Muscular Dystrophy,phase2,TERMINATED,PTC Therapeutics,
NCT01694576,Adjuvant chemotherapy with paclitaxel and nedaplatin,DRUG,Nasopharyngeal Carcinoma,phase2,TERMINATED,Jiangsu Cancer Institute & Hospital,
NCT02315417,gevokizumab,DRUG,Pyoderma Gangrenosum,phase3,TERMINATED,XOMA (US) LLC,
NCT02315417,Placebo,DRUG,Pyoderma Gangrenosum,phase3,TERMINATED,XOMA (US) LLC,
NCT02315417,gevokizumab open-label,DRUG,Pyoderma Gangrenosum,phase3,TERMINATED,XOMA (US) LLC,
NCT02422940,dalfampridine-ER 7.5 mg,DRUG,Post-ischemic Stroke,phase3,TERMINATED,Acorda Therapeutics,
NCT02422940,dalfampridine-ER 10 mg,DRUG,Post-ischemic Stroke,phase3,TERMINATED,Acorda Therapeutics,
NCT01103674,Numeris®-AF Guided Coagulation System with VisiTrax®,DEVICE,Paroxysmal Atrial Fibrillation,na,TERMINATED,nContact Surgical Inc.,
NCT00587990,Lower dose mesenchymal stem cell (MSC) injection,BIOLOGICAL,"Stem Cell Transplantation; Ventricular Dysfunction, Left",phase1; phase2,TERMINATED,Joshua M Hare,
NCT00587990,Placebo,OTHER,"Stem Cell Transplantation; Ventricular Dysfunction, Left",phase1; phase2,TERMINATED,Joshua M Hare,
NCT00587990,Higher dose MSC injection,BIOLOGICAL,"Stem Cell Transplantation; Ventricular Dysfunction, Left",phase1; phase2,TERMINATED,Joshua M Hare,
NCT02055690,Pazopanib,DRUG,"Ovarian Neoplasms; Neoplasms, Ovarian; Ovarian Cancer",phase1; phase2,TERMINATED,The Christie NHS Foundation Trust,
NCT02055690,Fosbretabulin,DRUG,"Ovarian Neoplasms; Neoplasms, Ovarian; Ovarian Cancer",phase1; phase2,TERMINATED,The Christie NHS Foundation Trust,
NCT03254160,DNS-3379,DRUG,Ischemic Stroke,phase2,TERMINATED,"Dart NeuroScience, LLC",
NCT03254160,Placebo,DRUG,Ischemic Stroke,phase2,TERMINATED,"Dart NeuroScience, LLC",
NCT00893620,Zenith(R) Connection Endovascular Covered Stent with the Zenith® Branch Endovascular Graft-Iliac Bifurcation and Zenith Flex(R) AAA Endovascular Graft,DEVICE,Aorto-iliac Aneurysms; Iliac Aneurysms,na,TERMINATED,Cook Group Incorporated,
NCT01063478,RAD001 (in addition to standard radiation and chemotherapy),DRUG,Non-Small Cell Lung Cancer,phase1,TERMINATED,University of Chicago,
NCT05998785,TAPESTRY Biointegrative Implant,DEVICE,Insertional Achilles Tendinopathy,na,TERMINATED,Zimmer Biomet,
NCT01189435,erlotinib,DRUG,Lung Cancer,phase2,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT04635735,Ipilimumab,DRUG,Relapsed/Refractory Multiple Myeloma,phase1; phase2,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT05315908,Community outreach method,OTHER,"Heart Failure; Coronary Artery Disease; Cancer; Chronic Kidney Diseases; COPD; Obesity; Sickle Cell Disease; Diabetes Mellitus, Type 2",na,TERMINATED,Jesse Nodora,
NCT02974140,Cataract Refractive Suite (CRS),DEVICE,Cataracts,na,TERMINATED,"Alcon, a Novartis Company",
NCT02974140,Standard manual technique,PROCEDURE,Cataracts,na,TERMINATED,"Alcon, a Novartis Company",
NCT02235389,Alteplase (Actilyse),DRUG,Myocardial Infarction,na,TERMINATED,Boehringer Ingelheim,
NCT02235389,Standard therapy,DRUG,Myocardial Infarction,na,TERMINATED,Boehringer Ingelheim,
NCT03498274,Fitting System,DEVICE,Hearing Loss,na,TERMINATED,Bernafon AG,
NCT03498274,Traditional Fitting System,DEVICE,Hearing Loss,na,TERMINATED,Bernafon AG,
NCT01228474,Select the Number of embryos to transfer,OTHER,Infertility; Oocyte Recipient; Single Embryo Transfer/Double Embryo Transfer; Cumulative Pregnancy Rate; Multiple Pregnancy,na,TERMINATED,Fundacion Dexeus,
NCT02423018,Pregabalin,DRUG,Substance-Related Disorders,phase4,TERMINATED,Centre for Addiction and Mental Health,
NCT02423018,Placebo,DRUG,Substance-Related Disorders,phase4,TERMINATED,Centre for Addiction and Mental Health,
NCT01359618,TC-5214,DRUG,Healthy Male,phase1,TERMINATED,AstraZeneca,
NCT01359618,Placebo comparator,OTHER,Healthy Male,phase1,TERMINATED,AstraZeneca,
NCT01359618,Moxifloxacin,DRUG,Healthy Male,phase1,TERMINATED,AstraZeneca,
NCT01359618,Moxifloxacin placebo comparator,OTHER,Healthy Male,phase1,TERMINATED,AstraZeneca,
NCT01916590,Bupivicaine,DRUG,Post-operative Pain,na,TERMINATED,"University of Colorado, Denver",
NCT01916590,placebo,DRUG,Post-operative Pain,na,TERMINATED,"University of Colorado, Denver",
NCT02864290,ASP1235,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,"Astellas Pharma Global Development, Inc.",
NCT02963610,Lenalidomide,DRUG,Relapsed or Refractory Solid Tumors; Nonsmall Cell Lung Cancer,phase1; phase2,TERMINATED,Fox Chase Cancer Center,
NCT02963610,Pembrolizumab,DRUG,Relapsed or Refractory Solid Tumors; Nonsmall Cell Lung Cancer,phase1; phase2,TERMINATED,Fox Chase Cancer Center,
NCT05005182,Biospecimen Collection,PROCEDURE,"Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified; Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",phase2,TERMINATED,Mayo Clinic,
NCT05005182,Bone Marrow Aspiration,PROCEDURE,"Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified; Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",phase2,TERMINATED,Mayo Clinic,
NCT05005182,Bone Marrow Biopsy,PROCEDURE,"Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified; Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",phase2,TERMINATED,Mayo Clinic,
NCT05005182,Hydroxyurea,DRUG,"Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified; Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",phase2,TERMINATED,Mayo Clinic,
NCT05005182,Luspatercept,BIOLOGICAL,"Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified; Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",phase2,TERMINATED,Mayo Clinic,
NCT05005182,Questionnaire Administration,OTHER,"Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified; Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",phase2,TERMINATED,Mayo Clinic,
NCT00865878,Aminolevulinic Acid,DRUG,Actinic Keratoses; Skin Neoplasms,phase2,TERMINATED,"DUSA Pharmaceuticals, Inc.",
NCT00865878,Vehicle,OTHER,Actinic Keratoses; Skin Neoplasms,phase2,TERMINATED,"DUSA Pharmaceuticals, Inc.",
NCT05753735,Piperacillin/Tazobactam,DRUG,Pancreatic Fistula,phase2,TERMINATED,Case Comprehensive Cancer Center,
NCT05753735,Amoxicillin/ Clavulanic acid,DRUG,Pancreatic Fistula,phase2,TERMINATED,Case Comprehensive Cancer Center,
NCT00912990,Cisatracurium,DRUG,"Intubation,Endotracheal",na,TERMINATED,"Rady Children's Hospital, San Diego",
NCT00912990,Normal saline,DRUG,"Intubation,Endotracheal",na,TERMINATED,"Rady Children's Hospital, San Diego",
NCT00513513,TMC114 (darunavir) / ritonavir,DRUG,HIV Infections,phase2,TERMINATED,"Tibotec Pharmaceuticals, Ireland",
NCT04703413,LoFric® OrigoTM and LoFric® SenseTM,DEVICE,Bladder Voiding Dysfunction,na,TERMINATED,Wellspect HealthCare,
NCT04420585,Desmopressin,DRUG,"Nocturnal Enuresis; Anemia, Sickle Cell",phase4,TERMINATED,Montefiore Medical Center,
NCT05457478,Medical Device Qardio® smart scale Usage and Evaluation,OTHER,Head and Neck Squamous Cell Carcinoma; Malignant Head and Neck Neoplasm,na,TERMINATED,OHSU Knight Cancer Institute,
NCT05457478,Questionnaire Administration,OTHER,Head and Neck Squamous Cell Carcinoma; Malignant Head and Neck Neoplasm,na,TERMINATED,OHSU Knight Cancer Institute,
NCT03350178,fecal microbiota transfer,DRUG,Intensive Care Units; Fecal Microbiota Transplantation,phase2,TERMINATED,MaaT Pharma,
NCT05200143,Ipilimumab,DRUG,Refractory Cutaneous Melanoma,phase2,TERMINATED,Providence Health & Services,
NCT05200143,Nivolumab,DRUG,Refractory Cutaneous Melanoma,phase2,TERMINATED,Providence Health & Services,
NCT05200143,Cabozantinib,DRUG,Refractory Cutaneous Melanoma,phase2,TERMINATED,Providence Health & Services,
NCT04110015,virtual visual field,DEVICE,Visual Pathway Disorder; Glaucoma; Retinal Disease,na,TERMINATED,New York City Health and Hospitals Corporation,
NCT00996008,placebo,DRUG,Mild to Moderate Atopic Dermatitis,phase2,TERMINATED,Creabilis SA,
NCT00996008,CT 327,DRUG,Mild to Moderate Atopic Dermatitis,phase2,TERMINATED,Creabilis SA,
NCT01044225,Cetuximab,DRUG,Glioblastoma,phase2,TERMINATED,Bart Neyns,
NCT01044225,Cilengitide EMD 121974,DRUG,Glioblastoma,phase2,TERMINATED,Bart Neyns,
NCT03054025,Smart Phone Monitoring Device,DEVICE,Breast Cancer,na,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT00761176,The Provant Therapy System,DEVICE,Diabetic Foot Ulcers,na,TERMINATED,"Regenesis Biomedical, Inc.",
NCT02052440,Baclofen,DRUG,Alcohol Withdrawal Syndrome,phase3,TERMINATED,Denver Health and Hospital Authority,
NCT02052440,Placebo,DRUG,Alcohol Withdrawal Syndrome,phase3,TERMINATED,Denver Health and Hospital Authority,
NCT01165450,Nexagon,DRUG,Persistent Corneal Epithelial Defects,phase2,TERMINATED,"University of California, San Francisco",
NCT01165450,Vehicle only,DRUG,Persistent Corneal Epithelial Defects,phase2,TERMINATED,"University of California, San Francisco",
NCT00598091,gemcitabine,DRUG,Refractory Solid Tumors; Pancreatic Adenocarcinoma,phase1,TERMINATED,Duke University,
NCT00598091,dasatinib,DRUG,Refractory Solid Tumors; Pancreatic Adenocarcinoma,phase1,TERMINATED,Duke University,
NCT00598091,gemcitabine,DRUG,Refractory Solid Tumors; Pancreatic Adenocarcinoma,phase1,TERMINATED,Duke University,
NCT00598091,dasatinib,DRUG,Refractory Solid Tumors; Pancreatic Adenocarcinoma,phase1,TERMINATED,Duke University,
NCT05008874,Natural History Observation,OTHER,AMN; AMN Gene Mutation; X-ALD,na,TERMINATED,"SwanBio Therapeutics, Inc.",
NCT00760318,Keppra,DRUG,Cervical Dystonia,phase2,TERMINATED,University of South Florida,
NCT00447226,Oral lapatinib tablets or placebo tablets,DRUG,Cancer,phase2,TERMINATED,GlaxoSmithKline,
NCT00706485,Yttrium-90 Plaque Applicator,DEVICE,Spinal Neoplasms,na,TERMINATED,Massachusetts General Hospital,
NCT03497715,Ibuprofen lysine,DRUG,Healthy Subjects,phase1,TERMINATED,Reckitt Benckiser Healthcare (UK) Limited,
NCT03497715,Ibuprofen Sodium,DRUG,Healthy Subjects,phase1,TERMINATED,Reckitt Benckiser Healthcare (UK) Limited,
NCT03497715,Ibuprofen,DRUG,Healthy Subjects,phase1,TERMINATED,Reckitt Benckiser Healthcare (UK) Limited,
NCT03497715,Ibuprofen (Nurofen),DRUG,Healthy Subjects,phase1,TERMINATED,Reckitt Benckiser Healthcare (UK) Limited,
NCT03497715,Ibuprofen (Wockhardt),DRUG,Healthy Subjects,phase1,TERMINATED,Reckitt Benckiser Healthcare (UK) Limited,
NCT00780325,CG100649 (2 mg),DRUG,Healthy Volunteers,phase1,TERMINATED,University of Pennsylvania,
NCT00780325,Celecoxib,DRUG,Healthy Volunteers,phase1,TERMINATED,University of Pennsylvania,
NCT00780325,Placebo capsules,DRUG,Healthy Volunteers,phase1,TERMINATED,University of Pennsylvania,
NCT00780325,Naproxen,DRUG,Healthy Volunteers,phase1,TERMINATED,University of Pennsylvania,
NCT00780325,Acetazolamide,DRUG,Healthy Volunteers,phase1,TERMINATED,University of Pennsylvania,
NCT00780325,CG100649 (8 mg),DRUG,Healthy Volunteers,phase1,TERMINATED,University of Pennsylvania,
NCT02957617,BIIB074,DRUG,Neuropathic Pain From Lumbosacral Radiculopathy,phase2,TERMINATED,Biogen,
NCT00147940,Acoustic rhinometry (procedure),PROCEDURE,Allergy,phase4,TERMINATED,University of Chicago,
NCT03708289,DXA scan,RADIATION,HIV-1; Treatment-naïve,na,TERMINATED,Universitair Ziekenhuis Brussel,
NCT03708289,Achilles bone US,OTHER,HIV-1; Treatment-naïve,na,TERMINATED,Universitair Ziekenhuis Brussel,
NCT03708289,Medical body composition measurements,OTHER,HIV-1; Treatment-naïve,na,TERMINATED,Universitair Ziekenhuis Brussel,
NCT03708289,Resting energy expenditure measurement,OTHER,HIV-1; Treatment-naïve,na,TERMINATED,Universitair Ziekenhuis Brussel,
NCT03699410,Neoadjuvant radiotherapy,RADIATION,Locally Advanced Rectal Cancer,na,TERMINATED,Dimitri Christoforidis,
NCT03699410,Neoadjuvant chemotherapy,DRUG,Locally Advanced Rectal Cancer,na,TERMINATED,Dimitri Christoforidis,
NCT03699410,Radical surgery,PROCEDURE,Locally Advanced Rectal Cancer,na,TERMINATED,Dimitri Christoforidis,
NCT00805285,Combination Oral Budesonide and Rectal Hydrocortisone,DRUG,Inflammatory Bowel Disease; Ulcerative Colitis,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT03525535,data collection,OTHER,Pulmonary Embolism,na,TERMINATED,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,
NCT06243835,Kindolor Tosylate,DRUG,Chronic Pain,phase1,TERMINATED,Lohocla Research Corporation,
NCT06243835,Placebo,DRUG,Chronic Pain,phase1,TERMINATED,Lohocla Research Corporation,
NCT01805908,111In-Pertuzumab + SPECT-CT,OTHER,Breast Cancer,phase1,TERMINATED,Ontario Clinical Oncology Group (OCOG),
NCT01088035,Carboplatin,DRUG,Ependymoma,phase2,TERMINATED,Ann & Robert H Lurie Children's Hospital of Chicago,
NCT01777776,LEE011,DRUG,Locally Advanced Metastatic BRAF Mutant Melanoma,phase1; phase2,TERMINATED,Array BioPharma,
NCT01777776,LGX818,DRUG,Locally Advanced Metastatic BRAF Mutant Melanoma,phase1; phase2,TERMINATED,Array BioPharma,
NCT05129540,Custom-made foot orthosis,DEVICE,Chronic Sciatica; Foot Deformity,na,TERMINATED,University of Seville,
NCT05129540,Placebo orthosis,DEVICE,Chronic Sciatica; Foot Deformity,na,TERMINATED,University of Seville,
NCT06659289,Efferon LPS,DEVICE,Cardiac Disease; Multiple Organ Dysfunction Syndrome,na,TERMINATED,Efferon JSC,
NCT00776191,Physioneal 35,DRUG,Endstage Renal Disease,phase4,TERMINATED,University of Erlangen-Nürnberg Medical School,
NCT00776191,Physioneal 40,DRUG,Endstage Renal Disease,phase4,TERMINATED,University of Erlangen-Nürnberg Medical School,
NCT05204485,Fibular intramedullary nail,PROCEDURE,Ankle Fractures,na,TERMINATED,University of Chicago,
NCT05204485,Open reduction and internal fixation,PROCEDURE,Ankle Fractures,na,TERMINATED,University of Chicago,
NCT00933985,dexrazoxane hydrochloride,DRUG,Acute Leukemias of Ambiguous Lineage; Acute Undifferentiated Leukemia; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Burkitt Lymphoma; Childhood Chronic Mye,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00933985,doxorubicin hydrochloride,DRUG,Acute Leukemias of Ambiguous Lineage; Acute Undifferentiated Leukemia; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Burkitt Lymphoma; Childhood Chronic Mye,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00933985,obatoclax mesylate,DRUG,Acute Leukemias of Ambiguous Lineage; Acute Undifferentiated Leukemia; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Burkitt Lymphoma; Childhood Chronic Mye,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00933985,liposomal vincristine sulfate,DRUG,Acute Leukemias of Ambiguous Lineage; Acute Undifferentiated Leukemia; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Burkitt Lymphoma; Childhood Chronic Mye,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00933985,pharmacological study,OTHER,Acute Leukemias of Ambiguous Lineage; Acute Undifferentiated Leukemia; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Burkitt Lymphoma; Childhood Chronic Mye,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00933985,laboratory biomarker analysis,OTHER,Acute Leukemias of Ambiguous Lineage; Acute Undifferentiated Leukemia; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Burkitt Lymphoma; Childhood Chronic Mye,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00334685,"[S,S]-Reboxetine + Pregabalin",DRUG,Pain,phase2,TERMINATED,Pfizer,
NCT00334685,Pregabalin,DRUG,Pain,phase2,TERMINATED,Pfizer,
NCT02910115,Cold laparotomy sponges,OTHER,Blood Loss; Dysfunctional Labor; Uterine Atony,na,TERMINATED,Baylor Research Institute,
NCT02910115,Pitocin,DRUG,Blood Loss; Dysfunctional Labor; Uterine Atony,na,TERMINATED,Baylor Research Institute,
NCT03596125,N-acetylcysteine,DRUG,Preterm Delivery,phase2; phase3,TERMINATED,Nantes University Hospital,
NCT03596125,Placebo,DRUG,Preterm Delivery,phase2; phase3,TERMINATED,Nantes University Hospital,
NCT04634825,Enoblituzumab,BIOLOGICAL,Head and Neck Cancer; Head and Neck Neoplasms; Head and Neck Squamous Cell Carcinoma,phase2,TERMINATED,MacroGenics,
NCT04634825,Retifanlimab,BIOLOGICAL,Head and Neck Cancer; Head and Neck Neoplasms; Head and Neck Squamous Cell Carcinoma,phase2,TERMINATED,MacroGenics,
NCT04634825,Tebotelimab,BIOLOGICAL,Head and Neck Cancer; Head and Neck Neoplasms; Head and Neck Squamous Cell Carcinoma,phase2,TERMINATED,MacroGenics,
NCT02087176,AZD1775,DRUG,Previously Treated Non Small Cell Lung Cancer,phase2,TERMINATED,AstraZeneca,
NCT02087176,AZD1775 Placebo,DRUG,Previously Treated Non Small Cell Lung Cancer,phase2,TERMINATED,AstraZeneca,
NCT02087176,Antimitotic Agent,DRUG,Previously Treated Non Small Cell Lung Cancer,phase2,TERMINATED,AstraZeneca,
NCT02087176,pegfiligrastim,DRUG,Previously Treated Non Small Cell Lung Cancer,phase2,TERMINATED,AstraZeneca,
NCT06095817,Internet Delivered Brief Intervention (IDBI),BEHAVIORAL,Alcohol Use Disorder; Depression,na,TERMINATED,Cornell University,
NCT04661540,CM4620-IE (Injectable Emulsion),DRUG,Pneumonia,phase2,TERMINATED,"CalciMedica, Inc.",
NCT04661540,Placebo,DRUG,Pneumonia,phase2,TERMINATED,"CalciMedica, Inc.",
NCT01820650,iTotal G2 CR Knee Replacement System,DEVICE,Osteoarthritis of the Knee,na,TERMINATED,Restor3D,
NCT05051150,Epinephrin 0.03,DRUG,Post-spinal Hypotension; Cesarean Section,phase4,TERMINATED,Kasr El Aini Hospital,
NCT05051150,Epinephrin 0.05,DRUG,Post-spinal Hypotension; Cesarean Section,phase4,TERMINATED,Kasr El Aini Hospital,
NCT05051150,Epinephrin 0.07,DRUG,Post-spinal Hypotension; Cesarean Section,phase4,TERMINATED,Kasr El Aini Hospital,
NCT00254891,PF-3512676 + Paclitaxel + Carboplatin,DRUG,"Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,Pfizer,
NCT00254891,Paclitaxel + Carboplatin,DRUG,"Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,Pfizer,
NCT00102791,ICA-17043,DRUG,Sickle Cell Disease,phase3,TERMINATED,Icagen,
NCT00252174,Stage 1 Active Methylenedioxymethamphetamine,DRUG,Anxiety Disorder; Cancer,phase2,TERMINATED,Brigham and Women's Hospital,
NCT00252174,Stage 1 Low dose Methylenedioxymethamphetamine,DRUG,Anxiety Disorder; Cancer,phase2,TERMINATED,Brigham and Women's Hospital,
NCT00252174,Psychotherapy,BEHAVIORAL,Anxiety Disorder; Cancer,phase2,TERMINATED,Brigham and Women's Hospital,
NCT00252174,Stage 2 Active Methylenedioxymethamphetamine,DRUG,Anxiety Disorder; Cancer,phase2,TERMINATED,Brigham and Women's Hospital,
NCT01533818,Amoxicillin,DRUG,Fast Breathing in Young Infants,phase4,TERMINATED,Aga Khan University,
NCT01533818,Sugar Syrup,DRUG,Fast Breathing in Young Infants,phase4,TERMINATED,Aga Khan University,
NCT01866774,Fecal calprotectin level,OTHER,Chronic Abdominal Pain; Chronic Diarrhea,na,TERMINATED,Queen's University,
NCT00967343,Donor lymphocyte preparation depleted of host functional alloreactive T-cells,BIOLOGICAL,Myeloid Leukemia; Lymphoblastic Leukemia; Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome; Myeloproliferative Disorders,phase2; phase3,TERMINATED,Kiadis Pharma,
NCT01647308,ISIS-APOCIIIRX,DRUG,Type 2 Diabetes,phase2,TERMINATED,"Ionis Pharmaceuticals, Inc.",
NCT01647308,Placebo,DRUG,Type 2 Diabetes,phase2,TERMINATED,"Ionis Pharmaceuticals, Inc.",
NCT00058825,Campath 1H,BIOLOGICAL,Hematologic Malignancies,phase1; phase2,TERMINATED,Baylor College of Medicine,
NCT00058825,Fludarabine,DRUG,Hematologic Malignancies,phase1; phase2,TERMINATED,Baylor College of Medicine,
NCT00058825,Stem Cell Transplant,PROCEDURE,Hematologic Malignancies,phase1; phase2,TERMINATED,Baylor College of Medicine,
NCT00058825,Total Body Irradiation (TBI),RADIATION,Hematologic Malignancies,phase1; phase2,TERMINATED,Baylor College of Medicine,
NCT00058825,FK506 (Tacrolimus) or Cyclosporine,DRUG,Hematologic Malignancies,phase1; phase2,TERMINATED,Baylor College of Medicine,
NCT01464476,Azimilide Dihydrochloride,DRUG,"Arrhythmias, Cardiac; Heart Diseases; Cardiovascular Diseases; Implantable Cardioverter Defibrillator",phase3,TERMINATED,Forest Laboratories,
NCT01464476,Placebo,DRUG,"Arrhythmias, Cardiac; Heart Diseases; Cardiovascular Diseases; Implantable Cardioverter Defibrillator",phase3,TERMINATED,Forest Laboratories,
NCT03129776,Hyperpolarized 13C-Pyruvate,DRUG,Uterine Cervical Neoplasms,phase1,TERMINATED,Sunnybrook Health Sciences Centre,
NCT03129776,18F-FDG,DRUG,Uterine Cervical Neoplasms,phase1,TERMINATED,Sunnybrook Health Sciences Centre,
NCT02441517,Enzalutamide,DRUG,Metastatic Castration Resistant Prostate Cancer,phase4,TERMINATED,"Astellas Pharma Global Development, Inc.",
NCT04541017,Biospecimen Collection,PROCEDURE,Mycosis Fungoides; Recurrent Mycosis Fungoides; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Sezary Syndrome; Refractory Mycosis Fungoides; Refractory Mycosis Fungoides and Sezary Syndro,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT04541017,Computed Tomography,PROCEDURE,Mycosis Fungoides; Recurrent Mycosis Fungoides; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Sezary Syndrome; Refractory Mycosis Fungoides; Refractory Mycosis Fungoides and Sezary Syndro,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT04541017,Magrolimab,BIOLOGICAL,Mycosis Fungoides; Recurrent Mycosis Fungoides; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Sezary Syndrome; Refractory Mycosis Fungoides; Refractory Mycosis Fungoides and Sezary Syndro,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT04541017,Mogamulizumab,BIOLOGICAL,Mycosis Fungoides; Recurrent Mycosis Fungoides; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Sezary Syndrome; Refractory Mycosis Fungoides; Refractory Mycosis Fungoides and Sezary Syndro,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT04541017,Positron Emission Tomography,PROCEDURE,Mycosis Fungoides; Recurrent Mycosis Fungoides; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Sezary Syndrome; Refractory Mycosis Fungoides; Refractory Mycosis Fungoides and Sezary Syndro,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT04541017,Punch Biopsy,PROCEDURE,Mycosis Fungoides; Recurrent Mycosis Fungoides; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Sezary Syndrome; Refractory Mycosis Fungoides; Refractory Mycosis Fungoides and Sezary Syndro,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT04019613,Lung ultrasound,OTHER,Dyspnea; Heart Failure With Preserved Ejection Fraction,na,TERMINATED,Mayo Clinic,
NCT03195660,ASV Therapy,DEVICE,Heart Failure With Normal Ejection Fraction; Sleep Apnea,na,TERMINATED,ResMed,
NCT02220088,TAI of FOLFOX,PROCEDURE,Hepatocellular Carcinoma,phase2; phase3,TERMINATED,Sun Yat-sen University,
NCT02220088,Sorafenib,DRUG,Hepatocellular Carcinoma,phase2; phase3,TERMINATED,Sun Yat-sen University,
NCT00400127,Silesian suspension belt,DEVICE,Amputee,na,TERMINATED,Nova Scotia Health Authority,
NCT02500927,ASP8273 Capsules,DRUG,EGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations,phase2,TERMINATED,Astellas Pharma Inc,
NCT02500927,ASP8273 Capsules A,DRUG,EGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations,phase2,TERMINATED,Astellas Pharma Inc,
NCT00077961,CAMPATH (alemtuzumab),DRUG,Non-Hodgkin's Lymphoma,phase1; phase2,TERMINATED,"Genzyme, a Sanofi Company",
NCT01911273,PF-03446962,DRUG,"Carcinoma, Hepatocellular",phase2,TERMINATED,Pfizer,
NCT01911273,Best Supportive Care,OTHER,"Carcinoma, Hepatocellular",phase2,TERMINATED,Pfizer,
NCT01911273,Placebo,OTHER,"Carcinoma, Hepatocellular",phase2,TERMINATED,Pfizer,
NCT01911273,Best Supportive Care,OTHER,"Carcinoma, Hepatocellular",phase2,TERMINATED,Pfizer,
NCT05251805,"Blood, bone marrow and lung tumor tissue collection",PROCEDURE,Non Small Cell Lung Cancer,na,TERMINATED,Universitair Ziekenhuis Brussel,
NCT01347866,PF-05212384,DRUG,Advanced Cancer,phase1,TERMINATED,Pfizer,
NCT01347866,PD-0325901,DRUG,Advanced Cancer,phase1,TERMINATED,Pfizer,
NCT01347866,PF-05212384,DRUG,Advanced Cancer,phase1,TERMINATED,Pfizer,
NCT01347866,irinotecan,DRUG,Advanced Cancer,phase1,TERMINATED,Pfizer,
NCT02044822,Idelalisib,DRUG,B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion,phase2,TERMINATED,Gilead Sciences,
NCT02044822,Rituximab,DRUG,B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion,phase2,TERMINATED,Gilead Sciences,
NCT03034902,Combined EEG and fNIRS,DEVICE,Stroke,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT01675037,Biological evaluation,OTHER,Obstructive Hydrocephalus,na,TERMINATED,"University Hospital, Toulouse",
NCT00295737,"bronchoscopy, allergen/endotoxin instillation",PROCEDURE,Atopy; Rhinitis; Bronchial Asthma,na,TERMINATED,Fraunhofer-Institute of Toxicology and Experimental Medicine,
NCT00006472,carboplatin,DRUG,Esophageal Cancer,phase2,TERMINATED,Medstar Health Research Institute,
NCT00006472,fluorouracil,DRUG,Esophageal Cancer,phase2,TERMINATED,Medstar Health Research Institute,
NCT00006472,paclitaxel,DRUG,Esophageal Cancer,phase2,TERMINATED,Medstar Health Research Institute,
NCT00006472,conventional surgery,PROCEDURE,Esophageal Cancer,phase2,TERMINATED,Medstar Health Research Institute,
NCT00006472,radiation therapy,RADIATION,Esophageal Cancer,phase2,TERMINATED,Medstar Health Research Institute,
NCT00987545,QAX576,DRUG,Keloids,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT00987545,QAX576 placebo,DRUG,Keloids,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01011777,MDC,DRUG,Bladder Exstrophy; Urinary Incontinence,phase1,TERMINATED,Johns Hopkins University,
NCT00906477,Modified CI therapy,PROCEDURE,Cerebrovascular Accident,phase3,TERMINATED,University Hospital of North Norway,
NCT02141477,Omacetaxine,DRUG,Leukemia,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02141477,Decitabine,DRUG,Leukemia,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02498977,Biomarker,OTHER,"Transplantation, Liver",phase4,TERMINATED,King's College London,
NCT02498977,"Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate mofetil or azathioprine",DRUG,"Transplantation, Liver",phase4,TERMINATED,King's College London,
NCT01617057,tiludronic acid,DRUG,Otosclerosis,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01617057,Placebo,DRUG,Otosclerosis,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00149357,Thrombophilia Testing,OTHER,Venous Thromboembolism; Fetal Death,na,TERMINATED,McMaster University,
NCT03601819,Pacritinib,DRUG,"Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Chronic Lymphocytic Leukemia; Lymphoproliferative Disorders; Waldenstrom Macroglobulinemia; Lymphoplasmacytic Lymphoma; Mantle Cell Lymphoma",phase1,TERMINATED,University of Michigan Rogel Cancer Center,
NCT04232228,No intervention,OTHER,Crohn Disease,na,TERMINATED,Janssen-Cilag Ltd.,
NCT02765165,USL311,DRUG,Solid Tumors (Phase 1); Relapsed/Recurrent GBM (Phase 2),phase1; phase2,TERMINATED,"Proximagen, LLC",
NCT02765165,USL311,DRUG,Solid Tumors (Phase 1); Relapsed/Recurrent GBM (Phase 2),phase1; phase2,TERMINATED,"Proximagen, LLC",
NCT02765165,USL311,DRUG,Solid Tumors (Phase 1); Relapsed/Recurrent GBM (Phase 2),phase1; phase2,TERMINATED,"Proximagen, LLC",
NCT02765165,Lomustine,DRUG,Solid Tumors (Phase 1); Relapsed/Recurrent GBM (Phase 2),phase1; phase2,TERMINATED,"Proximagen, LLC",
NCT03044600,Chart Review,OTHER,Parathyroid Disease; Hyperparathyroidism,na,TERMINATED,M.D. Anderson Cancer Center,
NCT03044600,HRPT2 Mutation Evaluation,OTHER,Parathyroid Disease; Hyperparathyroidism,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00060346,rituximab,BIOLOGICAL,Lymphoma,phase2,TERMINATED,Eastern Cooperative Oncology Group,
NCT00060346,cyclophosphamide,DRUG,Lymphoma,phase2,TERMINATED,Eastern Cooperative Oncology Group,
NCT00060346,Doxorubicin,DRUG,Lymphoma,phase2,TERMINATED,Eastern Cooperative Oncology Group,
NCT00060346,Prednisone,DRUG,Lymphoma,phase2,TERMINATED,Eastern Cooperative Oncology Group,
NCT00060346,Vincristine,DRUG,Lymphoma,phase2,TERMINATED,Eastern Cooperative Oncology Group,
NCT02921646,Measure of resting energetic expenditure,OTHER,Metastatic Pancreatic Cancer,na,TERMINATED,Center Eugene Marquis,
NCT03134703,Methadone,DRUG,Neonatal Abstinence Syndrome,phase2,TERMINATED,Johns Hopkins All Children's Hospital,
NCT03134703,Morphine,DRUG,Neonatal Abstinence Syndrome,phase2,TERMINATED,Johns Hopkins All Children's Hospital,
NCT06181227,AVD-104,DRUG,Diabetic Macular Edema; Diabetic Retinopathy,phase2,TERMINATED,"Aviceda Therapeutics, Inc.",
NCT04634461,Cardiac Monitor,DEVICE,Atrial Fibrillation Paroxysmal; Panic; Panic Disorder; Panic Attacks,na,TERMINATED,State University of New York at Buffalo,
NCT05016661,ABP-450,DRUG,Migraine,phase2,TERMINATED,"AEON Biopharma, Inc.",
NCT03025386,logatoms test,OTHER,Cochlear Implant,na,TERMINATED,"University Hospital, Montpellier",
NCT03025386,Electroencephalography,OTHER,Cochlear Implant,na,TERMINATED,"University Hospital, Montpellier",
NCT01103141,Micropuncture needle set,DEVICE,Complications,na,TERMINATED,Cook Group Incorporated,
NCT01103141,Standard gauge-18 needle set,DEVICE,Complications,na,TERMINATED,Cook Group Incorporated,
NCT02888756,iHIVARNA-01,BIOLOGICAL,HIV Infections,phase2,TERMINATED,Rob Gruters,
NCT02888756,TriMix,BIOLOGICAL,HIV Infections,phase2,TERMINATED,Rob Gruters,
NCT02888756,Placebo,BIOLOGICAL,HIV Infections,phase2,TERMINATED,Rob Gruters,
NCT03173053,Doxycycline,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Trimethoprim,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Sulfamethoxazole/trimethoprim,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Clindamycin,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Clarithromycin,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Ciprofloxacin,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Fusidic Acid,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Rifampin,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Chlorhexidine,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Mupirocin,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT03173053,Betadine,DRUG,Staphylococcus Aureus; Motility Disorder,na,TERMINATED,Radboud University Medical Center,
NCT02058537,Bethanechol,DRUG,Eosinophilic Esophagitis (EoE),phase2,TERMINATED,University of Iowa,
NCT00726037,Ontak,DRUG,Metastatic Pancreatic Cancer,phase2,TERMINATED,Loyola University,
NCT02959437,Azacitidine,DRUG,Solid Tumors; Advanced Malignancies; Metastatic Cancer,phase1; phase2,TERMINATED,Incyte Corporation,
NCT02959437,Pembrolizumab,DRUG,Solid Tumors; Advanced Malignancies; Metastatic Cancer,phase1; phase2,TERMINATED,Incyte Corporation,
NCT02959437,Epacadostat,DRUG,Solid Tumors; Advanced Malignancies; Metastatic Cancer,phase1; phase2,TERMINATED,Incyte Corporation,
NCT02959437,INCB057643,DRUG,Solid Tumors; Advanced Malignancies; Metastatic Cancer,phase1; phase2,TERMINATED,Incyte Corporation,
NCT02959437,Pembrolizumab,DRUG,Solid Tumors; Advanced Malignancies; Metastatic Cancer,phase1; phase2,TERMINATED,Incyte Corporation,
NCT02959437,Epacadostat,DRUG,Solid Tumors; Advanced Malignancies; Metastatic Cancer,phase1; phase2,TERMINATED,Incyte Corporation,
NCT02959437,INCB059872,DRUG,Solid Tumors; Advanced Malignancies; Metastatic Cancer,phase1; phase2,TERMINATED,Incyte Corporation,
NCT04639245,Atezolizumab,DRUG,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Triple-Negative Breast Carcinoma; Metastatic Urothelial Carcinoma; St,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT04639245,Cyclophosphamide,DRUG,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Triple-Negative Breast Carcinoma; Metastatic Urothelial Carcinoma; St,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT04639245,Fludarabine,DRUG,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Triple-Negative Breast Carcinoma; Metastatic Urothelial Carcinoma; St,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT04639245,MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells,BIOLOGICAL,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Triple-Negative Breast Carcinoma; Metastatic Urothelial Carcinoma; St,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT04639245,PD1 Inhibitor,BIOLOGICAL,Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Triple-Negative Breast Carcinoma; Metastatic Urothelial Carcinoma; St,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT03280277,Contrast-enhanced Magnetic Resonance Imaging,PROCEDURE,Locally Advanced Rectal Carcinoma; Stage III Rectal Cancer AJCC v7; Stage IIIA Rectal Cancer AJCC v7; Stage IIIB Rectal Cancer AJCC v7; Stage IIIC Rectal Cancer AJCC v7,early_phase1,TERMINATED,OHSU Knight Cancer Institute,
NCT03280277,Ferumoxytol,DRUG,Locally Advanced Rectal Carcinoma; Stage III Rectal Cancer AJCC v7; Stage IIIA Rectal Cancer AJCC v7; Stage IIIB Rectal Cancer AJCC v7; Stage IIIC Rectal Cancer AJCC v7,early_phase1,TERMINATED,OHSU Knight Cancer Institute,
NCT01620775,MRIs,OTHER,Chronic Low Back Pain; Diabetic Peripheral Neuropathy; Knee Osteoarthritis,na,TERMINATED,University of Michigan,
NCT01620775,Pain testing,OTHER,Chronic Low Back Pain; Diabetic Peripheral Neuropathy; Knee Osteoarthritis,na,TERMINATED,University of Michigan,
NCT03435575,Boosth,DEVICE,Physical Activity; Serious Game; Childhood Obesity; Overweight and Obesity,na,TERMINATED,Maastricht University Medical Center,
NCT06114875,Peer support intervention,BEHAVIORAL,"Distress, Emotional; Suicide",na,TERMINATED,Harvard University,
NCT02689219,Brentuximab Vedotin,DRUG,Germ Cell Tumors; Testis Cancer; Testicular Cancer; Embryonal Carcinoma; Nonseminomatous Germ Cell Tumor,phase2,TERMINATED,Nabil Adra,
NCT02358265,10 mg Rupatadine on demand,DRUG,Chronic Urticaria,phase3,TERMINATED,"Charite University, Berlin, Germany",
NCT02358265,10 mg Rupatadine,DRUG,Chronic Urticaria,phase3,TERMINATED,"Charite University, Berlin, Germany",
NCT02358265,20 mg Rupatadine,DRUG,Chronic Urticaria,phase3,TERMINATED,"Charite University, Berlin, Germany",
NCT02358265,10 mg Rupatadine on demand (sham updosing to 20 mg),DRUG,Chronic Urticaria,phase3,TERMINATED,"Charite University, Berlin, Germany",
NCT03778073,Cosibelimab,DRUG,B-cell Non Hodgkin Lymphoma; Richter's Transformation,phase1,TERMINATED,"TG Therapeutics, Inc.",
NCT03778073,Cosibelimab + Ublituximab + Bendamustine combination,DRUG,B-cell Non Hodgkin Lymphoma; Richter's Transformation,phase1,TERMINATED,"TG Therapeutics, Inc.",
NCT03778073,Cosibelimab + Ublituximab + Bendamustine combination,DRUG,B-cell Non Hodgkin Lymphoma; Richter's Transformation,phase1,TERMINATED,"TG Therapeutics, Inc.",
NCT04731441,Home-based Exercise Program Prior to CRS-HIPEC,BEHAVIORAL,Colon Cancer; Ovarian Cancer; GI Cancer; Gynecologic Cancer,na,TERMINATED,Milton S. Hershey Medical Center,
NCT04731441,Exercise Education,BEHAVIORAL,Colon Cancer; Ovarian Cancer; GI Cancer; Gynecologic Cancer,na,TERMINATED,Milton S. Hershey Medical Center,
NCT00607841,Ispinesib,DRUG,Breast Neoplasms,phase1,TERMINATED,Cytokinetics,
NCT00607841,Ispinesib,DRUG,Breast Neoplasms,phase1,TERMINATED,Cytokinetics,
NCT00607841,Ispinesib,DRUG,Breast Neoplasms,phase1,TERMINATED,Cytokinetics,
NCT01555554,Propranolol Hydrochloride,DRUG,Post-traumatic Stress Disorder,na,TERMINATED,"University of California, San Francisco",
NCT01555554,Placebo,OTHER,Post-traumatic Stress Disorder,na,TERMINATED,"University of California, San Francisco",
NCT00549822,Letrozole,DRUG,Breast Cancer,phase2,TERMINATED,Massachusetts General Hospital,
NCT00426829,Bevacizumab,DRUG,Liver Cancer; Hepatocellular Carcinoma; Cholangiocarcinoma,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT00426829,Proton Radiation Therapy,RADIATION,Liver Cancer; Hepatocellular Carcinoma; Cholangiocarcinoma,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02913131,Pyruvate (13C),DRUG,Prostate Cancer,phase1; phase2,TERMINATED,Rahul Aggarwal,
NCT02913131,MRI,DEVICE,Prostate Cancer,phase1; phase2,TERMINATED,Rahul Aggarwal,
NCT05071053,Ramucirumab (CYRAMZA®),DRUG,Adenocarcinoma Gastric; Gastrooesophageal Cancer,phase2,TERMINATED,Sanofi,
NCT05071053,Tusamitamab ravtansine (SAR408701),DRUG,Adenocarcinoma Gastric; Gastrooesophageal Cancer,phase2,TERMINATED,Sanofi,
NCT03986853,Blood sampling,PROCEDURE,Developmental Venous Anomaly,na,TERMINATED,Hopital Foch,
NCT02712437,PROSPECT,BEHAVIORAL,Breast Cancer; Insomnia,na,TERMINATED,University of Michigan Rogel Cancer Center,
NCT04948645,Fosigotifator,DRUG,ALS; Amyotrophic Lateral Sclerosis,phase1,TERMINATED,AbbVie,
NCT04948645,Placebo,DRUG,ALS; Amyotrophic Lateral Sclerosis,phase1,TERMINATED,AbbVie,
NCT00585845,"CRS-207, Live-attenuated Listeria monocytogenes expressing human Mesothelin",BIOLOGICAL,"Malignant Epithelial Mesothelioma; Adenocarcinoma of the Pancreas; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma of the Ovaries",phase1,TERMINATED,"Anza Therapeutics, Inc.",
NCT03958539,3D printed insoles for normal footware,DEVICE,"Diabetes Mellitus; Foot Ulcer, Diabetic; Primary Prevention",na,TERMINATED,Countess of Chester NHS Foundation Trust,
NCT07009977,self-guided mHealth app only,BEHAVIORAL,Alcohol Abuse; Substance Abuse; Post Traumatic Stress Disorder,na,TERMINATED,UConn Health,
NCT07009977,self-guided mHealth app + 'real-time' feedback,BEHAVIORAL,Alcohol Abuse; Substance Abuse; Post Traumatic Stress Disorder,na,TERMINATED,UConn Health,
NCT03139357,"GAD7, SF12, medical utilization, helpfulness questionnaire",OTHER,Life Stress,na,TERMINATED,University of Pittsburgh,
NCT03630601,Photoacoustic Imaging,PROCEDURE,Breast Carcinoma; Healthy Subject; Malignant Soft Tissue Neoplasm; Sarcoma; Skin Carcinoma,na,TERMINATED,Roswell Park Cancer Institute,
NCT00176930,Stem Cell Transplant,BIOLOGICAL,"Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-hodgkin's Lymphoma; Multiple Myeloma",na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00176930,Cyclophosphamide,DRUG,"Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-hodgkin's Lymphoma; Multiple Myeloma",na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00176930,Total Body Irradiation,RADIATION,"Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-hodgkin's Lymphoma; Multiple Myeloma",na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00176930,Busulfan,DRUG,"Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-hodgkin's Lymphoma; Multiple Myeloma",na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00176930,Equine ATG (ATGAM),DRUG,"Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-hodgkin's Lymphoma; Multiple Myeloma",na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00176930,CD4+/CD25+ cells,BIOLOGICAL,"Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-hodgkin's Lymphoma; Multiple Myeloma",na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00613730,Gemcitabine,DRUG,Cancer of Pancreas; Cancer of the Pancreas; Pancreas Cancer; Pancreatic Cancer,phase2,TERMINATED,Amgen,
NCT00613730,panitumumab,DRUG,Cancer of Pancreas; Cancer of the Pancreas; Pancreas Cancer; Pancreatic Cancer,phase2,TERMINATED,Amgen,
NCT01726465,Methylprednisolone,DRUG,"Ischemic Reperfusion Injury; Insufficiency; Hepatic, Postoperative; Liver Tumour",phase2,TERMINATED,Istituto Clinico Humanitas,
NCT01726465,N-acetylcysteine,DRUG,"Ischemic Reperfusion Injury; Insufficiency; Hepatic, Postoperative; Liver Tumour",phase2,TERMINATED,Istituto Clinico Humanitas,
NCT02218567,questionnaire qualilty of life,BEHAVIORAL,Huntington Disease,na,TERMINATED,"University Hospital, Angers",
NCT02218567,psychological interview,BEHAVIORAL,Huntington Disease,na,TERMINATED,"University Hospital, Angers",
NCT02218567,psychological tests,BEHAVIORAL,Huntington Disease,na,TERMINATED,"University Hospital, Angers",
NCT02218567,Motor evaluation,OTHER,Huntington Disease,na,TERMINATED,"University Hospital, Angers",
NCT02218567,Behavioral evaluation,BEHAVIORAL,Huntington Disease,na,TERMINATED,"University Hospital, Angers",
NCT02218567,cognitive tests,BEHAVIORAL,Huntington Disease,na,TERMINATED,"University Hospital, Angers",
NCT02818894,Lidocaine,DRUG,Total Hip Arthroplasty,phase4,TERMINATED,Thomas L Bradbury,
NCT02818894,Bupivacaine,DRUG,Total Hip Arthroplasty,phase4,TERMINATED,Thomas L Bradbury,
NCT00424294,"CP-195,543",DRUG,"Arthritis, Rheumatoid",phase2,TERMINATED,Pfizer,
NCT00424294,celecoxib,DRUG,"Arthritis, Rheumatoid",phase2,TERMINATED,Pfizer,
NCT00424294,Methotrexate,DRUG,"Arthritis, Rheumatoid",phase2,TERMINATED,Pfizer,
NCT00883766,Controlled ovarian hyperstimulation for IVF with a long agonist protocol,OTHER,Polycystic Ovary Syndrome; In Vitro Fertilization,na,TERMINATED,Fundacion Dexeus,
NCT00883766,Controlled ovarian hyperstimulation for IVF with an antagonist protocol,OTHER,Polycystic Ovary Syndrome; In Vitro Fertilization,na,TERMINATED,Fundacion Dexeus,
NCT00942422,defined green tea catechin extract,OTHER,Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00942422,gene expression analysis,OTHER,Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00942422,protein analysis,OTHER,Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00942422,laboratory biomarker analysis,OTHER,Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00258037,Pelvic Floor Muscle training,BEHAVIORAL,Stroke; Urinary Incontinence,phase2,TERMINATED,"Glostrup University Hospital, Copenhagen",
NCT00830401,Treatment of predefined abnormality by hysteroscopic surgery,PROCEDURE,Minor Intra-uterine Abnormalities,phase2,TERMINATED,UMC Utrecht,
NCT00830401,Ofloxacinum/Doxycycline,DRUG,Minor Intra-uterine Abnormalities,phase2,TERMINATED,UMC Utrecht,
NCT02049281,Vintafolide,DRUG,Solid Tumor,phase1,TERMINATED,Endocyte,
NCT02860481,blood sample for FSHR analysis,PROCEDURE,Cancer,na,TERMINATED,Institut Curie,
NCT02860481,blood sample for FSHR analysis,PROCEDURE,Cancer,na,TERMINATED,Institut Curie,
NCT01813019,AFQ056,DRUG,Patient Diagnosed With OCD and Resistant to SSRI Treatment; Failed SSRI Over 12 Weeks at Appropriate Doses,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01813019,Placebo,DRUG,Patient Diagnosed With OCD and Resistant to SSRI Treatment; Failed SSRI Over 12 Weeks at Appropriate Doses,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01193530,Bright Light Therapy,OTHER,Advanced Cancers,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01193530,Dim Red Light Therapy,OTHER,Advanced Cancers,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01193530,Questionnaires,BEHAVIORAL,Advanced Cancers,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01193530,Study Diaries,BEHAVIORAL,Advanced Cancers,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01193530,Red Light Litebook,DEVICE,Advanced Cancers,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01193530,Bright Light Litebook,DEVICE,Advanced Cancers,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT02447107,Electronic Diary,OTHER,Chronic Pain,na,TERMINATED,Weill Medical College of Cornell University,
NCT02447107,Questionnaire,OTHER,Chronic Pain,na,TERMINATED,Weill Medical College of Cornell University,
NCT04905407,Tamibarotene,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,Syros Pharmaceuticals,
NCT04905407,Venetoclax,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,Syros Pharmaceuticals,
NCT04905407,Azacitidine,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,Syros Pharmaceuticals,
NCT02929407,FE 204205,DRUG,Portal Hypertension,phase1,TERMINATED,Ferring Pharmaceuticals,
NCT02929407,Placebo,DRUG,Portal Hypertension,phase1,TERMINATED,Ferring Pharmaceuticals,
NCT03552692,Venetoclax,DRUG,T-Cell Lymphoma Relapsed; T-Cell Lymphoma Refractory,phase2,TERMINATED,Fondazione Italiana Linfomi - ETS,
NCT03624192,RECELL® Autologous Cell Harvesting Device,DEVICE,Skin; Deformity,na,TERMINATED,Avita Medical,
NCT03624192,Telfa™ Clear and Xeroform™ dressings,OTHER,Skin; Deformity,na,TERMINATED,Avita Medical,
NCT06058156,SAR444656 (KT-474),DRUG,Atopic Dermatitis,phase2,TERMINATED,Sanofi,
NCT06058156,Placebo,DRUG,Atopic Dermatitis,phase2,TERMINATED,Sanofi,
NCT02364856,Analgesia Nociception Index,DEVICE,Cerebral Palsy; Pain; Children,na,TERMINATED,"University Hospital, Lille",
NCT03546556,Fluorothymidine (FLT),DRUG,Graft Vs Host Disease,early_phase1,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT04552756,Seizure Diary,OTHER,High-grade Glioma,na,TERMINATED,University Hospital Schleswig-Holstein,
NCT02063945,Methylphenidate,DRUG,Attention Deficit/Hyperactivity Disorder; Oppositional Defiant Disorder; Conduct Disorder,phase4,TERMINATED,Sheba Medical Center,
NCT02063945,Risperidone,DRUG,Attention Deficit/Hyperactivity Disorder; Oppositional Defiant Disorder; Conduct Disorder,phase4,TERMINATED,Sheba Medical Center,
NCT00890630,Intracervical Balloon Catheter,PROCEDURE,"Fetal Membranes, Premature Rupture; Induced Labor",phase2,TERMINATED,McMaster University,
NCT00890630,Oxytocin,DRUG,"Fetal Membranes, Premature Rupture; Induced Labor",phase2,TERMINATED,McMaster University,
NCT01773330,esophageal manometry,PROCEDURE,Motility Disorder,phase1,TERMINATED,University of Florida,
NCT01773330,Gatorade,OTHER,Motility Disorder,phase1,TERMINATED,University of Florida,
NCT01773330,Supine position,OTHER,Motility Disorder,phase1,TERMINATED,University of Florida,
NCT01773330,Semi-recumbent position,OTHER,Motility Disorder,phase1,TERMINATED,University of Florida,
NCT01773330,Sitting,PROCEDURE,Motility Disorder,phase1,TERMINATED,University of Florida,
NCT01773330,Standing,PROCEDURE,Motility Disorder,phase1,TERMINATED,University of Florida,
NCT03056365,Advanced Nurse (AN),PROCEDURE,Alcohol Dependence,na,TERMINATED,"University Hospital, Lille",
NCT03056365,General Practitioner (GP),PROCEDURE,Alcohol Dependence,na,TERMINATED,"University Hospital, Lille",
NCT01245907,Applied relaxation,BEHAVIORAL,Hot Flashes; Menopause,na,TERMINATED,Mats Hammar,
NCT03822936,Preoperative chemotherapy,DRUG,Cancer of Pancreas; Pancreas Adenocarcinoma; Resectable Pancreatic Cancer,phase2,TERMINATED,CNAO National Center of Oncological Hadrontherapy,
NCT03822936,Preoperative radiotherapy,RADIATION,Cancer of Pancreas; Pancreas Adenocarcinoma; Resectable Pancreatic Cancer,phase2,TERMINATED,CNAO National Center of Oncological Hadrontherapy,
NCT03646344,Heme Arginate 25 MG/ML,DRUG,Renal Transplant Rejection; Renal Transplant Failure,phase3,TERMINATED,University of Edinburgh,
NCT03646344,0.9% Sodium-chloride,DRUG,Renal Transplant Rejection; Renal Transplant Failure,phase3,TERMINATED,University of Edinburgh,
NCT05641545,IVAC,BIOLOGICAL,Advanced Renal Cell Carcinoma,phase1,TERMINATED,SLK Kliniken Heilbronn GmbH,
NCT01920945,OnabotulinumtoxinA,DRUG,New Daily Persistent Headache,phase2,TERMINATED,St. Luke's-Roosevelt Hospital Center,
NCT00486395,CPAP,DEVICE,"Prematurity; Respiratory Distress Syndrome, Newborn",phase3,TERMINATED,Children's & Women's Health Centre of British Columbia,
NCT00486395,Mechanical ventilation,DEVICE,"Prematurity; Respiratory Distress Syndrome, Newborn",phase3,TERMINATED,Children's & Women's Health Centre of British Columbia,
NCT01141075,Ataluren,DRUG,"Amino Acid Metabolism, Inborn Errors",phase2,TERMINATED,PTC Therapeutics,
NCT04087512,Training on perturbation treadmill,OTHER,"Fall Risk, Fall Prevention",na,TERMINATED,Leon Brüll,
NCT04087512,Exercises of dynamic stability under unstable conditions,OTHER,"Fall Risk, Fall Prevention",na,TERMINATED,Leon Brüll,
NCT05256381,Nanrilkefusp Alfa,DRUG,Non-Small Cell Lung Cancer; Colorectal Cancer; Cutaneous Squamous Cell Carcinoma; Hepatocellular Carcinoma; Castration-resistant Prostate Cancer; Ovarian Cancer,phase2,TERMINATED,SOTIO Biotech AG,
NCT05256381,Pembrolizumab,DRUG,Non-Small Cell Lung Cancer; Colorectal Cancer; Cutaneous Squamous Cell Carcinoma; Hepatocellular Carcinoma; Castration-resistant Prostate Cancer; Ovarian Cancer,phase2,TERMINATED,SOTIO Biotech AG,
NCT00571519,Rivoglitazone HCl,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Daiichi Sankyo,
NCT00571519,rivoglitazone HCl,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Daiichi Sankyo,
NCT00571519,rivoglitazone HCl,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Daiichi Sankyo,
NCT00571519,placebo,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Daiichi Sankyo,
NCT00571519,pioglitazone HCl,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Daiichi Sankyo,
NCT00571519,pioglitazone HCl,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Daiichi Sankyo,
NCT00571519,pioglitazone HCl 45 mg,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Daiichi Sankyo,
NCT00571519,placebo,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Daiichi Sankyo,
NCT00571519,metformin,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Daiichi Sankyo,
NCT02046928,A6,DRUG,Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; CLL; SLL,phase2,TERMINATED,Ångstrom Pharmaceuticals,
NCT03566407,Colonoscopy,PROCEDURE,Crohn's Disease,na,TERMINATED,Prometheus Laboratories,
NCT00569465,Arginine,DRUG,Type 2 Diabetes Mellitus; Hypertension,phase4,TERMINATED,"University of Turin, Italy",
NCT00569465,Acetylcysteine,DRUG,Type 2 Diabetes Mellitus; Hypertension,phase4,TERMINATED,"University of Turin, Italy",
NCT00569465,Placebo,DRUG,Type 2 Diabetes Mellitus; Hypertension,phase4,TERMINATED,"University of Turin, Italy",
NCT00119600,AMG 114,DRUG,Anemia; Cancer,phase1; phase2,TERMINATED,Amgen,
NCT02650492,Immunostimulating Interstitial Laser Thermotherapy,DEVICE,Melanoma; Malignant Melanoma,na,TERMINATED,Clinical Laserthermia Systems AB,
NCT03492736,Melatonin,OTHER,Obstructive Sleep Apnea,early_phase1,TERMINATED,Naomi Deacon,
NCT03492736,Placebo,OTHER,Obstructive Sleep Apnea,early_phase1,TERMINATED,Naomi Deacon,
NCT02790736,propranolol,DRUG,Social Anxiety Disorder,phase4,TERMINATED,New York State Psychiatric Institute,
NCT02790736,Placebo,DRUG,Social Anxiety Disorder,phase4,TERMINATED,New York State Psychiatric Institute,
NCT00435071,Carpal Tunnel Release Surgery,PROCEDURE,Carpal Tunnel Syndrome,na,TERMINATED,Vanderbilt University,
NCT00435071,Carpal tunnel release surgery,PROCEDURE,Carpal Tunnel Syndrome,na,TERMINATED,Vanderbilt University,
NCT00432445,Proton Beam Radiation Therapy,RADIATION,Retinoblastoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00432445,Ophthalmic EUA,PROCEDURE,Retinoblastoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00332839,Everolimus,DRUG,Renal Transplantation,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT00332839,Cyclosporin A (CsA),DRUG,Renal Transplantation,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT00332839,Tacrolimus,DRUG,Renal Transplantation,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT00332839,Enteric Coated - Mycophenolate Sodium (EC-MPS),DRUG,Renal Transplantation,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT00332839,Corticosteroids,DRUG,Renal Transplantation,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT06435039,APL-1202,DRUG,Healthy Volunteers,phase1,TERMINATED,Syneos Health,
NCT06435039,APL-1501,DRUG,Healthy Volunteers,phase1,TERMINATED,Syneos Health,
NCT03237377,Durvalumab,DRUG,Non-Small Cell Lung Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT03237377,Tremelimumab,DRUG,Non-Small Cell Lung Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT03237377,Thoracic Radiation,RADIATION,Non-Small Cell Lung Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT03237377,lobectomy,PROCEDURE,Non-Small Cell Lung Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT03237377,Standard of care adjuvant chemotherapy,DRUG,Non-Small Cell Lung Cancer,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00947375,Lamictal TM,DRUG,Schizophrenia,phase4,TERMINATED,Central Mental Clinic for Outpatients of Baku City,
NCT00947375,Haloperidol Decanoate,DRUG,Schizophrenia,phase4,TERMINATED,Central Mental Clinic for Outpatients of Baku City,
NCT03706430,Pulse CO-Oximeter sensor,DEVICE,Surgery; Anesthesia,na,TERMINATED,Masimo Corporation,
NCT00796328,Phenylephrine infusion,DRUG,Spinal Induced Hypotension in Cesarean Delivery,phase4,TERMINATED,IWK Health Centre,
NCT04120467,Dance,OTHER,Stroke,na,TERMINATED,Anne-Violette Bruynnel,
NCT04120467,Standard rehabilitation,OTHER,Stroke,na,TERMINATED,Anne-Violette Bruynnel,
NCT04004000,Losmapimod,DRUG,Facioscapulohumeral Muscular Dystrophy 1,phase2,TERMINATED,Fulcrum Therapeutics,
NCT04172844,Azacitidine,DRUG,Acute Myelogenous Leukemia,phase1,TERMINATED,Medical College of Wisconsin,
NCT04172844,Venetoclax,DRUG,Acute Myelogenous Leukemia,phase1,TERMINATED,Medical College of Wisconsin,
NCT04172844,Pevonedistat,DRUG,Acute Myelogenous Leukemia,phase1,TERMINATED,Medical College of Wisconsin,
NCT01551095,PEGJ tube,DEVICE,GERD,phase2,TERMINATED,Johns Hopkins University,
NCT02703272,Ibrutinib,DRUG,"Lymphoma, Non-Hodgkin",phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02703272,Rituximab,DRUG,"Lymphoma, Non-Hodgkin",phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02703272,Ifosfamide,DRUG,"Lymphoma, Non-Hodgkin",phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02703272,Carboplatin,DRUG,"Lymphoma, Non-Hodgkin",phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02703272,Etoposide,DRUG,"Lymphoma, Non-Hodgkin",phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02703272,Vincristine,DRUG,"Lymphoma, Non-Hodgkin",phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02703272,Idarubicin,DRUG,"Lymphoma, Non-Hodgkin",phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT02703272,Dexamethasone,DRUG,"Lymphoma, Non-Hodgkin",phase3,TERMINATED,"Janssen Research & Development, LLC",
NCT01111539,Escitalopram,DRUG,Major Depressive Disorder (MDD),phase3,TERMINATED,"Otsuka Pharmaceutical Development & Commercialization, Inc.",
NCT01111539,Aripiprazole,DRUG,Major Depressive Disorder (MDD),phase3,TERMINATED,"Otsuka Pharmaceutical Development & Commercialization, Inc.",
NCT01111539,Blinded capsule,DRUG,Major Depressive Disorder (MDD),phase3,TERMINATED,"Otsuka Pharmaceutical Development & Commercialization, Inc.",
NCT01964339,BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.,OTHER,Obesity Hypoventilation Syndrome,na,TERMINATED,Philips Respironics,
NCT01964339,BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.,OTHER,Obesity Hypoventilation Syndrome,na,TERMINATED,Philips Respironics,
NCT01872377,CyberKnife® Stereotactic Body Radiotherapy(SBRT)Boost,RADIATION,Pancreatic Carcinoma Non-resectable,na,TERMINATED,Ottawa Hospital Research Institute,
NCT03787212,MiBo ThermoFlo,DEVICE,Dry Eye,na,TERMINATED,"Johnson & Johnson Vision Care, Inc.",
NCT03787212,Bruder Mask,DEVICE,Dry Eye,na,TERMINATED,"Johnson & Johnson Vision Care, Inc.",
NCT01937130,IDN-6556,DRUG,Acute on Chronic Hepatic Failure; Acute Liver Failure; Liver Cirrhosis; Acute Alcoholic Hepatitis,phase2,TERMINATED,Conatus Pharmaceuticals Inc.,
NCT01937130,Placebo,OTHER,Acute on Chronic Hepatic Failure; Acute Liver Failure; Liver Cirrhosis; Acute Alcoholic Hepatitis,phase2,TERMINATED,Conatus Pharmaceuticals Inc.,
NCT02362230,Icotinib,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,Sun Yat-sen University,
NCT03062007,BI-CON-02,DRUG,Metastatic Breast Cancer,phase1,TERMINATED,Biointegrator LLC,
NCT03806192,Telephone-Based Intervention,BEHAVIORAL,Acute Myeloid Leukemia,na,TERMINATED,University of Washington,
NCT03806192,"Behavioral, Psychological or Informational Intervention",OTHER,Acute Myeloid Leukemia,na,TERMINATED,University of Washington,
NCT03806192,Questionnaire Administration,OTHER,Acute Myeloid Leukemia,na,TERMINATED,University of Washington,
NCT03806244,Intraoperative acquisition (robotic c-Arm) of images,OTHER,Colorectal Cancer,na,TERMINATED,IHU Strasbourg,
NCT05049629,Lacrimera,DEVICE,Eye Diseases,na,TERMINATED,Vienna Institute for Research in Ocular Surgery,
NCT05049629,Hylo-Vision,DEVICE,Eye Diseases,na,TERMINATED,Vienna Institute for Research in Ocular Surgery,
NCT00944437,Helmet,DEVICE,"Respiratory Insufficiency; Respiratory Distress Syndrome, Adult; Chronic Obstructive Pulmonary Disease; Pulmonary Edema",na,TERMINATED,University of Parma,
NCT00944437,Full-face mask,DEVICE,"Respiratory Insufficiency; Respiratory Distress Syndrome, Adult; Chronic Obstructive Pulmonary Disease; Pulmonary Edema",na,TERMINATED,University of Parma,
NCT06397937,SHIFT team intervention,BEHAVIORAL,Stroke; Social Determinants of Health,na,TERMINATED,Columbia University,
NCT03316872,Pembrolizumab,DRUG,Hepatocellular Carcinoma,phase2,TERMINATED,"University Health Network, Toronto",
NCT03316872,Stereotactic Body Radiotherapy (SBRT),RADIATION,Hepatocellular Carcinoma,phase2,TERMINATED,"University Health Network, Toronto",
NCT01424475,Healthy,OTHER,Parkinson Disease,phase1,TERMINATED,GlaxoSmithKline,
NCT01424475,PKD Patients,OTHER,Parkinson Disease,phase1,TERMINATED,GlaxoSmithKline,
NCT03657212,Zolpidem,DRUG,Aging,phase4,TERMINATED,"University of California, Irvine",
NCT06012981,ACT,BEHAVIORAL,Compulsory Psychiatric Care Act; Psychosis; Acceptance & Commitment Therapy; Psychiatric Hospitalization; Psychiatric Disorder,na,TERMINATED,Uppsala University,
NCT01156519,Salivary Cortisol,OTHER,Obesity,na,TERMINATED,Nantes University Hospital,
NCT06337630,PLX038 + Tuvusertib,DRUG,Solid Tumor,phase1,TERMINATED,Institut Curie,
NCT05352230,Free style libre-2,DEVICE,Diabetes Mellitus; Kidney Transplant; Complications,na,TERMINATED,University of Alabama at Birmingham,
NCT00184067,Montanide ISA 51,BIOLOGICAL,Melanoma,phase2,TERMINATED,University of Southern California,
NCT00239200,Lapatinib,DRUG,Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus,phase2,TERMINATED,University of Michigan Rogel Cancer Center,
NCT05353400,Early urinary catheter removal,OTHER,Urinary Retention Postoperative,na,TERMINATED,Wake Forest University Health Sciences,
NCT05353400,Urinary catheter removal on POD 3,OTHER,Urinary Retention Postoperative,na,TERMINATED,Wake Forest University Health Sciences,
NCT05683600,Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001,BIOLOGICAL,COVID-19,phase3,TERMINATED,"Guangzhou Patronus Biotech Co., Ltd.",
NCT05683600,Placebo,BIOLOGICAL,COVID-19,phase3,TERMINATED,"Guangzhou Patronus Biotech Co., Ltd.",
NCT01628900,care management arm N°1 vs arm N°2,OTHER,Pyelonephritis,phase2,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01628900,Care management,OTHER,Pyelonephritis,phase2,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01305707,C-ECT,DEVICE,Depression,phase4,TERMINATED,Hospital Universitari de Bellvitge,
NCT01305707,PHARMACOTHERAPY,DRUG,Depression,phase4,TERMINATED,Hospital Universitari de Bellvitge,
NCT01097707,LY500307,DRUG,Benign Prostatic Hyperplasia,phase2,TERMINATED,Eli Lilly and Company,
NCT01097707,Placebo,DRUG,Benign Prostatic Hyperplasia,phase2,TERMINATED,Eli Lilly and Company,
NCT04333407,Aspirin 75mg,DRUG,COVID-19,na,TERMINATED,Imperial College London,
NCT04333407,Clopidogrel 75mg,DRUG,COVID-19,na,TERMINATED,Imperial College London,
NCT04333407,Rivaroxaban 2.5 MG,DRUG,COVID-19,na,TERMINATED,Imperial College London,
NCT04333407,Atorvastatin 40mg,DRUG,COVID-19,na,TERMINATED,Imperial College London,
NCT04333407,Omeprazole 20mg,DRUG,COVID-19,na,TERMINATED,Imperial College London,
NCT02279992,Vardenafil,DRUG,Glioma; Brain Neoplasms; Brain Metastasis,early_phase1,TERMINATED,Cedars-Sinai Medical Center,
NCT02279992,Carboplatin,DRUG,Glioma; Brain Neoplasms; Brain Metastasis,early_phase1,TERMINATED,Cedars-Sinai Medical Center,
NCT03668392,Asparaginase,DRUG,Acute Lymphoblastic Leukemia,phase2,TERMINATED,Gruppo Italiano Malattie EMatologiche dell'Adulto,
NCT01900795,V117957,DRUG,Postsurgical Pain Due to Third Molar Extraction,phase2,TERMINATED,Purdue Pharma LP,
NCT01900795,Ibuprofen,DRUG,Postsurgical Pain Due to Third Molar Extraction,phase2,TERMINATED,Purdue Pharma LP,
NCT01900795,Placebo,DRUG,Postsurgical Pain Due to Third Molar Extraction,phase2,TERMINATED,Purdue Pharma LP,
NCT06384495,REAL-A,PROCEDURE,Stroke,na,TERMINATED,University of Minnesota,
NCT06384495,REAL-C,PROCEDURE,Stroke,na,TERMINATED,University of Minnesota,
NCT06384495,SHAM,PROCEDURE,Stroke,na,TERMINATED,University of Minnesota,
NCT01101477,TCI titration by different Cet.,PROCEDURE,Flexible Bronchoscopy,na,TERMINATED,Chang Gung Memorial Hospital,
NCT02520557,Blood or Saliva,OTHER,SCAR,na,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT00581477,Droxidopa Oral Product,DRUG,Autonomic Nervous System Diseases; Orthostatic Hypotension; Dopamine Beta-Hydroxylase Deficiency; Orthostatic Intolerance,phase2; phase3,TERMINATED,Vanderbilt University,
NCT03144375,Medical optimization and education,OTHER,"Chronic Rhinosinusitis, Polyps",na,TERMINATED,University of Miami,
NCT03144375,Standard of Care sinus surgery,PROCEDURE,"Chronic Rhinosinusitis, Polyps",na,TERMINATED,University of Miami,
NCT02072057,Ruxolitinib,DRUG,Cancer Cachexia,phase2,TERMINATED,Kantonsspital Aarau,
NCT04363112,Mini Kid II,BEHAVIORAL,"Mental Disorder, Child",na,TERMINATED,"University Hospital, Brest",
NCT07012681,discharge training (oral and written brochure),OTHER,Intracranial Surgery,na,TERMINATED,Bahçeşehir University,
NCT07012681,discharge education (oral education),OTHER,Intracranial Surgery,na,TERMINATED,Bahçeşehir University,
NCT00796107,RG1507,DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT00796107,Letrozole,DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT00592007,Fulvestrant and Erlotinib,DRUG,Non Small Cell Lung Carcinoma,phase2,TERMINATED,"Lyudmila Bazhenova, M.D.",
NCT03234192,Therapeutic ultra sound,PROCEDURE,Lateral Epicondylitis; Tennis Elbow; Posterolateral Rotator Instability,na,TERMINATED,NYU Langone Health,
NCT03234192,Astym Treatment Technique,PROCEDURE,Lateral Epicondylitis; Tennis Elbow; Posterolateral Rotator Instability,na,TERMINATED,NYU Langone Health,
NCT03234192,Graston Treatment Technique,PROCEDURE,Lateral Epicondylitis; Tennis Elbow; Posterolateral Rotator Instability,na,TERMINATED,NYU Langone Health,
NCT00669136,AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost,DRUG,"Hepatocellular Carcinoma; Hepatoma; Liver Cancer, Adult; Liver Cell Carcinoma; Liver Cell Carcinoma, Adult; Cancer of Liver; Cancer of the Liver; Cancer, Hepatocellular; Hepatic Cancer; Hepatic Neopla",phase1,TERMINATED,"Lisa H. Butterfield, Ph.D.",
NCT04770246,TAS-117,DRUG,Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations; Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations,phase1,TERMINATED,"Taiho Oncology, Inc.",
NCT04770246,TAS-117,DRUG,Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations; Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations,phase1,TERMINATED,"Taiho Oncology, Inc.",
NCT04770246,TAS-117,DRUG,Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations; Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations,phase1,TERMINATED,"Taiho Oncology, Inc.",
NCT04770246,TAS-117,DRUG,Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations; Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations,phase1,TERMINATED,"Taiho Oncology, Inc.",
NCT04938388,Semaglutide Pill,DRUG,"Diabetes Mellitus, Type 2; Glucose Metabolism Disorders (Including Diabetes Mellitus)",phase4,TERMINATED,Sansum Diabetes Research Institute,
NCT04938388,Fresh organic vegetables,OTHER,"Diabetes Mellitus, Type 2; Glucose Metabolism Disorders (Including Diabetes Mellitus)",phase4,TERMINATED,Sansum Diabetes Research Institute,
NCT03646188,Placebo-containing MNA,DRUG,Basal Cell Carcinoma,phase1,TERMINATED,"SkinJect, Inc.",
NCT03646188,25 µg doxorubicin-containing MNA,DRUG,Basal Cell Carcinoma,phase1,TERMINATED,"SkinJect, Inc.",
NCT03646188,50 µg doxorubicin-containing MNA,DRUG,Basal Cell Carcinoma,phase1,TERMINATED,"SkinJect, Inc.",
NCT03646188,100 µg doxorubicin-containing MNA,DRUG,Basal Cell Carcinoma,phase1,TERMINATED,"SkinJect, Inc.",
NCT03646188,200 µg doxorubicin-containing MNA,DRUG,Basal Cell Carcinoma,phase1,TERMINATED,"SkinJect, Inc.",
NCT02070588,MRI,DEVICE,Mild Traumatic Brain Injury; Traumatic Brain Injury,na,TERMINATED,GE Healthcare,
NCT02782403,Axitinib,DRUG,Accelerated Phase Chronic Myelogenous Leukemia (CML); Blast Phase Chronic Myelogenous Leukemia (CML); Chronic Phase Phase Chronic Myelogenous Leukemia (CML); Philadelphia Chromosome Positive (Ph+) Pha,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02782403,Bosutinib,DRUG,Accelerated Phase Chronic Myelogenous Leukemia (CML); Blast Phase Chronic Myelogenous Leukemia (CML); Chronic Phase Phase Chronic Myelogenous Leukemia (CML); Philadelphia Chromosome Positive (Ph+) Pha,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02782403,Laboratory Biomarker Analysis,OTHER,Accelerated Phase Chronic Myelogenous Leukemia (CML); Blast Phase Chronic Myelogenous Leukemia (CML); Chronic Phase Phase Chronic Myelogenous Leukemia (CML); Philadelphia Chromosome Positive (Ph+) Pha,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02683161,Varenicline,DRUG,Cigarette Smoking; Obesity,phase2,TERMINATED,Johns Hopkins University,
NCT02683161,Contingency Management,BEHAVIORAL,Cigarette Smoking; Obesity,phase2,TERMINATED,Johns Hopkins University,
NCT02683161,Behavioral Counseling,BEHAVIORAL,Cigarette Smoking; Obesity,phase2,TERMINATED,Johns Hopkins University,
NCT05050461,Immunological analyses,OTHER,"Non-hodgkin Lymphoma,B Cell; Vaccination Failure",na,TERMINATED,Versailles Hospital,
NCT02081183,Mycophenolate mofetil (MMF),DRUG,Lupus Nephritis,phase3,TERMINATED,Hoffmann-La Roche,
NCT02081183,"Cyclophosphamide, Maintenance Phase",DRUG,Lupus Nephritis,phase3,TERMINATED,Hoffmann-La Roche,
NCT02081183,"Cyclophosphamide, Induction Phase",DRUG,Lupus Nephritis,phase3,TERMINATED,Hoffmann-La Roche,
NCT02081183,Prednisone,DRUG,Lupus Nephritis,phase3,TERMINATED,Hoffmann-La Roche,
NCT00753441,Surgical bypass,PROCEDURE,Pancreatic Cancer,na,TERMINATED,Heidelberg University,
NCT00753441,Endoscopic stenting,PROCEDURE,Pancreatic Cancer,na,TERMINATED,Heidelberg University,
NCT01320566,AeriSeal System,DEVICE,Pulmonary Emphysema; Chronic Obstructive Pulmonary Disease(COPD); Lung Diseases,phase2; phase3,TERMINATED,Aeris Therapeutics,
NCT01720056,Verapamil,DRUG,Keloid Scars,phase4,TERMINATED,The University of Western Australia,
NCT01720056,Kenalog 10,DRUG,Keloid Scars,phase4,TERMINATED,The University of Western Australia,
NCT00117351,VELCADE,DRUG,"Carcinoma, Non-Small-Cell Lung; Adenocarcinoma, Bronchiolo-Alveolar",phase2,TERMINATED,"Millennium Pharmaceuticals, Inc.",
NCT01624337,DHA-piperaquine,DRUG,Malaria,na,TERMINATED,"Armed Forces Research Institute of Medical Sciences, Thailand",
NCT01624337,placebo,DRUG,Malaria,na,TERMINATED,"Armed Forces Research Institute of Medical Sciences, Thailand",
NCT02831595,"GKS Prime Flex Bioloy by Permedica, a TiNbN coated fixed-bearing cruciate-retaining total knee prosthesis",DEVICE,Knee Arthritis,na,TERMINATED,Permedica spa,
NCT00975039,WST11,DRUG,Cholangiocarcinoma,phase2,TERMINATED,Steba Biotech S.A.,
NCT04839601,RNS System,DEVICE,Epilepsy; Partial Seizure; Neurostimulator; Complications; Drug Resistant Epilepsy; Focal Epilepsy,na,TERMINATED,NeuroPace,
NCT03717012,Nintedanib,DRUG,Idiopathic Pulmonary Fibrosis,phase4,TERMINATED,Boehringer Ingelheim,
NCT03717012,Pulmonary rehabilitation program,OTHER,Idiopathic Pulmonary Fibrosis,phase4,TERMINATED,Boehringer Ingelheim,
NCT00310830,Bosentan,DRUG,Pulmonary Hypertension,phase3,TERMINATED,Actelion,
NCT00843830,tumoral irradiation,RADIATION,Metastatic Pancreatic Carcinoma,phase1,TERMINATED,University of Michigan Rogel Cancer Center,
NCT00843830,Dendritic cell vaccination,BIOLOGICAL,Metastatic Pancreatic Carcinoma,phase1,TERMINATED,University of Michigan Rogel Cancer Center,
NCT00267527,CJC 1295,DRUG,Obesity; HIV Infections,phase2,TERMINATED,ConjuChem,
NCT00142727,Methadone,DRUG,Opioid-Related Disorders,phase2,TERMINATED,National Institute on Drug Abuse (NIDA),
NCT00142727,Full opioid agonist,DRUG,Opioid-Related Disorders,phase2,TERMINATED,National Institute on Drug Abuse (NIDA),
NCT00142727,Partial opioid agonist,DRUG,Opioid-Related Disorders,phase2,TERMINATED,National Institute on Drug Abuse (NIDA),
NCT00142727,Opioid antagonist,DRUG,Opioid-Related Disorders,phase2,TERMINATED,National Institute on Drug Abuse (NIDA),
NCT03705273,Dexamethasone IV for PO,DRUG,Asthma; Croup,phase4,TERMINATED,Vanderbilt University Medical Center,
NCT03705273,Dexamethasone crushed tablets,DRUG,Asthma; Croup,phase4,TERMINATED,Vanderbilt University Medical Center,
NCT01038141,Surgery for advanced haemorrhoidal disease,PROCEDURE,Symptomatic Haemorrhoidal Disease,na,TERMINATED,"University Hospital, Akershus",
NCT03357354,collective workshop,BEHAVIORAL,Obesity,na,TERMINATED,Assistance Publique Hopitaux De Marseille,
NCT02169505,Brentuximab Vedotin,DRUG,Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00636805,Palonosetron (Aloxi) and Dexamethasone,DRUG,Brain Cancer,phase2,TERMINATED,Duke University,
NCT04247594,Voxelotor,DRUG,Sickle Cell Disease,phase2,TERMINATED,Pfizer,
NCT02276794,Thrust Manipulation,OTHER,Low Back Pain; Mechanical Low Back Pain; Backache,na,TERMINATED,Federal University of Health Science of Porto Alegre,
NCT02276794,Non-thrust manipulation (NTM),OTHER,Low Back Pain; Mechanical Low Back Pain; Backache,na,TERMINATED,Federal University of Health Science of Porto Alegre,
NCT03198156,Transcranial Direct Current Stimulation,DEVICE,Hypersomnia,na,TERMINATED,Ohio State University,
NCT03198156,Sham stimulation,DEVICE,Hypersomnia,na,TERMINATED,Ohio State University,
NCT05613322,Resistell Phenotech,OTHER,Bacteremia Sepsis,na,TERMINATED,Resistell AG,
NCT01419522,Gait Training Method,OTHER,Traumatic Brain Injury; Walking Impairment; Gait Training,phase3,TERMINATED,National Institutes of Health Clinical Center (CC),
NCT05016622,BNT162b2 vaccine,BIOLOGICAL,Cancer,phase2,TERMINATED,Montefiore Medical Center,
NCT00287651,Pulsatile IV Insulin,PROCEDURE,"Diabetes Mellitus, With Complications",phase2; phase3,TERMINATED,Florida Atlantic University,
NCT00287651,Effects of Pulsatile IV Insulin on Diabetic Retinopathy,PROCEDURE,"Diabetes Mellitus, With Complications",phase2; phase3,TERMINATED,Florida Atlantic University,
NCT00287651,Effects of Pulsatile IV Insulin on Diabetic Retinopathy,PROCEDURE,"Diabetes Mellitus, With Complications",phase2; phase3,TERMINATED,Florida Atlantic University,
NCT01016951,AZD9164 Turbuhaler®,DRUG,Healthy; COPD,phase1,TERMINATED,AstraZeneca,
NCT01016951,Placebo Turbuhaler®,DRUG,Healthy; COPD,phase1,TERMINATED,AstraZeneca,
NCT01098331,Radical Prostatectomy,PROCEDURE,Prostate Cancer,na,TERMINATED,University of Southampton,
NCT01098331,Brachytherapy,PROCEDURE,Prostate Cancer,na,TERMINATED,University of Southampton,
NCT00623753,"EnvDNA, PolyEnv1, EnvPro",BIOLOGICAL,HIV Infections,phase1,TERMINATED,St. Jude Children's Research Hospital,
NCT05052372,Balversa,DRUG,Bladder Cancer; Urothelial Carcinoma; Transitional Cell Carcinoma; Platinum-Resistant Urothelial Carcinoma; Bladder Urothelial Carcinoma; FGFR Mutation; FGFR2 Gene Mutation; FGFR3 Gene Mutation; FGFR2,na,TERMINATED,xCures,
NCT05004077,AMIODARONE,DRUG,Atrial Fibrillation,phase4,TERMINATED,"Kevin W Hatton, MD, PhD",
NCT05748457,Non-manualised family therapy.,BEHAVIORAL,Anorexia Nervosa; Atypical Anorexia Nervosa,na,TERMINATED,"University Hospital, Akershus",
NCT05748457,Family Based Treatment,BEHAVIORAL,Anorexia Nervosa; Atypical Anorexia Nervosa,na,TERMINATED,"University Hospital, Akershus",
NCT03334812,LNA043,BIOLOGICAL,Knee Cartilage Lesion,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT03334812,placebo to LNA043,BIOLOGICAL,Knee Cartilage Lesion,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT05737212,500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq,RADIATION,Recurrent High-grade Glioma; Recurrent Glioblastoma; Recurrent Anaplastic Astrocytoma; Recurrent Anaplastic Oligodendroglioma,phase1; phase2,TERMINATED,"Dawonmedax Co., Ltd.",
NCT05737212,500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 11Gy-Eq,RADIATION,Recurrent High-grade Glioma; Recurrent Glioblastoma; Recurrent Anaplastic Astrocytoma; Recurrent Anaplastic Oligodendroglioma,phase1; phase2,TERMINATED,"Dawonmedax Co., Ltd.",
NCT05737212,500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 13Gy-Eq,RADIATION,Recurrent High-grade Glioma; Recurrent Glioblastoma; Recurrent Anaplastic Astrocytoma; Recurrent Anaplastic Oligodendroglioma,phase1; phase2,TERMINATED,"Dawonmedax Co., Ltd.",
NCT05366842,Stravix lyopreserved placental tissue (LPT),DRUG,Prostate Cancer,phase2,TERMINATED,Johns Hopkins University,
NCT05366842,Radical prostatectomy,PROCEDURE,Prostate Cancer,phase2,TERMINATED,Johns Hopkins University,
NCT03110354,DS-3201b,DRUG,"Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Acute",phase1,TERMINATED,Daiichi Sankyo,
NCT03537222,Myeloma Patient Outcome Scale (MyPOS),OTHER,Multiple Myeloma,na,TERMINATED,Zurich University of Applied Sciences,
NCT02227329,Ethanol,DRUG,Catheter-related Bloodstream Infection (CRBSI) Nos; Bloodstream Infection Due to Central Venous Catheter; Bloodstream Infection Due to Hickman Catheter,phase1; phase2,TERMINATED,Mayo Clinic,
NCT02227329,Heparin Lock,DRUG,Catheter-related Bloodstream Infection (CRBSI) Nos; Bloodstream Infection Due to Central Venous Catheter; Bloodstream Infection Due to Hickman Catheter,phase1; phase2,TERMINATED,Mayo Clinic,
NCT02227329,Normal Saline,DRUG,Catheter-related Bloodstream Infection (CRBSI) Nos; Bloodstream Infection Due to Central Venous Catheter; Bloodstream Infection Due to Hickman Catheter,phase1; phase2,TERMINATED,Mayo Clinic,
NCT00348829,mitral valve repair,PROCEDURE,Chronic Heart Failure; Mitral Insufficiency,phase2,TERMINATED,University of Leipzig,
NCT01912872,Omalizumab,DRUG,Severe IgE-mediated Asthma,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT01912872,Budesonide,DRUG,Severe IgE-mediated Asthma,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT01912872,Formoterol,DRUG,Severe IgE-mediated Asthma,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT01912872,Budesonide,DRUG,Severe IgE-mediated Asthma,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT01912872,Formoterol,DRUG,Severe IgE-mediated Asthma,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT02626377,Support provided by social worker,BEHAVIORAL,Breast Cancer; Colorectal Cancer; Prostate Cancer; Alzheimer Disease; Age-related Macular Degeneration; Parkinson Disease; Cardiac Disease; Ischemic Stroke; Hemorrhagic Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Besancon,
NCT02626377,Information booklet receipt,OTHER,Breast Cancer; Colorectal Cancer; Prostate Cancer; Alzheimer Disease; Age-related Macular Degeneration; Parkinson Disease; Cardiac Disease; Ischemic Stroke; Hemorrhagic Stroke,na,TERMINATED,Centre Hospitalier Universitaire de Besancon,
NCT04673175,Ceftolozane / Tazobactam Injection,DRUG,Pneumonia; Hematologic Malignancy; Pseudomonas Aeruginosa Infection; Bacteremia; Hematopoietic Stem Cell Transplant (HSCT),phase4,TERMINATED,Weill Medical College of Cornell University,
NCT01019512,questionnaire administration,OTHER,Breast Cancer; Lymphedema,na,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT01019512,lymphedema management,OTHER,Breast Cancer; Lymphedema,na,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT04316481,AngelMed Guardian System,DEVICE,Acute Coronary Syndrome,na,TERMINATED,Angel Medical Systems,
NCT01762488,Ablation of the renal arteries,PROCEDURE,Hypertension,phase3,TERMINATED,Henrik Vase,
NCT01762488,Renal angiography,PROCEDURE,Hypertension,phase3,TERMINATED,Henrik Vase,
NCT00167661,Campath-1H,DRUG,Disorder Related to Renal Transplantation,phase1; phase2,TERMINATED,"University of Wisconsin, Madison",
NCT01086761,MP0112,BIOLOGICAL,Wet Age-Related Macular Degeneration,phase1,TERMINATED,Allergan,
NCT01500161,Busulfan,DRUG,Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkins Disease; Non-Hodgkins Lymphoma; Aplastic Anemia; Multiple Myeloma; Myelodys,phase2,TERMINATED,Texas Oncology Cancer Center,
NCT01500161,Clofarabine,DRUG,Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkins Disease; Non-Hodgkins Lymphoma; Aplastic Anemia; Multiple Myeloma; Myelodys,phase2,TERMINATED,Texas Oncology Cancer Center,
NCT01500161,Fludarabine,DRUG,Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkins Disease; Non-Hodgkins Lymphoma; Aplastic Anemia; Multiple Myeloma; Myelodys,phase2,TERMINATED,Texas Oncology Cancer Center,
NCT01500161,Melphalan,DRUG,Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkins Disease; Non-Hodgkins Lymphoma; Aplastic Anemia; Multiple Myeloma; Myelodys,phase2,TERMINATED,Texas Oncology Cancer Center,
NCT01500161,Carmustine,DRUG,Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkins Disease; Non-Hodgkins Lymphoma; Aplastic Anemia; Multiple Myeloma; Myelodys,phase2,TERMINATED,Texas Oncology Cancer Center,
NCT01500161,Etoposide,DRUG,Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkins Disease; Non-Hodgkins Lymphoma; Aplastic Anemia; Multiple Myeloma; Myelodys,phase2,TERMINATED,Texas Oncology Cancer Center,
NCT01500161,Cytarabine,DRUG,Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkins Disease; Non-Hodgkins Lymphoma; Aplastic Anemia; Multiple Myeloma; Myelodys,phase2,TERMINATED,Texas Oncology Cancer Center,
NCT01221961,Masimo Radical-7,DEVICE,Major Spine Surgery Procedure,na,TERMINATED,Cedars-Sinai Medical Center,
NCT05199142,SDI-118,DRUG,Cognitive Decline,phase1,TERMINATED,Syndesi Therapeutics,
NCT05199142,Placebo,DRUG,Cognitive Decline,phase1,TERMINATED,Syndesi Therapeutics,
NCT01826370,Linagliptin,DRUG,"Diabetes Mellitus, Type 2",na,TERMINATED,Boehringer Ingelheim,
NCT05062083,11C-MC1,DRUG,Multiple Sclerosis,phase2,TERMINATED,National Institute of Mental Health (NIMH),
NCT05062083,11C-PS13,DRUG,Multiple Sclerosis,phase2,TERMINATED,National Institute of Mental Health (NIMH),
NCT05062083,Ketoprofen,DRUG,Multiple Sclerosis,phase2,TERMINATED,National Institute of Mental Health (NIMH),
NCT05062083,Celecoxib,DRUG,Multiple Sclerosis,phase2,TERMINATED,National Institute of Mental Health (NIMH),
NCT01491594,Eltrombopag,DRUG,"Sarcoma, Soft Tissue; Osteosarcoma; Neoplasms, Connective and Soft Tissue",phase1,TERMINATED,Duke University,
NCT03849456,GWP42006,DRUG,Autism Spectrum Disorder,phase2,TERMINATED,Jazz Pharmaceuticals,
NCT02511756,Computed tomography X-ray system,DEVICE,Metastatic Colorectal Cancer,na,TERMINATED,Patrick Veit-Haibach,
NCT03568253,Caries treatment,OTHER,Caries,na,TERMINATED,"University Hospital, Montpellier",
NCT03568253,Caries treatment,OTHER,Caries,na,TERMINATED,"University Hospital, Montpellier",
NCT01587053,therapeutic education program,OTHER,Cardio-vascular Diseases,na,TERMINATED,"University Hospital, Montpellier",
NCT01664637,10 mg TZP-102,DRUG,Diabetic Gastroparesis,phase2,TERMINATED,"Tranzyme, Inc.",
NCT01664637,Placebo,DRUG,Diabetic Gastroparesis,phase2,TERMINATED,"Tranzyme, Inc.",
NCT00739037,Placebo,DRUG,Alzheimer Disease,phase1,TERMINATED,Wyeth is now a wholly owned subsidiary of Pfizer,
NCT00739037,PAZ-417,DRUG,Alzheimer Disease,phase1,TERMINATED,Wyeth is now a wholly owned subsidiary of Pfizer,
NCT01764139,Blood sampling,PROCEDURE,Knee Pain,na,TERMINATED,Dr. S R Thanthulage,
NCT02553239,CoolLoop®,DEVICE,"Atrial Fibrillation (Paroxysmal); Arrhythmias, Cardiac; Cardiovascular Diseases; Heart Diseases; Pathologic Processes",na,TERMINATED,afreeze GmbH,
NCT06055777,SZEY-2108 for injetion,DRUG,Infections,phase1,TERMINATED,"Suzhou Erye Pharmaceutical Co., Ltd.",
NCT06055777,Placebo,DRUG,Infections,phase1,TERMINATED,"Suzhou Erye Pharmaceutical Co., Ltd.",
NCT02949375,Placebo Comparator,DRUG,Chronic Liver Disease,phase2,TERMINATED,"GRI Bio Operations, Inc.",
NCT02949375,Active Comparator:4.5mg GRI-0621,DRUG,Chronic Liver Disease,phase2,TERMINATED,"GRI Bio Operations, Inc.",
NCT02949375,Active Comparator: 6.0mg GRI-0621,DRUG,Chronic Liver Disease,phase2,TERMINATED,"GRI Bio Operations, Inc.",
NCT03062657,PRESTIGE LP™ Cervical Disc,DEVICE,Cervical Degenerative Disc Disease; Radiculopathy; Myelopathy,na,TERMINATED,Medtronic Spinal and Biologics,
NCT03101501,Mitomycin c,DRUG,Presbyopia,phase4,TERMINATED,Key-Whitman Eye Center,
NCT03101501,Raindrop Near Vision Inlay,DEVICE,Presbyopia,phase4,TERMINATED,Key-Whitman Eye Center,
NCT00915681,Silibinin,DRUG,Amatoxin Poisoning; Amanita Poisoning; Mushroom Poisoning; Liver Failure,phase2,TERMINATED,"Mylan Specialty, LP",
NCT03980262,"Healthy Children, Healthy Families+ (HCHF+)",BEHAVIORAL,Obesity,na,TERMINATED,Virginia Polytechnic Institute and State University,
NCT03980262,Money Smart,BEHAVIORAL,Obesity,na,TERMINATED,Virginia Polytechnic Institute and State University,
NCT04029688,Idasanutlin,DRUG,Acute Myeloid Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Neuroblastoma; Solid Tumors,phase1; phase2,TERMINATED,Hoffmann-La Roche,
NCT04029688,Venetoclax,DRUG,Acute Myeloid Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Neuroblastoma; Solid Tumors,phase1; phase2,TERMINATED,Hoffmann-La Roche,
NCT04029688,Cyclophosphamide,DRUG,Acute Myeloid Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Neuroblastoma; Solid Tumors,phase1; phase2,TERMINATED,Hoffmann-La Roche,
NCT04029688,Topotecan,DRUG,Acute Myeloid Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Neuroblastoma; Solid Tumors,phase1; phase2,TERMINATED,Hoffmann-La Roche,
NCT04029688,Fludarabine,DRUG,Acute Myeloid Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Neuroblastoma; Solid Tumors,phase1; phase2,TERMINATED,Hoffmann-La Roche,
NCT04029688,Cytarabine,DRUG,Acute Myeloid Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Neuroblastoma; Solid Tumors,phase1; phase2,TERMINATED,Hoffmann-La Roche,
NCT04029688,Intrathecal Chemotherapy,DRUG,Acute Myeloid Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Neuroblastoma; Solid Tumors,phase1; phase2,TERMINATED,Hoffmann-La Roche,
NCT04961827,Self-efficacy based images through instant messaging,BEHAVIORAL,Cancer,na,TERMINATED,The University of Hong Kong,
NCT04961827,Knowledge based images through instant messaging,BEHAVIORAL,Cancer,na,TERMINATED,The University of Hong Kong,
NCT00464061,Volinanserin,DRUG,Sleep Initiation and Maintenance Disorders,phase3,TERMINATED,Sanofi,
NCT00464061,Placebo,DRUG,Sleep Initiation and Maintenance Disorders,phase3,TERMINATED,Sanofi,
NCT02041442,Electrical mapping of the urinary bladder,PROCEDURE,Electrical Evaluation of Urinary Bladder,na,TERMINATED,Englewood Hospital and Medical Center,
NCT00283842,DVS SR,DRUG,Diabetic Neuropathies; Pain,phase3,TERMINATED,Wyeth is now a wholly owned subsidiary of Pfizer,
NCT00283842,Placebo,DRUG,Diabetic Neuropathies; Pain,phase3,TERMINATED,Wyeth is now a wholly owned subsidiary of Pfizer,
NCT00349986,Insuline glargine,DRUG,"Diabetes Mellitus, Type 2",phase4,TERMINATED,Sanofi,
NCT05682170,ZN-d5 ZN-c3,DRUG,Acute Myeloid Leukemia (AML),phase1; phase2,TERMINATED,"K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.",
NCT05682170,ZN-c3,DRUG,Acute Myeloid Leukemia (AML),phase1; phase2,TERMINATED,"K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.",
NCT03378973,Dexmedetomidine,DRUG,Spinal Fusion,phase4,TERMINATED,"Hospital for Special Surgery, New York",
NCT04216173,Acupuncture,OTHER,Post-Traumatic Headache; Traumatic Brain Injury,na,TERMINATED,University of Washington,
NCT02067741,CR1447,DRUG,Metastatic Breast Adenocarcinoma; Breast Cancer,phase2,TERMINATED,Swiss Cancer Institute,
NCT00872794,DePuy ASR™ Hip System,DEVICE,Rheumatoid Arthritis; Osteoarthritis; Post-traumatic Arthritis; Collagen Disorders; Avascular Necrosis; Nonunion of Femoral Fractures; Congenital Hip Dysplasia; Slipped Capital Femoral Epiphysis,phase4,TERMINATED,DePuy International,
NCT00575822,NDO Full-thickness Plicator,DEVICE,Gastroesophageal Reflux Disease (GERD),na,TERMINATED,"NDO Surgical, Inc.",
NCT00575822,Sham Control,DEVICE,Gastroesophageal Reflux Disease (GERD),na,TERMINATED,"NDO Surgical, Inc.",
NCT04955951,polarized light,DEVICE,Chronic Atopic Dermatitis,na,TERMINATED,Ahram Canadian University,
NCT04955951,Topical corticosteroid ointment,DRUG,Chronic Atopic Dermatitis,na,TERMINATED,Ahram Canadian University,
NCT00005856,oxaliplatin,DRUG,Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00005856,pharmacological study,OTHER,Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT02262429,ONS QIP,OTHER,Malnutrition,na,TERMINATED,Abbott Nutrition,
NCT02262429,ONS Standard Feeding,OTHER,Malnutrition,na,TERMINATED,Abbott Nutrition,
NCT00589329,erythromycin and metronidazole (antibiotics),DRUG,Length of Pregnancy Prolongation in Hours,na,TERMINATED,MetroHealth Medical Center,
NCT00589329,placebo,DRUG,Length of Pregnancy Prolongation in Hours,na,TERMINATED,MetroHealth Medical Center,
NCT02956629,Uprifosbuvir,DRUG,Hepatitis C,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT02956629,Ruzasvir,DRUG,Hepatitis C,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT02956629,Ribavirin,DRUG,Hepatitis C,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00085631,cisplatin,DRUG,Cervical Cancer,phase3,TERMINATED,Mark Dewhirst,
NCT00085631,hyperthermia treatment,PROCEDURE,Cervical Cancer,phase3,TERMINATED,Mark Dewhirst,
NCT00085631,brachytherapy,RADIATION,Cervical Cancer,phase3,TERMINATED,Mark Dewhirst,
NCT00085631,external beam radiation therapy,RADIATION,Cervical Cancer,phase3,TERMINATED,Mark Dewhirst,
NCT02322853,Tamoxifen,DRUG,Postmenopausal; Metastatic Breast Cancer,phase2,TERMINATED,Centre Francois Baclesse,
NCT02322853,Ralimetinib (LY2228820 dimesylate),DRUG,Postmenopausal; Metastatic Breast Cancer,phase2,TERMINATED,Centre Francois Baclesse,
NCT01493453,"aCD19z cells, IL2, pre conditioning Cyclophosphamide & Fludarabine",OTHER,CD19 Positive Non-Hodgkin Lymphoma,phase1,TERMINATED,The Christie NHS Foundation Trust,
NCT00133172,Tacrolimus,DRUG,Kidney Transplantation,phase4,TERMINATED,Astellas Pharma Inc,
NCT00133172,mycophenolate mofetil,DRUG,Kidney Transplantation,phase4,TERMINATED,Astellas Pharma Inc,
NCT00133172,Prednisone,DRUG,Kidney Transplantation,phase4,TERMINATED,Astellas Pharma Inc,
NCT00794339,64Cu-ATSM,DRUG,Cervical Cancer,phase2,TERMINATED,American College of Radiology,
NCT00794339,FDG,DRUG,Cervical Cancer,phase2,TERMINATED,American College of Radiology,
NCT02192541,Ziv-Aflibercept,DRUG,Neoplasms,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02192541,Ganetespib,DRUG,Neoplasms,phase1,TERMINATED,National Cancer Institute (NCI),
NCT04824794,GEN3014,BIOLOGICAL,Relapsed or Refractory Multiple Myeloma (RRMM); Diffuse Large B Cell Lymphoma (DLBCL); Acute Myeloid Leukemia (AML),phase1; phase2,TERMINATED,Genmab,
NCT04824794,Daratumumab,DRUG,Relapsed or Refractory Multiple Myeloma (RRMM); Diffuse Large B Cell Lymphoma (DLBCL); Acute Myeloid Leukemia (AML),phase1; phase2,TERMINATED,Genmab,
NCT07039929,INCB000631,DRUG,Healthy Participants,phase1,TERMINATED,Incyte Corporation,
NCT07039929,Placebo,DRUG,Healthy Participants,phase1,TERMINATED,Incyte Corporation,
NCT04837131,Ixazomib,DRUG,Systemic Sclerosis; Scleroderma; Diffuse Systemic Sclerosis; Diffuse Scleroderma; Diffuse Cutaneous Systemic Sclerosis; Diffuse Cutaneous Scleroderma; Progressive Systemic Sclerosis; Progressive Scler,phase2,TERMINATED,Michael M. Pham,
NCT03556202,Mirikizumab,DRUG,Psoriasis,phase3,TERMINATED,Eli Lilly and Company,
NCT02749045,SPECT imaging,RADIATION,Coronary Artery Disease,na,TERMINATED,Prem Soman,
NCT00667277,bevacizumab (Avastin),DRUG,Myelofibrosis,phase2,TERMINATED,Ronald Hoffman,
NCT02503501,Insulin glulisine,DRUG,Mild Cognitive Impairment; Alzheimer's Disease (AD),phase2,TERMINATED,HealthPartners Institute,
NCT02503501,Placebo,DRUG,Mild Cognitive Impairment; Alzheimer's Disease (AD),phase2,TERMINATED,HealthPartners Institute,
NCT04701281,Intra-arterial LIOX + Capecitabine,OTHER,Liver Metastasis Colon Cancer,phase1; phase2,TERMINATED,AllVascular,
NCT02160288,Botulinum Toxin-A,DRUG,Obstructed Defecation Syndrome (ODS),phase2,TERMINATED,Massachusetts General Hospital,
NCT02160288,Normal Saline,DRUG,Obstructed Defecation Syndrome (ODS),phase2,TERMINATED,Massachusetts General Hospital,
NCT01124227,icodextrin,DRUG,Congestive Heart Failure,phase3,TERMINATED,Martini Hospital Groningen,
NCT04954742,Riociguat,DRUG,Primary Pulmonary Arterial Hypertension; Chronic Thromboembolic Pulmonary Hypertension,phase4,TERMINATED,Heidelberg University,
NCT00879073,Bendamustine,DRUG,Brain Metastases,phase1,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT05676905,Neocement,DEVICE,Bone Deformity,na,TERMINATED,Bioceramed,
NCT00473005,Capecitabine,DRUG,Breast Cancer,phase1,TERMINATED,Stanford University,
NCT00473005,RAD001,DRUG,Breast Cancer,phase1,TERMINATED,Stanford University,
NCT02175654,Regorafenib,DRUG,Colorectal Neoplasms; Metastatic Disease,phase2,TERMINATED,Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD),
NCT00176956,Skin Biopsy,PROCEDURE,Dermatitis,phase3,TERMINATED,"Hordinsky, Maria K., MD",
NCT05612529,"US , Echocardiography",DEVICE,Septic Shock,na,TERMINATED,Assiut University,
NCT01803945,AVE8112,DRUG,Parkinson's Disease,phase1,TERMINATED,Michael J. Fox Foundation for Parkinson's Research,
NCT01803945,Placebo,DRUG,Parkinson's Disease,phase1,TERMINATED,Michael J. Fox Foundation for Parkinson's Research,
NCT01196845,cPAP,DEVICE,Decrease of Inflammation of Adipose Tissue; Sleep Apnea Syndrome,na,TERMINATED,"University Hospital, Grenoble",
NCT01196845,cPAP,DEVICE,Decrease of Inflammation of Adipose Tissue; Sleep Apnea Syndrome,na,TERMINATED,"University Hospital, Grenoble",
NCT01196845,cPAP,DEVICE,Decrease of Inflammation of Adipose Tissue; Sleep Apnea Syndrome,na,TERMINATED,"University Hospital, Grenoble",
NCT01196845,cPAP,DEVICE,Decrease of Inflammation of Adipose Tissue; Sleep Apnea Syndrome,na,TERMINATED,"University Hospital, Grenoble",
NCT04181762,secukinumab,DRUG,Lupus Nephritis,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT04181762,Placebo,DRUG,Lupus Nephritis,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT00257946,Repair of CDH w/SIS Gold,PROCEDURE,Congenital Diaphragmatic Hernia,phase3,TERMINATED,Children's Mercy Hospital Kansas City,
NCT00257946,Repair of CDH w/Alloderm,PROCEDURE,Congenital Diaphragmatic Hernia,phase3,TERMINATED,Children's Mercy Hospital Kansas City,
NCT03995927,Data collection and analysis,OTHER,Malignant Disease; Metastasis,na,TERMINATED,Wake Forest University Health Sciences,
NCT03995927,Quality of Life Questionnaire,OTHER,Malignant Disease; Metastasis,na,TERMINATED,Wake Forest University Health Sciences,
NCT00946283,Lactobacillus rhamnosus GG,OTHER,Breast Cancer; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblasto,na,TERMINATED,"Rutgers, The State University of New Jersey",
NCT03002454,99mTc MDP Injection:neutron-bombardment,DRUG,Cancer of Bone,phase3,TERMINATED,University of Manitoba,
NCT00580905,Adenosine,DRUG,Inflammation,phase1,TERMINATED,Vanderbilt University,
NCT00580905,Sodium Nitroprusside,DRUG,Inflammation,phase1,TERMINATED,Vanderbilt University,
NCT00580905,Adenosine,DRUG,Inflammation,phase1,TERMINATED,Vanderbilt University,
NCT01603394,pregabalin,DRUG,Postherpetic Neuralgia,phase4,TERMINATED,Pfizer,
NCT04264156,Lucinactant for Inhalation,OTHER,"Respiratory Distress Syndrome, Newborn",phase2,TERMINATED,Windtree Therapeutics,
NCT04264156,nCPAP Only,OTHER,"Respiratory Distress Syndrome, Newborn",phase2,TERMINATED,Windtree Therapeutics,
NCT03438851,NeuroCatch Platform™,DEVICE,Brain Injuries,na,TERMINATED,NeuroCatch Inc.,
NCT00352651,Pregabalin,DRUG,Herpes Zoster; Postherpetic Neuralgia,phase2,TERMINATED,"University of California, San Francisco",
NCT04000529,TNO155,DRUG,Non-small Cell Lung Carcinoma; Head and Neck Squamous Cell Carcinoma; Esophageal SCC; Gastrointestinal Stromal Tumors; Colorectal Cancer,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT04000529,Spartalizumab,DRUG,Non-small Cell Lung Carcinoma; Head and Neck Squamous Cell Carcinoma; Esophageal SCC; Gastrointestinal Stromal Tumors; Colorectal Cancer,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT04000529,Ribociclib,DRUG,Non-small Cell Lung Carcinoma; Head and Neck Squamous Cell Carcinoma; Esophageal SCC; Gastrointestinal Stromal Tumors; Colorectal Cancer,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT01350102,Bacitracin,DRUG,"Diabetes, Type 1; Diabetes, Type 2; Foot Ulcer, Diabetic",phase4,TERMINATED,Susan Hassenbein,
NCT01350102,AmeriGel®,DRUG,"Diabetes, Type 1; Diabetes, Type 2; Foot Ulcer, Diabetic",phase4,TERMINATED,Susan Hassenbein,
NCT01350102,Vitamin C,OTHER,"Diabetes, Type 1; Diabetes, Type 2; Foot Ulcer, Diabetic",phase4,TERMINATED,Susan Hassenbein,
NCT03401853,Laboratory Biomarker Analysis,OTHER,Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma,phase2,TERMINATED,University of Washington,
NCT03401853,Pembrolizumab,BIOLOGICAL,Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma,phase2,TERMINATED,University of Washington,
NCT03401853,Rituximab,BIOLOGICAL,Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma,phase2,TERMINATED,University of Washington,
NCT03401853,Obinutuzumab,BIOLOGICAL,Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma,phase2,TERMINATED,University of Washington,
NCT03444753,BMS-986299,DRUG,Advanced Cancer,phase1,TERMINATED,Bristol-Myers Squibb,
NCT03444753,Nivolumab,BIOLOGICAL,Advanced Cancer,phase1,TERMINATED,Bristol-Myers Squibb,
NCT03444753,Ipilimumab,BIOLOGICAL,Advanced Cancer,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01017653,Irinotecan,DRUG,Malignant Glioma of Brain,phase2,TERMINATED,Annick Desjardins,
NCT01017653,Panitumumab,DRUG,Malignant Glioma of Brain,phase2,TERMINATED,Annick Desjardins,
NCT02374853,Vancomycin,DRUG,INFECTION,phase2,TERMINATED,University of Alberta,
NCT02374853,No Vancomycin,OTHER,INFECTION,phase2,TERMINATED,University of Alberta,
NCT01774253,Vismodegib,DRUG,Pontine Glioma,phase2,TERMINATED,Giselle Sholler,
NCT01944839,E10030,DRUG,Age-Related Macular Degeneration,phase3,TERMINATED,Ophthotech Corporation,
NCT01944839,ranibizumab,DRUG,Age-Related Macular Degeneration,phase3,TERMINATED,Ophthotech Corporation,
NCT01944839,E10030 sham intravitreal injection,DRUG,Age-Related Macular Degeneration,phase3,TERMINATED,Ophthotech Corporation,
NCT00480077,"Programming (CRT-D, ICD OptiVol® and Cardiac Compass® )",DEVICE,Heart Failure,phase4,TERMINATED,Medtronic Cardiac Rhythm and Heart Failure,
NCT03266575,Pulmonary Rehabilitation Exercise,BEHAVIORAL,End Stage Liver Disease,na,TERMINATED,Mayo Clinic,
NCT03266575,Home Based Exercise,BEHAVIORAL,End Stage Liver Disease,na,TERMINATED,Mayo Clinic,
NCT05256875,"chemical adherence test, medication adherence questionnaire, pharmacy refill rate",OTHER,"Diabetes Mellitus, Type 2; Hypertension; Medication Adherence",na,TERMINATED,University of Leicester,
NCT00002796,fluorouracil,DRUG,Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00002796,sodium phenylbutyrate,DRUG,Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00002796,indomethacin,DRUG,Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00002796,recombinant interferon gamma,BIOLOGICAL,Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT01642862,Simvastatin,DRUG,Celiac Disease,phase1,TERMINATED,University of Zurich,
NCT03195088,BI 473494,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT03195088,Placebo,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT00616642,rosiglitazone maleate,DRUG,Brain and Central Nervous System Tumors,phase2,TERMINATED,Jonsson Comprehensive Cancer Center,
NCT05267470,Bemarituzumab,DRUG,Squamous-Cell Non-Small-Cell Lung Cancer,phase1,TERMINATED,Amgen,
NCT05267470,Docetaxel,DRUG,Squamous-Cell Non-Small-Cell Lung Cancer,phase1,TERMINATED,Amgen,
NCT05267470,Pembrolizumab,DRUG,Squamous-Cell Non-Small-Cell Lung Cancer,phase1,TERMINATED,Amgen,
NCT05267470,Carboplatin,DRUG,Squamous-Cell Non-Small-Cell Lung Cancer,phase1,TERMINATED,Amgen,
NCT05267470,Paclitaxel,DRUG,Squamous-Cell Non-Small-Cell Lung Cancer,phase1,TERMINATED,Amgen,
NCT05267470,Nab-paclitaxel,DRUG,Squamous-Cell Non-Small-Cell Lung Cancer,phase1,TERMINATED,Amgen,
NCT01980173,Routine care,PROCEDURE,Postpartum Hemorrhage,na,TERMINATED,Centre Hospitalier Universitaire de Nīmes,
NCT01980173,Bakri balloon,DEVICE,Postpartum Hemorrhage,na,TERMINATED,Centre Hospitalier Universitaire de Nīmes,
NCT01574573,"Self support, group sessions",BEHAVIORAL,GERD; Obesity,na,TERMINATED,Midwest Biomedical Research Foundation,
NCT00775541,Vitamin C,OTHER,Type 2 Diabetes,na,TERMINATED,"In-Young Choi, Ph.D.",
NCT00871741,GSK2202083A vaccine,BIOLOGICAL,Tetanus; Poliomyelitis; Neisseria Meningitidis; Haemophilus Influenzae Type b; Diphtheria; Acellular Pertussis; Hepatitis B,phase2,TERMINATED,GlaxoSmithKline,
NCT00871741,Infanrix hexa,BIOLOGICAL,Tetanus; Poliomyelitis; Neisseria Meningitidis; Haemophilus Influenzae Type b; Diphtheria; Acellular Pertussis; Hepatitis B,phase2,TERMINATED,GlaxoSmithKline,
NCT00871741,Menjugate,BIOLOGICAL,Tetanus; Poliomyelitis; Neisseria Meningitidis; Haemophilus Influenzae Type b; Diphtheria; Acellular Pertussis; Hepatitis B,phase2,TERMINATED,GlaxoSmithKline,
NCT01703754,Ad-RTS-hIL-12 and Veledimex,OTHER,Breast Cancer Nos Metastatic Recurrent,phase2,TERMINATED,Alaunos Therapeutics,
NCT01703754,Palifosfamide,DRUG,Breast Cancer Nos Metastatic Recurrent,phase2,TERMINATED,Alaunos Therapeutics,
NCT00616122,cyclophosphamide,DRUG,Breast Cancer,phase1; phase2,TERMINATED,"University of California, San Francisco",
NCT00616122,methotrexate,DRUG,Breast Cancer,phase1; phase2,TERMINATED,"University of California, San Francisco",
NCT00616122,sunitinib malate,DRUG,Breast Cancer,phase1; phase2,TERMINATED,"University of California, San Francisco",
NCT00616122,laboratory biomarker analysis,OTHER,Breast Cancer,phase1; phase2,TERMINATED,"University of California, San Francisco",
NCT00705822,Docetaxel + Estramustine + Hydrocortisone,DRUG,Prostatic Neoplasms,phase3,TERMINATED,Sanofi,
NCT00705822,Docetaxel + Prednisone,DRUG,Prostatic Neoplasms,phase3,TERMINATED,Sanofi,
NCT02225951,Nutritional product,OTHER,Gestational Diabetes Mellitus in Pregnancy,na,TERMINATED,"Danone Asia Pacific Holdings Pte, Ltd.",
NCT02225951,Standard breakfast according to ADA recommendations,OTHER,Gestational Diabetes Mellitus in Pregnancy,na,TERMINATED,"Danone Asia Pacific Holdings Pte, Ltd.",
NCT01223651,two step hyperinsulinaemic glucose clamp study.,PROCEDURE,"Diabetes Mellitus, Type 1",na,TERMINATED,The Royal Bournemouth Hospital,
NCT02764229,LYC-30937-EC,DRUG,"Colitis, Ulcerative",phase2,TERMINATED,Lycera Corp.,
NCT01574131,Fenofibrate,DRUG,Second or Third Degree Burns,phase4,TERMINATED,"The University of Texas Medical Branch, Galveston",
NCT01574131,Sugar Pill,DRUG,Second or Third Degree Burns,phase4,TERMINATED,"The University of Texas Medical Branch, Galveston",
NCT02440737,Educational Intervention,OTHER,Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT02440737,Follow-Up Care,OTHER,Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT02440737,Psychosocial Assessment and Care,PROCEDURE,Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT02440737,Questionnaire Administration,OTHER,Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT03507972,ankle ultrasound,RADIATION,Ankle Trauma,na,TERMINATED,"University Hospital, Lille",
NCT03507972,Member MRI,RADIATION,Ankle Trauma,na,TERMINATED,"University Hospital, Lille",
NCT04746339,Apixaban 2.5 MG,DRUG,Covid19; Thrombosis,phase4,TERMINATED,Brazilian Clinical Research Institute,
NCT04746339,Placebo,DRUG,Covid19; Thrombosis,phase4,TERMINATED,Brazilian Clinical Research Institute,
NCT02343939,Entospletinib,DRUG,Acute Myeloid Leukemia,phase1; phase2,TERMINATED,Gilead Sciences,
NCT02343939,Daunorubicin,DRUG,Acute Myeloid Leukemia,phase1; phase2,TERMINATED,Gilead Sciences,
NCT02343939,Cytarabine,DRUG,Acute Myeloid Leukemia,phase1; phase2,TERMINATED,Gilead Sciences,
NCT02343939,Decitabine,DRUG,Acute Myeloid Leukemia,phase1; phase2,TERMINATED,Gilead Sciences,
NCT02343939,Azacitidine,DRUG,Acute Myeloid Leukemia,phase1; phase2,TERMINATED,Gilead Sciences,
NCT02653196,Allogeneic hematopoietic stem cell transplant following thiotepa-based marrow ablative chemotherapy,PROCEDURE,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT02653196,Keratinocyte Growth Factor,DRUG,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT02653196,Alemtuzumab,DRUG,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT02653196,Thiotepa,DRUG,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT02653196,Etoposide,DRUG,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT02653196,Fludarabine,DRUG,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT02653196,Melphalan,DRUG,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT02653196,Tacrolimus,DRUG,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT02653196,Cyclosporine A,DRUG,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT02653196,Mycophenolate mofetil,DRUG,Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation,early_phase1,TERMINATED,Montefiore Medical Center,
NCT03339388,Enhanced Lithotripsy System,DEVICE,Urinary Stone,na,TERMINATED,Avvio Medical,
NCT01874288,DI-Leu16-IL2,DRUG,B-cell Non-Hodgkin Lymphoma,phase1; phase2,TERMINATED,"Alopexx Oncology, LLC",
NCT04064827,Paricalcitol,DRUG,Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism (SHPT),phase3,TERMINATED,AbbVie,
NCT02496286,Intraperitoneal Bevacizumab,DRUG,Malignant Ascites,phase1,TERMINATED,Eastern Regional Medical Center,
NCT01337154,Tamibarotene,DRUG,Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion; Stage IV Non-small Cell Lung Cancer,phase2,TERMINATED,CytRx,
NCT01337154,Placebo,DRUG,Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion; Stage IV Non-small Cell Lung Cancer,phase2,TERMINATED,CytRx,
NCT04079205,Wearable Device(exoRehab),DEVICE,Anterior Cruciate Ligament Reconstruction,na,TERMINATED,Seoul National University Bundang Hospital,
NCT04079205,Home rehabilitation program,BEHAVIORAL,Anterior Cruciate Ligament Reconstruction,na,TERMINATED,Seoul National University Bundang Hospital,
NCT01058005,BG00002 (natalizumab),DRUG,Relapsing Remitting Multiple Sclerosis,phase3,TERMINATED,Biogen,
NCT01058005,interferon beta-1a,DRUG,Relapsing Remitting Multiple Sclerosis,phase3,TERMINATED,Biogen,
NCT01058005,glatiramer acetate,DRUG,Relapsing Remitting Multiple Sclerosis,phase3,TERMINATED,Biogen,
NCT04987294,ALLN-346,DRUG,Hyperuricemia; Gout; Chronic Kidney Diseases,phase2,TERMINATED,Allena Pharmaceuticals,
NCT04987294,Placebo,DRUG,Hyperuricemia; Gout; Chronic Kidney Diseases,phase2,TERMINATED,Allena Pharmaceuticals,
NCT02253394,Ambrisentan plus Spironolactone,DRUG,Pulmonary Arterial Hypertension,phase4,TERMINATED,Brigham and Women's Hospital,
NCT02253394,Ambrisentan plus Placebo,DRUG,Pulmonary Arterial Hypertension,phase4,TERMINATED,Brigham and Women's Hospital,
NCT04608266,Camostat Mesylate,DRUG,Covid19,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04608266,Placebo,DRUG,Covid19,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT03948529,eltrombopag,DRUG,Leukemia; Graft Failure,phase2,TERMINATED,"University Hospital, Lille",
NCT03578029,RGN-137,DRUG,Junctional Epidermolysis Bullosa; Dystrophic Epidermolysis Bullosa,phase2,TERMINATED,"Lenus Therapeutics, LLC",
NCT03578029,Placebo,DRUG,Junctional Epidermolysis Bullosa; Dystrophic Epidermolysis Bullosa,phase2,TERMINATED,"Lenus Therapeutics, LLC",
NCT02160431,CBT for pediatric OCD,BEHAVIORAL,Obsessive Compulsive Disorder (OCD),na,TERMINATED,University of Texas at Austin,
NCT00809302,aplindore MR tablets or Placebo,DRUG,Early Parkinson Disease,phase2,TERMINATED,Neurogen Corporation,
NCT00537511,Pomalidomide,DRUG,"Carcinoma, Small Cell",phase1; phase2,TERMINATED,Celgene,
NCT00537511,Cisplatin,DRUG,"Carcinoma, Small Cell",phase1; phase2,TERMINATED,Celgene,
NCT00537511,Etoposide,DRUG,"Carcinoma, Small Cell",phase1; phase2,TERMINATED,Celgene,
NCT01408836,Plasma exchange,PROCEDURE,Wegener's Granulomatosis; Microscopic Polyangiitis,phase2; phase3,TERMINATED,Cambridge University Hospitals NHS Foundation Trust,
NCT01408836,Intravenous methyl prednisolone,DRUG,Wegener's Granulomatosis; Microscopic Polyangiitis,phase2; phase3,TERMINATED,Cambridge University Hospitals NHS Foundation Trust,
NCT01408836,Methyl prednisolone,DRUG,Wegener's Granulomatosis; Microscopic Polyangiitis,phase2; phase3,TERMINATED,Cambridge University Hospitals NHS Foundation Trust,
NCT02537964,washcloths impregnated with 2% chlorhexidine gluconate,OTHER,Infectious Disease Transmission,na,TERMINATED,Shaare Zedek Medical Center,
NCT03528564,Iron sucrose,DRUG,"Anemia, Iron Deficiency; Anemia of Chronic Disease; Hip Arthropathy; Knee Arthropathy",phase2,TERMINATED,Unity Health Toronto,
NCT03528564,Epoetin Alfa,DRUG,"Anemia, Iron Deficiency; Anemia of Chronic Disease; Hip Arthropathy; Knee Arthropathy",phase2,TERMINATED,Unity Health Toronto,
NCT03528564,Placebo,DRUG,"Anemia, Iron Deficiency; Anemia of Chronic Disease; Hip Arthropathy; Knee Arthropathy",phase2,TERMINATED,Unity Health Toronto,
NCT00448864,Ecallantide,DRUG,"Blood Loss, Surgical",phase2,TERMINATED,"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
NCT00448864,Placebo,DRUG,"Blood Loss, Surgical",phase2,TERMINATED,"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
NCT01337609,Ganeden BC30,DRUG,Major Depressive Disorder; Irritable Bowel Syndrome,phase4,TERMINATED,Massachusetts General Hospital,
NCT01337609,Placebo (sugar pill),OTHER,Major Depressive Disorder; Irritable Bowel Syndrome,phase4,TERMINATED,Massachusetts General Hospital,
NCT01337609,"Ganeden BC30, Placebo (sugar pill)",OTHER,Major Depressive Disorder; Irritable Bowel Syndrome,phase4,TERMINATED,Massachusetts General Hospital,
NCT05302609,SclerFIX,BIOLOGICAL,Scleral Thinning,phase2,TERMINATED,TBF Genie Tissulaire,
NCT05411263,"Comprehensive transthoracic echocardiography, Doppler echography & Kino-cardiograph (Kino)",OTHER,Congestion; Heart Failure; Right Heart Catheterisation; Central Venous Pressure; Doppler Echocardiography,na,TERMINATED,Vrije Universiteit Brussel,
NCT03511521,NPH Insulin,DRUG,"Hyperglycemia Steroid-induced; Insulin Resistance, Diabetes",phase4,TERMINATED,Northwestern University,
NCT03511521,glargine,DRUG,"Hyperglycemia Steroid-induced; Insulin Resistance, Diabetes",phase4,TERMINATED,Northwestern University,
NCT03511521,Insulin Aspart,DRUG,"Hyperglycemia Steroid-induced; Insulin Resistance, Diabetes",phase4,TERMINATED,Northwestern University,
NCT00657449,valdecoxib,DRUG,Acute Pain,phase4,TERMINATED,Pfizer,
NCT00657449,rofecoxib,DRUG,Acute Pain,phase4,TERMINATED,Pfizer,
NCT02964338,Fremanezumab,DRUG,Chronic Cluster Headache,phase3,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT02964338,Placebo,DRUG,Chronic Cluster Headache,phase3,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT00802048,Local anesthetic (Ropivacaine),DRUG,Hyperalgesia; Pain,phase3,TERMINATED,"University Hospital, Bordeaux",
NCT00802048,Saline,DRUG,Hyperalgesia; Pain,phase3,TERMINATED,"University Hospital, Bordeaux",
NCT04613648,Imaging,OTHER,Adhesive Capsulitis of the Shoulder; Hemiplegia,na,TERMINATED,Izmir Katip Celebi University,
NCT04278755,Drospirenone-Ethinyl Estradiol Oral Tablet,DRUG,Bulimia Nervosa; Binge Eating; Eating Disorders; Binge-Eating Disorder,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT00802685,Early ibuprofen,DRUG,Patent Ductus Arteriosus,na,TERMINATED,University of Miami,
NCT00802685,Late ibuprofen expectant group (placebo),OTHER,Patent Ductus Arteriosus,na,TERMINATED,University of Miami,
NCT00426985,Ketoprofen Topical Patch 20%,DRUG,Tendonitis; Bursitis,phase3,TERMINATED,Endo Pharmaceuticals,
NCT01186185,Fludrocortisone,DRUG,"Hearing Loss, Sensorineural",early_phase1,TERMINATED,Oregon Health and Science University,
NCT03671135,TCA Intrastromal Inlay,OTHER,Presbyopia,na,TERMINATED,"Allotex, Inc.",
NCT00194935,Topotecan,DRUG,Ovarian Cancer,phase2,TERMINATED,Weill Medical College of Cornell University,
NCT03088735,Blastocyst-stage embryo transfer strategy,PROCEDURE,"Oocyte Donation; Infertility, Female; Embryo Transfer",na,TERMINATED,Fundacion Dexeus,
NCT03088735,Cleavage-stage embryo transfer strategy,PROCEDURE,"Oocyte Donation; Infertility, Female; Embryo Transfer",na,TERMINATED,Fundacion Dexeus,
NCT02503735,Sofosbuvir/Ledipasvir FDC,DRUG,Hepatitis C; Chronic Kidney Disease,na,TERMINATED,Massachusetts General Hospital,
NCT05500508,AMXT1501,DRUG,Cancer; Solid Tumor; Solid Carcinoma; Advanced Cancer; DIPG Brain Tumor; Ovary Cancer; Breast Cancer; Papillary Thyroid Cancer; Head and Neck Cancer; Gastric Cancer; Nsclc; Mesotheliomas Pleural; Meso,phase1; phase2,TERMINATED,"Aminex Therapeutics, Inc.",
NCT05500508,DFMO,DRUG,Cancer; Solid Tumor; Solid Carcinoma; Advanced Cancer; DIPG Brain Tumor; Ovary Cancer; Breast Cancer; Papillary Thyroid Cancer; Head and Neck Cancer; Gastric Cancer; Nsclc; Mesotheliomas Pleural; Meso,phase1; phase2,TERMINATED,"Aminex Therapeutics, Inc.",
NCT02882334,Finger Force Manipulandum,DEVICE,Dystonic Disorders,na,TERMINATED,Fondation Ophtalmologique Adolphe de Rothschild,
NCT02882334,Conventional physiotherapy,OTHER,Dystonic Disorders,na,TERMINATED,Fondation Ophtalmologique Adolphe de Rothschild,
NCT02115464,Metformin plus Chemo-radiotherapy,DRUG,Lung Cancer,phase2,TERMINATED,Ontario Clinical Oncology Group (OCOG),
NCT02115464,Chemo-radiotherapy,RADIATION,Lung Cancer,phase2,TERMINATED,Ontario Clinical Oncology Group (OCOG),
NCT05978063,difelikefalin 2.0 mg tablets,DRUG,Pruritus; Notalgia Paresthetica,phase2; phase3,TERMINATED,"Cara Therapeutics, Inc.",
NCT05978063,difelikefalin 1.0 mg tablets,DRUG,Pruritus; Notalgia Paresthetica,phase2; phase3,TERMINATED,"Cara Therapeutics, Inc.",
NCT05978063,difelikefalin 0.25 mg tablets,DRUG,Pruritus; Notalgia Paresthetica,phase2; phase3,TERMINATED,"Cara Therapeutics, Inc.",
NCT05978063,Placebo tablets,DRUG,Pruritus; Notalgia Paresthetica,phase2; phase3,TERMINATED,"Cara Therapeutics, Inc.",
NCT04030793,Individualized transcranial direct current stimulation,DEVICE,Healthy Adults; Healthy Aging,na,TERMINATED,Samsung Medical Center,
NCT04030793,Conventional transcranial direct current stimulation,DEVICE,Healthy Adults; Healthy Aging,na,TERMINATED,Samsung Medical Center,
NCT02891616,fludeoxyglucose F 18,DRUG,Melanoma,phase1,TERMINATED,Washington University School of Medicine,
NCT02891616,Positron emission tomography-computed tomography,DEVICE,Melanoma,phase1,TERMINATED,Washington University School of Medicine,
NCT02891616,18F-fluorothymidine,DRUG,Melanoma,phase1,TERMINATED,Washington University School of Medicine,
NCT02891616,Positron emission tomography-magnetic resonance imaging,DEVICE,Melanoma,phase1,TERMINATED,Washington University School of Medicine,
NCT06306716,RENASYS Film with AIRLOCK Technology,DEVICE,Chronic Wounds; Acute Wounds,na,TERMINATED,"Smith & Nephew, Inc.",
NCT01043406,Seizure Advisory System,DEVICE,Epilepsy,phase1,TERMINATED,NeuroVista Corporation,
NCT04542304,Metolazone,DRUG,Chronic Kidney Disease; End Stage Renal Disease,phase2,TERMINATED,Stanford University,
NCT04542304,Placebo,DRUG,Chronic Kidney Disease; End Stage Renal Disease,phase2,TERMINATED,Stanford University,
NCT02461784,Semen & Data Collection,PROCEDURE,Inflammatory Bowel Disease (IBD),na,TERMINATED,"University of Wisconsin, Madison",
NCT00427947,ropivacaine/placebo,DRUG,Phantom Limb; Leg Amputation,phase3,TERMINATED,"University Hospital, Bordeaux",
NCT03530449,OCT Angiography,DEVICE,Retinal Vascular; Normal Eyes,na,TERMINATED,Heidelberg Engineering GmbH,
NCT03530449,Color Fundus Photography,DEVICE,Retinal Vascular; Normal Eyes,na,TERMINATED,Heidelberg Engineering GmbH,
NCT03530449,Optical Coherence Tomography,DEVICE,Retinal Vascular; Normal Eyes,na,TERMINATED,Heidelberg Engineering GmbH,
NCT00611858,Cetuximab,DRUG,Rectal Cancer,phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT00611858,5-Fluorouracil,DRUG,Rectal Cancer,phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT00611858,Radiation,RADIATION,Rectal Cancer,phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT02170948,Dexmedetomidine,DRUG,Anesthesia,na,TERMINATED,"University Health Network, Toronto",
NCT04071626,Ertugliflozin 5 mg,DRUG,"Heart Failure, Diastolic; Diabetes Mellitus, Type 2",phase4,TERMINATED,University Hospitals Cleveland Medical Center,
NCT04071626,Placebo oral tablet,DRUG,"Heart Failure, Diastolic; Diabetes Mellitus, Type 2",phase4,TERMINATED,University Hospitals Cleveland Medical Center,
NCT01050426,"UFT, Leucovorin",OTHER,Pancreatic Cancer,phase2,TERMINATED,Royal Marsden NHS Foundation Trust,
NCT01050426,UFT/ Leucovorin + Cetuximab + Radiotherapy,OTHER,Pancreatic Cancer,phase2,TERMINATED,Royal Marsden NHS Foundation Trust,
NCT00003926,amifostine trihydrate,DRUG,Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Chordoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma,phase1,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00003926,busulfan,DRUG,Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Chordoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma,phase1,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00003926,filgrastim,DRUG,Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Chordoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma,phase1,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00003926,melphalan,DRUG,Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Chordoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma,phase1,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00003926,thiotepa,DRUG,Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Chordoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma,phase1,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00003926,peripheral blood stem cell transplantation (PBSC),PROCEDURE,Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Chordoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma,phase1,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT01679535,nutrition and hygiene education,BEHAVIORAL,Child Nutrition Disorders,na,TERMINATED,University of New Mexico,
NCT02410343,TV-1106,DRUG,Growth Hormone Deficiency,phase3,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT02410343,Placebo,DRUG,Growth Hormone Deficiency,phase3,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT05003908,AlloRx,BIOLOGICAL,Diabetes,phase1,TERMINATED,The Foundation for Orthopaedics and Regenerative Medicine,
NCT02028325,Fluorescein Sodium,DRUG,Adult Intracranial Neoplasm; Vascular: Intracranial,phase4,TERMINATED,Indiana University,
NCT03199040,Durvalumab,DRUG,Triple Negative Breast Cancer; Triple Negative Breast Neoplasms; TNBC - Triple-Negative Breast Cancer; Triple-negative Breast Carcinoma,phase1,TERMINATED,Washington University School of Medicine,
NCT03199040,Neoantigen DNA vaccine,BIOLOGICAL,Triple Negative Breast Cancer; Triple Negative Breast Neoplasms; TNBC - Triple-Negative Breast Cancer; Triple-negative Breast Carcinoma,phase1,TERMINATED,Washington University School of Medicine,
NCT03199040,TDS-IM system (Inchor Medical Systems),DEVICE,Triple Negative Breast Cancer; Triple Negative Breast Neoplasms; TNBC - Triple-Negative Breast Cancer; Triple-negative Breast Carcinoma,phase1,TERMINATED,Washington University School of Medicine,
NCT03199040,Peripheral blood draw,PROCEDURE,Triple Negative Breast Cancer; Triple Negative Breast Neoplasms; TNBC - Triple-Negative Breast Cancer; Triple-negative Breast Carcinoma,phase1,TERMINATED,Washington University School of Medicine,
NCT03941834,Rimegepant,DRUG,Trigeminal Neuralgia,phase2,TERMINATED,Pfizer,
NCT03941834,Placebo,DRUG,Trigeminal Neuralgia,phase2,TERMINATED,Pfizer,
NCT04543409,Benralizumab,BIOLOGICAL,Eosinophilic Esophagitis,phase3,TERMINATED,AstraZeneca,
NCT04543409,Matching placebo,BIOLOGICAL,Eosinophilic Esophagitis,phase3,TERMINATED,AstraZeneca,
NCT02245087,Atorvastatin,DRUG,Coronary Artery Disease,phase2,TERMINATED,"University Health Network, Toronto",
NCT02566421,Laboratory Biomarker Analysis,OTHER,Metastatic Neoplasm; Recurrent Neoplasm; Recurrent Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer; Unr,na,TERMINATED,Wake Forest University Health Sciences,
NCT02566421,Quality-of-Life Assessment,OTHER,Metastatic Neoplasm; Recurrent Neoplasm; Recurrent Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer; Unr,na,TERMINATED,Wake Forest University Health Sciences,
NCT02566421,Targeted Therapy,OTHER,Metastatic Neoplasm; Recurrent Neoplasm; Recurrent Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer; Unr,na,TERMINATED,Wake Forest University Health Sciences,
NCT00315614,Islet Transplantation and Bone Marrow,BIOLOGICAL,Type 1 Diabetes Mellitus,phase2,TERMINATED,University of Miami,
NCT00565916,Estrogen,DRUG,Postmenopausal Syndrome,na,TERMINATED,Washington University School of Medicine,
NCT00565916,Progesterone,DRUG,Postmenopausal Syndrome,na,TERMINATED,Washington University School of Medicine,
NCT00565916,Placebo,DRUG,Postmenopausal Syndrome,na,TERMINATED,Washington University School of Medicine,
NCT03565406,Mocetinostat Induction Phase + Ipilimumab + Nivolumab,DRUG,Melanoma,phase1,TERMINATED,NYU Langone Health,
NCT03565406,Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab,DRUG,Melanoma,phase1,TERMINATED,NYU Langone Health,
NCT03018704,Topiramate,DRUG,Alcohol Use Disorder,phase4,TERMINATED,VA Office of Research and Development,
NCT03018704,placebo,DRUG,Alcohol Use Disorder,phase4,TERMINATED,VA Office of Research and Development,
NCT00416884,Campath,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT00416884,Fludarabine,DRUG,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT00416884,Total Body Irradiation (TBI),RADIATION,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT00416884,T-Cell Deplete,OTHER,Leukemia,phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT00700947,Beta-blocker therapy (TOPROL-XL® ),DRUG,Heart Disease; Mitral Regurgitation; Heart Valve Disease; Mitral Valve Insufficiency,phase1,TERMINATED,Wake Forest University Health Sciences,
NCT03829449,rVA576,DRUG,Paroxysmal Nocturnal Hemoglobinuria,phase3,TERMINATED,AKARI Therapeutics,
NCT01636648,Aortic Valve Replacement,DEVICE,Aortic Valve Stenosis; Aortic Valve Insufficiency,na,TERMINATED,Medtronic Cardiac Rhythm and Heart Failure,
NCT00003508,Antineoplaston therapy (Atengenal + Astugenal),DRUG,Malignant Mesothelioma,phase2,TERMINATED,Burzynski Research Institute,
NCT02580708,Rociletinib,DRUG,Non-small Cell Lung Cancer,phase1; phase2,TERMINATED,"Clovis Oncology, Inc.",
NCT02580708,Trametinib,DRUG,Non-small Cell Lung Cancer,phase1; phase2,TERMINATED,"Clovis Oncology, Inc.",
NCT00834899,Eptifibatide,DRUG,Sickle Cell Disease,phase1; phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT00834899,Placebo,DRUG,Sickle Cell Disease,phase1; phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT00617721,Blood withdrawal,OTHER,Unexplained Isolated Provoked Hemorrhages; Familial Bleeding Disorder; Scott Syndrome,na,TERMINATED,"University Hospital, Strasbourg, France",
NCT00762814,Gait tests with and without the use of a tactile sensory cue (electrical stimulation using a TENS unit),DEVICE,Parkinson Disease,early_phase1,TERMINATED,Washington University School of Medicine,
NCT02416414,QuantiFERON Monitor Assay,DEVICE,Cell-mediated Immune Response,na,TERMINATED,"QIAGEN Gaithersburg, Inc",
NCT02416414,Existing methodology,DEVICE,Cell-mediated Immune Response,na,TERMINATED,"QIAGEN Gaithersburg, Inc",
NCT05938816,Mindfulness-Based Stress Reduction (MBSR),BEHAVIORAL,Ptsd,na,TERMINATED,Oregon Health and Science University,
NCT05938816,Health and Wellness Education (HWE),BEHAVIORAL,Ptsd,na,TERMINATED,Oregon Health and Science University,
NCT06524804,BY101298 Capsules,DRUG,"Solid Tumor, Adult",phase1; phase2,TERMINATED,"Chengdu Baiyu Pharmaceutical Co., Ltd.",
NCT06524804,palliative radiotherapy,RADIATION,"Solid Tumor, Adult",phase1; phase2,TERMINATED,"Chengdu Baiyu Pharmaceutical Co., Ltd.",
NCT06524804,BY101298 Capsules,DRUG,"Solid Tumor, Adult",phase1; phase2,TERMINATED,"Chengdu Baiyu Pharmaceutical Co., Ltd.",
NCT06524804,curative radiotherapy,RADIATION,"Solid Tumor, Adult",phase1; phase2,TERMINATED,"Chengdu Baiyu Pharmaceutical Co., Ltd.",
NCT01238133,Carboplatin,DRUG,Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast C,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01238133,Gamma-Secretase Inhibitor RO4929097,DRUG,Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast C,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01238133,Laboratory Biomarker Analysis,OTHER,Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast C,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01238133,Paclitaxel,DRUG,Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast C,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01238133,Pharmacological Study,OTHER,Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast C,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01238133,Therapeutic Conventional Surgery,PROCEDURE,Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast C,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02579733,Azathioprine,DRUG,Ulcerative Colitis,phase4,TERMINATED,Kyungpook National University Hospital,
NCT02579733,Placebo,DRUG,Ulcerative Colitis,phase4,TERMINATED,Kyungpook National University Hospital,
NCT02894333,behavioral observation,BEHAVIORAL,Parkinson Disease,na,TERMINATED,Fondation Ophtalmologique Adolphe de Rothschild,
NCT03201952,Ursodeoxycholic Acid,DRUG,Glucose Intolerance; Gastric Bypass Surgery,phase1,TERMINATED,Vanderbilt University Medical Center,
NCT03201952,Placebos,DRUG,Glucose Intolerance; Gastric Bypass Surgery,phase1,TERMINATED,Vanderbilt University Medical Center,
NCT01662349,MOE Antimicrobial Plasma Treatment System,DEVICE,Acne Vulgaris,na,TERMINATED,Moe Medical Devices,
NCT00347438,Capecitabine,DRUG,Breast Cancer,phase2,TERMINATED,University of Chicago,
NCT01796548,Oxybutinin Extended-Release,DRUG,"Detrusor Function, Overactive",phase4,TERMINATED,"Janssen-Cilag Ltd.,Thailand",
NCT02187848,SAR408701,DRUG,Neoplasm Malignant,phase1,TERMINATED,Sanofi,
NCT03173326,General anesthesia,PROCEDURE,Knee Arthroscopy; General Anesthesia; Subarachnoid Block,na,TERMINATED,Vanderbilt University Medical Center,
NCT03173326,Subarachnoid block,PROCEDURE,Knee Arthroscopy; General Anesthesia; Subarachnoid Block,na,TERMINATED,Vanderbilt University Medical Center,
NCT04365985,Naltrexone,DRUG,COVID-19; Acute Respiratory Distress Syndrome; Severe Acute Respiratory Syndrome (SARS); Coronavirus Infections,phase2,TERMINATED,Corewell Health East,
NCT04365985,Ketamine,DRUG,COVID-19; Acute Respiratory Distress Syndrome; Severe Acute Respiratory Syndrome (SARS); Coronavirus Infections,phase2,TERMINATED,Corewell Health East,
NCT04365985,Placebo,OTHER,COVID-19; Acute Respiratory Distress Syndrome; Severe Acute Respiratory Syndrome (SARS); Coronavirus Infections,phase2,TERMINATED,Corewell Health East,
NCT02285543,TPF induction chemotherapy,DRUG,"Mouth Neoplasms; Carcinoma, Squamous Cell",phase2,TERMINATED,Shanghai Jiao Tong University School of Medicine,
NCT02285543,surgery,PROCEDURE,"Mouth Neoplasms; Carcinoma, Squamous Cell",phase2,TERMINATED,Shanghai Jiao Tong University School of Medicine,
NCT02285543,radiotherapy,RADIATION,"Mouth Neoplasms; Carcinoma, Squamous Cell",phase2,TERMINATED,Shanghai Jiao Tong University School of Medicine,
NCT05473715,"Aflibercept(BAY86-5321, Eylea)",DRUG,Neovascular (Wet) Age-related Macular Degeneration,phase4,TERMINATED,Bayer,
NCT04628715,RSA biofeedback,DEVICE,Autism Spectrum Disorder,na,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT02177825,Imatinib Mesylate,DRUG,Plexiform Neurofibromas,phase2,TERMINATED,St. Justine's Hospital,
NCT00127517,peptide-nucleic acid solution AVR118,DRUG,Cancer,phase2,TERMINATED,Advanced Viral Research Corp,
NCT05262517,Rimegepant,DRUG,Temporomandibular Disorders (TMD),phase3,TERMINATED,Pfizer,
NCT05262517,Placebo,DRUG,Temporomandibular Disorders (TMD),phase3,TERMINATED,Pfizer,
NCT02985840,Ondansetron,DRUG,Nausea; Abdominal Pain,phase4,TERMINATED,OhioHealth,
NCT02985840,Dexamethasone,DRUG,Nausea; Abdominal Pain,phase4,TERMINATED,OhioHealth,
NCT01143350,Bras A (EHPAD Training and stimulation),OTHER,Alzheimer's Disease,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT01143350,EHPAD Control,OTHER,Alzheimer's Disease,na,TERMINATED,Centre Hospitalier Universitaire de Nice,
NCT02106091,AFM11,DRUG,Relapsed B-Cell Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma,phase1,TERMINATED,Affimed GmbH,
NCT01488864,Applied Relaxation (AR),BEHAVIORAL,Menopause; Hot Flashes,na,TERMINATED,Elizabeth Nedstrand,
NCT05947006,Standard care,OTHER,Febrile Seizure,na,TERMINATED,"University Hospital, Toulouse",
NCT05947006,CONSULFE consultation,OTHER,Febrile Seizure,na,TERMINATED,"University Hospital, Toulouse",
NCT02943733,TAS-102,DRUG,Neuroendocrine Tumors; Neoplasms; Cancer; Tumors,phase1,TERMINATED,"University of Wisconsin, Madison",
NCT02943733,Temozolomide,DRUG,Neuroendocrine Tumors; Neoplasms; Cancer; Tumors,phase1,TERMINATED,"University of Wisconsin, Madison",
NCT02943733,Filgrastim,DRUG,Neuroendocrine Tumors; Neoplasms; Cancer; Tumors,phase1,TERMINATED,"University of Wisconsin, Madison",
NCT02943733,Pegfilgrastim,DRUG,Neuroendocrine Tumors; Neoplasms; Cancer; Tumors,phase1,TERMINATED,"University of Wisconsin, Madison",
NCT02087033,ritmonutra,OTHER,Arrhythmia,na,TERMINATED,IRCCS Policlinico S. Donato,
NCT02087033,placebo,OTHER,Arrhythmia,na,TERMINATED,IRCCS Policlinico S. Donato,
NCT05964452,Methimazole Tablets,DRUG,Graves Disease,na,TERMINATED,Cook County Health,
NCT05435352,Core needle biopsy,PROCEDURE,Triple Negative Breast Cancer; Triple Negative Breast Neoplasms,na,TERMINATED,"Ourotech, Inc.",
NCT02988947,PNE+HyP,OTHER,"Knee Arthroplasty, Total",na,TERMINATED,University of Minho,
NCT02621749,Renal replacement therapy,DEVICE,Cerebral Embolism,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT02457949,Non-synchronized social assistance receipt,OTHER,Drug Use,na,TERMINATED,University of British Columbia,
NCT02457949,cheque divided into two equal disbursements,OTHER,Drug Use,na,TERMINATED,University of British Columbia,
NCT01023438,Strategy for assisted uptitration,OTHER,Chronic Heart Failure,na,TERMINATED,Niguarda Hospital,
NCT01023438,Usual care,OTHER,Chronic Heart Failure,na,TERMINATED,Niguarda Hospital,
NCT01700348,Airflosser,DEVICE,Gingivitis,na,TERMINATED,Tufts University,
NCT01700348,Manual Floss,DEVICE,Gingivitis,na,TERMINATED,Tufts University,
NCT00657826,"ATS 3f® Aortic Bioprosthesis, Model 1000, 19mm",DEVICE,Heart Valve Diseases,na,TERMINATED,Medtronic Cardiovascular,
NCT00014443,thalidomide,DRUG,Brain and Central Nervous System Tumors,phase2,TERMINATED,Rush University Medical Center,
NCT00014443,topotecan hydrochloride,DRUG,Brain and Central Nervous System Tumors,phase2,TERMINATED,Rush University Medical Center,
NCT00613535,Mechanical debridement,DEVICE,Torn Meniscus,phase4,TERMINATED,"Smith & Nephew, Inc.",
NCT00613535,Paragon T2,DEVICE,Torn Meniscus,phase4,TERMINATED,"Smith & Nephew, Inc.",
NCT00613535,Lavage debridement,PROCEDURE,Torn Meniscus,phase4,TERMINATED,"Smith & Nephew, Inc.",
NCT00613535,Mechanical Debridement,DEVICE,Torn Meniscus,phase4,TERMINATED,"Smith & Nephew, Inc.",
NCT00613535,RF- based Debridement,DEVICE,Torn Meniscus,phase4,TERMINATED,"Smith & Nephew, Inc.",
NCT03955835,Treatment with Credo® stent together with the NeuroSpeed® PTA balloon catheter.,DEVICE,Acute Ischemic Stroke; Intracranial Stenosis,na,TERMINATED,Acandis GmbH,
NCT03308435,Geriatric assessment,OTHER,Aortic Valve Stenosis; Clinical Trial; Depression; Frail Elderly Syndrome; Inflammation,na,TERMINATED,Medical University of Graz,
NCT03308435,Psychiatric assessment,OTHER,Aortic Valve Stenosis; Clinical Trial; Depression; Frail Elderly Syndrome; Inflammation,na,TERMINATED,Medical University of Graz,
NCT03308435,Inflammatory assessment,OTHER,Aortic Valve Stenosis; Clinical Trial; Depression; Frail Elderly Syndrome; Inflammation,na,TERMINATED,Medical University of Graz,
NCT03308435,Cardiological assessment,OTHER,Aortic Valve Stenosis; Clinical Trial; Depression; Frail Elderly Syndrome; Inflammation,na,TERMINATED,Medical University of Graz,
NCT01192776,Whole-body Cooling,PROCEDURE,"Infant, Newborn; Hypoxia, Brain; Hypoxia-Ischemia, Brain; Encephalopathy, Hypoxic-Ischemic; Hypoxic-Ischemic Encephalopathy; Ischemic-Hypoxic Encephalopathy",na,TERMINATED,NICHD Neonatal Research Network,
NCT03145909,ABBV-176,DRUG,Advanced Solid Tumors Cancer,phase1,TERMINATED,AbbVie,
NCT01175863,Grey scale intravascular ultrasound (Galaxy or Virtual histology-Intravascular Ultrasound),DEVICE,Coronary Artery Stenosis,phase4,TERMINATED,Ajou University School of Medicine,
NCT01175863,Pressure wire(Radi Medical Systems),DEVICE,Coronary Artery Stenosis,phase4,TERMINATED,Ajou University School of Medicine,
NCT00630487,Placebo,DRUG,Growth Hormone Deficiency,phase3,TERMINATED,Pfizer,
NCT00630487,Somatropin,DRUG,Growth Hormone Deficiency,phase3,TERMINATED,Pfizer,
NCT00491387,Metoprolol Succinate,DRUG,Hypertension,phase4,TERMINATED,University of Cincinnati,
NCT03616821,Brazikumab,DRUG,Ulcerative Colitis; IBD,phase2,TERMINATED,AstraZeneca,
NCT03616821,Placebo,DRUG,Ulcerative Colitis; IBD,phase2,TERMINATED,AstraZeneca,
NCT01956604,Clonidine,DRUG,Delirium,phase2,TERMINATED,Oslo University Hospital,
NCT01956604,Placebo,DRUG,Delirium,phase2,TERMINATED,Oslo University Hospital,
NCT00923949,Pioglitazone,DRUG,Non-Small-Cell Lung Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT05228938,VNOTES,PROCEDURE,Salpingectomy,na,TERMINATED,"HaEmek Medical Center, Israel",
NCT05228938,laparoscopic,PROCEDURE,Salpingectomy,na,TERMINATED,"HaEmek Medical Center, Israel",
NCT03490838,177Lu-PSMA-R2,DRUG,Prostatic Neoplasm,phase1,TERMINATED,Advanced Accelerator Applications,
NCT00225355,Rosiglitazone,DRUG,Angina Pectoris; Metabolic Syndrome X,phase4,TERMINATED,University of Glasgow,
NCT00596778,chest physiotherapy,OTHER,Abdominal Surgery; Spirometry; Chest Physiotherapy,na,TERMINATED,University of Sao Paulo,
NCT06929585,Genicular artery embolization,PROCEDURE,Osteoarthritis (OA) of the Knee,na,TERMINATED,National Taiwan University Hospital,
NCT06929585,Intra-articular injection with corticosteroids.,PROCEDURE,Osteoarthritis (OA) of the Knee,na,TERMINATED,National Taiwan University Hospital,
NCT00441025,Alemtuzumab,DRUG,Peripheral T-Cell Lymphoma,phase2,TERMINATED,Mahidol University,
NCT00974740,Atorvastatin,DRUG,Type 1 Diabetes,phase1,TERMINATED,Profil Institut für Stoffwechselforschung GmbH,
NCT00974740,atorvastatin matching placebo,DRUG,Type 1 Diabetes,phase1,TERMINATED,Profil Institut für Stoffwechselforschung GmbH,
NCT00629850,Powerlung Performer,DEVICE,Spinal Cord Injury,na,TERMINATED,"Texas State University, San Marcos",
NCT01975844,Individualized Anemia Mangement Protocol,OTHER,Anemia; End Stage Renal Disease,phase4,TERMINATED,Michael Germain,
NCT02514109,Neurological assessment and Blood sample,OTHER,Neuronopathy,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT04504032,Rivaroxaban,DRUG,COVID-19,phase2,TERMINATED,Gates Medical Research Institute,
NCT04504032,Placebo,DRUG,COVID-19,phase2,TERMINATED,Gates Medical Research Institute,
NCT03196063,Eccentric,OTHER,Patellar Tendinopathy,na,TERMINATED,Universidade Cidade de Sao Paulo,
NCT03196063,Modified Protocol,OTHER,Patellar Tendinopathy,na,TERMINATED,Universidade Cidade de Sao Paulo,
NCT03943693,Double shock,DEVICE,Atrial Fibrillation,phase4,TERMINATED,University of Oklahoma,
NCT03943693,Single shock,DEVICE,Atrial Fibrillation,phase4,TERMINATED,University of Oklahoma,
NCT02506114,PROSTVAC V/F,BIOLOGICAL,Prostatic Neoplasms,phase2,TERMINATED,Lawrence Fong,
NCT02506114,Ipilimumab,DRUG,Prostatic Neoplasms,phase2,TERMINATED,Lawrence Fong,
NCT02479204,ACT-334441 2 mg,DRUG,Healthy Subjects,phase1,TERMINATED,Viatris Innovation GmbH,
NCT02479204,ACT-334441 4 mg,DRUG,Healthy Subjects,phase1,TERMINATED,Viatris Innovation GmbH,
NCT02479204,Placebo,DRUG,Healthy Subjects,phase1,TERMINATED,Viatris Innovation GmbH,
NCT02479204,Atenolol,DRUG,Healthy Subjects,phase1,TERMINATED,Viatris Innovation GmbH,
NCT02479204,Diltiazem ER,DRUG,Healthy Subjects,phase1,TERMINATED,Viatris Innovation GmbH,
NCT04611204,Descriptive cohort,OTHER,Transthyretin Amyloidosis; Carpal Tunnel Syndrome,na,TERMINATED,"University Hospital, Toulouse",
NCT04240704,JBH492,DRUG,Non-Hodgkins Lymphoma; Chronic Lymphocytic Leukemia,phase1,TERMINATED,Novartis Pharmaceuticals,
NCT00737633,VI-0521,DRUG,Diabetes,phase2,TERMINATED,VIVUS LLC,
NCT02744833,GMI-1271,DRUG,Deep Venous Thrombosis,phase1; phase2,TERMINATED,GlycoMimetics Incorporated,
NCT02744833,Enoxaparin Sodium (Lovenox®),DRUG,Deep Venous Thrombosis,phase1; phase2,TERMINATED,GlycoMimetics Incorporated,
NCT04032652,Rectal dialysis,PROCEDURE,Ulcerative Colitis,phase2,TERMINATED,Endeavor Health,
NCT04032652,Rectal dialysis,DRUG,Ulcerative Colitis,phase2,TERMINATED,Endeavor Health,
NCT04525352,RP-L401,BIOLOGICAL,Infantile Malignant Osteopetrosis,phase1,TERMINATED,Rocket Pharmaceuticals Inc.,
NCT02266849,Loperamide,DRUG,Rectal Cancer; Ulcerative Colitis; Short Bowel Syndrome,phase3,TERMINATED,Odense University Hospital,
NCT02266849,Placebo,DRUG,Rectal Cancer; Ulcerative Colitis; Short Bowel Syndrome,phase3,TERMINATED,Odense University Hospital,
NCT00417248,Cisplatin,DRUG,Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,"Nasser Hanna, M.D.",
NCT00417248,Etoposide,DRUG,Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,"Nasser Hanna, M.D.",
NCT00417248,Radiotherapy,PROCEDURE,Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,"Nasser Hanna, M.D.",
NCT00417248,Sorafenib,DRUG,Non-Small Cell Lung Cancer,phase1; phase2,TERMINATED,"Nasser Hanna, M.D.",
NCT00039455,trastuzumab,BIOLOGICAL,HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00039455,alvocidib,DRUG,HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00039455,laboratory biomarker analysis,OTHER,HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00039455,pharmacological study,OTHER,HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02975778,Pain Monitor™,DEVICE,Pain,na,TERMINATED,Hopital Foch,
NCT00876915,dalteparin injection,DRUG,Venous Thromboembolism; Pulmonary Embolism,phase3,TERMINATED,University of Rochester,
NCT01324635,Panobinostat,DRUG,Recurrent Glioma; High-grade Meningioma; Brain Metastasis,phase1,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT01324635,Stereotactic body radiation therapy,RADIATION,Recurrent Glioma; High-grade Meningioma; Brain Metastasis,phase1,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT01324635,Quality-of-life assessment,PROCEDURE,Recurrent Glioma; High-grade Meningioma; Brain Metastasis,phase1,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT01324635,Stereotactic radiosurgery,RADIATION,Recurrent Glioma; High-grade Meningioma; Brain Metastasis,phase1,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT00478244,busulfan,DRUG,Epidermolysis Bullosa,na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00478244,cyclophosphamide,DRUG,Epidermolysis Bullosa,na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00478244,fludarabine phosphate,DRUG,Epidermolysis Bullosa,na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00478244,hematopoietic bone marrow transplantation,PROCEDURE,Epidermolysis Bullosa,na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT03577899,0.5 mg Conbercept Intravitreal Injection,BIOLOGICAL,Neovascular Age-related Macular Degeneration,phase3,TERMINATED,"Chengdu Kanghong Biotech Co., Ltd.",
NCT03577899,1.0 mg Conbercept Intravitreal Injection,BIOLOGICAL,Neovascular Age-related Macular Degeneration,phase3,TERMINATED,"Chengdu Kanghong Biotech Co., Ltd.",
NCT03577899,2.0 mg Aflibercept Intravitreal Injection,BIOLOGICAL,Neovascular Age-related Macular Degeneration,phase3,TERMINATED,"Chengdu Kanghong Biotech Co., Ltd.",
NCT02906332,Pembrolizumab,DRUG,Multiple Myeloma,phase2,TERMINATED,Hackensack Meridian Health,
NCT02906332,Lenalidomide,DRUG,Multiple Myeloma,phase2,TERMINATED,Hackensack Meridian Health,
NCT02906332,Dexamethasone,DRUG,Multiple Myeloma,phase2,TERMINATED,Hackensack Meridian Health,
NCT03107598,colloid preload,DRUG,Hypotension,na,TERMINATED,"University Hospital, Mahdia",
NCT00882193,Betaine,DRUG,Chronic Hepatitis C; Genotype 1; Relapse,early_phase1,TERMINATED,University of Nebraska,
NCT00882193,Peginterferon alpha 2a,DRUG,Chronic Hepatitis C; Genotype 1; Relapse,early_phase1,TERMINATED,University of Nebraska,
NCT00882193,Ribavirin,DRUG,Chronic Hepatitis C; Genotype 1; Relapse,early_phase1,TERMINATED,University of Nebraska,
NCT01077193,Gastric Plication,PROCEDURE,Morbid Obesity,na,TERMINATED,Ethicon Endo-Surgery,
NCT02053116,PF-05175157,DRUG,Type 2 Diabetes Mellitus,phase2,TERMINATED,Pfizer,
NCT02053116,Placebo,DRUG,Type 2 Diabetes Mellitus,phase2,TERMINATED,Pfizer,
NCT02192216,Exercise,BEHAVIORAL,Neoplasms,na,TERMINATED,"Department of Public Health, Denmark",
NCT03699904,Valaciclovir,DRUG,COPD; EBV,phase2,TERMINATED,Belfast Health and Social Care Trust,
NCT03699904,Placebo capsules (containing Avicel blend),DRUG,COPD; EBV,phase2,TERMINATED,Belfast Health and Social Care Trust,
NCT01513447,Intracutaneous injections,DRUG,Labor Pain,na,TERMINATED,Northwestern University,
NCT00898443,Epidural anesthetic,OTHER,Tubal Ligation; Bilateral Tubal Ligation,na,TERMINATED,University of Alabama at Birmingham,
NCT00898443,Spinal anesthetic,OTHER,Tubal Ligation; Bilateral Tubal Ligation,na,TERMINATED,University of Alabama at Birmingham,
NCT02862535,Andecaliximab,DRUG,Gastric Adenocarcinoma,phase1,TERMINATED,Gilead Sciences,
NCT02862535,S-1,DRUG,Gastric Adenocarcinoma,phase1,TERMINATED,Gilead Sciences,
NCT02862535,Cisplatin,DRUG,Gastric Adenocarcinoma,phase1,TERMINATED,Gilead Sciences,
NCT02862535,Oxaliplatin,DRUG,Gastric Adenocarcinoma,phase1,TERMINATED,Gilead Sciences,
NCT02862535,Nivolumab,DRUG,Gastric Adenocarcinoma,phase1,TERMINATED,Gilead Sciences,
NCT02730325,Serum-derived bovine immunoglobulin/protein isolate (SBI),OTHER,Clostridium Difficile,na,TERMINATED,Northwestern University,
NCT02730325,Placebo,OTHER,Clostridium Difficile,na,TERMINATED,Northwestern University,
NCT03962725,Neuromuscular Blocking Agents,DRUG,Respiratory Failure; Respiratory Infection; Aspiration Pneumonia; Pneumonitis; Atelectasis; Bronchospasm,phase4,TERMINATED,Beth Israel Deaconess Medical Center,
NCT03962725,Anesthetic Adjuncts,DRUG,Respiratory Failure; Respiratory Infection; Aspiration Pneumonia; Pneumonitis; Atelectasis; Bronchospasm,phase4,TERMINATED,Beth Israel Deaconess Medical Center,
NCT01668225,Blood test,PROCEDURE,Infertility,na,TERMINATED,Clinique Ovo,
NCT00347906,laser treatment,PROCEDURE,Age-Related Macular Degeneration,na,TERMINATED,"University Hospital, Linkoeping",
NCT00334204,measuring Platelet Function Analyser-100 (PFA-100) platelet function before kidney biopsy,DEVICE,"Kidney Failure, Acute; Kidney Failure, Chronic; Blood Platelet Disorders; Hemorrhage",phase4,TERMINATED,University of Mississippi Medical Center,
NCT00923247,Bortezomib,DRUG,Medullary Thyroid Carcinoma,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT00923247,Vandetanib,DRUG,Medullary Thyroid Carcinoma,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT02240758,confocal endomicroscopy with the CELLVIZIO® system (Mauna Kea technology),PROCEDURE,"Low Grade Glioma (LGG), High Grade Glioma (HGG)",phase1,TERMINATED,Hospices Civils de Lyon,
NCT04041258,pseudoarthrosis of clavicle,PROCEDURE,Pseudoarthrosis of the Clavicle,na,TERMINATED,Istituto Ortopedico Rizzoli,
NCT04060849,Nozin,DRUG,Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Solid Neoplasm,phase1,TERMINATED,Fred Hutchinson Cancer Center,
NCT04060849,Best Practice,OTHER,Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Solid Neoplasm,phase1,TERMINATED,Fred Hutchinson Cancer Center,
NCT02610049,Cognitive Processing therapy,BEHAVIORAL,"Post-traumatic Stress Disorder; Stress Disorder, Post-Traumatic",na,TERMINATED,Hampton VA Medical Center,
NCT02610049,Art + CPT,BEHAVIORAL,"Post-traumatic Stress Disorder; Stress Disorder, Post-Traumatic",na,TERMINATED,Hampton VA Medical Center,
NCT02610049,CPT + Art Therapy,BEHAVIORAL,"Post-traumatic Stress Disorder; Stress Disorder, Post-Traumatic",na,TERMINATED,Hampton VA Medical Center,
NCT02584049,Osteopathy,OTHER,Pain,na,TERMINATED,Hôpital NOVO,
NCT02584049,Sham osteopathy,OTHER,Pain,na,TERMINATED,Hôpital NOVO,
NCT04132349,Ulipristal Acetate 5 mg,DRUG,Uterine Fibroid; Heavy Menstrual Bleeding,phase4,TERMINATED,Mỹ Đức Hospital,
NCT03805243,test of sensors for somnonaute device,DEVICE,Healthy,na,TERMINATED,BioSerenity,
NCT03805243,test of sensors for uronaute device,DEVICE,Healthy,na,TERMINATED,BioSerenity,
NCT03805243,test of sensors for toconaute device,DEVICE,Healthy,na,TERMINATED,BioSerenity,
NCT03805243,test of sensors for neuronaute device,DEVICE,Healthy,na,TERMINATED,BioSerenity,
NCT03805243,test of sensors for cardioskin device,DEVICE,Healthy,na,TERMINATED,BioSerenity,
NCT03347435,"genetic tests for CYP2C19*2, CYP2C19*17 and ABCB1 3435",OTHER,Acute Coronary Syndromes,na,TERMINATED,Azienda Ospedaliero-Universitaria di Parma,
NCT03347435,clinical algorithm,OTHER,Acute Coronary Syndromes,na,TERMINATED,Azienda Ospedaliero-Universitaria di Parma,
NCT01408043,plerixafor,DRUG,Adult Acute Lymphoblastic Leukemia in Remission; Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell ,na,TERMINATED,Case Comprehensive Cancer Center,
NCT01408043,filgrastim,BIOLOGICAL,Adult Acute Lymphoblastic Leukemia in Remission; Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell ,na,TERMINATED,Case Comprehensive Cancer Center,
NCT01408043,etoposide,DRUG,Adult Acute Lymphoblastic Leukemia in Remission; Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell ,na,TERMINATED,Case Comprehensive Cancer Center,
NCT01408043,leukapheresis,PROCEDURE,Adult Acute Lymphoblastic Leukemia in Remission; Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell ,na,TERMINATED,Case Comprehensive Cancer Center,
NCT01928615,Trastuzumab - intravenous solution,DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT01928615,Trastuzumab - subcutaneous solution,DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT01928615,Chemotherapy,DRUG,Breast Cancer,phase2,TERMINATED,Hoffmann-La Roche,
NCT03020368,Leeches,BIOLOGICAL,Rhizarthrosis,na,TERMINATED,"Charite University, Berlin, Germany",
NCT03020368,Diclofenac,DRUG,Rhizarthrosis,na,TERMINATED,"Charite University, Berlin, Germany",
NCT02940691,Grazoprevir/elbasvir,DRUG,Hepatitis C,phase4,TERMINATED,Kirby Institute,
NCT03393000,Trans Sodium Crocetinate plus SOC,DRUG,Glioblastoma,phase3,TERMINATED,Diffusion Pharmaceuticals Inc,
NCT03393000,Standard of Care (SOC),OTHER,Glioblastoma,phase3,TERMINATED,Diffusion Pharmaceuticals Inc,
NCT03648372,TAK-981,DRUG,Neoplasms; Lymphoma; Hematologic Neoplasms,phase1; phase2,TERMINATED,Takeda,
NCT01431157,Nocturnal nasal oxygen,PROCEDURE,Sleep Apnea; Heart Failure,na,TERMINATED,"University of Maryland, Baltimore",
NCT01431157,No nasal oxygen,OTHER,Sleep Apnea; Heart Failure,na,TERMINATED,"University of Maryland, Baltimore",
NCT03774719,Hand-carried ultrasound,DEVICE,Hydronephrosis; Ultrasound; Acute Kidney Injury,na,TERMINATED,Washington University School of Medicine,
NCT03476928,Vilaprisan (BAY1002670),DRUG,Uterine Fibroids and Heavy Menstrual Bleeding,phase3,TERMINATED,Bayer,
NCT02868528,chromosome screening with NGS technology,OTHER,Infertility,na,TERMINATED,Reproductive & Genetic Hospital of CITIC-Xiangya,
NCT00626600,Oxycodone Hydrochloride,DRUG,Severe Caner Pain,phase3,TERMINATED,Mundipharma Research Limited,
NCT00315211,Intravenous Topotecan,DRUG,Mediastinal Neoplasms,phase2,TERMINATED,Aultman Health Foundation,
NCT00315211,Intravenous Docetaxel,DRUG,Mediastinal Neoplasms,phase2,TERMINATED,Aultman Health Foundation,
NCT00736411,acupuncture,PROCEDURE,Infertility,na,TERMINATED,Pacific Fertility Center,
NCT00736411,IVF,PROCEDURE,Infertility,na,TERMINATED,Pacific Fertility Center,
NCT01623271,Gabapentin,DRUG,Complex Regional Pain Syndrome I (CRPS I),na,TERMINATED,Massachusetts General Hospital,
NCT01478698,Tissue Plasminogen Activator (tPA),DRUG,"Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory",phase1,TERMINATED,Sir Charles Gairdner Hospital,
NCT01478698,recombinant deoxyribonuclease (DNase),DRUG,"Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory",phase1,TERMINATED,Sir Charles Gairdner Hospital,
NCT02924298,SLIMM,BEHAVIORAL,Chronic Kidney Disease; End Stage Renal Disease,na,TERMINATED,Srinvasan Beddhu,
NCT01104298,Doxorubicin,DRUG,Sarcoma,phase2,TERMINATED,Grupo Espanol de Investigacion en Sarcomas,
NCT01104298,Trabectedin,DRUG,Sarcoma,phase2,TERMINATED,Grupo Espanol de Investigacion en Sarcomas,
NCT03890198,LCAR-C182A cells,BIOLOGICAL,Gastric Cancer; Pancreatic Ductal Adenocarcinoma,early_phase1,TERMINATED,First Affiliated Hospital Xi'an Jiaotong University,
NCT02671916,questionnaire,BEHAVIORAL,Critically Ill,na,TERMINATED,Prof. Dr. med. Cristoph Haberthür,
NCT03602716,HD-tDCS,DEVICE,Schizophrenia,na,TERMINATED,Shanghai Mental Health Center,
NCT03602716,Sham HD-tDCS,DEVICE,Schizophrenia,na,TERMINATED,Shanghai Mental Health Center,
NCT04940416,Neurofit (oculometric testing),DEVICE,Cirrhosis; Hepatic Encephalopathy,na,TERMINATED,Stanford University,
NCT04207645,Modified RIPASA score,OTHER,Acute Appendicitis,na,TERMINATED,Soba University Hospital,
NCT02529475,Gadoteric acid,DRUG,Meniere Disease,phase4,TERMINATED,"University Hospital, Grenoble",
NCT04241757,ElectroCardioGram (ECG),OTHER,Indication for ElectroCardioGram,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT02586012,rFVIII,DRUG,Hemophilia,phase2,TERMINATED,Craig Seaman,
NCT03635112,Placebo,DRUG,Crohn's Disease,phase2,TERMINATED,Theravance Biopharma,
NCT03635112,TD-1473,DRUG,Crohn's Disease,phase2,TERMINATED,Theravance Biopharma,
NCT02148419,no intervention,OTHER,Quality of Life,na,TERMINATED,"University Children's Hospital, Zurich",
NCT00279565,buprenorphine,DRUG,"Hepatitis C, Chronic",phase4,TERMINATED,Indivior Inc.,
NCT00279565,methadone,DRUG,"Hepatitis C, Chronic",phase4,TERMINATED,Indivior Inc.,
NCT00279565,pegylated interferon alfa-2b plus ribavirin,DRUG,"Hepatitis C, Chronic",phase4,TERMINATED,Indivior Inc.,
NCT00572767,Dextro-Amphetamin,DRUG,Stroke,phase4,TERMINATED,Reha Rheinfelden,
NCT00572767,Glucose,OTHER,Stroke,phase4,TERMINATED,Reha Rheinfelden,
NCT00785811,L-arginine aspartate (Targifor),DRUG,Muscular Fatigue,phase4,TERMINATED,Sanofi,
NCT00785811,Placebo L-arginine aspartate (Targifor),DRUG,Muscular Fatigue,phase4,TERMINATED,Sanofi,
NCT00726271,"light olive oil, fish oil capsules, flax seed oil capsules",OTHER,Obesity,na,TERMINATED,State University of New York - Upstate Medical University,
NCT02749071,Laparoscopic implantation surgery,PROCEDURE,"Gastroesophageal Reflux Disease (GERD); Reflux, Gastroesophageal; Gastroesophageal Reflux; Acid Reflux",na,TERMINATED,EndoStim Inc.,
NCT02749071,EndoStim stimulation for first six months of study,DEVICE,"Gastroesophageal Reflux Disease (GERD); Reflux, Gastroesophageal; Gastroesophageal Reflux; Acid Reflux",na,TERMINATED,EndoStim Inc.,
NCT02749071,EndoStim stimulation from Month 6 thru end of study,DEVICE,"Gastroesophageal Reflux Disease (GERD); Reflux, Gastroesophageal; Gastroesophageal Reflux; Acid Reflux",na,TERMINATED,EndoStim Inc.,
NCT02749071,Sham EndoStim stimulation for first six months of study,DEVICE,"Gastroesophageal Reflux Disease (GERD); Reflux, Gastroesophageal; Gastroesophageal Reflux; Acid Reflux",na,TERMINATED,EndoStim Inc.,
NCT01011699,nicotinamide,DRUG,Chronic Renal Failure; Hemodialysis,phase3,TERMINATED,"Centre Hospitalier Universitaire, Amiens",
NCT01011699,sevelamer,DRUG,Chronic Renal Failure; Hemodialysis,phase3,TERMINATED,"Centre Hospitalier Universitaire, Amiens",
NCT01011699,cinacalcet,DRUG,Chronic Renal Failure; Hemodialysis,phase3,TERMINATED,"Centre Hospitalier Universitaire, Amiens",
NCT00762398,Masimo hemoglobin-meter,DEVICE,Adult Patient Undergoing Major Surgery,na,TERMINATED,"University of California, Irvine",
NCT00762398,drawing blood sample,BIOLOGICAL,Adult Patient Undergoing Major Surgery,na,TERMINATED,"University of California, Irvine",
NCT00899977,Placebo,DRUG,Refractory Hypertension,phase1; phase2,TERMINATED,Targacept Inc.,
NCT00899977,TC-5214,DRUG,Refractory Hypertension,phase1; phase2,TERMINATED,Targacept Inc.,
NCT05417581,adipose surgery,PROCEDURE,Digestive Organs--Cancer; Bariatric Surgery Candidate; Parietal Region Trauma,na,TERMINATED,"University Hospital, Clermont-Ferrand",
NCT01532765,Pars plana vitrectomy and epiretinal membrane peel,PROCEDURE,Epiretinal Membrane,na,TERMINATED,Sunnybrook Health Sciences Centre,
NCT01532765,ILM peel assisted by ICG,PROCEDURE,Epiretinal Membrane,na,TERMINATED,Sunnybrook Health Sciences Centre,
NCT01532765,CE-IOL,PROCEDURE,Epiretinal Membrane,na,TERMINATED,Sunnybrook Health Sciences Centre,
NCT02460367,Docetaxel,DRUG,Non-small Cell Lung Cancer; Progression of Non-small Cell Lung Cancer; Non-small Cell Lung Cancer Recurrent,phase1,TERMINATED,NewLink Genetics Corporation,
NCT02460367,Tergenpumatucel-L,BIOLOGICAL,Non-small Cell Lung Cancer; Progression of Non-small Cell Lung Cancer; Non-small Cell Lung Cancer Recurrent,phase1,TERMINATED,NewLink Genetics Corporation,
NCT02460367,Indoximod,DRUG,Non-small Cell Lung Cancer; Progression of Non-small Cell Lung Cancer; Non-small Cell Lung Cancer Recurrent,phase1,TERMINATED,NewLink Genetics Corporation,
NCT04852107,"Spinal Cord Stimulation, association of both (DUAL), Dorsal Root Ganglion stimulation",OTHER,"Pain, Neuropathic",na,TERMINATED,Poitiers University Hospital,
NCT04306536,Fortifit®,OTHER,Femur Fracture,na,TERMINATED,Barichella Michela,
NCT00427011,E2007,DRUG,Parkinson's Disease,phase2,TERMINATED,Eisai Inc.,
NCT05762744,Exenatide Injection (before the first FSIGT),DRUG,Type 2 Diabetes,phase1,TERMINATED,"University of Maryland, Baltimore",
NCT05762744,Exenatide injection before the second FSIGT),DRUG,Type 2 Diabetes,phase1,TERMINATED,"University of Maryland, Baltimore",
NCT03274544,PROLUNG,OTHER,Idiopathic Pulmonary Fibrosis,na,TERMINATED,The University of Hong Kong,
NCT01050244,Whole soybean soymilk powder,OTHER,Neuralgia,phase2,TERMINATED,Dr. Yoram Shir,
NCT01050244,Whole milk powder,OTHER,Neuralgia,phase2,TERMINATED,Dr. Yoram Shir,
NCT02665364,IFNα-Kinoid,BIOLOGICAL,Systemic Lupus Erythematosus,phase2,TERMINATED,Neovacs,
NCT02665364,Placebo,OTHER,Systemic Lupus Erythematosus,phase2,TERMINATED,Neovacs,
NCT02665364,ISA 51 VG,OTHER,Systemic Lupus Erythematosus,phase2,TERMINATED,Neovacs,
NCT03254264,Early Start Denver Model,BEHAVIORAL,Autism Spectrum Disorder,na,TERMINATED,Hôpital le Vinatier,
NCT03254264,'as-usual' intervention,BEHAVIORAL,Autism Spectrum Disorder,na,TERMINATED,Hôpital le Vinatier,
NCT02252432,Ketamine,DRUG,Laminectomy,phase4,TERMINATED,Cedars-Sinai Medical Center,
NCT02252432,Methadone,DRUG,Laminectomy,phase4,TERMINATED,Cedars-Sinai Medical Center,
NCT02252432,Ketamine + methadone,DRUG,Laminectomy,phase4,TERMINATED,Cedars-Sinai Medical Center,
NCT00004093,carboplatin,DRUG,Lung Cancer,phase1; phase2,TERMINATED,Northwestern University,
NCT00004093,Gemcitabine,DRUG,Lung Cancer,phase1; phase2,TERMINATED,Northwestern University,
NCT00004093,paclitaxel,DRUG,Lung Cancer,phase1; phase2,TERMINATED,Northwestern University,
NCT00004093,vinorelbine,DRUG,Lung Cancer,phase1; phase2,TERMINATED,Northwestern University,
NCT00004093,radiation therapy,RADIATION,Lung Cancer,phase1; phase2,TERMINATED,Northwestern University,
NCT00004093,Navelbine,DRUG,Lung Cancer,phase1; phase2,TERMINATED,Northwestern University,
NCT00004093,Taxol,DRUG,Lung Cancer,phase1; phase2,TERMINATED,Northwestern University,
NCT04549363,Belantamab mafodotin,DRUG,Multiple Myeloma,phase3,TERMINATED,GlaxoSmithKline,
NCT00811993,RG1507,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,RO1507,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,bevacizumab [Avastin],DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,capecitabine [Xeloda],DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,carboplatin,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,cetuximab,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,docetaxel,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,erlotinib [Tarceva],DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,etoposide,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,gemcitabine,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,irinotecan,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,mFOLFOX6,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,paclitaxel,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,pemetrexel,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,sorafenib,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,temozolomide,DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00811993,trastuzumab [Herceptin],DRUG,Neoplasms,phase1,TERMINATED,Hoffmann-La Roche,
NCT00518687,V710,BIOLOGICAL,Staphylococcus Aureus; Bacteremia; Mediastinitis,phase2; phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00518687,Placebo,BIOLOGICAL,Staphylococcus Aureus; Bacteremia; Mediastinitis,phase2; phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01125293,Everolimus,DRUG,Waldenstrom's Macroglobulinemia,phase1; phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT01125293,Rituximab,DRUG,Waldenstrom's Macroglobulinemia,phase1; phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT01125293,Bortezomib,DRUG,Waldenstrom's Macroglobulinemia,phase1; phase2,TERMINATED,Dana-Farber Cancer Institute,
NCT00181181,atorvastatin,DRUG,Hypertension,phase4,TERMINATED,Johns Hopkins University,
NCT00181181,placebo,OTHER,Hypertension,phase4,TERMINATED,Johns Hopkins University,
NCT01465581,Division of the filum terminal,PROCEDURE,Neurogenic Incontinence; Dysfunctional Voiding,na,TERMINATED,Nemours Children's Clinic,
NCT02844907,Exendin (9-39),DRUG,Insulin Secretion,phase4,TERMINATED,VA Office of Research and Development,
NCT02844907,Dexamethasone,DRUG,Insulin Secretion,phase4,TERMINATED,VA Office of Research and Development,
NCT02844907,Hyperglycemic Clamp,OTHER,Insulin Secretion,phase4,TERMINATED,VA Office of Research and Development,
NCT03149107,N-Acetylcysteine,DRUG,Prodromal Schizophrenia,phase3,TERMINATED,"University Hospital, Bonn",
NCT03149107,Placebo,DRUG,Prodromal Schizophrenia,phase3,TERMINATED,"University Hospital, Bonn",
NCT03149107,IPPI (Integrated Preventive Psychological Intervention),BEHAVIORAL,Prodromal Schizophrenia,phase3,TERMINATED,"University Hospital, Bonn",
NCT03149107,PSM (Psychological stress management),BEHAVIORAL,Prodromal Schizophrenia,phase3,TERMINATED,"University Hospital, Bonn",
NCT00377507,catechin extracts,OTHER,Elderly,na,TERMINATED,Masahiro Morikawa,
NCT04502836,Preliminary psychological intervention,BEHAVIORAL,Precocious Puberty,na,TERMINATED,Rabin Medical Center,
NCT04651764,ColubrisMX Endoluminal Surgical (ELS) System,DEVICE,Rectal Adenoma; Rectal Polyp; Rectal Lesion,na,TERMINATED,ColubrisMX,
NCT05223699,MGTA-117,BIOLOGICAL,Acute Myeloid Leukemia; Myelodysplasia,phase1,TERMINATED,"Magenta Therapeutics, Inc.",
NCT00369499,PFO Closure,DEVICE,Migraine,na,TERMINATED,Abbott Medical Devices,
NCT03495999,hyperuricemia,OTHER,Hyperuricemia; Metabolic Syndrome; Left Ventricular Diastolic Dysfunction,na,TERMINATED,"National Defense Medical Center, Taiwan",
NCT02706899,vadastuximab talirine,DRUG,Myelodysplastic Syndrome,phase1; phase2,TERMINATED,Seagen Inc.,
NCT02706899,Azacitidine,DRUG,Myelodysplastic Syndrome,phase1; phase2,TERMINATED,Seagen Inc.,
NCT02706899,Placebo (for 33A),DRUG,Myelodysplastic Syndrome,phase1; phase2,TERMINATED,Seagen Inc.,
NCT01558232,Tibion Bionic Leg,DEVICE,Stroke,na,TERMINATED,"Tibion Bionics, Inc.",
NCT03067363,MOR107,DRUG,Safety,phase1,TERMINATED,Alan Richardson,
NCT03067363,Placebo,DRUG,Safety,phase1,TERMINATED,Alan Richardson,
NCT03067363,Low sodium diet,OTHER,Safety,phase1,TERMINATED,Alan Richardson,
NCT04267939,Elimusertib (BAY1895344),DRUG,Advanced Solid Tumors (Excluding Prostate Cancer); Ovarian Cancer,phase1,TERMINATED,Bayer,
NCT04267939,Niraparib,DRUG,Advanced Solid Tumors (Excluding Prostate Cancer); Ovarian Cancer,phase1,TERMINATED,Bayer,
NCT04816877,Opioid,DRUG,Acute Pancreatitis,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT05265975,ATG-010,DRUG,Diffuse Large B-cell Lymphoma; Indolent Non-Hodgkin Lymphoma,phase1; phase2,TERMINATED,Antengene Corporation,
NCT05265975,Lenalidomide,DRUG,Diffuse Large B-cell Lymphoma; Indolent Non-Hodgkin Lymphoma,phase1; phase2,TERMINATED,Antengene Corporation,
NCT05265975,Rituximab,DRUG,Diffuse Large B-cell Lymphoma; Indolent Non-Hodgkin Lymphoma,phase1; phase2,TERMINATED,Antengene Corporation,
NCT02532075,Inspiratory Warm Up,OTHER,Chronic Obstructive Pulmonary Disease,na,TERMINATED,University of Portsmouth,
NCT02532075,Expiratory Warm Up,OTHER,Chronic Obstructive Pulmonary Disease,na,TERMINATED,University of Portsmouth,
NCT02532075,Combination Warm Up,OTHER,Chronic Obstructive Pulmonary Disease,na,TERMINATED,University of Portsmouth,
NCT02532075,Control Trial,OTHER,Chronic Obstructive Pulmonary Disease,na,TERMINATED,University of Portsmouth,
NCT03449030,TAK-164,DRUG,"Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies",phase1,TERMINATED,"Millennium Pharmaceuticals, Inc.",
NCT03449030,89Zr-TAK-164,DRUG,"Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies",phase1,TERMINATED,"Millennium Pharmaceuticals, Inc.",
NCT02130765,Cardiac catheter ablation with ICD/CRT-D,DEVICE,Monomorphic Ventricular Tachycardia,na,TERMINATED,Abbott Medical Devices,
NCT00442507,Erlotinib,DRUG,Esophageal Neoplasms; Esophageal Diseases,phase2,TERMINATED,Washington University School of Medicine,
NCT00442507,Avastin,DRUG,Esophageal Neoplasms; Esophageal Diseases,phase2,TERMINATED,Washington University School of Medicine,
NCT00225992,Arsenic Trioxide,DRUG,Myelodysplastic Syndrome (MDS),phase2,TERMINATED,"Oncology Specialties, Alabama",
NCT00484536,CDP323,DRUG,Multiple Sclerosis,phase2,TERMINATED,UCB Pharma,
NCT00484536,placebo,DRUG,Multiple Sclerosis,phase2,TERMINATED,UCB Pharma,
NCT00484536,CDP323,DRUG,Multiple Sclerosis,phase2,TERMINATED,UCB Pharma,
NCT02975336,Placebo,DRUG,Systemic Lupus Erythematosus,phase2,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02975336,M2951,DRUG,Systemic Lupus Erythematosus,phase2,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02975336,M2951,DRUG,Systemic Lupus Erythematosus,phase2,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02975336,M2951,DRUG,Systemic Lupus Erythematosus,phase2,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02975336,M2951,DRUG,Systemic Lupus Erythematosus,phase2,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02885571,SomnoDent Flex with DentiTrac,DEVICE,Obstructive Sleep Apnea,na,TERMINATED,Seoul National University Hospital,
NCT03879044,Transcranial Direct Current Stimulation,DEVICE,Shift-Work Sleep Disorder,na,TERMINATED,Ohio State University,
NCT01544244,GSC physical therapy,PROCEDURE,Shoulder; Tendinopathy,na,TERMINATED,Centre Hospitalier Universitaire de Nīmes,
NCT01544244,Standard physical therapy,PROCEDURE,Shoulder; Tendinopathy,na,TERMINATED,Centre Hospitalier Universitaire de Nīmes,
NCT00461344,Docetaxel,DRUG,Ductal Carcinoma,phase2,TERMINATED,Sanofi,
NCT00461344,Doxorubicin,DRUG,Ductal Carcinoma,phase2,TERMINATED,Sanofi,
NCT02978144,AxV-128/Tc,DRUG,Chronic Obstructive Pulmonary Disease (COPD),phase2,TERMINATED,Columbia University,
NCT02681809,ocriplasmin 0.0625mg,DRUG,Diabetic Retinopathy; Posterior Vitreous Detachment; Disease Progression,phase2,TERMINATED,ThromboGenics,
NCT02681809,ocriplasmin 0.125mg,DRUG,Diabetic Retinopathy; Posterior Vitreous Detachment; Disease Progression,phase2,TERMINATED,ThromboGenics,
NCT02681809,Sham injection,DRUG,Diabetic Retinopathy; Posterior Vitreous Detachment; Disease Progression,phase2,TERMINATED,ThromboGenics,
NCT01444209,Iodine Implants,RADIATION,Pituitary Macroadenoma,phase2,TERMINATED,University of Texas Southwestern Medical Center,
NCT00568009,SLV320,DRUG,Congestive Heart Failure,na,TERMINATED,Solvay Pharmaceuticals,
NCT03597009,Talimogene laherparepvec (TVEC),DRUG,Malignant Pleural Effusion; Stage IV Metastatic Cancer; Lung Cancer,phase1; phase2,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT03597009,Nivolumab,DRUG,Malignant Pleural Effusion; Stage IV Metastatic Cancer; Lung Cancer,phase1; phase2,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT00517699,rituximab [MabThera/Rituxan],DRUG,Lymphoma,phase2,TERMINATED,Hoffmann-La Roche,
NCT00517699,Methotrexate,DRUG,Lymphoma,phase2,TERMINATED,Hoffmann-La Roche,
NCT00517699,Cytarabine,DRUG,Lymphoma,phase2,TERMINATED,Hoffmann-La Roche,
NCT03081598,PBI-4050,DRUG,Type 2 Diabetes Mellitus; Metabolic Syndrome,phase2,TERMINATED,Liminal BioSciences Ltd.,
NCT03081598,Placebo,OTHER,Type 2 Diabetes Mellitus; Metabolic Syndrome,phase2,TERMINATED,Liminal BioSciences Ltd.,
NCT04477993,Janus Kinase Inhibitor (ruxolitinib),DRUG,Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV2,phase2; phase3,TERMINATED,Vanderson Geraldo Rocha,
NCT04477993,Placebo,OTHER,Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV2,phase2; phase3,TERMINATED,Vanderson Geraldo Rocha,
NCT01633593,Donepezil,DRUG,Elderly; Delirium of Unknown (Axis III) Etiology; Intensive Care (ICU) Myopathy,phase4,TERMINATED,University of Sao Paulo,
NCT00882414,FERINJECT® (Ferric carboxymaltose),DRUG,Thrombocytosis; Iron-Deficiency Anemia,phase2,TERMINATED,Vifor Pharma,
NCT00882414,Placebo,DRUG,Thrombocytosis; Iron-Deficiency Anemia,phase2,TERMINATED,Vifor Pharma,
NCT01319539,Akt Inhibitor MK2206,DRUG,Estrogen Receptor Negative; Estrogen Receptor Positive; HER2/Neu Negative; HER2/Neu Positive; Progesterone Receptor Negative; Progesterone Receptor Positive; Stage IA Breast Cancer; Stage IB Breast Ca,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01319539,Therapeutic Conventional Surgery,PROCEDURE,Estrogen Receptor Negative; Estrogen Receptor Positive; HER2/Neu Negative; HER2/Neu Positive; Progesterone Receptor Negative; Progesterone Receptor Positive; Stage IA Breast Cancer; Stage IB Breast Ca,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01319539,Pharmacological Study,OTHER,Estrogen Receptor Negative; Estrogen Receptor Positive; HER2/Neu Negative; HER2/Neu Positive; Progesterone Receptor Negative; Progesterone Receptor Positive; Stage IA Breast Cancer; Stage IB Breast Ca,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01319539,Laboratory Biomarker Analysis,OTHER,Estrogen Receptor Negative; Estrogen Receptor Positive; HER2/Neu Negative; HER2/Neu Positive; Progesterone Receptor Negative; Progesterone Receptor Positive; Stage IA Breast Cancer; Stage IB Breast Ca,phase2,TERMINATED,National Cancer Institute (NCI),
NCT03217175,Bihormonal Bionic Pancreas,DEVICE,Type 1 Diabetes Mellitus,na,TERMINATED,Massachusetts General Hospital,
NCT03217175,Insulin Only Bionic Pancreas,DEVICE,Type 1 Diabetes Mellitus,na,TERMINATED,Massachusetts General Hospital,
NCT03217175,Glucagon,DRUG,Type 1 Diabetes Mellitus,na,TERMINATED,Massachusetts General Hospital,
NCT03217175,Placebo,DRUG,Type 1 Diabetes Mellitus,na,TERMINATED,Massachusetts General Hospital,
NCT03995901,FCR001,BIOLOGICAL,Transplanted Organ Rejection,phase3,TERMINATED,Talaris Therapeutics Inc.,
NCT01124812,131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiotherapy (EBRT) and Concurrent Chemotherapy,OTHER,Non Small Cell Lung Cancer,phase1,TERMINATED,Philogen S.p.A.,
NCT00671112,Bortezomib,DRUG,714leukemia; Lymphoma,phase1,TERMINATED,"Brian Hill, MD, PhD",
NCT00671112,Everolimus,DRUG,714leukemia; Lymphoma,phase1,TERMINATED,"Brian Hill, MD, PhD",
NCT01118819,Clostridium novyi-NT spores,BIOLOGICAL,Solid Tumor Malignancies,phase1,TERMINATED,"BioMed Valley Discoveries, Inc",
NCT01838200,Bacillus Calmette-Guérin (BCG) vaccine,BIOLOGICAL,Metastatic Melanoma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT01838200,Ipilimumab,DRUG,Metastatic Melanoma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT01838200,Isoniazid,DRUG,Metastatic Melanoma,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT05534100,Biostrap EVO Wristband,DEVICE,Posttraumatic Stress Disorder,na,TERMINATED,Rush University Medical Center,
NCT03423407,Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI),DEVICE,PET/CT,na,TERMINATED,Washington University School of Medicine,
NCT05565092,ALXN1820,DRUG,Sickle Cell Disease (SCD),phase2,TERMINATED,"Alexion Pharmaceuticals, Inc.",
NCT02959411,Tolvaptan,DRUG,Heart Failure; Hyponatremia,phase4,TERMINATED,University of Calgary,
NCT02959411,Standard of care diuretic therapy,DRUG,Heart Failure; Hyponatremia,phase4,TERMINATED,University of Calgary,
NCT04056611,JNJ-53718678 250 mg,DRUG,Respiratory Syncytial Virus Infections,phase2,TERMINATED,Janssen Sciences Ireland UC,
NCT04056611,Placebo,DRUG,Respiratory Syncytial Virus Infections,phase2,TERMINATED,Janssen Sciences Ireland UC,
NCT04056611,JNJ-53718678 125 mg,DRUG,Respiratory Syncytial Virus Infections,phase2,TERMINATED,Janssen Sciences Ireland UC,
NCT02314611,PROFEMUR® Gladiator HA Coated Modular Femoral Stem,DEVICE,Joint Disease,na,TERMINATED,MicroPort Orthopedics Inc.,
NCT04985136,camrelizumab；Rivoceranib,DRUG,Advanced Hepatocellular Carcinoma (HCC),phase3,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT04985136,Rivoceranib,DRUG,Advanced Hepatocellular Carcinoma (HCC),phase3,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT04985136,Sorafenib,DRUG,Advanced Hepatocellular Carcinoma (HCC),phase3,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT04985136,Regorafenib,DRUG,Advanced Hepatocellular Carcinoma (HCC),phase3,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT04614636,FT538,DRUG,"Acute Myeloid Leukemia; AML, Adult; Multiple Myeloma; Myeloma",phase1,TERMINATED,Fate Therapeutics,
NCT04614636,Cyclophosphamide,DRUG,"Acute Myeloid Leukemia; AML, Adult; Multiple Myeloma; Myeloma",phase1,TERMINATED,Fate Therapeutics,
NCT04614636,Fludarabine,DRUG,"Acute Myeloid Leukemia; AML, Adult; Multiple Myeloma; Myeloma",phase1,TERMINATED,Fate Therapeutics,
NCT04614636,Daratumumab,DRUG,"Acute Myeloid Leukemia; AML, Adult; Multiple Myeloma; Myeloma",phase1,TERMINATED,Fate Therapeutics,
NCT04614636,Elotuzumab,DRUG,"Acute Myeloid Leukemia; AML, Adult; Multiple Myeloma; Myeloma",phase1,TERMINATED,Fate Therapeutics,
NCT01377311,Transplant of cultured limbal stem cells on cornea,PROCEDURE,Unilateral Limbal Stem Cell Insufficiency,phase1,TERMINATED,National Taiwan University Hospital,
NCT01415271,Internet Communication,OTHER,Type 2 Diabetes,na,TERMINATED,Endocrine Research Society,
NCT03125434,"EOS full-spine, MRI, gait analysis",OTHER,Healthy Volunteers; Dynamic Stability Margin; Gait; Paraspinal Muscles,na,TERMINATED,Centre d'Investigation Clinique et Technologique 805,
NCT02630134,These patients receive the Baeta device and take it home,OTHER,"Pain Measurement; Assessment, Pain",na,TERMINATED,NYU Langone Health,
NCT01574599,Occupational therapy- Repetitive Facilitative Exercise,OTHER,Stroke,na,TERMINATED,Mayo Clinic,
NCT00307099,Meropenem,DRUG,Bacterial Infection,phase3,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00307099,Standard antibiotic therapy,DRUG,Bacterial Infection,phase3,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02839798,NEST (NeoSync EEG Synchronized TMS),DEVICE,Major Depressive Episode; Bipolar Depression; Bipolar Disorder; Mood Disorders,phase2,TERMINATED,Butler Hospital,
NCT05243563,MonaLisa Touch,DEVICE,Vulvar Lichen Sclerosus,phase2; phase3,TERMINATED,University of South Alabama,
NCT05243563,Topical steroid,DRUG,Vulvar Lichen Sclerosus,phase2; phase3,TERMINATED,University of South Alabama,
NCT00900666,placebo,DRUG,Stiff Knee Gait; Brain Injuries,na,TERMINATED,Mary Free Bed Rehabilitation Hospital,
NCT00900666,botulinum toxin A (BTX-A),DRUG,Stiff Knee Gait; Brain Injuries,na,TERMINATED,Mary Free Bed Rehabilitation Hospital,
NCT01762956,Pelvic floor muscles training,OTHER,Prostate Cancer; Urologic Diseases,na,TERMINATED,University of Sao Paulo,
NCT01894022,Ambrisentan 5 mg,DRUG,Hypertension,phase3,TERMINATED,GlaxoSmithKline,
NCT00583102,Cytarabine,DRUG,Acute Myeloid Leukemia,phase1; phase2,TERMINATED,University of Iowa,
NCT00583102,Lovastatin,DRUG,Acute Myeloid Leukemia,phase1; phase2,TERMINATED,University of Iowa,
NCT02352753,Denosumab,DRUG,Osteogenesis Imperfecta,phase3,TERMINATED,Amgen,
NCT00198653,Newborn Thermal Care Practice,BEHAVIORAL,Hypothermia,na,TERMINATED,Johns Hopkins Bloomberg School of Public Health,
NCT00895245,fosaprepitant dimeglumine,DRUG,Nausea and Vomiting; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squa,phase2,TERMINATED,University of Washington,
NCT00895245,cisplatin,DRUG,Nausea and Vomiting; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squa,phase2,TERMINATED,University of Washington,
NCT00895245,palonosetron hydrochloride,DRUG,Nausea and Vomiting; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squa,phase2,TERMINATED,University of Washington,
NCT00895245,dexamethasone,DRUG,Nausea and Vomiting; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squa,phase2,TERMINATED,University of Washington,
NCT00895245,Functional Living Index-Emesis Questionnaire,OTHER,Nausea and Vomiting; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squa,phase2,TERMINATED,University of Washington,
NCT00895245,Emesis Diary,BEHAVIORAL,Nausea and Vomiting; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squa,phase2,TERMINATED,University of Washington,
NCT00895245,Radiotherapy,RADIATION,Nausea and Vomiting; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squa,phase2,TERMINATED,University of Washington,
NCT00677872,PRX-08066,DRUG,COPD; Pulmonary Hypertension,phase2,TERMINATED,"Epix Pharmaceuticals, Inc.",
NCT00242372,Tesaglitazar 0.5,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,AstraZeneca,
NCT00242372,Insulin at least 30 units/day,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,AstraZeneca,
NCT00162695,"Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide",DRUG,Rhabdomyosarcoma; Malignant Soft Tissue,phase3,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT03185481,1 mg QD to 15 mg QD PF-06649751,DRUG,Parkinson's Disease With Motor Fluctuations,phase2,TERMINATED,Pfizer,
NCT03185481,3 mg QD to 15 mg QD PF-06649751,DRUG,Parkinson's Disease With Motor Fluctuations,phase2,TERMINATED,Pfizer,
NCT03185481,7 mg QD to 15 mg QD PF-06649751,DRUG,Parkinson's Disease With Motor Fluctuations,phase2,TERMINATED,Pfizer,
NCT03185481,15 mg QD PF-06649751,DRUG,Parkinson's Disease With Motor Fluctuations,phase2,TERMINATED,Pfizer,
NCT03185481,1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study),DRUG,Parkinson's Disease With Motor Fluctuations,phase2,TERMINATED,Pfizer,
NCT03185481,3 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study),DRUG,Parkinson's Disease With Motor Fluctuations,phase2,TERMINATED,Pfizer,
NCT03185481,7 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study),DRUG,Parkinson's Disease With Motor Fluctuations,phase2,TERMINATED,Pfizer,
NCT03185481,15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD,DRUG,Parkinson's Disease With Motor Fluctuations,phase2,TERMINATED,Pfizer,
NCT03645681,InnAVasc arteriovenous graft surgical implant,DEVICE,"Kidney Failure, Chronic; Renal Dialysis",na,TERMINATED,W.L.Gore & Associates,
NCT00891800,Brachytherapy,DEVICE,Breast Cancer Metastatic to the Liver,phase2,TERMINATED,"St. Joseph's Hospital, Florida",
NCT00891800,SIR-Sphere,DEVICE,Breast Cancer Metastatic to the Liver,phase2,TERMINATED,"St. Joseph's Hospital, Florida",
NCT04099836,Atezolizumab,DRUG,Non Small Cell Lung Cancer,phase2,TERMINATED,Duke University,
NCT04099836,Bevacizumab,DRUG,Non Small Cell Lung Cancer,phase2,TERMINATED,Duke University,
NCT03058211,Echocardiography,OTHER,"Pneumonia, Pneumococcal; Myocardial Ischemia",na,TERMINATED,"Alejandro Rodriguez Oviedo , MD",
NCT03058211,Cardiac Magnetic resonance,OTHER,"Pneumonia, Pneumococcal; Myocardial Ischemia",na,TERMINATED,"Alejandro Rodriguez Oviedo , MD",
NCT03710564,Brolucizumab,BIOLOGICAL,Age-Related Macular Degeneration,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT03710564,Aflibercept,BIOLOGICAL,Age-Related Macular Degeneration,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT00813501,immunosuppressive therapy,BIOLOGICAL,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative,na,TERMINATED,City of Hope Medical Center,
NCT00813501,immunological diagnostic method,OTHER,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative,na,TERMINATED,City of Hope Medical Center,
NCT00813501,allogeneic hematopoietic stem cell transplantation,PROCEDURE,Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative,na,TERMINATED,City of Hope Medical Center,
NCT01608919,blood tests,OTHER,Venous Thromboembolism,na,TERMINATED,"University of Colorado, Denver",
NCT04506619,No Intervention,OTHER,Retinopathy of Prematurity (ROP); Intraventricular Hemorrhage; Bronchopulmonary Dysplasia; Chronic Lung Disease of Prematurity,na,TERMINATED,Oak Hill Bio Ltd,
NCT02296528,Swallowing Expansion Device,DEVICE,Oropharyngeal Dysphagia (OPD); Dysphagia,na,TERMINATED,"Peter Belafsky, MD",
NCT00081900,DENSPM ),DRUG,"Carcinoma, Hepatocellular",phase1; phase2,TERMINATED,"Genzyme, a Sanofi Company",
NCT02934932,Brexpiprazole,DRUG,Post Traumatic Stress Disorder,phase2,TERMINATED,Duke University,
NCT00084487,becatecarin,DRUG,Extensive Stage Small Cell Lung Cancer; Limited Stage Small Cell Lung Cancer; Recurrent Small Cell Lung Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT05035862,Albuterol Sulfate,DRUG,Asthma,phase1,TERMINATED,Emory University,
NCT05035862,Interferon gamma-primed mesenchymal stromal cells (MSCs),DRUG,Asthma,phase1,TERMINATED,Emory University,
NCT05035862,Prednisone,DRUG,Asthma,phase1,TERMINATED,Emory University,
NCT03066388,Pulse pressure variations,OTHER,Systemic Inflammatory Response Syndrome; Circulatory Failure; Mechanical Ventilation,na,TERMINATED,"University Hospital, Lille",
NCT00718588,MTRX1011A,DRUG,Rheumatoid Arthritis,phase1,TERMINATED,"Genentech, Inc.",
NCT02382588,gancyclovir gel,DRUG,Herpes Zoster Keratitis,phase2,TERMINATED,Northwestern University,
NCT02382588,Hypromellose gel,DRUG,Herpes Zoster Keratitis,phase2,TERMINATED,Northwestern University,
NCT00369603,Razadyne ER,DRUG,Alzheimer's Disease,phase4,TERMINATED,Duke University,
NCT00369603,Aricept,DRUG,Alzheimer's Disease,phase4,TERMINATED,Duke University,
NCT00004261,EF5,DRUG,Breast Cancer; Cervical Cancer; Head and Neck Cancer; Prostate Cancer; Sarcoma,phase1,TERMINATED,"University Health Network, Toronto",
NCT00004261,flow cytometry,OTHER,Breast Cancer; Cervical Cancer; Head and Neck Cancer; Prostate Cancer; Sarcoma,phase1,TERMINATED,"University Health Network, Toronto",
NCT00004261,fluorescent antibody technique,OTHER,Breast Cancer; Cervical Cancer; Head and Neck Cancer; Prostate Cancer; Sarcoma,phase1,TERMINATED,"University Health Network, Toronto",
NCT00004261,immunohistochemistry staining method,OTHER,Breast Cancer; Cervical Cancer; Head and Neck Cancer; Prostate Cancer; Sarcoma,phase1,TERMINATED,"University Health Network, Toronto",
NCT00004261,biopsy,PROCEDURE,Breast Cancer; Cervical Cancer; Head and Neck Cancer; Prostate Cancer; Sarcoma,phase1,TERMINATED,"University Health Network, Toronto",
NCT03539861,Hemodialysis,DEVICE,End Stage Renal Disease; Acute Kidney Injury; Chronic Kidney Disease Stage 5,na,TERMINATED,University of Michigan,
NCT04727073,Experimental: Spironolactone,DRUG,Heart Failure with Mid-range Ejection Fraction; Heart Failure with Preserved Ejection Fraction,phase3,TERMINATED,"Charite University, Berlin, Germany",
NCT04727073,Placebo Comparator,DRUG,Heart Failure with Mid-range Ejection Fraction; Heart Failure with Preserved Ejection Fraction,phase3,TERMINATED,"Charite University, Berlin, Germany",
NCT01233505,veliparib,DRUG,Adenocarcinoma of the Pancreas; Adenocarcinoma of the Stomach; BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Ovarian Mucinous Cystadenocarcinoma; Recurrent Breast Cancer; Recurrent Colon Cancer; Rec,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01233505,capecitabine,DRUG,Adenocarcinoma of the Pancreas; Adenocarcinoma of the Stomach; BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Ovarian Mucinous Cystadenocarcinoma; Recurrent Breast Cancer; Recurrent Colon Cancer; Rec,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01233505,oxaliplatin,DRUG,Adenocarcinoma of the Pancreas; Adenocarcinoma of the Stomach; BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Ovarian Mucinous Cystadenocarcinoma; Recurrent Breast Cancer; Recurrent Colon Cancer; Rec,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01233505,pharmacological study,OTHER,Adenocarcinoma of the Pancreas; Adenocarcinoma of the Stomach; BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Ovarian Mucinous Cystadenocarcinoma; Recurrent Breast Cancer; Recurrent Colon Cancer; Rec,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01233505,laboratory biomarker analysis,OTHER,Adenocarcinoma of the Pancreas; Adenocarcinoma of the Stomach; BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Ovarian Mucinous Cystadenocarcinoma; Recurrent Breast Cancer; Recurrent Colon Cancer; Rec,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03085394,tranexamic acid,DRUG,Intra-Operative Injury - Other; Post Operative Hemorrhage; Tranexamic Acid,phase3,TERMINATED,Sheba Medical Center,
NCT03085394,Placebo,DRUG,Intra-Operative Injury - Other; Post Operative Hemorrhage; Tranexamic Acid,phase3,TERMINATED,Sheba Medical Center,
NCT03397966,recombinant human BNP(1-32),DRUG,Obesity; Cardiovascular Physiological Phenomena; Metabolism,phase4,TERMINATED,VA Office of Research and Development,
NCT03397966,"placebo (control, normal saline)",DRUG,Obesity; Cardiovascular Physiological Phenomena; Metabolism,phase4,TERMINATED,VA Office of Research and Development,
NCT01389856,Bosentan,DRUG,Persistent Pulmonary Hypertension of the Newborn,phase3,TERMINATED,Actelion,
NCT01389856,Matching placebo,DRUG,Persistent Pulmonary Hypertension of the Newborn,phase3,TERMINATED,Actelion,
NCT00672451,rhubarb extract,OTHER,Diabetic Kidney Disease,phase2,TERMINATED,Wake Forest University,
NCT00672451,placebo,OTHER,Diabetic Kidney Disease,phase2,TERMINATED,Wake Forest University,
NCT00443729,Comparator: raltegravir,DRUG,HIV Infection,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00443729,Comparator: placebo,DRUG,HIV Infection,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00443729,Comparator: lopinavir (+) ritonavir,DRUG,HIV Infection,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00443729,Comparator: placebo,DRUG,HIV Infection,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT02699853,Questionnaire Administration,OTHER,Stage 0is Bladder Urothelial Carcinoma; Stage I Bladder Urothelial Carcinoma; Stage II Bladder Urothelial Carcinoma; Stage III Bladder Urothelial Carcinoma,na,TERMINATED,University of Southern California,
NCT02699853,Radical Cystectomy,PROCEDURE,Stage 0is Bladder Urothelial Carcinoma; Stage I Bladder Urothelial Carcinoma; Stage II Bladder Urothelial Carcinoma; Stage III Bladder Urothelial Carcinoma,na,TERMINATED,University of Southern California,
NCT02699853,Radical Cystectomy,PROCEDURE,Stage 0is Bladder Urothelial Carcinoma; Stage I Bladder Urothelial Carcinoma; Stage II Bladder Urothelial Carcinoma; Stage III Bladder Urothelial Carcinoma,na,TERMINATED,University of Southern California,
NCT06126003,Observation,OTHER,Breast Cancer,na,TERMINATED,BioCorteX Inc,
NCT03023527,Nivolumab,DRUG,Multiple Myeloma,phase1,TERMINATED,PETHEMA Foundation,
NCT03023527,Pomalidomide,DRUG,Multiple Myeloma,phase1,TERMINATED,PETHEMA Foundation,
NCT03023527,Dexamethasone,DRUG,Multiple Myeloma,phase1,TERMINATED,PETHEMA Foundation,
NCT03023527,Elotuzumab,DRUG,Multiple Myeloma,phase1,TERMINATED,PETHEMA Foundation,
NCT03264742,Ghrelin,OTHER,"DEMMMI, Nine-Hole-PEG-Test, mRS; Stroke, Acute",na,TERMINATED,Kantonsspital Winterthur KSW,
NCT00823342,CLEVUDINE + TENOFOVIR PLACEBO,DRUG,HBe Negative Chronic Hepatitis B; Hepatitis B Viral Infection,phase3,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00823342,CLEVUDINE IN ASSOCIATION TENOFOVIR,DRUG,HBe Negative Chronic Hepatitis B; Hepatitis B Viral Infection,phase3,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00823342,TENOFOVIR + CLEVUDINE PLACEBO,DRUG,HBe Negative Chronic Hepatitis B; Hepatitis B Viral Infection,phase3,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00427583,imatinib mesylate,DRUG,Malignant Peripheral Nerve Sheath Tumors,phase2; phase3,TERMINATED,Novartis Pharmaceuticals,
NCT00237783,dialysate sodium (140 mmol/L),DRUG,Hemodialysis; Hypotension,phase1,TERMINATED,Yale University,
NCT00237783,individualized dialysate sodium,DRUG,Hemodialysis; Hypotension,phase1,TERMINATED,Yale University,
NCT02081105,PEEP of 5 or 15 cm H2O,OTHER,Acute Respiratory Distress Syndrome (ARDS),na,TERMINATED,Hospices Civils de Lyon,
NCT03644251,amniotic and umbilical cord matrix,OTHER,Discogenic Back Pain,na,TERMINATED,"BioTissue Holdings, Inc",
NCT01007851,triptorelin acetate,DRUG,Infertility,phase3,TERMINATED,"V.K.V. American Hospital, Istanbul",
NCT01007851,NaCl %0.9,DRUG,Infertility,phase3,TERMINATED,"V.K.V. American Hospital, Istanbul",
NCT03697551,Satoreotide trizoxetan,DRUG,Breast Cancer,phase2,TERMINATED,Ipsen,
NCT00717431,Hippocampal Electrical Stimulation,PROCEDURE,Temporal Lobe Epilepsy,phase3,TERMINATED,University of Calgary,
NCT01412502,IES-R and HDAS scores,OTHER,"Stress Disorders, Post-Traumatic",na,TERMINATED,Centre Hospitalier Universitaire de Nīmes,
NCT01644526,Hemoaccess Valve System,DEVICE,End Stage Renal Disease,na,TERMINATED,Diaxamed LLC,
NCT05793476,Fotona Dynamis Er:YAG Laser System,DEVICE,Episiotomy Wound; Laser; Vulvodynia; Vulva Pain,na,TERMINATED,Istanbul University - Cerrahpasa,
NCT05793476,Fotona Dynamis Er:YAG Laser System with Sham handpiece,DEVICE,Episiotomy Wound; Laser; Vulvodynia; Vulva Pain,na,TERMINATED,Istanbul University - Cerrahpasa,
NCT03313076,Omega-3 fatty acids (fish oil),DRUG,Chronic Pain Following Thermal Burn Injury,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT03313076,Vitamin D3 (cholecalciferol),DRUG,Chronic Pain Following Thermal Burn Injury,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT03313076,Vitamin D3 (cholecalciferol) placebo,DRUG,Chronic Pain Following Thermal Burn Injury,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT03313076,Omega-3 fatty acid placebo,DRUG,Chronic Pain Following Thermal Burn Injury,phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT02864368,5-day TMZ,DRUG,Glioblastoma; Glioblastoma Multiforme,phase1,TERMINATED,"Eric Thompson, M.D.",
NCT02864368,21-day TMZ,DRUG,Glioblastoma; Glioblastoma Multiforme,phase1,TERMINATED,"Eric Thompson, M.D.",
NCT02864368,PEP-CMV: Component A,BIOLOGICAL,Glioblastoma; Glioblastoma Multiforme,phase1,TERMINATED,"Eric Thompson, M.D.",
NCT02864368,Tetanus-Diphtheria booster,DRUG,Glioblastoma; Glioblastoma Multiforme,phase1,TERMINATED,"Eric Thompson, M.D.",
NCT02864368,Tetanus Pre-Conditioning,DRUG,Glioblastoma; Glioblastoma Multiforme,phase1,TERMINATED,"Eric Thompson, M.D.",
NCT02864368,PEP-CMV: Component B,BIOLOGICAL,Glioblastoma; Glioblastoma Multiforme,phase1,TERMINATED,"Eric Thompson, M.D.",
NCT00651391,Ezetimibe + Simvastatin,DRUG,Hypercholesterolemia; Atherosclerosis,phase3,TERMINATED,Organon and Co,
NCT00651391,Simvastatin,DRUG,Hypercholesterolemia; Atherosclerosis,phase3,TERMINATED,Organon and Co,
NCT00651391,Placebo,DRUG,Hypercholesterolemia; Atherosclerosis,phase3,TERMINATED,Organon and Co,
NCT03263091,Roxadustat,DRUG,"Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts); Anemia",phase3,TERMINATED,Kyntra Bio,
NCT03263091,Placebo,DRUG,"Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts); Anemia",phase3,TERMINATED,Kyntra Bio,
NCT05251974,Quest beta blocker assay,OTHER,Congestive Heart Failure; Medication Adherence,na,TERMINATED,Summa Health System,
NCT06457997,PHN-010,DRUG,Lung Cancer; Colon Cancer; Endometrial Cancer; Ovarian Cancer; Cervical Cancer; Advanced Solid Tumor; Advanced Cancer,phase1,TERMINATED,Pheon Therapeutics,
NCT05242510,Patching,PROCEDURE,Exotropia,na,TERMINATED,University of Rochester,
NCT05242510,Prism Adaptation,PROCEDURE,Exotropia,na,TERMINATED,University of Rochester,
NCT02875613,Avelumab,DRUG,Nasopharyngeal Cancer,phase2,TERMINATED,"Assuntina Sacco, M.D.",
NCT01069120,Proellex,DRUG,Uterine Fibroids,phase3,TERMINATED,Repros Therapeutics Inc.,
NCT01069120,Proellex,DRUG,Uterine Fibroids,phase3,TERMINATED,Repros Therapeutics Inc.,
NCT02121184,Routine oxytocin,DRUG,Pregnancy; Labor Pain,na,TERMINATED,Northwestern University,
NCT02121184,Half-dose oxytocin,DRUG,Pregnancy; Labor Pain,na,TERMINATED,Northwestern University,
NCT01938833,Romidepsin,DRUG,HER2-negative Breast Cancer; Inflammatory Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT01938833,Abraxane,DRUG,HER2-negative Breast Cancer; Inflammatory Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer,phase1; phase2,TERMINATED,Sidney Kimmel Cancer Center at Thomas Jefferson University,
NCT05611047,Clinical assessment,OTHER,Multiple Sclerosis,na,TERMINATED,"University Hospital, Bordeaux",
NCT05611047,Classical cognitive evaluation of several domains:,OTHER,Multiple Sclerosis,na,TERMINATED,"University Hospital, Bordeaux",
NCT05611047,Ecological evaluation,OTHER,Multiple Sclerosis,na,TERMINATED,"University Hospital, Bordeaux",
NCT05611047,Patent reported outcomes (PRO's),BEHAVIORAL,Multiple Sclerosis,na,TERMINATED,"University Hospital, Bordeaux",
NCT05611047,Telerehabilitation : active procedure,OTHER,Multiple Sclerosis,na,TERMINATED,"University Hospital, Bordeaux",
NCT05611047,Telerehabilitation : comparator procedure,OTHER,Multiple Sclerosis,na,TERMINATED,"University Hospital, Bordeaux",
NCT00069849,ABT-089,DRUG,Alzheimer's Disease,phase2,TERMINATED,Abbott,
NCT02356458,Ibrutinib,DRUG,Mantle Cell Lymphoma,phase1; phase2,TERMINATED,Swiss Cancer Institute,
NCT02356458,bortezomib,DRUG,Mantle Cell Lymphoma,phase1; phase2,TERMINATED,Swiss Cancer Institute,
NCT01126255,Clobetasol propionate 0.05%,DRUG,Vulvar Lichen Sclerosus,phase2,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT01126255,Progesterone 8%,DRUG,Vulvar Lichen Sclerosus,phase2,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT02751385,Microgynon,DRUG,"Carcinoma, Non-Small-Cell Lung",phase1,TERMINATED,Boehringer Ingelheim,
NCT02751385,Nintedanib,DRUG,"Carcinoma, Non-Small-Cell Lung",phase1,TERMINATED,Boehringer Ingelheim,
NCT00744185,propranolol treatment,DRUG,"Hemangioma, Capillary",phase2; phase3,TERMINATED,"University Hospital, Bordeaux",
NCT00744185,placebo treatment,DRUG,"Hemangioma, Capillary",phase2; phase3,TERMINATED,"University Hospital, Bordeaux",
NCT04862143,Alpelisib,DRUG,Advanced Breast Cancer,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04862143,Fulvestrant,DRUG,Advanced Breast Cancer,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04862143,Goserelin,DRUG,Advanced Breast Cancer,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02386735,Placebo,DRUG,"Pulmonary Disease, Chronic Obstructive; Adverse Effect of Glucocorticoids and Synthetic Analogues; Disease Exacerbation",na,TERMINATED,Prof. Dr. Jörg Leuppi,
NCT02386735,Prednisone,DRUG,"Pulmonary Disease, Chronic Obstructive; Adverse Effect of Glucocorticoids and Synthetic Analogues; Disease Exacerbation",na,TERMINATED,Prof. Dr. Jörg Leuppi,
NCT01358708,LACTEOL® 340 mg,DRUG,Diarrhea-predominant Irritable Bowel Syndrome,phase3,TERMINATED,Forest Laboratories,
NCT01358708,PLACEBO,DRUG,Diarrhea-predominant Irritable Bowel Syndrome,phase3,TERMINATED,Forest Laboratories,
NCT00618540,alemtuzumab,BIOLOGICAL,"Histiocytosis, Langerhans-cell",phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00618540,fludarabine phosphate,DRUG,"Histiocytosis, Langerhans-cell",phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00618540,melphalan,DRUG,"Histiocytosis, Langerhans-cell",phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00618540,stem cell transplantation,PROCEDURE,"Histiocytosis, Langerhans-cell",phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT05148468,Active spinal cord stimulation,DEVICE,"Parkinson Disease; Gait Disorders, Neurologic",na,TERMINATED,University of Sao Paulo General Hospital,
NCT05148468,Sham spinal cord stimulation,DEVICE,"Parkinson Disease; Gait Disorders, Neurologic",na,TERMINATED,University of Sao Paulo General Hospital,
NCT00003491,Antineoplaston therapy (Atengenal + Astugenal),DRUG,Stage IV Lung Cancer,phase2,TERMINATED,Burzynski Research Institute,
NCT02817113,NC-6004,DRUG,Head and Neck Neoplasms,phase1,TERMINATED,"Orient Europharma Co., Ltd.",
NCT02817113,Cetuximab,DRUG,Head and Neck Neoplasms,phase1,TERMINATED,"Orient Europharma Co., Ltd.",
NCT02817113,5-FU,DRUG,Head and Neck Neoplasms,phase1,TERMINATED,"Orient Europharma Co., Ltd.",
NCT00801060,Lumiliximab + FCR,DRUG,Chronic Lymphocytic Leukemia,phase2,TERMINATED,Biogen,
NCT00801060,FCR,DRUG,Chronic Lymphocytic Leukemia,phase2,TERMINATED,Biogen,
NCT03264820,Laser Doppler,DEVICE,Vascular Diseases,na,TERMINATED,Rennes University Hospital,
NCT03264820,Laser speckle,DEVICE,Vascular Diseases,na,TERMINATED,Rennes University Hospital,
NCT03264820,pain evaluation,BEHAVIORAL,Vascular Diseases,na,TERMINATED,Rennes University Hospital,
NCT03264820,Blood pressure and heart rate,OTHER,Vascular Diseases,na,TERMINATED,Rennes University Hospital,
NCT04381182,Apollo Wearable Device,DEVICE,Stress; Heart Rate Variability,na,TERMINATED,Joseph Maroon,
NCT01789047,Topiramate,DRUG,Idiopathic Parkinson's Disease; Drug Induced Dyskinesia,phase2,TERMINATED,Rush University Medical Center,
NCT01789047,Placebo,DRUG,Idiopathic Parkinson's Disease; Drug Induced Dyskinesia,phase2,TERMINATED,Rush University Medical Center,
NCT01789047,Amantadine,DRUG,Idiopathic Parkinson's Disease; Drug Induced Dyskinesia,phase2,TERMINATED,Rush University Medical Center,
NCT06272058,Avenciguat (BI 685509),DRUG,Healthy; Liver Diseases,phase1,TERMINATED,Boehringer Ingelheim,
NCT01973348,4-hour AmblyZ glasses,DEVICE,Amblyopia,na,TERMINATED,Indiana University,
NCT01973348,12-hour AmblyZ glasses,DEVICE,Amblyopia,na,TERMINATED,Indiana University,
NCT01973348,2-hour patching,DEVICE,Amblyopia,na,TERMINATED,Indiana University,
NCT01973348,6-hour patching,DEVICE,Amblyopia,na,TERMINATED,Indiana University,
NCT05099926,Reducing Exercise Sensitivity with Exposure Training,BEHAVIORAL,Acute Coronary Syndrome; Fear Anxiety; Physical Inactivity,na,TERMINATED,Columbia University,
NCT02650635,Cyclophosphamide,DRUG,Colorectal Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Recurrent Breast Carcinoma; Recurrent Colorectal Carcinoma; Recurrent Melanoma of the Skin; Recurrent Non-Small Cell Lung Carcinoma; Re,phase1,TERMINATED,Mayo Clinic,
NCT02650635,Laboratory Biomarker Analysis,OTHER,Colorectal Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Recurrent Breast Carcinoma; Recurrent Colorectal Carcinoma; Recurrent Melanoma of the Skin; Recurrent Non-Small Cell Lung Carcinoma; Re,phase1,TERMINATED,Mayo Clinic,
NCT02650635,Pegfilgrastim,BIOLOGICAL,Colorectal Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Recurrent Breast Carcinoma; Recurrent Colorectal Carcinoma; Recurrent Melanoma of the Skin; Recurrent Non-Small Cell Lung Carcinoma; Re,phase1,TERMINATED,Mayo Clinic,
NCT02650635,Pharmacological Study,OTHER,Colorectal Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Recurrent Breast Carcinoma; Recurrent Colorectal Carcinoma; Recurrent Melanoma of the Skin; Recurrent Non-Small Cell Lung Carcinoma; Re,phase1,TERMINATED,Mayo Clinic,
NCT02650635,TLR8 Agonist VTX-2337,DRUG,Colorectal Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Recurrent Breast Carcinoma; Recurrent Colorectal Carcinoma; Recurrent Melanoma of the Skin; Recurrent Non-Small Cell Lung Carcinoma; Re,phase1,TERMINATED,Mayo Clinic,
NCT02120976,JTT-252 or Placebo,DRUG,Diabetes Mellitus,phase1,TERMINATED,Akros Pharma Inc.,
NCT02120976,JTT-252,DRUG,Diabetes Mellitus,phase1,TERMINATED,Akros Pharma Inc.,
NCT00116389,talabostat mesylate tablets,DRUG,Pancreatic Cancer; Neoplasm Metastasis; Adenocarcinoma,phase2,TERMINATED,Point Therapeutics,
NCT00116389,gemcitabine,DRUG,Pancreatic Cancer; Neoplasm Metastasis; Adenocarcinoma,phase2,TERMINATED,Point Therapeutics,
NCT00122668,non-nucleoside reverse transcriptase inhibitors,DRUG,HIV Infections; HIV-Associated Lipodystrophy Syndrome,phase4,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00122668,nucleoside reverse transcriptase inhibitors,DRUG,HIV Infections; HIV-Associated Lipodystrophy Syndrome,phase4,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00122668,protease inhibitor,DRUG,HIV Infections; HIV-Associated Lipodystrophy Syndrome,phase4,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT02943668,Deferasirox,DRUG,Anemia; Myelodysplastic Syndrome,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT02943668,Laboratory Biomarker Analysis,OTHER,Anemia; Myelodysplastic Syndrome,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT02029690,ADI-PEG 20,DRUG,Pleural Mesothelioma Malignant Advanced; Peritoneal Mesothelioma Malignant Advanced; Non-squamous Non-small Cell Lung Carcinoma; Uveal Melanoma; Hepatocellular Carcinoma; Glioma; Sarcomatoid Carcinoma,phase1,TERMINATED,Polaris Group,
NCT00434590,Enteric coated mycophenolate sodium (Myfortic®),DRUG,Kidney Transplantation,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT00670410,Related donor transplant,PROCEDURE,Neuroblastoma,phase1,TERMINATED,Columbia University,
NCT00670410,Cord blood transplant,PROCEDURE,Neuroblastoma,phase1,TERMINATED,Columbia University,
NCT00670410,Busulfan,DRUG,Neuroblastoma,phase1,TERMINATED,Columbia University,
NCT00670410,Thymoglobulin,DRUG,Neuroblastoma,phase1,TERMINATED,Columbia University,
NCT00670410,Fludarabine,DRUG,Neuroblastoma,phase1,TERMINATED,Columbia University,
NCT06237855,Self-drain removal,OTHER,Ventral Hernia,na,TERMINATED,Wake Forest University Health Sciences,
NCT05312008,Intranasal oxytocin,DRUG,Alcohol Use Disorder,phase2,TERMINATED,Indiana University,
NCT05312008,Intranasal placebo,DRUG,Alcohol Use Disorder,phase2,TERMINATED,Indiana University,
NCT02475525,Arginine enriched oral nutritional supplement,OTHER,Peripheral Vascular Disease; Claudication,na,TERMINATED,University of Limerick,
NCT01374217,Tadalafil,DRUG,Multiple Myeloma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01374217,Lenalidomide,DRUG,Multiple Myeloma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01374217,Dexamethasone,DRUG,Multiple Myeloma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT01374217,Clarithromycin,DRUG,Multiple Myeloma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00227617,bevacizumab,BIOLOGICAL,Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome; Neuroendocrine Tumor,phase2; phase3,TERMINATED,"University of California, San Francisco",
NCT00227617,5-fluorouracil,DRUG,Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome; Neuroendocrine Tumor,phase2; phase3,TERMINATED,"University of California, San Francisco",
NCT00227617,leucovorin,DRUG,Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome; Neuroendocrine Tumor,phase2; phase3,TERMINATED,"University of California, San Francisco",
NCT00227617,oxaliplatin,DRUG,Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome; Neuroendocrine Tumor,phase2; phase3,TERMINATED,"University of California, San Francisco",
NCT01077440,DNA analysis,OTHER,Cancer Survivor; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblas,na,TERMINATED,Vanderbilt University,
NCT01077440,polymerase chain reaction,OTHER,Cancer Survivor; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblas,na,TERMINATED,Vanderbilt University,
NCT01077440,flow cytometry,OTHER,Cancer Survivor; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblas,na,TERMINATED,Vanderbilt University,
NCT01077440,laboratory biomarker analysis,OTHER,Cancer Survivor; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblas,na,TERMINATED,Vanderbilt University,
NCT00316017,7.5% hypertonic saline/6% Dextran-70 (HSD),DRUG,"Shock, Traumatic",phase3,TERMINATED,University of Washington,
NCT00316017,7.5% hypertonic saline (HS),DRUG,"Shock, Traumatic",phase3,TERMINATED,University of Washington,
NCT00316017,0.9% normal saline,DRUG,"Shock, Traumatic",phase3,TERMINATED,University of Washington,
NCT00979940,Atorvastatin,DRUG,Coronary Artery Disease,na,TERMINATED,Indiana University School of Medicine,
NCT01116791,Cytoreductive Surgery (CRS) plus Hyperthermic Intraoperative Peritoneal Chemotherapy with Cisplatin (HIPC),PROCEDURE,Peritoneal Carcinomatosis; Gastrointestinal Cancer,phase2,TERMINATED,Baki Topal,
NCT02873624,Laparoscopic cholecystectomy,PROCEDURE,"Acute Kidney Injury ,Laparoscopic Cholecystectomy",na,TERMINATED,Western Galilee Hospital-Nahariya,
NCT03151096,Riboflavin,OTHER,High Blood Pressure; MTHFR C677T Genotype,na,TERMINATED,London School of Hygiene and Tropical Medicine,
NCT03151096,Placebo,OTHER,High Blood Pressure; MTHFR C677T Genotype,na,TERMINATED,London School of Hygiene and Tropical Medicine,
NCT06785103,Risk assessment messaging,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,U=U messaging,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,Healthy Living messaging,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,Community benefits messaging,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,Fresh start effect,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,Education-based messaging (#1),BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,Education-based #2 messaging (gamification),BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,Default appointment messaging,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,Reserved for you messaging,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,Social norms messaging,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT06785103,Empowerment messaging,BEHAVIORAL,HIV,na,TERMINATED,"University of California, San Francisco",
NCT00303303,Crotaline Polyvalent Immune Fab (ovine) (active initial and maintenance therapy),BIOLOGICAL,Snake Envenomation,phase4,TERMINATED,Wake Forest University Health Sciences,
NCT00303303,Crotaline Immune Fab (ovine) (active initial therapy; placebo maintenance therapy),BIOLOGICAL,Snake Envenomation,phase4,TERMINATED,Wake Forest University Health Sciences,
NCT00303303,Placebo,BIOLOGICAL,Snake Envenomation,phase4,TERMINATED,Wake Forest University Health Sciences,
NCT00976027,Trivalent inactivated influenza vaccine High Dose,BIOLOGICAL,Influenza,phase3,TERMINATED,Sanofi,
NCT00976027,Trivalent inactivated influenza vaccine,BIOLOGICAL,Influenza,phase3,TERMINATED,Sanofi,
NCT01728961,Artemether/Lumefantrine (AL),DRUG,HIV Infection; Malaria,phase4,TERMINATED,International Maternal Pediatric Adolescent AIDS Clinical Trials Group,
NCT01319669,recombinant human thrombopoietin,DRUG,"Carcinoma, Non-Small-Cell Lung",phase2; phase3,TERMINATED,Chinese Society of Lung Cancer,
NCT04900766,Mitoxantrone Hydrochloride Liposome Injection,DRUG,Unresectable or Metastatic Bone and Soft Tissue Sarcoma,phase1,TERMINATED,"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",
NCT04470622,Aprepitant injectable emulsion,DRUG,COVID-19,phase2,TERMINATED,Heron Therapeutics,
NCT04470622,Saline Placebo,DRUG,COVID-19,phase2,TERMINATED,Heron Therapeutics,
NCT03709251,High Intensity Walking,BEHAVIORAL,Frailty,na,TERMINATED,Northwestern University,
NCT03709251,Casual Speed Walking,BEHAVIORAL,Frailty,na,TERMINATED,Northwestern University,
NCT00915629,Lactibiane candisis 5M,OTHER,Vaginal Candidiasis,na,TERMINATED,PiLeJe,
NCT02994953,Avelumab,DRUG,Advanced Solid Tumors,phase1,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02994953,M9241,DRUG,Advanced Solid Tumors,phase1,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02994953,Avelumab (Once weekly),DRUG,Advanced Solid Tumors,phase1,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02994953,M9241 (MTD),DRUG,Advanced Solid Tumors,phase1,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT02994953,Avelumab (Expansion cohort),DRUG,Advanced Solid Tumors,phase1,TERMINATED,"EMD Serono Research & Development Institute, Inc.",
NCT03188653,CeraVe® Eczema Soothing Body Wash,OTHER,Atopic Dermatitis,na,TERMINATED,University of Arizona,
NCT03188653,Cetaphil® RestoraDerm® Eczema Calming Body Wash,OTHER,Atopic Dermatitis,na,TERMINATED,University of Arizona,
NCT03188653,Dove® Sensitive Skin Body Wash,OTHER,Atopic Dermatitis,na,TERMINATED,University of Arizona,
NCT03188653,Eucerin® Skin Calming Body Wash,OTHER,Atopic Dermatitis,na,TERMINATED,University of Arizona,
NCT03188653,Aveeno® Skin Relief Body Wash,OTHER,Atopic Dermatitis,na,TERMINATED,University of Arizona,
NCT03188653,MooGoo® Milk Wash,OTHER,Atopic Dermatitis,na,TERMINATED,University of Arizona,
NCT03188653,Free & Clear Liquid Cleanser,OTHER,Atopic Dermatitis,na,TERMINATED,University of Arizona,
NCT01858753,Autologous fibroblasts,BIOLOGICAL,Restrictive Burn Scars,phase2,TERMINATED,"Castle Creek Biosciences, LLC.",
NCT01858753,placebo sterile saline,BIOLOGICAL,Restrictive Burn Scars,phase2,TERMINATED,"Castle Creek Biosciences, LLC.",
NCT00651131,daptomycin,DRUG,Wound Infections,phase4,TERMINATED,"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
NCT01762137,Flow Diversion,PROCEDURE,Intracranial Aneurysm,phase4,TERMINATED,Medical University of South Carolina,
NCT01762137,Coiling,PROCEDURE,Intracranial Aneurysm,phase4,TERMINATED,Medical University of South Carolina,
NCT00004037,docetaxel,DRUG,Ovarian Cancer; Primary Peritoneal Cavity Cancer,phase2,TERMINATED,Gynecologic Oncology Group,
NCT00156572,Sodium supplementation,PROCEDURE,Bronchopulmonary Dysplasia; Hyponatremia on Diuretics,phase3,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT00156572,Fluid restriction,PROCEDURE,Bronchopulmonary Dysplasia; Hyponatremia on Diuretics,phase3,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT00823095,Nitric Oxide,DRUG,Chronic Ulcer of Lower Extremity,phase2,TERMINATED,Loma Linda University,
NCT05778695,Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate,OTHER,Parkinson Disease; Lewy Body Dementia; Parkinson Disease Dementia,na,TERMINATED,University of Michigan,
NCT00768339,AEG35156 antisense IV infusion,DRUG,"Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell",phase1; phase2,TERMINATED,Aegera Therapeutics,
NCT06108739,Cyclophosphamid,DRUG,Hematologic Malignancy,phase3,TERMINATED,Peking University People's Hospital,
NCT06108739,ATG,DRUG,Hematologic Malignancy,phase3,TERMINATED,Peking University People's Hospital,
NCT03302949,Lacprodan® DI-8090,OTHER,"Tuberculosis; Tuberculosis, Pulmonary; Undernutrition; Malnutrition",na,TERMINATED,University of Aarhus,
NCT02104349,Mindfulness meditation,BEHAVIORAL,"Meditation; Spine Surgery; Pain, Postoperative",na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT01025648,"E004 (epinephrine inhalation aerosol), 90 mcg/actuation",DRUG,Asthma,phase1; phase2,TERMINATED,"Amphastar Pharmaceuticals, Inc.",
NCT01025648,E004 Placebo,DRUG,Asthma,phase1; phase2,TERMINATED,"Amphastar Pharmaceuticals, Inc.",
NCT01025648,"E004 (epinephrine inhalation aerosol), 125 mcg",DRUG,Asthma,phase1; phase2,TERMINATED,"Amphastar Pharmaceuticals, Inc.",
NCT01025648,"E004 (epinephrine inhalation aerosol), 220 mcg",DRUG,Asthma,phase1; phase2,TERMINATED,"Amphastar Pharmaceuticals, Inc.",
NCT01025648,"epinephrine inhalation aerosol, CFC propelled",DRUG,Asthma,phase1; phase2,TERMINATED,"Amphastar Pharmaceuticals, Inc.",
NCT01025648,"E004 (epinephrine inhalation aerosol), 160 mcg",DRUG,Asthma,phase1; phase2,TERMINATED,"Amphastar Pharmaceuticals, Inc.",
NCT00558558,Haelan,DRUG,Anorexia; Weight Loss; Cachexia,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00152815,antioxidant vitamin E,DRUG,HIV Infections; Fatty Liver,phase2,TERMINATED,Johane Allard,
NCT00152815,weight reduction and exercise,BEHAVIORAL,HIV Infections; Fatty Liver,phase2,TERMINATED,Johane Allard,
NCT04810208,Docetaxel,DRUG,Solid Tumor,phase1,TERMINATED,Lidds AB,
NCT00450008,GM-CSF,DRUG,Prostatic Neoplasms,phase2,TERMINATED,The Methodist Hospital Research Institute,
NCT00450008,thalidomide,DRUG,Prostatic Neoplasms,phase2,TERMINATED,The Methodist Hospital Research Institute,
NCT00450008,docetaxel,DRUG,Prostatic Neoplasms,phase2,TERMINATED,The Methodist Hospital Research Institute,
NCT04581525,transcranial direct current stimulation,DEVICE,"Pain, Neuropathic; Complex Regional Pain Syndromes; Phantom Limb Pain; Spinal Cord Injuries",na,TERMINATED,Susan McDowell,
NCT01618591,Single dose rifaximin 1650 mg,DRUG,Acute Watery Diarrhea; Dysentery/Febrile Diarrhea,na,TERMINATED,Uniformed Services University of the Health Sciences,
NCT01618591,Single dose azithromycin 500 mg,DRUG,Acute Watery Diarrhea; Dysentery/Febrile Diarrhea,na,TERMINATED,Uniformed Services University of the Health Sciences,
NCT01618591,Single dose levofloxacin 500 mg,DRUG,Acute Watery Diarrhea; Dysentery/Febrile Diarrhea,na,TERMINATED,Uniformed Services University of the Health Sciences,
NCT01618591,Single dose azithromycin 1000 mg plus loperamide,DRUG,Acute Watery Diarrhea; Dysentery/Febrile Diarrhea,na,TERMINATED,Uniformed Services University of the Health Sciences,
NCT01618591,Single dose azithromycin 1000 mg plus placebo,DRUG,Acute Watery Diarrhea; Dysentery/Febrile Diarrhea,na,TERMINATED,Uniformed Services University of the Health Sciences,
NCT04128774,Dexamethasone,DRUG,"Glioblastoma, Adult",na,TERMINATED,"Amsterdam UMC, location VUmc",
NCT03275974,Carbon C 11 Glutamine,BIOLOGICAL,RAS Wild Type; Stage IV Colorectal Cancer; Stage IVA Colorectal Cancer; Stage IVB Colorectal Cancer,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT03275974,Fluorine F 18 L-glutamate Derivative BAY94-9392,BIOLOGICAL,RAS Wild Type; Stage IV Colorectal Cancer; Stage IVA Colorectal Cancer; Stage IVB Colorectal Cancer,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT03275974,Positron Emission Tomography,PROCEDURE,RAS Wild Type; Stage IV Colorectal Cancer; Stage IVA Colorectal Cancer; Stage IVB Colorectal Cancer,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT03275974,Blood Draw,PROCEDURE,RAS Wild Type; Stage IV Colorectal Cancer; Stage IVA Colorectal Cancer; Stage IVB Colorectal Cancer,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT01264874,Vitamin D3 ( Colecalciferol),DRUG,Melanoma,phase3,TERMINATED,European Institute of Oncology,
NCT01264874,placebo,OTHER,Melanoma,phase3,TERMINATED,European Institute of Oncology,
NCT01914718,DA-EPOCH-R,DRUG,Diffuse Large B-cell Lymphoma,phase2,TERMINATED,Fudan University,
NCT03635697,Mindfulness Auditory Intervention,BEHAVIORAL,Anxiety; Depression; Mindfulness,na,TERMINATED,UConn Health,
NCT04732897,dynamic dressing,PROCEDURE,Hallux Abductovalgus,na,TERMINATED,Centre Hospitalier Annecy Genevois,
NCT00379197,naltrexone,DRUG,Breast Cancer,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00379197,PET scan,PROCEDURE,Breast Cancer,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT04352413,PLM60,DRUG,Small Cell Lung Cancer,phase2,TERMINATED,"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",
NCT06602960,Accurate Sleep Data Feedback,BEHAVIORAL,"Sleep; Sleep Quality; Sleepiness, Daytime; Technology",na,TERMINATED,"NextSense, Inc.",
NCT06602960,Inflated Sleep Data Feedback,BEHAVIORAL,"Sleep; Sleep Quality; Sleepiness, Daytime; Technology",na,TERMINATED,"NextSense, Inc.",
NCT06602960,Deflated Sleep Data Feedback,BEHAVIORAL,"Sleep; Sleep Quality; Sleepiness, Daytime; Technology",na,TERMINATED,"NextSense, Inc.",
NCT06602960,Accurate Sleep Data Feedback + Sleep-related Educational Information,BEHAVIORAL,"Sleep; Sleep Quality; Sleepiness, Daytime; Technology",na,TERMINATED,"NextSense, Inc.",
NCT00574860,EN3285,DRUG,Oral Mucositis; Head and Neck Cancer,phase3,TERMINATED,Endo Pharmaceuticals,
NCT00574860,Placebo,DRUG,Oral Mucositis; Head and Neck Cancer,phase3,TERMINATED,Endo Pharmaceuticals,
NCT00574860,Standard of care,OTHER,Oral Mucositis; Head and Neck Cancer,phase3,TERMINATED,Endo Pharmaceuticals,
NCT03814382,Acupuncture needle,DEVICE,Alzheimer's Dementia With Behavioral Disturbance,na,TERMINATED,Massachusetts General Hospital,
NCT01783873,standardized bronchial challenge test (SCL SCL • • GenaSOL ™ GenaSIC ™),OTHER,Occupational Asthma,na,TERMINATED,"University Hospital, Strasbourg, France",
NCT00460473,Dexmedetomidine,DRUG,Delirium,phase3,TERMINATED,"Hospira, now a wholly owned subsidiary of Pfizer",
NCT00460473,Placebo,DRUG,Delirium,phase3,TERMINATED,"Hospira, now a wholly owned subsidiary of Pfizer",
NCT03382769,Cochlear implantation,DEVICE,"Hearing Loss, Sensorineural; Hearing Loss, Bilateral",na,TERMINATED,Cochlear,
NCT05223673,Futuximab/modotuximab,BIOLOGICAL,Metastatic Colorectal Cancer,phase3,TERMINATED,Institut de Recherches Internationales Servier,
NCT05223673,Trifluridine/Tipiracil,DRUG,Metastatic Colorectal Cancer,phase3,TERMINATED,Institut de Recherches Internationales Servier,
NCT05223673,Trifluridine/Tipiracil,DRUG,Metastatic Colorectal Cancer,phase3,TERMINATED,Institut de Recherches Internationales Servier,
NCT00308594,Dexamethasone,DRUG,Cervical Radiculopathy,phase2,TERMINATED,University of Manitoba,
NCT04506866,InterStim Micro,DEVICE,Overactive Bladder; Fecal Incontinence; Non-obstructive Urinary Retention,na,TERMINATED,MedtronicNeuro,
NCT00020722,therapeutic autologous lymphocytes,BIOLOGICAL,Breast Cancer,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00020722,"Ifosfamide, carboplatin, and etoposide (ICE) regimen",DRUG,Breast Cancer,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00020722,"Cyclophosphamide, Thiotepa, Carboplatin (CTC) or STAMP V (CTC)",DRUG,Breast Cancer,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00020722,Leukapheresis,PROCEDURE,Breast Cancer,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00020722,peripheral blood stem cell transplantation (PBSCT),PROCEDURE,Breast Cancer,phase2,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT01644253,20 mg/kg TRU-016 + Rituximab,BIOLOGICAL,Chronic Lymphocytic Leukemia; Peripheral T-cell Lymphoma,phase1,TERMINATED,Aptevo Therapeutics,
NCT01644253,10 mg/kg TRU-016 + Rituximab,BIOLOGICAL,Chronic Lymphocytic Leukemia; Peripheral T-cell Lymphoma,phase1,TERMINATED,Aptevo Therapeutics,
NCT01644253,TRU-016 20 mg/kg + Obinutuzumab,BIOLOGICAL,Chronic Lymphocytic Leukemia; Peripheral T-cell Lymphoma,phase1,TERMINATED,Aptevo Therapeutics,
NCT01644253,TRU-016 6-20 mg/kg + idelalisib + rituximab,BIOLOGICAL,Chronic Lymphocytic Leukemia; Peripheral T-cell Lymphoma,phase1,TERMINATED,Aptevo Therapeutics,
NCT01644253,TRU-016 10-20 mg/kg + ibrutinib,BIOLOGICAL,Chronic Lymphocytic Leukemia; Peripheral T-cell Lymphoma,phase1,TERMINATED,Aptevo Therapeutics,
NCT01644253,TRU-016 10-20 mg/kg + bendamustine,BIOLOGICAL,Chronic Lymphocytic Leukemia; Peripheral T-cell Lymphoma,phase1,TERMINATED,Aptevo Therapeutics,
NCT02529696,Accelerometer,DEVICE,Anesthesia,na,TERMINATED,University of Minnesota,
NCT03727503,PPV from the capstesia,OTHER,Surgery,na,TERMINATED,Erasme University Hospital,
NCT01855061,Biopsy,PROCEDURE,Neoplasm Metastasis,na,TERMINATED,P.O. Witteveen,
NCT01855061,Blood samples,PROCEDURE,Neoplasm Metastasis,na,TERMINATED,P.O. Witteveen,
NCT01855061,Pharmacokinetics,PROCEDURE,Neoplasm Metastasis,na,TERMINATED,P.O. Witteveen,
NCT01855061,Midazolam clearance test,PROCEDURE,Neoplasm Metastasis,na,TERMINATED,P.O. Witteveen,
NCT01811927,PRO-Kinetic Energy Stent,DEVICE,Coronary Artery Disease,na,TERMINATED,Biotronik AG,
NCT00748969,Somatropin (DNA origin),DRUG,Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis VI,phase2; phase3,TERMINATED,Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center,
NCT04050969,Bariatric surgery,PROCEDURE,Atrial Fibrillation; Morbid Obesity,na,TERMINATED,Stanford University,
NCT04050969,Atrial Fibrillation (AF) Catheter Ablation,PROCEDURE,Atrial Fibrillation; Morbid Obesity,na,TERMINATED,Stanford University,
NCT05315583,Collection of biological samples,OTHER,COVID-19; SARS CoV 2 Infection,na,TERMINATED,Centre Hospitalier Régional d'Orléans,
NCT01853241,Single Balloon,PROCEDURE,Gastrointestinal Hemorrhage; Inflammatory Bowel Disease; Gastrointestinal Neoplasms,na,TERMINATED,Johns Hopkins University,
NCT01853241,Spirus,PROCEDURE,Gastrointestinal Hemorrhage; Inflammatory Bowel Disease; Gastrointestinal Neoplasms,na,TERMINATED,Johns Hopkins University,
NCT03960541,Efprezimod alfa (human CD24 extracellular domain and human IgG1 Fc fusion protein),DRUG,HIV Infections; Dyslipidemias,phase2,TERMINATED,"Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
NCT03960541,Saline Solution,DRUG,HIV Infections; Dyslipidemias,phase2,TERMINATED,"Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
NCT03714854,transcranial magnetic stimulation,DEVICE,Parkinson Disease,na,TERMINATED,"University Hospital, Grenoble",
NCT02101554,Ages 7-11,DRUG,Moderate-severe Pain,phase4,TERMINATED,Pfizer,
NCT02101554,ages 12-17,DRUG,Moderate-severe Pain,phase4,TERMINATED,Pfizer,
NCT05098405,"MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q3w regimen)",DRUG,Advanced Malignant Solid Tumor,phase1,TERMINATED,Molecular Partners AG,
NCT05098405,"MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regimen)",DRUG,Advanced Malignant Solid Tumor,phase1,TERMINATED,Molecular Partners AG,
NCT04211922,Alkotinib Capsules,DRUG,ALK-positive Non-small Cell Lung Cancer,phase2,TERMINATED,"Suzhou Zelgen Biopharmaceuticals Co.,Ltd",
NCT02540551,Injection of radioactive tracer combined with Patent Blue,PROCEDURE,Ovarian Neoplasms; Sentinel Node,phase1,TERMINATED,Maastricht University Medical Center,
NCT01977729,Sertraline,DRUG,Anxiety Disorder of Adolescence,phase2,TERMINATED,Yale University,
NCT01977729,Cognitive Behavioral Therapy,BEHAVIORAL,Anxiety Disorder of Adolescence,phase2,TERMINATED,Yale University,
NCT05234437,tigilanol tiglate,DRUG,Melanoma,phase2,TERMINATED,QBiotics Group Limited,
NCT02928445,RVT-101 35 mg,DRUG,Dementia With Lewy Bodies,phase2; phase3,TERMINATED,Axovant Sciences Ltd.,
NCT02928445,RVT-101 70 mg,DRUG,Dementia With Lewy Bodies,phase2; phase3,TERMINATED,Axovant Sciences Ltd.,
NCT03094169,AVID100 IV,DRUG,"Solid Tumor, Adult; Triple Negative Breast Cancer; Head and Neck Squamous Cell Carcinoma; Non Small Cell Lung Cancer",phase1; phase2,TERMINATED,Formation Biologics,
NCT00159354,predisolone,DRUG,COPD,na,TERMINATED,Imperial College London,
NCT05301894,NBI-827104,DRUG,Epileptic Encephalopathy; Continuous Spike and Wave During Sleep,phase2,TERMINATED,Neurocrine Biosciences,
NCT02838966,Nestle IMPACT Advanced Recovery,OTHER,Pancreatic Adenocarcinoma,na,TERMINATED,University of Louisville,
NCT02838966,Nestle Boost High Protein Drink,OTHER,Pancreatic Adenocarcinoma,na,TERMINATED,University of Louisville,
NCT03341156,Kcentra,DRUG,Heart Disease End Stage; Heart Failure，Congestive,phase3,TERMINATED,"University of Maryland, Baltimore",
NCT03341156,"Frozen Plasma Product, Human",DRUG,Heart Disease End Stage; Heart Failure，Congestive,phase3,TERMINATED,"University of Maryland, Baltimore",
NCT02557529,Progressive Resistance Training,BEHAVIORAL,Head and Neck Neoplasms; Weight Loss,na,TERMINATED,Herlev Hospital,
NCT02557529,physical activity,BEHAVIORAL,Head and Neck Neoplasms; Weight Loss,na,TERMINATED,Herlev Hospital,
NCT02557529,Diet diary,BEHAVIORAL,Head and Neck Neoplasms; Weight Loss,na,TERMINATED,Herlev Hospital,
NCT03779802,Device programming of ABBOTT CRT pacemaker or defibrillator,OTHER,Heart Failure; Cardiac Resynchronization Therapy,na,TERMINATED,CMC Ambroise Paré,
NCT03746353,early ileostomy closure,PROCEDURE,Colonic Neoplasms; Ileostomy - Stoma; Colorectal Surgery,na,TERMINATED,"Instituto Nacional de Cancerologia, Columbia",
NCT02693002,Estradiol/Norethindrone acetate,DRUG,Menopause,phase4,TERMINATED,Gretchen Wells,
NCT02693002,Placebo,DRUG,Menopause,phase4,TERMINATED,Gretchen Wells,
NCT04808362,OMO-103,BIOLOGICAL,Advanced Solid Tumors; Pancreatic Cancer; CRC,phase1; phase2,TERMINATED,Peptomyc S.L.,
NCT05760703,STSG-0002 Injection,DRUG,Chronic Hepatitis b,phase2,TERMINATED,"Staidson (Beijing) Biopharmaceuticals Co., Ltd",
NCT01765803,Mellaril,DRUG,Healthy Subjects,early_phase1,TERMINATED,New Mexico Cancer Research Alliance,
NCT00020670,CD 40,BIOLOGICAL,Leukemia,early_phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT00290654,Tamoxifen,DRUG,Breast Cancer,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00290654,Lumpectomy,PROCEDURE,Breast Cancer,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00290654,brachytherapy,RADIATION,Breast Cancer,phase2,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT02487394,Exhaled Breath Condensate (EBC),PROCEDURE,Asthma; COPD,na,TERMINATED,"The University of Texas Medical Branch, Galveston",
NCT00196651,IL-2,DRUG,HIV Infection,phase2,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00196651,LIPO-6T,BIOLOGICAL,HIV Infection,phase2,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00196651,ALVAC VIH 1433,BIOLOGICAL,HIV Infection,phase2,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT03078829,Treatment with a GnRh agonists,DRUG,Gender Dysphoria,na,TERMINATED,"University of California, San Francisco",
NCT03676231,SGM-1019,DRUG,Nonalcoholic Steatohepatitis,phase2,TERMINATED,Second Genome,
NCT03676231,Placebo,DRUG,Nonalcoholic Steatohepatitis,phase2,TERMINATED,Second Genome,
NCT03633747,Propranolol Hydrochloride,DRUG,Hemangioma Liver,phase1; phase2,TERMINATED,"Second Affiliated Hospital, School of Medicine, Zhejiang University",
NCT02281838,labetalol/hydralazine/enalapril,DRUG,Intracerebral Hemorrhage,phase2,TERMINATED,University of Alberta,
NCT00203385,Divalproex,DRUG,PTSD,phase4,TERMINATED,Tuscaloosa Research & Education Advancement Corporation,
NCT00820443,Ceramic on metal prosthesis,DEVICE,Total Hip Replacement System,phase4,TERMINATED,MicroPort Orthopedics Inc.,
NCT00245115,filgrastim,BIOLOGICAL,Leukemia,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00245115,busulfan,DRUG,Leukemia,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00245115,cyclophosphamide,DRUG,Leukemia,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00245115,in vitro-treated bone marrow transplantation,PROCEDURE,Leukemia,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00245115,in vitro-treated peripheral blood stem cell transplantation,PROCEDURE,Leukemia,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT05326035,WJ05129,DRUG,Locally Advanced or Metastatic Malignant Solid Tumors,phase1; phase2,TERMINATED,"Suzhou Junjing BioSciences Co., Ltd.",
NCT05326035,Paclitaxel injection,DRUG,Locally Advanced or Metastatic Malignant Solid Tumors,phase1; phase2,TERMINATED,"Suzhou Junjing BioSciences Co., Ltd.",
NCT01044108,NNC 0070-0002-0453,DRUG,Metabolism and Nutrition Disorder; Obesity,phase1,TERMINATED,Novo Nordisk A/S,
NCT01044108,'2-0453,DRUG,Metabolism and Nutrition Disorder; Obesity,phase1,TERMINATED,Novo Nordisk A/S,
NCT01044108,placebo,DRUG,Metabolism and Nutrition Disorder; Obesity,phase1,TERMINATED,Novo Nordisk A/S,
NCT03651076,"Traxi panniculus retraction (Clinical Innovations, LLC)",DEVICE,"Obesity, Morbid; Cesarean Section Complications",na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT03942276,High intensity interval training,OTHER,Hypertension; Menopause,na,TERMINATED,Federal University of Uberlandia,
NCT03942276,Moderate intensity continuous training,OTHER,Hypertension; Menopause,na,TERMINATED,Federal University of Uberlandia,
NCT03942276,Control,OTHER,Hypertension; Menopause,na,TERMINATED,Federal University of Uberlandia,
NCT02387840,Magnetic Resonance Imaging,DEVICE,Neurofibromatosis Type 1; Brain Tumor; Glioma,na,TERMINATED,Case Comprehensive Cancer Center,
NCT02387840,Magnetic Resonance Fingerprinting,DEVICE,Neurofibromatosis Type 1; Brain Tumor; Glioma,na,TERMINATED,Case Comprehensive Cancer Center,
NCT00805974,Biological examinations (blood and urinary).,BIOLOGICAL,Type 1 Diabetes,na,TERMINATED,"University Hospital, Grenoble",
NCT05631574,BMF-219,DRUG,Non Small Cell Lung Cancer; Pancreatic Cancer; Colorectal Cancer; NSCLC; PDAC; CRC; Relapsed Cancer; Refractory Cancer; Stage III Pancreatic Cancer; Stage IV Pancreatic Cancer; Stage III Non-small Cel,phase1,TERMINATED,Biomea Fusion Inc.,
NCT03195010,Platelet Transfusion,BIOLOGICAL,"Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; B-Cell Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Hematolog",phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT03195010,Platelet Transfusion,BIOLOGICAL,"Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; B-Cell Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Hematolog",phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT04918810,Docetaxel intermittent,DRUG,Castration Resistant Prostatic Cancer,phase2,TERMINATED,Australian and New Zealand Urogenital and Prostate Cancer Trials Group,
NCT00611052,the Adolescent Coping with Stress,BEHAVIORAL,Depressive Disorder,na,TERMINATED,Finnish Institute for Health and Welfare,
NCT00611052,Treatment as usual,BEHAVIORAL,Depressive Disorder,na,TERMINATED,Finnish Institute for Health and Welfare,
NCT00611052,usual health education,OTHER,Depressive Disorder,na,TERMINATED,Finnish Institute for Health and Welfare,
NCT00763347,SYR-619,DRUG,Diabetes Mellitus,phase2,TERMINATED,Takeda,
NCT00763347,SYR-619,DRUG,Diabetes Mellitus,phase2,TERMINATED,Takeda,
NCT00763347,SYR-619,DRUG,Diabetes Mellitus,phase2,TERMINATED,Takeda,
NCT00763347,SYR-619,DRUG,Diabetes Mellitus,phase2,TERMINATED,Takeda,
NCT00763347,Placebo,DRUG,Diabetes Mellitus,phase2,TERMINATED,Takeda,
NCT00763347,Alogliptin,DRUG,Diabetes Mellitus,phase2,TERMINATED,Takeda,
NCT00719849,anti-thymocyte globulin,BIOLOGICAL,Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00719849,cyclophosphamide,DRUG,Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00719849,cyclosporine,DRUG,Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00719849,fludarabine phosphate,DRUG,Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00719849,mycophenolate mofetil,DRUG,Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00719849,umbilical cord blood transplantation,PROCEDURE,Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00719849,total body irradiation,RADIATION,Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00985738,Dutasteride,DRUG,Prostate Cancer,phase2,TERMINATED,"University of Colorado, Denver",
NCT00985738,Placebo,OTHER,Prostate Cancer,phase2,TERMINATED,"University of Colorado, Denver",
NCT05712278,SAR445419,DRUG,Acute Myeloid Leukaemia,phase1,TERMINATED,Sanofi,
NCT05712278,fludarabine,DRUG,Acute Myeloid Leukaemia,phase1,TERMINATED,Sanofi,
NCT05712278,cytarabine,DRUG,Acute Myeloid Leukaemia,phase1,TERMINATED,Sanofi,
NCT01003678,Clofarabine,DRUG,Myelodysplastic Syndrome,phase1,TERMINATED,Roswell Park Cancer Institute,
NCT00325078,Infliximab,DRUG,Chronic Granulomatous Disease; Crohn'S-like IBD; Inflammatory Bowel Disease (IBD),phase1; phase2,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT05710185,Deucravacitinib,DRUG,Palmoplantar Pustulosis,phase4,TERMINATED,Brigham and Women's Hospital,
NCT04040985,Total Knee Arthroplasty using LEGION™ Total Knee System,PROCEDURE,Osteo Arthritis Knee; Total Knee Replacement,na,TERMINATED,"Smith & Nephew, Inc.",
NCT00735943,No intervention,OTHER,Vascular Endothelial Growth Factor; Macular Degeneration,na,TERMINATED,Pfizer,
NCT01687543,L. plantarum 299 and L. plantarum 299v (+maltodextrin),OTHER,Clostridium Difficile Colonisation; Impact of Enteral Probiotics on Certain Lab Parameters,na,TERMINATED,Region Skane,
NCT01687543,Maltodextrin,OTHER,Clostridium Difficile Colonisation; Impact of Enteral Probiotics on Certain Lab Parameters,na,TERMINATED,Region Skane,
NCT05358808,TCB008,DRUG,Acute Myeloid Leukemia; Myelodysplastic Syndromes,phase2,TERMINATED,TC Biopharm,
NCT02808676,Vitamin D3,OTHER,Mild Cognitive Impairment,na,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02808676,Exercises (E),OTHER,Mild Cognitive Impairment,na,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02808676,Cognitive Training (CT),OTHER,Mild Cognitive Impairment,na,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02808676,placebo D3,OTHER,Mild Cognitive Impairment,na,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02808676,control cognitive training,OTHER,Mild Cognitive Impairment,na,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02808676,Placebo exercise,OTHER,Mild Cognitive Impairment,na,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02532868,MK-0457,DRUG,Cancer,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT04154150,Intravenous ketamine,DRUG,"Suicide, Attempted",phase4,TERMINATED,Rebecca Price,
NCT04154150,Cognitive training,BEHAVIORAL,"Suicide, Attempted",phase4,TERMINATED,Rebecca Price,
NCT04154150,Sham Training,BEHAVIORAL,"Suicide, Attempted",phase4,TERMINATED,Rebecca Price,
NCT00352690,Paclitaxel poliglumex,DRUG,"Carcinoma, Non-Small-Cell Lung",phase2,TERMINATED,Washington University School of Medicine,
NCT00352690,Carboplatin,DRUG,"Carcinoma, Non-Small-Cell Lung",phase2,TERMINATED,Washington University School of Medicine,
NCT00352690,External beam radiation therapy,RADIATION,"Carcinoma, Non-Small-Cell Lung",phase2,TERMINATED,Washington University School of Medicine,
NCT03642990,Nicotinamide Riboside,DRUG,Chemotherapy-induced Peripheral Neuropathy; Breast Cancer Metastatic; Platinum-resistant Recurrent Ovarian Cancer; Head and Neck Cancer Stage IV; Endometrial Cancer Stage IV,phase2,TERMINATED,"Donna Hammond, PhD",
NCT04017910,EchoMark/EchoSure,DEVICE,Arteriovenous Fistula; Arteriovenous Graft,na,TERMINATED,"Sonavex, Inc.",
NCT02324790,iNAP® Sleep Therapy System,DEVICE,Obstructive Sleep Apnea,na,TERMINATED,"Somnics, Inc.",
NCT02713906,X-Ray Knee Guide group,DEVICE,Arthroplasty; Replacement; Knee,na,TERMINATED,Materialise,
NCT01162304,Extended Release Oxycodone,DRUG,Chronic Pain,phase4,TERMINATED,University of Rochester,
NCT01162304,Immediate Release Oxycodone,DRUG,Chronic Pain,phase4,TERMINATED,University of Rochester,
NCT03824704,Rucaparib,DRUG,Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; High Grade Serous Carcinoma; Endometrioid Adenocarcinoma,phase2,TERMINATED,pharmaand GmbH,
NCT03824704,Nivolumab,DRUG,Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; High Grade Serous Carcinoma; Endometrioid Adenocarcinoma,phase2,TERMINATED,pharmaand GmbH,
NCT02094352,Ketamine Infusion + Epidural Infusion,DRUG,Complex Regional Pain Syndrome,phase2,TERMINATED,"Hospital for Special Surgery, New York",
NCT02094352,Control Group + Epidural infusion,DRUG,Complex Regional Pain Syndrome,phase2,TERMINATED,"Hospital for Special Surgery, New York",
NCT02094352,Ketamine Booster Infusion,DRUG,Complex Regional Pain Syndrome,phase2,TERMINATED,"Hospital for Special Surgery, New York",
NCT02094352,Control Group Booster Infusion,DRUG,Complex Regional Pain Syndrome,phase2,TERMINATED,"Hospital for Special Surgery, New York",
NCT00673049,"CP 751,871 (Figitumumab)",DRUG,"Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinoma, Adenosquamous Cell",phase3,TERMINATED,Pfizer,
NCT00673049,Erlotinib,DRUG,"Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinoma, Adenosquamous Cell",phase3,TERMINATED,Pfizer,
NCT00673049,Erlotinib,DRUG,"Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinoma, Adenosquamous Cell",phase3,TERMINATED,Pfizer,
NCT00145938,sildenafil,DRUG,Pulmonary Hypertension,phase2,TERMINATED,University of Chicago,
NCT05479058,Filgotinib,DRUG,Ulcerative Colitis,phase3,TERMINATED,Galapagos NV,
NCT05479058,Placebo,DRUG,Ulcerative Colitis,phase3,TERMINATED,Galapagos NV,
NCT00628355,lidocaine,DRUG,Pelvic Pain,phase4,TERMINATED,University of Sao Paulo,
NCT00628355,Ischemic compression,PROCEDURE,Pelvic Pain,phase4,TERMINATED,University of Sao Paulo,
NCT06419478,postoperative symptoms,OTHER,Patients With Primary Liver Cancer (PLC) Undergoing Curative Surgical Procedures; Importance of Identifying Core Symptoms for Improving Symptom Management in PLC Patients; Application of Network Analy,na,TERMINATED,Mengmeng Yuan,
NCT05194735,Neoantigen specific TCR-T cell drug product,BIOLOGICAL,Gynecologic Cancer; Colorectal Cancer; Pancreatic Cancer; Non-small Cell Lung Cancer; Cholangiocarcinoma; Ovarian Cancer; Endometrial Cancer; Ovarian Carcinoma; Ovary Neoplasm; Squamous Cell Lung Canc,phase1; phase2,TERMINATED,Alaunos Therapeutics,
NCT05194735,Aldesleukin (IL-2),BIOLOGICAL,Gynecologic Cancer; Colorectal Cancer; Pancreatic Cancer; Non-small Cell Lung Cancer; Cholangiocarcinoma; Ovarian Cancer; Endometrial Cancer; Ovarian Carcinoma; Ovary Neoplasm; Squamous Cell Lung Canc,phase1; phase2,TERMINATED,Alaunos Therapeutics,
NCT04591808,Atorvastatin/Perindopril,DRUG,Dyslipidemias; Hypertension,phase3,TERMINATED,Institut de Recherches Internationales Servier,
NCT04591808,Atorvastatin,DRUG,Dyslipidemias; Hypertension,phase3,TERMINATED,Institut de Recherches Internationales Servier,
NCT04591808,Perindopril,DRUG,Dyslipidemias; Hypertension,phase3,TERMINATED,Institut de Recherches Internationales Servier,
NCT02766140,SHR1020 plus Docetaxel,DRUG,Non Squamous Non Small Cell Lung,phase3,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT02766140,Placebo plus Docetaxel,DRUG,Non Squamous Non Small Cell Lung,phase3,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT03808740,Atomoxetine,DRUG,Orthostatic Intolerance,phase1,TERMINATED,Vanderbilt University Medical Center,
NCT03808740,Placebo,DRUG,Orthostatic Intolerance,phase1,TERMINATED,Vanderbilt University Medical Center,
NCT02972450,GTU-MultiHIV B-clade vaccine + MVA HIV-B HIV vaccine,BIOLOGICAL,HIV-1-infection,phase1; phase2,TERMINATED,"ANRS, Emerging Infectious Diseases",
NCT02972450,GTU-MultiHIV B-clade vaccine + MVA HIV-B HIV vaccine+ Vedolizumab,BIOLOGICAL,HIV-1-infection,phase1; phase2,TERMINATED,"ANRS, Emerging Infectious Diseases",
NCT02972450,Vedolizumab 300 MG [Entyvio],DRUG,HIV-1-infection,phase1; phase2,TERMINATED,"ANRS, Emerging Infectious Diseases",
NCT02972450,Placebo,OTHER,HIV-1-infection,phase1; phase2,TERMINATED,"ANRS, Emerging Infectious Diseases",
NCT02953418,Radiofrequency ablation,DEVICE,Esophageal Squamous Cell Neoplasia (ESCN),na,TERMINATED,Medtronic - MITG,
NCT02739555,Thermal destruction with radiofrequency or laser,DEVICE,Osteoid Osteoma,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02739555,Acide Zoledronique,DRUG,Osteoid Osteoma,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04198285,Retrograde bladder filling,PROCEDURE,Urinary Retention; Postoperative Complications; Surgery,na,TERMINATED,Women's College Hospital,
NCT02584335,"Lidocaine solution (""A"")",DRUG,Wounds; Local Anesthesia,phase4,TERMINATED,Hospital Universitari de Bellvitge,
NCT02584335,"Saline solution (""B"")",DRUG,Wounds; Local Anesthesia,phase4,TERMINATED,Hospital Universitari de Bellvitge,
NCT04654325,conjunctival swab,OTHER,SARS-CoV-2,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00124917,Radiation,RADIATION,Prostate Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01209689,Tocilizumab,DRUG,"Spondylitis, Ankylosing",phase3,TERMINATED,Hoffmann-La Roche,
NCT01209689,Placebo,DRUG,"Spondylitis, Ankylosing",phase3,TERMINATED,Hoffmann-La Roche,
NCT05378750,Diuretic algorithm,OTHER,Hypertension,na,TERMINATED,University of Alberta,
NCT00359450,BMS-275183 (oral taxane),DRUG,Non-small Cell Lung Cancer,phase2,TERMINATED,Bristol-Myers Squibb,
NCT00394550,supraglottoplasty with laser,PROCEDURE,"Sleep Apnea, Obstructive; Respiration Disorders",na,TERMINATED,Indiana University School of Medicine,
NCT00394550,supraglottoplasty with laser,PROCEDURE,"Sleep Apnea, Obstructive; Respiration Disorders",na,TERMINATED,Indiana University School of Medicine,
NCT00419913,Dehydroepiandrosterone,OTHER,Infertility; Decreased Ovarian Reserve,phase2; phase3,TERMINATED,Center for Human Reproduction,
NCT01738360,Arsenic trioxide,DRUG,Systemic Lupus,phase2,TERMINATED,Nantes University Hospital,
NCT03237182,Individualized TB treatment with multiple drugs,DRUG,"Tuberculosis, Multidrug-Resistant",phase4,TERMINATED,Centre for the AIDS Programme of Research in South Africa,
NCT03237182,Standardized TB treatment with multiple drugs,DRUG,"Tuberculosis, Multidrug-Resistant",phase4,TERMINATED,Centre for the AIDS Programme of Research in South Africa,
NCT01575782,Chloroquine,DRUG,Small Cell Lung Cancer,phase1,TERMINATED,Maastricht Radiation Oncology,
NCT03573882,Voxelotor,DRUG,Sickle Cell Disease,phase3,TERMINATED,Pfizer,
NCT04410523,CSJ117,DRUG,Asthma,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04410523,Placebo,DRUG,Asthma,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02847052,Non interventional study,OTHER,Inflammatory Bowel Disease,na,TERMINATED,Nantes University Hospital,
NCT01415947,V Chordal,DEVICE,Mitral Leaflet Prolapse,phase2,TERMINATED,Edwards Lifesciences,
NCT00278655,Hematopoietic stem cell transplantation,BIOLOGICAL,Multiple Sclerosis,phase1; phase2,TERMINATED,Northwestern University,
NCT00431626,Dutasteride (Avodart),DRUG,Benign Prostatic Hyperplasia,phase3,TERMINATED,Northwestern University,
NCT00431626,Placebo,DRUG,Benign Prostatic Hyperplasia,phase3,TERMINATED,Northwestern University,
NCT05848115,Bi-level Positive Airway Pressure,DEVICE,Asthma in Children,na,TERMINATED,"University of Colorado, Denver",
NCT05848115,Sham Bi-level Positive Airway Pressure,DEVICE,Asthma in Children,na,TERMINATED,"University of Colorado, Denver",
NCT02508935,XARTEMIS XR,DRUG,Acute Pain,phase4,TERMINATED,Mallinckrodt,
NCT03597035,Spironolactone,DRUG,Type2 Diabetes; Hyperkalemia,phase4,TERMINATED,University Hospitals Cleveland Medical Center,
NCT04975035,Zolodine,DRUG,Schizophrenia,phase1; phase2,TERMINATED,"Second Affiliated Hospital, School of Medicine, Zhejiang University",
NCT03796650,Fecal microbiota transplantation,OTHER,Clostridium Difficile Infection,phase3,TERMINATED,Oslo University Hospital,
NCT03796650,Vancomycin,DRUG,Clostridium Difficile Infection,phase3,TERMINATED,Oslo University Hospital,
NCT00934791,Tacrolimus,DRUG,Polycystic Liver Disease,na,TERMINATED,Mayo Clinic,
NCT00934791,Sirolimus,DRUG,Polycystic Liver Disease,na,TERMINATED,Mayo Clinic,
NCT00934791,Mycophenolate Mofetil,DRUG,Polycystic Liver Disease,na,TERMINATED,Mayo Clinic,
NCT00934791,Prednisone,DRUG,Polycystic Liver Disease,na,TERMINATED,Mayo Clinic,
NCT00830791,MK-0941 20 mg,DRUG,Type 2 Diabetes,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT00830791,MK-0941 5 mg,DRUG,Type 2 Diabetes,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT05876091,Vaping,OTHER,Tobacco-Related Carcinoma,na,TERMINATED,Roswell Park Cancer Institute,
NCT05876091,Biospecimen Collection,PROCEDURE,Tobacco-Related Carcinoma,na,TERMINATED,Roswell Park Cancer Institute,
NCT05876091,Questionnaire Administration,OTHER,Tobacco-Related Carcinoma,na,TERMINATED,Roswell Park Cancer Institute,
NCT03992274,Enhanced implementation of PrEP,OTHER,HIV/AIDS,na,TERMINATED,Columbia University,
NCT06515418,Oral Azelaprag (BGE-105),DRUG,Obesity,phase2,TERMINATED,"BioAge Labs, Inc.",
NCT06515418,Oral Placebo for Azelaprag (BGE-105),DRUG,Obesity,phase2,TERMINATED,"BioAge Labs, Inc.",
NCT06515418,Tirzepatide,DRUG,Obesity,phase2,TERMINATED,"BioAge Labs, Inc.",
NCT06515418,Tirzepatide Placebo,DRUG,Obesity,phase2,TERMINATED,"BioAge Labs, Inc.",
NCT00176826,Stem Cell Transplant,PROCEDURE,Hemophagocytic Lymphohistiocytosis; X-Linked Lymphoproliferative Disorders; Chediak-Higashi Syndrome; Griscelli Syndrome; Immunologic Diseases; Langerhans-Cell Histiocytosis; Hematologic Diseases,phase2; phase3,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00176826,Myeloablative conditioning regimen,DRUG,Hemophagocytic Lymphohistiocytosis; X-Linked Lymphoproliferative Disorders; Chediak-Higashi Syndrome; Griscelli Syndrome; Immunologic Diseases; Langerhans-Cell Histiocytosis; Hematologic Diseases,phase2; phase3,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT06469385,ENS-002,BIOLOGICAL,Atopic Dermatitis; Atopic Dermatitis Eczema,phase1,TERMINATED,Concerto Biosciences,
NCT00866476,"CVD 1208S, a Shigella flexneri 2a live, oral vaccine",BIOLOGICAL,Shigella,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT00866476,Placebo,OTHER,Shigella,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT00820040,acellular porcine dermal collagen mesh,DEVICE,Hernia,phase2,TERMINATED,Medtronic - MITG,
NCT03873168,HEMOBLAST™ Bellows,DEVICE,Hemostasis,na,TERMINATED,Biom'Up France SAS,
NCT01329250,Moxifloxacin,DRUG,Tuberculosis,phase4,TERMINATED,University Medical Center Groningen,
NCT04998591,Fasting,BEHAVIORAL,"Sub Fertility, Female; Fertility Disorders; Fertility Issues; Sub-fertility; IVF",na,TERMINATED,"Charite University, Berlin, Germany",
NCT04436120,De novo tumor tissue biopsy,PROCEDURE,Disease Progression,na,TERMINATED,Pfizer,
NCT04436120,Research blood draws,PROCEDURE,Disease Progression,na,TERMINATED,Pfizer,
NCT02605824,n-acetylcystine,DRUG,Asthma,phase4,TERMINATED,"University of California, San Francisco",
NCT02605824,0.9% saline,DRUG,Asthma,phase4,TERMINATED,"University of California, San Francisco",
NCT02149823,Syntocinon 24 Intranasal Units (IU),DRUG,Borderline Personality Disorder; BPD; Schizotypal Personality Disorder; SPD; Autism Spectrum Disorder; Schizophrenia; Schizoaffective Disorder; Bipolar Disorder,phase1,TERMINATED,Maria de las Mercedes Perez Rodriguez,
NCT02149823,Syntocinon 40 Intranasal Units (IU),DRUG,Borderline Personality Disorder; BPD; Schizotypal Personality Disorder; SPD; Autism Spectrum Disorder; Schizophrenia; Schizoaffective Disorder; Bipolar Disorder,phase1,TERMINATED,Maria de las Mercedes Perez Rodriguez,
NCT02149823,Intranasal Placebo,DRUG,Borderline Personality Disorder; BPD; Schizotypal Personality Disorder; SPD; Autism Spectrum Disorder; Schizophrenia; Schizoaffective Disorder; Bipolar Disorder,phase1,TERMINATED,Maria de las Mercedes Perez Rodriguez,
NCT01257178,LY2624803,DRUG,Insomnia,phase1,TERMINATED,Eli Lilly and Company,
NCT01974778,Meal,OTHER,Obesity; Diabetes; Cardiovascular Disease,na,TERMINATED,Bayside Health,
NCT01158885,Clofarabine,DRUG,"Minimal Residual Disease; Leukemia, Lymphoblastic, Acute; Leukemia, Myelogenous, Acute",phase2,TERMINATED,Therapeutic Advances in Childhood Leukemia Consortium,
NCT01158885,Cytarabine intravenous,DRUG,"Minimal Residual Disease; Leukemia, Lymphoblastic, Acute; Leukemia, Myelogenous, Acute",phase2,TERMINATED,Therapeutic Advances in Childhood Leukemia Consortium,
NCT01158885,Methotrexate,DRUG,"Minimal Residual Disease; Leukemia, Lymphoblastic, Acute; Leukemia, Myelogenous, Acute",phase2,TERMINATED,Therapeutic Advances in Childhood Leukemia Consortium,
NCT01158885,Intrathecal (IT) Cytarabine,DRUG,"Minimal Residual Disease; Leukemia, Lymphoblastic, Acute; Leukemia, Myelogenous, Acute",phase2,TERMINATED,Therapeutic Advances in Childhood Leukemia Consortium,
NCT04837989,Diabetes Body Project,BEHAVIORAL,"Feeding and Eating Disorders; Diabetes Mellitus, Type 1; Body Image",na,TERMINATED,Oslo University Hospital,
NCT04837989,Psychoeducation,BEHAVIORAL,"Feeding and Eating Disorders; Diabetes Mellitus, Type 1; Body Image",na,TERMINATED,Oslo University Hospital,
NCT00385450,Nelfinavir/placebo,DRUG,Cardiopulmonary Bypass,phase1,TERMINATED,Mayo Clinic,
NCT01051791,Everolimus 10mg daily,DRUG,Squamous Cell Carcinoma of the Head and Neck,phase2,TERMINATED,"Julie E. Bauman, MD, MPH",
NCT03545997,Montelukast 10mg,DRUG,"Sleep Apnea, Obstructive",phase3,TERMINATED,"University Hospital, Grenoble",
NCT03545997,Placebo,DRUG,"Sleep Apnea, Obstructive",phase3,TERMINATED,"University Hospital, Grenoble",
NCT02144155,Oxytocin: 24IU - 168 IU,DRUG,Schizophrenia,na,TERMINATED,"University of California, San Diego",
NCT02144155,Placebo,DRUG,Schizophrenia,na,TERMINATED,"University of California, San Diego",
NCT01844726,GLYX-13,DRUG,Psychiatric Illness; Healthy,phase2,TERMINATED,Northwestern University,
NCT01844726,Placebo,DRUG,Psychiatric Illness; Healthy,phase2,TERMINATED,Northwestern University,
NCT00585585,betahistine dihydrochloride,DRUG,Recurrent Major Depressive Disorder With Atypical Features,phase2,TERMINATED,University of Cincinnati,
NCT03192215,Apixaban,DRUG,Stroke,phase3,TERMINATED,Columbia University,
NCT03192215,Aspirin,DRUG,Stroke,phase3,TERMINATED,Columbia University,
NCT03312725,WEB aneurysm embolization system,DEVICE,Ruptured and Unruptured Intracranial Aneurysms,na,TERMINATED,Medical Therapy Solutions,
NCT00882076,Clofarabine,DRUG,Leukemia,phase1,TERMINATED,Milton S. Hershey Medical Center,
NCT00882076,Mitoxantrone,DRUG,Leukemia,phase1,TERMINATED,Milton S. Hershey Medical Center,
NCT00882076,Etoposide,DRUG,Leukemia,phase1,TERMINATED,Milton S. Hershey Medical Center,
NCT05030350,PH94B,DRUG,Social Anxiety Disorder,phase3,TERMINATED,"VistaGen Therapeutics, Inc.",
NCT00793650,Bortezomib,DRUG,Cancer; Multiple Myeloma,phase1; phase2,TERMINATED,Emory University,
NCT00793650,Melphalan,DRUG,Cancer; Multiple Myeloma,phase1; phase2,TERMINATED,Emory University,
NCT00793650,Autologous PBSC Transplant,PROCEDURE,Cancer; Multiple Myeloma,phase1; phase2,TERMINATED,Emory University,
NCT00204997,Laparoscopic ovarian transposition,PROCEDURE,Cervical Cancer,na,TERMINATED,"University of Wisconsin, Madison",
NCT03050060,Atezolizumab,DRUG,Metastatic Kidney Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Renal Cell Cancer AJCC v7; Stage IV Lung Non-Small Cell Cancer AJCC v7,phase2,TERMINATED,University of Washington,
NCT03050060,Hypofractionated Radiation Therapy,RADIATION,Metastatic Kidney Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Renal Cell Cancer AJCC v7; Stage IV Lung Non-Small Cell Cancer AJCC v7,phase2,TERMINATED,University of Washington,
NCT03050060,Laboratory Biomarker Analysis,OTHER,Metastatic Kidney Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Renal Cell Cancer AJCC v7; Stage IV Lung Non-Small Cell Cancer AJCC v7,phase2,TERMINATED,University of Washington,
NCT03050060,Nelfinavir Mesylate,DRUG,Metastatic Kidney Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Renal Cell Cancer AJCC v7; Stage IV Lung Non-Small Cell Cancer AJCC v7,phase2,TERMINATED,University of Washington,
NCT03050060,Nivolumab,BIOLOGICAL,Metastatic Kidney Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Renal Cell Cancer AJCC v7; Stage IV Lung Non-Small Cell Cancer AJCC v7,phase2,TERMINATED,University of Washington,
NCT03050060,Pembrolizumab,BIOLOGICAL,Metastatic Kidney Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Renal Cell Cancer AJCC v7; Stage IV Lung Non-Small Cell Cancer AJCC v7,phase2,TERMINATED,University of Washington,
NCT01204320,Paclitaxel-coated Balloon,PROCEDURE,Stable Angina; Unstable Angina,phase4,TERMINATED,Ospedale San Donato,
NCT01204320,Paclitaxel-eluting Stent,DEVICE,Stable Angina; Unstable Angina,phase4,TERMINATED,Ospedale San Donato,
NCT00645359,diffusion MRI,PROCEDURE,Diffuse Large B Cell Lymphoma,na,TERMINATED,University of Michigan Rogel Cancer Center,
NCT02898233,Deprexis,OTHER,Depression,na,TERMINATED,University of Texas at Austin,
NCT02898233,Active low-level light therapy,DEVICE,Depression,na,TERMINATED,University of Texas at Austin,
NCT02898233,Sham low-level light therapy,DEVICE,Depression,na,TERMINATED,University of Texas at Austin,
NCT03608358,Dapagliflozin 10 mg,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,AstraZeneca,
NCT03608358,Dapagliflozin 5 mg,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,AstraZeneca,
NCT03608358,Dapagliflozin 10 mg placebo to match,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,AstraZeneca,
NCT03608358,Dapagliflozin 5 mg placebo to match,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,AstraZeneca,
NCT03608358,Saxagliptin 5 mg,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,AstraZeneca,
NCT03608358,Metformin,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,AstraZeneca,
NCT04954248,Injected radiotracer with PET Insert,OTHER,Brain Diseases; Covid19,na,TERMINATED,Stanford University,
NCT05556525,Fluorescein,OTHER,Lung Carcinoma,na,TERMINATED,Mayo Clinic,
NCT05556525,Image-Guided Needle Confocal Laser Endomicroscopy,DEVICE,Lung Carcinoma,na,TERMINATED,Mayo Clinic,
NCT05556525,Ultrasound-Guided Transbronchial Needle Aspiration,PROCEDURE,Lung Carcinoma,na,TERMINATED,Mayo Clinic,
NCT01586325,JNJ-47910382 30 mg,DRUG,Chronic Hepatitis C Infection,phase1,TERMINATED,Janssen R&D Ireland,
NCT01586325,JNJ-47910382 90 mg,DRUG,Chronic Hepatitis C Infection,phase1,TERMINATED,Janssen R&D Ireland,
NCT01586325,JNJ-47910382 200 mg,DRUG,Chronic Hepatitis C Infection,phase1,TERMINATED,Janssen R&D Ireland,
NCT01586325,Placebo,DRUG,Chronic Hepatitis C Infection,phase1,TERMINATED,Janssen R&D Ireland,
NCT02734576,Venous Sinus Stenting with the Precise Pro Stent,DEVICE,Tinnitus; Pulsatile Tinnitus; Venous Sinus Stenosis; Dural Sinus Stenosis,na,TERMINATED,Weill Medical College of Cornell University,
NCT01798576,Pegylated Interferon alfa-2a,DRUG,"Hepatitis C, Chronic",na,TERMINATED,Hoffmann-La Roche,
NCT01798576,Ribavirin,DRUG,"Hepatitis C, Chronic",na,TERMINATED,Hoffmann-La Roche,
NCT03783650,Control condition,BEHAVIORAL,Pediatric Hypertension,na,TERMINATED,Montefiore Medical Center,
NCT03783650,QIC with PCP and without subspecialist,BEHAVIORAL,Pediatric Hypertension,na,TERMINATED,Montefiore Medical Center,
NCT03783650,QIC with Subspecialist,BEHAVIORAL,Pediatric Hypertension,na,TERMINATED,Montefiore Medical Center,
NCT03783650,Hub and Spoke co-management,BEHAVIORAL,Pediatric Hypertension,na,TERMINATED,Montefiore Medical Center,
NCT03783650,Sustainability of changes,BEHAVIORAL,Pediatric Hypertension,na,TERMINATED,Montefiore Medical Center,
NCT06821750,PF-07314470,BIOLOGICAL,Healthy,phase1,TERMINATED,Pfizer,
NCT06821750,Placebo for PF-07314470,BIOLOGICAL,Healthy,phase1,TERMINATED,Pfizer,
NCT05109650,BAT6026,DRUG,Advanced Solid Tumour,phase1,TERMINATED,Bio-Thera Solutions,
NCT05109650,BAT1308,DRUG,Advanced Solid Tumour,phase1,TERMINATED,Bio-Thera Solutions,
NCT01353690,AMDC,BIOLOGICAL,Ischemic Heart Disease,phase1; phase2,TERMINATED,Cook MyoSite,
NCT05220397,Janssen Ad26.CoV2.S Vaccine,BIOLOGICAL,Kidney Transplant Recipient,phase3,TERMINATED,Mark Stegall,
NCT05220397,Reduction in Immunosuppression Medication,OTHER,Kidney Transplant Recipient,phase3,TERMINATED,Mark Stegall,
NCT05220397,Maintenance in Immunosuppression Medication,OTHER,Kidney Transplant Recipient,phase3,TERMINATED,Mark Stegall,
NCT02243124,cenersen,DRUG,Myelodysplastic Syndromes,phase1,TERMINATED,"Eleos, Inc.",
NCT02243124,Dexamethasone,DRUG,Myelodysplastic Syndromes,phase1,TERMINATED,"Eleos, Inc.",
NCT02374424,GA101_DHAP,DRUG,"Diffuse, Large B-Cell, Lymphoma",phase2,TERMINATED,Fondazione Italiana Linfomi - ETS,
NCT03649347,Augmented reality exposure therapy,BEHAVIORAL,Phobias Snakes; Phobias Spiders,na,TERMINATED,Wayne State University,
NCT02439047,Biological samples collection,PROCEDURE,Cancer,na,TERMINATED,Centre Oscar Lambret,
NCT00232349,galantamine,DRUG,Schizophrenia; Psychotic Disorder,phase4,TERMINATED,Seattle Institute for Biomedical and Clinical Research,
NCT04920448,N-Acetyl cysteine,DRUG,"Stroke, Ischemic",phase2,TERMINATED,"University Hospital, Caen",
NCT00899678,Certolizumab Pegol,DRUG,Crohn's Disease,phase2,TERMINATED,UCB Celltech,
NCT00899678,Certolizumab Pegol,DRUG,Crohn's Disease,phase2,TERMINATED,UCB Celltech,
NCT00629876,Peginesatide,DRUG,Anemia,phase1,TERMINATED,Takeda,
NCT00848497,Testim®,DRUG,Hypogonadism; Erectile Dysfunction,early_phase1,TERMINATED,Mohit Khera,
NCT00848497,Placebo Testim®,OTHER,Hypogonadism; Erectile Dysfunction,early_phase1,TERMINATED,Mohit Khera,
NCT00848497,Viagra®,DRUG,Hypogonadism; Erectile Dysfunction,early_phase1,TERMINATED,Mohit Khera,
NCT00404313,MK0633,DRUG,Asthma,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00404313,Comparator: placebo,DRUG,Asthma,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00895024,Phone Interview/Questionnaire,BEHAVIORAL,Advanced Cancer,na,TERMINATED,M.D. Anderson Cancer Center,
NCT02952859,Irreversible electroporation,OTHER,Pancreatic Cancer,na,TERMINATED,"Insel Gruppe AG, University Hospital Bern",
NCT03601936,Evivo Infant Gut Bifidobacterium Screening Test,DEVICE,Gut Microbiome,na,TERMINATED,"Evolve BioSystems, Inc.",
NCT02314598,No treatment,OTHER,Lead Insulation Failure,na,TERMINATED,Medtronic BRC,
NCT00778063,dexmedetomidine,DRUG,Otitis Media,na,TERMINATED,Ochsner Health System,
NCT00778063,saline,DRUG,Otitis Media,na,TERMINATED,Ochsner Health System,
NCT02079493,Total Knee Arthroplasty,DEVICE,Osteoarthritis of the Knee,na,TERMINATED,Tufts Medical Center,
NCT00564993,Dobutamin,DRUG,Tetralogy of Fallot,phase3,TERMINATED,Competence Network for Congenital Heart Defects,
NCT04372121,75 mg linzagolix tablet,DRUG,Endometriosis,phase3,TERMINATED,"Kissei Pharmaceutical Co., Ltd.",
NCT04372121,200 mg linzagolix tablet,DRUG,Endometriosis,phase3,TERMINATED,"Kissei Pharmaceutical Co., Ltd.",
NCT04372121,Add-back capsule (E2 1 mg / NETA 0.5 mg),DRUG,Endometriosis,phase3,TERMINATED,"Kissei Pharmaceutical Co., Ltd.",
NCT04372121,Placebo tablet to match 75 mg linzagolix tablet,DRUG,Endometriosis,phase3,TERMINATED,"Kissei Pharmaceutical Co., Ltd.",
NCT04372121,Placebo tablet to match 200 mg linzagolix tablet,DRUG,Endometriosis,phase3,TERMINATED,"Kissei Pharmaceutical Co., Ltd.",
NCT04372121,Placebo capsule to match Add-back capsule,DRUG,Endometriosis,phase3,TERMINATED,"Kissei Pharmaceutical Co., Ltd.",
NCT03752814,SYNOSTE Nitinail System,DEVICE,Leg Length Inequality,na,TERMINATED,SYNOSTE Oy,
NCT00745316,Tonapofylline,DRUG,Renal Insufficiency; Heart Failure,phase2,TERMINATED,Biogen,
NCT00745316,Placebo,DRUG,Renal Insufficiency; Heart Failure,phase2,TERMINATED,Biogen,
NCT05651633,lidocaine hydrochloride 5mg/g,DRUG,Acute Otitis Media; Pain,phase3,TERMINATED,UMC Utrecht,
NCT02193152,Pazopanib,DRUG,"Carcinoma, Non-Small Cell Lung; Non-Small Cell Lung Cancer; Nonsmall Cell Lung Cancer",phase2,TERMINATED,Washington University School of Medicine,
NCT02091752,Ruxolitinib,DRUG,Primary Myelofibrosis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04844749,VERU-111,DRUG,Metastatic Castration-resistant Prostate Cancer; Androgen Resistant Prostatic Cancer,phase3,TERMINATED,Veru Inc.,
NCT04844749,"Enzalutamide, Abiraterone",DRUG,Metastatic Castration-resistant Prostate Cancer; Androgen Resistant Prostatic Cancer,phase3,TERMINATED,Veru Inc.,
NCT00479258,Inhaled insulin (Exubera),DRUG,"Diabetes Mellitus, Type 1",phase3,TERMINATED,Pfizer,
NCT00479258,Subcutaneous Insulin (subject's prescribed),DRUG,"Diabetes Mellitus, Type 1",phase3,TERMINATED,Pfizer,
NCT00169026,Clozapine versus typical (conventional) and atypical antipsychotic medications,DRUG,Schizophrenia; Dual Diagnosis; Schizoaffective Disorder; Psychotic Disorder; Substance Abuse; Alcohol Abuse,phase4,TERMINATED,Dartmouth-Hitchcock Medical Center,
NCT03608878,adagloxad simolenin/OBI-821,BIOLOGICAL,Hepatocellular Carcinoma,phase2,TERMINATED,Chang Gung Memorial Hospital,
NCT03608878,TACE,PROCEDURE,Hepatocellular Carcinoma,phase2,TERMINATED,Chang Gung Memorial Hospital,
NCT00150878,Conditioning therapy,OTHER,Acute Myeloid Leukemia,phase3,TERMINATED,University Hospital Carl Gustav Carus,
NCT02070978,Atacicept 75 mg,DRUG,"Lupus Erythematosus, Systemic",phase2,TERMINATED,EMD Serono,
NCT02070978,Atacicept 150 mg,DRUG,"Lupus Erythematosus, Systemic",phase2,TERMINATED,EMD Serono,
NCT02070978,Atacicept 150 mg,DRUG,"Lupus Erythematosus, Systemic",phase2,TERMINATED,EMD Serono,
NCT02933671,Suprainguinal fascia iliaca (SIFI) block,PROCEDURE,Hip Osteoarthritis; Primary Total Hip Arthroplasty; Pain,phase4,TERMINATED,Duke University,
NCT02933671,Sham block,PROCEDURE,Hip Osteoarthritis; Primary Total Hip Arthroplasty; Pain,phase4,TERMINATED,Duke University,
NCT02933671,Ropivacaine,DRUG,Hip Osteoarthritis; Primary Total Hip Arthroplasty; Pain,phase4,TERMINATED,Duke University,
NCT02933671,Saline,DRUG,Hip Osteoarthritis; Primary Total Hip Arthroplasty; Pain,phase4,TERMINATED,Duke University,
NCT04725344,ACTIV'DOS group,OTHER,Chronic Disease; Lumbago,na,TERMINATED,"University Hospital, Brest",
NCT04725344,Usual practise,OTHER,Chronic Disease; Lumbago,na,TERMINATED,"University Hospital, Brest",
NCT02867644,standard care,OTHER,Breast Cancer,na,TERMINATED,Institut de Cancérologie de Lorraine,
NCT02867644,standard care + conversational hypnosis,OTHER,Breast Cancer,na,TERMINATED,Institut de Cancérologie de Lorraine,
NCT00279409,aripiprazole,DRUG,Attention Deficit Hyperactivity Disorder,phase2,TERMINATED,New York State Psychiatric Institute,
NCT00279409,Sugar pill,DRUG,Attention Deficit Hyperactivity Disorder,phase2,TERMINATED,New York State Psychiatric Institute,
NCT05365399,smartphone-based screening tool for neonatal jaundice,DEVICE,Neonatal Jaundice,na,TERMINATED,Picterus AS,
NCT02606799,CytoSorb cytokine elimination,DEVICE,Inflammation,na,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT03207399,Epclusa,DRUG,"Hepatitis C, Chronic; Lung Transplant",phase4,TERMINATED,Duke University,
NCT00671593,House Dust Mite,BIOLOGICAL,Atopic Asthma; Healthy,phase1,TERMINATED,John Sundy,
NCT00671593,Diluent,BIOLOGICAL,Atopic Asthma; Healthy,phase1,TERMINATED,John Sundy,
NCT00495716,acyclovir,DRUG,Genital Herpes,phase4,TERMINATED,University of Washington,
NCT00495716,acyclovir,DRUG,Genital Herpes,phase4,TERMINATED,University of Washington,
NCT01927484,25 mg/week oral methotrexate tablets,DRUG,Reduction in Pain; Reduction of Inflammation; Improvement in Function,na,TERMINATED,University of Alexandria,
NCT01927484,25mg/week oral placebo tablets,DRUG,Reduction in Pain; Reduction of Inflammation; Improvement in Function,na,TERMINATED,University of Alexandria,
NCT03740984,Interventions are self controlled by the patient via a mp3 player and noise reduction headphones.,OTHER,Breast Neoplasm; Ovary Cancer,na,TERMINATED,Dr. Horst Schmidt Klinik GmbH,
NCT03936933,Goserelin acetate 3.6 mg Injection,DRUG,Breast Cancer,phase3,TERMINATED,Eurofarma Laboratorios S.A.,
NCT03936933,ZOLADEX® 3.6mg Injection,DRUG,Breast Cancer,phase3,TERMINATED,Eurofarma Laboratorios S.A.,
NCT01392352,Pazopanib,DRUG,Renal Cell Carcinoma; Soft Tissue Sarcoma; Glioblastoma; Ovarian Cancer; Cervical Cancer; Breast Cancer; Non-small Cell Lung Cancer; Small Cell Lung Cancer; Pancreatic Cancer; Melanoma; Gastrointestin,phase2,TERMINATED,Cambridge University Hospitals NHS Foundation Trust,
NCT04269252,CHI-907,OTHER,Anxiety,phase2,TERMINATED,Canopy Growth Corporation,
NCT04269252,CHI-804,OTHER,Anxiety,phase2,TERMINATED,Canopy Growth Corporation,
NCT05043649,Camsirubicin,DRUG,Advanced Soft-tissue Sarcoma,phase1,TERMINATED,Monopar Therapeutics,
NCT04117958,AMG 199,DRUG,MUC17-positive Solid Tumors,phase1,TERMINATED,Amgen,
NCT03859648,BONEBRIDGE,DEVICE,"Hearing Loss, Conductive; Hearing Loss, Mixed",na,TERMINATED,Med-El Corporation,
NCT04605848,Infrared themrography,OTHER,Pheochromocytoma; Paraganglioma,na,TERMINATED,University of Avignon,
NCT01267643,Alefacept,DRUG,Aplastic Anemia,phase1,TERMINATED,The Cleveland Clinic,
NCT02056171,quetiapine,DRUG,Delirium,phase1; phase2,TERMINATED,Weill Medical College of Cornell University,
NCT02056171,Placebo,OTHER,Delirium,phase1; phase2,TERMINATED,Weill Medical College of Cornell University,
NCT04582409,HSY244,DRUG,Atrial Fibrillation,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04582409,Placebo,OTHER,Atrial Fibrillation,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT00610532,phenytoin,DRUG,Epilepsy,phase4,TERMINATED,Jim McAuley,
NCT00610532,phenytoin and probenecid,DRUG,Epilepsy,phase4,TERMINATED,Jim McAuley,
NCT02452463,Durvalumab,BIOLOGICAL,Lung Non-Squamous Non-Small Cell Carcinoma; Radiation-Induced Pneumonitis; Stage II Lung Non-Small Cell Cancer AJCC v7; Stage IIA Lung Non-Small Cell Carcinoma AJCC v7; Stage IIB Lung Non-Small Cell C,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT02452463,Nintedanib,DRUG,Lung Non-Squamous Non-Small Cell Carcinoma; Radiation-Induced Pneumonitis; Stage II Lung Non-Small Cell Cancer AJCC v7; Stage IIA Lung Non-Small Cell Carcinoma AJCC v7; Stage IIB Lung Non-Small Cell C,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT02452463,Placebo,OTHER,Lung Non-Squamous Non-Small Cell Carcinoma; Radiation-Induced Pneumonitis; Stage II Lung Non-Small Cell Cancer AJCC v7; Stage IIA Lung Non-Small Cell Carcinoma AJCC v7; Stage IIB Lung Non-Small Cell C,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT02452463,Quality-of-Life Assessment,PROCEDURE,Lung Non-Squamous Non-Small Cell Carcinoma; Radiation-Induced Pneumonitis; Stage II Lung Non-Small Cell Cancer AJCC v7; Stage IIA Lung Non-Small Cell Carcinoma AJCC v7; Stage IIB Lung Non-Small Cell C,phase2,TERMINATED,Roswell Park Cancer Institute,
NCT02314793,ASP2205,DRUG,Healthy Subjects; Pharmacokinetics of ASP2205,phase1,TERMINATED,Astellas Pharma Europe B.V.,
NCT02314793,Placebo,DRUG,Healthy Subjects; Pharmacokinetics of ASP2205,phase1,TERMINATED,Astellas Pharma Europe B.V.,
NCT03411421,AL-794,DRUG,Healthy,phase1,TERMINATED,Alios Biopharma Inc.,
NCT03411421,Placebo,DRUG,Healthy,phase1,TERMINATED,Alios Biopharma Inc.,
NCT00244504,moxonidine,DRUG,Cardiac Disease; Vascular Surgery,phase3,TERMINATED,"University Hospital, Basel, Switzerland",
NCT01759238,Capecitabine,DRUG,Colorectal Cancer; Metastases,phase2,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT01759238,Bevacizumab,DRUG,Colorectal Cancer; Metastases,phase2,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT01759238,Radiotherapy,RADIATION,Colorectal Cancer; Metastases,phase2,TERMINATED,Universitätsklinikum Hamburg-Eppendorf,
NCT01813838,ACADESINE 140mg/kg/d,DRUG,SMD,phase1; phase2,TERMINATED,Groupe Francophone des Myelodysplasies,
NCT01813838,ACADESINE 210mg/kg/d,DRUG,SMD,phase1; phase2,TERMINATED,Groupe Francophone des Myelodysplasies,
NCT01813838,ACADESINE 315mg/kg/d,DRUG,SMD,phase1; phase2,TERMINATED,Groupe Francophone des Myelodysplasies,
NCT04739358,Tepotinib,DRUG,Advanced Non-Small Cell Lung Cancer With MET Mutations,phase1; phase2,TERMINATED,"Criterium, Inc.",
NCT01545648,Denosumab,DRUG,Early Stage Breast Cancer,phase2,TERMINATED,"Hope Rugo, MD",
NCT00852709,Clofarabine,DRUG,Myelodysplastic Syndrome; Acute Myeloid Leukemia; Myeloproliferative Disorders; Acute Lymphocytic Leukemia; Acute Promyelocytic Leukemia; Acute Leukemia; Chronic Myelogenous Leukemia; Myelofibrosis; C,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00852709,Cyclophosphamide,DRUG,Myelodysplastic Syndrome; Acute Myeloid Leukemia; Myeloproliferative Disorders; Acute Lymphocytic Leukemia; Acute Promyelocytic Leukemia; Acute Leukemia; Chronic Myelogenous Leukemia; Myelofibrosis; C,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00324987,Bevacizumab,BIOLOGICAL,Gastrointestinal Stromal Tumor,phase3,TERMINATED,National Cancer Institute (NCI),
NCT00324987,Imatinib Mesylate,DRUG,Gastrointestinal Stromal Tumor,phase3,TERMINATED,National Cancer Institute (NCI),
NCT00324987,Laboratory Biomarker Analysis,OTHER,Gastrointestinal Stromal Tumor,phase3,TERMINATED,National Cancer Institute (NCI),
NCT00324987,Pharmacological Study,OTHER,Gastrointestinal Stromal Tumor,phase3,TERMINATED,National Cancer Institute (NCI),
NCT02097121,BOTOX®,BIOLOGICAL,Urinary Incontinence; Urinary Bladder; Overactive,phase3,TERMINATED,Allergan,
NCT02701452,COAGO,OTHER,Ovarian Hyperstimulation Syndrome; Hypercoagulability,na,TERMINATED,"University Hospital, Lille",
NCT02637947,catheter ablation using magnetic navigation,DEVICE,"Tachycardia, Ventricular",na,TERMINATED,Stereotaxis,
NCT02637947,catheter ablation using manual navigation,DEVICE,"Tachycardia, Ventricular",na,TERMINATED,Stereotaxis,
NCT02686749,Catheter Ablation,DEVICE,Congestive Heart Failure; Left Ventricular Failure; Atrial Fibrillation,phase4,TERMINATED,The Cleveland Clinic,
NCT02686749,FDA approved anti arrhythmic drug,DRUG,Congestive Heart Failure; Left Ventricular Failure; Atrial Fibrillation,phase4,TERMINATED,The Cleveland Clinic,
NCT00589238,carboplatin,DRUG,Breast Cancer,phase2,TERMINATED,"National Cancer Centre, Singapore",
NCT00589238,cyclophosphamide,DRUG,Breast Cancer,phase2,TERMINATED,"National Cancer Centre, Singapore",
NCT00589238,doxorubicin hydrochloride,DRUG,Breast Cancer,phase2,TERMINATED,"National Cancer Centre, Singapore",
NCT00589238,paclitaxel,DRUG,Breast Cancer,phase2,TERMINATED,"National Cancer Centre, Singapore",
NCT01362348,pazopanib eye drops,DRUG,Macular Degeneration,phase2,TERMINATED,GlaxoSmithKline,
NCT03758378,Dietary intervention,OTHER,Obesity,na,TERMINATED,McMaster University,
NCT01433978,Eltrombopag,DRUG,Idiopathic Thrombocytopenic Purpura,phase3,TERMINATED,Eisai Inc.,
NCT01433978,Avatrombopag,DRUG,Idiopathic Thrombocytopenic Purpura,phase3,TERMINATED,Eisai Inc.,
NCT01433978,Standard of care,DRUG,Idiopathic Thrombocytopenic Purpura,phase3,TERMINATED,Eisai Inc.,
NCT01705392,Bevacizumab,DRUG,Metastatic Malignant Melanoma; Unresectable Malignant Melanoma,phase2,TERMINATED,Haukeland University Hospital,
NCT01705392,Propranolol,DRUG,Metastatic Malignant Melanoma; Unresectable Malignant Melanoma,phase2,TERMINATED,Haukeland University Hospital,
NCT01705392,Enalapril,DRUG,Metastatic Malignant Melanoma; Unresectable Malignant Melanoma,phase2,TERMINATED,Haukeland University Hospital,
NCT01705392,Dacarbazine,DRUG,Metastatic Malignant Melanoma; Unresectable Malignant Melanoma,phase2,TERMINATED,Haukeland University Hospital,
NCT02244944,EZ-Urso combination therapy,DRUG,Nonalcoholic Fatty Liver Disease (NAFLD),phase2,TERMINATED,"Gregory Graf, PhD",
NCT00907764,regadenoson,DRUG,Heart Disease; Coronary Artery Disease,phase2,TERMINATED,Gilead Sciences,
NCT05839509,GH001,DRUG,Bipolar II Disorder,phase2,TERMINATED,GH Research Ireland Limited,
NCT02801799,Varying infusion rates of Ropivacaine 0.2%,DRUG,"Other Acute Postoperative Pain; Pain, Postoperative; Anaesthesia",phase1,TERMINATED,Nordsjaellands Hospital,
NCT01911793,Stoma Tube,DEVICE,Ileus; Bowel Obstruction,na,TERMINATED,Cedars-Sinai Medical Center,
NCT01814904,colestilan-L,DRUG,Chronic Kidney Disease; Dialysis; Hyperphosphatemia; Paediatric,phase3,TERMINATED,Tanabe Pharma Corporation,
NCT01814904,colestilan-M,DRUG,Chronic Kidney Disease; Dialysis; Hyperphosphatemia; Paediatric,phase3,TERMINATED,Tanabe Pharma Corporation,
NCT01814904,colestilan-H,DRUG,Chronic Kidney Disease; Dialysis; Hyperphosphatemia; Paediatric,phase3,TERMINATED,Tanabe Pharma Corporation,
NCT01814904,CBPB,DRUG,Chronic Kidney Disease; Dialysis; Hyperphosphatemia; Paediatric,phase3,TERMINATED,Tanabe Pharma Corporation,
NCT00093652,gefitinib,DRUG,Esophageal Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT00093652,oxaliplatin,DRUG,Esophageal Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT00093652,conventional surgery,PROCEDURE,Esophageal Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT00093652,neoadjuvant therapy,PROCEDURE,Esophageal Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT00093652,radiation therapy,RADIATION,Esophageal Cancer,phase1; phase2,TERMINATED,Roswell Park Cancer Institute,
NCT03578952,TAVR with Evolut R valve,DEVICE,"Aortic Valve; Aortic Valve Insufficiency; Aortic Regurgitation; Regurgitation, Aortic Valve; Aortic Incompetence",na,TERMINATED,Seung-Jung Park,
NCT04576247,Combined aerobic and resistance exercise,BEHAVIORAL,Breast Cancer Female; Overweight and Obesity,na,TERMINATED,"University of Colorado, Denver",
NCT00783471,"Erlotinib, Docetaxel",DRUG,Advanced Non-Small Cell Lung Cancer,phase2,TERMINATED,Hellenic Cooperative Oncology Group,
NCT00783471,"Docetaxel, Erlotinib",DRUG,Advanced Non-Small Cell Lung Cancer,phase2,TERMINATED,Hellenic Cooperative Oncology Group,
NCT03652571,Nortriptyline,DRUG,Functional Dyspepsia,phase3,TERMINATED,Maastricht University Medical Center,
NCT03652571,Placebo,DRUG,Functional Dyspepsia,phase3,TERMINATED,Maastricht University Medical Center,
NCT00124644,cytarabine,DRUG,Leukemia,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT00124644,daunorubicin hydrochloride,DRUG,Leukemia,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT00124644,etoposide,DRUG,Leukemia,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT00124644,tipifarnib,DRUG,Leukemia,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT00124644,chemotherapy,PROCEDURE,Leukemia,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT00124644,enzyme inhibitor therapy,PROCEDURE,Leukemia,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT00124644,high-dose chemotherapy,PROCEDURE,Leukemia,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT05256134,Gantenerumab,DRUG,Alzheimers Disease,phase3,TERMINATED,Hoffmann-La Roche,
NCT05256134,Placebo,DRUG,Alzheimers Disease,phase3,TERMINATED,Hoffmann-La Roche,
NCT01130909,AZD6765,DRUG,Healthy,phase1,TERMINATED,AstraZeneca,
NCT01130909,AZD6765,DRUG,Healthy,phase1,TERMINATED,AstraZeneca,
NCT01130909,Ketamine,DRUG,Healthy,phase1,TERMINATED,AstraZeneca,
NCT01130909,Placebo,DRUG,Healthy,phase1,TERMINATED,AstraZeneca,
NCT02197663,acupuncture(44mm in length and 32-gauge),PROCEDURE,Stroke,phase1,TERMINATED,China Medical University Hospital,
NCT02263287,LeSCoD scale,OTHER,Alzheimer Disease; Lewy Body Disease,na,TERMINATED,Nantes University Hospital,
NCT04812704,Whey protein,OTHER,Cancer; Surgery; Prehabilitation,na,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT02548533,AFXL,DEVICE,Cicatrix,phase4,TERMINATED,Netherlands Institute for Pigment Disorders,
NCT02548533,AHES,DRUG,Cicatrix,phase4,TERMINATED,Netherlands Institute for Pigment Disorders,
NCT02548533,EMLA cream,DRUG,Cicatrix,phase4,TERMINATED,Netherlands Institute for Pigment Disorders,
NCT04678947,Baxter Retching Faces (BARF) scale,BEHAVIORAL,Nausea,na,TERMINATED,Washington University School of Medicine,
NCT01198158,Bevacizumab,BIOLOGICAL,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7,phase3,TERMINATED,National Cancer Institute (NCI),
NCT01198158,Everolimus,DRUG,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7,phase3,TERMINATED,National Cancer Institute (NCI),
NCT01198158,Laboratory Biomarker Analysis,OTHER,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7,phase3,TERMINATED,National Cancer Institute (NCI),
NCT01198158,Pharmacological Study,OTHER,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7,phase3,TERMINATED,National Cancer Institute (NCI),
NCT06788236,AVTR101,DRUG,Sarcopenia,phase2,TERMINATED,Aventi Biotechnology Inc.,
NCT06788236,Placebo,DRUG,Sarcopenia,phase2,TERMINATED,Aventi Biotechnology Inc.,
NCT04770844,Acquisitions,OTHER,Premature Birth,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03938532,Volume Targeted Ventilation (VTV) using the Philips Respironics NM3 monitor,DEVICE,"Prematurity; BPD - Bronchopulmonary Dysplasia; Respiratory Distress Syndrome, Newborn",na,TERMINATED,Baystate Medical Center,
NCT03938532,Tidal Volume Measurement using the Philips Respironics NM3 monitor,DEVICE,"Prematurity; BPD - Bronchopulmonary Dysplasia; Respiratory Distress Syndrome, Newborn",na,TERMINATED,Baystate Medical Center,
NCT02762487,The LINX® Reflux Management System,DEVICE,GERD; Gastroesophageal Reflux Disease; Obesity; LSG; Laparoscopic Sleeve Gastrectomy,na,TERMINATED,Torax Medical Incorporated,
NCT02654587,OSE2101,BIOLOGICAL,Non Small Cell Lung Cancer,phase3,TERMINATED,OSE Immunotherapeutics,
NCT02654587,Docetaxel,DRUG,Non Small Cell Lung Cancer,phase3,TERMINATED,OSE Immunotherapeutics,
NCT02654587,Pemetrexed,DRUG,Non Small Cell Lung Cancer,phase3,TERMINATED,OSE Immunotherapeutics,
NCT00253721,Melphalan,DRUG,Brain and Central Nervous System Tumors; Lymphoma; Metastatic Cancer,phase1,TERMINATED,OHSU Knight Cancer Institute,
NCT02068521,somavaratan,DRUG,Pediatric Growth Hormone Deficiency,phase2; phase3,TERMINATED,Versartis Inc.,
NCT00872404,"CP-751,871",DRUG,Head and Neck Cancer,phase2,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT05375604,CDK-004,DRUG,Advanced Hepatocellular Carcinoma (HCC); Gastric Cancer Metastatic to Liver; Colorectal Cancer Metastatic to Liver,phase1,TERMINATED,Codiak BioSciences,
NCT02796352,High dose bolus interleukin-2 (HD IL2),DRUG,Melanoma,phase2,TERMINATED,Ahmad Tarhini,
NCT01236352,BMS-911543,DRUG,Cancer,phase1; phase2,TERMINATED,Bristol-Myers Squibb,
NCT04430348,PTX-35,DRUG,Advanced Solid Tumor,phase1,TERMINATED,"Pelican Therapeutics, Inc.",
NCT04602507,Ivermectin,DRUG,Covid19; Severe Acute Respiratory Syndrome,phase2,TERMINATED,CES University,
NCT04602507,Placebo,OTHER,Covid19; Severe Acute Respiratory Syndrome,phase2,TERMINATED,CES University,
NCT06013371,PF-07038124,DRUG,Seborrheic Dermatitis; Papulopustular Rosacea,phase2,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT06013371,Placebo Ointment,DRUG,Seborrheic Dermatitis; Papulopustular Rosacea,phase2,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT02389764,BIBF 1120,DRUG,Breast Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02389764,Phone Call,BEHAVIORAL,Breast Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01606709,GnRH agonist,DRUG,Endometrial Receptivity; Ovarian Hyperstimulation Syndrome,phase4,TERMINATED,UConn Health,
NCT01606709,hCG,DRUG,Endometrial Receptivity; Ovarian Hyperstimulation Syndrome,phase4,TERMINATED,UConn Health,
NCT02934009,Dermal nuclear magnetic resonance (NMR)-profile measurement,DEVICE,"Exposure to Magnetic Field; Hypotension During Dialysis; Disturbance; Balance, Fluid",na,TERMINATED,RWTH Aachen University,
NCT00321698,Intensity-Modulated Radiation Therapy (IMRT),RADIATION,Prostate Cancer,phase1; phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT00321698,Docetaxel+IMRT,DRUG,Prostate Cancer,phase1; phase2,TERMINATED,OHSU Knight Cancer Institute,
NCT02343263,Bupivacaine,DRUG,"Pain, Postoperative; Postoperative Hemorrhage",phase2,TERMINATED,Indiana University School of Medicine,
NCT02343263,Fibrin Sealant,BIOLOGICAL,"Pain, Postoperative; Postoperative Hemorrhage",phase2,TERMINATED,Indiana University School of Medicine,
NCT00788606,"bevacizumab, Rituximab",DRUG,Non-Hodgkin's Lymphoma; B-cell Lymphoma,phase2,TERMINATED,Royal Marsden NHS Foundation Trust,
NCT03592784,Food Order Therapy,BEHAVIORAL,Gestational Diabetes,na,TERMINATED,Weill Medical College of Cornell University,
NCT03592784,Medical Nutrition Therapy,BEHAVIORAL,Gestational Diabetes,na,TERMINATED,Weill Medical College of Cornell University,
NCT00134238,torcetrapib/atorvastatin,DRUG,Mixed Hyperlipidemia,phase3,TERMINATED,Pfizer,
NCT00134238,atorvastatin,DRUG,Mixed Hyperlipidemia,phase3,TERMINATED,Pfizer,
NCT03091855,Questionnaire,OTHER,Atrial Fibrillation; Dementia; Cognitive Decline,na,TERMINATED,"Intermountain Health Care, Inc.",
NCT03091855,Magnetic Resonance Imaging,OTHER,Atrial Fibrillation; Dementia; Cognitive Decline,na,TERMINATED,"Intermountain Health Care, Inc.",
NCT01378871,IMTOX-25,DRUG,Adult T Cell Leukemia; Adult T Cell Lymphoma,phase2,TERMINATED,Amit Verma,
NCT00528671,phenprocoumon,DRUG,Mechanical Heart Valve Recipients,phase4,TERMINATED,Heart and Diabetes Center North-Rhine Westfalia,
NCT00528671,phenprocoumon,DRUG,Mechanical Heart Valve Recipients,phase4,TERMINATED,Heart and Diabetes Center North-Rhine Westfalia,
NCT00528671,phenprocoumon,DRUG,Mechanical Heart Valve Recipients,phase4,TERMINATED,Heart and Diabetes Center North-Rhine Westfalia,
NCT03573336,Vilaprisan (BAY1002670),DRUG,Endometriosis,phase2,TERMINATED,Bayer,
NCT03573336,Matching Placebo,DRUG,Endometriosis,phase2,TERMINATED,Bayer,
NCT03828136,Novum Vitrium® Cervical Interbody Device,DEVICE,Symptomatic Cervical Disc Disease,na,TERMINATED,Bio2 Technologies,
NCT03828136,Allograft Ring or Block,DEVICE,Symptomatic Cervical Disc Disease,na,TERMINATED,Bio2 Technologies,
NCT00141544,esterified estrogens 1.25 mg and methyltestosterone 2.5 mg,DRUG,Menopause,phase2,TERMINATED,Solvay Pharmaceuticals,
NCT00141544,Esterified estrogens 1.25 mg,DRUG,Menopause,phase2,TERMINATED,Solvay Pharmaceuticals,
NCT02864264,BMS-986184,DRUG,Healthy Volunteers; Ulcerative Colitis,phase1,TERMINATED,Bristol-Myers Squibb,
NCT02864264,Placebo matching BMS-986184,DRUG,Healthy Volunteers; Ulcerative Colitis,phase1,TERMINATED,Bristol-Myers Squibb,
NCT02748798,HP 3He,DRUG,Lung Transplant; Lung Resection; Lung Cancer; Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Emphysema; Mesothelioma; Asbestosis; Pulmonary Embolism; Interstitial Lung Disease; Pulmon,early_phase1,TERMINATED,Thunder Bay Regional Health Research Institute,
NCT02748798,HP 129Xe,DRUG,Lung Transplant; Lung Resection; Lung Cancer; Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Emphysema; Mesothelioma; Asbestosis; Pulmonary Embolism; Interstitial Lung Disease; Pulmon,early_phase1,TERMINATED,Thunder Bay Regional Health Research Institute,
NCT02748798,PFP,DRUG,Lung Transplant; Lung Resection; Lung Cancer; Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Emphysema; Mesothelioma; Asbestosis; Pulmonary Embolism; Interstitial Lung Disease; Pulmon,early_phase1,TERMINATED,Thunder Bay Regional Health Research Institute,
NCT02748798,SF6,DRUG,Lung Transplant; Lung Resection; Lung Cancer; Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Emphysema; Mesothelioma; Asbestosis; Pulmonary Embolism; Interstitial Lung Disease; Pulmon,early_phase1,TERMINATED,Thunder Bay Regional Health Research Institute,
NCT02748798,129Xe Small and Large Human Lung Coil,DEVICE,Lung Transplant; Lung Resection; Lung Cancer; Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Emphysema; Mesothelioma; Asbestosis; Pulmonary Embolism; Interstitial Lung Disease; Pulmon,early_phase1,TERMINATED,Thunder Bay Regional Health Research Institute,
NCT02748798,3He Human Lung Coil,DEVICE,Lung Transplant; Lung Resection; Lung Cancer; Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Emphysema; Mesothelioma; Asbestosis; Pulmonary Embolism; Interstitial Lung Disease; Pulmon,early_phase1,TERMINATED,Thunder Bay Regional Health Research Institute,
NCT02748798,PFP and SF6 Human Lung Coil,DEVICE,Lung Transplant; Lung Resection; Lung Cancer; Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Emphysema; Mesothelioma; Asbestosis; Pulmonary Embolism; Interstitial Lung Disease; Pulmon,early_phase1,TERMINATED,Thunder Bay Regional Health Research Institute,
NCT03994263,ITind device implant,DEVICE,BPH,na,TERMINATED,Medi-Tate Ltd.,
NCT05318963,LCAR-AIO cells product,BIOLOGICAL,B-cell Lymphoma Recurrent; B-cell Lymphoma Refractory,phase1,TERMINATED,"Institute of Hematology & Blood Diseases Hospital, China",
NCT04600921,Ertugliflozin 5 mg,DRUG,Heart Failure With Reduced Ejection Fraction; Heart Failure With Mid Range Ejection Fraction; Implantable Cardioverter-Defibrillators; Cardiac Resynchronization Therapy,phase3,TERMINATED,Medical University of Graz,
NCT04600921,Placebo 5mg,DRUG,Heart Failure With Reduced Ejection Fraction; Heart Failure With Mid Range Ejection Fraction; Implantable Cardioverter-Defibrillators; Cardiac Resynchronization Therapy,phase3,TERMINATED,Medical University of Graz,
NCT02281721,Surpass Flow Diverter(s),DEVICE,Cerebral Aneurysm,na,TERMINATED,Stryker Neurovascular,
NCT00671606,Intraoperative Lymphatic Mapping,PROCEDURE,Endometrial Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT03021252,High intensity IEMT,DEVICE,Swallowing Disorder; Stroke; Respiratory Muscle Training; Malnutrition,na,TERMINATED,Parc de Salut Mar,
NCT03021252,Sham IEMT,DEVICE,Swallowing Disorder; Stroke; Respiratory Muscle Training; Malnutrition,na,TERMINATED,Parc de Salut Mar,
NCT04073147,Venetoclax,DRUG,Primary CNS Lymphoma,phase1,TERMINATED,Klinikum Stuttgart,
NCT04073147,Obinutuzumab,DRUG,Primary CNS Lymphoma,phase1,TERMINATED,Klinikum Stuttgart,
NCT03110549,TMB-607,DRUG,Human Immunodeficiency Virus,phase1,TERMINATED,TaiMed Biologics Inc.,
NCT03110549,Placebo,DRUG,Human Immunodeficiency Virus,phase1,TERMINATED,TaiMed Biologics Inc.,
NCT00527748,Non-Measuring Ankle Exerciser,DEVICE,Plantar Fasciitis; Flatfoot; Calcaneus Fractures,na,TERMINATED,University of Missouri-Columbia,
NCT03298048,Low fecal microbiota dose,BIOLOGICAL,Recurrent C. Difficile Infection,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT03298048,Mid fecal microbiota dose,BIOLOGICAL,Recurrent C. Difficile Infection,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT03298048,High fecal microbiota dose,BIOLOGICAL,Recurrent C. Difficile Infection,phase2,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT01724619,[F-18] fluorinated dihydrotestosterone (FDHT),DRUG,Prostate Cancer,early_phase1,TERMINATED,Wake Forest University Health Sciences,
NCT02454075,YF476,DRUG,Zollinger-Ellison Syndrome,phase2,TERMINATED,Trio Medicines Ltd.,
NCT03170557,Traditional chinese acupuncture,OTHER,Pain; Spinal Cord Injuries,na,TERMINATED,Montecatone Rehabilitation Institute S.p.A.,
NCT03170557,Aspecific needle skin stimulation,OTHER,Pain; Spinal Cord Injuries,na,TERMINATED,Montecatone Rehabilitation Institute S.p.A.,
NCT03297957,Hands-free goggle system,DEVICE,Head and Neck Cancer; Cancer of the Head and Neck,na,TERMINATED,Washington University School of Medicine,
NCT01023919,Device: Polymer-based sirolimus-eluting stent(Cypher stent ) and Polymer-free paclitaxel-eluting stent (YinYi stent),DEVICE,Coronary Artery Disease; Diabetes Mellitus,na,TERMINATED,Harbin Medical University,
NCT02706730,OTO-104,DRUG,Meniere's Disease,phase3,TERMINATED,"Otonomy, Inc.",
NCT02444728,Hydroxychloroquine,DRUG,Thrombocytopenia,phase3,TERMINATED,Chinese SLE Treatment And Research Group,
NCT02444728,Cyclophosphamide,DRUG,Thrombocytopenia,phase3,TERMINATED,Chinese SLE Treatment And Research Group,
NCT02444728,Azathioprine,DRUG,Thrombocytopenia,phase3,TERMINATED,Chinese SLE Treatment And Research Group,
NCT02444728,Methylprednisolone,DRUG,Thrombocytopenia,phase3,TERMINATED,Chinese SLE Treatment And Research Group,
NCT03248765,post-surgical opioid use measured at 1 day and 1 week.,OTHER,"Pain, Chronic; Opioid Use",na,TERMINATED,Washington University School of Medicine,
NCT00232167,Indiplon,DRUG,Insomnia; Depression,phase3,TERMINATED,Neurocrine Biosciences,
NCT00232167,Sertraline,DRUG,Insomnia; Depression,phase3,TERMINATED,Neurocrine Biosciences,
NCT02585167,operation,PROCEDURE,Anal Fistula,na,TERMINATED,University of Southern Denmark,
NCT02585167,VAAFT,DEVICE,Anal Fistula,na,TERMINATED,University of Southern Denmark,
NCT00539500,Carboplatin,DRUG,Neuroblastoma,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT00539500,Etoposide,DRUG,Neuroblastoma,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT00539500,Melphalan,DRUG,Neuroblastoma,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT00539500,Stem Cell Infusion,PROCEDURE,Neuroblastoma,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT00539500,ClinicMACS,DEVICE,Neuroblastoma,phase2; phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT00796900,Dantrolene,DRUG,Hyperthermia,phase2; phase3,TERMINATED,Medical University of Vienna,
NCT00796900,Placebo,DRUG,Hyperthermia,phase2; phase3,TERMINATED,Medical University of Vienna,
NCT05664100,FX-345,DRUG,"Hearing Loss, Sensorineural",phase1,TERMINATED,Frequency Therapeutics,
NCT05664100,Placebo,DRUG,"Hearing Loss, Sensorineural",phase1,TERMINATED,Frequency Therapeutics,
NCT04793399,Bosutinib 400 MG Monotherapy,DRUG,Chronic Phase-Chronic Myeloid Leukemia,phase1; phase2,TERMINATED,Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica,
NCT04793399,Bosutinib 400 MG + Atezolizumab 840 MG in 14 ML Injection,DRUG,Chronic Phase-Chronic Myeloid Leukemia,phase1; phase2,TERMINATED,Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica,
NCT04536532,HEC121120 tablets,DRUG,"Hepatitis B, Chronic",phase1; phase2,TERMINATED,"Sunshine Lake Pharma Co., Ltd.",
NCT04536532,HEC121120 placebo tablets,DRUG,"Hepatitis B, Chronic",phase1; phase2,TERMINATED,"Sunshine Lake Pharma Co., Ltd.",
NCT04536532,entecavir tablets,DRUG,"Hepatitis B, Chronic",phase1; phase2,TERMINATED,"Sunshine Lake Pharma Co., Ltd.",
NCT04536532,entecavir placebo tablets,DRUG,"Hepatitis B, Chronic",phase1; phase2,TERMINATED,"Sunshine Lake Pharma Co., Ltd.",
NCT03810898,Radioligand [¹¹C]CHDI-00485180-R,RADIATION,Huntington Disease,early_phase1,TERMINATED,"CHDI Foundation, Inc.",
NCT03810898,Radioligand [¹¹C]CHDI-00485626,RADIATION,Huntington Disease,early_phase1,TERMINATED,"CHDI Foundation, Inc.",
NCT01169493,VVI-40,DEVICE,Heart Failure; Right Bundle-Branch Block,na,TERMINATED,Duke University,
NCT01169493,RV DDD-40,DEVICE,Heart Failure; Right Bundle-Branch Block,na,TERMINATED,Duke University,
NCT01169493,BiV DDD-40,DEVICE,Heart Failure; Right Bundle-Branch Block,na,TERMINATED,Duke University,
NCT00275314,Valganciclovir,DRUG,Kidney Transplant,phase3,TERMINATED,University of Pittsburgh,
NCT03950414,CMV specific T-cells,BIOLOGICAL,Cytomegalovirus Infections; Solid Organ Transplant,phase1,TERMINATED,"University of Wisconsin, Madison",
NCT01441414,PF-04856884,BIOLOGICAL,Metastatic Renal Cell Carcinoma,phase2,TERMINATED,Pfizer,
NCT01441414,Axitinib (AG-013736),DRUG,Metastatic Renal Cell Carcinoma,phase2,TERMINATED,Pfizer,
NCT01441414,Axitinib (AG-013736),DRUG,Metastatic Renal Cell Carcinoma,phase2,TERMINATED,Pfizer,
NCT02822716,IRE treatment,PROCEDURE,Hepatic Malignant Tumors; Pancreatic Cancer,na,TERMINATED,Chinese University of Hong Kong,
NCT02822716,Ultrasound,DEVICE,Hepatic Malignant Tumors; Pancreatic Cancer,na,TERMINATED,Chinese University of Hong Kong,
NCT00136916,Inhaled Insulin,DRUG,Diabetes Mellitus,phase3,TERMINATED,Pfizer,
NCT00136916,Subcutaneous insulin,DRUG,Diabetes Mellitus,phase3,TERMINATED,Pfizer,
NCT05107206,Mechanical Thrombectomy using the Envi™-SR Thrombectomy device,DEVICE,Acute Ischemic Stroke,na,TERMINATED,NeuroVasc Technologies,
NCT05107206,Mechanical Thrombectomy using the Solitaire or Trevo Revascularization Device,DEVICE,Acute Ischemic Stroke,na,TERMINATED,NeuroVasc Technologies,
NCT03453606,Home respiratory rehabilitation,OTHER,Chronic Obstructive Pulmonary Disease,na,TERMINATED,"University Hospital, Lille",
NCT03453606,Center respiratory rehabilitation,OTHER,Chronic Obstructive Pulmonary Disease,na,TERMINATED,"University Hospital, Lille",
NCT03051802,Navigated Endoscopy,DEVICE,Esophagus Cancer; Lung Cancer,na,TERMINATED,"University Health Network, Toronto",
NCT03831945,VRC-HIVMAB060-00-AB (VRC01),BIOLOGICAL,HIV,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT03831945,10-1074,BIOLOGICAL,HIV,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT03831945,Normal Saline Placebo,BIOLOGICAL,HIV,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00145145,MAGE-3.A1 peptide and CpG 7909,BIOLOGICAL,Malignant Melanoma,phase1; phase2,TERMINATED,Ludwig Institute for Cancer Research,
NCT01317472,dexlansoprazole,DRUG,Laryngopharyngeal Reflux,na,TERMINATED,Indiana University,
NCT01317472,Placebo,DRUG,Laryngopharyngeal Reflux,na,TERMINATED,Indiana University,
NCT03192995,lorcaserin,DRUG,Cocaine Use Disorder,phase2,TERMINATED,Glenn-Milo Santos,
NCT03192995,Placebo Oral Tablet,DRUG,Cocaine Use Disorder,phase2,TERMINATED,Glenn-Milo Santos,
NCT03192995,Substance use counseling,BEHAVIORAL,Cocaine Use Disorder,phase2,TERMINATED,Glenn-Milo Santos,
NCT03192995,ACASI,BEHAVIORAL,Cocaine Use Disorder,phase2,TERMINATED,Glenn-Milo Santos,
NCT03192995,Cocaine metabolites,OTHER,Cocaine Use Disorder,phase2,TERMINATED,Glenn-Milo Santos,
NCT03192995,Ecological Momentary Assessment (EMA),BEHAVIORAL,Cocaine Use Disorder,phase2,TERMINATED,Glenn-Milo Santos,
NCT03192995,Balloon Analogue Risk Task (BART),BEHAVIORAL,Cocaine Use Disorder,phase2,TERMINATED,Glenn-Milo Santos,
NCT03192995,Qualitative Exit Interview,BEHAVIORAL,Cocaine Use Disorder,phase2,TERMINATED,Glenn-Milo Santos,
NCT00524095,azithromycin and fluticasone,DRUG,Bronchiectasis; Pulmonary Disease; Chronic Bronchitis,phase2,TERMINATED,University of Milan,
NCT00524095,fluticasone and azithromycin,DRUG,Bronchiectasis; Pulmonary Disease; Chronic Bronchitis,phase2,TERMINATED,University of Milan,
NCT00302601,Scintigraphic interpretation,PROCEDURE,Pulmonary Embolism; Right Heart Strain,na,TERMINATED,Odense University Hospital,
NCT00005612,filgrastim,BIOLOGICAL,Ovarian Cancer,phase1; phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005612,carboplatin,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005612,cyclophosphamide,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005612,etoposide,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005612,paclitaxel,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005612,topotecan hydrochloride,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT00005612,peripheral blood stem cell transplantation,PROCEDURE,Ovarian Cancer,phase1; phase2,TERMINATED,H. Lee Moffitt Cancer Center and Research Institute,
NCT04489381,Nitazoxanide,DRUG,Enterovirus; Rhinovirus,phase3,TERMINATED,Romark Laboratories L.C.,
NCT04489381,Placebo,DRUG,Enterovirus; Rhinovirus,phase3,TERMINATED,Romark Laboratories L.C.,
NCT04489381,Vitamin Super B-Complex,OTHER,Enterovirus; Rhinovirus,phase3,TERMINATED,Romark Laboratories L.C.,
NCT00750581,Indomethacin,DRUG,Patent Ductus Arteriosus,phase2; phase3,TERMINATED,University of Calgary,
NCT01259830,Arcoxia®120 mg,DRUG,Post-operative Pain,phase4,TERMINATED,Claudia Spies,
NCT01259830,P Tablet White Lichtenstein,DRUG,Post-operative Pain,phase4,TERMINATED,Claudia Spies,
NCT00369967,NuvaRing,DRUG,Contraception Desired,na,TERMINATED,Virginia Commonwealth University,
NCT03278236,TRF,BEHAVIORAL,Type2 Diabetes; Insulin Resistance,na,TERMINATED,University of Adelaide,
NCT00943371,MK6349,DRUG,Type 2 Diabetes Mellitus,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT00943371,Comparator: Placebo to MK6349,DRUG,Type 2 Diabetes Mellitus,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01937364,Baclofen,DRUG,Alcoholism; Alcohol Withdrawal,phase2,TERMINATED,Essentia Health,
NCT01937364,Placebo,DRUG,Alcoholism; Alcohol Withdrawal,phase2,TERMINATED,Essentia Health,
NCT05608499,Duobrii,DRUG,Acne Keloidalis Nuchae; AKN,phase3,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT05608499,Placebo,DRUG,Acne Keloidalis Nuchae; AKN,phase3,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT05608499,Bryhali,DRUG,Acne Keloidalis Nuchae; AKN,phase3,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT01748032,Cognitive training,BEHAVIORAL,Depression,na,TERMINATED,Rotman Research Institute at Baycrest,
NCT02015637,Delafloxacin,DRUG,Gonorrhea,phase3,TERMINATED,"Melinta Therapeutics, Inc.",
NCT02015637,Ceftriaxone,DRUG,Gonorrhea,phase3,TERMINATED,"Melinta Therapeutics, Inc.",
NCT02420795,Akt/ERK Inhibitor ONC201,DRUG,Central Nervous System Lymphoma; Gastric Mantle Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Non-Hodgkin Lymphoma; Splenic,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02420795,Laboratory Biomarker Analysis,OTHER,Central Nervous System Lymphoma; Gastric Mantle Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Non-Hodgkin Lymphoma; Splenic,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02420795,Pharmacological Study,OTHER,Central Nervous System Lymphoma; Gastric Mantle Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Non-Hodgkin Lymphoma; Splenic,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT06111339,Ketamine,DRUG,Opioid Use Disorder; Suicidal Ideation,phase2,TERMINATED,Brigham and Women's Hospital,
NCT06111339,Saline Solution,OTHER,Opioid Use Disorder; Suicidal Ideation,phase2,TERMINATED,Brigham and Women's Hospital,
NCT01641939,Taxane,DRUG,Gastric Cancer,phase2; phase3,TERMINATED,Hoffmann-La Roche,
NCT01641939,trastuzumab emtansine,DRUG,Gastric Cancer,phase2; phase3,TERMINATED,Hoffmann-La Roche,
NCT01641939,trastuzumab emtansine,DRUG,Gastric Cancer,phase2; phase3,TERMINATED,Hoffmann-La Roche,
NCT05026177,Simufilam,DRUG,Alzheimer Disease,phase3,TERMINATED,"Cassava Sciences, Inc.",
NCT05026177,Placebo,DRUG,Alzheimer Disease,phase3,TERMINATED,"Cassava Sciences, Inc.",
NCT02468557,Idelalisib,DRUG,Previously Untreated Pancreatic Ductal Adenocarcinoma; Relapsed/Refractory Pancreatic Ductal Adenocarcinoma,phase1,TERMINATED,Gilead Sciences,
NCT02468557,Nab-paclitaxel,DRUG,Previously Untreated Pancreatic Ductal Adenocarcinoma; Relapsed/Refractory Pancreatic Ductal Adenocarcinoma,phase1,TERMINATED,Gilead Sciences,
NCT02468557,mFOLFOX6,DRUG,Previously Untreated Pancreatic Ductal Adenocarcinoma; Relapsed/Refractory Pancreatic Ductal Adenocarcinoma,phase1,TERMINATED,Gilead Sciences,
NCT03069612,Repetitive Transcranial Magnetic Stimulation (rTMS),DEVICE,Cannabis Use Disorder; Psychosis,na,TERMINATED,Centre for Addiction and Mental Health,
NCT00686881,Peginterferon alfa-2b (PegIFN-2b),BIOLOGICAL,"Hepatitis C, Chronic",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00686881,Comparator: Stronger neo minophagen C (SNMC),DRUG,"Hepatitis C, Chronic",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01855607,topical menthol,DRUG,Breast Cancer; Colon Cancer; Neuropathy,phase2,TERMINATED,Columbia University,
NCT01855607,placebo lotion,DRUG,Breast Cancer; Colon Cancer; Neuropathy,phase2,TERMINATED,Columbia University,
NCT01981499,PF-05180999,DRUG,Migraine,phase1,TERMINATED,Pfizer,
NCT01981499,Placebo,DRUG,Migraine,phase1,TERMINATED,Pfizer,
NCT01981499,120 mg MR PF-05180999,DRUG,Migraine,phase1,TERMINATED,Pfizer,
NCT01981499,360 mg MR PF-05180999,DRUG,Migraine,phase1,TERMINATED,Pfizer,
NCT01981499,10 mg cetirizine,DRUG,Migraine,phase1,TERMINATED,Pfizer,
NCT01981499,Placebo,DRUG,Migraine,phase1,TERMINATED,Pfizer,
NCT01628198,Celcius Thermacool Catheter or Chilli II Cooled Ablation Catheter,DEVICE,Uncontrolled Hypertension,na,TERMINATED,Vivek Reddy,
NCT04818021,Adaptation,BEHAVIORAL,Speech; Consolidation,na,TERMINATED,Yale University,
NCT04818021,Facial Skin Stretch,BEHAVIORAL,Speech; Consolidation,na,TERMINATED,Yale University,
NCT02489604,177Lu-DOTATATE 25.9 GBq activity,DRUG,Neuroendocrine Tumors,phase2,TERMINATED,Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS,
NCT02489604,177Lu-DOTATATE 18.5 GBq activity,DRUG,Neuroendocrine Tumors,phase2,TERMINATED,Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00117884,851B,DRUG,Papillomavirus Infections,phase2,TERMINATED,Takeda,
NCT00030381,4'-iodo-4'-deoxydoxorubicin,DRUG,Primary Systemic Amyloidosis,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00030381,pharmacological study,OTHER,Primary Systemic Amyloidosis,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01365130,jevtana,DRUG,Esophageal; Gastrooesophageal Cancer; Gastric Cancer,phase2,TERMINATED,howard safran,
NCT02451111,Ibrutinib,DRUG,Follicular Lymphoma,phase2,TERMINATED,Swiss Cancer Institute,
NCT02451111,Rituximab,DRUG,Follicular Lymphoma,phase2,TERMINATED,Swiss Cancer Institute,
NCT03754244,TQB3456,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",
NCT01124344,Placebo,DRUG,Major Depression,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01124344,BMS-866949,DRUG,Major Depression,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01124344,BMS-866949,DRUG,Major Depression,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01124344,BMS-866949,DRUG,Major Depression,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01124344,BMS-866949,DRUG,Major Depression,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01124344,BMS-866949,DRUG,Major Depression,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01124344,BMS-866949,DRUG,Major Depression,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01124344,BMS-866949,DRUG,Major Depression,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01054534,Placement of interstim lead,PROCEDURE,Urinary Incontinence,na,TERMINATED,Mayo Clinic,
NCT03342534,"DC-stimulator (Neuroconn, Germany)",DEVICE,Stroke,na,TERMINATED,Adrian Guggisberg,
NCT07116499,Placebo,DRUG,Acute Migraine,phase2,TERMINATED,Kallyope Inc.,
NCT07116499,K-645 dose level 1,DRUG,Acute Migraine,phase2,TERMINATED,Kallyope Inc.,
NCT07116499,K-645 dose level 2,DRUG,Acute Migraine,phase2,TERMINATED,Kallyope Inc.,
NCT05140499,Liposomal bupivacaine,DRUG,"Pain, Postoperative; Amputation",phase4,TERMINATED,Aurora Quaye,
NCT05140499,Bupivacaine Hydrochloride 0.5 % Injectable Solution,DRUG,"Pain, Postoperative; Amputation",phase4,TERMINATED,Aurora Quaye,
NCT02097732,Ipilimumab,DRUG,Metastatic Melanoma; Brain Metastases,phase2,TERMINATED,University of Michigan Rogel Cancer Center,
NCT02097732,Stereotactic Radiosurgery,PROCEDURE,Metastatic Melanoma; Brain Metastases,phase2,TERMINATED,University of Michigan Rogel Cancer Center,
NCT03883321,Cognitive behavioral stress management,OTHER,Perceived Stress,na,TERMINATED,"University Hospital, Grenoble",
NCT02271516,188Re-BMEDA-liposome,RADIATION,Tumors,phase1,TERMINATED,"National Atomic Research Institute, Taiwan",
NCT06943716,Modified Catheter Antegrade Cerebral Perfusion (Modified bACP),PROCEDURE,Acute Type A Aortic Dissection,na,TERMINATED,China Medical University Hospital,
NCT06943716,Conventional Brain Perfusion,PROCEDURE,Acute Type A Aortic Dissection,na,TERMINATED,China Medical University Hospital,
NCT01164514,CPG 7909,BIOLOGICAL,Bacterial Sepsis,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01164514,J5-OMP Vaccine,BIOLOGICAL,Bacterial Sepsis,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01164514,Placebo,DRUG,Bacterial Sepsis,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01122914,Anakinra,DRUG,Anakinra; Kineret; Atopic Dermatitis; Eczema; Allergic Disease,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT03169114,Amikacin Injection,DRUG,Appendicitis; Surgery,na,TERMINATED,Raja Isteri Pengiran Anak Saleha Hospital,
NCT03169114,Appendicectomy,PROCEDURE,Appendicitis; Surgery,na,TERMINATED,Raja Isteri Pengiran Anak Saleha Hospital,
NCT02654314,Melatonin,DRUG,Delirium,phase3,TERMINATED,Yale University,
NCT02654314,Placebo,OTHER,Delirium,phase3,TERMINATED,Yale University,
NCT00019604,computed tomography,PROCEDURE,"Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,National Institutes of Health Clinical Center (CC),
NCT00019604,magnetic resonance imaging,PROCEDURE,"Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,National Institutes of Health Clinical Center (CC),
NCT00019604,positron emission tomography,PROCEDURE,"Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,National Institutes of Health Clinical Center (CC),
NCT00019604,radiofrequency ablation,PROCEDURE,"Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,National Institutes of Health Clinical Center (CC),
NCT00019604,radionuclide imaging,PROCEDURE,"Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,National Institutes of Health Clinical Center (CC),
NCT00019604,ultrasound imaging,PROCEDURE,"Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,National Institutes of Health Clinical Center (CC),
NCT00019604,fludeoxyglucose F 18 (FDG-PET),RADIATION,"Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,National Institutes of Health Clinical Center (CC),
NCT00019604,gadopentetate dimeglumine,RADIATION,"Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,National Institutes of Health Clinical Center (CC),
NCT00965419,Edivoxetine,DRUG,Attention Deficit Hyperactivity Disorder,phase2; phase3,TERMINATED,Eli Lilly and Company,
NCT01290328,Epoetin Alfa,DRUG,Anemia,na,TERMINATED,"Mehrotra, Anita, M.D.",
NCT01524965,Immediate mobilisation after locking-plate osteosynthesis,PROCEDURE,Humeral Fracture,na,TERMINATED,University of Helsinki,
NCT01524965,Standard mobilisation after locking plate osteosynthesis,PROCEDURE,Humeral Fracture,na,TERMINATED,University of Helsinki,
NCT01524965,Osteosynthesis with a locking plate (Philos),DEVICE,Humeral Fracture,na,TERMINATED,University of Helsinki,
NCT00862836,Vandetanib,DRUG,Ovarian Cancer,phase1; phase2,TERMINATED,"Genzyme, a Sanofi Company",
NCT01716234,Posaconazole 12 mg/kg/day BID,DRUG,Fungal Infections,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01716234,Posaconazole 18 mg/kg/day BID,DRUG,Fungal Infections,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01716234,Posaconazole 18 mg/kg/day TID,DRUG,Fungal Infections,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01716234,Posaconazole 12 mg/kg/day TID,DRUG,Fungal Infections,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT04111809,Blood and urine collection,BIOLOGICAL,Multiple Myeloma,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04626232,N-SLEEVE technique,PROCEDURE,Severe Obesity; GERD; Bariatric Surgery Candidate; Morbid Obesity,na,TERMINATED,"University Hospital, Montpellier",
NCT04626232,SLEEVE,PROCEDURE,Severe Obesity; GERD; Bariatric Surgery Candidate; Morbid Obesity,na,TERMINATED,"University Hospital, Montpellier",
NCT03523663,no intervention. measure eye movement data,OTHER,Attention Deficit Hyperactivity Disorder,na,TERMINATED,"University of Wisconsin, Madison",
NCT00589693,Doripenem,DRUG,Ventilator-Associated Pneumonia,phase3,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT00589693,Imipenem-Cilastatin,DRUG,Ventilator-Associated Pneumonia,phase3,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT00589693,Placebo,DRUG,Ventilator-Associated Pneumonia,phase3,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT01352416,Ranolazine,DRUG,"Heart; Dysfunction Postoperative, Cardiac Surgery",phase3,TERMINATED,Corewell Health East,
NCT01352416,Placebo,DRUG,"Heart; Dysfunction Postoperative, Cardiac Surgery",phase3,TERMINATED,Corewell Health East,
NCT04515004,leucoselect phytosome,DRUG,Early Stage Lung Cancer (I and II),phase2,TERMINATED,VA Office of Research and Development,
NCT03151304,Pracinostat,DRUG,Myelodysplastic Syndromes,phase2,TERMINATED,Helsinn Healthcare SA,
NCT03151304,Azacitidine,DRUG,Myelodysplastic Syndromes,phase2,TERMINATED,Helsinn Healthcare SA,
NCT02462200,Breast-conserving surgery (BCS),PROCEDURE,Breast Cancer; Cancer of Breast; Cancer of the Breast,phase2,TERMINATED,Washington University School of Medicine,
NCT02462200,Cavity shave margins (CSM),PROCEDURE,Breast Cancer; Cancer of Breast; Cancer of the Breast,phase2,TERMINATED,Washington University School of Medicine,
NCT02462200,BREAST-Q Questionnaire,BEHAVIORAL,Breast Cancer; Cancer of Breast; Cancer of the Breast,phase2,TERMINATED,Washington University School of Medicine,
NCT02462200,3-D breast imaging,DEVICE,Breast Cancer; Cancer of Breast; Cancer of the Breast,phase2,TERMINATED,Washington University School of Medicine,
NCT02462200,Indocyanine green,OTHER,Breast Cancer; Cancer of Breast; Cancer of the Breast,phase2,TERMINATED,Washington University School of Medicine,
NCT02462200,Intraoperative imaging device,DEVICE,Breast Cancer; Cancer of Breast; Cancer of the Breast,phase2,TERMINATED,Washington University School of Medicine,
NCT02462200,Peripheral blood draw,PROCEDURE,Breast Cancer; Cancer of Breast; Cancer of the Breast,phase2,TERMINATED,Washington University School of Medicine,
NCT00326911,cetuximab,BIOLOGICAL,Metastatic Pancreatic Cancer,phase2,TERMINATED,Eli Lilly and Company,
NCT00326911,bevacizumab,BIOLOGICAL,Metastatic Pancreatic Cancer,phase2,TERMINATED,Eli Lilly and Company,
NCT00326911,gemcitabine,DRUG,Metastatic Pancreatic Cancer,phase2,TERMINATED,Eli Lilly and Company,
NCT00326911,cetuximab,BIOLOGICAL,Metastatic Pancreatic Cancer,phase2,TERMINATED,Eli Lilly and Company,
NCT01984463,Fentanyl,DRUG,Postoperative Pain; Shoulder Pain,na,TERMINATED,Centre hospitalier de l'Université de Montréal (CHUM),
NCT01984463,Morphine,DRUG,Postoperative Pain; Shoulder Pain,na,TERMINATED,Centre hospitalier de l'Université de Montréal (CHUM),
NCT03300921,Paricalcitol,DRUG,Pancreatic Cancer,phase1,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT06018506,BR108 injection,DRUG,Hematologic Malignancy,phase1,TERMINATED,"BioRay Pharmaceutical Co., Ltd.",
NCT01720563,Astragalus polysaccharides 500 mg,DRUG,Cancer-related Fatigue,phase2,TERMINATED,PhytoHealth Corporation,
NCT01720563,Placebo,DRUG,Cancer-related Fatigue,phase2,TERMINATED,PhytoHealth Corporation,
NCT01720563,Concurrent chemoradiotherapy with PUL (cisplatin/tegafur plus uracil (UFT)/leucovorin) every 2 weeks,PROCEDURE,Cancer-related Fatigue,phase2,TERMINATED,PhytoHealth Corporation,
NCT04593784,Ciraparantag,DRUG,Healthy,phase2,TERMINATED,"AMAG Pharmaceuticals, Inc.",
NCT04593784,Placebo,DRUG,Healthy,phase2,TERMINATED,"AMAG Pharmaceuticals, Inc.",
NCT04593784,Point-of-Care Coagulometer (investigational device),DEVICE,Healthy,phase2,TERMINATED,"AMAG Pharmaceuticals, Inc.",
NCT04148352,Dupilumab,DRUG,Allergies Food Milk,phase2,TERMINATED,"Andrew J Long, PharmD",
NCT04148352,Placebo,OTHER,Allergies Food Milk,phase2,TERMINATED,"Andrew J Long, PharmD",
NCT02724033,regional nerve block,PROCEDURE,"Anesthesia, Pediatrics, Surgery",phase4,TERMINATED,Indiana University,
NCT02724033,Antiemetic,DRUG,"Anesthesia, Pediatrics, Surgery",phase4,TERMINATED,Indiana University,
NCT02748564,Aldesleukin,BIOLOGICAL,Metastatic Melanoma; Stage III Mucosal Melanoma of the Head and Neck; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma; Stage IVA Mucosal Melanoma o,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT02748564,Laboratory Biomarker Analysis,OTHER,Metastatic Melanoma; Stage III Mucosal Melanoma of the Head and Neck; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma; Stage IVA Mucosal Melanoma o,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT02748564,Pembrolizumab,BIOLOGICAL,Metastatic Melanoma; Stage III Mucosal Melanoma of the Head and Neck; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma; Stage IVA Mucosal Melanoma o,phase2,TERMINATED,"Rutgers, The State University of New Jersey",
NCT04034914,Questionnaire administration,OTHER,Malignant Neoplasm,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT04363606,Questionnaires,OTHER,Chronic Fatigue Syndrome; Intensive Care Unit; Muscle,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT04363606,blood test,BIOLOGICAL,Chronic Fatigue Syndrome; Intensive Care Unit; Muscle,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT04363606,Maximal effort test,OTHER,Chronic Fatigue Syndrome; Intensive Care Unit; Muscle,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT04363606,actigraphy,DEVICE,Chronic Fatigue Syndrome; Intensive Care Unit; Muscle,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT04363606,Neuromuscular evaluation,DEVICE,Chronic Fatigue Syndrome; Intensive Care Unit; Muscle,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT04363606,stool analysis,OTHER,Chronic Fatigue Syndrome; Intensive Care Unit; Muscle,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT04363606,food diary,OTHER,Chronic Fatigue Syndrome; Intensive Care Unit; Muscle,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT04578106,Trastuzumab and pertuzumab Subcutaneous Fixed-Dose Combination,BIOLOGICAL,HER2-positive Breast Cancer; Stage I Breast Cancer,phase2,TERMINATED,Fundacio Clinic Barcelona,
NCT04552704,CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc,BIOLOGICAL,Advanced Malignant Solid Neoplasm,phase1; phase2,TERMINATED,Tianhong Li,
NCT04552704,Placebo Administration,DRUG,Advanced Malignant Solid Neoplasm,phase1; phase2,TERMINATED,Tianhong Li,
NCT00131404,taranabant,DRUG,Obesity,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00131404,Comparator: Placebo,DRUG,Obesity,phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT00415584,Cinacalcet HCl,DRUG,Secondary Hyperparathyroidism; Hypercalcemia,phase1; phase2,TERMINATED,Montefiore Medical Center,
NCT02286284,Apheresis for extracorporal removal of sFlt-1,DEVICE,Preeclampsia,phase2,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT05068284,ABBV-154,DRUG,Crohn's Disease,phase2,TERMINATED,AbbVie,
NCT05068284,Placebo,DRUG,Crohn's Disease,phase2,TERMINATED,AbbVie,
NCT05068284,ABBV-154,DRUG,Crohn's Disease,phase2,TERMINATED,AbbVie,
NCT05068284,Placebo,DRUG,Crohn's Disease,phase2,TERMINATED,AbbVie,
NCT00119184,External cephalic version,PROCEDURE,Breech Presentation,phase1,TERMINATED,Hadassah Medical Organization,
NCT00119184,spinal anesthesia,DRUG,Breech Presentation,phase1,TERMINATED,Hadassah Medical Organization,
NCT05584332,"Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)",BIOLOGICAL,Cervical Cancer; Genital Wart; CIN1; CIN2; CIN3; Vain I; Vain III; Vin I; Vin II; Vin III; AIS; VAIN - Vaginal Intraepithelial Neoplasia 2,phase3,TERMINATED,"Shanghai Bovax Biotechnology Co., Ltd.",
NCT05584332,Placebo,BIOLOGICAL,Cervical Cancer; Genital Wart; CIN1; CIN2; CIN3; Vain I; Vain III; Vin I; Vin II; Vin III; AIS; VAIN - Vaginal Intraepithelial Neoplasia 2,phase3,TERMINATED,"Shanghai Bovax Biotechnology Co., Ltd.",
NCT01485432,PiCCO® Monitoring,DEVICE,Renal Transplant Surgery,na,TERMINATED,Technical University of Munich,
NCT00892632,ERCP and Confocal imaging,PROCEDURE,Biliary Stricture,na,TERMINATED,Mayo Clinic,
NCT02830087,Tourniquet Cuff Pressure,PROCEDURE,"Tourniquets; Knee Arthroplasty, Total; Knee Replacement, Total",na,TERMINATED,Wake Forest University Health Sciences,
NCT05019521,Danicopan,DRUG,Geographic Atrophy,phase2,TERMINATED,"Alexion Pharmaceuticals, Inc.",
NCT05019521,Placebo,DRUG,Geographic Atrophy,phase2,TERMINATED,"Alexion Pharmaceuticals, Inc.",
NCT03056014,N-acetyl cysteine,DRUG,Ameliorating Oxidative Stress in Type 1 Diabetes,early_phase1,TERMINATED,"University of Maryland, Baltimore",
NCT03056014,omega 6 Fish oil ( PUFA),OTHER,Ameliorating Oxidative Stress in Type 1 Diabetes,early_phase1,TERMINATED,"University of Maryland, Baltimore",
NCT03056014,Placebo,OTHER,Ameliorating Oxidative Stress in Type 1 Diabetes,early_phase1,TERMINATED,"University of Maryland, Baltimore",
NCT01425216,Sorafenib,DRUG,Keloids,phase2,TERMINATED,"Tirgan, Michael H., M.D.",
NCT00017433,arsenic trioxide,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,CTI BioPharma,
NCT00239733,Anti-D,DRUG,Thrombocytopenia; Hepatitis C; HIV Infections,phase4,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00815633,Alefacept,DRUG,Pityriasis Rubra Pilaris,phase4,TERMINATED,Joshua Zeichner,
NCT05142332,Covid-19 vaccine education materials,OTHER,Covid-19 Vaccine; Vaccine Hesitancy,na,TERMINATED,"University of California, San Francisco",
NCT02221232,Chloraprep,DRUG,Surgical Site Infection,phase2,TERMINATED,"Zurex Pharma, Inc.",
NCT02221232,ZuraPrep,DRUG,Surgical Site Infection,phase2,TERMINATED,"Zurex Pharma, Inc.",
NCT02221232,ZuraPrep Vehicle,DRUG,Surgical Site Infection,phase2,TERMINATED,"Zurex Pharma, Inc.",
NCT01197963,Sleeve Gastrectomy and Ileal transposition,PROCEDURE,Type 2 Diabetes Mellitus,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT01197963,dietary and medical management,OTHER,Type 2 Diabetes Mellitus,na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT01875263,Cloxacilin,DRUG,Staphylococcus,phase3,TERMINATED,Fundación Pública Andaluza Progreso y Salud,
NCT01875263,Cloxacillin,DRUG,Staphylococcus,phase3,TERMINATED,Fundación Pública Andaluza Progreso y Salud,
NCT01875263,Levofloxacin,DRUG,Staphylococcus,phase3,TERMINATED,Fundación Pública Andaluza Progreso y Salud,
NCT02393833,Blood samples collection,PROCEDURE,Breast Cancer,na,TERMINATED,ETOP IBCSG Partners Foundation,
NCT00716833,Etoricoxibe,DRUG,Pain; Abdominal Surgery; Thoracic Surgery,phase3,TERMINATED,Ludwig-Maximilians - University of Munich,
NCT00716833,Placebo,DRUG,Pain; Abdominal Surgery; Thoracic Surgery,phase3,TERMINATED,Ludwig-Maximilians - University of Munich,
NCT00863512,cisplatin,DRUG,Lung Cancer,phase3,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT00863512,docetaxel,DRUG,Lung Cancer,phase3,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT00863512,gemcitabine hydrochloride,DRUG,Lung Cancer,phase3,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT00863512,pemetrexed disodium,DRUG,Lung Cancer,phase3,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT00863512,vinorelbine tartrate,DRUG,Lung Cancer,phase3,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT00863512,standard follow-up care,PROCEDURE,Lung Cancer,phase3,TERMINATED,Alliance for Clinical Trials in Oncology,
NCT03812107,Moderate Treatment Approach,OTHER,Opioid-use Disorder,na,TERMINATED,Boston Medical Center,
NCT03812107,Intensive Treatment Approach,OTHER,Opioid-use Disorder,na,TERMINATED,Boston Medical Center,
NCT06310707,ePatch ® Extended Wear Holter (EWH),DEVICE,Arrythmia; Syncope,na,TERMINATED,Philips Clinical & Medical Affairs Global,
NCT01013792,Wound Dressing,DEVICE,"Foot Ulcer, Diabetic",na,TERMINATED,Solventum US LLC,
NCT01013792,Wound Dressing,DEVICE,"Foot Ulcer, Diabetic",na,TERMINATED,Solventum US LLC,
NCT03339336,BIIB074,DRUG,Small Fiber Neuropathy; Diabetes Mellitus,phase2,TERMINATED,Biogen,
NCT03339336,Placebo,DRUG,Small Fiber Neuropathy; Diabetes Mellitus,phase2,TERMINATED,Biogen,
NCT01426334,dasatinib,DRUG,"Accelerated Phase Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia",phase1,TERMINATED,National Cancer Institute (NCI),
NCT01426334,diagnostic laboratory biomarker analysis,OTHER,"Accelerated Phase Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia",phase1,TERMINATED,National Cancer Institute (NCI),
NCT01426334,pharmacological study,OTHER,"Accelerated Phase Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia",phase1,TERMINATED,National Cancer Institute (NCI),
NCT01426334,cyclosporine,DRUG,"Accelerated Phase Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia",phase1,TERMINATED,National Cancer Institute (NCI),
NCT05446064,Stigma-reduction intervention,BEHAVIORAL,"HIV Infections; Stigma, Social; Care Eliciting Behavior",na,TERMINATED,"University of California, Los Angeles",
NCT02380209,CEST MRI,OTHER,Breast Cancer,early_phase1,TERMINATED,University of Arizona,
NCT00360087,Bosentan,DRUG,Pulmonary Hypertension; Sickle Cell Anemia,phase3,TERMINATED,Actelion,
NCT04587193,Robotic-assist gait training device,DEVICE,Parkinson Disease,na,TERMINATED,Virginia Commonwealth University,
NCT00815516,micafungin,DRUG,Candidiasis,phase3,TERMINATED,"Astellas Pharma Global Development, Inc.",
NCT00815516,amphotericin B deoxycholate,DRUG,Candidiasis,phase3,TERMINATED,"Astellas Pharma Global Development, Inc.",
NCT00249704,Vitamin D + Sham Exercise,DRUG,"Elderly, Frail",phase1,TERMINATED,Pfizer,
NCT00249704,Vitamin D Placebo + Exercise,PROCEDURE,"Elderly, Frail",phase1,TERMINATED,Pfizer,
NCT00249704,Vitamin D Placebo + Sham Exercise,PROCEDURE,"Elderly, Frail",phase1,TERMINATED,Pfizer,
NCT00249704,Vitamin D + Exercise,DRUG,"Elderly, Frail",phase1,TERMINATED,Pfizer,
NCT04950504,CNP-201,DRUG,Peanut Allergy,phase1,TERMINATED,"COUR Pharmaceutical Development Company, Inc.",
NCT04950504,Placebo,DRUG,Peanut Allergy,phase1,TERMINATED,"COUR Pharmaceutical Development Company, Inc.",
NCT03500952,Birth Control After Pregnancy,OTHER,Contraception; Pregnancy Related,na,TERMINATED,Dartmouth-Hitchcock Medical Center,
NCT03500952,Postpartum Birth Control,OTHER,Contraception; Pregnancy Related,na,TERMINATED,Dartmouth-Hitchcock Medical Center,
NCT04076852,Administration of questionnaires,OTHER,Tourette Syndrome,na,TERMINATED,I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio,
NCT03529552,Anterior Cruciate Ligament Reconstruction,PROCEDURE,Anterior Cruciate Ligament Rupture,na,TERMINATED,Centre Hospitalier Universitaire de Nīmes,
NCT02439281,Clonidine,DRUG,Postoperative Pain,na,TERMINATED,Mihaela Visoiu,
NCT02439281,Ropivacaine,DRUG,Postoperative Pain,na,TERMINATED,Mihaela Visoiu,
NCT00771381,18F-FAZA PET scan,DRUG,Breast Neoplasm,phase2,TERMINATED,AHS Cancer Control Alberta,
NCT00771381,FluGlucoScan Injection (18F-FDB) PET scan,DRUG,Breast Neoplasm,phase2,TERMINATED,AHS Cancer Control Alberta,
NCT05133128,blood samples,OTHER,Immune System,na,TERMINATED,Servier,
NCT00372567,sunitinib malate,DRUG,Gastrointestinal Stromal Tumor,phase3,TERMINATED,Pfizer,
NCT00372567,imatinib mesylate,DRUG,Gastrointestinal Stromal Tumor,phase3,TERMINATED,Pfizer,
NCT02445092,washing the insemination catheter with sperm washing media,OTHER,Infertility; Pregnancy,na,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT01806636,PneumRx Coil System,DEVICE,Emphysema,na,TERMINATED,Boston Scientific Corporation,
NCT00317434,lapatinib,DRUG,Ovarian Cancer,phase1,TERMINATED,University of Alabama at Birmingham,
NCT01774487,Pentoxifylline,DRUG,Biliary Atresia,phase2,TERMINATED,Baylor College of Medicine,
NCT04269993,Cannabis: placebo and medium THC/medium CBD,DRUG,Rheumatoid Arthritis; Psoriatic Arthritis,phase2,TERMINATED,Brown University,
NCT02796521,dietary counseling,OTHER,Malnutrition,na,TERMINATED,"University Hospital, Grenoble",
NCT02796521,nutritional workshop with enrichment during a meal,OTHER,Malnutrition,na,TERMINATED,"University Hospital, Grenoble",
NCT04838314,regional analgesia,PROCEDURE,Liver Transplant Disorder,na,TERMINATED,Vinmec Healthcare System,
NCT02753816,Tranexamic Acid,DRUG,Tranexamic Acid; Burn; Major Surgery,na,TERMINATED,Corewell Health West,
NCT02753816,Placebo Comparator,DRUG,Tranexamic Acid; Burn; Major Surgery,na,TERMINATED,Corewell Health West,
NCT02783404,Amoxicillin,DRUG,Bacteraemia; Endocarditis,phase4,TERMINATED,University of Santiago de Compostela,
NCT02783404,Amoxicillin-Potassium Clavulanate,DRUG,Bacteraemia; Endocarditis,phase4,TERMINATED,University of Santiago de Compostela,
NCT00878592,Dietary and life style modification,BEHAVIORAL,Post Liver Transplantation Weight Gain; Post Liver Transplantation Obesity; Nonalcoholic Steatohepatitis,na,TERMINATED,University of Pittsburgh,
NCT00913692,Glutamine,DRUG,Herpes Labialis; Herpes Simplex Virus,phase2,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00913692,Glycine,DRUG,Herpes Labialis; Herpes Simplex Virus,phase2,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT03500744,Erector spinae plane block,PROCEDURE,Hysterectomy; Cystectomy; Regional Anesthesia,na,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT03500744,Sham block,PROCEDURE,Hysterectomy; Cystectomy; Regional Anesthesia,na,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02640534,Enzalutamide,DRUG,Cancer of the Prostate; Prostate Cancer,phase2,TERMINATED,Swiss Cancer Institute,
NCT02640534,Metformin,DRUG,Cancer of the Prostate; Prostate Cancer,phase2,TERMINATED,Swiss Cancer Institute,
NCT00444834,Carvedilol,DRUG,Hypertension,phase2,TERMINATED,Egalet Ltd,
NCT04097821,Ruxolitinib,DRUG,Myelofibrosis,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04097821,Siremadlin,DRUG,Myelofibrosis,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04097821,Crizanlizumab,DRUG,Myelofibrosis,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04097821,Sabatolimab,DRUG,Myelofibrosis,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04097821,Rineterkib,DRUG,Myelofibrosis,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04097821,NIS793,DRUG,Myelofibrosis,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT03222414,Non-invasive BP recording with conical Ultracheck Curve BP cuff,DEVICE,Pre-Eclampsia; Morbid Obesity; Parturient; Blood Pressure,na,TERMINATED,Vanderbilt University Medical Center,
NCT03222414,Non-invasive BP recording with traditional cylindrical BP cuff,DEVICE,Pre-Eclampsia; Morbid Obesity; Parturient; Blood Pressure,na,TERMINATED,Vanderbilt University Medical Center,
NCT03222414,Direct invasive arterial pressure,OTHER,Pre-Eclampsia; Morbid Obesity; Parturient; Blood Pressure,na,TERMINATED,Vanderbilt University Medical Center,
NCT02468414,MDGN201 TARGTEPO,BIOLOGICAL,Anemia of End Stage Renal Disease,phase2,TERMINATED,"Aevi Genomic Medicine, LLC, a Cerecor company",
NCT02468414,MDGN201 TARGTEPO,BIOLOGICAL,Anemia of End Stage Renal Disease,phase2,TERMINATED,"Aevi Genomic Medicine, LLC, a Cerecor company",
NCT01061606,temsirolimus,DRUG,Recurrent Uterine Sarcoma; Uterine Carcinosarcoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00216281,Clozapine augmented with atomoxetine up to 40 mg or placebo,DRUG,Schizophrenia,phase3,TERMINATED,Indiana University School of Medicine,
NCT03955471,Niraparib,DRUG,Ovarian Neoplasms,phase2,TERMINATED,"Tesaro, Inc.",
NCT03955471,Dostarlimab,DRUG,Ovarian Neoplasms,phase2,TERMINATED,"Tesaro, Inc.",
NCT00682344,Levobupivacaïne,DRUG,Surgical Pathology of the Leg or the Foot.,phase3,TERMINATED,Assistance Publique Hopitaux De Marseille,
NCT05094934,NNC0385-0434 A 100 mg,DRUG,Chronic Kidney Disease,phase1,TERMINATED,Novo Nordisk A/S,
NCT06038799,Caregiver Skills Training (CST),BEHAVIORAL,Parenting,na,TERMINATED,University of Pittsburgh,
NCT02819999,Rovalpituzumab Tesirine,DRUG,Small Cell Lung Cancer,phase1,TERMINATED,AbbVie,
NCT02819999,Cisplatin,DRUG,Small Cell Lung Cancer,phase1,TERMINATED,AbbVie,
NCT02819999,Etoposide,DRUG,Small Cell Lung Cancer,phase1,TERMINATED,AbbVie,
NCT00862563,Topiramate,DRUG,Alcoholism; Alcohol Dependence; Alcohol Abuse,phase2,TERMINATED,Boston Medical Center,
NCT00862563,Zonisamide,DRUG,Alcoholism; Alcohol Dependence; Alcohol Abuse,phase2,TERMINATED,Boston Medical Center,
NCT00862563,Levetiracetam,DRUG,Alcoholism; Alcohol Dependence; Alcohol Abuse,phase2,TERMINATED,Boston Medical Center,
NCT00862563,Sugar Pill,DRUG,Alcoholism; Alcohol Dependence; Alcohol Abuse,phase2,TERMINATED,Boston Medical Center,
NCT01283763,Topical Imiquimod,DRUG,Cervical Intraepithelial Neoplasia,phase3,TERMINATED,Medical University of Vienna,
NCT01283763,Conization,PROCEDURE,Cervical Intraepithelial Neoplasia,phase3,TERMINATED,Medical University of Vienna,
NCT01473693,"MRI Screening Form, MRI, Demographic / Medical Data form",OTHER,Non-small Cell Lung Cancer,na,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT01473693,"MRI Screening Form, MRI. Demographic / Medical Data",OTHER,Non-small Cell Lung Cancer,na,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00036816,MART-1 antigen,BIOLOGICAL,Intraocular Melanoma,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00036816,NA17-A antigen,BIOLOGICAL,Intraocular Melanoma,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00036816,gp100 antigen,BIOLOGICAL,Intraocular Melanoma,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00036816,tyrosinase peptide,BIOLOGICAL,Intraocular Melanoma,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT03698916,Celecoxib cream 8%,DRUG,"Osteoarthritis, Knee",na,TERMINATED,Credit Valley Rheumatology,
NCT03684304,Abdominal binder,DEVICE,Pelvic Organ Prolapse; Abdominal Surgery; Laparoscopic Surgery; Post Operative Pain,na,TERMINATED,University Hospitals Cleveland Medical Center,
NCT04278833,Triamcinolone or Betamethasone,DRUG,Osteoarthritis; Tendinopathy; Impingement Shoulder,phase4,TERMINATED,Stanford University,
NCT04278833,Dexamethasone,DRUG,Osteoarthritis; Tendinopathy; Impingement Shoulder,phase4,TERMINATED,Stanford University,
NCT00607152,Rasburicase,DRUG,Hyperuricemia,phase3,TERMINATED,Sanofi,
NCT00607152,Allopurinol,DRUG,Hyperuricemia,phase3,TERMINATED,Sanofi,
NCT02805452,Succinate of Solifenacin,DRUG,Overactive Bladder,phase3,TERMINATED,Center Eugene Marquis,
NCT02805452,Placebo of Succinate of Solifenacin,DRUG,Overactive Bladder,phase3,TERMINATED,Center Eugene Marquis,
NCT00321100,bevacizumab,DRUG,Colorectal Neoplasms,phase2,TERMINATED,Fox Chase Cancer Center,
NCT00321100,cetuximab,DRUG,Colorectal Neoplasms,phase2,TERMINATED,Fox Chase Cancer Center,
NCT00321100,Oxaliplatin,DRUG,Colorectal Neoplasms,phase2,TERMINATED,Fox Chase Cancer Center,
NCT00321100,Capecitabine,DRUG,Colorectal Neoplasms,phase2,TERMINATED,Fox Chase Cancer Center,
NCT04362007,ASTX660,DRUG,"Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)",phase1; phase2,TERMINATED,"Otsuka Pharmaceutical Co., Ltd.",
NCT04362007,ASTX660,DRUG,"Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)",phase1; phase2,TERMINATED,"Otsuka Pharmaceutical Co., Ltd.",
NCT04362007,ASTX660,DRUG,"Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)",phase1; phase2,TERMINATED,"Otsuka Pharmaceutical Co., Ltd.",
NCT00966992,Zoledronic acid,DRUG,Uterine Cervical Neoplasms,phase2,TERMINATED,Washington University School of Medicine,
NCT03261336,"Calcitriol, Ketoconazole, Hydrocortisone",DRUG,Castration-resistant Prostate Cancer,phase2,TERMINATED,"Donald Trump, MD",
NCT01485536,AUY922,DRUG,Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00996944,Ropinirole immediate release (IR),DRUG,Restless Legs Syndrome,phase2,TERMINATED,GlaxoSmithKline,
NCT00996944,Placebo,DRUG,Restless Legs Syndrome,phase2,TERMINATED,GlaxoSmithKline,
NCT02375334,Medical Chart Review,OTHER,Malignant Glioma; Myelosuppression,na,TERMINATED,Wake Forest University Health Sciences,
NCT00134264,torcetrapib/atorvastatin,DRUG,Coronary Disease; Diabetes Mellitus,phase3,TERMINATED,Pfizer,
NCT00134264,atorvastatin,DRUG,Coronary Disease; Diabetes Mellitus,phase3,TERMINATED,Pfizer,
NCT04720664,SM-88,DRUG,Breast Cancer; Metastatic Breast Cancer; Hormone Receptor Positive Breast Carcinoma,phase2,TERMINATED,Georgetown University,
NCT00956709,"levobupivacaïne 0,5 %",DRUG,Nerve Block,phase4,TERMINATED,Nantes University Hospital,
NCT00956709,"ropivacaïne 0,5 %",DRUG,Nerve Block,phase4,TERMINATED,Nantes University Hospital,
NCT01627899,One Touch VerioIQ Blood Glucose Monitor,DEVICE,Diabetes,na,TERMINATED,LifeScan,
NCT00076206,CCI-779,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,Wyeth is now a wholly owned subsidiary of Pfizer,
NCT00076206,Placebo,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,Wyeth is now a wholly owned subsidiary of Pfizer,
NCT04580004,Med Optimization Arm,OTHER,Heart Failure,na,TERMINATED,University of Michigan,
NCT01116284,Revision of gastric bypass,PROCEDURE,Morbid Obesity,na,TERMINATED,Baystate Medical Center,
NCT01159067,deferasirox,DRUG,Iron Overload; Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL),phase2,TERMINATED,City of Hope Medical Center,
NCT01261767,anti-IL-20,DRUG,Inflammation; Psoriasis,phase1,TERMINATED,Novo Nordisk A/S,
NCT01261767,placebo,DRUG,Inflammation; Psoriasis,phase1,TERMINATED,Novo Nordisk A/S,
NCT02142192,natalizumab,DRUG,Relapsing Multiple Sclerosis,phase2,TERMINATED,Biogen,
NCT04265534,Telaglenastat,DRUG,Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation,phase2,TERMINATED,"Calithera Biosciences, Inc",
NCT04265534,Carboplatin Chemotherapy,DRUG,Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation,phase2,TERMINATED,"Calithera Biosciences, Inc",
NCT04265534,Pemetrexed Chemotherapy,DRUG,Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation,phase2,TERMINATED,"Calithera Biosciences, Inc",
NCT04265534,Pembrolizumab Immunotherapy,BIOLOGICAL,Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation,phase2,TERMINATED,"Calithera Biosciences, Inc",
NCT04265534,Placebo,DRUG,Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation,phase2,TERMINATED,"Calithera Biosciences, Inc",
NCT04265534,Folic acid 400 -1000 μg,OTHER,Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation,phase2,TERMINATED,"Calithera Biosciences, Inc",
NCT04265534,Vitamin B12 1000 μg,OTHER,Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation,phase2,TERMINATED,"Calithera Biosciences, Inc",
NCT04265534,Dexamethasone 4 mg,DRUG,Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation,phase2,TERMINATED,"Calithera Biosciences, Inc",
NCT00981799,Nelarabine,DRUG,Relapsed T-Cell Acute Lymphoblastic Leukemia; Relapsed T-Cell Lymphoblastic Lymphoma,phase1; phase2,TERMINATED,Therapeutic Advances in Childhood Leukemia Consortium,
NCT00981799,Etoposide,DRUG,Relapsed T-Cell Acute Lymphoblastic Leukemia; Relapsed T-Cell Lymphoblastic Lymphoma,phase1; phase2,TERMINATED,Therapeutic Advances in Childhood Leukemia Consortium,
NCT00981799,Cyclophosphamide,DRUG,Relapsed T-Cell Acute Lymphoblastic Leukemia; Relapsed T-Cell Lymphoblastic Lymphoma,phase1; phase2,TERMINATED,Therapeutic Advances in Childhood Leukemia Consortium,
NCT00981799,Methotrexate,DRUG,Relapsed T-Cell Acute Lymphoblastic Leukemia; Relapsed T-Cell Lymphoblastic Lymphoma,phase1; phase2,TERMINATED,Therapeutic Advances in Childhood Leukemia Consortium,
NCT00981799,Filgrastim,DRUG,Relapsed T-Cell Acute Lymphoblastic Leukemia; Relapsed T-Cell Lymphoblastic Lymphoma,phase1; phase2,TERMINATED,Therapeutic Advances in Childhood Leukemia Consortium,
NCT01283321,Human fibrinogen concentrate,DRUG,Heart Valve Disease; Coronary Artery Disease,phase2,TERMINATED,Emory University,
NCT01283321,apheresis platelets,OTHER,Heart Valve Disease; Coronary Artery Disease,phase2,TERMINATED,Emory University,
NCT00176514,Administration of the antineoplastic,DRUG,Mucositis,na,TERMINATED,University of Medicine and Dentistry of New Jersey,
NCT04067804,Dynamic Adaptation Process,BEHAVIORAL,Discipline Practices,na,TERMINATED,Pacific Institute for Research and Evaluation,
NCT05645133,Diagnostic Test,DEVICE,Pediatric ALL; Healthy,na,TERMINATED,HemoSonics LLC,
NCT00034333,MTC-DOX for Injection,DRUG,"Carcinoma, Hepatocellular",phase2; phase3,TERMINATED,FeRx,
NCT02169752,Ambrisentan,DRUG,Pre-Pulmonary Atrial Hypertension,na,TERMINATED,National Jewish Health,
NCT05604287,ID119031166M,DRUG,Healthy Participants,phase1,TERMINATED,IlDong Pharmaceutical Co Ltd,
NCT05604287,Placebo,DRUG,Healthy Participants,phase1,TERMINATED,IlDong Pharmaceutical Co Ltd,
NCT02882087,Placebo plus MTX,DRUG,Moderate and Severe Rheumatoid Arthritis,phase2,TERMINATED,"RemeGen Co., Ltd.",
NCT02882087,RC18 160 mg plus MTX,DRUG,Moderate and Severe Rheumatoid Arthritis,phase2,TERMINATED,"RemeGen Co., Ltd.",
NCT01892293,Treatment with NY-ESO-1c259-modified T cells,DRUG,Multiple Myeloma,phase1; phase2,TERMINATED,Adaptimmune,
NCT01088906,Pemetrexed/Cisplatin,DRUG,"Carcinoma, Non Small Cell Lung",phase2,TERMINATED,Spanish Lung Cancer Group,
NCT02375984,Tumor Infiltrating Lymphocytes (TIL),BIOLOGICAL,Metastatic Melanoma,phase2,TERMINATED,Saint John's Cancer Institute,
NCT00689052,pramipexole ER,DRUG,Fibromyalgia,phase2,TERMINATED,Boehringer Ingelheim,
NCT00689052,placebo,DRUG,Fibromyalgia,phase2,TERMINATED,Boehringer Ingelheim,
NCT04333628,chloroquine,DRUG,COVID-19,phase2; phase3,TERMINATED,"HaEmek Medical Center, Israel",
NCT04333628,standard care,OTHER,COVID-19,phase2; phase3,TERMINATED,"HaEmek Medical Center, Israel",
NCT02382965,transcranial focused ultrasound,DEVICE,Sub-cortical Stimulation,na,TERMINATED,University of Minnesota,
NCT02848911,AFM11,DRUG,"Leukemia, B-Cell",phase1,TERMINATED,Affimed GmbH,
NCT03262571,Lung ultrasound,OTHER,Chronic Heart Failure; Lung; Congestive; Acute Decompensated Heart Failure,phase3,TERMINATED,IRCCS San Raffaele,
NCT03330834,CAR-T cells to treat advanced lung cancer,BIOLOGICAL,Advanced Lung Cancer,phase1,TERMINATED,Sun Yat-sen University,
NCT02387164,Alum-GAD,DRUG,"Diabetes Mellitus, Type 1; Prediabetic State",phase2,TERMINATED,Lund University,
NCT02387164,Vitamin D3,DRUG,"Diabetes Mellitus, Type 1; Prediabetic State",phase2,TERMINATED,Lund University,
NCT00700609,Attachment Based Family therapy (ABFT),BEHAVIORAL,Depressive Disorder; Mood Disorder; Major Depression,phase2,TERMINATED,Helse Stavanger HF,
NCT02502799,Brief Early Intervention,BEHAVIORAL,Attention Deficit Hyperactivity Disorder,phase3,TERMINATED,Florida International University,
NCT02502799,Parent Training with Adolescent Cognitive Behavioral Therapy,BEHAVIORAL,Attention Deficit Hyperactivity Disorder,phase3,TERMINATED,Florida International University,
NCT02502799,Methylphenidate,DRUG,Attention Deficit Hyperactivity Disorder,phase3,TERMINATED,Florida International University,
NCT03095833,Odors,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,Visual stimulation,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,Experimental Task,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,Blood tests,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,Questionnaires and test administered,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,fMRI,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,Odors 2,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,Images,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,Experimental Task fMRI,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,Genotyping for susceptibility to β-ionone,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT03095833,Experimental Task 2,OTHER,Healthy,na,TERMINATED,Hospices Civils de Lyon,
NCT01584752,Gore-BioA Fistula Plug,PROCEDURE,Anal Fistula; Fecal Incontinence; Surgery,na,TERMINATED,Central Finland Hospital District,
NCT03156764,Qp/Qs ratio monitoring,OTHER,"Anesthesia, General; Congenital Heart Disease; Blood Gas Monitoring, Transcutaneous; Blood Gas Analysis",na,TERMINATED,Seoul National University Hospital,
NCT02586909,RVT-101 35 mg tablets,DRUG,Alzheimer's Disease,phase3,TERMINATED,Axovant Sciences Ltd.,
NCT06420232,weighted blanket,DEVICE,Food Neophobia; Picky Eating; Avoidant Restrictive Food Intake Disorder; Anxiety State,na,TERMINATED,"The University of Texas Medical Branch, Galveston",
NCT04360421,Liposomal bupivacaine,DRUG,"Amputation; Anesthesia, Local; Opioid Use",phase4,TERMINATED,Loma Linda University,
NCT03830216,Connected insulin pen and smartphone app,DEVICE,Diabetes Mellitus,na,TERMINATED,"Companion Medical, Inc.",
NCT03830216,Inactive connected insulin pen without smartphone app,DEVICE,Diabetes Mellitus,na,TERMINATED,"Companion Medical, Inc.",
NCT02390284,Latanoprost,DRUG,Glaucoma,phase3,TERMINATED,University of Miami,
NCT02390284,Bimatoprost,DRUG,Glaucoma,phase3,TERMINATED,University of Miami,
NCT02390284,Travoprost,DRUG,Glaucoma,phase3,TERMINATED,University of Miami,
NCT02390284,Timolol,DRUG,Glaucoma,phase3,TERMINATED,University of Miami,
NCT02390284,Dorzolamide,DRUG,Glaucoma,phase3,TERMINATED,University of Miami,
NCT02390284,Brinzolamide,DRUG,Glaucoma,phase3,TERMINATED,University of Miami,
NCT02390284,Acetazolamide,DRUG,Glaucoma,phase3,TERMINATED,University of Miami,
NCT02390284,Methazolamide,DRUG,Glaucoma,phase3,TERMINATED,University of Miami,
NCT03408652,denosumab,DRUG,Metastatic Renal Cell Carcinoma,phase3,TERMINATED,Centre Leon Berard,
NCT02748252,stroke center referral,OTHER,"Cerebrovascular Accident, Acute; HIV",na,TERMINATED,Fondation Ophtalmologique Adolphe de Rothschild,
NCT00977132,Valproic aicd,DRUG,Myelodysplastic Syndrome MDS,phase2,TERMINATED,"Heinrich-Heine University, Duesseldorf",
NCT00977132,Lenalidomide,DRUG,Myelodysplastic Syndrome MDS,phase2,TERMINATED,"Heinrich-Heine University, Duesseldorf",
NCT02206763,Momelotinib (MMB),DRUG,EGFR Mutated EGFR TKI Naive Metastatic NSCLC,phase1,TERMINATED,Sierra Oncology LLC - a GSK company,
NCT02206763,Erlotinib,DRUG,EGFR Mutated EGFR TKI Naive Metastatic NSCLC,phase1,TERMINATED,Sierra Oncology LLC - a GSK company,
NCT00588887,Duracon®,DEVICE,Degenerative Arthritis; Osteoarthritis; Rheumatoid Arthritis; Knee Arthritis,na,TERMINATED,"Biomet Orthopedics, LLC",
NCT00588887,Vanguard™,DEVICE,Degenerative Arthritis; Osteoarthritis; Rheumatoid Arthritis; Knee Arthritis,na,TERMINATED,"Biomet Orthopedics, LLC",
NCT01628887,Educational Intervention,OTHER,Cancer Survivor; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer,na,TERMINATED,City of Hope Medical Center,
NCT01082887,TIL-Ad-INFg,OTHER,Metastatic Melanoma,phase1; phase2,TERMINATED,Nantes University Hospital,
NCT01524887,"Immune Globulin Intravenous (Human), 10% Solution",BIOLOGICAL,Alzheimer´s Disease,phase3,TERMINATED,Baxalta now part of Shire,
NCT01524887,Human albumin 0.25%,BIOLOGICAL,Alzheimer´s Disease,phase3,TERMINATED,Baxalta now part of Shire,
NCT00947921,Plasty,PROCEDURE,Functional Mitral Regurgitation,na,TERMINATED,Cardiochirurgia E.H.,
NCT00947921,Prosthesis,PROCEDURE,Functional Mitral Regurgitation,na,TERMINATED,Cardiochirurgia E.H.,
NCT02393716,Endurant Evo AAA Stent Graft System,DEVICE,Abdominal Aortic Aneurysm; AAA,na,TERMINATED,Medtronic Cardiovascular,
NCT02393716,Endovascular aneurysm repair (EVAR),PROCEDURE,Abdominal Aortic Aneurysm; AAA,na,TERMINATED,Medtronic Cardiovascular,
NCT00089804,abetimus sodium (LJP 394) and/or placebo solution,DRUG,"Lupus Erythematosus, Systemic; Lupus Nephritis",phase3,TERMINATED,La Jolla Pharmaceutical Company,
NCT00089804,abetimus sodium (LJP 394),DRUG,"Lupus Erythematosus, Systemic; Lupus Nephritis",phase3,TERMINATED,La Jolla Pharmaceutical Company,
NCT00089804,Phosphate-buffered saline,DRUG,"Lupus Erythematosus, Systemic; Lupus Nephritis",phase3,TERMINATED,La Jolla Pharmaceutical Company,
NCT00629252,Sertindole,DRUG,Schizophrenia,na,TERMINATED,University of Zurich,
NCT00629252,Risperidone,DRUG,Schizophrenia,na,TERMINATED,University of Zurich,
NCT01843062,Selumetinib,DRUG,Differentiated Thyroid Cancer,phase3,TERMINATED,AstraZeneca,
NCT01843062,Placebo,DRUG,Differentiated Thyroid Cancer,phase3,TERMINATED,AstraZeneca,
NCT01843062,Radioactive Iodine Therapy,DRUG,Differentiated Thyroid Cancer,phase3,TERMINATED,AstraZeneca,
NCT00787462,Pregabalin,DRUG,Small-Fiber Neuropathy,na,TERMINATED,University of Alberta,
NCT00787462,Placebo,DRUG,Small-Fiber Neuropathy,na,TERMINATED,University of Alberta,
NCT04007146,Transcutaneous oxymetry measurement,OTHER,Cardiac Output,na,TERMINATED,"University Hospital, Angers",
NCT01119742,Butenafine Hydrochloride 1%,DRUG,Interdigital Tinea Pedis,phase1,TERMINATED,"Sun Pharmaceutical Industries, Inc.",
NCT01119742,Butenafine Hydrochloride 1% B,DRUG,Interdigital Tinea Pedis,phase1,TERMINATED,"Sun Pharmaceutical Industries, Inc.",
NCT01119742,Butenafine Hydrochloride 1%,DRUG,Interdigital Tinea Pedis,phase1,TERMINATED,"Sun Pharmaceutical Industries, Inc.",
NCT01119742,Vehicle A,DRUG,Interdigital Tinea Pedis,phase1,TERMINATED,"Sun Pharmaceutical Industries, Inc.",
NCT01119742,Vehicle B,DRUG,Interdigital Tinea Pedis,phase1,TERMINATED,"Sun Pharmaceutical Industries, Inc.",
NCT01016561,intracavitary balloon brachytherapy,RADIATION,Cervical Cancer,na,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT01016561,external beam radiation therapy,RADIATION,Cervical Cancer,na,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT01016561,intensity-modulated radiation therapy,RADIATION,Cervical Cancer,na,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT01016561,radiation therapy treatment planning/simulation,RADIATION,Cervical Cancer,na,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT01016561,3-dimensional conformal radiation therapy,RADIATION,Cervical Cancer,na,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT01016561,Cisplatin,DRUG,Cervical Cancer,na,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT00626561,Bevacizumab,DRUG,Cervical Cancer; Uterine Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00626561,Paclitaxel,DRUG,Cervical Cancer; Uterine Cancer,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00115661,Rosiglitazone,DRUG,Endometriosis,phase2,TERMINATED,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),
NCT01264770,Fostamatinib and placebo injections,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,AstraZeneca,
NCT01264770,Fostamatinib and placebo injections,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,AstraZeneca,
NCT01264770,Fostamatinib and placebo injections,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,AstraZeneca,
NCT01264770,Adalimumab and placebo of fostamatinib,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,AstraZeneca,
NCT01264770,"Placebo of fostamatinib, fostamatinib, and placebo injections",DRUG,Rheumatoid Arthritis,phase2,TERMINATED,AstraZeneca,
NCT01207973,BI 113823,DRUG,Osteoarthritis,phase1,TERMINATED,Boehringer Ingelheim,
NCT03339973,allo-APZ2-PAOD,BIOLOGICAL,Peripheral Arterial Occlusive Disease,phase1; phase2,TERMINATED,RHEACELL GmbH & Co. KG,
NCT03339973,Placebo,DRUG,Peripheral Arterial Occlusive Disease,phase1; phase2,TERMINATED,RHEACELL GmbH & Co. KG,
NCT02278783,regorafenib,DRUG,Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer,phase2,TERMINATED,University of Utah,
NCT00906841,90Y-DOTA-hLL2,DRUG,B-cell Lymphoma,phase2,TERMINATED,French Innovative Leukemia Organisation,
NCT03237754,tDCS device from neuroConn,DEVICE,Double-blind Design; Sham-controlled; Randomized,na,TERMINATED,University of Zurich,
NCT04371666,Pamrevlumab,DRUG,Duchenne Muscular Dystrophy,phase3,TERMINATED,Kyntra Bio,
NCT04371666,Placebo,DRUG,Duchenne Muscular Dystrophy,phase3,TERMINATED,Kyntra Bio,
NCT04371666,Corticosteroids,DRUG,Duchenne Muscular Dystrophy,phase3,TERMINATED,Kyntra Bio,
NCT03956056,Neoantigen Peptide Vaccine,BIOLOGICAL,Pancreas Cancer; Pancreatic Cancer; Cancer of the Pancreas,phase1,TERMINATED,Washington University School of Medicine,
NCT03956056,Poly ICLC,DRUG,Pancreas Cancer; Pancreatic Cancer; Cancer of the Pancreas,phase1,TERMINATED,Washington University School of Medicine,
NCT03956056,Blood for immune monitoring,PROCEDURE,Pancreas Cancer; Pancreatic Cancer; Cancer of the Pancreas,phase1,TERMINATED,Washington University School of Medicine,
NCT02346422,MYDICAR Phase 1,OTHER,Ischemic Cardiomyopathy; Non-ischemic Cardiomyopathy; Heart Failure; Cardiomyopathies,phase1; phase2,TERMINATED,Celladon Corporation,
NCT02346422,MYDICAR Phase 2,OTHER,Ischemic Cardiomyopathy; Non-ischemic Cardiomyopathy; Heart Failure; Cardiomyopathies,phase1; phase2,TERMINATED,Celladon Corporation,
NCT02346422,Placebo Phase 2 only,OTHER,Ischemic Cardiomyopathy; Non-ischemic Cardiomyopathy; Heart Failure; Cardiomyopathies,phase1; phase2,TERMINATED,Celladon Corporation,
NCT03395288,D-Mannose,DRUG,Urinary Tract Infections,phase2; phase3,TERMINATED,Washington University School of Medicine,
NCT02402803,Dried blood spot testing and phlebotomy,OTHER,Hyperlipidemias; Cardiovascular Diseases,na,TERMINATED,Cedars-Sinai Medical Center,
NCT02859727,CDZ173,DRUG,Activated PI3Kdelta Syndrome (APDS); PASLI Disease,phase2; phase3,TERMINATED,Pharming Technologies B.V.,
NCT00113386,filgrastim,BIOLOGICAL,Lung Cancer,phase3,TERMINATED,Radiation Therapy Oncology Group,
NCT00113386,pegfilgrastim,BIOLOGICAL,Lung Cancer,phase3,TERMINATED,Radiation Therapy Oncology Group,
NCT00113386,cisplatin,DRUG,Lung Cancer,phase3,TERMINATED,Radiation Therapy Oncology Group,
NCT00113386,docetaxel,DRUG,Lung Cancer,phase3,TERMINATED,Radiation Therapy Oncology Group,
NCT00113386,adjuvant therapy,PROCEDURE,Lung Cancer,phase3,TERMINATED,Radiation Therapy Oncology Group,
NCT00113386,conventional surgery,PROCEDURE,Lung Cancer,phase3,TERMINATED,Radiation Therapy Oncology Group,
NCT00113386,neoadjuvant therapy,PROCEDURE,Lung Cancer,phase3,TERMINATED,Radiation Therapy Oncology Group,
NCT00113386,radiation therapy,RADIATION,Lung Cancer,phase3,TERMINATED,Radiation Therapy Oncology Group,
NCT02511483,Propranolol PO,DRUG,Postoperative Pain,phase2,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT02511483,IV-PCA morphine,DRUG,Postoperative Pain,phase2,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT02511483,Placebo PO,DRUG,Postoperative Pain,phase2,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT02511483,Quantitative Sensory Testing (QST),PROCEDURE,Postoperative Pain,phase2,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT02511483,Psychometric assessment,OTHER,Postoperative Pain,phase2,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT02511483,COMT-haplotypes,OTHER,Postoperative Pain,phase2,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT01448005,wearable defibrillator (LifeVest),DEVICE,Sudden Cardiac Death; Ventricular Fibrillation; Ventricular Tachycardia; Ventricular Dysfunction; Myocardial Ischemia,na,TERMINATED,Zoll Medical Corporation,
NCT01242956,verum group,BEHAVIORAL,Stroke; Upper Limb Paresis,phase2,TERMINATED,RWTH Aachen University,
NCT01242956,Placebo group,BEHAVIORAL,Stroke; Upper Limb Paresis,phase2,TERMINATED,RWTH Aachen University,
NCT01799629,Glycerin suppositories,DRUG,"Infant, Very Low Birth Weight",na,TERMINATED,King Faisal Specialist Hospital & Research Center,
NCT02770729,Moxifloxacin,DRUG,Endophthalmitis,phase3,TERMINATED,"University of Campinas, Brazil",
NCT02770729,No injection of moxifloxacin,DRUG,Endophthalmitis,phase3,TERMINATED,"University of Campinas, Brazil",
NCT02770443,withdrawal,DRUG,Dilated Cardiomyopathy,na,TERMINATED,McGill University,
NCT02770443,standard of CARE,DRUG,Dilated Cardiomyopathy,na,TERMINATED,McGill University,
NCT03721315,Intervention,BEHAVIORAL,COPD Exacerbation,na,TERMINATED,Albert Einstein Healthcare Network,
NCT00610935,Peramivir,DRUG,Influenza,phase3,TERMINATED,BioCryst Pharmaceuticals,
NCT00610935,Placebo,DRUG,Influenza,phase3,TERMINATED,BioCryst Pharmaceuticals,
NCT00351325,BMS-663513,DRUG,Advanced Solid Malignancies,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01495676,Radiation + cisplatin,OTHER,Infiltrating Bladder Urothelial Carcinoma,na,TERMINATED,Institut du Cancer de Montpellier - Val d'Aurelle,
NCT01495676,Radiation + cisplatin + gemcitabine,OTHER,Infiltrating Bladder Urothelial Carcinoma,na,TERMINATED,Institut du Cancer de Montpellier - Val d'Aurelle,
NCT02399917,Azacitidine,DRUG,Acute Biphenotypic Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02399917,Lirilumab,BIOLOGICAL,Acute Biphenotypic Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT04026568,4-Aminopyridine,DRUG,Nerve Injury,phase2; phase3,TERMINATED,Milton S. Hershey Medical Center,
NCT04026568,Placebo oral tablet,DRUG,Nerve Injury,phase2; phase3,TERMINATED,Milton S. Hershey Medical Center,
NCT04902950,Tranexamic acid,DRUG,Panniculectomy; Abdominoplasty,phase4,TERMINATED,The Reading Hospital and Medical Center,
NCT04902950,Saline,DRUG,Panniculectomy; Abdominoplasty,phase4,TERMINATED,The Reading Hospital and Medical Center,
NCT00620074,voriconazole,DRUG,Aspergillosis,phase4,TERMINATED,Pfizer,
NCT00620074,anidulafungin,DRUG,Aspergillosis,phase4,TERMINATED,Pfizer,
NCT00484718,celecoxib,DRUG,Osteoarthritis,phase4,TERMINATED,Pfizer,
NCT00484718,Oxycodone,DRUG,Osteoarthritis,phase4,TERMINATED,Pfizer,
NCT00484718,placebo,DRUG,Osteoarthritis,phase4,TERMINATED,Pfizer,
NCT05221320,Ulixertinib,DRUG,"Tumor, Solid; Gastrointestinal Cancer",phase2,TERMINATED,"BioMed Valley Discoveries, Inc",
NCT05221320,Hydroxychloroquine,DRUG,"Tumor, Solid; Gastrointestinal Cancer",phase2,TERMINATED,"BioMed Valley Discoveries, Inc",
NCT03742323,Idelalisib,DRUG,Acute Lymphoblastic Leukemia,phase1; phase2,TERMINATED,PETHEMA Foundation,
NCT02760927,Endotracheal Tube Fastener,DEVICE,Respiratory Depression; Respiratory Failure; Ventilatory Depression,na,TERMINATED,Hollister Incorporated,
NCT03485742,No intervention,OTHER,Statins; Myocardial Infarction,na,TERMINATED,Jordan Collaborating Cardiology Group,
NCT00001827,aldesleukin,BIOLOGICAL,Ovarian Neoplasm,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00001827,incomplete Freund's adjuvant,BIOLOGICAL,Ovarian Neoplasm,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00001827,p53 peptide vaccine,BIOLOGICAL,Ovarian Neoplasm,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00001827,sargramostim,BIOLOGICAL,Ovarian Neoplasm,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00001827,therapeutic autologous dendritic cells,BIOLOGICAL,Ovarian Neoplasm,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00001827,in vitro-treated peripheral blood stem cell transplantation,PROCEDURE,Ovarian Neoplasm,phase2,TERMINATED,National Cancer Institute (NCI),
NCT04770142,TIRA catheter,DEVICE,Hypertrophic Obstructive Cardiomyopathy,na,TERMINATED,"Tau-MEDICAL Co., Ltd.",
NCT03085641,Nasal high flow oxygen therapy,DEVICE,Central Sleep Apnea; Cheyne-Stokes Respiration,na,TERMINATED,University Medical Center Groningen,
NCT00101205,oxaliplatin,DRUG,Angioimmunoblastic T-cell Lymphoma; B-cell Childhood Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Gra,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00101205,etoposide,DRUG,Angioimmunoblastic T-cell Lymphoma; B-cell Childhood Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Gra,phase1,TERMINATED,National Cancer Institute (NCI),
NCT03693105,Active SAINT Stimulation,DEVICE,Major Depressive Disorder; Major Depressive Episode; Suicidal Ideation,phase2; phase3,TERMINATED,Magnus Medical,
NCT03693105,Sham SAINT Stimulation,DEVICE,Major Depressive Disorder; Major Depressive Episode; Suicidal Ideation,phase2; phase3,TERMINATED,Magnus Medical,
NCT04860466,CC-96673,DRUG,"Lymphoma, Non-Hodgkin",phase1,TERMINATED,Celgene,
NCT04889222,INVSENSOR00050,DEVICE,Healthy,na,TERMINATED,Masimo Corporation,
NCT04889222,RD SET SpO2,DEVICE,Healthy,na,TERMINATED,Masimo Corporation,
NCT00107666,CTI-01 (ethyl pyruvate),DRUG,Coronary Disease; Heart Valve Diseases,phase2,TERMINATED,Critical Therapeutics,
NCT01701856,Interferon beta-1b,DRUG,Relapsing-remitting Multiple Sclerosis,phase4,TERMINATED,Claudio Gobbi,
NCT04150029,MBG453,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04150029,Venetoclax,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04150029,Azacitidine,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT00500396,Open-Sky Vitrectomy,PROCEDURE,Retinopathy of Prematurity,phase4,TERMINATED,Asociación para Evitar la Ceguera en México,
NCT00001962,Daclizumab,DRUG,Aplastic Anemia; Pure Red Cell Aplasia; Diamond Blackfan Anemia,phase2,TERMINATED,"National Heart, Lung, and Blood Institute (NHLBI)",
NCT06851442,TQB3912 tablets in combination with fulvestrant injection± TQB3616 capsules,DRUG,Breast Cancer,phase1; phase2,TERMINATED,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",
NCT01583842,124I-Metaiodobenzylguanidine (MIBG) (no-carrier added),DRUG,Neuroblastoma,early_phase1,TERMINATED,Miguel Pampaloni,
NCT01583842,124I-MIBG (carrier added),DRUG,Neuroblastoma,early_phase1,TERMINATED,Miguel Pampaloni,
NCT01583842,Positron Emission Tomography (PET) /Computerized tomography (CT),PROCEDURE,Neuroblastoma,early_phase1,TERMINATED,Miguel Pampaloni,
NCT01737086,Lactobacillus reuteri DSM 17938 and zinc sulphate,OTHER,Acute Gastroenteritis,phase2; phase3,TERMINATED,Umeå University,
NCT01737086,placebo,OTHER,Acute Gastroenteritis,phase2; phase3,TERMINATED,Umeå University,
NCT05167370,Amifostine,DRUG,Solid Tumors; Brain Tumors,phase2,TERMINATED,"Children's Hospital Medical Center, Cincinnati",
NCT01440283,Intensity Modulated Radiation Therapy (IMRT),RADIATION,Abdominal Neuroblastoma,phase2,TERMINATED,St. Jude Children's Research Hospital,
NCT04643405,APG-1387 for Injection,DRUG,Advanced Pancreatic Cancer,phase1; phase2,TERMINATED,Ascentage Pharma Group Inc.,
NCT04643405,Gemcitabine,DRUG,Advanced Pancreatic Cancer,phase1; phase2,TERMINATED,Ascentage Pharma Group Inc.,
NCT04643405,Nab paclitaxel,DRUG,Advanced Pancreatic Cancer,phase1; phase2,TERMINATED,Ascentage Pharma Group Inc.,
NCT04625205,NEO-PTC-01,BIOLOGICAL,Unresectable Melanoma; Metastatic Melanoma,phase1,TERMINATED,BioNTech US Inc.,
NCT04625205,IL-2,DRUG,Unresectable Melanoma; Metastatic Melanoma,phase1,TERMINATED,BioNTech US Inc.,
NCT04625205,PD-1 Inhibitors,DRUG,Unresectable Melanoma; Metastatic Melanoma,phase1,TERMINATED,BioNTech US Inc.,
NCT00312754,Atazanavir,DRUG,HIV Infections,phase4,TERMINATED,Bristol-Myers Squibb,
NCT00638196,Linoleic Acid/Oleic Acid,DRUG,Multiple Sclerosis,phase1,TERMINATED,University of Rochester,
NCT01590979,Ranolazine,DRUG,"Atrial Fibrillation New Onset; Hemorrhage; Prolonged QTc Interval; Ventricular Tachycardia; Medical Care; Complications, Late Effect of Complications",na,TERMINATED,Northwell Health,
NCT01590979,Placebo,DRUG,"Atrial Fibrillation New Onset; Hemorrhage; Prolonged QTc Interval; Ventricular Tachycardia; Medical Care; Complications, Late Effect of Complications",na,TERMINATED,Northwell Health,
NCT01333059,Midazolam,DRUG,Respiratory Failure,na,TERMINATED,"Javier Gelvez, MD",
NCT01333059,Normal saline,DRUG,Respiratory Failure,na,TERMINATED,"Javier Gelvez, MD",
NCT01333059,Fentanyl,DRUG,Respiratory Failure,na,TERMINATED,"Javier Gelvez, MD",
NCT02026180,Micropuncture Access,DEVICE,Vascular Access Complications,na,TERMINATED,North Texas Veterans Healthcare System,
NCT04449380,Interferon-ß-1a,DRUG,COVID-19 Virus Infection,phase2,TERMINATED,Emanuele Bosi,
NCT04449380,Standard of Care (SOC),OTHER,COVID-19 Virus Infection,phase2,TERMINATED,Emanuele Bosi,
NCT00487279,Defibrillator,DEVICE,Coronary Artery Disease; Left Ventricular Dysfunction; Sudden Cardiac Death,na,TERMINATED,Abbott Medical Devices,
NCT00487279,Control,OTHER,Coronary Artery Disease; Left Ventricular Dysfunction; Sudden Cardiac Death,na,TERMINATED,Abbott Medical Devices,
NCT00778479,Sepraspray,DEVICE,Adhesion Prevention (Abdominal),na,TERMINATED,"Genzyme, a Sanofi Company",
NCT01195779,"GSK Bio's influenza vaccine GSK2584786A, different formulations",BIOLOGICAL,Influenza; Influenza Vaccines,phase2,TERMINATED,GlaxoSmithKline,
NCT01195779,GSK Bio's influenza vaccine GSK2321138A,BIOLOGICAL,Influenza; Influenza Vaccines,phase2,TERMINATED,GlaxoSmithKline,
NCT01195779,Fluarix™,BIOLOGICAL,Influenza; Influenza Vaccines,phase2,TERMINATED,GlaxoSmithKline,
NCT05947461,100mg diclofenac,DRUG,Post-ERCP Acute Pancreatitis; NSAIDs; Indomethacin; Diclofenac; Endoscopic Retrograde Cholangiopancreatography,na,TERMINATED,"Air Force Military Medical University, China",
NCT05947461,100mg indomethacin,DRUG,Post-ERCP Acute Pancreatitis; NSAIDs; Indomethacin; Diclofenac; Endoscopic Retrograde Cholangiopancreatography,na,TERMINATED,"Air Force Military Medical University, China",
NCT00566761,bevacizumab and triamcinolone,DRUG,Macular Edema; Central Retinal Vein Occlusion,phase4,TERMINATED,Asociación para Evitar la Ceguera en México,
NCT01111942,radiation combined with weekly carboplatin,OTHER,Head and Neck Cancer,early_phase1,TERMINATED,Southern Illinois University,
NCT01111942,conservation surgery,PROCEDURE,Head and Neck Cancer,early_phase1,TERMINATED,Southern Illinois University,
NCT00221286,pegylated interferon alfa-2a,DRUG,Chronic Hepatitis B; HIV Infections,phase3,TERMINATED,"University Hospital, Bonn",
NCT00221286,tenofovir DF / emtricitabine combination therapy,DRUG,Chronic Hepatitis B; HIV Infections,phase3,TERMINATED,"University Hospital, Bonn",
NCT00221286,pegIFN / TDF / FTC combination therapy,DRUG,Chronic Hepatitis B; HIV Infections,phase3,TERMINATED,"University Hospital, Bonn",
NCT02256683,Dabigatran etexilate,DRUG,Atrial Fibrillation or Atrial Flutter; Thrombosis of Left Atrial Appendage,phase2,TERMINATED,Johannes Gutenberg University Mainz,
NCT02256683,Phenprocoumon,DRUG,Atrial Fibrillation or Atrial Flutter; Thrombosis of Left Atrial Appendage,phase2,TERMINATED,Johannes Gutenberg University Mainz,
NCT01852305,Lab Sleep Study Group,OTHER,Obstructive Sleep Apnea,na,TERMINATED,"University Health Network, Toronto",
NCT01852305,Oximetry,DEVICE,Obstructive Sleep Apnea,na,TERMINATED,"University Health Network, Toronto",
NCT04049266,KSI-301,DRUG,Wet Macular Degeneration,phase2; phase3,TERMINATED,Kodiak Sciences Inc,
NCT04049266,Aflibercept,DRUG,Wet Macular Degeneration,phase2; phase3,TERMINATED,Kodiak Sciences Inc,
NCT04049266,Sham Procedure,OTHER,Wet Macular Degeneration,phase2; phase3,TERMINATED,Kodiak Sciences Inc,
NCT00952666,TRUS-RALRP,DEVICE,Prostate Cancer,early_phase1,TERMINATED,Johns Hopkins University,
NCT00111488,Flex 4 and Generator,DEVICE,Atrial Fibrillation,phase3,TERMINATED,Boston Scientific Corporation,
NCT04024046,Uqora,OTHER,Urinary Tract Infections,na,TERMINATED,Hawthorne Effect Inc.,
NCT04024046,Group1,OTHER,Urinary Tract Infections,na,TERMINATED,Hawthorne Effect Inc.,
NCT04024046,Group 2,OTHER,Urinary Tract Infections,na,TERMINATED,Hawthorne Effect Inc.,
NCT01519427,Akt inhibitor MK2206,DRUG,Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV Melanoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01519427,selumetinib,DRUG,Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV Melanoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01519427,laboratory biomarker analysis,OTHER,Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV Melanoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00157261,tenecteplase,DRUG,Heart Arrest,phase3,TERMINATED,Boehringer Ingelheim,
NCT04676061,Norethindrone acetate (NTA),DRUG,Birth Control; Contraception; Implant; Breakthrough Bleeding; Uterine Bleeding,phase4,TERMINATED,Baylor Research Institute,
NCT04676061,Placebo,DRUG,Birth Control; Contraception; Implant; Breakthrough Bleeding; Uterine Bleeding,phase4,TERMINATED,Baylor Research Institute,
NCT00259142,"Chloroquine, sulphadoxine-pyrimethamine",DRUG,Fever; Anaemia; Malaria,na,TERMINATED,DBL -Institute for Health Research and Development,
NCT00493441,AVN944,DRUG,Pancreatic Cancer,phase2,TERMINATED,Vertex Pharmaceuticals Incorporated,
NCT00006046,monoclonal antibody hu3S193,BIOLOGICAL,Colorectal Cancer,phase1,TERMINATED,Ludwig Institute for Cancer Research,
NCT04669288,Azithromycin,DRUG,Asthma; Wheezing,phase3,TERMINATED,University of Arizona,
NCT04669288,Placebo,DRUG,Asthma; Wheezing,phase3,TERMINATED,University of Arizona,
NCT01643603,Dasatinib,DRUG,Non-Hodgkin's Lymphoma; Hodgkin's Lymphoma; Myeloid Leukemia; Multiple Myeloma; Myelodysplastic Syndrome; Lymphoid Leukemia,phase1,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT01643603,laboratory biomarker analysis,OTHER,Non-Hodgkin's Lymphoma; Hodgkin's Lymphoma; Myeloid Leukemia; Multiple Myeloma; Myelodysplastic Syndrome; Lymphoid Leukemia,phase1,TERMINATED,Barbara Ann Karmanos Cancer Institute,
NCT00766870,Lu AA34893,DRUG,Major Depressive Disorder,phase2,TERMINATED,H. Lundbeck A/S,
NCT00766870,Venlafaxine extended release,DRUG,Major Depressive Disorder,phase2,TERMINATED,H. Lundbeck A/S,
NCT00766870,Placebo,DRUG,Major Depressive Disorder,phase2,TERMINATED,H. Lundbeck A/S,
NCT00955266,Calcium Chloride,DRUG,Diastolic Dysfunction,phase4,TERMINATED,Brigham and Women's Hospital,
NCT00955266,Placebo,DRUG,Diastolic Dysfunction,phase4,TERMINATED,Brigham and Women's Hospital,
NCT04681456,There is no medical intervention for the purposes of this Registry.,BEHAVIORAL,Non-melanoma Skin Cancer,na,TERMINATED,GenesisCare USA,
NCT01217346,no intervention is involved in this study,OTHER,Obstructive Sleep Apnea; Cardiac Syndrome X; Endothelial Dysfunction,na,TERMINATED,The University of Hong Kong,
NCT05199961,Digital Health Coaching,BEHAVIORAL,"Lymphoma, Large B-Cell, Diffuse",na,TERMINATED,Pack Health,
NCT05665569,"Flourish HEC, which contains BioNourish",DEVICE,Pelvic Floor Disorders,na,TERMINATED,Vaginal Biome Science,
NCT05665569,Routine pelvic physical therapy,OTHER,Pelvic Floor Disorders,na,TERMINATED,Vaginal Biome Science,
NCT02454283,Vanoxerine HCl,DRUG,Atrial Fibrillation or Flutter,phase3,TERMINATED,"Laguna Pharmaceuticals, Inc.",
NCT02454283,Placebo,DRUG,Atrial Fibrillation or Flutter,phase3,TERMINATED,"Laguna Pharmaceuticals, Inc.",
NCT00373113,Capecitabine,DRUG,Breast Neoplasms,phase3,TERMINATED,Pfizer,
NCT00373113,Sunitinib malate,DRUG,Breast Neoplasms,phase3,TERMINATED,Pfizer,
NCT01238224,Tadalafil,DRUG,Type 2 Diabetes,phase1,TERMINATED,Vastra Gotaland Region,
NCT01983423,Endometrial Biopsy,DEVICE,Infertility; Pregnancy,na,TERMINATED,Jon Havelock,
NCT01268280,Placebo,DRUG,Myasthenia Gravis,phase2,TERMINATED,Cytokinetics,
NCT01268280,250 mg CK-2017357,DRUG,Myasthenia Gravis,phase2,TERMINATED,Cytokinetics,
NCT01268280,500 mg CK-2017357,DRUG,Myasthenia Gravis,phase2,TERMINATED,Cytokinetics,
NCT04146779,Yoga Video,BEHAVIORAL,Head and Neck Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT04146779,Posture and Strengthening Video,BEHAVIORAL,Head and Neck Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT04146779,Relaxation Video,BEHAVIORAL,Head and Neck Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT04146779,Breath Work Video,BEHAVIORAL,Head and Neck Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT04146779,Satisfaction Survey,BEHAVIORAL,Head and Neck Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT04146779,Guided Yoga Session,BEHAVIORAL,Head and Neck Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT04146779,Written Yoga Instructions,BEHAVIORAL,Head and Neck Cancer,na,TERMINATED,Vanderbilt-Ingram Cancer Center,
NCT05246280,TC99m-tilmanocept,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Navidea Biopharmaceuticals,
NCT03223662,Chemoradiotherapy,OTHER,Esophageal Cancer; Esophageal Adenocarcinoma; Esophageal Squamous Cell Cancer; Esophageal Neoplasms; Squamous Cell Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT03223662,Esophagectomy,PROCEDURE,Esophageal Cancer; Esophageal Adenocarcinoma; Esophageal Squamous Cell Cancer; Esophageal Neoplasms; Squamous Cell Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT04244396,"TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE)",DEVICE,Persistent Atrial Fibrillation,na,TERMINATED,Abbott Medical Devices,
NCT00469846,L-arginine supplementation in a medical food,PROCEDURE,Pre-Eclampsia,phase2,TERMINATED,Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes,
NCT00469846,Vitamin C and E supplementation in a medical food,PROCEDURE,Pre-Eclampsia,phase2,TERMINATED,Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes,
NCT02363946,ARC-AAT Injection,DRUG,Alpha-1 Antitrypsin Deficiency,phase1,TERMINATED,Arrowhead Pharmaceuticals,
NCT02363946,Placebo,OTHER,Alpha-1 Antitrypsin Deficiency,phase1,TERMINATED,Arrowhead Pharmaceuticals,
NCT02363946,Diphenhydramine,DRUG,Alpha-1 Antitrypsin Deficiency,phase1,TERMINATED,Arrowhead Pharmaceuticals,
NCT00995046,FVIII,DRUG,Hemophilia A,na,TERMINATED,Hospices Civils de Lyon,
NCT00995046,FVIII,DRUG,Hemophilia A,na,TERMINATED,Hospices Civils de Lyon,
NCT00103103,bortezomib,DRUG,Gastric Cancer,phase2,TERMINATED,California Cancer Consortium,
NCT00103103,fluorouracil,DRUG,Gastric Cancer,phase2,TERMINATED,California Cancer Consortium,
NCT00103103,leucovorin calcium,DRUG,Gastric Cancer,phase2,TERMINATED,California Cancer Consortium,
NCT01308203,Extended release niacin/laropiprant,DRUG,Coronary Artery Disease; Dyslipidemias,phase4,TERMINATED,Daniel A. Siniawski,
NCT01308203,placebo,DRUG,Coronary Artery Disease; Dyslipidemias,phase4,TERMINATED,Daniel A. Siniawski,
NCT04431661,Optical Coherence Tomography,PROCEDURE,Out of Hospital Cardiac Arrest,na,TERMINATED,Ceric Sàrl,
NCT04431661,Coronary Angiography,PROCEDURE,Out of Hospital Cardiac Arrest,na,TERMINATED,Ceric Sàrl,
NCT04431661,Per cutaneous coronary intervention,PROCEDURE,Out of Hospital Cardiac Arrest,na,TERMINATED,Ceric Sàrl,
NCT05607342,Osanetant,DRUG,Prostate Adenocarcinoma,early_phase1,TERMINATED,University of Kansas Medical Center,
NCT01362686,Donepezil,DRUG,Dementia; Alzheimer's Disease,na,TERMINATED,Indiana University,
NCT01362686,Galantamine,DRUG,Dementia; Alzheimer's Disease,na,TERMINATED,Indiana University,
NCT01362686,Rivastigmine,DRUG,Dementia; Alzheimer's Disease,na,TERMINATED,Indiana University,
NCT01583686,Fludarabine,DRUG,Cervical Cancer; Pancreatic Cancer; Ovarian Cancer; Mesothelioma; Lung Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT01583686,Anti-mesothelin chimeric T cell receptor (CAR) transduced peripheral blood lymphocytes (PBL),BIOLOGICAL,Cervical Cancer; Pancreatic Cancer; Ovarian Cancer; Mesothelioma; Lung Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT01583686,Cyclophosphamide,DRUG,Cervical Cancer; Pancreatic Cancer; Ovarian Cancer; Mesothelioma; Lung Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT01583686,Aldesleukin,DRUG,Cervical Cancer; Pancreatic Cancer; Ovarian Cancer; Mesothelioma; Lung Cancer,phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT04459286,Nitazoxanide and atazanavir/ritonavir,DRUG,Covid-19,phase2,TERMINATED,Obafemi Awolowo University,
NCT04459286,Standard of Care,OTHER,Covid-19,phase2,TERMINATED,Obafemi Awolowo University,
NCT00362505,Clevudine,DRUG,Hepatitis B,phase3,TERMINATED,Bukwang Pharmaceutical,
NCT01240694,CEP-33457,DRUG,Systemic Lupus Erythematosus,phase3,TERMINATED,"Cephalon, Inc.",
NCT04287894,Durvalumab,DRUG,Stage III NSCLC,phase1,TERMINATED,The Netherlands Cancer Institute,
NCT04287894,Tremelimumab,DRUG,Stage III NSCLC,phase1,TERMINATED,The Netherlands Cancer Institute,
NCT04287894,Pemetrexed,DRUG,Stage III NSCLC,phase1,TERMINATED,The Netherlands Cancer Institute,
NCT04287894,Cisplatin,DRUG,Stage III NSCLC,phase1,TERMINATED,The Netherlands Cancer Institute,
NCT04287894,chemo radiotherapy,RADIATION,Stage III NSCLC,phase1,TERMINATED,The Netherlands Cancer Institute,
NCT04287894,Resection,PROCEDURE,Stage III NSCLC,phase1,TERMINATED,The Netherlands Cancer Institute,
NCT00260494,acupuncture,OTHER,Postoperative Complications; Surgical Wound Infection; Surgical Wound Dehiscence,na,TERMINATED,"University of California, San Francisco",
NCT00260494,sham acupuncture,OTHER,Postoperative Complications; Surgical Wound Infection; Surgical Wound Dehiscence,na,TERMINATED,"University of California, San Francisco",
NCT01882166,fostimon,DRUG,"Infertility, Female",na,TERMINATED,St. Olavs Hospital,
NCT01882166,puregon,DRUG,"Infertility, Female",na,TERMINATED,St. Olavs Hospital,
NCT00434356,bevacizumab,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,"Genentech, Inc.",
NCT00434356,sunitinib,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,"Genentech, Inc.",
NCT00434356,paclitaxel,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,"Genentech, Inc.",
NCT00152529,Screening (Behavior),BEHAVIORAL,Depression,na,TERMINATED,University of Chicago,
NCT01533753,Gabapentin,DRUG,Prostate Cancer,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT01533753,Venlafaxine,DRUG,Prostate Cancer,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT02381795,Nasal Carbon Dioxide,DRUG,Cluster Headache,phase2,TERMINATED,"Cady, Roger, M.D.",
NCT04683939,BNT141,DRUG,Solid Tumor; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma; Pancreatic Cancer; Biliary Tract Cancer; Cholangiocarcinoma; Metastatic Cancer,phase1; phase2,TERMINATED,BioNTech SE,
NCT04683939,Nab-paclitaxel,DRUG,Solid Tumor; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma; Pancreatic Cancer; Biliary Tract Cancer; Cholangiocarcinoma; Metastatic Cancer,phase1; phase2,TERMINATED,BioNTech SE,
NCT04683939,Gemcitabine,DRUG,Solid Tumor; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma; Pancreatic Cancer; Biliary Tract Cancer; Cholangiocarcinoma; Metastatic Cancer,phase1; phase2,TERMINATED,BioNTech SE,
NCT02991768,Entocort,DRUG,Diarrhea,phase2,TERMINATED,University of Kansas Medical Center,
NCT02991768,Placebos,DRUG,Diarrhea,phase2,TERMINATED,University of Kansas Medical Center,
NCT03489174,Monthly Pregnancy Screening,OTHER,Substance Use Disorders; Prenatal Care; Pregnancy Outcome,na,TERMINATED,McMaster University,
NCT03489174,Usual Care,OTHER,Substance Use Disorders; Prenatal Care; Pregnancy Outcome,na,TERMINATED,McMaster University,
NCT05633797,FibriCheck,DEVICE,Atrial Fibrillation,na,TERMINATED,Jessa Hospital,
NCT04685824,Biofeedback Training,DEVICE,Macular Degeneration,na,TERMINATED,Michael Reber,
NCT04685824,Immersive Virtual-Reality,DEVICE,Macular Degeneration,na,TERMINATED,Michael Reber,
NCT01060423,Cetuximab,DRUG,Colorectal Cancer,phase2,TERMINATED,"Hans-Joachim Schmoll, MD",
NCT01060423,Irinotecan,DRUG,Colorectal Cancer,phase2,TERMINATED,"Hans-Joachim Schmoll, MD",
NCT01060423,Irinotecan eluting BEADS,DEVICE,Colorectal Cancer,phase2,TERMINATED,"Hans-Joachim Schmoll, MD",
NCT00497679,AZD1152,DRUG,Solid Tumours,phase1,TERMINATED,AstraZeneca,
NCT02918396,Scar-Based Radio-frequency Ablation,DEVICE,Persistent Atrial Fibrillation,na,TERMINATED,Johns Hopkins University,
NCT02918396,Rotor Anchors Radio-frequency Ablation,DEVICE,Persistent Atrial Fibrillation,na,TERMINATED,Johns Hopkins University,
NCT02918396,Conventional PVI by Radio-frequency Ablation,DEVICE,Persistent Atrial Fibrillation,na,TERMINATED,Johns Hopkins University,
NCT00434096,rimonabant (SR141716),DRUG,Obesity,phase3,TERMINATED,Sanofi,
NCT00434096,placebo,DRUG,Obesity,phase3,TERMINATED,Sanofi,
NCT02357862,Mitral Valve Annuloplasty,PROCEDURE,Tricuspid (Valve); Deformity,na,TERMINATED,Universitaire Ziekenhuizen KU Leuven,
NCT05133362,Gait training with EksoNR,DEVICE,"Gait, Hemiplegic; Physical Therapy",na,TERMINATED,Alvernia University,
NCT05133362,Backward gait training with EksoNR,PROCEDURE,"Gait, Hemiplegic; Physical Therapy",na,TERMINATED,Alvernia University,
NCT05795946,Whole food-based B and D vitamins,OTHER,"Nutrition, Healthy",na,TERMINATED,Standard Process Inc.,
NCT02183246,Porfiromycin,DRUG,Head and Neck Neoplasms,phase3,TERMINATED,Boehringer Ingelheim,
NCT02183246,Placebo,DRUG,Head and Neck Neoplasms,phase3,TERMINATED,Boehringer Ingelheim,
NCT02183246,Radiotherapy,RADIATION,Head and Neck Neoplasms,phase3,TERMINATED,Boehringer Ingelheim,
NCT02746146,Systematic use of a prognostic score,OTHER,"Kidney Failure, Chronic",na,TERMINATED,Centre Hospitalier Universitaire de Nīmes,
NCT03994146,Remifentanil,DRUG,"Child, Only; Pain; Tonsillectomy; Remifentanil",phase4,TERMINATED,"University Hospital, Akershus",
NCT03994146,Sodium Chloride 9mg/mL,DRUG,"Child, Only; Pain; Tonsillectomy; Remifentanil",phase4,TERMINATED,"University Hospital, Akershus",
NCT02925988,EEG monitoring,DEVICE,Critically Ill,na,TERMINATED,Tel-Aviv Sourasky Medical Center,
NCT01888042,Everolimus,DRUG,Kidney Cancer,phase2,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT01241942,Steen Solution™,DEVICE,Emphysema; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Pulmonary Fibrosis; Bronchiectasis; Sarcoidosis; Pulmonary Hypertension; Alpha-1 Antitrypsin Deficiency,na,TERMINATED,"University of North Carolina, Chapel Hill",
NCT01241942,Conventional Lung Transplant,OTHER,Emphysema; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Pulmonary Fibrosis; Bronchiectasis; Sarcoidosis; Pulmonary Hypertension; Alpha-1 Antitrypsin Deficiency,na,TERMINATED,"University of North Carolina, Chapel Hill",
NCT04197986,Infigratinib,DRUG,Upper Tract Urothelial Carcinomas; Urothelial Bladder Cancer,phase3,TERMINATED,"QED Therapeutics, a BridgeBio company",
NCT04197986,Placebo,DRUG,Upper Tract Urothelial Carcinomas; Urothelial Bladder Cancer,phase3,TERMINATED,"QED Therapeutics, a BridgeBio company",
NCT01033370,clevidipine.,DRUG,Aortic Aneurysm; Aortic Disease,phase4,TERMINATED,"Asma Zainab, M.D.",
NCT00488670,Escitalopram,DRUG,Depressive Disorder,phase3,TERMINATED,University of British Columbia,
NCT02501473,G100,DRUG,Follicular Low Grade Non-Hodgkin's Lymphoma,phase1; phase2,TERMINATED,"Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
NCT02501473,Pembrolizumab,DRUG,Follicular Low Grade Non-Hodgkin's Lymphoma,phase1; phase2,TERMINATED,"Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
NCT02501473,Rituximab,DRUG,Follicular Low Grade Non-Hodgkin's Lymphoma,phase1; phase2,TERMINATED,"Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
NCT02783573,Lanabecestat,DRUG,Alzheimer's Disease,phase3,TERMINATED,AstraZeneca,
NCT02783573,Placebo,DRUG,Alzheimer's Disease,phase3,TERMINATED,AstraZeneca,
NCT02580669,Neuropsychological assessment,OTHER,"Progressive Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting",na,TERMINATED,"University Hospital, Montpellier",
NCT02580669,Neurologic consultation,OTHER,"Progressive Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting",na,TERMINATED,"University Hospital, Montpellier",
NCT02580669,MRIs (with vasoreactivity testing),OTHER,"Progressive Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting",na,TERMINATED,"University Hospital, Montpellier",
NCT00286169,Amrubicin Hydrochloride,DRUG,Small-cell Lung Cancer,phase3,TERMINATED,"Sumitomo Pharma Co., Ltd.",
NCT04335305,Tocilizumab,DRUG,"COVID-19; Pneumonia, Viral",phase2,TERMINATED,MedSIR,
NCT04335305,Pembrolizumab (MK-3475),BIOLOGICAL,"COVID-19; Pneumonia, Viral",phase2,TERMINATED,MedSIR,
NCT00881205,Rivastigmine transdermal patch,DRUG,Multiple Sclerosis; Cognitive Impairment,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT00881205,Placebo,DRUG,Multiple Sclerosis; Cognitive Impairment,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT02523794,Electro-kinetically Modified Water,OTHER,Pelvic Pain,na,TERMINATED,Revalesio Corporation,
NCT02523794,Placebo,OTHER,Pelvic Pain,na,TERMINATED,Revalesio Corporation,
NCT02812966,Lutonix,DEVICE,Peripheral Arterial Disease,na,TERMINATED,Wake Forest University Health Sciences,
NCT02812966,IN.PACT,DEVICE,Peripheral Arterial Disease,na,TERMINATED,Wake Forest University Health Sciences,
NCT03474666,Strict Glycemic Control Group,PROCEDURE,Liver Transplantation; Surgical Wound Infection,na,TERMINATED,Ramon Oliveira,
NCT03474666,Standard Glycemic Control Group,PROCEDURE,Liver Transplantation; Surgical Wound Infection,na,TERMINATED,Ramon Oliveira,
NCT01444066,Dilation of the esophagus,PROCEDURE,Dysphagia With Normal Endoscopy,na,TERMINATED,Washington University School of Medicine,
NCT00812266,topotecan + cisplatin,DRUG,Extensive Disease; First-Line; Small Cell Lung Cancer,phase3,TERMINATED,Danish Oncological Lung Cancer Group,
NCT00812266,Etoposide + carboplatin,DRUG,Extensive Disease; First-Line; Small Cell Lung Cancer,phase3,TERMINATED,Danish Oncological Lung Cancer Group,
NCT02956122,GLASSIA,BIOLOGICAL,Graft Versus Host Disease,phase2; phase3,TERMINATED,Baxalta now part of Shire,
NCT02956122,methylprednisolone or equivalent steroid,DRUG,Graft Versus Host Disease,phase2; phase3,TERMINATED,Baxalta now part of Shire,
NCT02956122,Albumin,BIOLOGICAL,Graft Versus Host Disease,phase2; phase3,TERMINATED,Baxalta now part of Shire,
NCT03929822,Contrast-Enhanced Spectral Mammography,OTHER,Breast Screening,na,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00920322,rTMS 5 x weekly,DEVICE,Depression,phase4,TERMINATED,"Northside Clinic, Australia",
NCT00920322,rTMS 3 times weekly,DEVICE,Depression,phase4,TERMINATED,"Northside Clinic, Australia",
NCT00623129,questionnaire administration,OTHER,Head and Neck Cancer; Radiation Toxicity; Xerostomia,na,TERMINATED,Mayo Clinic,
NCT00623129,electroacupuncture therapy,PROCEDURE,Head and Neck Cancer; Radiation Toxicity; Xerostomia,na,TERMINATED,Mayo Clinic,
NCT00623129,management of therapy complications,PROCEDURE,Head and Neck Cancer; Radiation Toxicity; Xerostomia,na,TERMINATED,Mayo Clinic,
NCT00623129,quality-of-life assessment,PROCEDURE,Head and Neck Cancer; Radiation Toxicity; Xerostomia,na,TERMINATED,Mayo Clinic,
NCT01409629,Computer game,BEHAVIORAL,Study Individuals' Activity Choices After Playing a Computer Game,na,TERMINATED,University at Buffalo,
NCT04417231,CRP apheresis,DEVICE,"Stroke, Ischemic",na,TERMINATED,Pentracor GmbH,
NCT05284331,addition of two follow-up visits post infection,OTHER,"Complications; Implant, Orthopedic, Infection or Inflammation",na,TERMINATED,Centre Hospitalier Metropole Savoie,
NCT02030431,Dynaloc,DEVICE,Femoral Neck Fracture,na,TERMINATED,Aarhus University Hospital,
NCT02030431,Cancellous screws,DEVICE,Femoral Neck Fracture,na,TERMINATED,Aarhus University Hospital,
NCT01810302,Nicardipine hydrochloride,DRUG,Cerebral Vasospasm,phase2,TERMINATED,University of Florida,
NCT01810302,Preservative-free normal saline,DRUG,Cerebral Vasospasm,phase2,TERMINATED,University of Florida,
NCT01741753,BKM120,DRUG,Prostate Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT01741753,Abiraterone,DRUG,Prostate Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT01741753,Prednisone,DRUG,Prostate Cancer,phase1,TERMINATED,Dana-Farber Cancer Institute,
NCT06009237,ABBV-903,DRUG,Healthy Volunteers,phase1,TERMINATED,AbbVie,
NCT06009237,Placebo for ABBV-903,DRUG,Healthy Volunteers,phase1,TERMINATED,AbbVie,
NCT00567437,NT-pro-BNP levels,OTHER,Aortic Stenosis,na,TERMINATED,Duke University,
NCT02175745,18F-fluoro-dihydroxyphenylalanine,DRUG,Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed G,na,TERMINATED,Erik Mittra,
NCT02175745,Positron emission tomography (PET),PROCEDURE,Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed G,na,TERMINATED,Erik Mittra,
NCT02175745,Computed tomography (CT),PROCEDURE,Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed G,na,TERMINATED,Erik Mittra,
NCT02175745,Magnetic resonance imaging,PROCEDURE,Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed G,na,TERMINATED,Erik Mittra,
NCT03256318,No intervention,OTHER,"Physical Disability; Quality of Life; Social Interaction; Health, Subjective",na,TERMINATED,Allina Health System,
NCT01285297,Bone Marrow Aspirate Concentrate,BIOLOGICAL,Angina,na,TERMINATED,"Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.",
NCT01681797,Fluorescence angiography (Fluobeam™ imaging system developed by Fluoptics company),DEVICE,Reconstructive Surgery,na,TERMINATED,"University Hospital, Grenoble",
NCT05617313,Pembrolizumab,DRUG,Non Small Cell Lung Cancer; Metastatic NSCLC; Recurrent Non Small Cell Lung Cancer,phase2,TERMINATED,Jeffrey Clarke,
NCT05617313,GT103,DRUG,Non Small Cell Lung Cancer; Metastatic NSCLC; Recurrent Non Small Cell Lung Cancer,phase2,TERMINATED,Jeffrey Clarke,
NCT00584779,Gabapentin,DRUG,PK Properties Of Gabapentin In Subjects With Impaired Renal Function,phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT00584779,Gabapentin,DRUG,PK Properties Of Gabapentin In Subjects With Impaired Renal Function,phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT00584779,Gabapentin,DRUG,PK Properties Of Gabapentin In Subjects With Impaired Renal Function,phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT00584779,Gabapentin,DRUG,PK Properties Of Gabapentin In Subjects With Impaired Renal Function,phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT03889496,indium-111-exendin SPECT/CT,RADIATION,Diabetes Mellitus,na,TERMINATED,Radboud University Medical Center,
NCT01583088,phenique nerve stimulation NeurX™ (Synapse Biomedical),DEVICE,Amyotrophic Lateral Sclerosis; Respiratory Insufficiency,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT01583088,sham phrenic nerve stimulation,DEVICE,Amyotrophic Lateral Sclerosis; Respiratory Insufficiency,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT04393727,CONVALESCENT PLASMA,BIOLOGICAL,COVID; SARS-CoV 2,phase2,TERMINATED,"Azienda Ospedaliero, Universitaria Pisana",
NCT00758342,Travoprost 0.004% + Brinzolamide 1.0%,DRUG,Intraocular Pressure,phase4,TERMINATED,Alcon Research,
NCT00758342,Travoprost 0.004% + Tears Natural,DRUG,Intraocular Pressure,phase4,TERMINATED,Alcon Research,
NCT00408473,Flecainide,DRUG,Atrial Fibrillation,phase4,TERMINATED,MEDA Pharma GmbH & Co. KG,
NCT02258854,Dose 2 gevokizumab,DRUG,Uveitis,phase3,TERMINATED,XOMA (US) LLC,
NCT00904605,Lidoderm,DRUG,Osteoarthritis of the Knee,phase4,TERMINATED,Endo Pharmaceuticals,
NCT00904605,Celecoxib,DRUG,Osteoarthritis of the Knee,phase4,TERMINATED,Endo Pharmaceuticals,
NCT01307605,Rituximab,BIOLOGICAL,Lymphoma,phase2,TERMINATED,Swiss Cancer Institute,
NCT01307605,lenalidomide,DRUG,Lymphoma,phase2,TERMINATED,Swiss Cancer Institute,
NCT00504894,Placebo,DRUG,Healthy,phase4,TERMINATED,Weill Medical College of Cornell University,
NCT00504894,Propofol,DRUG,Healthy,phase4,TERMINATED,Weill Medical College of Cornell University,
NCT00504894,Thiopental,DRUG,Healthy,phase4,TERMINATED,Weill Medical College of Cornell University,
NCT00165594,E7070,DRUG,Gastric Cancer,phase1; phase2,TERMINATED,"Eisai Co., Ltd.",
NCT05814666,Danvatirsen,DRUG,HNSCC,phase2,TERMINATED,Flamingo Therapeutics NV,
NCT05814666,Pembrolizumab,DRUG,HNSCC,phase2,TERMINATED,Flamingo Therapeutics NV,
NCT01881451,18F-EF5 PET/CT scan,DRUG,Ovarian Cancer; Ovarian Neoplasms,na,TERMINATED,British Columbia Cancer Agency,
NCT01881451,Optional biopsy,PROCEDURE,Ovarian Cancer; Ovarian Neoplasms,na,TERMINATED,British Columbia Cancer Agency,
NCT02187029,PF-06743649,DRUG,Gout,phase1,TERMINATED,Pfizer,
NCT02187029,Placebo,OTHER,Gout,phase1,TERMINATED,Pfizer,
NCT02187029,PF-06743649,DRUG,Gout,phase1,TERMINATED,Pfizer,
NCT02187029,Placebo,OTHER,Gout,phase1,TERMINATED,Pfizer,
NCT01059929,Dexmedetomidine,DRUG,Mechanical Ventilation; Critical Illness,phase4,TERMINATED,University of Chicago,
NCT01059929,Propofol,DRUG,Mechanical Ventilation; Critical Illness,phase4,TERMINATED,University of Chicago,
NCT01059929,Fentanyl,DRUG,Mechanical Ventilation; Critical Illness,phase4,TERMINATED,University of Chicago,
NCT01059929,Midazolam,DRUG,Mechanical Ventilation; Critical Illness,phase4,TERMINATED,University of Chicago,
NCT01059929,Physical and Occupational Therapy,BEHAVIORAL,Mechanical Ventilation; Critical Illness,phase4,TERMINATED,University of Chicago,
NCT01616537,QUALITY OF LIFE QUESTIONNAIRE,OTHER,Malignant Mast Cell Tumors; Solid Organ Sites,na,TERMINATED,Centre Antoine Lacassagne,
NCT00622245,Lu AA34893,DRUG,Depression in Patients With Bipolar Disorder,phase2,TERMINATED,H. Lundbeck A/S,
NCT00622245,Quetiapine fumarate,DRUG,Depression in Patients With Bipolar Disorder,phase2,TERMINATED,H. Lundbeck A/S,
NCT00622245,Placebo,DRUG,Depression in Patients With Bipolar Disorder,phase2,TERMINATED,H. Lundbeck A/S,
NCT03454672,Tixel,DEVICE,Wrinkle,na,TERMINATED,Novoxel Ltd.,
NCT03454672,Laser,DEVICE,Wrinkle,na,TERMINATED,Novoxel Ltd.,
NCT04502472,Convalescent plasma transfusion,BIOLOGICAL,Covid-19,phase2; phase3,TERMINATED,Inova Health Care Services,
NCT00698139,Medtronic Pacemaker,DEVICE,Heart Failure,na,TERMINATED,Columbia University,
NCT03472924,Kinesiotaping,DEVICE,"Neural Inhibition; Injuries, Ankle",na,TERMINATED,Oregon State University,
NCT04084223,Ultrasound,OTHER,Rheumatoid Arthritis,na,TERMINATED,"University Hospital, Montpellier",
NCT03283423,Image-guided Lymphadanectomy in AMIGO,DEVICE,Lymphadenopathy Retroperitoneal; Lymphoma,na,TERMINATED,Brigham and Women's Hospital,
NCT03521479,Squaric Acid Dibutyl Ester,DRUG,Herpes Labialis; HSV,phase2,TERMINATED,"Squarex, LLC",
NCT03849079,Hyponut,OTHER,Peanut Allergy,na,TERMINATED,"University Hospital, Montpellier",
NCT00790296,Thyrotropin releasing hormone (TRH),DRUG,Cancer-related Fatigue,phase2,TERMINATED,UConn Health,
NCT00790296,Placebo,DRUG,Cancer-related Fatigue,phase2,TERMINATED,UConn Health,
NCT03141996,Vibration to upper posterior neck muscles,OTHER,Unilateral Spatial Neglect,na,TERMINATED,"Intermountain Health Care, Inc.",
NCT03141996,Standard of Care,OTHER,Unilateral Spatial Neglect,na,TERMINATED,"Intermountain Health Care, Inc.",
NCT03617146,Health coaching,BEHAVIORAL,Diabetes Distress,na,TERMINATED,Baylor College of Medicine,
NCT03617146,Diabetes Distress-specific Education,OTHER,Diabetes Distress,na,TERMINATED,Baylor College of Medicine,
NCT00896961,EF5,DRUG,Stage I Adult Soft Tissue Sarcoma; Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage II Adult Soft Tissue Sarcoma; Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage II,na,TERMINATED,National Cancer Institute (NCI),
NCT00896961,diagnostic laboratory biomarker analysis,OTHER,Stage I Adult Soft Tissue Sarcoma; Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage II Adult Soft Tissue Sarcoma; Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage II,na,TERMINATED,National Cancer Institute (NCI),
NCT00896961,pharmacological study,OTHER,Stage I Adult Soft Tissue Sarcoma; Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage II Adult Soft Tissue Sarcoma; Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage II,na,TERMINATED,National Cancer Institute (NCI),
NCT00607061,Blood sample collection,PROCEDURE,Low Birth Weight,na,TERMINATED,Nantes University Hospital,
NCT00206661,Sargramostim (Leukine),DRUG,Crohn Disease,phase1; phase2,TERMINATED,"Genzyme, a Sanofi Company",
NCT00206661,Sargramostim (Leukine),DRUG,Crohn Disease,phase1; phase2,TERMINATED,"Genzyme, a Sanofi Company",
NCT05049642,Lacrimera,DEVICE,Eye Diseases,na,TERMINATED,Vienna Institute for Research in Ocular Surgery,
NCT01527942,Acetaminophen,DRUG,Obesity; Pain,na,TERMINATED,Trinity Health Of New England,
NCT01527942,Placebo,DRUG,Obesity; Pain,na,TERMINATED,Trinity Health Of New England,
NCT01600742,Vorinostat,DRUG,Brain Metastasis,phase2,TERMINATED,National Taiwan University Hospital,
NCT01600742,Placebo,DRUG,Brain Metastasis,phase2,TERMINATED,National Taiwan University Hospital,
NCT01902186,raltegravir and atazanavir and ritonavir,DRUG,HIV Infection; Osteopenia,phase4,TERMINATED,Giovanni Di Perri,
NCT01902186,tenofovir/emtricitabine and atazanavir and ritonavir,DRUG,HIV Infection; Osteopenia,phase4,TERMINATED,Giovanni Di Perri,
NCT00278486,Hematopoietic stem cell transplantation.,BIOLOGICAL,Retinal Disease,phase1,TERMINATED,"Richard Burt, MD",
NCT04676386,"Primary Immune Response (PIR) test by Biodesix, Inc.",OTHER,"NSCLC Stage IV; NSCLC, Stage IIIC",na,TERMINATED,Addario Lung Cancer Medical Institute,
NCT02572973,Acoustic Neuromodulation (ANM),OTHER,Separation Anxiety Disorder; Generalized Anxiety Disorder; Social Phobia,na,TERMINATED,Weill Medical College of Cornell University,
NCT01837069,Metoprolol,DRUG,Osteoarthritis; Cardiovascular Disease,phase4,TERMINATED,NYU Langone Health,
NCT01837069,Lisinopril,DRUG,Osteoarthritis; Cardiovascular Disease,phase4,TERMINATED,NYU Langone Health,
NCT01837069,Atorvastatin,DRUG,Osteoarthritis; Cardiovascular Disease,phase4,TERMINATED,NYU Langone Health,
NCT01837069,Lifestyle counseling,BEHAVIORAL,Osteoarthritis; Cardiovascular Disease,phase4,TERMINATED,NYU Langone Health,
NCT01982383,Micropulse Laser Treatment,DEVICE,Central Serous Chorioretinopathy,na,TERMINATED,George Washington University,
NCT01982383,No treatment,OTHER,Central Serous Chorioretinopathy,na,TERMINATED,George Washington University,
NCT01740154,transcranial magnetic stimulation,PROCEDURE,Fatigue; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer,na,TERMINATED,Case Comprehensive Cancer Center,
NCT01740154,electromyography,PROCEDURE,Fatigue; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer,na,TERMINATED,Case Comprehensive Cancer Center,
NCT01740154,survey administration,OTHER,Fatigue; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer,na,TERMINATED,Case Comprehensive Cancer Center,
NCT01740154,sunitinib malate,DRUG,Fatigue; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer,na,TERMINATED,Case Comprehensive Cancer Center,
NCT00747305,sunitinib malate,DRUG,Kidney Cancer,phase1,TERMINATED,Harry Drabkin,
NCT00747305,gene expression analysis,OTHER,Kidney Cancer,phase1,TERMINATED,Harry Drabkin,
NCT00747305,reverse transcriptase-polymerase chain reaction,OTHER,Kidney Cancer,phase1,TERMINATED,Harry Drabkin,
NCT00747305,western blotting,OTHER,Kidney Cancer,phase1,TERMINATED,Harry Drabkin,
NCT00747305,immunohistochemistry staining method,OTHER,Kidney Cancer,phase1,TERMINATED,Harry Drabkin,
NCT00747305,laboratory biomarker analysis,OTHER,Kidney Cancer,phase1,TERMINATED,Harry Drabkin,
NCT00747305,adjuvant therapy,PROCEDURE,Kidney Cancer,phase1,TERMINATED,Harry Drabkin,
NCT00747305,neoadjuvant therapy,PROCEDURE,Kidney Cancer,phase1,TERMINATED,Harry Drabkin,
NCT00747305,therapeutic conventional surgery,PROCEDURE,Kidney Cancer,phase1,TERMINATED,Harry Drabkin,
NCT03432494,Transcaval closure device (TCD),DEVICE,Aortic Stenosis,na,TERMINATED,"National Heart, Lung, and Blood Institute (NHLBI)",
NCT03722966,Varenicline,DRUG,Smoking Cessation,phase2,TERMINATED,University of Oklahoma,
NCT03722966,Oral Nicotine Replacement Therapy (NRT),DRUG,Smoking Cessation,phase2,TERMINATED,University of Oklahoma,
NCT03722966,Medication Reminders,BEHAVIORAL,Smoking Cessation,phase2,TERMINATED,University of Oklahoma,
NCT03722966,Tobacco Cessation Counseling,BEHAVIORAL,Smoking Cessation,phase2,TERMINATED,University of Oklahoma,
NCT00547066,veltuzumab,BIOLOGICAL,"Purpura, Thrombocytopenic, Idiopathic; Autoimmune Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Autoimmune",phase1; phase2,TERMINATED,Gilead Sciences,
NCT01292122,VCT-01,DEVICE,Wounds,na,TERMINATED,Organogenesis,
NCT03257722,Pembrolizumab,DRUG,Non Small Cell Lung Cancer; Metastasis; Recurrence,phase1; phase2,TERMINATED,Asha Nayak,
NCT03257722,Idelalisib,DRUG,Non Small Cell Lung Cancer; Metastasis; Recurrence,phase1; phase2,TERMINATED,Asha Nayak,
NCT03403751,Reltecimod 0.5 mg/kg,DRUG,Acute Kidney Injury; Peritonitis; Necrotizing Soft Tissue Infection,phase3,TERMINATED,Atox Bio Ltd,
NCT03403751,Placebo,DRUG,Acute Kidney Injury; Peritonitis; Necrotizing Soft Tissue Infection,phase3,TERMINATED,Atox Bio Ltd,
NCT03552029,Quizartinib,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Daiichi Sankyo,
NCT03552029,Milademetan,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Daiichi Sankyo,
NCT03552029,Milademetan,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Daiichi Sankyo,
NCT03015831,Colchicine,DRUG,Atrial Fibrillation; Cardiac Surgery; Colchicine Adverse Reaction,phase3,TERMINATED,Jordan Collaborating Cardiology Group,
NCT03015831,Placebo Oral Tablet,DRUG,Atrial Fibrillation; Cardiac Surgery; Colchicine Adverse Reaction,phase3,TERMINATED,Jordan Collaborating Cardiology Group,
NCT03821831,Continuous Positive Airway Pressure,DEVICE,Pediatric Obstructive Sleep Apnea; Pediatric Obesity,na,TERMINATED,University of Alberta,
NCT03821831,Orthodontic intervention,DEVICE,Pediatric Obstructive Sleep Apnea; Pediatric Obesity,na,TERMINATED,University of Alberta,
NCT01011231,Gamma Knife Radiosurgery,PROCEDURE,Glioblastoma,phase2,TERMINATED,"University of California, San Francisco",
NCT01208402,Esmolol,DRUG,"High-risk, Non-cardiovascular Surgeries",phase3,TERMINATED,Duke University,
NCT03352453,Rapastinel,DRUG,"Depressive Disorder, Major",phase2,TERMINATED,"Naurex, Inc, an affiliate of Allergan plc",
NCT03352453,Placebo,DRUG,"Depressive Disorder, Major",phase2,TERMINATED,"Naurex, Inc, an affiliate of Allergan plc",
NCT04428437,Lenvatinib,DRUG,Hepatocellular Carcinoma,na,TERMINATED,Humanity & Health Medical Group Limited,
NCT01274429,Peanut flour,DRUG,Peanut Allergy,phase1; phase2,TERMINATED,"University of North Carolina, Chapel Hill",
NCT00357929,Permissive hypercarbia,PROCEDURE,"Respiration, Artificial; Respiratory Distress Syndrome, Adult",na,TERMINATED,Milton S. Hershey Medical Center,
NCT03818672,Rifaximin,DRUG,Severe Hepatic Impairment,phase4,TERMINATED,"Bausch Health Americas, Inc.",
NCT01380795,CTC,BIOLOGICAL,Non-small Cell Lung Cancer Metastatic,early_phase1,TERMINATED,Centre Georges Francois Leclerc,
NCT00000175,Estrogen,DRUG,Cognition Disorders; Mood Disorders,na,TERMINATED,National Institute on Aging (NIA),
NCT00000175,Testosterone,DRUG,Cognition Disorders; Mood Disorders,na,TERMINATED,National Institute on Aging (NIA),
NCT03776357,VERA clinic,DEVICE,Total Joint Replacement Surgery,na,TERMINATED,Derek Amanatullah,
NCT05965401,Pharmacogenetic-guided dosing,OTHER,Depression in Adolescence,na,TERMINATED,University of Calgary,
NCT05965401,GLAD-PC guided dosing,OTHER,Depression in Adolescence,na,TERMINATED,University of Calgary,
NCT03352791,DSM-H Hospice Edition performance improvement program,BEHAVIORAL,Dementia,na,TERMINATED,NYU Langone Health,
NCT03352791,Usual Care,BEHAVIORAL,Dementia,na,TERMINATED,NYU Langone Health,
NCT04949191,Pemigatinib,DRUG,Advanced Malignancies,phase2,TERMINATED,Incyte Corporation,
NCT04949191,Retifanlimab,DRUG,Advanced Malignancies,phase2,TERMINATED,Incyte Corporation,
NCT04949191,Pembrolizumab,DRUG,Advanced Malignancies,phase2,TERMINATED,Incyte Corporation,
NCT02489097,Nitrous Oxide,DRUG,"Anesthesia; Delirium, Dementia, Amnestic, Cognitive Disorders",phase4,TERMINATED,"University Hospital, Geneva",
NCT02489097,Placebo,OTHER,"Anesthesia; Delirium, Dementia, Amnestic, Cognitive Disorders",phase4,TERMINATED,"University Hospital, Geneva",
NCT00633997,Vildagliptin,DRUG,"Diabetes Mellitus, Type 2",phase1; phase2,TERMINATED,Novartis,
NCT00633997,Vildagliptin,DRUG,"Diabetes Mellitus, Type 2",phase1; phase2,TERMINATED,Novartis,
NCT00843310,Lenalidomide (Revlimid),DRUG,Multiple Myeloma,phase2,TERMINATED,NYU Langone Health,
NCT00843310,Melphalan,DRUG,Multiple Myeloma,phase2,TERMINATED,NYU Langone Health,
NCT00843310,Dexamethasone,DRUG,Multiple Myeloma,phase2,TERMINATED,NYU Langone Health,
NCT00094120,MSI-1256F (Squalamine Lactate),DRUG,Macular Degeneration,phase2,TERMINATED,Genaera Corporation,
NCT03740724,FCX-013,OTHER,"Morphea; Scleroderma, Localized; Scleroderma",phase1; phase2,TERMINATED,"Castle Creek Biosciences, LLC.",
NCT03740724,veledimex,DRUG,"Morphea; Scleroderma, Localized; Scleroderma",phase1; phase2,TERMINATED,"Castle Creek Biosciences, LLC.",
NCT05234424,THRIVE,OTHER,Apneic Oxygenation,na,TERMINATED,Uppsala University Hospital,
NCT03615924,Ticagrelor,DRUG,Sickle Cell Disease,phase3,TERMINATED,AstraZeneca,
NCT03615924,Placebo,DRUG,Sickle Cell Disease,phase3,TERMINATED,AstraZeneca,
NCT03233724,Decitabine (DAC),DRUG,"Carcinoma, Non-Small-Cell Lung; Lung Cancer; Non-Small Cell Lung Cancer; Carcinoma, Esophageal; Malignant Pleural Mesotheliomas",phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT03233724,Tetrahydrouridine (THU),DRUG,"Carcinoma, Non-Small-Cell Lung; Lung Cancer; Non-Small Cell Lung Cancer; Carcinoma, Esophageal; Malignant Pleural Mesotheliomas",phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT03233724,Pembrolizumab,DRUG,"Carcinoma, Non-Small-Cell Lung; Lung Cancer; Non-Small Cell Lung Cancer; Carcinoma, Esophageal; Malignant Pleural Mesotheliomas",phase1; phase2,TERMINATED,National Cancer Institute (NCI),
NCT02064023,insulin pump,DEVICE,Type 1 Diabetes; Type 2 Diabetes; Pregnancy,na,TERMINATED,University of British Columbia,
NCT02064023,multiple daily insulin injection,OTHER,Type 1 Diabetes; Type 2 Diabetes; Pregnancy,na,TERMINATED,University of British Columbia,
NCT00852059,Immediate release methylphenidate (Medikinet®),DRUG,ADHD,phase4,TERMINATED,Prof. Huss,
NCT00852059,Extended release methylphenidate (Medikinet retard®),DRUG,ADHD,phase4,TERMINATED,Prof. Huss,
NCT02064959,Temperature management Zoll Intravascular Temperature Management device,DEVICE,"Subdural Hematoma, Traumatic",na,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT03652259,SRP-9003,OTHER,"Limb-Girdle Muscular Dystrophy, Type 2E",phase1; phase2,TERMINATED,"Sarepta Therapeutics, Inc.",
NCT00436579,sorafenib tosylate,DRUG,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,National Cancer Institute (NCI),
NCT00436579,pharmacological study,OTHER,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,National Cancer Institute (NCI),
NCT00436579,assessment of therapy complications,PROCEDURE,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,National Cancer Institute (NCI),
NCT00436579,laboratory biomarker analysis,OTHER,"Unspecified Adult Solid Tumor, Protocol Specific",phase1,TERMINATED,National Cancer Institute (NCI),
NCT00835679,cetuximab,BIOLOGICAL,Liver Metastases; Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Ade,early_phase1,TERMINATED,National Cancer Institute (NCI),
NCT00835679,dasatinib,DRUG,Liver Metastases; Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Ade,early_phase1,TERMINATED,National Cancer Institute (NCI),
NCT00835679,therapeutic conventional surgery,PROCEDURE,Liver Metastases; Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Ade,early_phase1,TERMINATED,National Cancer Institute (NCI),
NCT00835679,laboratory biomarker analysis,OTHER,Liver Metastases; Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Ade,early_phase1,TERMINATED,National Cancer Institute (NCI),
NCT02369796,TAK-448,DRUG,Hypogonadotropic Hypogonadism,phase2,TERMINATED,Takeda,
NCT02092961,Fostamatinib,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,AstraZeneca,
NCT02092961,Adalimumab,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,AstraZeneca,
NCT02092961,Placebo of Fostamatinib,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,AstraZeneca,
NCT02092961,Placebo of Adalimumab,DRUG,Rheumatoid Arthritis,phase2,TERMINATED,AstraZeneca,
NCT02826161,Napabucasin,DRUG,"Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT02826161,Paclitaxel,DRUG,"Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT00855842,osmotic dilator insertion,DEVICE,"Abortion, Induced",na,TERMINATED,Boston University,
NCT00875342,DCS,DRUG,Posttraumatic Stress Disorder,na,TERMINATED,Weill Medical College of Cornell University,
NCT00875342,Placebo,OTHER,Posttraumatic Stress Disorder,na,TERMINATED,Weill Medical College of Cornell University,
NCT01034670,Dual axis endoscopic microscope,DEVICE,Gastrointestinal Diseases; Gastric (Stomach) Cancer; Gastrointestinal Stromal Tumor (GIST),na,TERMINATED,Stanford University,
NCT01034670,wide field fluorescence system,DEVICE,Gastrointestinal Diseases; Gastric (Stomach) Cancer; Gastrointestinal Stromal Tumor (GIST),na,TERMINATED,Stanford University,
NCT01034670,CellVizio,DEVICE,Gastrointestinal Diseases; Gastric (Stomach) Cancer; Gastrointestinal Stromal Tumor (GIST),na,TERMINATED,Stanford University,
NCT01034670,fluorescent Peptide,DRUG,Gastrointestinal Diseases; Gastric (Stomach) Cancer; Gastrointestinal Stromal Tumor (GIST),na,TERMINATED,Stanford University,
NCT01034670,fluorescein,DRUG,Gastrointestinal Diseases; Gastric (Stomach) Cancer; Gastrointestinal Stromal Tumor (GIST),na,TERMINATED,Stanford University,
NCT01034670,indocyanine green,DRUG,Gastrointestinal Diseases; Gastric (Stomach) Cancer; Gastrointestinal Stromal Tumor (GIST),na,TERMINATED,Stanford University,
NCT02151383,Serelaxin,DRUG,Acute Heart Failure,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT05694741,AZD0186,DRUG,Type 2 Diabetes,phase1,TERMINATED,AstraZeneca,
NCT05694741,Placebo,DRUG,Type 2 Diabetes,phase1,TERMINATED,AstraZeneca,
NCT03534141,Esophageal cooling/warming device,DEVICE,Cirrhosis; End Stage Liver Disease; Acute Kidney Injury; Liver Transplant; Complications; Chronic Kidney Diseases; Hepatitis c; Hepatitis B; NASH - Nonalcoholic Steatohepatitis; Alcoholic Cirrhosis; H,na,TERMINATED,"University of California, San Francisco",
NCT03534141,Mild hypothermia,OTHER,Cirrhosis; End Stage Liver Disease; Acute Kidney Injury; Liver Transplant; Complications; Chronic Kidney Diseases; Hepatitis c; Hepatitis B; NASH - Nonalcoholic Steatohepatitis; Alcoholic Cirrhosis; H,na,TERMINATED,"University of California, San Francisco",
NCT03534141,Normothermia,OTHER,Cirrhosis; End Stage Liver Disease; Acute Kidney Injury; Liver Transplant; Complications; Chronic Kidney Diseases; Hepatitis c; Hepatitis B; NASH - Nonalcoholic Steatohepatitis; Alcoholic Cirrhosis; H,na,TERMINATED,"University of California, San Francisco",
NCT03453541,Ketorolac Tromethamine,DRUG,Analgesic Adverse Reaction,phase4,TERMINATED,Albany Medical College,
NCT03453541,0.9% Normal Saline,DRUG,Analgesic Adverse Reaction,phase4,TERMINATED,Albany Medical College,
NCT01491854,Bloodsampling,OTHER,Short Children Born Small for Gestational Age (SGA),na,TERMINATED,Sandoz,
NCT03770494,LY3405105,DRUG,Solid Tumor,phase1,TERMINATED,Eli Lilly and Company,
NCT00531466,tolperisone HCl (AV650),DRUG,Muscle Spasticity,phase2,TERMINATED,Avigen,
NCT00531466,Placebo,DRUG,Muscle Spasticity,phase2,TERMINATED,Avigen,
NCT06062056,EHR alert,OTHER,Vaccine Hesitancy,na,TERMINATED,Boston College,
NCT06062056,Motivational Interviewing,BEHAVIORAL,Vaccine Hesitancy,na,TERMINATED,Boston College,
NCT06062056,Warm hand off to nurse,BEHAVIORAL,Vaccine Hesitancy,na,TERMINATED,Boston College,
NCT01807156,Tivozanib,DRUG,Hepatocellular Cancer,phase2,TERMINATED,Emory University,
NCT04054856,Body Sensor Network,DEVICE,Parkinson Disease,na,TERMINATED,RWTH Aachen University,
NCT05037266,COVID-19 Vaccine Janssen (Ad26.COV2-S),BIOLOGICAL,Healthy Volunteers,phase4,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT05434351,vaginal dehydroepiandrosterone,OTHER,Genitourinary Syndrome of Menopause,na,TERMINATED,Chinese University of Hong Kong,
NCT00567229,rituximab,BIOLOGICAL,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00567229,lenalidomide,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00567229,microarray analysis,OTHER,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00567229,flow cytometry,OTHER,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00567229,laboratory biomarker analysis,OTHER,Multiple Myeloma and Plasma Cell Neoplasm,phase2,TERMINATED,Memorial Sloan Kettering Cancer Center,
NCT00493831,"nicotine polacrilex, transdermal system or inhaler",DRUG,Cigarette Smoking,na,TERMINATED,University of Nebraska,
NCT06207331,Dexmedetomidine 0.5 μg/kg,DRUG,Respiratory Function Tests; Chronic Obstructive Pulmonary Disease; Dexmedetomidine,na,TERMINATED,The Second Affiliated Hospital of Chongqing Medical University,
NCT06207331,Dexmedetomidine 1 μg/kg,DRUG,Respiratory Function Tests; Chronic Obstructive Pulmonary Disease; Dexmedetomidine,na,TERMINATED,The Second Affiliated Hospital of Chongqing Medical University,
NCT06207331,Saline,DRUG,Respiratory Function Tests; Chronic Obstructive Pulmonary Disease; Dexmedetomidine,na,TERMINATED,The Second Affiliated Hospital of Chongqing Medical University,
NCT00670202,Fasudil Hydrochloride,DRUG,Carotid Stenosis,phase2,TERMINATED,Brigham and Women's Hospital,
NCT00670202,Placebo Oral Tablet,DRUG,Carotid Stenosis,phase2,TERMINATED,Brigham and Women's Hospital,
NCT01189253,doxorubicin hydrochloride,DRUG,Sarcoma,phase2; phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT01189253,trabectedin,DRUG,Sarcoma,phase2; phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT01189253,laboratory biomarker analysis,OTHER,Sarcoma,phase2; phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT01189253,quality-of-life assessment,PROCEDURE,Sarcoma,phase2; phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT04613453,Ketamine Infusion,DRUG,Adolescent Suicide; Adolescent Depression,phase2,TERMINATED,Yale University,
NCT04613453,Midazolam Infusion,DRUG,Adolescent Suicide; Adolescent Depression,phase2,TERMINATED,Yale University,
NCT01351753,Metformin,DRUG,Obesity; Metabolic Syndrome X,phase2,TERMINATED,University of Iowa,
NCT01351753,Orlistat,DRUG,Obesity; Metabolic Syndrome X,phase2,TERMINATED,University of Iowa,
NCT01351753,Topiramate,DRUG,Obesity; Metabolic Syndrome X,phase2,TERMINATED,University of Iowa,
NCT01351753,Placebo,DRUG,Obesity; Metabolic Syndrome X,phase2,TERMINATED,University of Iowa,
NCT01151553,CRT Therapy,DEVICE,Congestive Heart Failure,na,TERMINATED,Emory University,
NCT03626545,Canakinumab,DRUG,Non-Small-Cell Lung,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT03626545,Docetaxel,DRUG,Non-Small-Cell Lung,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT03626545,Placebo,OTHER,Non-Small-Cell Lung,phase3,TERMINATED,Novartis Pharmaceuticals,
NCT05703945,Progressive training program,OTHER,Healthy Ageing,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT05703945,Control group,OTHER,Healthy Ageing,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT01301482,Ear Acupuncture,DEVICE,Acute Sore Throat,na,TERMINATED,Mike O'Callaghan Military Hospital,
NCT00831480,everolimus,DRUG,Kidney Cancer,phase2,TERMINATED,Linda C. Higgins,
NCT03637296,Critical time intervention,OTHER,Schizophrenia; Medical Complication,na,TERMINATED,New York State Psychiatric Institute,
NCT00034788,Becaplermin,DRUG,Foot Ulcer; Diabetic Foot; Skin Ulcer; Diabetic Neuropathies,phase3,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT05993169,Body Composition optimization visits,OTHER,"Obesity, Morbid",na,TERMINATED,Jacob M. Elkins,
NCT05224869,Medical Device Usage and Evaluation,DEVICE,Prostate Cancer,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT05224869,CT simulation,PROCEDURE,Prostate Cancer,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT05224869,Stereotactic body radiation therapy,PROCEDURE,Prostate Cancer,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT05224869,Brachytherapy,RADIATION,Prostate Cancer,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT05224869,Post-implant dosimetry scan,PROCEDURE,Prostate Cancer,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT00499369,irinotecan hydrochloride,DRUG,Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase3,TERMINATED,National Cancer Institute (NCI),
NCT00499369,leucovorin calcium,DRUG,Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase3,TERMINATED,National Cancer Institute (NCI),
NCT00499369,fluorouracil,DRUG,Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase3,TERMINATED,National Cancer Institute (NCI),
NCT00499369,cetuximab,BIOLOGICAL,Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase3,TERMINATED,National Cancer Institute (NCI),
NCT00499369,bevacizumab,BIOLOGICAL,Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase3,TERMINATED,National Cancer Institute (NCI),
NCT00362869,Levofloxacin,DRUG,Escherichia Coli Infections,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00362869,Placebo,DRUG,Escherichia Coli Infections,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT00362869,Enteroaggregative E. coli (EAEC),BIOLOGICAL,Escherichia Coli Infections,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT04140669,Automated Myocardial Performance Index (MPI),DEVICE,Twin to Twin Transfusion Syndrome; Congenital Diaphragmatic Hernia; Neural Tube Defects; Lower Urinary Tract Infection,na,TERMINATED,Mayo Clinic,
NCT00242541,Octreotide acetate,DRUG,Acromegaly,phase4,TERMINATED,Novartis Pharmaceuticals,
NCT06652841,transShield Embolic Protection System,DEVICE,Aortic Stenosis,na,TERMINATED,"TransAortic Medical, Inc.",
NCT01367405,Surgical decompression,PROCEDURE,Central Spinal Cord Syndrome,na,TERMINATED,Radboud University Medical Center,
NCT01367405,Conservative treatment,PROCEDURE,Central Spinal Cord Syndrome,na,TERMINATED,Radboud University Medical Center,
NCT04372966,Total hip arthroplasty,DEVICE,Hip Fractures,na,TERMINATED,NHS Lothian,
NCT04872556,Laser acupuncture device,DEVICE,Pain Cancer; Joint Pain,na,TERMINATED,Chang Gung Memorial Hospital,
NCT04872556,Pseudo-laser acupuncture,DEVICE,Pain Cancer; Joint Pain,na,TERMINATED,Chang Gung Memorial Hospital,
NCT03150056,GSK525762,DRUG,Solid Tumours,phase1,TERMINATED,GlaxoSmithKline,
NCT03150056,Abiraterone,DRUG,Solid Tumours,phase1,TERMINATED,GlaxoSmithKline,
NCT03150056,Enzalutamide,DRUG,Solid Tumours,phase1,TERMINATED,GlaxoSmithKline,
NCT03150056,Prednisone,DRUG,Solid Tumours,phase1,TERMINATED,GlaxoSmithKline,
NCT02930122,anakinra (150mg),DRUG,Anterior Cruciate Ligament Tear,phase2,TERMINATED,"Cale Jacobs, PhD",
NCT02930122,Saline intraarticularly,OTHER,Anterior Cruciate Ligament Tear,phase2,TERMINATED,"Cale Jacobs, PhD",
NCT00329329,satraplatin and capecitabine,DRUG,Malignancies,phase1,TERMINATED,Agennix,
NCT02164929,TAP block,PROCEDURE,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Epidural,PROCEDURE,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Paravertebral block,PROCEDURE,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Acetaminophen 1g IV,DRUG,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Dexamethasone 4mg,DRUG,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Midazolam up to 2mg,DRUG,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Propofol 1-2.5 mg/kg,DRUG,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Sevoflurane to keep a bispectral index of between 40-60,DRUG,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Local infiltration with 10 mL of plain ropivacaine 0.25%,DRUG,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Lidocaine,DRUG,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Epinephrine,DRUG,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT02164929,Hydromorphone,DRUG,Laparoscopic Colorectal Resection,na,TERMINATED,Duke University,
NCT01475253,Lidocaine Releasing Intravesical System - LiRIS®,DRUG,Interstitial Cystitis,phase2,TERMINATED,Allergan,
NCT01475253,LiRIS Placebo,OTHER,Interstitial Cystitis,phase2,TERMINATED,Allergan,
NCT01475253,Sham Cystoscopy Procedure,PROCEDURE,Interstitial Cystitis,phase2,TERMINATED,Allergan,
NCT01138553,Mifepristone,DRUG,Invasive Breast Cancer; Ductal Carcinoma in Situ,early_phase1,TERMINATED,"University of California, San Diego",
NCT02773472,electroacupuncture,DEVICE,Acute Pain,na,TERMINATED,The University of Hong Kong,
NCT02773472,morphine,DRUG,Acute Pain,na,TERMINATED,The University of Hong Kong,
NCT01495572,Fludarabine,DRUG,Metastatic Melanoma; Skin Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01495572,Cyclophosphamide,DRUG,Metastatic Melanoma; Skin Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01495572,Aldesleukin,DRUG,Metastatic Melanoma; Skin Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01495572,MART-1 Reactive CD8+ PBL,DRUG,Metastatic Melanoma; Skin Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT03752372,hematopoietic stem cell transplantation,PROCEDURE,Inflammatory Bowel Diseases; Microbiota,na,TERMINATED,Children's Hospital of Fudan University,
NCT01587872,Fujinon EC-450BI5 double-balloon colonoscope,PROCEDURE,Colorectal Cancer; Colorectal Adenomas; Inflammatory Bowel Disease,na,TERMINATED,Sorlandet Hospital HF,
NCT05109195,Standard of Care (SOC),OTHER,"Depressive Disorder, Major",na,TERMINATED,"Janssen Research & Development, LLC",
NCT01716039,MTX 12.5,DRUG,Ulcerative Colitis,phase2,TERMINATED,Alimentiv Inc.,
NCT01716039,MTX 25,DRUG,Ulcerative Colitis,phase2,TERMINATED,Alimentiv Inc.,
NCT01716039,Adalimumab,DRUG,Ulcerative Colitis,phase2,TERMINATED,Alimentiv Inc.,
NCT02029495,210 mg brodalumab,DRUG,Psoriatic Arthritis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT02029495,140 mg brodalumab,DRUG,Psoriatic Arthritis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT02029495,Placebo,DRUG,Psoriatic Arthritis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT00884039,anecortave acetate,DRUG,Transplant; Intraocular Pressure,na,TERMINATED,Cornea Research Foundation of America,
NCT00884039,30 mg anecortave acetate,DRUG,Transplant; Intraocular Pressure,na,TERMINATED,Cornea Research Foundation of America,
NCT00945477,Pazopanib (GW786034),DRUG,Prostate Cancer,phase2,TERMINATED,"Illinois CancerCare, P.C.",
NCT01913301,Alagebrium,DRUG,Diastolic Heart Failure,phase2,TERMINATED,Cardiovascular Clinical Sciences Inc,
NCT04860401,Measurement of tissue oxygenation with novel diagnostic near-infrared spectroscopy device (OxyPrem) (no clinical decisions based on oxygenation levels),DEVICE,Tissue Oxygenation Measurement,na,TERMINATED,Hans Ulrich Bucher,
NCT03661424,HER2 BATs,DRUG,Breast Cancer Female; Leptomeningeal Metastases,phase1,TERMINATED,University of Virginia,
NCT01058759,Enoxaparin,DRUG,Non-small Cell Lung Cancer,phase3,TERMINATED,Hannover Medical School,
NCT01058759,No Enoxaparin,OTHER,Non-small Cell Lung Cancer,phase3,TERMINATED,Hannover Medical School,
NCT02632279,Tryptophan (TRP) depletion,OTHER,Parkinson's Disease,na,TERMINATED,Maastricht University Medical Center,
NCT02632279,Placebo,OTHER,Parkinson's Disease,na,TERMINATED,Maastricht University Medical Center,
NCT02632279,Stimulator ON,DEVICE,Parkinson's Disease,na,TERMINATED,Maastricht University Medical Center,
NCT02632279,Stimulator OFF,DEVICE,Parkinson's Disease,na,TERMINATED,Maastricht University Medical Center,
NCT04284462,Flavored carbonated soft drink (CSD),OTHER,Sweetness Liking Adaptation,na,TERMINATED,PepsiCo Global R&D,
NCT00595296,GeneSearch™ Breast Lymph Node (BLN) Assay,DEVICE,Breast Cancer,na,TERMINATED,"Janssen Diagnostics, LLC",
NCT00444262,hemodynamic optimisation guided using esophageal Doppler,PROCEDURE,Hip Fractures,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00444262,VOLUVEN and others solute,DRUG,Hip Fractures,phase3,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02359162,Gemcitabine,DRUG,"Lymphoma, Extranodal NK-T-Cell",phase3,TERMINATED,Sun Yat-sen University,
NCT02359162,Oxaliplatin,DRUG,"Lymphoma, Extranodal NK-T-Cell",phase3,TERMINATED,Sun Yat-sen University,
NCT02359162,Pegaspargase,DRUG,"Lymphoma, Extranodal NK-T-Cell",phase3,TERMINATED,Sun Yat-sen University,
NCT02359162,Etoposide,DRUG,"Lymphoma, Extranodal NK-T-Cell",phase3,TERMINATED,Sun Yat-sen University,
NCT02359162,Vincristine,DRUG,"Lymphoma, Extranodal NK-T-Cell",phase3,TERMINATED,Sun Yat-sen University,
NCT02359162,Doxorubicin,DRUG,"Lymphoma, Extranodal NK-T-Cell",phase3,TERMINATED,Sun Yat-sen University,
NCT02359162,Cyclophosphamide,DRUG,"Lymphoma, Extranodal NK-T-Cell",phase3,TERMINATED,Sun Yat-sen University,
NCT02359162,Prednisone,DRUG,"Lymphoma, Extranodal NK-T-Cell",phase3,TERMINATED,Sun Yat-sen University,
NCT02359162,IMRT,RADIATION,"Lymphoma, Extranodal NK-T-Cell",phase3,TERMINATED,Sun Yat-sen University,
NCT00095862,allogeneic GM-CSF-secreting breast cancer vaccine,BIOLOGICAL,"Breast Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase1; phase2,TERMINATED,Wiseman Research Initiatives LLC,
NCT00095862,recombinant interferon alfa,BIOLOGICAL,"Breast Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase1; phase2,TERMINATED,Wiseman Research Initiatives LLC,
NCT00095862,cyclophosphamide,DRUG,"Breast Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase1; phase2,TERMINATED,Wiseman Research Initiatives LLC,
NCT02759562,Andecaliximab,DRUG,Cystic Fibrosis,phase2,TERMINATED,Gilead Sciences,
NCT02759562,Placebo,DRUG,Cystic Fibrosis,phase2,TERMINATED,Gilead Sciences,
NCT01947946,Benralizumab,BIOLOGICAL,Asthma,phase3,TERMINATED,AstraZeneca,
NCT01947946,Placebo,BIOLOGICAL,Asthma,phase3,TERMINATED,AstraZeneca,
NCT00286988,Topiramate,DRUG,Vomiting,phase4,TERMINATED,Monarch Medical Research,
NCT01677988,Neo-adjuvant Chemotherapy,DRUG,Adenocarcinoma of Head of Pancreas,phase2,TERMINATED,Medical University of South Carolina,
NCT01677988,Chemoradiation,RADIATION,Adenocarcinoma of Head of Pancreas,phase2,TERMINATED,Medical University of South Carolina,
NCT01677988,Surgical Resection,PROCEDURE,Adenocarcinoma of Head of Pancreas,phase2,TERMINATED,Medical University of South Carolina,
NCT05022303,Larazotide Acetate,DRUG,Covid19; Multisystem Inflammatory Syndrome in Children,phase2,TERMINATED,Massachusetts General Hospital,
NCT05022303,Placebo,DRUG,Covid19; Multisystem Inflammatory Syndrome in Children,phase2,TERMINATED,Massachusetts General Hospital,
NCT01915303,Pasireotide with or without cabergoline,DRUG,Cushings Disease,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01972061,Foot stimulation,DEVICE,Overactive Bladder,na,TERMINATED,"Christopher J Chermansky, MD",
NCT00176761,Interleukin-2 (IL-2),DRUG,Metastatic Colorectal Cancer,phase2,TERMINATED,University of Michigan Rogel Cancer Center,
NCT00641342,onlay mesh,DEVICE,Parastomal Hernia,phase2; phase3,TERMINATED,"University Hospital, Gentofte, Copenhagen",
NCT00472186,Lansoprazole,DRUG,Post-tonsillectomy Pain; Post-tonsillectomy Activity; Post-tonsillectomy Hydration,phase4,TERMINATED,Boston Children's Hospital,
NCT00472186,Placebo,DRUG,Post-tonsillectomy Pain; Post-tonsillectomy Activity; Post-tonsillectomy Hydration,phase4,TERMINATED,Boston Children's Hospital,
NCT04732286,Atezolizumab,DRUG,"Carcinoma, Hepatocellular",phase3,TERMINATED,Hoffmann-La Roche,
NCT04732286,Bevacizumab,DRUG,"Carcinoma, Hepatocellular",phase3,TERMINATED,Hoffmann-La Roche,
NCT01133873,Propoxyphene napsylate (XP20C),DRUG,Healthy,phase4,TERMINATED,Xanodyne Pharmaceuticals,
NCT01133873,Placebo,DRUG,Healthy,phase4,TERMINATED,Xanodyne Pharmaceuticals,
NCT06077773,Oral EP262,DRUG,Chronic Spontaneous Urticaria,phase2,TERMINATED,"Escient Pharmaceuticals, Inc",
NCT06077773,Placebo,DRUG,Chronic Spontaneous Urticaria,phase2,TERMINATED,"Escient Pharmaceuticals, Inc",
NCT03183869,Fecal microbiota,DRUG,Autoimmune Diseases; Relapsing Multiple Sclerosis,phase2,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT02419469,Cytarabine,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Daunorubicin,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Vincristine,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Prednisone,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,PEG asparaginase,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Ofatumumab,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Rituximab,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Methotrexate,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Cyclophosphamide,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Mercaptopurine,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Doxorubicin,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Dexamethasone acetate,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT02419469,Thioguanine,DRUG,Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT03605069,QR-313,DRUG,"Epidermolysis Bullosa Dystrophica, Recessive; Epidermolysis Bullosa Dystrophica, Dominant",phase1; phase2,TERMINATED,Phoenicis Therapeutics,
NCT03605069,Placebo,DRUG,"Epidermolysis Bullosa Dystrophica, Recessive; Epidermolysis Bullosa Dystrophica, Dominant",phase1; phase2,TERMINATED,Phoenicis Therapeutics,
NCT02452983,Sertraline,DRUG,Myelodysplastic Syndromes,phase1,TERMINATED,Gustavo Rivero,
NCT02452983,Bone Marrow Aspirate/Biopsy,PROCEDURE,Myelodysplastic Syndromes,phase1,TERMINATED,Gustavo Rivero,
NCT00794183,CRT device settings,DEVICE,Heart Failure,early_phase1,TERMINATED,University of Minnesota,
NCT00782041,Oxaliplatin,DRUG,Uterine Neoplasms,phase2,TERMINATED,Sanofi,
NCT00782041,5-FluoroUracil,DRUG,Uterine Neoplasms,phase2,TERMINATED,Sanofi,
NCT00782041,Folinic acid,DRUG,Uterine Neoplasms,phase2,TERMINATED,Sanofi,
NCT01760941,Radiation Therapy,RADIATION,Symptomatic Osseous Bone Lesions From Any Malignancy,na,TERMINATED,Virginia Commonwealth University,
NCT01760941,Quality-of-Life Assessment,OTHER,Symptomatic Osseous Bone Lesions From Any Malignancy,na,TERMINATED,Virginia Commonwealth University,
NCT01760941,Survey Administration,OTHER,Symptomatic Osseous Bone Lesions From Any Malignancy,na,TERMINATED,Virginia Commonwealth University,
NCT02999854,ATIR101,BIOLOGICAL,Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome,phase3,TERMINATED,Kiadis Pharma,
NCT02999854,Cyclophosphamide,DRUG,Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome,phase3,TERMINATED,Kiadis Pharma,
NCT02999854,"T-cell depleted HSCT from a related, haploidentical donor",PROCEDURE,Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome,phase3,TERMINATED,Kiadis Pharma,
NCT02999854,"T-cell replete HSCT from a related, haploidentical donor",PROCEDURE,Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome,phase3,TERMINATED,Kiadis Pharma,
NCT04528654,Mobile Health Application,OTHER,Cardiovascular Risk Factor; Hypertension,na,TERMINATED,McMaster University,
NCT00350766,Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation,PROCEDURE,Acute Myocardial Infarction,phase2; phase3,TERMINATED,"Ministry of Health, Brazil",
NCT00225056,docetaxel and capecitabine,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,"Oncology Specialties, Alabama",
NCT00517751,X-STOP PEEK,DEVICE,Lumbar Spinal Stenosis,phase4,TERMINATED,Medtronic Spine LLC,
NCT01282151,Taxotere,DRUG,"Carcinoma, Non Small Cell Lung",phase3,TERMINATED,Chonnam National University Hospital,
NCT01282151,Pemetrexed,DRUG,"Carcinoma, Non Small Cell Lung",phase3,TERMINATED,Chonnam National University Hospital,
NCT00229229,Low glycemic load diet,OTHER,Obesity; Cardiovascular Disease; Metabolic Syndrome,phase4,TERMINATED,Queen's University,
NCT00229229,Canada Food Guide Diet,OTHER,Obesity; Cardiovascular Disease; Metabolic Syndrome,phase4,TERMINATED,Queen's University,
NCT00229229,Low glycemic index diet,OTHER,Obesity; Cardiovascular Disease; Metabolic Syndrome,phase4,TERMINATED,Queen's University,
NCT00229229,Low carbohydrate diet,OTHER,Obesity; Cardiovascular Disease; Metabolic Syndrome,phase4,TERMINATED,Queen's University,
NCT02428231,dimethyl fumarate,DRUG,Multiple Sclerosis,phase3,TERMINATED,Biogen,
NCT00573131,OncoGel (Paclitaxel gel),DRUG,Esophageal Cancer; Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma,phase2,TERMINATED,Boston Scientific Corporation,
NCT00573131,cisplatin,DRUG,Esophageal Cancer; Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma,phase2,TERMINATED,Boston Scientific Corporation,
NCT00573131,5-FU,DRUG,Esophageal Cancer; Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma,phase2,TERMINATED,Boston Scientific Corporation,
NCT00573131,radiation therapy,RADIATION,Esophageal Cancer; Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma,phase2,TERMINATED,Boston Scientific Corporation,
NCT00573131,esophageal resection,PROCEDURE,Esophageal Cancer; Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma,phase2,TERMINATED,Boston Scientific Corporation,
NCT00301431,DVS-233,DRUG,Fibromyalgia,phase2; phase3,TERMINATED,Wyeth is now a wholly owned subsidiary of Pfizer,
NCT02672202,Duloxetine,DRUG,Post-operative Chronic Pain,na,TERMINATED,Rambam Health Care Campus,
NCT02672202,Pregabalin,DRUG,Post-operative Chronic Pain,na,TERMINATED,Rambam Health Care Campus,
NCT02672202,Placebo,DRUG,Post-operative Chronic Pain,na,TERMINATED,Rambam Health Care Campus,
NCT05394402,SHR0410 Injection,DRUG,Postsurgical Pain,phase2,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT05394402,Placebo for SHR0410 Injection,DRUG,Postsurgical Pain,phase2,TERMINATED,"Jiangsu HengRui Medicine Co., Ltd.",
NCT04650594,MUTARS® modular reconstruction prostheses,PROCEDURE,Knee Disease; Bone Cancer,na,TERMINATED,"University Hospital, Lille",
NCT05971056,Care transition,OTHER,Multiple Myeloma,na,TERMINATED,Washington University School of Medicine,
NCT05971056,No care transition,OTHER,Multiple Myeloma,na,TERMINATED,Washington University School of Medicine,
NCT05274451,LYL797,BIOLOGICAL,"Triple Negative Breast Cancer; TNBC - Triple-Negative Breast Cancer; Non-small Cell Lung Cancer; Non Small Cell Lung Cancer; Non Small Cell Lung Cancer Metastatic; Non-Small Cell Carcinoma of Lung, TN",phase1,TERMINATED,"Lyell Immunopharma, Inc.",
NCT01813851,Exercise training in addition to nutritional support,DEVICE,"Chronic Renal Failure, Hemodialysis Treatment, Protein-energy Wasting",na,TERMINATED,Nantes University Hospital,
NCT02600429,RGN-259,DRUG,Neurotrophic Keratopathy,phase3,TERMINATED,"ReGenTree, LLC",
NCT02600429,Placebo,DRUG,Neurotrophic Keratopathy,phase3,TERMINATED,"ReGenTree, LLC",
NCT00387829,DuraGen Plus Adhesion Barrier Matrix,DEVICE,Spinal Injuries; Adhesions,na,TERMINATED,Integra LifeSciences Corporation,
NCT00748631,balloon kyphoplasty,DEVICE,Vertebral Fracture; Multiple Myeloma; Osteolytic Metastases,na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT06546553,PF-07826390,DRUG,Neoplasms; Non-small-cell Lung Cancer; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Colorectal Carcinoma; Ovarian Carcinoma,phase1,TERMINATED,Pfizer,
NCT06546553,sasanlimab,BIOLOGICAL,Neoplasms; Non-small-cell Lung Cancer; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Colorectal Carcinoma; Ovarian Carcinoma,phase1,TERMINATED,Pfizer,
NCT06546553,SOC (anti-PD-1 + platinum -based chemo),OTHER,Neoplasms; Non-small-cell Lung Cancer; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Colorectal Carcinoma; Ovarian Carcinoma,phase1,TERMINATED,Pfizer,
NCT01408953,bevacizumab,BIOLOGICAL,Keloid,phase2,TERMINATED,"Tirgan, Michael H., M.D.",
NCT02235545,St. Jude Medical Optisure Lead,DEVICE,"Heart Failure; Tachycardia, Ventricular",na,TERMINATED,Abbott Medical Devices,
NCT04566445,GT005,DRUG,Dry Age-related Macular Degeneration,phase2,TERMINATED,Gyroscope Therapeutics Limited,
NCT05452902,EXCAP Exercise,BEHAVIORAL,Chemotherapy-induced Peripheral Neuropathy,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT05452902,Nutrition Education,BEHAVIORAL,Chemotherapy-induced Peripheral Neuropathy,phase2,TERMINATED,"University of Maryland, Baltimore",
NCT03089502,Exercise Rehabilitation,OTHER,"Breast Cancer; Left Ventricular Dysfunction; Heart Failure, Systolic",na,TERMINATED,"University Health Network, Toronto",
NCT00319202,Candesartan,DRUG,Glucose Intolerance; Obesity,phase4,TERMINATED,Fundación Cardiovascular de Colombia,
NCT00319202,Placebo,DRUG,Glucose Intolerance; Obesity,phase4,TERMINATED,Fundación Cardiovascular de Colombia,
NCT04141995,Digoxin,DRUG,Pancreas Cancer; Adenocarcinoma of the Pancreas,phase2,TERMINATED,University of Nebraska,
NCT04141995,5Fluorouracil,DRUG,Pancreas Cancer; Adenocarcinoma of the Pancreas,phase2,TERMINATED,University of Nebraska,
NCT04141995,Calcium Leucovorin,DRUG,Pancreas Cancer; Adenocarcinoma of the Pancreas,phase2,TERMINATED,University of Nebraska,
NCT04141995,Irinotecan,DRUG,Pancreas Cancer; Adenocarcinoma of the Pancreas,phase2,TERMINATED,University of Nebraska,
NCT04141995,Oxaliplatin,DRUG,Pancreas Cancer; Adenocarcinoma of the Pancreas,phase2,TERMINATED,University of Nebraska,
NCT03902977,quilting,PROCEDURE,Breast Cancer Female,na,TERMINATED,Lindenhofgruppe AG,
NCT03902977,conventional suture,PROCEDURE,Breast Cancer Female,na,TERMINATED,Lindenhofgruppe AG,
NCT00938457,stereotactic radiation therapy,RADIATION,Unspecified Adult Solid Tumor,phase1; phase2,TERMINATED,Mayo Clinic,
NCT00938457,implanted fiducial-based imaging,PROCEDURE,Unspecified Adult Solid Tumor,phase1; phase2,TERMINATED,Mayo Clinic,
NCT00938457,cone-beam computed tomography,PROCEDURE,Unspecified Adult Solid Tumor,phase1; phase2,TERMINATED,Mayo Clinic,
NCT04230135,Hap-pas-Hapi,DEVICE,Psychological Distress,na,TERMINATED,University of Zurich,
NCT05280717,sotrovimab,BIOLOGICAL,Covid19,phase1,TERMINATED,"Vir Biotechnology, Inc.",
NCT05280717,sotrovimab,BIOLOGICAL,Covid19,phase1,TERMINATED,"Vir Biotechnology, Inc.",
NCT05280717,sotrovimab,BIOLOGICAL,Covid19,phase1,TERMINATED,"Vir Biotechnology, Inc.",
NCT05280717,sotrovimab,BIOLOGICAL,Covid19,phase1,TERMINATED,"Vir Biotechnology, Inc.",
NCT05280717,sotrovimab,BIOLOGICAL,Covid19,phase1,TERMINATED,"Vir Biotechnology, Inc.",
NCT05280717,sotrovimab,BIOLOGICAL,Covid19,phase1,TERMINATED,"Vir Biotechnology, Inc.",
NCT05280717,sotrovimab,BIOLOGICAL,Covid19,phase1,TERMINATED,"Vir Biotechnology, Inc.",
NCT00712517,propofol,DRUG,Varicose Vein; Postoperative Pain,na,TERMINATED,The Cleveland Clinic,
NCT00712517,sevoflurane,DRUG,Varicose Vein; Postoperative Pain,na,TERMINATED,The Cleveland Clinic,
NCT04663568,Levonorgestrel-releasing intrauterine system,DEVICE,Tubal Ligation,na,TERMINATED,Assiut University,
NCT01315418,1-Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®),OTHER,Upper Respiratory Tract Infections; Rhinopharyngitis; Sore Throat; Sinusitis; Otitis; Lower Respiratory Tract Infections; Bronchitis; Pneumopathy; Flu; Flu-like Syndromes; Gastroenteritis,na,TERMINATED,Danone Global Research & Innovation Center,
NCT01315418,2-Non fermented dairy product (control),OTHER,Upper Respiratory Tract Infections; Rhinopharyngitis; Sore Throat; Sinusitis; Otitis; Lower Respiratory Tract Infections; Bronchitis; Pneumopathy; Flu; Flu-like Syndromes; Gastroenteritis,na,TERMINATED,Danone Global Research & Innovation Center,
NCT00381810,Rituximab,DRUG,"Lupus Erythematosus, Systemic",phase3,TERMINATED,"Genentech, Inc.",
NCT00381810,Methylprednisolone,DRUG,"Lupus Erythematosus, Systemic",phase3,TERMINATED,"Genentech, Inc.",
NCT00381810,Acetaminophen,DRUG,"Lupus Erythematosus, Systemic",phase3,TERMINATED,"Genentech, Inc.",
NCT00381810,Diphenhydramine,DRUG,"Lupus Erythematosus, Systemic",phase3,TERMINATED,"Genentech, Inc.",
NCT03481413,Ablation,DEVICE,Arrythmia,na,TERMINATED,"EPD Solutions, A Philips Company",
NCT02229760,Tipranavir capsules,DRUG,HIV Infections,phase1; phase2,TERMINATED,Boehringer Ingelheim,
NCT02229760,Ritonavir capsules,DRUG,HIV Infections,phase1; phase2,TERMINATED,Boehringer Ingelheim,
NCT03849820,Robotic-assisted partial nephrectomy,DEVICE,Renal Cancer,na,TERMINATED,Intuitive Surgical,
NCT03849820,Open partial nephrectomy,OTHER,Renal Cancer,na,TERMINATED,Intuitive Surgical,
NCT00594620,Flav-ein capsules,OTHER,Prostate Cancer,phase2,TERMINATED,University of Kansas Medical Center,
NCT00594620,Placebo,DRUG,Prostate Cancer,phase2,TERMINATED,University of Kansas Medical Center,
NCT03969420,Alvocidib (flavopiridol) and cytarabine (Ara-C),DRUG,Acute Myeloid Leukemia (AML),phase2,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT03969420,Alvocidib (flavopiridol),DRUG,Acute Myeloid Leukemia (AML),phase2,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT04945824,Dexamethasone Ophthalmic,DRUG,Healthy,early_phase1,TERMINATED,"Ocular Therapeutix, Inc.",
NCT04945824,Dilator,DEVICE,Healthy,early_phase1,TERMINATED,"Ocular Therapeutix, Inc.",
NCT01228994,Baclofen 30 mg/day,DRUG,Nicotine Dependence,phase2,TERMINATED,Centre for Addiction and Mental Health,
NCT01228994,placebo pill,DRUG,Nicotine Dependence,phase2,TERMINATED,Centre for Addiction and Mental Health,
NCT01228994,Baclofen 60 mg/day,DRUG,Nicotine Dependence,phase2,TERMINATED,Centre for Addiction and Mental Health,
NCT05237531,Standardized Preoperative Education,BEHAVIORAL,Distal Radius Fracture,na,TERMINATED,Emory University,
NCT05237531,Standard of care,BEHAVIORAL,Distal Radius Fracture,na,TERMINATED,Emory University,
NCT05237531,Preoperative and postoperative questionnaires,BEHAVIORAL,Distal Radius Fracture,na,TERMINATED,Emory University,
NCT02352831,Tosedostat,DRUG,Pancreatic Cancer; Cancer of Pancreas; Cancer of the Pancreas; Pancreas Cancer,phase1; phase2,TERMINATED,Washington University School of Medicine,
NCT02352831,Capecitabine,DRUG,Pancreatic Cancer; Cancer of Pancreas; Cancer of the Pancreas; Pancreas Cancer,phase1; phase2,TERMINATED,Washington University School of Medicine,
NCT02352831,Fresh tissue biopsy,PROCEDURE,Pancreatic Cancer; Cancer of Pancreas; Cancer of the Pancreas; Pancreas Cancer,phase1; phase2,TERMINATED,Washington University School of Medicine,
NCT03715153,BUMETANIDE (S95008) for week 0 - 26,DRUG,Autism Spectrum Disorder (ASD),phase3,TERMINATED,Institut de Recherches Internationales Servier,
NCT03715153,PLACEBO for week 0 - 26,DRUG,Autism Spectrum Disorder (ASD),phase3,TERMINATED,Institut de Recherches Internationales Servier,
NCT03715153,Open-Label BUMETANIDE (S95008) for weeks 26 - 52,DRUG,Autism Spectrum Disorder (ASD),phase3,TERMINATED,Institut de Recherches Internationales Servier,
NCT04051853,Sorafenib,DRUG,BCLC Stage C HCC; CP-B Liver Cirrhosis,phase2,TERMINATED,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),
NCT04051853,Midazolam clearance test,OTHER,BCLC Stage C HCC; CP-B Liver Cirrhosis,phase2,TERMINATED,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),
NCT04051853,CYP cocktail clearance test,OTHER,BCLC Stage C HCC; CP-B Liver Cirrhosis,phase2,TERMINATED,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),
NCT05198375,Lung ultrasound score (LUS),OTHER,"Respiratory Distress Syndrome, Newborn",na,TERMINATED,Azienda Ospedaliero-Universitaria Careggi,
NCT03345901,Pemafibrate,DRUG,Diabetic Retinopathy; Diabetic Macular Edema,phase3,TERMINATED,Jaeb Center for Health Research,
NCT03345901,Placebo,DRUG,Diabetic Retinopathy; Diabetic Macular Edema,phase3,TERMINATED,Jaeb Center for Health Research,
NCT02864940,Lumosity,DEVICE,Ruptured Aneurysm; Memory Deficits; Subarachnoid Hemorrhage,na,TERMINATED,Rush University Medical Center,
NCT02864940,Crossword puzzle,DEVICE,Ruptured Aneurysm; Memory Deficits; Subarachnoid Hemorrhage,na,TERMINATED,Rush University Medical Center,
NCT00955240,cetuximab,BIOLOGICAL,Anal Cancer,phase2,TERMINATED,UNICANCER,
NCT00955240,cisplatin,DRUG,Anal Cancer,phase2,TERMINATED,UNICANCER,
NCT00955240,fluorouracil,DRUG,Anal Cancer,phase2,TERMINATED,UNICANCER,
NCT00955240,laboratory biomarker analysis,OTHER,Anal Cancer,phase2,TERMINATED,UNICANCER,
NCT00955240,radiation therapy,RADIATION,Anal Cancer,phase2,TERMINATED,UNICANCER,
NCT02053350,Alanyl-glutamine,DRUG,Clostridium Difficile Infection,phase2,TERMINATED,University of Virginia,
NCT01520350,Low dose Adjunctive Aripiprazole,DRUG,Bipolar Disorder; Depressive Episode,phase3,TERMINATED,Serge Beaulieu,
NCT01520350,placebo,DRUG,Bipolar Disorder; Depressive Episode,phase3,TERMINATED,Serge Beaulieu,
NCT05854290,CRT,BEHAVIORAL,Mild Cognitive Impairment,na,TERMINATED,University of Michigan,
NCT05854290,CBT,BEHAVIORAL,Mild Cognitive Impairment,na,TERMINATED,University of Michigan,
NCT05854290,Modifiable lifestyle factors,BEHAVIORAL,Mild Cognitive Impairment,na,TERMINATED,University of Michigan,
NCT05854290,Usual care Psychoeducation,BEHAVIORAL,Mild Cognitive Impairment,na,TERMINATED,University of Michigan,
NCT00923390,2G-1 TCR Retroviral Vector-Transduced lyn,OTHER,Renal Cancer; Kidney Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00923390,Aldesleukin,DRUG,Renal Cancer; Kidney Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00923390,Cyclophosphamide,DRUG,Renal Cancer; Kidney Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00923390,Fludarabine,DRUG,Renal Cancer; Kidney Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00923390,(PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte,DRUG,Renal Cancer; Kidney Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00416910,Filgrastim,BIOLOGICAL,Chronic Lymphocytic Leukemia,phase3,TERMINATED,German CLL Study Group,
NCT00416910,Fludarabine,DRUG,Chronic Lymphocytic Leukemia,phase3,TERMINATED,German CLL Study Group,
NCT00416910,Cyclophosphamide,DRUG,Chronic Lymphocytic Leukemia,phase3,TERMINATED,German CLL Study Group,
NCT00416910,Mitoxantrone,DRUG,Chronic Lymphocytic Leukemia,phase3,TERMINATED,German CLL Study Group,
NCT01602679,oral micronized progesterone suspension,DRUG,Female Reproductive Physiology,phase1,TERMINATED,University of Virginia,
NCT01602679,Placebo,DRUG,Female Reproductive Physiology,phase1,TERMINATED,University of Virginia,
NCT00118196,arsenic trioxide,DRUG,Leukemia; Myelodysplastic Syndromes,phase2,TERMINATED,Medical University of South Carolina,
NCT00118196,azacitidine,DRUG,Leukemia; Myelodysplastic Syndromes,phase2,TERMINATED,Medical University of South Carolina,
NCT02524288,ENG-E2 125 μg/300 μg vaginal ring,DRUG,Contraception,phase3,TERMINATED,Organon and Co,
NCT02631603,Placebo,DRUG,Hypersensitivity Pneumonitis; Exogenous Allergic Alveolitis,phase2,TERMINATED,Matthias Griese,
NCT02631603,Prednisolone,DRUG,Hypersensitivity Pneumonitis; Exogenous Allergic Alveolitis,phase2,TERMINATED,Matthias Griese,
NCT00950027,povidone iodine,DRUG,Ventilator Associated Pneumonia,phase3,TERMINATED,Rennes University Hospital,
NCT00950027,Placebo,DRUG,Ventilator Associated Pneumonia,phase3,TERMINATED,Rennes University Hospital,
NCT01540227,Regular Treatment for Syphilis,DRUG,Syphilis; Primary Syphilis; Secondary Syphilis; Early-Latent Syphilis,na,TERMINATED,Ottawa Hospital Research Institute,
NCT02862873,Spinal anaesthesia,PROCEDURE,Hypotension,na,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT02862873,Ondansetron,DRUG,Hypotension,na,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT02862873,saline solution,OTHER,Hypotension,na,TERMINATED,Centre Hospitalier Universitaire Dijon,
NCT00636441,Doxorubicin/Cyclophosphamide (AC) or Docetaxel/Cyclophosphamide (TC),DRUG,Early-Stage Breast Cancer,phase2,TERMINATED,Duke University,
NCT00928941,cognitive training,BEHAVIORAL,Post-Traumatic Stress Disorder,na,TERMINATED,US Department of Veterans Affairs,
NCT00928941,video game,BEHAVIORAL,Post-Traumatic Stress Disorder,na,TERMINATED,US Department of Veterans Affairs,
NCT03805841,tarloxotinib bromide,DRUG,"NSCLC, Stage IV; NSCLC Stage IIIB; NSCLC, Stage IIIC; NSCLC, Recurrent; EGFR Exon 20 Insertion Mutation; HER2-activating Mutation; ERBB Fusion; NRG1 Fusion",phase2,TERMINATED,Rain Oncology Inc,
NCT00582166,Ibritumomab Tiuxetan (Zevalin) + Rituximab,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT04396366,QBW251,DRUG,Bronchiectasis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT04396366,Placebo,DRUG,Bronchiectasis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02540629,"Bundled EMS CPR approach including dispatcher-assisted CPR, 3-person team CPR, and feedback CPR monitoring device",PROCEDURE,Out-of-Hospital Cardiac Arrest,na,TERMINATED,Seoul National University Hospital,
NCT00122629,peg-interferon alfa-2b,DRUG,"Hepatitis C, Chronic",phase3,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00122629,ribavirin,DRUG,"Hepatitis C, Chronic",phase3,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00122629,amantadine,DRUG,"Hepatitis C, Chronic",phase3,TERMINATED,French National Agency for Research on AIDS and Viral Hepatitis,
NCT00546949,Minimal invasive decompression,PROCEDURE,Lumbar Spinal Stenosis; Radiculopathy,na,TERMINATED,Norwegian University of Science and Technology,
NCT00546949,Interspinous Process Decompression (IPD),PROCEDURE,Lumbar Spinal Stenosis; Radiculopathy,na,TERMINATED,Norwegian University of Science and Technology,
NCT02817347,piperacillin 4% + tazobactam 0.5% + dexamethasone 0.1%,DRUG,Otitis Media; Otorrhea,phase1; phase2,TERMINATED,Yuhan Corporation,
NCT02817347,piperacillin 8% + tazobactam 1.0% + dexamethasone 0.1%,DRUG,Otitis Media; Otorrhea,phase1; phase2,TERMINATED,Yuhan Corporation,
NCT02817347,piperacillin 2% + tazobactam 0.25%,DRUG,Otitis Media; Otorrhea,phase1; phase2,TERMINATED,Yuhan Corporation,
NCT02817347,piperacillin 4% + tazobactam 0.5%,DRUG,Otitis Media; Otorrhea,phase1; phase2,TERMINATED,Yuhan Corporation,
NCT02817347,piperacillin 8% + tazobactam 1.0%,DRUG,Otitis Media; Otorrhea,phase1; phase2,TERMINATED,Yuhan Corporation,
NCT03774238,FMD analysis,OTHER,COPD Patients; Healthy,na,TERMINATED,"University Hospital, Montpellier",
NCT00601848,chemotherapy,DRUG,Lung Cancer; Metastatic Cancer,phase2,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT00601848,porfimer sodium,DRUG,Lung Cancer; Metastatic Cancer,phase2,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT00601848,immunohistochemistry staining method,OTHER,Lung Cancer; Metastatic Cancer,phase2,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT00601848,laboratory biomarker analysis,OTHER,Lung Cancer; Metastatic Cancer,phase2,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT00601848,spectroscopy,PROCEDURE,Lung Cancer; Metastatic Cancer,phase2,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT00601848,therapeutic conventional surgery,PROCEDURE,Lung Cancer; Metastatic Cancer,phase2,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT00734526,Temozolomide,DRUG,Glioblastoma; Gliosarcoma,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT00734526,Radiation,RADIATION,Glioblastoma; Gliosarcoma,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT00734526,Sorafenib,DRUG,Glioblastoma; Gliosarcoma,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT04290455,Microblepharoexfoliative procedure with BlephEx™,DEVICE,Anterior Blepharitis,na,TERMINATED,"University of California, Los Angeles",
NCT04290455,Eyelid cleansing with eyelid wipes (Optase),PROCEDURE,Anterior Blepharitis,na,TERMINATED,"University of California, Los Angeles",
NCT04290455,Daily eyelid cleansing with eyelid wipes (Optase),PROCEDURE,Anterior Blepharitis,na,TERMINATED,"University of California, Los Angeles",
NCT05247658,Therapeutic lens alone,OTHER,Myopia; Astigmatism; Hypermetropia,phase3,TERMINATED,TBF Genie Tissulaire,
NCT05247658,Therapeutic lens + amniotic membrane (Visio-AMTRIX),OTHER,Myopia; Astigmatism; Hypermetropia,phase3,TERMINATED,TBF Genie Tissulaire,
NCT03880955,ReUnion RSA System,DEVICE,Shoulder Arthroplasty,na,TERMINATED,Stryker Trauma and Extremities,
NCT02780479,Dexamethasone,DRUG,Asthma; Status Asthmaticus; Wheezes,phase4,TERMINATED,University of Florida,
NCT02780479,Prednisone,DRUG,Asthma; Status Asthmaticus; Wheezes,phase4,TERMINATED,University of Florida,
NCT00065559,celecoxib,DRUG,Diabetic Nephropathy,na,TERMINATED,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
NCT03558984,D-PLEX,DRUG,Surgical Site Infection; Sternal Infection; Cardiac Surgery,phase3,TERMINATED,PolyPid Ltd.,
NCT03558984,Standard of Care,OTHER,Surgical Site Infection; Sternal Infection; Cardiac Surgery,phase3,TERMINATED,PolyPid Ltd.,
NCT00143247,Exubera® (inhaled insulin),DRUG,Diabetes Mellitus,phase2,TERMINATED,Pfizer,
NCT00762047,Durasphere FI,DEVICE,Fecal Incontinence,phase2,TERMINATED,Carbon Medical Technologies,
NCT00762047,Sham,DEVICE,Fecal Incontinence,phase2,TERMINATED,Carbon Medical Technologies,
NCT04944758,Light therapy,DEVICE,Major Depression in Remission,na,TERMINATED,University of British Columbia,
NCT03483948,HMPL-523,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Hutchison Medipharma Limited,
NCT03483948,Azacitidine,DRUG,Acute Myeloid Leukemia,phase1,TERMINATED,Hutchison Medipharma Limited,
NCT05866926,FAB122,DRUG,Amyotrophic Lateral Sclerosis,phase3,TERMINATED,Ferrer Internacional S.A.,
NCT00273026,salmeterol xinafoate/fluticasone propionate,DRUG,Asthma,phase4,TERMINATED,GlaxoSmithKline,
NCT04343755,Convalescent Plasma,BIOLOGICAL,COVID-19,phase2,TERMINATED,Hackensack Meridian Health,
NCT00343655,Atorvastatin,DRUG,Cardiovascular Diseases,phase3,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT00636155,cenersen sodium,DRUG,"Lymphoma, Small Lymphocytic; Leukemia, Lymphocytic, Chronic",phase2,TERMINATED,David Rizzieri,
NCT00636155,Rituximab,DRUG,"Lymphoma, Small Lymphocytic; Leukemia, Lymphocytic, Chronic",phase2,TERMINATED,David Rizzieri,
NCT00636155,Cyclophosphamide,DRUG,"Lymphoma, Small Lymphocytic; Leukemia, Lymphocytic, Chronic",phase2,TERMINATED,David Rizzieri,
NCT00636155,Fludarabine,DRUG,"Lymphoma, Small Lymphocytic; Leukemia, Lymphocytic, Chronic",phase2,TERMINATED,David Rizzieri,
NCT05517226,Cotadutide,OTHER,Hepatic Impairment,phase1,TERMINATED,AstraZeneca,
NCT04218448,Hypnorelaxation,OTHER,Neuropathy;Peripheral,na,TERMINATED,Fondation Hôpital Saint-Joseph,
NCT01416948,Methylphenidate Hydrochloride 20 mg,DRUG,Posttraumatic Stress Disorder; Traumatic Brain Injury,phase2,TERMINATED,"INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium",
NCT01416948,Placebo Capsule,DRUG,Posttraumatic Stress Disorder; Traumatic Brain Injury,phase2,TERMINATED,"INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium",
NCT01416948,Galantamine 12 mg,DRUG,Posttraumatic Stress Disorder; Traumatic Brain Injury,phase2,TERMINATED,"INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium",
NCT01641926,PEG-Intron™,BIOLOGICAL,"Hepatitis B, Chronic",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT01641926,PEGASYS™,BIOLOGICAL,"Hepatitis B, Chronic",phase3,TERMINATED,Merck Sharp & Dohme LLC,
NCT04273048,Diet Intervention - Group 1,OTHER,"Infertility, Female",na,TERMINATED,Arkansas Children's Hospital Research Institute,
NCT04273048,Exercise Intervention - Group 1,OTHER,"Infertility, Female",na,TERMINATED,Arkansas Children's Hospital Research Institute,
NCT00448448,Brace,DEVICE,Adolescent Idiopathic Scoliosis,na,TERMINATED,"Stuart L. Weinstein, MD",
NCT00448448,Observation,OTHER,Adolescent Idiopathic Scoliosis,na,TERMINATED,"Stuart L. Weinstein, MD",
NCT05384548,Problematic smart phone use course,BEHAVIORAL,"Addiction, Smartphone",na,TERMINATED,Canterbury Christ Church University,
NCT02196259,"Anesthetics, Dissociative",DRUG,Changes in Brain Network Connectivity,na,TERMINATED,University of Michigan,
NCT02042703,anterior segment OCT,DEVICE,Exfoliation Syndrome; Primary Open Angle Glaucoma; Cataracts,na,TERMINATED,Duke University,
NCT02770703,DynaMesh visible mesh,DEVICE,Unilateral Simple Inguinal Hernia,na,TERMINATED,"University Hospital, Basel, Switzerland",
NCT04855227,robotic-assisted ventral hernia repair,PROCEDURE,Ventral Hernia,na,TERMINATED,Intuitive Surgical,
NCT04697069,Imsidolimab,BIOLOGICAL,Acneiform Eruptions,phase2,TERMINATED,Vanda Pharmaceuticals,
NCT04697069,Placebo,BIOLOGICAL,Acneiform Eruptions,phase2,TERMINATED,Vanda Pharmaceuticals,
NCT01345669,Placebo,DRUG,Head and Neck Neoplasms,phase3,TERMINATED,Boehringer Ingelheim,
NCT01345669,Afatinib,DRUG,Head and Neck Neoplasms,phase3,TERMINATED,Boehringer Ingelheim,
NCT04794569,tinzaparin,DRUG,Deep Vein Thrombosis; Post Thrombotic Syndrome,phase4,TERMINATED,Sunnybrook Health Sciences Centre,
NCT04794569,Rivaroxaban,DRUG,Deep Vein Thrombosis; Post Thrombotic Syndrome,phase4,TERMINATED,Sunnybrook Health Sciences Centre,
NCT00700154,Insulin infusion,PROCEDURE,Diabetes Mellitus; Insulin Resistance; Hyperglycemia; Surgery; Ulcers; Infection,na,TERMINATED,Karolinska Institutet,
NCT00164905,Doppler ultrasound probe,DEVICE,Peptic Ulcer Hemorrhage,na,TERMINATED,Chinese University of Hong Kong,
NCT01666405,Urgent(R) PC Neuromodulation System,DEVICE,Fecal Incontinence,phase1,TERMINATED,"Uroplasty, Inc",
NCT01975194,Rosuvastatin,DRUG,Stroke; Transient Ischemic Attack,phase4,TERMINATED,Wayne State University,
NCT00123266,Microplasmin,DRUG,Stroke,phase2,TERMINATED,ThromboGenics,
NCT01015456,mycophenolate sodium,DRUG,Lupus Nephritis,phase3,TERMINATED,Chulalongkorn University,
NCT01015456,cyclophosphamide,DRUG,Lupus Nephritis,phase3,TERMINATED,Chulalongkorn University,
NCT01744522,Leech therapy,PROCEDURE,Postherpetic Neuralgia,na,TERMINATED,Universität Duisburg-Essen,
NCT01400451,Ipilimumab (BMS-734016),DRUG,Melanoma,phase1,TERMINATED,Bristol-Myers Squibb,
NCT01400451,Vemurafenib,DRUG,Melanoma,phase1,TERMINATED,Bristol-Myers Squibb,
NCT03221751,prazosin hydrochloride,DRUG,Dementia,phase4,TERMINATED,VA Office of Research and Development,
NCT03221751,placebo,DRUG,Dementia,phase4,TERMINATED,VA Office of Research and Development,
NCT02718131,INFUSE Bone Graft (BMP-2),DEVICE,NF1; Congenital Pseudarthrosis of Tibia,na,TERMINATED,University of Alabama at Birmingham,
NCT02718131,Control Group,PROCEDURE,NF1; Congenital Pseudarthrosis of Tibia,na,TERMINATED,University of Alabama at Birmingham,
NCT00101231,alvocidib,DRUG,Adult Acute Basophilic Leukemia; Adult Acute Eosinophilic Leukemia; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leuk,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00454402,Alfuzosin,DRUG,Prostatic Hyperplasia,phase3,TERMINATED,Sanofi,
NCT00177853,celecoxib,DRUG,Pancreatic Cancer,phase1,TERMINATED,University of Pittsburgh,
NCT00177853,irinotecan,DRUG,Pancreatic Cancer,phase1,TERMINATED,University of Pittsburgh,
NCT00177853,concurrent radiotherapy,PROCEDURE,Pancreatic Cancer,phase1,TERMINATED,University of Pittsburgh,
NCT00961753,optimized ibuprofen,DRUG,Patent Ductus Arteriosus,phase4,TERMINATED,OSF Healthcare System,
NCT00961753,Standard Ibuprofen,DRUG,Patent Ductus Arteriosus,phase4,TERMINATED,OSF Healthcare System,
NCT00482053,Autologous hematopoietic stem cell transplantation (auto-HSCT),PROCEDURE,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Allogeneic hematopoietic stem cell transplantation (allo-HSCT),PROCEDURE,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Total lymphoid irradiation (TLI),PROCEDURE,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Rituximab,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Carmustine,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Etoposide,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Filgrastim,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Anti-thymocyte globulin (ATG),DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Cyclosporine,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Mycophenolate mofetil (MMF),DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Cyclophosphamide,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Acetaminophen,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Diphenhydramine,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Hydrocortisone,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT00482053,Methylprednisolone,DRUG,"Lymphoma, B-cell; Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma (DLBCL); Malignant Lymphoma, Non-Hodgkin",phase2,TERMINATED,Stanford University,
NCT06506045,FlowSense,DEVICE,Hydrocephalus,na,TERMINATED,"Rhaeos, Inc.",
NCT01323595,Celecoxib,DRUG,Pain,na,TERMINATED,Weill Medical College of Cornell University,
NCT01323595,Sugar Pill,DRUG,Pain,na,TERMINATED,Weill Medical College of Cornell University,
NCT01385839,Hair transplantation,PROCEDURE,Alopecia Areata; Alopecia; Balding,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT01385839,Hypodermic needle irritation,PROCEDURE,Alopecia Areata; Alopecia; Balding,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT03300362,Seasonal influenza vaccine,DRUG,Influenza,phase2,TERMINATED,Barinthus Biotherapeutics,
NCT03300362,MVA-NP+M1,DRUG,Influenza,phase2,TERMINATED,Barinthus Biotherapeutics,
NCT03300362,Sodium chloride,DRUG,Influenza,phase2,TERMINATED,Barinthus Biotherapeutics,
NCT02405442,Andecaliximab,DRUG,Crohn's Disease,phase2,TERMINATED,Gilead Sciences,
NCT02405442,Placebo,DRUG,Crohn's Disease,phase2,TERMINATED,Gilead Sciences,
NCT01542242,Liraglutide,DRUG,Diabetes Mellitus Type 2; Prader Willi Syndrome,phase4,TERMINATED,Vancouver General Hospital,
NCT00850473,PET/CT,OTHER,Myocardial Infarction; Coronary Artery Disease; Cardiac Catheterization,na,TERMINATED,Washington University School of Medicine,
NCT00427973,cediranib maleate,DRUG,Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer; Recurrent Adult Primary Liver Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00427973,laboratory biomarker analysis,OTHER,Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer; Recurrent Adult Primary Liver Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00427973,computed tomography,PROCEDURE,Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer; Recurrent Adult Primary Liver Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00427973,dynamic contrast-enhanced magnetic resonance imaging,PROCEDURE,Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer; Recurrent Adult Primary Liver Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00427973,pharmacological study,OTHER,Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer; Recurrent Adult Primary Liver Cancer,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01202773,LY2127399,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Eli Lilly and Company,
NCT01202773,Placebo Q4W,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Eli Lilly and Company,
NCT01202773,Placebo Q2W,DRUG,Rheumatoid Arthritis,phase3,TERMINATED,Eli Lilly and Company,
NCT02262169,Omeprazole,DRUG,Non-Bleeding Peptic Ulcers,phase3,TERMINATED,Dexa Medica Group,
NCT02262169,Placebo caplet of DLBS2411,DRUG,Non-Bleeding Peptic Ulcers,phase3,TERMINATED,Dexa Medica Group,
NCT02262169,DLBS2411,DRUG,Non-Bleeding Peptic Ulcers,phase3,TERMINATED,Dexa Medica Group,
NCT02262169,Placebo capsule of Omeprazole,DRUG,Non-Bleeding Peptic Ulcers,phase3,TERMINATED,Dexa Medica Group,
NCT00252369,Infliximab,DRUG,Crohn's Disease,na,TERMINATED,Sheba Medical Center,
NCT00252369,Instillation of fibrin glue,PROCEDURE,Crohn's Disease,na,TERMINATED,Sheba Medical Center,
NCT01110083,EMD 1204831,DRUG,Solid Tumors,phase1,TERMINATED,EMD Serono,
NCT00616954,ATG-F,DRUG,Allogeneic Haplo-Stem Cell Transplatation (SCT); Graft Versus Host Disease,phase3,TERMINATED,Hadassah Medical Organization,
NCT04308954,[18F]flumazenil,DRUG,Fragile X Syndrome (FXS); Idiopathic Intellectual Developmental Disorder (IDD),phase1,TERMINATED,Stanford University,
NCT01266005,Clevudine,DRUG,Chronic Hepatitis B,phase4,TERMINATED,Bukwang Pharmaceutical,
NCT01266005,Entecavir,DRUG,Chronic Hepatitis B,phase4,TERMINATED,Bukwang Pharmaceutical,
NCT01590394,Large plastic biliary stent,DEVICE,Stricture; Obstruction; Cancer,na,TERMINATED,Mayo Clinic,
NCT00519194,Epicor LP Cardiac Ablation System,DEVICE,Atrial Fibrillation,na,TERMINATED,Abbott Medical Devices,
NCT00519194,Surgical ablation of permanent AF,PROCEDURE,Atrial Fibrillation,na,TERMINATED,Abbott Medical Devices,
NCT04858594,Planned Chemotherapy,OTHER,Acute Myeloid Leukemia,na,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT01381666,INS316 solution for inhalation,DRUG,Interstitial Lung Disease,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01381666,hypertonic saline 3% sodium chloride solution,DRUG,Interstitial Lung Disease,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT00886366,AZD6714,DRUG,Type 2 Diabetes,phase1,TERMINATED,AstraZeneca,
NCT00886366,Placebo,DRUG,Type 2 Diabetes,phase1,TERMINATED,AstraZeneca,
NCT00886366,AZD6714,DRUG,Type 2 Diabetes,phase1,TERMINATED,AstraZeneca,
NCT00886366,AZD6714,DRUG,Type 2 Diabetes,phase1,TERMINATED,AstraZeneca,
NCT00410566,rhASM,DRUG,Acid Sphingomyelinase Deficiency; Niemann-Pick Disease,phase1,TERMINATED,"Genzyme, a Sanofi Company",
NCT00410566,rhASM,DRUG,Acid Sphingomyelinase Deficiency; Niemann-Pick Disease,phase1,TERMINATED,"Genzyme, a Sanofi Company",
NCT00410566,rhASM,DRUG,Acid Sphingomyelinase Deficiency; Niemann-Pick Disease,phase1,TERMINATED,"Genzyme, a Sanofi Company",
NCT00410566,rhASM,DRUG,Acid Sphingomyelinase Deficiency; Niemann-Pick Disease,phase1,TERMINATED,"Genzyme, a Sanofi Company",
NCT00410566,rhASM,DRUG,Acid Sphingomyelinase Deficiency; Niemann-Pick Disease,phase1,TERMINATED,"Genzyme, a Sanofi Company",
NCT03802656,Anterior Vertebral Body Tethering,DEVICE,Scoliosis; Spinal Curvatures; Spinal Diseases; Bone Diseases; Musculoskeletal Disease; Adolescent Idiopathic Scoliosis; Juvenile; Scoliosis,na,TERMINATED,Ochsner Health System,
NCT01895829,Magnetic Resonance Imaging (MRI),PROCEDURE,Head and Neck Cancer,early_phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT01895829,Ferumoxytol,DRUG,Head and Neck Cancer,early_phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT04326231,Usability assessment of Cognoa ASD Therapeutic Device,DEVICE,Autism Spectrum Disorder,na,TERMINATED,"Cognoa, Inc.",
NCT02343302,Jackson-Pratt Drain,DEVICE,Pancreatic Fistula,na,TERMINATED,Johns Hopkins University,
NCT02343302,Non-suctioning drainage,DEVICE,Pancreatic Fistula,na,TERMINATED,Johns Hopkins University,
NCT00429702,Decadron®,DRUG,"Nausea; Vomiting; Unspecified Childhood Solid Tumor, Protocol Specific",phase2,TERMINATED,University of South Florida,
NCT00429702,Benadryl®,DRUG,"Nausea; Vomiting; Unspecified Childhood Solid Tumor, Protocol Specific",phase2,TERMINATED,University of South Florida,
NCT00429702,Ativan®,DRUG,"Nausea; Vomiting; Unspecified Childhood Solid Tumor, Protocol Specific",phase2,TERMINATED,University of South Florida,
NCT00429702,ondansetron hydrochloride,DRUG,"Nausea; Vomiting; Unspecified Childhood Solid Tumor, Protocol Specific",phase2,TERMINATED,University of South Florida,
NCT01563653,4 diagnostic tests for surgical success,PROCEDURE,"Urinary Incontinence, Stress",na,TERMINATED,Centre Hospitalier Universitaire de Nīmes,
NCT01343537,Neuro Monitoring,OTHER,Cerebral Vasospasm; SAH; Aneurysm,early_phase1,TERMINATED,State University of New York - Upstate Medical University,
NCT05888337,Contoura LASIK with Phorcides planning strategy,DEVICE,Myopia; Astigmatism,na,TERMINATED,Bismarck Lasik,
NCT05888337,Contoura LASIK with manifest refraction planning strategy,DEVICE,Myopia; Astigmatism,na,TERMINATED,Bismarck Lasik,
NCT05492045,D-1553,DRUG,NSCLC,phase1; phase2,TERMINATED,"InventisBio Co., Ltd",
NCT05492045,Other,DRUG,NSCLC,phase1; phase2,TERMINATED,"InventisBio Co., Ltd",
NCT03681301,virtual reality simulator,OTHER,Medical Education,na,TERMINATED,Yonsei University,
NCT00610701,Anterior pin placement,DEVICE,"Fractures, Closed",na,TERMINATED,University of Missouri-Columbia,
NCT00610701,Lateral pin placement,DEVICE,"Fractures, Closed",na,TERMINATED,University of Missouri-Columbia,
NCT03539757,Non-Contrast Magnetic Resonance Imaging,DEVICE,Liver Fibrosis,na,TERMINATED,"Children's Hospital Medical Center, Cincinnati",
NCT02960191,Magnetic resonance imaging (MRI),DEVICE,Suicidal Behavior,na,TERMINATED,"University Hospital, Montpellier",
NCT03965091,Fremanezumab,DRUG,Fibromyalgia,phase2,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT03965091,Placebo,DRUG,Fibromyalgia,phase2,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT02809118,AM-111 0.4 mg/ml,DRUG,"Hearing Loss, Idiopathic Sudden Sensorineural",phase3,TERMINATED,"Auris Medical, Inc.",
NCT02809118,AM-111 0.8 mg/ml,DRUG,"Hearing Loss, Idiopathic Sudden Sensorineural",phase3,TERMINATED,"Auris Medical, Inc.",
NCT02809118,Placebo,OTHER,"Hearing Loss, Idiopathic Sudden Sensorineural",phase3,TERMINATED,"Auris Medical, Inc.",
NCT03912818,Carboplatin,DRUG,Bladder Adenocarcinoma; Bladder Mixed Adenocarcinoma; Bladder Squamous Cell Carcinoma; Bladder Urothelial Carcinoma; Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant; Infiltrating Bladder,phase2,TERMINATED,Stanford University,
NCT03912818,Cisplatin,DRUG,Bladder Adenocarcinoma; Bladder Mixed Adenocarcinoma; Bladder Squamous Cell Carcinoma; Bladder Urothelial Carcinoma; Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant; Infiltrating Bladder,phase2,TERMINATED,Stanford University,
NCT03912818,Cystectomy,PROCEDURE,Bladder Adenocarcinoma; Bladder Mixed Adenocarcinoma; Bladder Squamous Cell Carcinoma; Bladder Urothelial Carcinoma; Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant; Infiltrating Bladder,phase2,TERMINATED,Stanford University,
NCT03912818,Doxorubicin,DRUG,Bladder Adenocarcinoma; Bladder Mixed Adenocarcinoma; Bladder Squamous Cell Carcinoma; Bladder Urothelial Carcinoma; Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant; Infiltrating Bladder,phase2,TERMINATED,Stanford University,
NCT03912818,Durvalumab,BIOLOGICAL,Bladder Adenocarcinoma; Bladder Mixed Adenocarcinoma; Bladder Squamous Cell Carcinoma; Bladder Urothelial Carcinoma; Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant; Infiltrating Bladder,phase2,TERMINATED,Stanford University,
NCT03912818,Gemcitabine,DRUG,Bladder Adenocarcinoma; Bladder Mixed Adenocarcinoma; Bladder Squamous Cell Carcinoma; Bladder Urothelial Carcinoma; Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant; Infiltrating Bladder,phase2,TERMINATED,Stanford University,
NCT03912818,Methotrexate,DRUG,Bladder Adenocarcinoma; Bladder Mixed Adenocarcinoma; Bladder Squamous Cell Carcinoma; Bladder Urothelial Carcinoma; Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant; Infiltrating Bladder,phase2,TERMINATED,Stanford University,
NCT03912818,Vinblastine,DRUG,Bladder Adenocarcinoma; Bladder Mixed Adenocarcinoma; Bladder Squamous Cell Carcinoma; Bladder Urothelial Carcinoma; Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant; Infiltrating Bladder,phase2,TERMINATED,Stanford University,
NCT02777190,Misoprostol,DRUG,"Labor; Forced or Induced, Affecting Fetus or Newborn; Pregnancy",phase4,TERMINATED,Milton S. Hershey Medical Center,
NCT00178282,Pelvic Floor Muscle exercises,PROCEDURE,Urinary Incontinence,na,TERMINATED,University of Rochester,
NCT02590159,BONGO NASAL EPAP,DEVICE,Obstructive Sleep Apnea,na,TERMINATED,InnoMed Healthscience Inc.,
NCT02716259,Scaling and root planing,PROCEDURE,Periodontitis; Cardiovascular Diseases,na,TERMINATED,Universidad Complutense de Madrid,
NCT02716259,Supragingival prophylaxis,PROCEDURE,Periodontitis; Cardiovascular Diseases,na,TERMINATED,Universidad Complutense de Madrid,
NCT02770820,Aldesleukin,BIOLOGICAL,Acute Myeloid Leukemia; EBV-Positive Neoplastic Cells Present; HLA-A*0201 Positive Cells Present; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Elevated WT1,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT02770820,Autologous WT1-TCRc4 Gene-transduced CD8-positive Tcm/Tn Lymphocytes,BIOLOGICAL,Acute Myeloid Leukemia; EBV-Positive Neoplastic Cells Present; HLA-A*0201 Positive Cells Present; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Elevated WT1,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT02770820,Laboratory Biomarker Analysis,OTHER,Acute Myeloid Leukemia; EBV-Positive Neoplastic Cells Present; HLA-A*0201 Positive Cells Present; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Elevated WT1,phase1; phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT03175523,quantitative coronary angiography guided Bioresorbable scaffold implantation,DEVICE,Coronary Stenosis,na,TERMINATED,Seung-Jung Park,
NCT03175523,imaging guided Bioresorbable scaffold implantation,DEVICE,Coronary Stenosis,na,TERMINATED,Seung-Jung Park,
NCT01943188,stereotactic body radiation therapy,RADIATION,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1,TERMINATED,Stanford University,
NCT01943188,cyclophosphamide,DRUG,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1,TERMINATED,Stanford University,
NCT01943188,therapeutic autologous lymphocytes,BIOLOGICAL,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1,TERMINATED,Stanford University,
NCT01943188,laboratory biomarker analysis,OTHER,Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer,phase1,TERMINATED,Stanford University,
NCT00536003,progesterone,DRUG,Preterm Delivery; Morbidity; Perinatal Mortality,phase3,TERMINATED,begoña Martinez de Tejada,
NCT00536003,placebo,DRUG,Preterm Delivery; Morbidity; Perinatal Mortality,phase3,TERMINATED,begoña Martinez de Tejada,
NCT03548870,CWRT with low frequency transcutaneous electrical nerve stimulation,OTHER,COPD; Physical Activity; Rehabilitation; TEN,na,TERMINATED,Groupe Hospitalier du Havre,
NCT03548870,CWRT with sham-low frequency transcutaneous electrical nerve stimulation,OTHER,COPD; Physical Activity; Rehabilitation; TEN,na,TERMINATED,Groupe Hospitalier du Havre,
NCT01290770,blood sample,OTHER,Atherosclerosis,na,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT02907073,BF4,DRUG,Myeloma; Endometrial Cancer,phase1; phase2,TERMINATED,Mayo Clinic,
NCT03356873,Vitamin D,DRUG,Vitamin D Deficiency; Glucose Intolerance; Oxidative Stress; Insulin Resistance,na,TERMINATED,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,
NCT03356873,Placebo,OTHER,Vitamin D Deficiency; Glucose Intolerance; Oxidative Stress; Insulin Resistance,na,TERMINATED,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,
NCT00580073,FOLFOX4,DRUG,Rectal Cancer,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT00580073,Cetuximab,DRUG,Rectal Cancer,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT04587869,CBT Coping Intervention,BEHAVIORAL,"Discrimination, Social; Health Care Utilization",na,TERMINATED,RAND,
NCT00976183,Vorinostat,DRUG,Ovarian Neoplasms,phase1; phase2,TERMINATED,Gynecologic Oncology Associates,
NCT00976183,Vorinostat,DRUG,Ovarian Neoplasms,phase1; phase2,TERMINATED,Gynecologic Oncology Associates,
NCT01097083,Coriolus Versicolor,DRUG,Carcinoma; Therapy,phase2,TERMINATED,"National University Hospital, Singapore",
NCT01450683,Itraconazole,DRUG,Prostate Cancer; Prostatic Neoplasms; Castrate-resistant Prostate Cancer (CRPC); Androgen-insensitive Prostate Cancer; Hormone-refractory Prostate Cancer; Metastatic Disease,phase2,TERMINATED,Stanford University,
NCT00744354,bortezomib,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase1,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT00744354,pegylated liposomal doxorubicin hydrochloride,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase1,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT00744354,vorinostat,DRUG,Multiple Myeloma and Plasma Cell Neoplasm,phase1,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT05263505,Baricitinib 2 MG [Olumiant],DRUG,Mucous Membrane Pemphigoid; Cicatrizing Conjunctivitis,phase2,TERMINATED,Washington University School of Medicine,
NCT05263505,Methotrexate,DRUG,Mucous Membrane Pemphigoid; Cicatrizing Conjunctivitis,phase2,TERMINATED,Washington University School of Medicine,
NCT05263505,Azathioprine,DRUG,Mucous Membrane Pemphigoid; Cicatrizing Conjunctivitis,phase2,TERMINATED,Washington University School of Medicine,
NCT05263505,Mycophenolate,DRUG,Mucous Membrane Pemphigoid; Cicatrizing Conjunctivitis,phase2,TERMINATED,Washington University School of Medicine,
NCT05987605,1A46 Drug Substance,DRUG,Advanced Malignancies,phase1,TERMINATED,"BioRay Pharmaceutical Co., Ltd.",
NCT01983566,BI 207127 high fat,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT01983566,BI 207127 with Omeprazole,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT01983566,BI 207127,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT01983566,BI 207127 low fat,DRUG,Healthy,phase1,TERMINATED,Boehringer Ingelheim,
NCT04912856,XEN496,DRUG,Epilepsy; Epilepsy in Children; Epilepsy; Seizure; Disease; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Epileptic Syndromes,phase3,TERMINATED,Xenon Pharmaceuticals Inc.,
NCT00359151,Celecoxib,DRUG,Osteoarthritis; Pain,phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT00359151,Placebo,DRUG,Osteoarthritis; Pain,phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT02840929,Second-look OGD,PROCEDURE,OGD; Gastric Ulcer Induced by Anti-platelet Agent; Duodenal Ulcer Induced by Anti-platelet Agent,na,TERMINATED,The University of Hong Kong,
NCT02840929,Esomeprazole,DRUG,OGD; Gastric Ulcer Induced by Anti-platelet Agent; Duodenal Ulcer Induced by Anti-platelet Agent,na,TERMINATED,The University of Hong Kong,
NCT00005608,leucovorin calcium,DRUG,Breast Cancer,phase2,TERMINATED,Northwestern University,
NCT00005608,tegafur-uracil,DRUG,Breast Cancer,phase2,TERMINATED,Northwestern University,
NCT02678325,Standardized high protein enteral nutrition,OTHER,High Enteral Protein Nutrition; Muscle Breakdown; Autophagy,na,TERMINATED,"University Hospital, Basel, Switzerland",
NCT02678325,Standardized normal protein enteral nutrition,OTHER,High Enteral Protein Nutrition; Muscle Breakdown; Autophagy,na,TERMINATED,"University Hospital, Basel, Switzerland",
NCT02054117,Intracerebral Hemorrhage,OTHER,Intracerebral Hemorrhage,na,TERMINATED,University of Florida,
NCT03945240,Group 1 -- using Pinnacle Series Laser Device,PROCEDURE,Neck Pain,na,TERMINATED,Paul Crawford,
NCT03945240,Group 2 -- using Pinnacle Series Laser Device,PROCEDURE,Neck Pain,na,TERMINATED,Paul Crawford,
NCT03945240,Group 3 -- using Phoenix Thera-Lase Device,PROCEDURE,Neck Pain,na,TERMINATED,Paul Crawford,
NCT04364568,Magnetic Resonance Imaging,RADIATION,Traumatic Brain Injury,na,TERMINATED,"University Hospital, Grenoble",
NCT01050491,sitaxentan,DRUG,Effect of Sitaxsentan on Airway Remodeling in Severe Asthma,phase2,TERMINATED,"Institut National de la Santé Et de la Recherche Médicale, France",
NCT01050491,placebo,DRUG,Effect of Sitaxsentan on Airway Remodeling in Severe Asthma,phase2,TERMINATED,"Institut National de la Santé Et de la Recherche Médicale, France",
NCT03014297,everolimus,DRUG,Neuroendocrine Tumors; Everolimus,phase1,TERMINATED,"Lowell Anthony, MD",
NCT03014297,fosbretabulin,DRUG,Neuroendocrine Tumors; Everolimus,phase1,TERMINATED,"Lowell Anthony, MD",
NCT03521310,Skin-to-skin,PROCEDURE,Prematurity,na,TERMINATED,"Björn Westrup, MD PhD",
NCT03521310,Conventional care,PROCEDURE,Prematurity,na,TERMINATED,"Björn Westrup, MD PhD",
NCT03639610,Melflufen,DRUG,Renal Impairment; Multiple Myeloma,phase2,TERMINATED,Oncopeptides AB,
NCT03639610,Dexamethasone,DRUG,Renal Impairment; Multiple Myeloma,phase2,TERMINATED,Oncopeptides AB,
NCT02165813,Nitazoxanide,DRUG,Gastroenteritis,phase2; phase3,TERMINATED,Telethon Kids Institute,
NCT02165813,placebo,DRUG,Gastroenteritis,phase2; phase3,TERMINATED,Telethon Kids Institute,
NCT00440180,Anastrozole,DRUG,Obesity; Oligospermia,phase3,TERMINATED,University of Utah,
NCT00440180,Placebo,DRUG,Obesity; Oligospermia,phase3,TERMINATED,University of Utah,
NCT05315479,N1539,DRUG,Post Operative Pain,phase4,TERMINATED,Baudax Bio,
NCT01522196,Varespladib,DRUG,Sickle Cell Disease; Vaso-occlusive Crisis,phase2,TERMINATED,Anthera Pharmaceuticals,
NCT01522196,Placebo (Normal Saline),OTHER,Sickle Cell Disease; Vaso-occlusive Crisis,phase2,TERMINATED,Anthera Pharmaceuticals,
NCT05194462,Pericoach® by Analytica,DEVICE,Urinary Incontinence; Pelvic Floor Disorders,na,TERMINATED,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),
NCT05194462,Pelvic Floor Physical Therapy,OTHER,Urinary Incontinence; Pelvic Floor Disorders,na,TERMINATED,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),
NCT00660062,escitalopram,DRUG,Major Depression,phase4,TERMINATED,"Hillerod Hospital, Denmark",
NCT00660062,escitalopram,DRUG,Major Depression,phase4,TERMINATED,"Hillerod Hospital, Denmark",
NCT00660062,escitalopram,DRUG,Major Depression,phase4,TERMINATED,"Hillerod Hospital, Denmark",
NCT00660062,nortriptyline,DRUG,Major Depression,phase4,TERMINATED,"Hillerod Hospital, Denmark",
NCT01708603,210 mg brodalumab,DRUG,Moderate to Severe Plaque Psoriasis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT01708603,140 mg brodalumab,DRUG,Moderate to Severe Plaque Psoriasis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT01708603,ustekinumab,DRUG,Moderate to Severe Plaque Psoriasis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT01708603,placebo,DRUG,Moderate to Severe Plaque Psoriasis,phase3,TERMINATED,"Bausch Health Americas, Inc.",
NCT02450227,Spinach - Whole leaf (10 mg lutein),OTHER,Ileostomy; Functional Disturbance; Healthy,na,TERMINATED,University of Copenhagen,
NCT02450227,Spinach - Minced (10 mg/lutein),OTHER,Ileostomy; Functional Disturbance; Healthy,na,TERMINATED,University of Copenhagen,
NCT01775670,Off-the-shelf splint,DEVICE,Trapeziometacarpal (TMC) Arthrosis,na,TERMINATED,Massachusetts General Hospital,
NCT01775670,OT Splint,DEVICE,Trapeziometacarpal (TMC) Arthrosis,na,TERMINATED,Massachusetts General Hospital,
NCT03412370,Cognitive Assessment,OTHER,Health Status Unknown,na,TERMINATED,University of Southern California,
NCT03412370,Questionnaire Administration,OTHER,Health Status Unknown,na,TERMINATED,University of Southern California,
NCT00800670,Ad5Ag85A,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,McMaster University,
NCT00800670,Ad5Ag85A,BIOLOGICAL,Tuberculosis,phase1,TERMINATED,McMaster University,
NCT03013673,No intervention,OTHER,"Leishmaniasis, Visceral",na,TERMINATED,"Institute of Tropical Medicine, Belgium",
NCT05786469,Veltassa Oral Powder Product,DRUG,Hyperkalemia,phase3,TERMINATED,Mario Negri Institute for Pharmacological Research,
NCT05786469,Placebo,OTHER,Hyperkalemia,phase3,TERMINATED,Mario Negri Institute for Pharmacological Research,
NCT03911869,encorafenib,DRUG,Brain Metastases,phase2,TERMINATED,Pfizer,
NCT03911869,binimetinib,DRUG,Brain Metastases,phase2,TERMINATED,Pfizer,
NCT01897441,Cyclophosphamide,DRUG,Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,na,TERMINATED,Albert Einstein College of Medicine,
NCT01897441,Cytology Specimen Collection Procedure,OTHER,Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,na,TERMINATED,Albert Einstein College of Medicine,
NCT01897441,Doxorubicin Hydrochloride,DRUG,Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,na,TERMINATED,Albert Einstein College of Medicine,
NCT01897441,Laboratory Biomarker Analysis,OTHER,Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,na,TERMINATED,Albert Einstein College of Medicine,
NCT01897441,Paclitaxel,DRUG,Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,na,TERMINATED,Albert Einstein College of Medicine,
NCT01897441,Trastuzumab,BIOLOGICAL,Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,na,TERMINATED,Albert Einstein College of Medicine,
NCT01897441,Endocrine therapy,DRUG,Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer,na,TERMINATED,Albert Einstein College of Medicine,
NCT06347666,Caregiver coaching,BEHAVIORAL,Developmental Delay,na,TERMINATED,Rush University Medical Center,
NCT04454190,Collection of genetic material,OTHER,"Glaucoma; Primary Open Angle Glaucoma; Glaucoma, Suspect",na,TERMINATED,Duke University,
NCT04090697,Oxandrolone,DRUG,Hypoplastic Left Heart; Congenital Heart Disease,phase1; phase2,TERMINATED,Carelon Research,
NCT01372813,vandetanib,DRUG,Advanced Clear Cell Renal Carcinoma,phase2,TERMINATED,National Cancer Institute (NCI),
NCT04295720,Transcranial magnetic stimulation (TMS),DEVICE,Chemo-brain,na,TERMINATED,University of Arizona,
NCT03404713,Pathways to Health,BEHAVIORAL,"Overweight and Obesity; Pediatric Obesity; Eating, Binge",na,TERMINATED,Virginia Commonwealth University,
NCT03404713,Be4U,BEHAVIORAL,"Overweight and Obesity; Pediatric Obesity; Eating, Binge",na,TERMINATED,Virginia Commonwealth University,
NCT02412124,Supportive Care,PROCEDURE,Cervical Carcinoma; Ovarian Carcinoma; Uterine Corpus Cancer; Vaginal Carcinoma; Vulvar Carcinoma,na,TERMINATED,City of Hope Medical Center,
NCT02412124,Quality-of-Life Assessment,OTHER,Cervical Carcinoma; Ovarian Carcinoma; Uterine Corpus Cancer; Vaginal Carcinoma; Vulvar Carcinoma,na,TERMINATED,City of Hope Medical Center,
NCT02412124,Questionnaire Administration,OTHER,Cervical Carcinoma; Ovarian Carcinoma; Uterine Corpus Cancer; Vaginal Carcinoma; Vulvar Carcinoma,na,TERMINATED,City of Hope Medical Center,
NCT03998423,Fecal Microbiota Transplant,BIOLOGICAL,Alzheimer Disease,phase1,TERMINATED,"University of Wisconsin, Madison",
NCT01625923,Olanzapine,DRUG,Idiopathic Gastroparesis,na,TERMINATED,University of Michigan,
NCT02225223,STAR™ Tumor Ablation System,DEVICE,Metastatic Lesions in Vertebral Bodies,na,TERMINATED,"Merit Medical Systems, Inc.",
NCT02225223,StabiliT® Vertebral Augmentation System,DEVICE,Metastatic Lesions in Vertebral Bodies,na,TERMINATED,"Merit Medical Systems, Inc.",
NCT01705080,EnligHTN,DEVICE,Hypertension; Blood Pressure,na,TERMINATED,Abbott Medical Devices,
NCT00617279,GORE PROPATEN Vascular Graft,DEVICE,Peripheral Arterial Occlusive Disease,phase4,TERMINATED,W.L.Gore & Associates,
NCT00617279,Disadvantaged Autologous Vein Graft,PROCEDURE,Peripheral Arterial Occlusive Disease,phase4,TERMINATED,W.L.Gore & Associates,
NCT00648479,The Guiding Star,DEVICE,Fracture,phase1; phase2,TERMINATED,Hadassah Medical Organization,
NCT00648479,fluoroscopy (OEC 9800 - General Electric),DEVICE,Fracture,phase1; phase2,TERMINATED,Hadassah Medical Organization,
NCT02984813,GlaucoHealth,DRUG,Open-angle Glaucoma; Diabetic Retinopathy,phase1,TERMINATED,The New York Eye & Ear Infirmary,
NCT02984813,GlaucoSelect,DRUG,Open-angle Glaucoma; Diabetic Retinopathy,phase1,TERMINATED,The New York Eye & Ear Infirmary,
NCT02984813,Placebo,DRUG,Open-angle Glaucoma; Diabetic Retinopathy,phase1,TERMINATED,The New York Eye & Ear Infirmary,
NCT04234113,Nanrilkefusp alfa,DRUG,Thyroid Cancer; Renal Cell Carcinoma; Non Small Cell Lung Cancer; Small-cell Lung Cancer; Bladder Cancer; Melanoma; Merkel Cell Carcinoma; Skin Squamous Cell Carcinoma; Microsatellite Instability High,phase1,TERMINATED,SOTIO Biotech AG,
NCT04234113,Pembrolizumab,DRUG,Thyroid Cancer; Renal Cell Carcinoma; Non Small Cell Lung Cancer; Small-cell Lung Cancer; Bladder Cancer; Melanoma; Merkel Cell Carcinoma; Skin Squamous Cell Carcinoma; Microsatellite Instability High,phase1,TERMINATED,SOTIO Biotech AG,
NCT01316523,Rituximab,DRUG,Non Hodgkin's Lymphoma,phase2,TERMINATED,"University of California, Davis",
NCT01316523,Lenalidomide,DRUG,Non Hodgkin's Lymphoma,phase2,TERMINATED,"University of California, Davis",
NCT00492479,"Kinerase Pro+Therapy Line day repair, serum, night repair",DRUG,Skin Aging,phase4,TERMINATED,Innovative Medical,
NCT00492479,Kinerase Pro+Therapy Line Ultra rich day repair,DRUG,Skin Aging,phase4,TERMINATED,Innovative Medical,
NCT00492479,LubriDerm,DRUG,Skin Aging,phase4,TERMINATED,Innovative Medical,
NCT05711979,AARC,BEHAVIORAL,"Obesity, Childhood",na,TERMINATED,Duke University,
NCT00307879,"Drug: G-CSF (Dong-A pharmaceutical, Seoul, Korea)",DRUG,Myocardial Infarction,phase2,TERMINATED,Seoul National University Hospital,
NCT00307879,collection of mobilized peripheral blood stem cells,PROCEDURE,Myocardial Infarction,phase2,TERMINATED,Seoul National University Hospital,
NCT00307879,Intracoronary infusion of mobilized cells,PROCEDURE,Myocardial Infarction,phase2,TERMINATED,Seoul National University Hospital,
NCT00287859,topotecan hydrochloride,DRUG,Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer,phase1,TERMINATED,"Masonic Cancer Center, University of Minnesota",
NCT00680459,70% ethanol,DRUG,Bloodstream Infection,phase3,TERMINATED,Baystate Medical Center,
NCT00680459,heparin flush solution,DRUG,Bloodstream Infection,phase3,TERMINATED,Baystate Medical Center,
NCT02077959,lenalidomide,DRUG,Multiple Myeloma,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT02077959,pidilizumab,BIOLOGICAL,Multiple Myeloma,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT02077959,pharmacological study,OTHER,Multiple Myeloma,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT02077959,laboratory biomarker analysis,OTHER,Multiple Myeloma,phase1,TERMINATED,Ohio State University Comprehensive Cancer Center,
NCT01958580,Gemcitabine Hydrochloride,DRUG,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01958580,Docetaxel,DRUG,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01958580,Internal Radiation Therapy,RADIATION,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01958580,Intensity-Modulated Radiation Therapy,RADIATION,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01958580,External Beam Radiation Therapy,RADIATION,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT01958580,Laboratory Biomarker Analysis,OTHER,Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC U,na,TERMINATED,Albert Einstein College of Medicine,
NCT00222079,Esomeprazole (Nexium),DRUG,Gastro-esophageal Reflux,na,TERMINATED,Douglas Trask,
NCT01946880,Mycophenolate Mofetil,DRUG,Systemic Lupus Erythematosus; SLE,phase2,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01946880,Hydroxychloroquine or Chloroquine,DRUG,Systemic Lupus Erythematosus; SLE,phase2,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT01946880,Prednisone,DRUG,Systemic Lupus Erythematosus; SLE,phase2,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT04426279,questionnaire assesment,OTHER,Sars-CoV2; Rheumatoid Arthritis; Rheumatic Diseases,na,TERMINATED,"University Hospital, Lille",
NCT02905279,Biofeedback Relaxation Training,BEHAVIORAL,Specific Phobia,na,TERMINATED,University of Texas at Austin,
NCT02905279,Exposure Therapy,BEHAVIORAL,Specific Phobia,na,TERMINATED,University of Texas at Austin,
NCT02905279,Exposure with Threat-Relevant Opposite Actions,BEHAVIORAL,Specific Phobia,na,TERMINATED,University of Texas at Austin,
NCT02905279,Exposure with Threat-Irrelevant Opposite Actions,BEHAVIORAL,Specific Phobia,na,TERMINATED,University of Texas at Austin,
NCT04059159,Connected Catheter,DEVICE,Neurogenic Bladder; Urinary Retention; Urologic Diseases,na,TERMINATED,Spinal Singularity,
NCT00808080,AMLCTL,BIOLOGICAL,AML,phase1; phase2,TERMINATED,"Thomas A. Lane, MD",
NCT01646580,ciclopirox,DRUG,Dermatomycoses,phase4,TERMINATED,Ferrer Internacional S.A.,
NCT04376827,Guselkumab Dose 1,DRUG,Lupus Nephritis,phase2,TERMINATED,"Janssen Research & Development, LLC",
NCT04376827,Placebo,DRUG,Lupus Nephritis,phase2,TERMINATED,"Janssen Research & Development, LLC",
NCT04376827,Guselkumab Dose 2,DRUG,Lupus Nephritis,phase2,TERMINATED,"Janssen Research & Development, LLC",
NCT04376827,Standard-of-care treatment,DRUG,Lupus Nephritis,phase2,TERMINATED,"Janssen Research & Development, LLC",
NCT04153786,Temporary changes in an already-implanted medical device (biventricular pacemaker),OTHER,LVAD (Left Ventricular Assist Device) Driveline Infection,na,TERMINATED,"University of California, Davis",
NCT03915886,JNJ-0440,DRUG,Healthy,phase1,TERMINATED,Janssen Pharmaceutical K.K.,
NCT03915886,Placebo,DRUG,Healthy,phase1,TERMINATED,Janssen Pharmaceutical K.K.,
NCT02881554,Computed Tomography,PROCEDURE,Hepatocellular Carcinoma; Intrahepatic Cholangiocarcinoma; Stage IV Liver Cancer; Stage IVA Liver Cancer; Stage IVB Liver Cancer; Vascular Thrombosis,na,TERMINATED,University of Washington,
NCT02881554,Single Photon Emission Computed Tomography,PROCEDURE,Hepatocellular Carcinoma; Intrahepatic Cholangiocarcinoma; Stage IV Liver Cancer; Stage IVA Liver Cancer; Stage IVB Liver Cancer; Vascular Thrombosis,na,TERMINATED,University of Washington,
NCT02881554,Technetium Tc-99m Sulfur Colloid,DRUG,Hepatocellular Carcinoma; Intrahepatic Cholangiocarcinoma; Stage IV Liver Cancer; Stage IVA Liver Cancer; Stage IVB Liver Cancer; Vascular Thrombosis,na,TERMINATED,University of Washington,
NCT02353754,Intrathecal morphine injection,DRUG,Pain,phase4,TERMINATED,"Pacira Pharmaceuticals, Inc",
NCT02353754,EXPAREL,DRUG,Pain,phase4,TERMINATED,"Pacira Pharmaceuticals, Inc",
NCT01155154,cephalexin,DRUG,Simple Hand Lacerations,na,TERMINATED,State University of New York - Downstate Medical Center,
NCT01155154,clindamycin,DRUG,Simple Hand Lacerations,na,TERMINATED,State University of New York - Downstate Medical Center,
NCT01155154,placebo,DRUG,Simple Hand Lacerations,na,TERMINATED,State University of New York - Downstate Medical Center,
NCT04631705,DZIF-10c,BIOLOGICAL,SARS-CoV-2 Infection,phase1; phase2,TERMINATED,University of Cologne,
NCT04631705,DZIF-10c,BIOLOGICAL,SARS-CoV-2 Infection,phase1; phase2,TERMINATED,University of Cologne,
NCT04631705,Placebo,DRUG,SARS-CoV-2 Infection,phase1; phase2,TERMINATED,University of Cologne,
NCT04631705,Placebo,DRUG,SARS-CoV-2 Infection,phase1; phase2,TERMINATED,University of Cologne,
NCT01264094,Clevudine,DRUG,Chronic Hepatitis B,phase4,TERMINATED,Bukwang Pharmaceutical,
NCT02340156,SGT-53,OTHER,RECURRENT GLIOBLASTOMA,phase2,TERMINATED,"SynerGene Therapeutics, Inc.",
NCT02340156,Temozolomide,DRUG,RECURRENT GLIOBLASTOMA,phase2,TERMINATED,"SynerGene Therapeutics, Inc.",
NCT01870856,Spectacles,DEVICE,Lid Wiper Epitheliopathy,na,TERMINATED,Alcon Research,
NCT01870856,Delefilcon A contact lenses,DEVICE,Lid Wiper Epitheliopathy,na,TERMINATED,Alcon Research,
NCT01870856,Etafilcon A contact lenses,DEVICE,Lid Wiper Epitheliopathy,na,TERMINATED,Alcon Research,
NCT05242822,KIN-3248,DRUG,"Solid Tumor, Adult; Intrahepatic Cholangiocarcinoma; Urothelial Carcinoma",phase1,TERMINATED,Kinnate Biopharma,
NCT04499729,IntelliCare,DEVICE,Depression,na,TERMINATED,"Adaptive Health, Inc",
NCT04499729,Treatment as Usual (TAU),BEHAVIORAL,Depression,na,TERMINATED,"Adaptive Health, Inc",
NCT03137329,Exercise program,BEHAVIORAL,Obesity,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT03137329,Nutrition,OTHER,Obesity,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT03137329,WLS,PROCEDURE,Obesity,na,TERMINATED,Beth Israel Deaconess Medical Center,
NCT00090129,Onercept,DRUG,"Arthritis, Psoriatic",phase3,TERMINATED,EMD Serono,
NCT00090129,Placebo,DRUG,"Arthritis, Psoriatic",phase3,TERMINATED,EMD Serono,
NCT00302731,"Estradiol , estriol , progesterone",DRUG,Menopause,phase2,TERMINATED,"Jeanne Drisko, MD, CNS, FACN",
NCT00302731,"estradiol, progesterone",DRUG,Menopause,phase2,TERMINATED,"Jeanne Drisko, MD, CNS, FACN",
NCT00302731,"estriol, progesterone",DRUG,Menopause,phase2,TERMINATED,"Jeanne Drisko, MD, CNS, FACN",
NCT00302731,equine estrogens m-progesteroneacetate,DRUG,Menopause,phase2,TERMINATED,"Jeanne Drisko, MD, CNS, FACN",
NCT02285153,Acetylsalicylic acid lysinate,DRUG,Critical Illness,phase3,TERMINATED,Medical University of Vienna,
NCT02285153,0.9% sodium-chloride solution,DRUG,Critical Illness,phase3,TERMINATED,Medical University of Vienna,
NCT06229353,Gardasil 9,BIOLOGICAL,Human Papilloma Virus,na,TERMINATED,University of Alabama at Birmingham,
NCT01488253,Sirolimus,DRUG,"Acute Leukemia in Remission; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myeloid, Accelerated-Phase",phase2,TERMINATED,The Korean Society of Blood and Marrow Transplantation,
NCT01488253,Tacrolimus,DRUG,"Acute Leukemia in Remission; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myeloid, Accelerated-Phase",phase2,TERMINATED,The Korean Society of Blood and Marrow Transplantation,
NCT01805037,brentuximab vedotin,DRUG,Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Contiguous Stage II Adult Burkitt Lymph,phase1; phase2,TERMINATED,Northwestern University,
NCT01805037,rituximab,BIOLOGICAL,Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Contiguous Stage II Adult Burkitt Lymph,phase1; phase2,TERMINATED,Northwestern University,
NCT01805037,laboratory biomarker analysis,OTHER,Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Contiguous Stage II Adult Burkitt Lymph,phase1; phase2,TERMINATED,Northwestern University,
NCT03695172,Ropivacaine,DRUG,"Pain, Postoperative; Cesarean Section",phase4,TERMINATED,Duke University,
NCT03695172,TAP block,PROCEDURE,"Pain, Postoperative; Cesarean Section",phase4,TERMINATED,Duke University,
NCT03695172,QL block,BIOLOGICAL,"Pain, Postoperative; Cesarean Section",phase4,TERMINATED,Duke University,
NCT03695172,ESP block,PROCEDURE,"Pain, Postoperative; Cesarean Section",phase4,TERMINATED,Duke University,
NCT02784795,LY3039478,DRUG,Solid Tumor; Breast Cancer; Colon Cancer; Cholangiocarcinoma; Soft Tissue Sarcoma,phase1,TERMINATED,Eli Lilly and Company,
NCT02784795,Taladegib,DRUG,Solid Tumor; Breast Cancer; Colon Cancer; Cholangiocarcinoma; Soft Tissue Sarcoma,phase1,TERMINATED,Eli Lilly and Company,
NCT02784795,Abemaciclib,DRUG,Solid Tumor; Breast Cancer; Colon Cancer; Cholangiocarcinoma; Soft Tissue Sarcoma,phase1,TERMINATED,Eli Lilly and Company,
NCT02784795,Cisplatin,DRUG,Solid Tumor; Breast Cancer; Colon Cancer; Cholangiocarcinoma; Soft Tissue Sarcoma,phase1,TERMINATED,Eli Lilly and Company,
NCT02784795,Gemcitabine,DRUG,Solid Tumor; Breast Cancer; Colon Cancer; Cholangiocarcinoma; Soft Tissue Sarcoma,phase1,TERMINATED,Eli Lilly and Company,
NCT02784795,Carboplatin,DRUG,Solid Tumor; Breast Cancer; Colon Cancer; Cholangiocarcinoma; Soft Tissue Sarcoma,phase1,TERMINATED,Eli Lilly and Company,
NCT02784795,LY3023414,DRUG,Solid Tumor; Breast Cancer; Colon Cancer; Cholangiocarcinoma; Soft Tissue Sarcoma,phase1,TERMINATED,Eli Lilly and Company,
NCT00428272,Lexatumumab alone,DRUG,Ewing's Sarcoma; Osteosarcoma; Neuroblastoma; Rhabdomyosarcoma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00428272,Lexatumumab in combination,DRUG,Ewing's Sarcoma; Osteosarcoma; Neuroblastoma; Rhabdomyosarcoma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00428272,Interferon gamma 1b in combination,DRUG,Ewing's Sarcoma; Osteosarcoma; Neuroblastoma; Rhabdomyosarcoma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT00428272,Gamma 1b potential expansion,DRUG,Ewing's Sarcoma; Osteosarcoma; Neuroblastoma; Rhabdomyosarcoma,phase1,TERMINATED,National Cancer Institute (NCI),
NCT02419495,Capecitabine,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Carboplatin,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Cyclophosphamide,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Doxorubicin,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Eribulin,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Fluorouracil,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Ipilimumab,BIOLOGICAL,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Irinotecan Hydrochloride,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Leucovorin Calcium,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Nivolumab,BIOLOGICAL,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Olaparib,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Oxaliplatin,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Paclitaxel,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Pembrolizumab,BIOLOGICAL,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Pemetrexed,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Selinexor,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT02419495,Topotecan,DRUG,Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Meta,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT00474695,Lucentis,DRUG,Age-Related Maculopathy,na,TERMINATED,University of Utah,
NCT02989675,10% dextrose,DRUG,Hypoglycemia Non Diabetics; Emergencies; Pediatric ALL; Critical Illness,na,TERMINATED,Helena Hildenwall,
NCT01486550,"Voluven (Hydroxyethyl starch 130/0,4)",DRUG,Kidney Cancer,phase4,TERMINATED,Regional Hospital Holstebro,
NCT01486550,Sodium Chloride 9mg/ml,DRUG,Kidney Cancer,phase4,TERMINATED,Regional Hospital Holstebro,
NCT05256810,ALN-XDH,DRUG,Gout,phase1; phase2,TERMINATED,Alnylam Pharmaceuticals,
NCT05256810,Placebo,DRUG,Gout,phase1; phase2,TERMINATED,Alnylam Pharmaceuticals,
NCT00374413,Artificial disk,DEVICE,Degenerative Disc Disease (DDD),na,TERMINATED,SpinalMotion,
NCT00374413,Artificial disc,DEVICE,Degenerative Disc Disease (DDD),na,TERMINATED,SpinalMotion,
NCT01448382,PillCam® capsule with Given PillCam® Platform,DEVICE,Upper GI Bleeding,phase1,TERMINATED,Medtronic - MITG,
NCT04639024,ADCT-301,DRUG,Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS); Myeloproliferative Neoplasm (MDS/MPN),phase2,TERMINATED,"Gwynn Long, M.D.",
NCT00881023,Microfracture,PROCEDURE,Defect of Articular Cartilage; Osteochondritis Dissecans,na,TERMINATED,DePuy Mitek,
NCT00881023,Cartilage Autograft Implantation System,DEVICE,Defect of Articular Cartilage; Osteochondritis Dissecans,na,TERMINATED,DePuy Mitek,
NCT06527859,Levothyroxin,DRUG,"Pregnancy Related; Thyroid Stimulating; Hormone, C",na,TERMINATED,Third Affiliated Hospital of Zhengzhou University,
NCT04068259,PBI-4547,DRUG,Healthy Subjects,phase1,TERMINATED,Liminal BioSciences Ltd.,
NCT04068259,Placebo,OTHER,Healthy Subjects,phase1,TERMINATED,Liminal BioSciences Ltd.,
NCT04137159,Functional Electrical Stimulation rowing exercise,OTHER,Spinal Cord Injuries,na,TERMINATED,Spaulding Rehabilitation Hospital,
NCT03730896,Dry needling,PROCEDURE,Cervicogenic Headache,na,TERMINATED,Florida Gulf Coast University,
NCT00421096,Gemcitabine,DRUG,Uterine Cervical Cancer,phase2,TERMINATED,Centre Oscar Lambret,
NCT00421096,Radiotherapy,PROCEDURE,Uterine Cervical Cancer,phase2,TERMINATED,Centre Oscar Lambret,
NCT00421096,Cisplatin,DRUG,Uterine Cervical Cancer,phase2,TERMINATED,Centre Oscar Lambret,
NCT01992861,Computed Tomography,PROCEDURE,"Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Cervical Undifferentiated Carcinoma; Recurrent Cervical Carcinoma; Stage IB2 Cervi",na,TERMINATED,University of Washington,
NCT01992861,Diffusion Weighted Imaging,PROCEDURE,"Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Cervical Undifferentiated Carcinoma; Recurrent Cervical Carcinoma; Stage IB2 Cervi",na,TERMINATED,University of Washington,
NCT01992861,Dynamic Contrast-Enhanced Magnetic Resonance Imaging,PROCEDURE,"Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Cervical Undifferentiated Carcinoma; Recurrent Cervical Carcinoma; Stage IB2 Cervi",na,TERMINATED,University of Washington,
NCT01992861,Fludeoxyglucose F-18,RADIATION,"Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Cervical Undifferentiated Carcinoma; Recurrent Cervical Carcinoma; Stage IB2 Cervi",na,TERMINATED,University of Washington,
NCT01992861,Magnetic Resonance Spectroscopic Imaging,PROCEDURE,"Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Cervical Undifferentiated Carcinoma; Recurrent Cervical Carcinoma; Stage IB2 Cervi",na,TERMINATED,University of Washington,
NCT01992861,Positron Emission Tomography,PROCEDURE,"Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Cervical Undifferentiated Carcinoma; Recurrent Cervical Carcinoma; Stage IB2 Cervi",na,TERMINATED,University of Washington,
NCT01239342,Akt Inhibitor MK2206,DRUG,Metastatic Kidney Carcinoma; Recurrent Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01239342,Everolimus,DRUG,Metastatic Kidney Carcinoma; Recurrent Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01239342,Laboratory Biomarker Analysis,OTHER,Metastatic Kidney Carcinoma; Recurrent Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7,phase2,TERMINATED,National Cancer Institute (NCI),
NCT01935986,probiotic,OTHER,Upper Respiratory Tract Infection,phase2,TERMINATED,Probi AB,
NCT01935986,placebo,OTHER,Upper Respiratory Tract Infection,phase2,TERMINATED,Probi AB,
NCT01416870,"ICI176,334-1",DRUG,Healthy,phase1,TERMINATED,AstraZeneca,
NCT01416870,Casodex 80 mg tablet,DRUG,Healthy,phase1,TERMINATED,AstraZeneca,
NCT04934670,T-Guard,DRUG,Steroid-Refractory Acute Graft Versus Host Disease,phase3,TERMINATED,Xenikos,
NCT04934670,Ruxolitinib,DRUG,Steroid-Refractory Acute Graft Versus Host Disease,phase3,TERMINATED,Xenikos,
NCT03963973,RDN-929 oral capsule,DRUG,Healthy,phase1,TERMINATED,"Alkermes, Inc.",
NCT03963973,Placebo oral capsule,DRUG,Healthy,phase1,TERMINATED,"Alkermes, Inc.",
NCT06298669,Biventricular Pacing,DEVICE,Heart Failure,na,TERMINATED,Indiana University,
NCT06298669,Right Ventricular Pacing,DEVICE,Heart Failure,na,TERMINATED,Indiana University,
NCT02029469,Ascension HRA device,DEVICE,"Shoulder Arthritis Osteoarthritis; Rheumatoid Arthritis Shoulder; Acquired Deformity of Head; Post-traumatic Arthrosis of Other Joints, Shoulder Region",na,TERMINATED,"Ascension Orthopedics, Inc.",
NCT01262183,CRT + Panitumumab,DRUG,Irresectable Squamous Cell or Adenocarcinoma of the Oesophagus,phase2,TERMINATED,Radboud University Medical Center,
NCT01262183,Concurrent chemoradiation therapy without panitumumab,DRUG,Irresectable Squamous Cell or Adenocarcinoma of the Oesophagus,phase2,TERMINATED,Radboud University Medical Center,
NCT00502554,photopheresis,PROCEDURE,Bronchiolitis Obliterans,na,TERMINATED,Hannover Medical School,
NCT03965494,BGB 324 (before surgery),DRUG,Brain and Central Nervous System Tumors,early_phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT03965494,BGB 324 (after surgery),DRUG,Brain and Central Nervous System Tumors,early_phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00210366,Idarubicin,DRUG,"Lymphoma, B-Cell",phase2,TERMINATED,International Extranodal Lymphoma Study Group (IELSG),
NCT00224666,Cortex stimulation,DEVICE,Rebel Neuropathic Pains,phase2,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02114489,ibandronate,DRUG,Aseptic Hip Necrosis; Hip Necrosis,phase3,TERMINATED,"Brigitte Jolles, MD",
NCT02114489,Placebo,DRUG,Aseptic Hip Necrosis; Hip Necrosis,phase3,TERMINATED,"Brigitte Jolles, MD",
NCT01361750,gastric tube,PROCEDURE,Oesophageal Cancer,na,TERMINATED,Peking University,
NCT01757691,Fingolimod 0.5mg/daily,DRUG,Acute Demylelinating Optic Neuritis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01757691,Placebo,DRUG,Acute Demylelinating Optic Neuritis,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02635074,Cytarabine,DRUG,Recurrent Adult Acute Myeloid Leukemia,phase1,TERMINATED,Steven E. Coutre,
NCT02635074,Ibrutinib,DRUG,Recurrent Adult Acute Myeloid Leukemia,phase1,TERMINATED,Steven E. Coutre,
NCT02635074,Idarubicin,DRUG,Recurrent Adult Acute Myeloid Leukemia,phase1,TERMINATED,Steven E. Coutre,
NCT00597597,Erlotinib,DRUG,Metastatic Breast Cancer,phase2,TERMINATED,Rush University Medical Center,
NCT05589597,EO4010,DRUG,Colorectal Cancer Metastatic,phase1; phase2,TERMINATED,Enterome,
NCT00407797,Pregabalin,DRUG,Partial Seizures,phase4,TERMINATED,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,
NCT03248479,Magrolimab,DRUG,Hematological Malignancies,phase1,TERMINATED,Gilead Sciences,
NCT03248479,Azacitidine,DRUG,Hematological Malignancies,phase1,TERMINATED,Gilead Sciences,
NCT04121988,MRI,OTHER,Pituitary ACTH Secreting Adenoma,na,TERMINATED,Asan Medical Center,
NCT00051688,tezacitabine,DRUG,Colorectal Neoplasms,phase2,TERMINATED,Chiron Corporation,
NCT00051688,oxaliplatin,DRUG,Colorectal Neoplasms,phase2,TERMINATED,Chiron Corporation,
NCT04227327,Abemaciclib,DRUG,Advanced Breast Cancer,phase2,TERMINATED,University of Milano Bicocca,
NCT04227327,Aromatase Inhibitors,DRUG,Advanced Breast Cancer,phase2,TERMINATED,University of Milano Bicocca,
NCT03946670,MBG453,DRUG,Myelodysplastic Syndromes,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT03946670,Placebo,DRUG,Myelodysplastic Syndromes,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT03946670,Hypomethylating agents,DRUG,Myelodysplastic Syndromes,phase2,TERMINATED,Novartis Pharmaceuticals,
NCT01405573,Best Supportive Care,OTHER,Advanced Adult Hepatocellular Carcinoma,phase3,TERMINATED,"National Cancer Institute, Naples",
NCT01405573,sorafenib,DRUG,Advanced Adult Hepatocellular Carcinoma,phase3,TERMINATED,"National Cancer Institute, Naples",
NCT00020683,incyclinide,DRUG,AIDS-related Kaposi Sarcoma; HIV Infection,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00020683,incyclinide,DRUG,AIDS-related Kaposi Sarcoma; HIV Infection,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00020683,laboratory biomarker analysis,OTHER,AIDS-related Kaposi Sarcoma; HIV Infection,phase2,TERMINATED,National Cancer Institute (NCI),
NCT00184054,Arsenic Trioxide (ATO),DRUG,Acute Myelogenous Leukemia,phase2,TERMINATED,University of Southern California,
NCT00184054,Ascorbic Acid,DRUG,Acute Myelogenous Leukemia,phase2,TERMINATED,University of Southern California,
NCT05204082,Single Use Vein Entry Indicator Device,DEVICE,Intravenous Access,na,TERMINATED,Mayo Clinic,
NCT03848182,Gemcitabine,DRUG,Pancreatic Cancer,phase2,TERMINATED,Albert Einstein College of Medicine,
NCT03848182,TT vaccine booster,BIOLOGICAL,Pancreatic Cancer,phase2,TERMINATED,Albert Einstein College of Medicine,
NCT04650282,Lidocaine in SphenoCath device,OTHER,Concussion; Headache,phase2,TERMINATED,University of Michigan,
NCT04650282,Saline Solution in SphenoCath device,OTHER,Concussion; Headache,phase2,TERMINATED,University of Michigan,
NCT00238082,HFA-134A Beclomethasone DIpropionate (QVAR),DRUG,COPD,na,TERMINATED,National Jewish Health,
NCT03595982,Procardia XL 30Mg,DRUG,Hypertension in Pregnancy; Hypertension in Postpartum,phase4,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT03595982,Procardia XL 60Mg,DRUG,Hypertension in Pregnancy; Hypertension in Postpartum,phase4,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT04152382,LY3462817 - IV,DRUG,Psoriasis,phase1,TERMINATED,Eli Lilly and Company,
NCT04152382,LY3462817 - SC,DRUG,Psoriasis,phase1,TERMINATED,Eli Lilly and Company,
NCT04152382,Placebo - IV,DRUG,Psoriasis,phase1,TERMINATED,Eli Lilly and Company,
NCT04152382,Placebo - SC,DRUG,Psoriasis,phase1,TERMINATED,Eli Lilly and Company,
NCT04152382,LY3509754,DRUG,Psoriasis,phase1,TERMINATED,Eli Lilly and Company,
NCT04152382,Placebo,DRUG,Psoriasis,phase1,TERMINATED,Eli Lilly and Company,
NCT01626924,2-Iminobiotin,DRUG,Perinatal Asphyxia,phase2,TERMINATED,Neurophyxia B.V.,
NCT06153420,CIN-103,DRUG,Irritable Bowel Syndrome With Diarrhea,phase2,TERMINATED,"CinPhloro Pharma, LLC",
NCT06153420,Placebo,DRUG,Irritable Bowel Syndrome With Diarrhea,phase2,TERMINATED,"CinPhloro Pharma, LLC",
NCT00278824,Matrix Transdermal Fentanyl/CHADD Drug Delivery System,DRUG,Pain,phase2,TERMINATED,ZARS Pharma Inc.,
NCT00278824,Placebo Patch,DRUG,Pain,phase2,TERMINATED,ZARS Pharma Inc.,
NCT01364220,Rosuvastatin,DRUG,Stroke,phase3,TERMINATED,Severance Hospital,
NCT01364220,Placebo tablet,OTHER,Stroke,phase3,TERMINATED,Severance Hospital,
NCT02057224,Renal denervation using Medtronic Symplicity System (mono-electrode),PROCEDURE,Insulin Resistance; Hypertension,na,TERMINATED,Umeå University,
NCT04176497,68Ga-HBED-CC-PSMA,DRUG,Prostate Cancer,phase2,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT01852110,MK-7622,DRUG,Alzheimer's Disease,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01852110,Placebo,DRUG,Alzheimer's Disease,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01852110,AChEI,DRUG,Alzheimer's Disease,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01738620,psychological counseling,BEHAVIORAL,Esophageal Cancer; Sleep Disturbance; Quality of Life,na,TERMINATED,University of Padova,
NCT01738620,prevention of sleep disorders in ICU,BEHAVIORAL,Esophageal Cancer; Sleep Disturbance; Quality of Life,na,TERMINATED,University of Padova,
NCT03417024,Automated Breast Ultrasound,DEVICE,Breast Cancer,na,TERMINATED,GE Healthcare,
NCT03417024,Digital Breast Tomosynthesis,DEVICE,Breast Cancer,na,TERMINATED,GE Healthcare,
NCT01729923,Capecitabine,DRUG,Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase2,TERMINATED,University of Washington,
NCT01729923,Celecoxib,DRUG,Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase2,TERMINATED,University of Washington,
NCT01729923,Intensity-Modulated Radiation Therapy,RADIATION,Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase2,TERMINATED,University of Washington,
NCT01729923,Laboratory Biomarker Analysis,OTHER,Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase2,TERMINATED,University of Washington,
NCT01729923,Quality-of-Life Assessment,OTHER,Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase2,TERMINATED,University of Washington,
NCT01729923,Radiation Therapy,RADIATION,Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase2,TERMINATED,University of Washington,
NCT01729923,Stereotactic Radiosurgery,RADIATION,Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase2,TERMINATED,University of Washington,
NCT01729923,Therapeutic Conventional Surgery,PROCEDURE,Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer,phase2,TERMINATED,University of Washington,
NCT00006220,arsenic trioxide,DRUG,Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase1; phase2,TERMINATED,Washington University School of Medicine,
NCT00006220,tretinoin,DRUG,Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes,phase1; phase2,TERMINATED,Washington University School of Medicine,
NCT02829723,BLZ945,DRUG,Advanced Solid Tumors,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02829723,PDR001,DRUG,Advanced Solid Tumors,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT00667810,bapineuzumab,DRUG,Alzheimer Disease,phase3,TERMINATED,Pfizer,
NCT00667810,bapineuzumab,DRUG,Alzheimer Disease,phase3,TERMINATED,Pfizer,
NCT00667810,placebo,DRUG,Alzheimer Disease,phase3,TERMINATED,Pfizer,
NCT00240513,Minocycline,DRUG,Acne Vulgaris,phase4,TERMINATED,Derm Research @ 888 Inc.,
NCT00240513,Minocycline plus tretinoin,DRUG,Acne Vulgaris,phase4,TERMINATED,Derm Research @ 888 Inc.,
NCT02013791,Vehicle,DRUG,Dry Eye Syndromes,phase2,TERMINATED,Allergan,
NCT02013791,Sham,OTHER,Dry Eye Syndromes,phase2,TERMINATED,Allergan,
NCT02013791,Cyclosporine New Ophthalmic Formulation,DRUG,Dry Eye Syndromes,phase2,TERMINATED,Allergan,
NCT02802774,Plaster Splint,OTHER,Distal Radius Fractures,na,TERMINATED,"University of California, San Francisco",
NCT02802774,Velcro Brace,OTHER,Distal Radius Fractures,na,TERMINATED,"University of California, San Francisco",
NCT02802774,Soft Dressing,OTHER,Distal Radius Fractures,na,TERMINATED,"University of California, San Francisco",
NCT02485990,Tremelimumab,DRUG,Primary Peritoneal Carcinoma,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT02485990,Olaparib,DRUG,Primary Peritoneal Carcinoma,phase1,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT05169710,SEP-4199 CR 200 mg,DRUG,"Depressive Episodes, Bipolar I Depression",phase3,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT05169710,SEP-4199 CR 400 mg,DRUG,"Depressive Episodes, Bipolar I Depression",phase3,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT05169710,Placebo,DRUG,"Depressive Episodes, Bipolar I Depression",phase3,TERMINATED,"Sumitomo Pharma America, Inc.",
NCT00539097,Juven (Ross Products) protein supplement,OTHER,Burn; Reconstructive Surgical Procedure,phase2; phase3,TERMINATED,Shriners Hospitals for Children,
NCT02501213,Spironolactone (+/- Furosemide),DRUG,Cancer,phase2,TERMINATED,Centre Oscar Lambret,
NCT03538886,Coronary artery bypass grafting (CABG),PROCEDURE,Coronary Artery Disease,na,TERMINATED,Aalborg University Hospital,
NCT03538886,Percutaneous coronary intervention (PCI),PROCEDURE,Coronary Artery Disease,na,TERMINATED,Aalborg University Hospital,
NCT05982405,Training group: Inspiratory muscle training,OTHER,Chronic Venous Insufficiency,na,TERMINATED,Izmir Democracy University,
NCT05982405,Control group: Thoracic expansion exercise,OTHER,Chronic Venous Insufficiency,na,TERMINATED,Izmir Democracy University,
NCT05250856,CNP-201,DRUG,Peanut Allergy,phase1,TERMINATED,"COUR Pharmaceutical Development Company, Inc.",
NCT05250856,Placebo,DRUG,Peanut Allergy,phase1,TERMINATED,"COUR Pharmaceutical Development Company, Inc.",
NCT03933956,Empagliflozin 10 MG,DRUG,Diabetic Nephropathies,phase3,TERMINATED,Singapore General Hospital,
NCT03420222,AVP-786,DRUG,Intermittent Explosive Disorder,phase2,TERMINATED,"Otsuka Pharmaceutical Development & Commercialization, Inc.",
NCT03420222,Placebo,DRUG,Intermittent Explosive Disorder,phase2,TERMINATED,"Otsuka Pharmaceutical Development & Commercialization, Inc.",
NCT03617445,FMT oral capsule,DRUG,Clostridium Difficile Infection Recurrence,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT03617445,Oral Vancomycin,DRUG,Clostridium Difficile Infection Recurrence,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT03617445,FMT oral placebo,DRUG,Clostridium Difficile Infection Recurrence,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT03617445,Oral Vancomycin placebo,DRUG,Clostridium Difficile Infection Recurrence,phase2,TERMINATED,"University of Wisconsin, Madison",
NCT03249272,Regadenoson,DRUG,Hypertrophic Cardiomyopathy; Non-ischemic Dilated Cardiomyopathy; Microvascular Ischaemia of Myocardium,phase4,TERMINATED,Duke University,
NCT03249272,Adenosine,DRUG,Hypertrophic Cardiomyopathy; Non-ischemic Dilated Cardiomyopathy; Microvascular Ischaemia of Myocardium,phase4,TERMINATED,Duke University,
NCT02356939,intraductal removable stent custom-made segment (2 cm),DEVICE,"Transplantation, Liver",na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT02356939,stent extraction by ERCP,PROCEDURE,"Transplantation, Liver",na,TERMINATED,Assistance Publique - Hôpitaux de Paris,
NCT00881777,Radiofrequency heating of the myocardial infarct scar,PROCEDURE,Heart Failure,phase1; phase2,TERMINATED,"CoRepair, Inc.",
NCT00881777,Coronary Artery Bypass Grafting (CABG) surgery,PROCEDURE,Heart Failure,phase1; phase2,TERMINATED,"CoRepair, Inc.",
NCT03670069,Itacitinib,DRUG,Metastatic Leiomyosarcoma; Metastatic Synovial Sarcoma; Metastatic Undifferentiated Pleomorphic Sarcoma; Advanced Myxoid Liposarcoma; Advanced Soft Tissue Sarcoma; Metastatic Myxoid Liposarcoma; Metas,phase1,TERMINATED,Fred Hutchinson Cancer Center,
NCT03670069,Laboratory Biomarker Analysis,OTHER,Metastatic Leiomyosarcoma; Metastatic Synovial Sarcoma; Metastatic Undifferentiated Pleomorphic Sarcoma; Advanced Myxoid Liposarcoma; Advanced Soft Tissue Sarcoma; Metastatic Myxoid Liposarcoma; Metas,phase1,TERMINATED,Fred Hutchinson Cancer Center,
NCT00809341,Rituximab,BIOLOGICAL,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00809341,Cyclophosphamide,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00809341,Doxorubicin,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00809341,Vincristine,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00809341,Prednisone,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00809341,Ifosfamide,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00809341,Carboplatin,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00809341,Etoposide,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00809341,High-dose cyclophosphamide,DRUG,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT00809341,PET scan,PROCEDURE,Non-Hodgkin's Lymphoma,phase2,TERMINATED,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
NCT04080505,SSKI- Potassium Iodide,DRUG,Graves Disease,phase3,TERMINATED,Columbia University,
NCT01403194,CPAP/BiPAP,DEVICE,Sleep Disordered Breathing,na,TERMINATED,Mayo Clinic,
NCT00094666,"MK0928, gaboxadol / Duration of Treatment - 6 weeks",DRUG,Primary Insomnia,phase3,TERMINATED,H. Lundbeck A/S,
NCT00094666,Comparator: placebo / Duration of Treatment - 6 weeks,DRUG,Primary Insomnia,phase3,TERMINATED,H. Lundbeck A/S,
NCT00505622,Perampanel,DRUG,Parkinson's Disease,phase3,TERMINATED,Eisai Limited,
NCT02324205,DBT and FFDM,DEVICE,"Breast Cancer; Tumors, Breast",na,TERMINATED,GE Healthcare,
NCT00548366,Sodium restriction,OTHER,Ascites,phase4,TERMINATED,University of Texas Southwestern Medical Center,
NCT00548366,Sodium restriction,OTHER,Ascites,phase4,TERMINATED,University of Texas Southwestern Medical Center,
NCT00514566,Suture for midline abdominal closure,DEVICE,Laparotomy,na,TERMINATED,"Christian Medical College and Hospital, Ludhiana, India",
NCT02134366,Clobazam,DRUG,Epilepsia Partialis Continua; Kojewnikov's Epilepsy; Epilepsy,phase3,TERMINATED,The Cooper Health System,
NCT02134366,Clonazepam,DRUG,Epilepsia Partialis Continua; Kojewnikov's Epilepsy; Epilepsy,phase3,TERMINATED,The Cooper Health System,
NCT02134366,Lorazepam,DRUG,Epilepsia Partialis Continua; Kojewnikov's Epilepsy; Epilepsy,phase3,TERMINATED,The Cooper Health System,
NCT04516122,Biospecimen Collection,PROCEDURE,Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Patholog,na,TERMINATED,M.D. Anderson Cancer Center,
NCT04516122,Dual X-ray Absorptiometry,PROCEDURE,Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Patholog,na,TERMINATED,M.D. Anderson Cancer Center,
NCT02060305,Bevacizumab intra-articular injection,DRUG,Hemophilia; Synovitis,phase1,TERMINATED,National Taiwan University Hospital,
NCT00200694,"ramipril 5 mg + valsartan 80 mg/day,",DRUG,Heavy Proteinuria,phase4,TERMINATED,Nantes University Hospital,
NCT00200694,"ramipril 10 mg + valsartan 160 mg/day,",DRUG,Heavy Proteinuria,phase4,TERMINATED,Nantes University Hospital,
NCT00200694,ramipril 5 mg + valsartan 80 mg/day + increased dosage of furosémide.,DRUG,Heavy Proteinuria,phase4,TERMINATED,Nantes University Hospital,
NCT04253522,Cognitive training,BEHAVIORAL,Dysexecutive Syndrome,na,TERMINATED,"University Hospital, Toulouse",
NCT03055481,High irradiance level of phototherapy,OTHER,Neonatal Jaundice,na,TERMINATED,Nagoya University,
NCT03055481,Low irradiance level of phototherapy,OTHER,Neonatal Jaundice,na,TERMINATED,Nagoya University,
NCT04926181,Apalutamide,DRUG,Small Cell Neuroendocrine Carcinoma; Prostate Cancer; Small Cell Carcinoma,phase2,TERMINATED,Rahul Aggarwal,
NCT04926181,Cetrelimab,BIOLOGICAL,Small Cell Neuroendocrine Carcinoma; Prostate Cancer; Small Cell Carcinoma,phase2,TERMINATED,Rahul Aggarwal,
NCT00596830,"CP-751,871 (Figitumumab)",DRUG,"Carcinoma, Squamous Cell; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,Pfizer,
NCT00596830,Carboplatin,DRUG,"Carcinoma, Squamous Cell; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,Pfizer,
NCT00596830,Paclitaxel,DRUG,"Carcinoma, Squamous Cell; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,Pfizer,
NCT00596830,Carboplatin,DRUG,"Carcinoma, Squamous Cell; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,Pfizer,
NCT00596830,Paclitaxel,DRUG,"Carcinoma, Squamous Cell; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung",phase3,TERMINATED,Pfizer,
NCT01827930,Imatinib Mesylate 600 MG Oral Tablet,DRUG,"Leukemia, Myeloid, Chronic-Phase",phase3,TERMINATED,Institut Bergonié,
NCT01827930,Imatinib Mesylate 400 MG Oral Tablet,DRUG,"Leukemia, Myeloid, Chronic-Phase",phase3,TERMINATED,Institut Bergonié,
NCT01827930,Imatinib Mesylate,DRUG,"Leukemia, Myeloid, Chronic-Phase",phase3,TERMINATED,Institut Bergonié,
NCT01288430,DS-2248,DRUG,Solid Tumors; Non-small Cell Lung Carcinoma,phase1,TERMINATED,Daiichi Sankyo,
NCT05262530,BNT142,BIOLOGICAL,Solid Tumor,phase1; phase2,TERMINATED,BioNTech SE,
NCT02475330,Flaxseed,OTHER,Lung Cancer,phase2,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT03376230,"Collect of blood, urines, and intestinal biopsies",OTHER,Inflammatory Bowel Diseases,na,TERMINATED,"University Hospital, Lille",
NCT03371381,JNJ-64041757,BIOLOGICAL,Adenocarcinoma of Lung,phase1; phase2,TERMINATED,"Janssen Research & Development, LLC",
NCT03371381,Nivolumab,DRUG,Adenocarcinoma of Lung,phase1; phase2,TERMINATED,"Janssen Research & Development, LLC",
NCT04493619,PLX2853,DRUG,Gynecologic Neoplasms; Epithelial Ovarian Cancer,phase1; phase2,TERMINATED,Opna Bio LLC,
NCT04493619,Carboplatin,DRUG,Gynecologic Neoplasms; Epithelial Ovarian Cancer,phase1; phase2,TERMINATED,Opna Bio LLC,
NCT05589519,Partial rehabilitation using PEEK,DEVICE,Prosthesis Survival,na,TERMINATED,Malo Clinic,
NCT03590730,ICD implantation,DEVICE,Valvular Heart Disease; Implantable Cardioverter Defibrillator; Sudden Cardiac Death; Primary Prevention,na,TERMINATED,Keimyung University Dongsan Medical Center,
NCT01845012,Daily hemodialysis at low dialysate flow,OTHER,End Stage Renal Disease,na,TERMINATED,Association Pour L'utilisation Rein Artificiel Région Lyonnaise,
NCT01062230,Bortezomib (Velcade),DRUG,Multiple Myeloma,phase2,TERMINATED,University of Arkansas,
NCT02294812,Cognitive training,BEHAVIORAL,Hearing Loss; Deafness and Auditory Perception,na,TERMINATED,Aaron Newman,
NCT00155883,Taxteral,DRUG,Gastric Cancer,phase2,TERMINATED,National Taiwan University Hospital,
NCT00155883,5-Fluorouracil,DRUG,Gastric Cancer,phase2,TERMINATED,National Taiwan University Hospital,
NCT00155883,Leucovorin,DRUG,Gastric Cancer,phase2,TERMINATED,National Taiwan University Hospital,
NCT02846883,1 million MSCs/kg,BIOLOGICAL,Abdominal Aortic Aneurysm,phase1,TERMINATED,VA Office of Research and Development,
NCT02846883,3 million MSCs/kg,BIOLOGICAL,Abdominal Aortic Aneurysm,phase1,TERMINATED,VA Office of Research and Development,
NCT02846883,Placebo,DRUG,Abdominal Aortic Aneurysm,phase1,TERMINATED,VA Office of Research and Development,
NCT00710541,ventilators designed for non invasive ventilation,DEVICE,Chronic Obstructive Pulmonary Disease; Hypercapnia,na,TERMINATED,Deutsche Lungenstiftung e.V.,
NCT00978354,Furosemide,DRUG,Acute Renal Failure,phase2; phase3,TERMINATED,University of Alberta,
NCT00978354,Normal Saline,DRUG,Acute Renal Failure,phase2; phase3,TERMINATED,University of Alberta,
NCT00081887,Clofarabine,DRUG,Chronic Lymphocytic Leukemia; Leukemia,phase1,TERMINATED,M.D. Anderson Cancer Center,
NCT05429021,IMM-BCP-01,DRUG,SARS-CoV2 Infection; COVID-19,phase1,TERMINATED,"Immunome, Inc.",
NCT05429021,Placebo,DRUG,SARS-CoV2 Infection; COVID-19,phase1,TERMINATED,"Immunome, Inc.",
NCT02750514,Nivolumab,BIOLOGICAL,Advanced Cancer,phase2,TERMINATED,Bristol-Myers Squibb,
NCT02750514,Dasatinib,DRUG,Advanced Cancer,phase2,TERMINATED,Bristol-Myers Squibb,
NCT02750514,Relatlimab,BIOLOGICAL,Advanced Cancer,phase2,TERMINATED,Bristol-Myers Squibb,
NCT02750514,Ipilimumab,BIOLOGICAL,Advanced Cancer,phase2,TERMINATED,Bristol-Myers Squibb,
NCT02750514,BMS-986205,DRUG,Advanced Cancer,phase2,TERMINATED,Bristol-Myers Squibb,
NCT04885816,Drug Eluting Balloon (DEB),DEVICE,High Bleeding Risk; Coronary Artery Disease (CAD); Percutaneous Coronary Intervention (PCI),na,TERMINATED,Instituto Nacional de Cardiologia Ignacio Chavez,
NCT04885816,Drug Eluting Stents (DES),DEVICE,High Bleeding Risk; Coronary Artery Disease (CAD); Percutaneous Coronary Intervention (PCI),na,TERMINATED,Instituto Nacional de Cardiologia Ignacio Chavez,
NCT06256484,ATA3219,DRUG,Relapsed/Refractory B-cell Non-Hodgkin Lymphoma,phase1,TERMINATED,Atara Biotherapeutics,
NCT03287804,AUTO2,BIOLOGICAL,Multiple Myeloma,phase1; phase2,TERMINATED,Autolus Limited,
NCT05017233,Spectral CT,DEVICE,CT Scanning,na,TERMINATED,"Philips (China) Investment CO., LTD",
NCT01996852,Cognitive-behavioral Meetings,BEHAVIORAL,Prostate Cancer; Erectile Dysfunction Following Radical Prostatectomy; Erectile Dysfunction Following Simple Prostatectomy; Erectile Dysfunction,na,TERMINATED,Case Comprehensive Cancer Center,
NCT01996852,sildenafil citrate,DRUG,Prostate Cancer; Erectile Dysfunction Following Radical Prostatectomy; Erectile Dysfunction Following Simple Prostatectomy; Erectile Dysfunction,na,TERMINATED,Case Comprehensive Cancer Center,
NCT01996852,Vacuum Constriction Device,DEVICE,Prostate Cancer; Erectile Dysfunction Following Radical Prostatectomy; Erectile Dysfunction Following Simple Prostatectomy; Erectile Dysfunction,na,TERMINATED,Case Comprehensive Cancer Center,
NCT00705549,Gemcitabine,DRUG,Non-Small-Cell Lung Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00705549,Cisplatin,DRUG,Non-Small-Cell Lung Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00705549,Docetaxel,DRUG,Non-Small-Cell Lung Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00705549,Cisplatin,DRUG,Non-Small-Cell Lung Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00705549,Vinorelbine,DRUG,Non-Small-Cell Lung Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00705549,Pemetrexate,DRUG,Non-Small-Cell Lung Cancer,phase2,TERMINATED,Hellenic Oncology Research Group,
NCT00003147,Ad5CMV-p53 gene,BIOLOGICAL,Liver Cancer,phase1,TERMINATED,National Cancer Institute (NCI),
NCT01260649,ketamine,DRUG,Major Depressive Disorder,phase4,TERMINATED,Massachusetts General Hospital,
NCT01260649,IV Saline,OTHER,Major Depressive Disorder,phase4,TERMINATED,Massachusetts General Hospital,
NCT01260649,ECT,PROCEDURE,Major Depressive Disorder,phase4,TERMINATED,Massachusetts General Hospital,
NCT01260649,Muscle Relaxant,DRUG,Major Depressive Disorder,phase4,TERMINATED,Massachusetts General Hospital,
NCT01260649,Anesthetic Agents,DRUG,Major Depressive Disorder,phase4,TERMINATED,Massachusetts General Hospital,
NCT03322449,Animal Diet,OTHER,Inflammation,na,TERMINATED,Tufts University,
NCT03322449,Plant Diet,OTHER,Inflammation,na,TERMINATED,Tufts University,
NCT05611749,Duloxetine 60 MG,DRUG,Acute Post-operative Pain; Chronic Post Operative Pain; Narcotic Use; Opioid Use; Opioid Addiction,phase2,TERMINATED,Scripps Health,
NCT05611749,Placebo,OTHER,Acute Post-operative Pain; Chronic Post Operative Pain; Narcotic Use; Opioid Use; Opioid Addiction,phase2,TERMINATED,Scripps Health,
NCT00557206,Oxaliplatin and Docetaxel,DRUG,Neoplasms; Head and Neck Neoplasms,phase2,TERMINATED,Minneapolis Veterans Affairs Medical Center,
NCT02045433,SABR Boost Therapy,RADIATION,Locally Advanced Cervical Cancer,phase2,TERMINATED,University of Texas Southwestern Medical Center,
NCT03807349,N-Force Screws Augmented with N-Force Blue,DEVICE,Intracapsular Proximal Femur Fracture; Garden Grade I Subcapital Fracture of Femoral Neck; Garden Grade II Subcapital Fracture of Femoral Neck,na,TERMINATED,Zimmer Biomet,
NCT02818049,Bronchoalveolar Lavage,PROCEDURE,Bronchioalveolar Lavage,na,TERMINATED,"University Hospital, Limoges",
NCT01445821,Peripheral Blood Stem Cells,BIOLOGICAL,"Scleroderma, Systemic",phase3,TERMINATED,Northwestern University,
NCT01445821,Cyclophosphamide,DRUG,"Scleroderma, Systemic",phase3,TERMINATED,Northwestern University,
NCT01445821,Mesna,DRUG,"Scleroderma, Systemic",phase3,TERMINATED,Northwestern University,
NCT01445821,rATG,DRUG,"Scleroderma, Systemic",phase3,TERMINATED,Northwestern University,
NCT01445821,Methylprednisolone,DRUG,"Scleroderma, Systemic",phase3,TERMINATED,Northwestern University,
NCT01445821,Filgrastim,DRUG,"Scleroderma, Systemic",phase3,TERMINATED,Northwestern University,
NCT01445821,Fludarabine,DRUG,"Scleroderma, Systemic",phase3,TERMINATED,Northwestern University,
NCT03057314,Amorphous Calcium Carbonate,DRUG,"Solid Malignancies, With or Without Lung Metastases",phase1,TERMINATED,Amorphical Ltd.,
NCT02161016,map3,DEVICE,"Foot Deformities, Acquired; Disorder of Joint of Foot; Fracture of Foot; Deformity of Bone",phase4,TERMINATED,RTI Surgical,
NCT03644706,ADV7103,DRUG,Distal Renal Tubular Acidosis,phase3,TERMINATED,Advicenne Pharma,
NCT03644706,Placebo,DRUG,Distal Renal Tubular Acidosis,phase3,TERMINATED,Advicenne Pharma,
NCT03535506,Palbociclib,DRUG,DCIS,phase2,TERMINATED,Georgetown University,
NCT00498433,Aliskiren,DRUG,Hypertension; Abdominal Obesity,phase2,TERMINATED,Novartis,
NCT00498433,Amlodipine,DRUG,Hypertension; Abdominal Obesity,phase2,TERMINATED,Novartis,
NCT00498433,Placebo of Aliskiren,DRUG,Hypertension; Abdominal Obesity,phase2,TERMINATED,Novartis,
NCT00498433,Placebo of amlodipine,DRUG,Hypertension; Abdominal Obesity,phase2,TERMINATED,Novartis,
NCT00752206,Saracatinib,DRUG,Osteosarcoma,phase2,TERMINATED,Sarcoma Alliance for Research through Collaboration,
NCT00752206,Placebo,DRUG,Osteosarcoma,phase2,TERMINATED,Sarcoma Alliance for Research through Collaboration,
NCT00127595,"gemcitabine, oxaliplatin",DRUG,"Carcinoma, Transitional Cell",phase2,TERMINATED,"Gustave Roussy, Cancer Campus, Grand Paris",
NCT04435795,Normal Saline intranasal and placebo inhaler,DRUG,COVID 19,phase2; phase3,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT04435795,Ciclesonide,DRUG,COVID 19,phase2; phase3,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT04435795,Ciclesonide nasal,DRUG,COVID 19,phase2; phase3,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT00942539,Midazolam,DRUG,Pain; Anxiety,phase2,TERMINATED,Rambam Health Care Campus,
NCT04379375,Nudge,BEHAVIORAL,Health Behavior; COVID-19,na,TERMINATED,Medical College of Wisconsin,
NCT00691821,Standard Dressings,OTHER,Skin Ulcer; Pressure Ulcer,phase4,TERMINATED,St. Joseph's Healthcare Hamilton,
NCT00691821,"Negative Pressure Wound Therapy (Vacuum-Assisted Closure System [V.A.C.® Therapy™, KCI Medical Canada Inc., Mississauga, Ontario])",DEVICE,Skin Ulcer; Pressure Ulcer,phase4,TERMINATED,St. Joseph's Healthcare Hamilton,
NCT01442714,Azacitidine,DRUG,Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS),phase2,TERMINATED,Stanford University,
NCT01442714,Lenalidomide,DRUG,Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS),phase2,TERMINATED,Stanford University,
NCT00961714,OsseoFix Spinal Fracture Reduction System,DEVICE,Vertebral Compression Fractures,na,TERMINATED,"Alphatec Spine, Inc.",
NCT02509338,Electrode deep brain stimulation (Monopolar DBS Lead Model 09064-40cm),DEVICE,Generalized Dystonia; Segmental Dystonia; Tardive Dystonia,na,TERMINATED,"University Hospital, Montpellier",
NCT00522938,CHR-2797 (tosedostat),DRUG,"Carcinoma, Non-Small-Cell Lung",phase1; phase2,TERMINATED,Chroma Therapeutics,
NCT00522938,erlotinib,DRUG,"Carcinoma, Non-Small-Cell Lung",phase1; phase2,TERMINATED,Chroma Therapeutics,
NCT04497038,Cabozantinib,DRUG,Advanced Adult Hepatocellular Carcinoma,phase1; phase2,TERMINATED,University of Michigan Rogel Cancer Center,
NCT01612806,PriMatrix,DEVICE,Venous Stasis Ulcer,na,TERMINATED,Integra LifeSciences Corporation,
NCT01612806,PriMatrix Ag,DEVICE,Venous Stasis Ulcer,na,TERMINATED,Integra LifeSciences Corporation,
NCT01612806,moist wound therapy,PROCEDURE,Venous Stasis Ulcer,na,TERMINATED,Integra LifeSciences Corporation,
NCT06682806,PRT3789,DRUG,Advanced Solid Tumor; Esophageal Cancer; Metastatic Solid Tumor; Non-small Cell Lung Cancers; SMARCA4 Gene Mutation,phase2,TERMINATED,Prelude Therapeutics,
NCT06682806,pembrolizumab,DRUG,Advanced Solid Tumor; Esophageal Cancer; Metastatic Solid Tumor; Non-small Cell Lung Cancers; SMARCA4 Gene Mutation,phase2,TERMINATED,Prelude Therapeutics,
NCT00679484,olmesartan medoxomil + candesartan cilexetil placebo,DRUG,Chronic Heart Failure; High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level,phase3,TERMINATED,"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company",
NCT00679484,olmesartan medoxomil placebo + candesartan cilexetil,DRUG,Chronic Heart Failure; High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level,phase3,TERMINATED,"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company",
NCT00022633,gemcitabine hydrochloride,DRUG,Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer,phase2,TERMINATED,SWOG Cancer Research Network,
NCT00022633,paclitaxel,DRUG,Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer,phase2,TERMINATED,SWOG Cancer Research Network,
NCT03940352,HDM201,DRUG,Acute Myeloid Leukemia (AML); High-risk Myelodysplastic Syndrome (MDS),phase1,TERMINATED,Novartis Pharmaceuticals,
NCT03940352,MBG453,BIOLOGICAL,Acute Myeloid Leukemia (AML); High-risk Myelodysplastic Syndrome (MDS),phase1,TERMINATED,Novartis Pharmaceuticals,
NCT03940352,Venetoclax,DRUG,Acute Myeloid Leukemia (AML); High-risk Myelodysplastic Syndrome (MDS),phase1,TERMINATED,Novartis Pharmaceuticals,
NCT03411057,Mindfulness Based Stress Reduction (MBSR),BEHAVIORAL,Rheumatoid Arthritis; Psoriatic Arthritis; Scleroderma,na,TERMINATED,Johns Hopkins University,
NCT03411057,Control,OTHER,Rheumatoid Arthritis; Psoriatic Arthritis; Scleroderma,na,TERMINATED,Johns Hopkins University,
NCT06364657,Eye Exam,OTHER,Sjogren's Syndrome; Dry Eye; Neurotrophic Keratitis,na,TERMINATED,Johns Hopkins University,
NCT04845945,PCV15,BIOLOGICAL,Heart Transplant Infection Prevention,na,TERMINATED,Montefiore Medical Center,
NCT04030572,Clonidine Pill,DRUG,Neuro-Degenerative Disease; Cancer,early_phase1,TERMINATED,Weill Medical College of Cornell University,
NCT02357472,dehydroepiandrosterone,OTHER,Infertility,na,TERMINATED,ShangHai Ji Ai Genetics & IVF Institute,
NCT04713995,Dietary recommendations,OTHER,Axial Spondyloarthritis,na,TERMINATED,Viome,
NCT01391039,Perflutren lipid microsphere,DRUG,Ductal Carcinoma In-situ,na,TERMINATED,Sunnybrook Health Sciences Centre,
NCT02130401,TNM Device,DEVICE,Type 2 Diabetes,na,TERMINATED,Scion NeuroStim,
NCT01856101,BEZ235,DRUG,Carcinoma Transitional Cell,phase2,TERMINATED,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,
NCT00358657,Allogeneic Bone Marrow Transplantation,PROCEDURE,Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00358657,Cyclophosphamide,DRUG,Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00358657,Fludarabine Phosphate,DRUG,Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00358657,Laboratory Biomarker Analysis,OTHER,Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00358657,Mycophenolate Mofetil,DRUG,Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00358657,Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation,PROCEDURE,Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00358657,Sirolimus,DRUG,Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00358657,Tacrolimus,DRUG,Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT00358657,Total-Body Irradiation,RADIATION,Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder,phase2,TERMINATED,Fred Hutchinson Cancer Center,
NCT05041101,Eribulin Mesylate,DRUG,Breast Inflammatory Carcinoma; Recurrent Breast Inflammatory Carcinoma; Stage IV Breast Inflammatory Carcinoma,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT05041101,Grapiprant,DRUG,Breast Inflammatory Carcinoma; Recurrent Breast Inflammatory Carcinoma; Stage IV Breast Inflammatory Carcinoma,phase1; phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01884675,Ambrisentan 5 mg,DRUG,Hypertension,phase3,TERMINATED,GlaxoSmithKline,
NCT01884675,Placebo,DRUG,Hypertension,phase3,TERMINATED,GlaxoSmithKline,
NCT01866657,Vasoconstrictor Agents,DRUG,Hypoxia,na,TERMINATED,University Hospitals Cleveland Medical Center,
NCT01866657,Head/neck repositioning,OTHER,Hypoxia,na,TERMINATED,University Hospitals Cleveland Medical Center,
NCT01866657,Increase ETCO2,OTHER,Hypoxia,na,TERMINATED,University Hospitals Cleveland Medical Center,
NCT01866657,IV fluid bolus,OTHER,Hypoxia,na,TERMINATED,University Hospitals Cleveland Medical Center,
NCT01866657,Additional anesthesia,DRUG,Hypoxia,na,TERMINATED,University Hospitals Cleveland Medical Center,
NCT01866657,RBC transfusion,BIOLOGICAL,Hypoxia,na,TERMINATED,University Hospitals Cleveland Medical Center,
NCT01866657,Increase FiO2,DRUG,Hypoxia,na,TERMINATED,University Hospitals Cleveland Medical Center,
NCT00454701,Alefacept exposure,DRUG,Psoriasis,na,TERMINATED,Astellas Pharma Inc,
NCT00928772,CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM,DEVICE,Anxiety,phase4,TERMINATED,University of Oklahoma,
NCT00928772,MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY,DRUG,Anxiety,phase4,TERMINATED,University of Oklahoma,
NCT00928772,NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED,OTHER,Anxiety,phase4,TERMINATED,University of Oklahoma,
NCT04271475,Macitentan,DRUG,Chronic Thromboembolic Pulmonary Hypertension,phase3,TERMINATED,Actelion,
NCT04271475,Placebo,DRUG,Chronic Thromboembolic Pulmonary Hypertension,phase3,TERMINATED,Actelion,
NCT01284075,Guided imagery and music therapy,BEHAVIORAL,Ovarian Cancer; Uterine Cancer,na,TERMINATED,University of Minnesota,
NCT01284075,White Noise,BEHAVIORAL,Ovarian Cancer; Uterine Cancer,na,TERMINATED,University of Minnesota,
NCT01284075,No intervention,OTHER,Ovarian Cancer; Uterine Cancer,na,TERMINATED,University of Minnesota,
NCT05394857,SHR-1314,DRUG,Active Moderate to Severe Graves' Orbitopathy,phase2,TERMINATED,"Suzhou Suncadia Biopharmaceuticals Co., Ltd.",
NCT03876977,Robotic laparoscopic decompression of pudendal nerve entrapment,PROCEDURE,Robotic Decompression,na,TERMINATED,"University Hospital, Strasbourg, France",
NCT04206501,Medtronic ICD with Opti Vol-Monitor,DEVICE,Ischemic and Non-ischemic Cardiomyopathy,na,TERMINATED,University of Rochester,
NCT03215030,Modakafusp alfa,DRUG,Multiple Myeloma,phase1; phase2,TERMINATED,Teva Branded Pharmaceutical Products R&D LLC,
NCT03215030,Dexamethasone,DRUG,Multiple Myeloma,phase1; phase2,TERMINATED,Teva Branded Pharmaceutical Products R&D LLC,
NCT03320265,PC-mAb,DRUG,Arterial Inflammation; Cardiovascular Diseases,phase2,TERMINATED,Athera Biotechnologies AB,
NCT03320265,Placebo,DRUG,Arterial Inflammation; Cardiovascular Diseases,phase2,TERMINATED,Athera Biotechnologies AB,
NCT03168919,Fractionated Radiation,RADIATION,Glioma,na,TERMINATED,University of Alabama at Birmingham,
NCT03168919,Temozolomide,DRUG,Glioma,na,TERMINATED,University of Alabama at Birmingham,
NCT03168919,MRI,DEVICE,Glioma,na,TERMINATED,University of Alabama at Birmingham,
NCT00674128,Cyanoacrylate tissue adhesive (Dermabond),DEVICE,Cardiovascular Disease,na,TERMINATED,Mayo Clinic,
NCT00674128,Polyglactin 910 suture (Vicryl),DEVICE,Cardiovascular Disease,na,TERMINATED,Mayo Clinic,
NCT04377165,Gamification,BEHAVIORAL,COVID; Influenza; Gastroenteritis,na,TERMINATED,The University of Queensland,
NCT04377165,Newsfeed function,BEHAVIORAL,COVID; Influenza; Gastroenteritis,na,TERMINATED,The University of Queensland,
NCT02188719,Anti-Thymocyte Globulin - Rabbit,BIOLOGICAL,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,darTreg Infusion,BIOLOGICAL,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Everolimus,DRUG,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Tacrolimus,DRUG,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Mycophenolate mofetil,DRUG,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Prednisone,DRUG,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Acetaminophen,DRUG,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Diphenhydramine,DRUG,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Anti-Infective Prophylaxis,DRUG,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Leukapheresis,PROCEDURE,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Blood draws,PROCEDURE,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Liver biopsies,PROCEDURE,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT02188719,Liver transplantation,PROCEDURE,Liver Transplantation,phase1,TERMINATED,National Institute of Allergy and Infectious Diseases (NIAID),
NCT04374019,Ivermectin,DRUG,COVID; Sars-CoV2,phase2,TERMINATED,Susanne Arnold,
NCT04374019,Camostat Mesilate,DRUG,COVID; Sars-CoV2,phase2,TERMINATED,Susanne Arnold,
NCT04374019,Artemesia annua,OTHER,COVID; Sars-CoV2,phase2,TERMINATED,Susanne Arnold,
NCT04374019,Artesunate,DRUG,COVID; Sars-CoV2,phase2,TERMINATED,Susanne Arnold,
NCT03116165,Modified prolonged exposure therapy,BEHAVIORAL,Post Traumatic Stress Disorder,na,TERMINATED,Karolinska Institutet,
NCT03116165,Attention control,BEHAVIORAL,Post Traumatic Stress Disorder,na,TERMINATED,Karolinska Institutet,
NCT01110330,Placebo cream,DRUG,Tinea Pedis,phase3,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT01110330,Ketoconazole 2% cream (formulation F012) (Nizoral),DRUG,Tinea Pedis,phase3,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT01110330,Ketoconazole 2% cream (formulation F126),DRUG,Tinea Pedis,phase3,TERMINATED,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
NCT03051165,Hypoglossal Nerve Stimulation Treatment Withdrawal,DEVICE,Obstructive Sleep Apnea,na,TERMINATED,Emory University,
NCT03790865,Livoletide,DRUG,Prader-Willi Syndrome; Hyperphagia,phase2; phase3,TERMINATED,Millendo Therapeutics SAS,
NCT03790865,Placebo,DRUG,Prader-Willi Syndrome; Hyperphagia,phase2; phase3,TERMINATED,Millendo Therapeutics SAS,
NCT01992029,Clinical evaluation,OTHER,Amyotrophic Lateral Sclerosis; ALS,na,TERMINATED,"University Hospital, Bordeaux",
NCT01992029,Muscular biopsy,PROCEDURE,Amyotrophic Lateral Sclerosis; ALS,na,TERMINATED,"University Hospital, Bordeaux",
NCT01992029,Lumbar puncture,PROCEDURE,Amyotrophic Lateral Sclerosis; ALS,na,TERMINATED,"University Hospital, Bordeaux",
NCT01992029,Blood sampling,PROCEDURE,Amyotrophic Lateral Sclerosis; ALS,na,TERMINATED,"University Hospital, Bordeaux",
NCT01992029,Neurological assessments,OTHER,Amyotrophic Lateral Sclerosis; ALS,na,TERMINATED,"University Hospital, Bordeaux",
NCT01992029,Neuro-muscular biopsy and lumbar puncture,PROCEDURE,Amyotrophic Lateral Sclerosis; ALS,na,TERMINATED,"University Hospital, Bordeaux",
NCT01992029,Muscular biopsy,PROCEDURE,Amyotrophic Lateral Sclerosis; ALS,na,TERMINATED,"University Hospital, Bordeaux",
NCT01992029,Blood sample,PROCEDURE,Amyotrophic Lateral Sclerosis; ALS,na,TERMINATED,"University Hospital, Bordeaux",
NCT01992029,Cervical spinal cord and brain MRI,DEVICE,Amyotrophic Lateral Sclerosis; ALS,na,TERMINATED,"University Hospital, Bordeaux",
NCT02873702,Dexlansoprazole,DRUG,Erosive Esophagitis,phase3,TERMINATED,Takeda,
NCT02873702,Lansoprazole,DRUG,Erosive Esophagitis,phase3,TERMINATED,Takeda,
NCT02873702,Placebo,DRUG,Erosive Esophagitis,phase3,TERMINATED,Takeda,
NCT02356237,No episiotomy,OTHER,Anal Sphincter Injury,na,TERMINATED,Lena Sagi-Dain,
NCT04010045,Endovascular Treatment of PAD,DEVICE,Peripheral Artery Disease,na,TERMINATED,Ra Medical Systems,
NCT06219551,Mobile messages via What's App,OTHER,Tobacco Use Cessation,na,TERMINATED,Recep Tayyip Erdogan University Training and Research Hospital,
NCT03203837,Plasma collection,OTHER,Hepatocellular Carcinoma,na,TERMINATED,Northwestern University,
NCT01288131,Cyclosporine combine with mycophenolate mofetil,DRUG,Anti-r-HuEpo Associated PRCA Subjects,phase3,TERMINATED,Chulalongkorn University,
NCT01288131,Cyclophosphamide + pred,DRUG,Anti-r-HuEpo Associated PRCA Subjects,phase3,TERMINATED,Chulalongkorn University,
NCT06086054,Navigation and EMR referral to childcare facility,BEHAVIORAL,Cervical Dysplasia,na,TERMINATED,University of Texas Southwestern Medical Center,
NCT04804254,ABBV-623,DRUG,B-cell Lymphoma,phase1,TERMINATED,AbbVie,
NCT04804254,ABBV-992,DRUG,B-cell Lymphoma,phase1,TERMINATED,AbbVie,
NCT03658551,Fluorescein,OTHER,"Cirrhosis, Liver",na,TERMINATED,Johannes Gutenberg University Mainz,
NCT01093066,optimal TURB,DRUG,Urothelial Carcinoma,phase2,TERMINATED,Centre Hospitalier Universitaire de Saint Etienne,
NCT03936751,CPAP,DEVICE,Obstructive Sleep Apnea; Pulmonary Edema Cardiac Cause,phase4,TERMINATED,University of Sao Paulo,
NCT03936751,Nasal Strips,DEVICE,Obstructive Sleep Apnea; Pulmonary Edema Cardiac Cause,phase4,TERMINATED,University of Sao Paulo,
NCT03563053,EryDex System,OTHER,Ataxia Telangiectasia; Genetic Syndrome,phase3,TERMINATED,Quince Therapeutics S.p.A.,
NCT04425629,casirivimab+imdevimab combination therapy,DRUG,COVID-19,phase3,TERMINATED,Regeneron Pharmaceuticals,
NCT04100629,digital support: text messages,BEHAVIORAL,Stress; Job Stress,na,TERMINATED,Duquesne University,
NCT06567002,MK-6552,DRUG,Healthy,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT00203853,"pillbox, wristwatch",DEVICE,HIV Infections,na,TERMINATED,University of Chicago,
NCT01095237,ProEndoTecc Vascular Graft,DEVICE,Peripheral Arterial Disease; Peripheral Vascular Disease,na,TERMINATED,NonWoTecc Medical GmbH,
NCT03926637,Multiple Sclerosis Performance Test (MSPT),OTHER,Multiple Sclerosis,na,TERMINATED,Biogen,
NCT01714037,Debio 0932,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,Debiopharm International SA,
NCT01714037,Cisplatin,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,Debiopharm International SA,
NCT01714037,Pemetrexed,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,Debiopharm International SA,
NCT01714037,Gemcitabine,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,Debiopharm International SA,
NCT01714037,Docetaxel,DRUG,Non-small Cell Lung Cancer,phase1,TERMINATED,Debiopharm International SA,
NCT00671645,"capecitabine, bevacizumab",DRUG,Rectal Cancer,phase2,TERMINATED,Austrian Breast & Colorectal Cancer Study Group,
NCT00796445,GSK 2132231A,DRUG,Melanoma,phase3,TERMINATED,GlaxoSmithKline,
NCT00796445,Placebo,DRUG,Melanoma,phase3,TERMINATED,GlaxoSmithKline,
NCT00023920,bevacizumab,BIOLOGICAL,"Blastic Phase Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive",phase2,TERMINATED,National Cancer Institute (NCI),
NCT00023920,idarubicin,DRUG,"Blastic Phase Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive",phase2,TERMINATED,National Cancer Institute (NCI),
NCT00023920,cytarabine,DRUG,"Blastic Phase Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive",phase2,TERMINATED,National Cancer Institute (NCI),
NCT00634582,paricalcitol,DRUG,Metastatic Cancer; Prostate Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT00634582,immunoenzyme technique,OTHER,Metastatic Cancer; Prostate Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT00634582,laboratory biomarker analysis,OTHER,Metastatic Cancer; Prostate Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT00634582,dual x-ray absorptometry,PROCEDURE,Metastatic Cancer; Prostate Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT00634582,quality-of-life assessment,PROCEDURE,Metastatic Cancer; Prostate Cancer,phase2,TERMINATED,Wake Forest University Health Sciences,
NCT00499382,Nuclear Medicine Cardiac Scan,PROCEDURE,Advanced Cancers,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00499382,PET/CT Cardiac Scan,PROCEDURE,Advanced Cancers,na,TERMINATED,M.D. Anderson Cancer Center,
NCT00675324,Laxabon,DRUG,Colonoscopy; Bowel Preparation,na,TERMINATED,Karolinska Institutet,
NCT00675324,Fresubin Energy drink,OTHER,Colonoscopy; Bowel Preparation,na,TERMINATED,Karolinska Institutet,
NCT04043910,fNIRS,DEVICE,"Hearing Loss, Unilateral",na,TERMINATED,"University Hospital, Toulouse",
NCT04043910,Speech intelligibility,OTHER,"Hearing Loss, Unilateral",na,TERMINATED,"University Hospital, Toulouse",
NCT04043910,Sound localisation,OTHER,"Hearing Loss, Unilateral",na,TERMINATED,"University Hospital, Toulouse",
NCT04043910,Speech assessments,OTHER,"Hearing Loss, Unilateral",na,TERMINATED,"University Hospital, Toulouse",
NCT04043910,Quality of Life,OTHER,"Hearing Loss, Unilateral",na,TERMINATED,"University Hospital, Toulouse",
NCT05078710,Telitacicept,DRUG,Anti Phospholipid Syndrome,phase2,TERMINATED,Peking Union Medical College Hospital,
NCT01500382,Vibegron,DRUG,Overactive Bladder; Overactive Urinary Bladder,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01500382,Tolterodine ER,DRUG,Overactive Bladder; Overactive Urinary Bladder,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01500382,Placebo (vibegron),OTHER,Overactive Bladder; Overactive Urinary Bladder,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01500382,Placebo (tolterodine ER),OTHER,Overactive Bladder; Overactive Urinary Bladder,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT01500382,Prophylactic Antibiotic,DRUG,Overactive Bladder; Overactive Urinary Bladder,phase1,TERMINATED,Merck Sharp & Dohme LLC,
NCT00193024,Docetaxel,DRUG,Breast Cancer,phase2,TERMINATED,"SCRI Development Innovations, LLC",
NCT00193024,Epirubicin,DRUG,Breast Cancer,phase2,TERMINATED,"SCRI Development Innovations, LLC",
NCT02256982,Gemcitabine,DRUG,Unresectable Intrahepatic Cholangiocarcinoma; Resectable Intrahepatic Cholangiocarcinoma,na,TERMINATED,Massachusetts General Hospital,
NCT02256982,Cisplatin,DRUG,Unresectable Intrahepatic Cholangiocarcinoma; Resectable Intrahepatic Cholangiocarcinoma,na,TERMINATED,Massachusetts General Hospital,
NCT02256982,Surgery,PROCEDURE,Unresectable Intrahepatic Cholangiocarcinoma; Resectable Intrahepatic Cholangiocarcinoma,na,TERMINATED,Massachusetts General Hospital,
NCT02256982,Radiation,RADIATION,Unresectable Intrahepatic Cholangiocarcinoma; Resectable Intrahepatic Cholangiocarcinoma,na,TERMINATED,Massachusetts General Hospital,
NCT01286220,Dilute bleach baths,OTHER,Moderate to Severe Atopic Dermatitis,na,TERMINATED,University of Texas Southwestern Medical Center,
NCT01286220,Water,OTHER,Moderate to Severe Atopic Dermatitis,na,TERMINATED,University of Texas Southwestern Medical Center,
NCT00303420,"Alteplase ""push"" protocol",DRUG,Thrombosis,phase4,TERMINATED,University of Manitoba,
NCT00303420,alteplase dwell arm,DRUG,Thrombosis,phase4,TERMINATED,University of Manitoba,
NCT00816582,Diagnostic Imaging: 18F-FDG PET/CT Scan - Baseline,PROCEDURE,Breast Cancer,na,TERMINATED,British Columbia Cancer Agency,
NCT00816582,Diagnostic Imaging: 18F-FES PET/CT - Baseline,PROCEDURE,Breast Cancer,na,TERMINATED,British Columbia Cancer Agency,
NCT00816582,Diagnostic Imaging: 18F-FES PET/CT - 3 month follow-up,PROCEDURE,Breast Cancer,na,TERMINATED,British Columbia Cancer Agency,
NCT04239482,L-arginine + Nitrate / Nitrite,OTHER,Nitric Oxide; Insulin Sensitivity; Vascular Function; L-arginine; Nitrate / Nitrite,na,TERMINATED,Maastricht University Medical Center,
NCT04239482,Placebo,OTHER,Nitric Oxide; Insulin Sensitivity; Vascular Function; L-arginine; Nitrate / Nitrite,na,TERMINATED,Maastricht University Medical Center,
NCT03646123,brentuximab vedotin,DRUG,Hodgkin Lymphoma,phase2,TERMINATED,Seagen Inc.,
NCT03646123,doxorubicin,DRUG,Hodgkin Lymphoma,phase2,TERMINATED,Seagen Inc.,
NCT03646123,vinblastine,DRUG,Hodgkin Lymphoma,phase2,TERMINATED,Seagen Inc.,
NCT03646123,dacarbazine,DRUG,Hodgkin Lymphoma,phase2,TERMINATED,Seagen Inc.,
NCT03646123,G-CSF,DRUG,Hodgkin Lymphoma,phase2,TERMINATED,Seagen Inc.,
NCT03646123,nivolumab,DRUG,Hodgkin Lymphoma,phase2,TERMINATED,Seagen Inc.,
NCT04258423,Tacrolimus,DRUG,Kidney Failure,phase3,TERMINATED,Indiana University,
NCT04258423,Everolimus,DRUG,Kidney Failure,phase3,TERMINATED,Indiana University,
NCT03626623,Cytal Wound Matrix 1-Layer,DEVICE,"Diabetes; Diabetic Foot; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1",na,TERMINATED,Integra LifeSciences Corporation,
NCT03626623,Standard of Care (SOC),OTHER,"Diabetes; Diabetic Foot; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1",na,TERMINATED,Integra LifeSciences Corporation,
NCT00899197,tamoxifen citrate,DRUG,Breast Cancer,na,TERMINATED,Wake Forest University Health Sciences,
NCT00899197,gene expression analysis,OTHER,Breast Cancer,na,TERMINATED,Wake Forest University Health Sciences,
NCT00899197,protein expression analysis,OTHER,Breast Cancer,na,TERMINATED,Wake Forest University Health Sciences,
NCT00899197,immunoenzyme technique,OTHER,Breast Cancer,na,TERMINATED,Wake Forest University Health Sciences,
NCT00899197,laboratory biomarker analysis,OTHER,Breast Cancer,na,TERMINATED,Wake Forest University Health Sciences,
NCT04411082,IMR-687,DRUG,β Thalassemia,phase2,TERMINATED,"Cardurion Pharmaceuticals, Inc.",
NCT04411082,Placebo,DRUG,β Thalassemia,phase2,TERMINATED,"Cardurion Pharmaceuticals, Inc.",
NCT00739882,Efalizumab - anti CD11a recombinant human monoclonal antibody,DRUG,Chronic Plaque Psoriasis,phase4,TERMINATED,"Merck KGaA, Darmstadt, Germany",
NCT00739882,Placebo,DRUG,Chronic Plaque Psoriasis,phase4,TERMINATED,"Merck KGaA, Darmstadt, Germany",
NCT00473824,Hepatitis C Immune Globulin Intravenous (Human) 5%,BIOLOGICAL,Sequelae of Viral Hepatitis; Transplantation Infection; Evidence of Liver Transplantation,phase2,TERMINATED,"ADMA Biologics, Inc.",
NCT02120482,Combined apheresis,DEVICE,Decreased Immunologic Activity; Antibody-mediated Rejection,na,TERMINATED,Medical University of Vienna,
NCT03140124,Exercise,BEHAVIORAL,Anxiety Disorders; Mood Disorders,na,TERMINATED,Boston University Charles River Campus,
NCT03140124,Worry Stone,BEHAVIORAL,Anxiety Disorders; Mood Disorders,na,TERMINATED,Boston University Charles River Campus,
NCT01175330,Omega-3 fish oil emulsion (Omegaven),DRUG,Ischemic Heart Disease; Atrial Fibrillation,phase3,TERMINATED,Meshalkin Research Institute of Pathology of Circulation,
NCT01175330,Intralipid,DRUG,Ischemic Heart Disease; Atrial Fibrillation,phase3,TERMINATED,Meshalkin Research Institute of Pathology of Circulation,
NCT01014481,"tenofovir, lamivudine, efavirenz",DRUG,HIV Infections; Tuberculosis,phase4,TERMINATED,Bamrasnaradura Infectious Diseases Institute,
NCT04015219,Self retained cryopreserved amniotic membrane,DEVICE,Dry Eye Syndromes,na,TERMINATED,"BioTissue Holdings, Inc",
NCT04015219,lifitegrast ophthalmic solution,OTHER,Dry Eye Syndromes,na,TERMINATED,"BioTissue Holdings, Inc",
NCT01759381,Negative pressure wound therapy (NPWT),DEVICE,Spinal Deformity,na,TERMINATED,Duke University,
NCT02681419,Needle fenestration,PROCEDURE,Glaucoma,phase4,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT02681419,Suture wick,PROCEDURE,Glaucoma,phase4,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT00929630,transsphincteric Seton positioning,PROCEDURE,Anal Fistulas,phase3,TERMINATED,Societa Italiana di Chirurgia ColoRettale,
NCT00929630,glue (Tissucol) treatment,PROCEDURE,Anal Fistulas,phase3,TERMINATED,Societa Italiana di Chirurgia ColoRettale,
NCT00929630,Fistula closing with biological glue,PROCEDURE,Anal Fistulas,phase3,TERMINATED,Societa Italiana di Chirurgia ColoRettale,
NCT00929630,Seton positioning into the fistula tract,PROCEDURE,Anal Fistulas,phase3,TERMINATED,Societa Italiana di Chirurgia ColoRettale,
NCT00226330,Tesaglitazar,DRUG,"Diabetes Mellitus, Type 2",phase3,TERMINATED,AstraZeneca,
NCT00226330,Pioglitazone,DRUG,"Diabetes Mellitus, Type 2",phase3,TERMINATED,AstraZeneca,
NCT00488930,Observational,OTHER,Morbid Obesity; Hyperglycemia; Diabetes Mellitus,na,TERMINATED,"University of California, San Diego",
NCT04590781,XmAb18087,BIOLOGICAL,Merkel Cell Carcinoma; Small Cell Lung Cancer,phase1; phase2,TERMINATED,"Xencor, Inc.",
NCT04590781,XmAb18087 ± Pembrolizumab,DRUG,Merkel Cell Carcinoma; Small Cell Lung Cancer,phase1; phase2,TERMINATED,"Xencor, Inc.",
NCT03893019,MB-CART20.1,BIOLOGICAL,Melanoma (Skin),early_phase1,TERMINATED,Miltenyi Biomedicine GmbH,
NCT03173430,Blinatumomab,DRUG,Multiple Myeloma,early_phase1,TERMINATED,Abramson Cancer Center at Penn Medicine,
NCT00252772,Tesaglitazar,DRUG,Type 2 Diabetes,phase3,TERMINATED,AstraZeneca,
NCT00252772,Dietary and Lifestyle counseling,BEHAVIORAL,Type 2 Diabetes,phase3,TERMINATED,AstraZeneca,
NCT00274495,Rosiglitazone and Pegasys/Ribavirin,DRUG,Chronic Hepatitis C Infection; Fatty Liver,phase4,TERMINATED,Beth Israel Medical Center,
NCT02283619,"None - no intervention, observational study",OTHER,Left Bundle Branch Block,na,TERMINATED,Duke University,
NCT00663819,GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement,DEVICE,Rectal Cancer; Ulcerative Colitis; Familial Adenomatous Polyposis; Diverticulitis,na,TERMINATED,W.L.Gore & Associates,
NCT00663819,Staple line without reinforcement,PROCEDURE,Rectal Cancer; Ulcerative Colitis; Familial Adenomatous Polyposis; Diverticulitis,na,TERMINATED,W.L.Gore & Associates,
NCT04041830,Visit 1,BEHAVIORAL,Normal Weight Adults; Adults With Obesity,na,TERMINATED,"University Hospital, Clermont-Ferrand",
NCT04041830,Visit 2,BEHAVIORAL,Normal Weight Adults; Adults With Obesity,na,TERMINATED,"University Hospital, Clermont-Ferrand",
NCT01403012,Withdrawal of venous blood samples,OTHER,Psoriasis,na,TERMINATED,Technical University of Munich,
NCT05582681,Cepheid POC HCV Viremia (RNA) test,OTHER,Hepatitis C,phase4,TERMINATED,Weill Medical College of Cornell University,
NCT05582681,HCV education from a health care provider,OTHER,Hepatitis C,phase4,TERMINATED,Weill Medical College of Cornell University,
NCT05582681,Glecaprevir and Pibrentasvir,DRUG,Hepatitis C,phase4,TERMINATED,Weill Medical College of Cornell University,
NCT00506012,T2000,DRUG,Myoclonus,phase2,TERMINATED,"Sun Pharmaceutical Industries, Inc.",
NCT01888081,A-dmDT390-bisFv(UCHT1) (Resimmune®),DRUG,Melanoma,phase1; phase2,TERMINATED,Angimmune LLC,
NCT01888081,Ionizing Radiation,RADIATION,Melanoma,phase1; phase2,TERMINATED,Angimmune LLC,
NCT03917719,Edasalonexent,DRUG,Duchenne Muscular Dystrophy,phase3,TERMINATED,Catabasis Pharmaceuticals,
NCT02915081,Blue light,OTHER,Acute Kidney Injury; Liver Injury; Inflammation,na,TERMINATED,University of Pittsburgh,
NCT02531295,Euphorbia kansui extract powder prepared as tea,DRUG,HIV; Human Immunodeficiency Virus,phase1,TERMINATED,"University of California, San Francisco",
NCT01656395,MK-1029,DRUG,Asthma,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01656395,Montelukast 10 mg,DRUG,Asthma,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT01656395,Placebo,DRUG,Asthma,phase2,TERMINATED,Merck Sharp & Dohme LLC,
NCT03868839,Telmisartan Pill,DRUG,Schizophrenia; Schizo Affective Disorder; Treatment-resistant Schizophrenia,phase2,TERMINATED,Xiaoduo Fan,
NCT00977912,Probiotic supplementation,OTHER,Necrotizing Enterocolitis,na,TERMINATED,Société des Produits Nestlé (SPN),
NCT00977912,Milk containing placebo,OTHER,Necrotizing Enterocolitis,na,TERMINATED,Société des Produits Nestlé (SPN),
NCT01761812,MRI with gadofosveset and MR elastography,OTHER,Prostate Cancer,na,TERMINATED,Sunnybrook Health Sciences Centre,
NCT00754767,L-carnitine L-tartrate,DRUG,Breast Cancer; Chemotherapeutic Agent Toxicity; Neurotoxicity,phase4,TERMINATED,HealthPartners Institute,
NCT00754767,placebo,OTHER,Breast Cancer; Chemotherapeutic Agent Toxicity; Neurotoxicity,phase4,TERMINATED,HealthPartners Institute,
NCT02335944,Capmatinib,DRUG,Non Small Cell Lung Cancer,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT02335944,Nazartinib,DRUG,Non Small Cell Lung Cancer,phase1; phase2,TERMINATED,Novartis Pharmaceuticals,
NCT00062699,Zemplar (paricalcitol injection),DRUG,End-Stage Kidney Disease,phase4,TERMINATED,Abbott,
NCT00062699,Calcijex,DRUG,End-Stage Kidney Disease,phase4,TERMINATED,Abbott,
NCT05619432,HMD: Immersive VR,DEVICE,"Vision, Low; Visual Impairment",na,TERMINATED,"University Health Network, Toronto",
NCT00449163,Bevacizumab,BIOLOGICAL,Colorectal Cancer,phase2,TERMINATED,University of Miami,
NCT00449163,Floxuridine,DRUG,Colorectal Cancer,phase2,TERMINATED,University of Miami,
NCT00449163,Irinotecan,DRUG,Colorectal Cancer,phase2,TERMINATED,University of Miami,
NCT00449163,Leucovorin,DRUG,Colorectal Cancer,phase2,TERMINATED,University of Miami,
NCT02119663,Ruxolitinib,DRUG,Pancreatic Cancer,phase3,TERMINATED,Incyte Corporation,
NCT02119663,Placebo,DRUG,Pancreatic Cancer,phase3,TERMINATED,Incyte Corporation,
NCT02119663,Capecitabine,DRUG,Pancreatic Cancer,phase3,TERMINATED,Incyte Corporation,
NCT03258814,Active Supervised Training (AST),BEHAVIORAL,Axial Spondyloarthritis,na,TERMINATED,AbbVie,
NCT03258814,Standard of Care (SOC) Physiotherapy,BEHAVIORAL,Axial Spondyloarthritis,na,TERMINATED,AbbVie,
NCT05553795,Early removal of chest drain,PROCEDURE,Esophageal Cancer,na,TERMINATED,Technische Universität Dresden,
NCT05553795,Chest drain,PROCEDURE,Esophageal Cancer,na,TERMINATED,Technische Universität Dresden,
NCT05366439,AT-752,DRUG,Dengue,phase1,TERMINATED,"Atea Pharmaceuticals, Inc.",
NCT05366439,Placebo Comparator,DRUG,Dengue,phase1,TERMINATED,"Atea Pharmaceuticals, Inc.",
NCT05970575,NE3107,DRUG,Traumatic Brain Injury,phase2,TERMINATED,Neurological Associates of West Los Angeles,
NCT02059057,LVRC System,DEVICE,Emphysema,na,TERMINATED,Boston Scientific Corporation,
NCT00775957,FLT-PET scan,PROCEDURE,Non-Hodgkin's Lymphoma,na,TERMINATED,University of Oklahoma,
NCT00775957,FDG-PET scan,PROCEDURE,Non-Hodgkin's Lymphoma,na,TERMINATED,University of Oklahoma,
NCT00498901,goserelin,DRUG,Breast Cancer,phase2,TERMINATED,University of Washington,
NCT00498901,letrozole,DRUG,Breast Cancer,phase2,TERMINATED,University of Washington,
NCT00498901,leuprolide acetate,DRUG,Breast Cancer,phase2,TERMINATED,University of Washington,
NCT00498901,conventional surgery,PROCEDURE,Breast Cancer,phase2,TERMINATED,University of Washington,
NCT04266301,Sabatolimab,DRUG,"Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic",phase3,TERMINATED,Novartis Pharmaceuticals,
NCT04266301,Azacitidine,DRUG,"Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic",phase3,TERMINATED,Novartis Pharmaceuticals,
NCT04266301,Placebo,DRUG,"Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic",phase3,TERMINATED,Novartis Pharmaceuticals,
NCT02687581,IO-therapy Glasses,DEVICE,Amblyopia,na,TERMINATED,Salus University,
NCT02687581,patch,DEVICE,Amblyopia,na,TERMINATED,Salus University,
NCT05601830,QN-030a,DRUG,Minimal Residual Disease,phase1,TERMINATED,"Institute of Hematology & Blood Diseases Hospital, China",
NCT05601830,Cyclophosphamid,DRUG,Minimal Residual Disease,phase1,TERMINATED,"Institute of Hematology & Blood Diseases Hospital, China",
NCT05601830,Fludarabine,DRUG,Minimal Residual Disease,phase1,TERMINATED,"Institute of Hematology & Blood Diseases Hospital, China",
NCT05601830,Cytarabine,DRUG,Minimal Residual Disease,phase1,TERMINATED,"Institute of Hematology & Blood Diseases Hospital, China",
NCT00847067,Paravertebral block,PROCEDURE,Breast Cancer,na,TERMINATED,Mayo Clinic,
NCT00847067,Sham injections,PROCEDURE,Breast Cancer,na,TERMINATED,Mayo Clinic,
NCT02381067,NuCel with Allograft Bone,OTHER,Spondylosis; Spinal Stenosis; Spondylolisthesis; Intervertebral Disc Disease; Intervertebral Disc Degeneration,na,TERMINATED,"NuTech Medical, Inc",
NCT04311567,Tofacitinib,DRUG,Rheumatoid Arthritis; Interstitial Lung Disease Due to Systemic Disease (Disorder); RA; ILD,phase4,TERMINATED,Vastra Gotaland Region,
NCT04311567,Methotrexate,DRUG,Rheumatoid Arthritis; Interstitial Lung Disease Due to Systemic Disease (Disorder); RA; ILD,phase4,TERMINATED,Vastra Gotaland Region,
NCT04973007,Gadoxetate disodium,DRUG,Oligometastatic Disease; Liver Metastases; Colorectal Cancer,phase4,TERMINATED,"University of Colorado, Denver",
NCT04973007,Gadobenate dimeglumine,DRUG,Oligometastatic Disease; Liver Metastases; Colorectal Cancer,phase4,TERMINATED,"University of Colorado, Denver",
NCT02610244,Modified Cogmed Training,OTHER,Attention Deficit Hyperactivity Disorder,na,TERMINATED,Cambridge Memorial Hospital,
NCT02114944,NIV,DEVICE,Acute Respiratory Failure; Acute on Chronic Respiratory Failure; Dyspnea,na,TERMINATED,Tufts Medical Center,
NCT02114944,CPAP,DEVICE,Acute Respiratory Failure; Acute on Chronic Respiratory Failure; Dyspnea,na,TERMINATED,Tufts Medical Center,
NCT02114944,Standard oxygen,DEVICE,Acute Respiratory Failure; Acute on Chronic Respiratory Failure; Dyspnea,na,TERMINATED,Tufts Medical Center,
NCT02114944,HFNC,DEVICE,Acute Respiratory Failure; Acute on Chronic Respiratory Failure; Dyspnea,na,TERMINATED,Tufts Medical Center,
NCT05313334,GAMBIT Task,BEHAVIORAL,Posttraumatic Stress Disorder,na,TERMINATED,Icahn School of Medicine at Mount Sinai,
NCT04421664,Hydroxychloroquine,DRUG,Corona Virus Infection; SARS-CoV Infection; Coronavirus,phase3,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT04421664,Placebo oral tablet,DRUG,Corona Virus Infection; SARS-CoV Infection; Coronavirus,phase3,TERMINATED,McGill University Health Centre/Research Institute of the McGill University Health Centre,
NCT02669264,ADCT-402,DRUG,Acute Lymphoblastic Leukemia,phase1,TERMINATED,ADC Therapeutics S.A.,
NCT00789399,Fondaparinux,DRUG,Deep Vein Thrombosis; Coronary Artery Bypass Surgery; Venous Thromboembolism,na,TERMINATED,Prairie Education and Research Cooperative,
NCT00789399,Placebo,OTHER,Deep Vein Thrombosis; Coronary Artery Bypass Surgery; Venous Thromboembolism,na,TERMINATED,Prairie Education and Research Cooperative,
NCT03769532,Pembrolizumab,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,Technische Universität Dresden,
NCT03769532,Azacitidine,DRUG,Acute Myeloid Leukemia,phase2,TERMINATED,Technische Universität Dresden,
NCT01891695,39.6 Gy radiation,RADIATION,Oropharyngeal Squamous Cell Carcinoma (OPSCCA); HPV (Human Papillomavirus)-Associated,na,TERMINATED,"Paul W. Read, MD",
NCT02890875,Ethanol lock,OTHER,Catheter-Related Infections,na,TERMINATED,Stanford University,
NCT02890875,Heparin lock,OTHER,Catheter-Related Infections,na,TERMINATED,Stanford University,
NCT04246619,Pregabalin,DRUG,Painful Diabetic Peripheral Neuropathy,phase4,TERMINATED,KRKA,
NCT04246619,Duloxetine,DRUG,Painful Diabetic Peripheral Neuropathy,phase4,TERMINATED,KRKA,
NCT00265928,bortezomib,DRUG,Lymphoma,phase2,TERMINATED,University of Virginia,
NCT00265928,rituximab,DRUG,Lymphoma,phase2,TERMINATED,University of Virginia,
NCT00265928,antibody therapy,PROCEDURE,Lymphoma,phase2,TERMINATED,University of Virginia,
NCT00265928,biological therapy,PROCEDURE,Lymphoma,phase2,TERMINATED,University of Virginia,
NCT00265928,enzyme inhibitor therapy,PROCEDURE,Lymphoma,phase2,TERMINATED,University of Virginia,
NCT00265928,monoclonal antibody therapy,PROCEDURE,Lymphoma,phase2,TERMINATED,University of Virginia,
NCT00567528,Ibuprofen,DRUG,Soft Tissue Injury,na,TERMINATED,Akron Children's Hospital,
NCT00567528,ibuprofen,DRUG,Soft Tissue Injury,na,TERMINATED,Akron Children's Hospital,
NCT01503528,Motor Sparing Nerve Block,PROCEDURE,Knee Joint Arthritis; Knee Joint Arthroplasty,phase4,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT01503528,Peri-articular Catheters,PROCEDURE,Knee Joint Arthritis; Knee Joint Arthroplasty,phase4,TERMINATED,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,
NCT03166800,Mitoquinone,DRUG,Multiple Sclerosis; Fatigue,phase1; phase2,TERMINATED,Oregon Health and Science University,
NCT03166800,Mitoquinone,DRUG,Multiple Sclerosis; Fatigue,phase1; phase2,TERMINATED,Oregon Health and Science University,
NCT03166800,Placebo,DRUG,Multiple Sclerosis; Fatigue,phase1; phase2,TERMINATED,Oregon Health and Science University,
NCT02872792,Early mobilisation with cyclo ergometer,DEVICE,Sepsis,na,TERMINATED,"University Hospital, Rouen",
NCT02872792,Standard physiotherapy,OTHER,Sepsis,na,TERMINATED,"University Hospital, Rouen",
NCT02784834,dimethyl fumarate,DRUG,Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma,phase1,TERMINATED,Michael Choi,
NCT02002234,Hemicraniotomy,PROCEDURE,Infarction,na,TERMINATED,University of the Philippines,
NCT02002234,Standard medical treatment,PROCEDURE,Infarction,na,TERMINATED,University of the Philippines,
NCT02311764,Carboplatin,DRUG,Prostatic Neoplasm,phase2,TERMINATED,Aurelius Omlin,
NCT00780832,Dietary Caffeine reduction,BEHAVIORAL,Overactive Bladder,na,TERMINATED,IWK Health Centre,
NCT00780832,Anticholinergic medication,DRUG,Overactive Bladder,na,TERMINATED,IWK Health Centre,
NCT01018563,MORAb-003,DRUG,Epithelial Ovarian Cancer,phase2,TERMINATED,Morphotek,
NCT01757496,Cough Assist,DEVICE,Bronchiolitis; Respiratory Syncytial Virus,na,TERMINATED,"University Hospital, Antwerp",
NCT06241573,Spesolimab,DRUG,Hidradenitis Suppurativa (HS),phase2; phase3,TERMINATED,Boehringer Ingelheim,
NCT00056056,bexarotene,DRUG,Lymphoma,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00056056,methoxypsoralen,DRUG,Lymphoma,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT00056056,UV light therapy,PROCEDURE,Lymphoma,phase3,TERMINATED,European Organisation for Research and Treatment of Cancer - EORTC,
NCT01949831,Assessment of functional ability in combination with follow-up at home,OTHER,Geriatric Disorder,na,TERMINATED,Aarhus University Hospital,
NCT00593931,fMRI,OTHER,"Diagnosis, Psychiatric",na,TERMINATED,"University of California, Davis",
NCT00927953,MGAWN1,BIOLOGICAL,West Nile Neuroinvasive Disease; West Nile Virus Infection; Encephalitis; Meningitis; Acute Flaccid Paralysis; West Nile Fever,phase2,TERMINATED,MacroGenics,
NCT00927953,Placebo - normal saline,BIOLOGICAL,West Nile Neuroinvasive Disease; West Nile Virus Infection; Encephalitis; Meningitis; Acute Flaccid Paralysis; West Nile Fever,phase2,TERMINATED,MacroGenics,
NCT05427045,home - exercise program,OTHER,Multiple Sclerosis; Back Pain,na,TERMINATED,University of Arkansas,
NCT03738800,CD5789 Cream 200 µg/g,DRUG,Lamellar Ichthyosis,phase2,TERMINATED,Mayne Pharma International Pty Ltd,
NCT03738800,CD5789 Cream 100 µg/g,DRUG,Lamellar Ichthyosis,phase2,TERMINATED,Mayne Pharma International Pty Ltd,
NCT03738800,CD5789 Cream Vehicle,DRUG,Lamellar Ichthyosis,phase2,TERMINATED,Mayne Pharma International Pty Ltd,
NCT00337792,oxycodone + lorazepam versus fentanyl + midazolam,DRUG,Undesired Pregnancy,na,TERMINATED,Planned Parenthood League of Massachusetts,
NCT02735512,Cytology Specimen Collection Procedure,OTHER,No Evidence of Disease; Stage II Bladder Cancer; Stage III Bladder Cancer; Stage IVA Bladder Cancer; Stage IVB Bladder Cancer,na,TERMINATED,University of Southern California,
NCT02735512,Laboratory Biomarker Analysis,OTHER,No Evidence of Disease; Stage II Bladder Cancer; Stage III Bladder Cancer; Stage IVA Bladder Cancer; Stage IVB Bladder Cancer,na,TERMINATED,University of Southern California,
NCT00456612,CyberKnife,PROCEDURE,Glioblastoma Multiforme,phase1; phase2,TERMINATED,Beth Israel Deaconess Medical Center,
NCT00820612,Indomethacin,DRUG,Post-ERCP Pancreatitis,phase4,TERMINATED,University of Michigan,
NCT00820612,Placebo suppositories,OTHER,Post-ERCP Pancreatitis,phase4,TERMINATED,University of Michigan,
NCT01362712,[F18]CP-18 Injection,RADIATION,Breast Cancer,phase1,TERMINATED,Siemens Molecular Imaging,
NCT02249481,Adductor Canal catheter delivering 0.0625% L- Bupivacaine,PROCEDURE,Total Knee Replacement,na,TERMINATED,University Hospital Plymouth NHS Trust,
NCT02249481,Femoral nerve catheter delivering 0.0625% L- Bupivacaine,PROCEDURE,Total Knee Replacement,na,TERMINATED,University Hospital Plymouth NHS Trust,
NCT05510128,Pharmacist management,OTHER,Cystitis Acute,na,TERMINATED,"University Hospital, Angers",
NCT00824928,Cryoablation / Cryotherapy,PROCEDURE,Recurrent Prostate Cancer,na,TERMINATED,"University of Colorado, Denver",
NCT03380507,Triple therapy group,DRUG,Septic Shock; Critical Illness,phase2; phase3,TERMINATED,Hamad Medical Corporation,
NCT05238207,BBI-001,DRUG,Hereditary Hemochromatosis,phase1,TERMINATED,Bond Biosciences,
NCT05238207,Original Fibre Metamucil,OTHER,Hereditary Hemochromatosis,phase1,TERMINATED,Bond Biosciences,
NCT02926092,Observation,OTHER,Retinitis Pigmentosa,na,TERMINATED,Shire,
NCT02354144,Carrageenan-based gel,OTHER,Human Papillomavirus Infection,phase2; phase3,TERMINATED,McGill University,
NCT02354144,Control gel,OTHER,Human Papillomavirus Infection,phase2; phase3,TERMINATED,McGill University,
NCT05911334,ROADE Program,BEHAVIORAL,Bulimia Nervosa; Anorexia Nervosa; Binge-Eating Disorder; Avoidant/Restrictive Food Intake Disorder,na,TERMINATED,University of New Mexico,
NCT05220098,TAK-280,DRUG,Unresectable Locally Advanced or Metastatic Cancer,phase1; phase2,TERMINATED,Takeda,
NCT05709093,Lemzoparlimab+Azacitidine (AZA),DRUG,Myelodysplastic Syndromes(MDS),phase3,TERMINATED,"TJ Biopharma Co., Ltd.",
NCT05709093,Azacitidine (AZA),DRUG,Myelodysplastic Syndromes(MDS),phase3,TERMINATED,"TJ Biopharma Co., Ltd.",
NCT02694393,sodium nitrite,DRUG,Cystic Fibrosis,phase1; phase2,TERMINATED,"Schmidhofer, Mark, MD",
NCT06528093,BI 765883,DRUG,Pancreatic Ductal Adenocarcinoma,phase1,TERMINATED,Boehringer Ingelheim,
NCT06528093,gemcitabine,DRUG,Pancreatic Ductal Adenocarcinoma,phase1,TERMINATED,Boehringer Ingelheim,
NCT06528093,nab-paclitaxel,DRUG,Pancreatic Ductal Adenocarcinoma,phase1,TERMINATED,Boehringer Ingelheim,
NCT04325893,Hydroxychloroquine,DRUG,Coronavirus,phase3,TERMINATED,"University Hospital, Angers",
NCT04325893,Placebo,DRUG,Coronavirus,phase3,TERMINATED,"University Hospital, Angers",
NCT02209506,MLN3126,DRUG,Safety; Tolerability; Pharmacokinetics; Pharmacodynamics,phase1,TERMINATED,Takeda,
NCT02209506,MLN3126 Matched Placebo,DRUG,Safety; Tolerability; Pharmacokinetics; Pharmacodynamics,phase1,TERMINATED,Takeda,
NCT01151904,brimonidine 0.2%/timolol 0.5% fixed combination ophthalmic solution,DRUG,"Glaucoma, Angle-Closure",phase4,TERMINATED,Allergan,
NCT01151904,latanoprost,DRUG,"Glaucoma, Angle-Closure",phase4,TERMINATED,Allergan,
NCT03704285,Propofol,DRUG,Anesthesia; Burned; Operative Wound,na,TERMINATED,"Victor Contreras, MSN",
NCT03704285,BIS,DEVICE,Anesthesia; Burned; Operative Wound,na,TERMINATED,"Victor Contreras, MSN",
NCT03863665,A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci,DEVICE,Intracerebral Hemorrhage,na,TERMINATED,"University College, London",
NCT01820507,Optiflow (Fisher&Paykel),DEVICE,Respiratory Failure,na,TERMINATED,Althaia Xarxa Assistencial Universitària de Manresa,
NCT01820507,Nasal cannulae or controlled oxygen concentration mask,DEVICE,Respiratory Failure,na,TERMINATED,Althaia Xarxa Assistencial Universitària de Manresa,
NCT05568407,Avelumab,DRUG,Bladder Cancer,na,TERMINATED,Pfizer,
NCT02431364,Verdinexor,DRUG,Healthy,phase1,TERMINATED,Karyopharm Therapeutics Inc,
NCT02431364,Placebo,OTHER,Healthy,phase1,TERMINATED,Karyopharm Therapeutics Inc,
NCT03383198,Liposomal bupivacaine right injection,DRUG,"Pain, Postoperative",phase4,TERMINATED,Prisma Health-Upstate,
NCT03383198,Liposomal bupivacaine left injection,DRUG,"Pain, Postoperative",phase4,TERMINATED,Prisma Health-Upstate,
NCT00939887,PF-04455242,DRUG,Bipolar Disorder; Depression,phase1,TERMINATED,Pfizer,
NCT01514721,Travoprost/Timolol Maleate BAK-Free Fixed Combination,DRUG,Glaucoma,phase4,TERMINATED,Alcon Research,
NCT03804814,Motivational Interviewing Training,BEHAVIORAL,Hepatitis C,na,TERMINATED,Nova Scotia Health Authority,
NCT05129384,B. infantis EVC001 or Lactose Placebo,OTHER,Infantile Colic,na,TERMINATED,"Evolve BioSystems, Inc.",
NCT00505947,infliximab,DRUG,Diabetic Macular Edema; Visual Acuity; Diabetic Retinopathy,phase3,TERMINATED,University of Athens,
NCT00505947,placebo,DRUG,Diabetic Macular Edema; Visual Acuity; Diabetic Retinopathy,phase3,TERMINATED,University of Athens,
NCT01191749,Alemtuzumab,DRUG,Leukemia,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT06536426,Knee Isometric Program (KIP),BEHAVIORAL,Anterior Knee Pain Syndrome,na,TERMINATED,The Methodist Hospital Research Institute,
NCT00516685,Recombinant Human rEGF-P64K/Montanide Vaccine,BIOLOGICAL,Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV,phase2; phase3,TERMINATED,Bioven Sdn. Bhd.,
NCT02102230,Cognitive Behavioral Therapy for Insomnia (CBT-I),BEHAVIORAL,Marijuana Abuse; Sleep Initiation and Maintenance Disorders,na,TERMINATED,VA Office of Research and Development,
NCT02102230,Cognitive Behavioral Therapy for Insomnia Plus Mobile App (CBT-I-MA),BEHAVIORAL,Marijuana Abuse; Sleep Initiation and Maintenance Disorders,na,TERMINATED,VA Office of Research and Development,
NCT02102230,Desensitization Treatment for Insomnia,BEHAVIORAL,Marijuana Abuse; Sleep Initiation and Maintenance Disorders,na,TERMINATED,VA Office of Research and Development,
NCT04321928,Personalized health education,BEHAVIORAL,SARS-CoV-2; Coronavirus; COVID-19; 2019-nCoV; 2019nCoV,na,TERMINATED,University of Pecs,
NCT04321928,General health education,BEHAVIORAL,SARS-CoV-2; Coronavirus; COVID-19; 2019-nCoV; 2019nCoV,na,TERMINATED,University of Pecs,
NCT02504892,Everolimus,DRUG,Renal Cancer; Birt-Hogg-Dube Syndrome,phase2,TERMINATED,National Cancer Institute (NCI),
NCT04594811,NT-I7,DRUG,Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC),phase1,TERMINATED,NeoImmuneTech,
NCT04594811,Nivolumab,DRUG,Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC),phase1,TERMINATED,NeoImmuneTech,
NCT04605744,Smoking cessation counseling,BEHAVIORAL,Chronic Pain; Smoking,na,TERMINATED,The Cooper Health System,
NCT05976334,[14C] Subasumstat,DRUG,Solid Tumors,phase1,TERMINATED,Takeda,
NCT05976334,Subasumstat,DRUG,Solid Tumors,phase1,TERMINATED,Takeda,
NCT00415909,Imatinib Mesylate (IM),DRUG,Chronic Myelogenous Leukemia,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00415909,TALL-104 cells,DRUG,Chronic Myelogenous Leukemia,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT00814463,MMSE,BEHAVIORAL,"Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,Duke University,
NCT00814463,QOL via FACT-Br,BEHAVIORAL,"Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,Duke University,
NCT00814463,MRI,PROCEDURE,"Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,Duke University,
NCT00814463,Post-operative SRS,RADIATION,"Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific",phase2,TERMINATED,Duke University,
NCT02247687,Protease inhibitor,DRUG,HIV-1 Infection; Treatment Resistant Disorders; Viremia,phase3,TERMINATED,"ANRS, Emerging Infectious Diseases",
NCT02247687,Isentress® (raltegravir),DRUG,HIV-1 Infection; Treatment Resistant Disorders; Viremia,phase3,TERMINATED,"ANRS, Emerging Infectious Diseases",
NCT02247687,Counseling arm,OTHER,HIV-1 Infection; Treatment Resistant Disorders; Viremia,phase3,TERMINATED,"ANRS, Emerging Infectious Diseases",
NCT01732887,Cognitive fitness training,OTHER,Deafness; Speech Intelligibility,na,TERMINATED,Aaron Newman,
NCT01767987,Ranolazine,DRUG,Acute Coronary Syndrome,phase2,TERMINATED,Harvey Hahn,
NCT01767987,Placebo,DRUG,Acute Coronary Syndrome,phase2,TERMINATED,Harvey Hahn,
NCT05451693,Outreach-ER,BEHAVIORAL,Dementia,na,TERMINATED,HealthPartners Institute,
NCT00437749,CBT-1,DRUG,Non-Small Cell Lung Cancer,phase3,TERMINATED,CBA Research,
NCT00437749,Placebo,OTHER,Non-Small Cell Lung Cancer,phase3,TERMINATED,CBA Research,
NCT01561001,SENSIMED Triggerfish®,DEVICE,Primary Open Angle Glaucoma,na,TERMINATED,Sensimed AG,
NCT00178581,Glutamine,DRUG,Trauma; Critical Illness; Shock,phase1,TERMINATED,"The University of Texas Health Science Center, Houston",
NCT00748228,dietary sodium,OTHER,Postural Tachycardia Syndrome,na,TERMINATED,Vanderbilt University,
NCT00748228,dietary sodium,OTHER,Postural Tachycardia Syndrome,na,TERMINATED,Vanderbilt University,
NCT00748228,dietary sodium,OTHER,Postural Tachycardia Syndrome,na,TERMINATED,Vanderbilt University,
NCT04221828,NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension,DRUG,"Prostate Cancer; Prostate Adenocarcinoma; Prostate Cancer Adenocarcinoma; Prostatic Neoplasm; Urogenital Neoplasms; Genital Neoplasms, Male; Localized Cancer",phase2,TERMINATED,"NanOlogy, LLC",
NCT02688465,Apomorphine,DRUG,Parkinson's Disease,phase4,TERMINATED,Fondation Ophtalmologique Adolphe de Rothschild,
NCT03760965,sotagliflozin (SAR439954),DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Sanofi,
NCT03760965,placebo,DRUG,Type 2 Diabetes Mellitus,phase3,TERMINATED,Sanofi,
NCT02010567,CRLX101,DRUG,Rectal Cancer,phase1; phase2,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT02010567,Capecitabine,DRUG,Rectal Cancer,phase1; phase2,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT02010567,Radiotherapy,RADIATION,Rectal Cancer,phase1; phase2,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT02010567,Surgery,PROCEDURE,Rectal Cancer,phase1; phase2,TERMINATED,UNC Lineberger Comprehensive Cancer Center,
NCT03636100,Cryoballoon ablation,DEVICE,Atrial Fibrillation,na,TERMINATED,Saint Luke's Health System,
NCT02256007,Paper and Pencil Assessments,OTHER,Stroke,na,TERMINATED,Cedars-Sinai Medical Center,
NCT04441892,QTc Meter,DEVICE,Long QT Syndrome,na,TERMINATED,Mayo Clinic,
NCT04450836,Regorafenib then Trifluridine/Tipiracil,DRUG,Metastatic Colorectal Cancer,phase2,TERMINATED,UNICANCER,
NCT04450836,Trifluridine/Tipiracil then Regorafenib,DRUG,Metastatic Colorectal Cancer,phase2,TERMINATED,UNICANCER,
NCT03430544,Cariprazine Oral Capsule [Vraylar],DRUG,Cocaine Use Disorder,phase2,TERMINATED,"Anna Rose Childress, Ph.D.",
NCT03430544,Placebo oral capsule,DRUG,Cocaine Use Disorder,phase2,TERMINATED,"Anna Rose Childress, Ph.D.",
NCT03734744,Vitamin D3,OTHER,Vitamin D Deficiency; Cystic Fibrosis,na,TERMINATED,University of Southern California,
NCT05948709,Incentives for Physical Activity,OTHER,Physical Activity,na,TERMINATED,"University of California, San Diego",
NCT02749409,Parecoxib,DRUG,Parecoxib; Rib Fractures,phase3,TERMINATED,Chang Gung Memorial Hospital,
NCT02749409,Morphine,DRUG,Parecoxib; Rib Fractures,phase3,TERMINATED,Chang Gung Memorial Hospital,
NCT03818399,SUBLOCADE,DRUG,Opioid Use Disorder,phase3,TERMINATED,Virginia Commonwealth University,
NCT03274999,TrueTear™ Application,DEVICE,Dry Eye Syndromes,na,TERMINATED,Allergan,
NCT02418598,Cohort1,OTHER,Parkinson Disease,phase1; phase2,TERMINATED,Jichi Medical University,
NCT02418598,Cohort2,OTHER,Parkinson Disease,phase1; phase2,TERMINATED,Jichi Medical University,
NCT00885963,sapacitabine,DRUG,Non-small Cell Lung Cancer,phase2,TERMINATED,"Cyclacel Pharmaceuticals, Inc.",
NCT06268821,FreeStyle Libre 2 Flash Glucose Monitoring System,DEVICE,Type 2 Diabetes Treated With Insulin,na,TERMINATED,Abbott Diabetes Care,
NCT02902484,Nintedanib,DRUG,Cancer of Pancreas,phase1; phase2,TERMINATED,University of Texas Southwestern Medical Center,
NCT03107052,Fremanezumab,DRUG,Cluster Headache,phase3,TERMINATED,"Teva Branded Pharmaceutical Products R&D, Inc.",
NCT01952847,Placebo,OTHER,Advanced Cancers,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01952847,Glutamine,DRUG,Advanced Cancers,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT01952847,Questionnaires,BEHAVIORAL,Advanced Cancers,phase3,TERMINATED,M.D. Anderson Cancer Center,
NCT04955249,Dexmedetomidine,DRUG,Elderly; Hip Fracture Surgery; Patient-controlled Analgesia; Dexmedetomidine; Postoperative Delirium,phase4,TERMINATED,Peking University First Hospital,
NCT04955249,Placebo,DRUG,Elderly; Hip Fracture Surgery; Patient-controlled Analgesia; Dexmedetomidine; Postoperative Delirium,phase4,TERMINATED,Peking University First Hospital,
NCT01310738,Antimoniate of N-methylglucamine,DRUG,Visceral Leishmaniasis,phase4,TERMINATED,University of Brasilia,
NCT01310738,amphotericin B deoxycholate,DRUG,Visceral Leishmaniasis,phase4,TERMINATED,University of Brasilia,
NCT01310738,Liposomal amphotericin B,DRUG,Visceral Leishmaniasis,phase4,TERMINATED,University of Brasilia,
NCT01310738,Liposomal amphotericin B,DRUG,Visceral Leishmaniasis,phase4,TERMINATED,University of Brasilia,
NCT01310738,Antimoniate of N-methylglucamine,DRUG,Visceral Leishmaniasis,phase4,TERMINATED,University of Brasilia,
NCT06768658,TAK-951,DRUG,Nausea and Vomitting,phase1,TERMINATED,Takeda,
NCT06768658,TAK-951 Placebo,DRUG,Nausea and Vomitting,phase1,TERMINATED,Takeda,
NCT03820648,Alexis,DEVICE,Surgical Site Infection,na,TERMINATED,Azienda Ospedaliera Universitaria Integrata Verona,
NCT03820648,Standard 3M™ Steri-Drape 2,DEVICE,Surgical Site Infection,na,TERMINATED,Azienda Ospedaliera Universitaria Integrata Verona,
NCT02736448,Capecitabine,DRUG,Gastro-entero-pancreatic Neuroendocrine Tumors,phase2,TERMINATED,Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS,
NCT02736448,Lu-PRRT,DRUG,Gastro-entero-pancreatic Neuroendocrine Tumors,phase2,TERMINATED,Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS,
NCT02736448,SS-LAR,DRUG,Gastro-entero-pancreatic Neuroendocrine Tumors,phase2,TERMINATED,Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS,
NCT01861665,Marcaine- 0.25%,DRUG,Post-operative Pain,na,TERMINATED,Weill Medical College of Cornell University,
NCT01861665,Marcaine 0.25%.,DRUG,Post-operative Pain,na,TERMINATED,Weill Medical College of Cornell University,
NCT03563365,Replenix Power of 3 Cream with resveratrol,OTHER,Acne Vulgaris,phase4,TERMINATED,Yardley Dermatology Associates,
NCT03563365,"Adapalene and Benzoyl peroxide gel, 0.1%/2.5%",DRUG,Acne Vulgaris,phase4,TERMINATED,Yardley Dermatology Associates,
NCT04460807,Exemestane,DRUG,Ovarian Cancer,phase3,TERMINATED,Ente Ospedaliero Ospedali Galliera,
NCT04460807,Placebo oral tablet,OTHER,Ovarian Cancer,phase3,TERMINATED,Ente Ospedaliero Ospedali Galliera,
NCT02004392,EVP-6124,DRUG,Alzheimer's Disease; Dementia,phase3,TERMINATED,FORUM Pharmaceuticals Inc,
NCT03121534,Blinatumomab,DRUG,Hematopoietic/Lymphoid Cancer; Richter's Transformation,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT03121534,Dexamethasone,DRUG,Hematopoietic/Lymphoid Cancer; Richter's Transformation,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT03121534,Ibrutinib,DRUG,Hematopoietic/Lymphoid Cancer; Richter's Transformation,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT03121534,Nivolumab,DRUG,Hematopoietic/Lymphoid Cancer; Richter's Transformation,phase2,TERMINATED,M.D. Anderson Cancer Center,
NCT01397734,Arsenic trioxide,DRUG,Chronic Myelogenous Leukemia,phase1,TERMINATED,Beth Israel Deaconess Medical Center,
NCT04231032,Asynchronous dual chamber pacing (DOO) with paced ventricular activation,OTHER,Hypertrophic Cardiomyopathy,na,TERMINATED,Barts & The London NHS Trust,
NCT04231032,Asynchronous atrial pacing (AOO) with intrinsic ventricular activation,OTHER,Hypertrophic Cardiomyopathy,na,TERMINATED,Barts & The London NHS Trust,
NCT05242432,Ad26/protein preF RSV Vaccine,BIOLOGICAL,Respiratory Syncytial Virus Prevention,phase3,TERMINATED,Janssen Pharmaceutical K.K.,
NCT05242432,Placebo,OTHER,Respiratory Syncytial Virus Prevention,phase3,TERMINATED,Janssen Pharmaceutical K.K.,
NCT01673984,Decapeptyl® SR 22.5mg,DRUG,Prostate Cancer,phase4,TERMINATED,Ipsen,
NCT01673984,Decapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mg,DRUG,Prostate Cancer,phase4,TERMINATED,Ipsen,
NCT03581084,N-acetylcysteine,DRUG,Asthma,phase4,TERMINATED,"University of California, San Francisco",
NCT03516084,ZL-2306(nirapairb),DRUG,Extensive-stage Small Cell Lung Cancer,phase3,TERMINATED,"Zai Lab (Shanghai) Co., Ltd.",
NCT03516084,Placebo,DRUG,Extensive-stage Small Cell Lung Cancer,phase3,TERMINATED,"Zai Lab (Shanghai) Co., Ltd.",
NCT05843149,Manual Therapy/Exercises,BEHAVIORAL,Chronic Low-back Pain,na,TERMINATED,"Charite University, Berlin, Germany",
NCT05843149,Physiotherapy/Back School,BEHAVIORAL,Chronic Low-back Pain,na,TERMINATED,"Charite University, Berlin, Germany",
NCT00282438,Autologous hematopoietic stem cell transplantation,BIOLOGICAL,Sarcoidosis,phase1; phase2,TERMINATED,Northwestern University,
NCT00282438,Allogeneic stem cell transplantation,BIOLOGICAL,Sarcoidosis,phase1; phase2,TERMINATED,Northwestern University,
NCT04159701,LY3454738,DRUG,Chronic Spontaneous Urticaria,phase2,TERMINATED,Eli Lilly and Company,
NCT04159701,Placebo,DRUG,Chronic Spontaneous Urticaria,phase2,TERMINATED,Eli Lilly and Company,
NCT01410201,Dexamethasone Intravitreal Implant,DRUG,Epiretinal Membrane; Macular Edema,na,TERMINATED,Barnes Retina Institute,
NCT05462912,custom foot orthotic,DEVICE,Arthropathy of Ankle or Foot,na,TERMINATED,"University of California, Davis",
